PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Adam, D				Adam, D			Royal Institution's director blasts scientific sexism	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					453	453						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466806				2022-12-28	WOS:000179611600011
J	Brumfiel, G				Brumfiel, G			Cosmology - It all adds up	NATURE			English	Editorial Material							POLARIZATION											Kovac JM, 2002, NATURE, V420, P772, DOI 10.1038/nature01269; Leitch EM, 2002, NATURE, V420, P763, DOI 10.1038/nature01271; SMOOT GF, 1992, ASTROPHYS J, V396, pL1, DOI 10.1086/186504; Zaldarriaga M, 2002, NATURE, V420, P747, DOI 10.1038/420747a	4	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					731	732		10.1038/420731a	http://dx.doi.org/10.1038/420731a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490906				2022-12-28	WOS:000179897300014
J	Adam, D				Adam, D			Field trials excluded from UK crop appraisal	NATURE			English	News Item																		Gura T, 2001, NATURE, V412, P760, DOI 10.1038/35090645; 2002, NATURE, V419, P327	2	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					453	453						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466806				2022-12-28	WOS:000179611600010
J	Brumfiel, G				Brumfiel, G			Antihydrogen - Holding up a mirror to physics' world view	NATURE			English	Editorial Material																		Amoretti M, 2002, NATURE, V419, P456, DOI 10.1038/nature01096; Gabrielse G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.213401; Gabrielse G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.233401	3	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					731	731		10.1038/420731b	http://dx.doi.org/10.1038/420731b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490906	Bronze			2022-12-28	WOS:000179897300015
J	Aldhous, P				Aldhous, P			Agribiotech - More heat than light	NATURE			English	Editorial Material																		Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Kaplinsky N, 2002, NATURE, V416, P601, DOI 10.1038/nature739; Metz M, 2002, NATURE, V416, P600, DOI 10.1038/nature738; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Quist D, 2002, NATURE, V416, P602, DOI 10.1038/nature740; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Surridge C, 2002, NATURE, V416, P576, DOI 10.1038/416576a; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	9	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					730	731		10.1038/420730a	http://dx.doi.org/10.1038/420730a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490904				2022-12-28	WOS:000179897300013
J	Cohen, J				Cohen, J			The immunopathogenesis of sepsis	NATURE			English	Review							PEPTIDOGLYCAN RECOGNITION PROTEINS; MIGRATION-INHIBITORY FACTOR; MITOGENIC EXOTOXIN-Z; TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION; CONFERS RESPONSIVENESS; LIPOTEICHOIC ACID; IMMUNE-RESPONSE; INNATE IMMUNITY; DROSOPHILA TOLL	Sepsis is a condition that results from a harmful or damaging host response to infection. Many of the components of the innate immune response that are normally concerned with host defences against infection can, under some circumstances, cause cell and tissue damage and hence multiple organ failure, the clinical hallmark of sepsis. Because of the high mortality of sepsis in the face of standard treatment, many efforts have been made to improve understanding of the dysregulation of the host response in sepsis. As a result, much has been learnt of the basic principles governing bacterial-host interactions, and new opportunities for therapeutic intervention have been revealed.	Brighton & Sussex Med Sch, Brighton BN1 9PH, E Sussex, England	University of Brighton; University of Sussex	Cohen, J (corresponding author), Brighton & Sussex Med Sch, Westlain House, Brighton BN1 9PH, E Sussex, England.	j.cohen@bsms.ac.uk	Reis-Silva, Thiago M./E-6318-2013					Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Cohen J, 1999, BRIT MED BULL, V55, P212, DOI 10.1258/0007142991902222; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Dinges MM, 2001, INFECT IMMUN, V69, P1256, DOI 10.1128/IAI.69.3.1256-1264.2001; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Herwald H, 1998, NAT MED, V4, P298, DOI 10.1038/nm0398-298; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Inohara N, 2002, CURR OPIN MICROBIOL, V5, P76, DOI 10.1016/S1369-5274(02)00289-8; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142; KOTB M, 1995, CLIN MICROBIOL REV, V8, P411, DOI 10.1128/CMR.8.3.411; LANDMANN R, 1995, J INFECT DIS, V171, P639, DOI 10.1093/infdis/171.3.639; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Lavoie PM, 1999, IMMUNOL REV, V168, P257, DOI 10.1111/j.1600-065X.1999.tb01297.x; Leturcq DJ, 1996, J CLIN INVEST, V98, P1533, DOI 10.1172/JCI118945; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Majcherczyk PA, 1999, J BIOL CHEM, V274, P12537, DOI 10.1074/jbc.274.18.12537; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Muller-Alouf H, 2001, INFECT IMMUN, V69, P4141, DOI 10.1128/IAI.69.6.4141-4145.2001; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Norrby-Teglund A, 2001, J INFECT DIS, V184, P853, DOI 10.1086/323443; Okajima K, 2001, IMMUNOL REV, V184, P258, DOI 10.1034/j.1600-065x.2001.1840123.x; Opal SM, 2002, CRIT CARE, V6, P125; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Papageorgiou AC, 2000, TRENDS MICROBIOL, V8, P369, DOI 10.1016/S0966-842X(00)01793-5; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Seydel U, 2000, EUR J BIOCHEM, V267, P3032; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sparwasser T, 1997, NATURE, V386, P336, DOI 10.1038/386336a0; Stuber F, 2001, J AM SOC NEPHROL, V12, pS60; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Unnikrishnan M, 2002, J IMMUNOL, V169, P2561, DOI 10.4049/jimmunol.169.5.2561; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VANDERPOLL T, 1999, SEPSIS, V3, P103; Vasselon T, 2002, INFECT IMMUN, V70, P1033, DOI 10.1128/IAI.70.3.1033-1041.2002; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang JE, 2000, INFECT IMMUN, V68, P3965, DOI 10.1128/IAI.68.7.3965-3970.2000; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang H, 2001, SHOCK, V15, P247, DOI 10.1097/00024382-200115040-00001; Yu B, 1997, J CLIN INVEST, V99, P315, DOI 10.1172/JCI119160	74	2016	2213	9	241	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					885	891		10.1038/nature01326	http://dx.doi.org/10.1038/nature01326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490963				2022-12-28	WOS:000179897300071
J	Kubo, T; Ohtani, E; Kondo, T; Kato, T; Toma, M; Hosoya, T; Sano, A; Kikegawa, T; Nagase, T				Kubo, T; Ohtani, E; Kondo, T; Kato, T; Toma, M; Hosoya, T; Sano, A; Kikegawa, T; Nagase, T			Metastable garnet in oceanic crust at the top of the lower mantle	NATURE			English	Article							SUBDUCTED BASALTIC CRUST; PHASE-TRANSFORMATIONS; SPINEL TRANSFORMATION; PEROVSKITE; TRANSITION; DISCONTINUITY; LITHOSPHERE; GENERATION; MECHANISMS; BOUNDARY	As oceanic tectonic plates descend into the Earth's lower mantle, garnet (in the basaltic crust) and silicate spinel (in the underlying peridotite layer) each decompose to form silicate perovskite-the 'post-garnet' and 'post-spinel' transformations, respectively. Recent phase equilibrium studies(1,2) have shown that the post-garnet transformation occurs in the shallow lower mantle in a cold slab, rather than at similar to800 km depth as earlier studies indicated(3-6), with the implication that the subducted basaltic crust is unlikely to become buoyant enough to delaminate as it enters the lower mantle. But here we report results of a kinetic study of the post-garnet transformation, obtained from in situ X-ray observations using sintered diamond anvils, which show that the kinetics of the post-garnet transformation are significantly slower than for the post-spinel transformation(7). Although metastable spinel quickly breaks down at a temperature of 1,000 K, we estimate that metastable garnet should survive of the order of 10 Myr even at 1,600 K. Accordingly, the expectation of where the subducted oceanic crust would be buoyant spans a much wider depth range at the top of the lower mantle, when transformation kinetics are taken into account.	Tohoku Univ, Grad Sch Sci, Inst Mineral Petrol & Econ Geol, Sendai, Miyagi 9808578, Japan; Univ Tsukuba, Inst Geosci, Tsukuba, Ibaraki 3058571, Japan; High Energy Accelerator Res Org, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; Tohoku Univ Museum, Sendai, Miyagi 9808578, Japan	Tohoku University; University of Tsukuba; High Energy Accelerator Research Organization (KEK); Tohoku University	Kubo, T (corresponding author), Tohoku Univ, Grad Sch Sci, Inst Mineral Petrol & Econ Geol, Sendai, Miyagi 9808578, Japan.	tkubo@mail.cc.tohoku.ac.jp	Sano-Furukawa, Asami/D-6895-2015; Ohtani, Eiji/AAD-8011-2019	Sano-Furukawa, Asami/0000-0002-1652-1623; Ohtani, Eiji/0000-0001-8631-0736				Akaogi M, 1999, PHYS EARTH PLANET IN, V114, P129, DOI 10.1016/S0031-9201(99)00039-4; ANDERSON OL, 1989, J APPL PHYS, V65, P1534, DOI 10.1063/1.342969; CAHN JW, 1956, ACTA METALL MATER, V4, P449, DOI 10.1016/0001-6160(56)90041-4; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Faust J, 1996, GEOPHYS RES LETT, V23, P3377, DOI 10.1029/96GL03027; Hirose K, 2001, EARTH PLANET SC LETT, V184, P567, DOI 10.1016/S0012-821X(00)00354-X; Hirose K, 1999, NATURE, V397, P53, DOI 10.1038/16225; IRIFUNE T, 1993, EARTH PLANET SC LETT, V117, P101, DOI 10.1016/0012-821X(93)90120-X; Irifune T, 1998, GEOPH MONOG SERIES, V101, P1; Karato S, 1997, PHYS EARTH PLANET IN, V99, P103, DOI 10.1016/S0031-9201(96)03198-6; KATO T, 1995, J GEOPHYS RES-SOL EA, V100, P20475, DOI 10.1029/95JB01688; KATO T, 1992, GEOPHYS MONOGR SER, V67, P33; KAWAI N, 1970, REV SCI INSTRUM, V41, P1178, DOI 10.1063/1.1684753; KAWAKATSU H, 1994, NATURE, V371, P301, DOI 10.1038/371301a0; KESSON SE, 1994, NATURE, V372, P767, DOI 10.1038/372767a0; Kirby SH, 1996, REV GEOPHYS, V34, P261, DOI 10.1029/96RG01050; Kondo T., 1993, HIGH TEMP HIGH PRESS, V25, P105; Kubo T, 2000, GEOPHYS RES LETT, V27, P807, DOI 10.1029/1999GL008430; Kubo T, 2002, PHYS EARTH PLANET IN, V129, P153, DOI 10.1016/S0031-9201(01)00270-9; Miyajima N, 1999, PHYS EARTH PLANET IN, V116, P117, DOI 10.1016/S0031-9201(99)00127-2; Niu FL, 1997, GEOPHYS RES LETT, V24, P429, DOI 10.1029/97GL00216; Oguri K, 2000, PHYS EARTH PLANET IN, V122, P175, DOI 10.1016/S0031-9201(00)00178-3; OHTANI E, 1989, REV SCI INSTRUM, V60, P922, DOI 10.1063/1.1140344; Ono S, 2001, EARTH PLANET SC LETT, V190, P57, DOI 10.1016/S0012-821X(01)00375-2; PAWLEY AR, 1993, SCIENCE, V261, P1024, DOI 10.1126/science.261.5124.1024; POIRIER JP, 1986, NATURE, V321, P603, DOI 10.1038/321603a0; Riedel MR, 1997, EARTH PLANET SC LETT, V148, P27, DOI 10.1016/S0012-821X(97)00016-2; RINGWOOD AE, 1994, PHYS EARTH PLANET IN, V86, P5, DOI 10.1016/0031-9201(94)05058-9	28	37	37	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					803	806		10.1038/nature01281	http://dx.doi.org/10.1038/nature01281			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490946				2022-12-28	WOS:000179897300053
J	He, K; Rimm, EB; Merchant, A; Rosner, BA; Stampfer, MJ; Willett, WC; Ascherio, A				He, K; Rimm, EB; Merchant, A; Rosner, BA; Stampfer, MJ; Willett, WC; Ascherio, A			Fish consumption and risk of stroke in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYUNSATURATED FATTY-ACIDS; FOOD FREQUENCY QUESTIONNAIRE; ISCHEMIC-HEART-DISEASE; EICOSAPENTAENOIC ACID; PLATELET-FUNCTION; CORONARY-DISEASE; DOSE-RESPONSE; VITAMIN-E; REPRODUCIBILITY; INHIBITION	Context The effect of fish consumption or long-chain omega-3 polyunsaturated fatty acid (PUFA) intake on risk of stroke remains uncertain. Objective To examine the relation of fish consumption and long-chain omega-3 PUFA intake and risk of stroke in men. Design and Setting The Health Professional Follow-up Study, a US prospective cohort study with 12 years of follow-up. Participants A total of 43 671 men aged 40 to 75 years who completed a detailed and validated semiquantitative food frequency questionnaire and who were free of cardiovascular disease at baseline in 1986. Main Outcome Measure Relative risk (RR) of stroke by subtype based on cumulative average fish consumption or long-chain omega-3 PUFA intake, ascertained in 1986, 1990, and 1994. Results We documented 608 strokes during the 12-year follow-up period, including 377 ischemic, 106 hemorrhagic, and 125 unclassified strokes. Compared with men who consumed fish less than once per month, the multivariate RR of ischemic stroke was significantly lower among those who ate fish 1 to 3 times per month (RR, 0.57; 95% confidence interval [Cl], 0.35-0.95). However, a higher frequency of fish intake was not associated with further risk reduction; the RR was 0.54 (95% Cl, 0.31-0.94) for men who consumed fish 5 or more times per week. This lack of linearity was confirmed by spline analyses. By dichotomized fish intake, the multivariate RR for men who consumed fish at least once per month compared with those who ate fish less than once per month was 0.56 (95% Cl, 0.38-0.83) for ischemic stroke and 1.36 (95% Cl, 0.48-3.82) for hemorrhagic stroke. The inverse association between fish intake and risk of ischemic stroke was not materially modified by use of aspirin. No significant associations were found between fish or long-chain omega-3 PUFA intake and risk of hemorrhagic stroke. Conclusion Our findings suggest that eating fish once per month or more can reduce the risk of ischemic stroke in men.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	He, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 335 Huntington Ave, Boston, MA 02115 USA.	khe@hsph.harvard.edu	Merchant, Anwar/B-5233-2009		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL35464] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Ascherio A, 1999, ANN INTERN MED, V130, P963, DOI 10.7326/0003-4819-130-12-199906150-00003; ASCHERIO A, 1995, NEW ENGL J MED, V332, P977, DOI 10.1056/NEJM199504133321501; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; BJERREGAARD P, 1988, INT J EPIDEMIOL, V17, P514, DOI 10.1093/ije/17.3.514; *CONS FOOD EC I, 1976, HDB 8 SER; De Caterina R, 1998, J LIPID RES, V39, P1062; DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829, DOI 10.1161/01.ATV.14.11.1829; DRISS F, 1984, THROMB RES, V36, P389, DOI 10.1016/0049-3848(84)90295-0; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Gillum RF, 1996, ARCH INTERN MED, V156, P537, DOI 10.1001/archinte.156.5.537; Greenland S, 1999, AM J EPIDEMIOL, V149, P1077; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; HARRIS WS, 1989, J LIPID RES, V30, P785; HIRAI A, 1980, LANCET, V2, P1132; HUI R, 1992, J HYPERTENS, V10, P1145, DOI 10.1097/00004872-199210000-00006; HUNTER DJ, 1992, AM J EPIDEMIOL, V135, P418, DOI 10.1093/oxfordjournals.aje.a116302; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Kang JX, 2000, AM J CLIN NUTR, V71, p202S, DOI 10.1093/ajcn/71.1.202S; KELI SO, 1994, STROKE, V25, P328, DOI 10.1161/01.STR.25.2.328; KNAPP HR, 1986, NEW ENGL J MED, V314, P937, DOI 10.1056/NEJM198604103141501; KRISTENSEN SD, 1989, J INTERN MED, V225, P141, DOI 10.1111/j.1365-2796.1989.tb01448.x; KROMANN N, 1980, ACTA MED SCAND, V208, P401; LEAF A, 1988, NEW ENGL J MED, V318, P549, DOI 10.1056/NEJM198803033180905; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; MCKEIGUE P, 1994, LANCET, V343, P1445, DOI 10.1016/S0140-6736(94)92575-5; MEYDANI M, 1991, J NUTR, V121, P484, DOI 10.1093/jn/121.4.484; MORRIS MC, 1995, AM J EPIDEMIOL, V142, P166, DOI 10.1093/oxfordjournals.aje.a117615; NESTEL PJ, 1990, ANNU REV NUTR, V10, P149, DOI 10.1146/annurev.nu.10.070190.001053; Orencia AJ, 1996, STROKE, V27, P204, DOI 10.1161/01.STR.27.2.204; PHILLIPSON BE, 1985, NEW ENGL J MED, V312, P1210, DOI 10.1056/NEJM198505093121902; RAPER NR, 1992, J AM COLL NUTR, V11, P304; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Roche HM, 2000, AM J CLIN NUTR, V71, p232S, DOI 10.1093/ajcn/71.1.232s; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; STEINBERG D, 1992, CIRCULATION, V85, P2338, DOI 10.1161/01.CIR.85.6.2337; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; *USDA, 1993, COMP FOODS RAW PROC; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Walker AE, 1981, STROKE S1, V12, P13; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; YAMORI Y, 1985, J NUTR SCI VITAMINOL, V31, P417, DOI 10.3177/jnsv.31.417; Zhang JJ, 1999, PREV MED, V28, P520, DOI 10.1006/pmed.1998.0472	50	238	243	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2002	288	24					3130	3136		10.1001/jama.288.24.3130	http://dx.doi.org/10.1001/jama.288.24.3130			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628QQ	12495393	Bronze			2022-12-28	WOS:000180008200023
J	Marcus, DM; Grollman, AP				Marcus, DM; Grollman, AP			Botanical medicines - The need for new regulations.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DIETARY-SUPPLEMENTS; HERBAL MEDICINES; PATENT MEDICINES; CHINESE		Baylor Coll Med, Houston, TX 77030 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA	Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Marcus, DM (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.							Ang-Lee MK, 2001, JAMA-J AM MED ASSOC, V286, P208, DOI 10.1001/jama.286.2.208; [Anonymous], 2002, Med Lett Drugs Ther, V44, P84; Arlt VM, 2002, MUTAGENESIS, V17, P265, DOI 10.1093/mutage/17.4.265; Au AM, 2000, B ENVIRON CONTAM TOX, V65, P112, DOI 10.1007/s001280000102; Blendon RJ, 2001, ARCH INTERN MED, V161, P805, DOI 10.1001/archinte.161.6.805; *CONS COM, 2002, LAB TEST RES; De Smet PAGM, 2002, NEW ENGL J MED, V347, P2046, DOI 10.1056/NEJMra020398; Ernst E, 1998, AM J MED, V104, P170, DOI 10.1016/S0002-9343(97)00397-5; Ernst E, 2002, J INTERN MED, V252, P107, DOI 10.1046/j.1365-2796.2002.00999.x; Ernst E, 2002, EUR J CLIN PHARMACOL, V57, P891, DOI 10.1007/s00228-001-0400-y; *FDA CTR FOOD SAF, 2002, DIET SUPPL WARN SAF; Fugh-Berman A, 2000, LANCET, V355, P134, DOI 10.1016/S0140-6736(99)06457-0; Fugh-Berman A, 2000, LANCET, V355, P1020; Goldman P, 2001, ANN INTERN MED, V135, P594, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00010; Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502; HILTS PJ, 2002, NY TIMES        0616, pC1; *HLTH CAN, 2002, HLTH CAN REQ REC CER; *JAP MIN HLTH LAB, 2002, REP JAP MIN HLTH LAB; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Ko RJ, 1998, NEW ENGL J MED, V339, P847, DOI 10.1056/NEJM199809173391214; Litovitz TL, 2002, AM J EMERG MED, V20, P391, DOI 10.1053/ajem.2002.34955; Luyckx VA, 2002, AM J KIDNEY DIS, V39, DOI 10.1053/ajkd.2002.31424; Marks LS, 2002, UROLOGY, V60, P369, DOI 10.1016/S0090-4295(02)01913-1; MENCIMER S, 2001, WASHINGTON MONTH SEP, P27; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; *OFF INSP GEN, 2001, OEI010000180; ROBBERS JE, 1999, TYLERS HERBS CHOICE; Samenuk D, 2002, MAYO CLIN PROC, V77, P12, DOI 10.4065/77.1.12; Sovak M, 2002, J NATL CANCER I, V94, P1275, DOI 10.1093/jnci/94.17.1275; Talalay P, 2001, ACAD MED, V76, P238, DOI 10.1097/00001888-200103000-00010; 2002, JAPAN TIMES     0721; 2002, NUTR BUSINESS J  MAY	33	150	159	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2002	347	25					2073	2076		10.1056/NEJMsb022858	http://dx.doi.org/10.1056/NEJMsb022858			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626LT	12490692				2022-12-28	WOS:000179874500014
J	Ng, CS; Watson, CJE; Palmer, CR; See, TC; Beharry, NA; Housden, BA; Bradley, JA; Dixon, AK				Ng, CS; Watson, CJE; Palmer, CR; See, TC; Beharry, NA; Housden, BA; Bradley, JA; Dixon, AK			Evaluation of early abdominopelvic computed tomography in patients with acute abdominal pain of unknown cause: prospective randomised study	BRITISH MEDICAL JOURNAL			English	Article							SMALL-BOWEL OBSTRUCTION; UNENHANCED HELICAL CT; ACUTE ABDOMEN; ACUTE APPENDICITIS; CONTRAST MATERIAL; DIAGNOSIS; DIVERTICULITIS; IMPACT; MANAGEMENT; FILM	Objectives To evaluate the impact of early abdominopelvic computed tomography in patients with acute abdominal pain of unknown cause on length of hospital stay and accuracy of diagnosis. Design Randomised, prospective controlled trial. Setting Teaching hospital in England. Participants 120 patients admitted with acute abdominal pain for which no immediate surgical intervention or computed tomography was indicated. Intervention 55 participants were prospectively randomised to early computed tomography (within 24 hours of admission) and 65 to standard practice (radiological investigations as indicated). Main outcome measures Length of hospital stay, accuracy of diagnosis, and, owing to a possible effect on inpatient mortality, deaths during the study. Results Early computed tomography reduced the length of hospital stay by 1.1 days (geometric mean 5.3 days (range 1 to 3 1) v 6.4 days (1 to 60)), but the difference was non-significant (95% confidence interval, 8% shorter stay to 56% longer stay, P=0.17). Early computed tomography missed significantly fewer serious diagnoses. Seven inpatients in the standard practice arm died. Only 50% (59 of 11 8) of diagnoses on admission were correct at follow up at 6 months, but this improved to 76% (90) of diagnoses after 24 hours. Conclusions Early abdominopelvic computed tomography for acute abdominal pain may reduce mortality and length of hospital stay. It can also identify unforeseen conditions and potentially serious complications.	Univ Cambridge, Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Dept Surg, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Appl Med Stat, Cambridge CB2 2SR, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Ng, CS (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Radiol, Box 57,1515 Holcombe Blvd, Houston, TX 77030 USA.							BALTHAZAR EJ, 1994, RADIOLOGY, V190, P31, DOI 10.1148/radiology.190.1.8259423; BIRNBAUM BA, 1994, RADIOL CLIN N AM, V32, P885; Birnbaum BA, 1998, AM J ROENTGENOL, V170, P361, DOI 10.2214/ajr.170.2.9456947; CHO KC, 1990, RADIOLOGY, V176, P111, DOI 10.1148/radiology.176.1.2191360; FUKUYA T, 1992, AM J ROENTGENOL, V158, P765, DOI 10.2214/ajr.158.4.1546591; Lane MJ, 1997, AM J ROENTGENOL, V168, P405, DOI 10.2214/ajr.168.2.9016216; Maglinte DDT, 1996, AM J ROENTGENOL, V167, P1451, DOI 10.2214/ajr.167.6.8956576; Malone AJ, 1999, SEMIN ULTRASOUND CT, V20, P68, DOI 10.1016/S0887-2171(99)90038-0; MALONE AJ, 1993, AM J ROENTGENOL, V160, P763, DOI 10.2214/ajr.160.4.8456661; Mindelzun RE, 1997, RADIOLOGY, V205, P43, DOI 10.1148/radiology.205.1.9314959; Puylaert JBCM, 1997, AM J ROENTGENOL, V168, P179, DOI 10.2214/ajr.168.1.8976943; Rao PM, 1998, AM J ROENTGENOL, V170, P1445, DOI 10.2214/ajr.170.6.9609151; Rao PM, 1997, RADIOLOGY, V202, P139, DOI 10.1148/radiology.202.1.8988203; Rao PM, 1997, AM J ROENTGENOL, V169, P1275, DOI 10.2214/ajr.169.5.9353441; Rosen MP, 2000, AM J ROENTGENOL, V174, P1391, DOI 10.2214/ajr.174.5.1741391; Safran DB, 2001, AM J EMERG MED, V19, P199, DOI 10.1053/ajem.2001.21721; SIEWERT B, 1994, AM J ROENTGENOL, V163, P1317, DOI 10.2214/ajr.163.6.7992721; Siewert B, 1997, AM J ROENTGENOL, V168, P173, DOI 10.2214/ajr.168.1.8976942; SMITH RC, 1995, RADIOLOGY, V194, P789, DOI 10.1148/radiology.194.3.7862980; STAPAKIS JC, 1992, J COMPUT ASSIST TOMO, V16, P713, DOI 10.1097/00004728-199209000-00008; TAOUREL P, 1992, GASTROINTEST RADIOL, V17, P287, DOI 10.1007/BF01888571; Urban BA, 2000, RADIOGRAPHICS, V20, P725, DOI 10.1148/radiographics.20.3.g00ma12725; Urban BA, 2000, SEMIN ULTRASOUND CT, V21, P20, DOI 10.1016/S0887-2171(00)90011-8	23	107	110	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1387	1389		10.1136/bmj.325.7377.1387	http://dx.doi.org/10.1136/bmj.325.7377.1387			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480851	Green Published			2022-12-28	WOS:000179975000020
J	Srygley, RB; Thomas, ALR				Srygley, RB; Thomas, ALR			Unconventional lift-generating mechanisms in free-flying butterflies	NATURE			English	Article							WEIS-FOGH MECHANISM; INSECT FLIGHT; 3-DIMENSIONAL SEPARATION; VORTEX; FLOW; AIRFOILS; AERODYNAMICS; VORTICES; DYNAMICS; HAWKMOTH	Flying insects generate forces that are too large to be accounted for by conventional steady-state aerodynamics(1,2). To investigate these mechanisms of force generation, we trained red admiral butterflies, Vanessa atalanta, to fly freely to and from artificial flowers in a wind tunnel, and used high-resolution, smoke-wire flow visualizations to obtain qualitative, high-speed digital images of the air flow around their wings. The images show that free-flying butterflies use a variety of unconventional aerodynamic mechanisms to generate force: wake capture(3), two different types of leading-edge vortex(3-7), active and inactive upstrokes(8), in addition to the use of rotational mechanisms 3 and the Weis-Fogh 'clap-and-fling' mechanism(9-12). Free-flying butterflies often used different aerodynamic mechanisms in successive strokes. There seems to be no one 'key' to insect flight, instead insects rely on a wide array of aerodynamic mechanisms to take off, manoeuvre, maintain steady flight, and for landing.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Thomas, ALR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.							Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Delery JM, 2001, ANNU REV FLUID MECH, V33, P129, DOI 10.1146/annurev.fluid.33.1.129; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; ELLINGTON CP, 1995, BIOL FLUID DYNAMICS, V49, P109; GADELHAK M, 1986, AIAA J, V24, P713, DOI 10.2514/3.9337; GURSUL I, 1992, AIAA J, V30, P1117, DOI 10.2514/3.11034; HORNUNG H, 1984, Z FLUGWISS WELTRAUM, V8, P77; HUANG MK, 1982, AIAA J, V20, P292, DOI 10.2514/3.7913; Legendre R., 1956, RECH AERO, V54, P3; LIGHTHILL M, 1963, LAMINAR BOUNDARY LAY, V2, P72; LIGHTHILL MJ, 1973, J FLUID MECH, V60, P1, DOI 10.1017/S0022112073000017; MAXWORTHY T, 1979, J FLUID MECH, V93, P47, DOI 10.1017/S0022112079001774; MAXWORTHY T, 1981, ANNU REV FLUID MECH, V13, P329, DOI 10.1146/annurev.fl.13.010181.001553; Mourtos NJ, 1996, J APPL MECH-T ASME, V63, P543, DOI 10.1115/1.2788902; PERRY AE, 1987, ANNU REV FLUID MECH, V19, P125, DOI 10.1146/annurev.fluid.19.1.125; Poincar? H., 1882, CR HEBD ACAD SCI, V94, P416; RAYNER JMV, 1986, NATURE, V321, P162, DOI 10.1038/321162a0; Riddle TW, 1999, J FLUID ENG-T ASME, V121, P555, DOI 10.1115/1.2823504; ROSSOW VJ, 1978, J AIRCRAFT, V15, P618, DOI 10.2514/3.58416; ROSSOW VJ, 1992, J AIRCRAFT, V29, P847, DOI 10.2514/3.46255; ROSSOW VJ, 1994, J AIRCRAFT, V31, P146, DOI 10.2514/3.46467; SAFFMAN PG, 1977, STUD APPL MATH, V57, P107; Sane SP, 2002, J EXP BIOL, V205, P1087; SPEDDING GR, 1993, ADV COMP ENV PHYSL, V11; TOBAK M, 1982, ANNU REV FLUID MECH, V14, P61, DOI 10.1146/annurev.fl.14.010182.000425; VandenBerg C, 1997, PHILOS T ROY SOC B, V352, P317, DOI 10.1098/rstb.1997.0023; WEISFOGH T, 1973, J EXP BIOL, V59, P169; Willmott AP, 1997, PHILOS T ROY SOC B, V352, P303, DOI 10.1098/rstb.1997.0022; Zbikowski R, 2002, PHILOS T ROY SOC A, V360, P273, DOI 10.1098/rsta. 2001.0930	30	261	283	3	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					660	664		10.1038/nature01223	http://dx.doi.org/10.1038/nature01223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478291				2022-12-28	WOS:000179751800043
J	Fitzgerald, DW; Behets, FMTF				Fitzgerald, DW; Behets, FMTF			Beyond folklore	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREGNANCY											Dennie CC, 1962, HIST SYPHILIS; Farmer P., 1999, INFECT INEQUALITIES; FARMER P, 1992, COMP STUDIES HLTH SY; Fitzgerald D W, 1998, Int J Infect Dis, V2, P127, DOI 10.1016/S1201-9712(98)90113-8; FITZGERALD DW, IN PRESS AM J PUBLIC; HIRA SK, 1990, GENITOURIN MED, V66, P159; JENNISKENS F, 1995, INT J GYNECOL OBSTET, V48, pS121, DOI 10.1016/0020-7292(95)02326-8; Moore JE, 1933, MODERN TREATMENT SYP, DOI [10.1001/jama.1943.02840480071034, DOI 10.1001/JAMA.1943.02840480071034]; RADOLF JD, 1999, SEXUALLY TRANSMITTED, P1168; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0	10	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2791	2792		10.1001/jama.288.22.2791	http://dx.doi.org/10.1001/jama.288.22.2791			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623YM	12472303				2022-12-28	WOS:000179732600001
J	Bockarie, MJ; Tisch, DJ; Kastens, W; Alexander, NDE; Dimber, Z; Bockarie, F; Ibam, E; Alpers, MP; Kazura, JW				Bockarie, MJ; Tisch, DJ; Kastens, W; Alexander, NDE; Dimber, Z; Bockarie, F; Ibam, E; Alpers, MP; Kazura, JW			Mass treatment to eliminate filariasis in Papua New Guinea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SINGLE-DOSE DIETHYLCARBAMAZINE; WUCHERERIA-BANCROFTI INFECTION; LYMPHATIC FILARIASIS; TRANSMISSION INTENSITY; ANOPHELINE MOSQUITOS; CIRCULATING ANTIGEN; DEC CHEMOTHERAPY; IVERMECTIN; EFFICACY; ALBENDAZOLE	Background: The global initiative to eradicate bancroftian filariasis currently relies on mass treatment with four to six annual doses of antifilarial drugs. The goal is to reduce the reservoir of microfilariae in the blood to a level that is insufficient to maintain transmission by the mosquito vector. Methods: In nearly 2500 residents of Papua New Guinea, we prospectively assessed the effects of four annual treatments with a single dose of diethylcarbamazine plus ivermectin or diethylcarbamazine alone on the incidence of microfilariae-positive infections, the severity of lymphatic disease, and the rate of transmission of Wuchereria bancrofti by mosquitoes. Random assignment to treatment regimens was carried out according to the village of residence, and villages were categorized as having moderate or high rates of transmission. Results: The four annual treatments with either drug regimen were taken by 77 to 86 percent of the members of the population who were at least five years old; treatments were well tolerated. The proportion with microfilariae-positive infections decreased by 86 to 98 percent, with a greater reduction in areas with a moderate rate of transmission than in those with a high rate. The respective aggregate frequencies of hydrocele and leg lymphedema were 15 percent and 5 percent before the trial began, and 5 percent (P<0.001) and 4 percent (P=0.04) after five years. Hydrocele and leg lymphedema were eliminated in 87 percent and 69 percent, respectively, of those who had these conditions at the outset. The rate of transmission by mosquitoes decreased substantially, and new microfilariae-positive infections in children were almost completely prevented over the five-year study period. Conclusions: Annual mass treatment with drugs such as diethylcarbamazine can virtually eliminate the reservoir of microfilariae and greatly reduce the frequency of clinical lymphatic abnormalities due to bancroftian filariasis. Eradication may be possible in areas with moderate rates of transmission, but longer periods of treatment or additional control measures may be necessary in areas with high rates of transmission.	Case Western Reserve Univ, Sch Med, Div Geog Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Int Hlth, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; London Sch Hyg & Trop Med, London WC1, England; Curtin Univ, Ctr Int Hlth, Perth, WA, Australia	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; PNG Institute Of Medical Research; University of London; London School of Hygiene & Tropical Medicine; Curtin University	Kazura, JW (corresponding author), Case Western Reserve Univ, Sch Med, Div Geog Med, 2109 Adelbert Rd,W137 Harlan Wood Bldg, Cleveland, OH 44106 USA.		Tisch, Daniel/Q-5044-2019; Bockarie, Moses/AAW-3130-2021; Bockarie, Moses/AAV-4578-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI033061] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI33061] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Addis D, 1997, LANCET, V350, P1036; Addiss DG, 1997, LANCET, V350, P480, DOI 10.1016/S0140-6736(97)02231-9; Behbehani K, 1998, Bull World Health Organ, V76 Suppl 2, P64; Bockarie MJ, 2000, AM J TROP MED HYG, V62, P363, DOI 10.4269/ajtmh.2000.62.363; Bockarie MJ, 1998, LANCET, V351, P162, DOI 10.1016/S0140-6736(97)07081-5; Brockarie M, 1996, AM J TROP MED HYG, V54, P577, DOI 10.4269/ajtmh.1996.54.577; Burkot T, 2002, TRENDS PARASITOL, V18, P109, DOI 10.1016/S1471-4922(01)02221-8; Das PK, 2001, T ROY SOC TROP MED H, V95, P336, DOI 10.1016/S0035-9203(01)90260-3; Dean M, 2000, LANCET, V355, P385, DOI 10.1016/S0140-6736(05)74012-5; DESOWITZ RS, 1974, AM J TROP MED HYG, V23, P877, DOI 10.4269/ajtmh.1974.23.877; Dreyer, 1997, Cad Saude Publica, V13, P537, DOI 10.1590/S0102-311X1997000300030; Esterre P, 2001, TROP MED INT HEALTH, V6, P190, DOI 10.1046/j.1365-3156.2001.00682.x; FAN PC, 1990, ACTA TROP, V47, P161, DOI 10.1016/0001-706X(90)90022-R; Freedman DO, 2001, TROP MED INT HEALTH, V6, P37, DOI 10.1046/j.1365-3156.2001.00666.x; Hawking F, 1976, Trop Dis Bull, V73, P967; Hii JLK, 2000, B ENTOMOL RES, V90, P211, DOI 10.1017/S000748530000033X; Horton J, 2000, PARASITOLOGY, V121, pS147, DOI 10.1017/S0031182000007423; Ismail MM, 1998, T ROY SOC TROP MED H, V92, P94, DOI 10.1016/S0035-9203(98)90972-5; KAZURA J, 1993, AM J TROP MED HYG, V49, P804, DOI 10.4269/ajtmh.1993.49.804; Kazura JW, 1997, J INFECT DIS, V176, P242, DOI 10.1086/514030; King CL, 2001, PARASITE IMMUNOL, V23, P363, DOI 10.1046/j.1365-3024.2001.00395.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mataika JU, 1998, B WORLD HEALTH ORGAN, V76, P575; MAXWELL CA, 1990, T ROY SOC TROP MED H, V84, P709, DOI 10.1016/0035-9203(90)90158-B; Meyrowitsch DW, 1996, T ROY SOC TROP MED H, V90, P423, DOI 10.1016/S0035-9203(96)90534-9; Michael E, 2001, PARASITE IMMUNOL, V23, P373, DOI 10.1046/j.1365-3024.2001.00398.x; MORE SJ, 1990, TROP MED PARASITOL, V41, P403; NELSON G S, 1958, Bull World Health Organ, V19, P204; Norman RA, 2000, EPIDEMIOL INFECT, V124, P529, DOI 10.1017/S0950268899003702; OTTESEN EA, 1990, NEW ENGL J MED, V322, P1113, DOI 10.1056/NEJM199004193221604; Ottesen EA, 1999, PARASITOL TODAY, V15, P382, DOI 10.1016/S0169-4758(99)01486-6; OTTESEN EA, 1985, REV INFECT DIS, V7, P341; PARTONO F, 1985, T ROY SOC TROP MED H, V79, P44, DOI 10.1016/0035-9203(85)90231-7; PEROLAT P, 1986, B SOC PATHOL EXOT, V79, P78; Plaisier AP, 1998, METHOD INFORM MED, V37, P97; ROCHET MJ, 1990, TROP MED PARASITOL, V41, P225; SMITH PG, 1991, METHODS FIELD TRIALS; SOUTHGATE BA, 1992, T ROY SOC TROP MED H, V86, P523, DOI 10.1016/0035-9203(92)90096-U; Srividya A, 1996, EPIDEMIOL INFECT, V117, P195, DOI 10.1017/S095026880000131X; Taylor MJ, 2000, PARASITOL TODAY, V16, P179, DOI 10.1016/S0169-4758(00)01661-6; Tisch DJ, 2001, J INFECT DIS, V184, P898, DOI 10.1086/323324; WALSH JF, 1978, T ROY SOC TROP MED H, V72, P675, DOI 10.1016/0035-9203(78)90039-1; WEBBER R H, 1975, Southeast Asian Journal of Tropical Medicine and Public Health, V6, P430; WEIL GJ, 1991, J INFECT DIS, V164, P814, DOI 10.1093/infdis/164.4.814; *WHO EXP COMM FIL, 1974, WHO TECH REP SER, V542, P1; ZIELKE E, 1980, TROPENMED PARASITOL, V31, P444	46	111	111	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2002	347	23					1841	1848		10.1056/NEJMoa021309	http://dx.doi.org/10.1056/NEJMoa021309			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NW	12466508	Bronze, Green Accepted			2022-12-28	WOS:000179596900004
J	Makoul, G				Makoul, G			Communication skills education in medical school and beyond	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Makoul, G (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.							*ASS AM MED COLL, 1999, 3 ASS AM MED COLL ME; Batalden P, 2002, HEALTH AFFAIR, V21, P103, DOI 10.1377/hlthaff.21.5.103; Brunett PH, 2001, ACAD MED, V76, P390, DOI 10.1097/00001888-200104000-00021; Hargie O, 1998, MED EDUC, V32, P25, DOI 10.1046/j.1365-2923.1998.00154.x; Horowitz SD, 2000, AM J PHYS MED REHAB, V79, P478, DOI 10.1097/00002060-200009000-00016; Klass D, 1998, FED B, V85, P177; Liaison Committee on Medical Education, 1998, FUNCT STRUCT MED SCH; Makoul G, 2001, PATIENT EDUC COUNS, V45, P23, DOI 10.1016/S0738-3991(01)00136-7; SILVERMAN J, 1998, SKILLS COMMUNICATING; US MED LICENSING EXA	10	78	80	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					93	93		10.1001/jama.289.1.93	http://dx.doi.org/10.1001/jama.289.1.93			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630XL	12503986	Bronze			2022-12-28	WOS:000180136600034
J	Chiu, SS; Lau, YL; Chan, KH; Wong, WHS; Peiris, JSM				Chiu, SS; Lau, YL; Chan, KH; Wong, WHS; Peiris, JSM			Influenza-related hospitalizations among children in Hong Kong	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-DISEASE; COST-EFFECTIVENESS; VIRUS INFECTION; YOUNG-CHILDREN; INFANTS; IMPACT; EPIDEMICS; DIAGNOSIS; VACCINE; ILLNESS	Background: It has been difficult to define the burden of influenza in children because of confounding by the cocirculation of respiratory syncytial virus (RSV). In Hong Kong, China, the influenza and RSV infection seasons sometimes do not overlap, thus providing an opportunity to estimate the rate of influenza-related hospitalization in a defined population, free from the effects of RSV. Methods: In a retrospective, population-based study, we estimated the influenza-associated excess rate of hospitalization among children 15 years old or younger in the Hong Kong Special Administrative Region from 1997 to 1999. Data from a single hospital with intensive use of virologic analyses for diagnosis were obtained to define and adjust for underestimation of the model. Results: Peaks of influenza and RSV infection activity were well separated in 1998 and 1999 but overlapped in 1997. The adjusted rates of excess hospitalization for acute respiratory disease that were attributable to influenza were 278.5 and 288.2 per 10,000 children less than 1 year of age in 1998 and 1999, respectively; 218.4 and 209.3 per 10,000 children 1 to less than 2 years of age; 125.6 and 77.3 per 10,000 children 2 to less than 5 years of age; 57.3 and 20.9 per 10,000 children 5 to less than 10 years of age; and 16.4 and 8.1 per 10,000 children 10 to 15 years of age. Conclusions: In the subtropics, influenza is an important cause of hospitalization among children, with rates exceeding those reported for temperate regions.	Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Peiris, JSM (corresponding author), Queen Mary Hosp, Dept Microbiol, Univ Pathol Bldg, Pokfulam, Hong Kong, Peoples R China.	malik@hkucc.hku.hk	Wong, Wilfred/Q-8751-2019; Chan, Kwok Hung/ABD-5399-2021; Chiu, Susan Shui Seng/C-4247-2009; Lau, Yu Lung/C-4322-2009	Chiu, Susan Shui Seng/0000-0002-3908-1974; Wong, Hing Sang Wilfred/0000-0001-8396-2368; Lau, Yu Lung/0000-0002-4780-0289				ADAMS PF, 1995, VITAL HLTH STAT, V10; [Anonymous], 2002, Wkly Epidemiol Rec, V77, P191; [Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; Chiu SS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e63; Cohen GM, 2000, PEDIATRICS, V106, P973, DOI 10.1542/peds.106.5.973; Drinka P, 1999, J AM GERIATR SOC, V47, P1363; Edwards KM, 2001, PEDIATRICS, V108, P1004, DOI 10.1542/peds.108.4.1004; Fitzner K. A., 1999, Hong Kong Medical Journal, V5, P87; Fitzner KA, 2001, HEALTH POLICY, V56, P215, DOI 10.1016/S0168-8510(00)00140-8; Glezen WP, 1999, JAMA-J AM MED ASSOC, V281, P944, DOI 10.1001/jama.281.10.944; GLEZEN WP, 1987, AM REV RESPIR DIS, V136, P550, DOI 10.1164/ajrccm/136.3.550; Glezen WP, 1997, PEDIATR INFECT DIS J, V16, P1065, DOI 10.1097/00006454-199711000-00012; *GOV HONG KONG SPE, INFL SURV; *HONG KONG GOV, 1993, HONG KONG COR REP; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; KIM HW, 1979, AM J EPIDEMIOL, V109, P464, DOI 10.1093/oxfordjournals.aje.a112704; McIntosh K, 2000, NEW ENGL J MED, V342, P275, DOI 10.1056/NEJM200001273420409; Monto Arnold S., 1997, Journal of Infectious Diseases, V176, pS32, DOI 10.1086/514172; MULLOOLY JP, 1982, AM J PUBLIC HEALTH, V72, P1008, DOI 10.2105/AJPH.72.9.1008; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Neuzil KM, 2001, INFECT DIS CLIN N AM, V15, P123, DOI 10.1016/S0891-5520(05)70271-3; Poland GA, 1999, PEDIATRICS, V103, P1280, DOI 10.1542/peds.103.6.1280; SHORTRIDGE KF, 1995, LANCET, V346, P1210, DOI 10.1016/S0140-6736(95)92906-1; SHORTRIDGE KF, 1982, LANCET, V2, P812; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; SUGAYA N, 1992, J INFECT DIS, V165, P373, DOI 10.1093/infdis/165.2.373; Szucs TD, 1999, PHARMACOECONOMICS, V16, P27, DOI 10.2165/00019053-199916001-00004; Woo PCY, 1997, J CLIN MICROBIOL, V35, P1579, DOI 10.1128/JCM.35.6.1579-1581.1997; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; 2000, N ENGL J MED, V342, P1752	32	225	241	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2097	2103		10.1056/NEJMoa020546	http://dx.doi.org/10.1056/NEJMoa020546			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501221	Bronze			2022-12-28	WOS:000180040900002
J	Kaczorowski, M; Kaczorowski, J				Kaczorowski, M; Kaczorowski, J			Ice cream evoked headaches (ICE-H) study: randomised trial of accelerated versus cautious ice cream eating regimen	BRITISH MEDICAL JOURNAL			English	Article									McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada; Dalewood Middle Sch, Hamilton, ON, Canada	McMaster University	Kaczorowski, J (corresponding author), McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada.							Raskin N, 1988, HEADACHE; SMITH RD, 1968, HDB CLIN NEUROLOGY, V5, P188	2	15	16	1	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1445	1446		10.1136/bmj.325.7378.1445	http://dx.doi.org/10.1136/bmj.325.7378.1445			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493658	Green Published			2022-12-28	WOS:000180188600010
J	Nelson, MR				Nelson, MR			The mummy's curse: historical cohort study	BRITISH MEDICAL JOURNAL			English	Article								Objective To examine survival of individuals exposed to the "mummy's curse" reputedly associated with the opening of the tomb of Tutankhamen in Luxor, Egypt, between February 1923 and November 1926. Design Retrospective cohort study. Participants 44 Westerners identified by Howard Carter as present in Egypt at the specified dates, 25 of whom were potentially exposed to the curse. Main outcome measures Length of survival after date of potential exposure. Results In the 25 people exposed to the curse the mean age at death was 70 years (SD 12) compared with 75 (13) in those not exposed (P=0.87 for difference). Survival after the date of exposure was 20.8 (15.2) v 28.9 (13.6) years respectively (P=0.95 for difference). Female sex was a predictor for survival (P=0.02). Conclusions There was no significant association between exposure to the mummy's curse and survival and thus no evidence to support the existence of a mummy's curse.	Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Prahran, Vic 3181, Australia	Florey Institute of Neuroscience & Mental Health; Monash University	Nelson, MR (corresponding author), Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Prahran, Vic 3181, Australia.							*A C BLACK, 1967, WHO WAS WHO, V3; *A C BLACK, 1980, WHO WAS WHO, V4; *A C BLACK, 1972, WHO WAS WHO, V7; *A C BLACK, 1972, WHO WAS WHO, V6; *A C BLACK, 1984, WHO WAS WHO, V5; *A C BLACK, 1967, WHO WAS WHO, V2; BRIER R, 1998, MURDER TUTANKHAMEN T; CARTER H, 1983, TOMB TUTANKHAMEN; DAWSON WR, 1995, WHO WHO EGYPTOLOGY; France Peter, 1991, RAPE EGYPT; MALEK J, 1922, H CARTERS PERSONAL 1; MALEK J, 1923, H CARTERS PERSONAL 2; Montserrat D., 1998, KMT MODERN J ANCIENT, V9, P70; Reeves N., 1995, COMPLETE TUTANKHAMUN; 1966, WHO WAS WHO AM, V1; 1995, DEBRETTS PEERAGE BAR; 1934, NY TIMES        0126, P19; 1975, BURKES PEERAGE BARON; 1995, DEBRETTS BARONETAGE	19	4	4	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1482	1484		10.1136/bmj.325.7378.1482	http://dx.doi.org/10.1136/bmj.325.7378.1482			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493675	Green Published			2022-12-28	WOS:000180188600028
J	Cerullo, G; Polli, D; Lanzani, G; De Silvestri, S; Hashimoto, H; Cogdell, RJ				Cerullo, G; Polli, D; Lanzani, G; De Silvestri, S; Hashimoto, H; Cogdell, RJ			Photosynthetic light harvesting by carotenoids: Detection of an intermediate excited state	SCIENCE			English	Article							BETA-CAROTENE; ELECTRONIC EXCITATIONS; ENERGY-TRANSFER; 1B(U)(+); DEPENDENCE; ABSORPTION; LIFETIME; COMPLEX; FINITE	We present the first direct evidence of the presence of an intermediate singlet excited state (S-x) mediating the internal conversion from S-2 to S-1 in carotenoids. The S-2 to S-x transition is extremely fast and is completed within approximately 50 femtoseconds. These results require a reassessment of the energy transfer pathways from carotenoids to chlorophylls in the primary step of photosynthesis.	Politecn Milan, Dipartimento Fis, Natl Lab Ultrafast & Ultraintense Opt Sci, INFM, I-20133 Milan, Italy; Univ Glasgow, Div Biochem & Mol Biol, Glasgow, Lanark, Scotland	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Polytechnic University of Milan; University of Glasgow	Cerullo, G (corresponding author), Politecn Milan, Dipartimento Fis, Natl Lab Ultrafast & Ultraintense Opt Sci, INFM, Piazza L da Vinci 32, I-20133 Milan, Italy.	giulio.cerullo@fisi.polimi.it	Cerullo, Giulio/F-6534-2011; Polli, Dario/B-4809-2011	Cerullo, Giulio/0000-0002-9534-2702; Polli, Dario/0000-0002-6960-5708				Cerullo G, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.241104; Cerullo G, 1998, OPT LETT, V23, P1283, DOI 10.1364/OL.23.001283; Damjanovic A, 1999, PHYS REV E, V59, P3293, DOI 10.1103/PhysRevE.59.3293; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Hofmann E, 1996, SCIENCE, V272, P1788, DOI 10.1126/science.272.5269.1788; ISLER O, 1971, CAROTENOIDS; KANDORI H, 1994, J AM CHEM SOC, V116, P2671, DOI 10.1021/ja00085a078; Koyama Y, 1999, ADV PHOTOSYNTH, V8, P161; Macpherson AN, 1998, J PHYS CHEM A, V102, P5049, DOI 10.1021/jp980979z; Macpherson AN, 2001, BIOPHYS J, V80, P923, DOI 10.1016/S0006-3495(01)76071-7; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; PELLEGRIN E, 1991, PHYS REV LETT, V66, P2022, DOI 10.1103/PhysRevLett.66.2022; Ritz T, 2000, PHOTOSYNTH RES, V66, P125, DOI 10.1023/A:1010750332320; Sashima T, 2000, J PHYS CHEM B, V104, P5011, DOI 10.1021/jp994185b; Sashima T, 1999, CHEM PHYS LETT, V299, P187, DOI 10.1016/S0009-2614(98)01278-0; SHREVE AP, 1991, CHEM PHYS LETT, V178, P89, DOI 10.1016/0009-2614(91)85058-5; TAVAN P, 1987, PHYS REV B, V36, P4337, DOI 10.1103/PhysRevB.36.4337; TAVAN P, 1986, J CHEM PHYS, V85, P6602, DOI 10.1063/1.451442; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; YOSHIZAWA M, 2001, PHYS REV B, V63; Zavelani-Rossi M, 2001, OPT LETT, V26, P1155, DOI 10.1364/OL.26.001155; Zhang JP, 2001, PHOTOCHEM PHOTOBIOL, V73, P219, DOI 10.1562/0031-8655(2001)073<0219:TAFTUS>2.0.CO;2; Zhang JP, 2000, CHEM PHYS LETT, V332, P351, DOI 10.1016/S0009-2614(00)01275-6	23	225	227	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2395	2398		10.1126/science.1074685	http://dx.doi.org/10.1126/science.1074685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493917				2022-12-28	WOS:000179915900059
J	Kitaura, R; Kitagawa, S; Kubota, Y; Kobayashi, TC; Kindo, K; Mita, Y; Matsuo, A; Kobayashi, M; Chang, HC; Ozawa, TC; Suzuki, M; Sakata, M; Takata, M				Kitaura, R; Kitagawa, S; Kubota, Y; Kobayashi, TC; Kindo, K; Mita, Y; Matsuo, A; Kobayashi, M; Chang, HC; Ozawa, TC; Suzuki, M; Sakata, M; Takata, M			Formation of a one-dimensional array of oxygen in a microporous metal-organic solid	SCIENCE			English	Article							METHANE; PYRAZINE-2,3-DICARBOXYLATE; TEMPERATURE; DIFFRACTION; MOLECULES; PZDC	We report the direct observation of dioxygen molecules physisorbed in the nanochannels of a microporous copper coordination polymer by the MEM (maximum entropy method)/Rietveld method, using in situ high-resolution synchrotron x-ray powder diffraction measurements. The obtained MEM electron density revealed that van der Waals dimers of physisorbed O-2 locate in the middle of nanochannels and form a one-dimensional ladder structure aligned to the host channel structure. The observed O-O stretching Raman band and magnetic susceptibilities are characteristic of the confined O-2 molecules in one-dimensional nanochannels of CPL-1 (coordination polymer 1 with pillared layer structure).	Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Sakyo Ku, Kyoto 6068501, Japan; Osaka Womens Univ, Dept Environm Sci, Osaka 5900035, Japan; Osaka Univ, Grad Sch Engn Sci, Dept Phys Sci, Osaka 5608531, Japan; Osaka Univ, Grad Sch Engn Sci, KYOKUGEN, Osaka 5608531, Japan; Nagoya Univ, Dept Appl Phys, Nagoya, Aichi 4648603, Japan; JASRI, Spring8, Koto, Hyougo, Japan	Kyoto University; Osaka Metropolitan University; Osaka University; Osaka University; Nagoya University; Japan Synchrotron Radiation Research Institute	Kitagawa, S (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Sakyo Ku, Kyoto 6068501, Japan.	Kitagawa@sbchem.kyoto-u.ac.jp	Kitaura, Ryo/B-8123-2008; Kitagawa, Susumu/AAB-1753-2019; KOBAYASHI, Tatsuo/B-1527-2011; Chang, Ho-Chol/N-2174-2016; Kubota, Yoshiki/M-4574-2019; Takata, Masaki/M-1525-2014; Ozawa, Tadashi C./B-2535-2012	Kitagawa, Susumu/0000-0001-6956-9543; Chang, Ho-Chol/0000-0001-5159-2737; Ozawa, Tadashi C./0000-0003-0118-115X; Kitaura, Ryo/0000-0001-8108-109X				BIER KD, 1984, J CHEM PHYS, V81, P1192, DOI 10.1063/1.447794; Eddaoudi M, 2001, ACCOUNTS CHEM RES, V34, P319, DOI 10.1021/ar000034b; Hirschfelder J. O., 1954, MOL THEORY GASES LIQ; Kanoh H, 1997, LANGMUIR, V13, P1047, DOI 10.1021/la951042h; Kitaura R, 2002, ANGEW CHEM INT EDIT, V41, P133, DOI 10.1002/1521-3773(20020104)41:1<133::AID-ANIE133>3.0.CO;2-R; KOBLER U, 1987, PHYS REV B, V35, P9809, DOI 10.1103/PhysRevB.35.9809; Kondo M, 1999, ANGEW CHEM INT EDIT, V38, P140, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<140::AID-ANIE140>3.0.CO;2-9; Miyahara M, 1997, J CHEM PHYS, V106, P2865, DOI 10.1063/1.473415; Mori W, 1997, MOL CRYST LIQ CRYS A, V306, P1, DOI 10.1080/10587259708047083; Moulton B, 2001, CHEM REV, V101, P1629, DOI 10.1021/cr9900432; Nishibori E, 2001, J PHYS CHEM SOLIDS, V62, P2095, DOI 10.1016/S0022-3697(01)00164-0; Noro S, 2000, ANGEW CHEM INT EDIT, V39, P2082; Seki K, 2001, CHEM COMMUN, P1496, DOI 10.1039/b104204c; Steele WA, 1996, LANGMUIR, V12, P145, DOI 10.1021/la940935r; TAKATA M, 1995, NATURE, V377, P46, DOI 10.1038/377046a0; Takata M, 2001, Z KRISTALLOGR, V216, P71, DOI 10.1524/zkri.216.2.71.20335; Tanaka H, 2002, J APPL CRYSTALLOGR, V35, P282, DOI 10.1107/S002188980200050X; UYEDA C, 1985, J PHYS SOC JPN, V54, P1107, DOI 10.1143/JPSJ.54.1107; Wang CR, 2000, NATURE, V408, P426, DOI 10.1038/35044195	19	543	550	5	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2358	2361		10.1126/science.1078481	http://dx.doi.org/10.1126/science.1078481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493907				2022-12-28	WOS:000179915900047
J	Lagunoff, D				Lagunoff, D			A Polish, Jewish scientist in 19th-century Prussia	SCIENCE			English	Biographical-Item									St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA	Saint Louis University	Lagunoff, D (corresponding author), St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA.	lagunofd@slucare1.sluh.edu							0	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2331	2331		10.1126/science.1080726	http://dx.doi.org/10.1126/science.1080726			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493897				2022-12-28	WOS:000179915900034
J	Mora-Duarte, J; Betts, R; Rotstein, C; Colombo, AL; Thompson-Moya, L; Smietana, J; Lupinacci, R; Sable, C; Kartsonis, N; Perfect, J				Mora-Duarte, J; Betts, R; Rotstein, C; Colombo, AL; Thompson-Moya, L; Smietana, J; Lupinacci, R; Sable, C; Kartsonis, N; Perfect, J		Caspofungin Invasive Candidiasis S	Comparison of caspofungin and amphotericin B for invasive candidiasis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIFUNGAL MK-0991 L-743,872; BLOOD-STREAM INFECTIONS; IN-VITRO ACTIVITY; ECHINOCANDIN ANTIFUNGAL; FLUCONAZOLE-RESISTANT; FUNGAL-INFECTIONS; RANDOMIZED TRIAL; CANDIDEMIA; SURVEILLANCE; MULTICENTER	Background: Caspofungin is an echinocandin agent with fungicidal activity against candida species. We performed a double-blind trial to compare caspofungin with amphotericin B deoxycholate for the primary treatment of invasive candidiasis. Methods: We enrolled patients who had clinical evidence of infection and a positive culture for candida species from blood or another site. Patients were stratified according to the severity of disease, as indicated by the Acute Physiology and Chronic Health Evaluation (APACHE II) score, and the presence or absence of neutropenia and were randomly assigned to receive either caspofungin or amphotericin B. The study was designed to compare the efficacy of caspofungin with that of amphotericin B in patients with invasive candidiasis and in a subgroup with candidemia. Results: Of the 239 patients enrolled, 224 were included in the modified intention-to-treat analysis. Base-line characteristics, including the percentage of patients with neutropenia and the mean APACHE II score, were similar in the two treatment groups. A modified intention-to-treat analysis showed that the efficacy of caspofungin was similar to that of amphotericin B, with successful outcomes in 73.4 percent of the patients treated with caspofungin and in 61.7 percent of those treated with amphotericin B (difference after adjustment for APACHE II score and neutropenic status, 12.7 percentage points; 95.6 percent confidence interval, -0.7 to 26.0). An analysis of patients who met prespecified criteria for evaluation showed that caspofungin was superior, with a favorable response in 80.7 percent of patients, as compared with 64.9 percent of those who received amphotericin B (difference, 15.4 percentage points; 95.6 percent confidence interval, 1.1 to 29.7). Caspofungin was as effective as amphotericin B in patients who had candidemia, with a favorable response in 71.7 percent and 62.8 percent of patients, respectively (difference, 10.0 percentage points; 95.0 percent confidence interval, -4.5 to 24.5). There were significantly fewer drug-related adverse events in the caspofungin group than in the amphotericin B group. Conclusions: Caspofungin is at least as effective as amphotericin B for the treatment of invasive candidiasis and, more specifically, candidemia.	CCSS, Neeman ICIC & Hosp Mexico, San Jose, Costa Rica; Univ Rochester, Rochester, NY USA; McMaster Univ, Hamilton, ON, Canada; UNIFESP, Escola Paulista Med, Sao Paulo, Brazil; Clin Santa Maria, Santiago, Chile; Merck Res Labs, W Point, PA USA	University of Rochester; McMaster University; Universidade Federal de Sao Paulo (UNIFESP); Merck & Company	Perfect, J (corresponding author), Duke Univ, Med Ctr, POB 3353,Trent Dr,Rm 1558,Duke S, Durham, NC 27710 USA.		Colombo, Arnaldo Lopes/V-4417-2019; Colombo, Arnaldo Lopes/H-4397-2012	Colombo, Arnaldo Lopes/0000-0003-0793-8491; 				Abruzzo GK, 1997, ANTIMICROB AGENTS CH, V41, P2333, DOI 10.1128/AAC.41.11.2333; Anaissie EJ, 1996, CLIN INFECT DIS, V23, P964, DOI 10.1093/clinids/23.5.964; Anaissie EJ, 1996, AM J MED, V101, P170, DOI 10.1016/S0002-9343(96)80072-6; Arathoon EG, 2002, ANTIMICROB AGENTS CH, V46, P451, DOI 10.1128/AAC.46.2.451-457.2002; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; BACHMAN SP, 2000, 40 INT C ANT AG CHEM, P352; Barchiesi F, 1999, EUR J CLIN MICROBIOL, V18, P302; Bartizal K, 1997, ANTIMICROB AGENTS CH, V41, P2326, DOI 10.1128/AAC.41.11.2326; BODEY GP, 1992, CANDIDIASIS PATHOGEN, P279; Colombo AL, 1999, DIAGN MICR INFEC DIS, V34, P281; GALLIS HA, 1990, REV INFECT DIS, V12, P308; GRANINGER W, 1993, J INFECTION, V26, P133, DOI 10.1016/0163-4453(93)92761-K; IKEMOTO H, 1989, DIAGN MICROBIOL INFE, V12, P239; Kao AS, 1999, CLIN INFECT DIS, V29, P1164, DOI 10.1086/313450; KUJATH P, 1989, INFECTION, V17, P111, DOI 10.1007/BF01646895; MartinezSuarez JV, 1996, ANTIMICROB AGENTS CH, V40, P1277, DOI 10.1128/AAC.40.5.1277; MEUNIER F, 1989, EUR J CLIN MICROBIOL, V8, P438, DOI 10.1007/BF01964058; Nelson PW, 1997, J MED VET MYCOL, V35, P285; NGUYEN MH, 1995, ARCH INTERN MED, V155, P2429, DOI 10.1001/archinte.155.22.2429; NOLLASALAS J, 1992, CLIN INFECT DIS, V14, P952, DOI 10.1093/clinids/14.4.952; NUCCI M, 2001, 41 INT C ANT AG CHEM, P393; Pfaller MA, 1999, DIAGN MICR INFEC DIS, V35, P19, DOI 10.1016/S0732-8893(99)00046-2; Pfaller MA, 2000, ANTIMICROB AGENTS CH, V44, P747, DOI 10.1128/AAC.44.3.747-751.2000; Phillips P, 1997, EUR J CLIN MICROBIOL, V16, P337, DOI 10.1007/BF01726360; REX JH, 1994, NEW ENGL J MED, V331, P1325, DOI 10.1056/NEJM199411173312001; REX JH, 1995, ANTIMICROB AGENTS CH, V39, P1, DOI 10.1128/AAC.39.1.1; Sable C A, 2002, Transpl Infect Dis, V4, P25, DOI 10.1034/j.1399-3062.2002.01004.x; VANTWOUT JW, 1988, J ANTIMICROB CHEMOTH, V21, P665, DOI 10.1093/jac/21.5.665; Vazquez JA, 1997, ANTIMICROB AGENTS CH, V41, P1612, DOI 10.1128/AAC.41.7.1612; Villanueva A, 2002, AM J MED, V113, P294, DOI 10.1016/S0002-9343(02)01191-9; Villanueva A, 2001, CLIN INFECT DIS, V33, P1529, DOI 10.1086/323401; Yamamura DLR, 1999, CAN MED ASSOC J, V160, P493	32	972	1037	0	42	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2002	347	25					2020	2029		10.1056/NEJMoa021585	http://dx.doi.org/10.1056/NEJMoa021585			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626LT	12490683				2022-12-28	WOS:000179874500005
J	Lewington, S; Clarke, R; Qizilbash, N; Peto, R; Collins, R				Lewington, S; Clarke, R; Qizilbash, N; Peto, R; Collins, R		Prospective Studies Collaboration	Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies	LANCET			English	Article							CORONARY HEART-DISEASE; ANTIHYPERTENSIVE DRUG-TREATMENT; REGRESSION DILUTION; MONICA PROJECT; STROKE; RISK; METAANALYSIS; TRIALS; SODIUM; HYPERTENSION	Background The age-specific relevance of blood pressure to cause-specific mortality is best assessed by collaborative meta-analysis of individual participant data from the separate prospective studies. Methods Information was obtained on each of one million adults with no previous vascular disease recorded at baseline in 61 prospective observational studies of blood pressure and mortality. During 12.7 million person-years at risk, there were about 56 000 vascular deaths (12 000 stroke, 34000 ischaemic heart disease [IHD], 10000 other vascular) and 66 000 other deaths at ages 40-89 years. Meta-analyses, involving "time-dependent" correction for regression dilution, related mortality during each decade of age at death to the estimated usual blood pressure at the start of that decade. Findings Within each decade of age at death, the proportional difference in the risk of vascular death associated with a given absolute difference in usual blood pressure is about the same down to at least 115 mm Hg usual systolic blood pressure (SBP) and 75 mm Hg usual diastolic blood pressure (DBP), below which there is little evidence. At ages 40-69 years, each difference of 20 mm Hg usual SBP (or, approximately equivalently, 10 mm Hg usual DBP) is associated with more than a twofold difference in the stroke death rate, and with twofold differences in the death rates from IHD and from other vascular causes. All of these proportional differences in vascular mortality are about half as extreme at ages 80-89 years as at,ages 40-49 years, but the annual absolute differences in risk are greater in old age. The age-specific associations are similar for men and women, and for cerebral haemorrhage and cerebral ischaemia. For predicting vascular mortality from a single blood pressure measurement, the average of SBP and DBP is slightly more informative than either alone, and pulse pressure is much less informative. Interpretation Throughout middle and old age, usual blood pressure is strongly and directly related to vascular (and overall) mortality, without any evidence of a threshold down to at least 115/75 mm Hg.	Radcliffe Infirm, CTSU, PSC Secretariat, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford	Lewington, S (corresponding author), Radcliffe Infirm, CTSU, PSC Secretariat, Oxford OX2 6HE, England.		Davey Smith, George/A-7407-2013; Lakić, Dragana/F-8688-2011	Davey Smith, George/0000-0002-1407-8314; Carstensen, John/0000-0003-2256-8089; Lewington, Sarah/0000-0002-4496-4771	NIA NIH HHS [P01 AG17625-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CHEN J, 1990, CHINA STUDY CHARACTE; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COLLINS R, 1994, BRIT MED BULL, V50, P272, DOI 10.1093/oxfordjournals.bmb.a072892; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COX DR, 1972, J R STAT SOC B, V34, P187; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Franklin SS, 2001, CIRCULATION, V103, P1245; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; Gueyffier F, 1997, STROKE, V28, P2557, DOI 10.1161/01.STR.28.12.2557; Iso H, 1999, J CARDIOVASC RISK, V6, P315; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; MARTIN MJ, 1986, LANCET, V2, P933; MURRAY CJL, 1996, GLOBAL PATTERN CAUSE; Neoptolemos JP, 2000, LANCET, V355, P1955, DOI 10.1016/S0140-6736(00)02327-8; Port S, 2000, LANCET, V355, P175, DOI 10.1016/S0140-6736(99)07051-8; Prospective Studies Collaboration, 1995, LANCET, V346, P647; Rodgers A, 1998, LANCET, V352, P1801; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; White WB, 2001, AM J CARDIOL, V87, P1278, DOI 10.1016/S0002-9149(01)01519-3; Yusuf S, 2000, NEW ENGL J MED, V342, P145	26	6754	7097	11	513	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1903	1913						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493255				2022-12-28	WOS:000179870200007
J	Kwong, PD; Doyle, ML; Casper, DJ; Cicala, C; Leavitt, SA; Majeed, S; Steenbeke, TD; Venturi, M; Chaiken, I; Fung, M; Katinger, H; Parren, PWLH; Robinson, J; Van Ryk, D; Wang, LP; Burton, DR; Freire, E; Wyatt, R; Sodroski, J; Hendrickson, WA; Arthos, J				Kwong, PD; Doyle, ML; Casper, DJ; Cicala, C; Leavitt, SA; Majeed, S; Steenbeke, TD; Venturi, M; Chaiken, I; Fung, M; Katinger, H; Parren, PWLH; Robinson, J; Van Ryk, D; Wang, LP; Burton, DR; Freire, E; Wyatt, R; Sodroski, J; Hendrickson, WA; Arthos, J			HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GP120 ENVELOPE GLYCOPROTEIN; HUMAN MONOCLONAL-ANTIBODY; TYPE-1 GP120; EFFICIENT NEUTRALIZATION; CELLS; RETROVIRUS; EPITOPES; COMPLEX; FUSION	The ability of human immunodeficiency virus (HIV-1) to persist and cause AIDS is dependent on its avoidance of antibody-mediated neutralization. The virus elicits abundant, envelope-directed antibodies that have little neutralization capacity(1). This lack of neutralization is paradoxical, given the functional conservation and exposure of receptor-binding sites on the gp120 envelope glycoprotein, which are larger than the typical antibody footprint(2) and should therefore be accessible for antibody binding. Because gp120-receptor interactions involve conformational reorganization(3), we measured the entropies of binding for 20 gp120-reactive antibodies. Here we show that recognition by receptor-binding-site antibodies induces conformational change. Correlation with neutralization potency and analysis of receptor-antibody thermodynamic cycles suggested a receptor-binding-site 'conformational masking' mechanism of neutralization escape. To understand how such an escape mechanism would be compatible with virus-receptor interactions, we tested a soluble dodecameric receptor molecule and found that it neutralized primary HIV-1 isolates with great potency, showing that simultaneous binding of viral envelope glycoproteins by multiple receptors creates sufficient avidity to compensate for such masking. Because this solution is available for cell-surface receptors but not for most antibodies, conformational masking enables HIV-1 to maintain receptor binding and simultaneously to resist neutralization.	NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; NIAID, NIH, Bethesda, MD 20892 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; GlaxosmithKline Pharmaceut, Dept Biol Struct, King Of Prussia, PA 19406 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Tanox Biosyst Inc, Cell Biol, Houston, TX 77025 USA; Univ Agr & Forestry, Inst Appl Microbiol, A-1190 Vienna, Austria; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Tulane Univ, Med Ctr, Dept Pediat, New Orleans, LA 70112 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Div AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; Columbia University; Howard Hughes Medical Institute; GlaxoSmithKline; Johns Hopkins University; University of Pennsylvania; Scripps Research Institute; Scripps Research Institute; Tulane University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kwong, PD (corresponding author), NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA.			Parren, Paul/0000-0002-4365-3859; Doyle, Michael/0000-0003-4569-6315	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000883, ZIAAI000883] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; Binley JM, 1998, AIDS RES HUM RETROV, V14, P191, DOI 10.1089/aid.1998.14.191; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Doyle ML, 2000, METHOD ENZYMOL, V323, P207; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; FUNG MSC, 1992, J VIROL, V66, P848, DOI 10.1128/JVI.66.2.848-856.1992; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Luque I, 1998, METHOD ENZYMOL, V295, P100; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; MOORE JP, 1992, J VIROL, V66, P235, DOI 10.1128/JVI.66.1.235-243.1992; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; POSNER MR, 1991, J IMMUNOL, V146, P4325; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; TRAUNECKER A, 1989, NATURE, V339, P68, DOI 10.1038/339068a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; WEISS RA, 1985, NATURE, V316, P69, DOI 10.1038/316069a0; Wyatt R, 1997, J VIROL, V71, P9722, DOI 10.1128/JVI.71.12.9722-9731.1997; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhou JY, 1997, J VIROL, V71, P2512, DOI 10.1128/JVI.71.3.2512-2517.1997; Zhu P, 2001, J VIROL, V75, P6682, DOI 10.1128/JVI.75.14.6682-6686.2001	30	712	760	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					678	682		10.1038/nature01188	http://dx.doi.org/10.1038/nature01188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478295				2022-12-28	WOS:000179751800048
J	Knust, E; Bossinger, O				Knust, E; Bossinger, O			Composition and formation of intercellular junctions in epithelial cells	SCIENCE			English	Review							ZONULA ADHERENS FORMATION; ADHESION MOLECULE JAM; CAENORHABDITIS-ELEGANS; TIGHT JUNCTIONS; COOPERATIVE REGULATION; DROSOPHILA STARDUST; SEPTATE JUNCTION; C-ELEGANS; POLARITY; PROTEIN	The polarized nature of epithelial cells is manifested by the nonrandom partitioning of organelles within the cells, the concentration of intercellular junctions at one pole, and the asymmetric distribution of proteins and lipids within the plasma membrane. These features allow epithelia to fulfill their specific tasks, such as targeted uptake and secretion of molecules and the segregation of different tissue compartments. The accessibility of Drosophila melanogaster and Caenorhabditis elegans to genetic and cell biological analyses, combined with the study of mammalian cells in culture, provides an ideal basis for understanding the mechanisms that control the establishment and maintenance of epithelial cell polarity and tissue integrity. Here, we focus on some of the best-studied junctions and membrane-associated protein complexes and their relation to cell polarity. Comparisons between fly, worm, and vertebrate epithelia reveal marked similarities with respect to the molecules used, and pronounced differences in the organization of the junctions themselves.	Univ Dusseldorf, Inst Genet, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Knust, E (corresponding author), Univ Dusseldorf, Inst Genet, Univ Str 1, D-40225 Dusseldorf, Germany.		Knust, Elisabeth/B-4338-2017					Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bilder D, 2000, NAT CELL BIOL, V2, pE114, DOI 10.1038/35017119; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; BILDER D, IN PRESS NATURE CELL; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chen LS, 2001, J CELL BIOL, V154, P841, DOI 10.1083/jcb.200009004; den Hollander AI, 2002, MECH DEVELOP, V110, P203, DOI 10.1016/S0925-4773(01)00568-8; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Fleming TP, 2000, SEMIN CELL DEV BIOL, V11, P291, DOI 10.1006/scdb.2000.0179; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; HURD DD, IN PRESS DEV BIOL; Hutter H, 2000, SCIENCE, V287, P989, DOI 10.1126/science.287.5455.989; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Johnson K, 2002, CURR BIOL, V12, P1675, DOI 10.1016/S0960-9822(02)01180-6; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Labouesse M, 1997, DEV DYNAM, V210, P19, DOI 10.1002/(SICI)1097-0177(199709)210:1<19::AID-AJA3>3.0.CO;2-4; Lecuit T, 2002, TRAFFIC, V3, P92, DOI 10.1034/j.1600-0854.2002.030202.x; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; Lemmers C, 2002, J BIOL CHEM, V277, P25408, DOI 10.1074/jbc.M202196200; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Maduro MF, 2002, DEV BIOL, V246, P68, DOI 10.1006/dbio.2002.0655; McMahon L, 2001, J CELL SCI, V114, P2265; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Michaux G, 2001, GENE, V277, P83, DOI 10.1016/S0378-1119(01)00700-4; Muller HAJ, 2000, DEV DYNAM, V218, P52; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; PODBILEWICZ B, 1994, DEV BIOL, V161, P408, DOI 10.1006/dbio.1994.1041; Roh MH, 2002, J BIOL CHEM, V277, P27501, DOI 10.1074/jbc.M201177200; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Simske JS, 2001, BIOESSAYS, V23, P12, DOI 10.1002/1521-1878(200101)23:1&lt;12::AID-BIES1003&gt;3.0.CO;2-R; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ward RE, 1998, J CELL BIOL, V140, P1463, DOI 10.1083/jcb.140.6.1463; Watari Y, 1998, GENE, V224, P53, DOI 10.1016/S0378-1119(98)00527-7; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	49	315	335	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1955	1959		10.1126/science.1072161	http://dx.doi.org/10.1126/science.1072161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471248				2022-12-28	WOS:000179629200035
J	Stocum, DL				Stocum, DL			A tail of transdifferentiation	SCIENCE			English	Editorial Material							NEURAL STEM-CELLS; ADULT; REGENERATION; BRAIN		Indiana Univ Purdue Univ, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA; Indiana Univ Purdue Univ, Sch Sci, Ctr Regenerat Biol & Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Stocum, DL (corresponding author), Indiana Univ Purdue Univ, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA.							Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Blau HM, 2002, NATURE, V419, P437, DOI 10.1038/419437a; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Kruger GM, 2002, CELL, V110, P399, DOI 10.1016/S0092-8674(02)00899-1; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; McGann CJ, 2001, P NATL ACAD SCI USA, V98, P13699, DOI 10.1073/pnas.221297398; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047	11	16	18	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1901	+		10.1126/science.1079853	http://dx.doi.org/10.1126/science.1079853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471238				2022-12-28	WOS:000179629200025
J	Bates, NR; Pequignet, AC; Johnson, RJ; Gruber, N				Bates, NR; Pequignet, AC; Johnson, RJ; Gruber, N			A short-term sink for atmospheric CO2 in subtropical mode water of the North Atlantic Ocean	NATURE			English	Article							INTERANNUAL VARIABILITY; TIME-SERIES; SEA; OSCILLATION; GYRE	Large-scale features of ocean circulation, such as deep water formation in the northern North Atlantic Ocean(1), are known to regulate the long-term physical uptake of CO2 from the atmosphere by moving CO2-laden surface waters into the deep ocean. But the importance of CO2 uptake into water masses that ventilate shallower ocean depths, such as subtropical mode waters(2) of the subtropical gyres, are poorly quantified. Here we report that, between 1988 and 2001, dissolved CO2 concentrations in subtropical mode waters of the North Atlantic have increased at a rate twice that expected from these waters keeping in equilibrium with increasing atmospheric CO2. This accounts for an extra similar to0.4-2.8 Pg C (1 Pg = 10(15) g) over this period (that is, about 0.03-0.24 Pg Cyr(-1)), equivalent to similar to3-10% of the current net annual ocean uptake of CO2 (ref. 3). We suggest that the lack of strong winter mixing events, to greater than 300 m in depth, in recent decades is responsible for this accumulation, which would otherwise disturb the mode water layer and liberate accumulated CO2 back to the atmosphere. However, future climate variability (which influences subtropical mode water formation(1,4-8)) and changes in the North Atlantic Oscillation(9) (leading to a return of deep winter mixing events) may reduce CO2 accumulation in subtropical mode waters. We therefore conclude that, although CO2 uptake by subtropical mode waters in the North Atlantic-and possibly elsewhere-does not always represent a long-term CO2 sink, the phenomenon is likely to contribute substantially to interannual variability in oceanic CO2 uptake(3).	Bermuda Biol Stn Res Inc, Ferry Reach GE01, Bermuda; Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Bates, NR (corresponding author), Bermuda Biol Stn Res Inc, Ferry Reach GE01, Bermuda.	nick@bbsr.edu	Gruber, Nicolas/B-7013-2009; Pequignet, Christine/H-5618-2014	Gruber, Nicolas/0000-0002-2085-2310; 				Alfultis MA, 2001, J PHYS OCEANOGR, V31, P2066, DOI 10.1175/1520-0485(2001)031<2066:AAICIT>2.0.CO;2; Bates NR, 1996, DEEP-SEA RES PT II, V43, P347, DOI 10.1016/0967-0645(95)00093-3; Bates NR, 2001, DEEP-SEA RES PT II, V48, P1507, DOI 10.1016/S0967-0645(00)00151-X; BEHRINGER DW, 1980, DEEP-SEA RES, V27, P225, DOI 10.1016/0198-0149(80)90014-X; Conte MH, 2001, DEEP-SEA RES PT II, V48, P1471, DOI 10.1016/S0967-0645(00)00150-8; Dickson R, 1996, PROG OCEANOGR, V38, P241, DOI 10.1016/S0079-6611(97)00002-5; GRAEDEL TE, 1988, APPL GEOCHEM, V3, P37; HANAWA K, 2001, INT GEOPHYSICS SERIE, V77, P378; Hazeleger W, 1998, J PHYS OCEANOGR, V28, P266, DOI 10.1175/1520-0485(1998)028<0266:MWVIAM>2.0.CO;2; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jenkins WJ, 1982, J MAR RES, V40, P265; Jenkins WJ, 1998, J GEOPHYS RES-OCEANS, V103, P15817, DOI 10.1029/98JC00141; Joyce TM, 2000, J CLIMATE, V13, P2550, DOI 10.1175/1520-0442(2000)013<2550:TRBDVO>2.0.CO;2; Joyce TM, 1996, J CLIMATE, V9, P3121, DOI 10.1175/1520-0442(1996)009<3121:TLTHRA>2.0.CO;2; KARL DM, IN PRESS DEEP SEA RE; Keeling C. D., 1993, GLOBAL CARBON CYCLE, P413; Klein B, 1996, DEEP-SEA RES PT I, V43, P1777, DOI 10.1016/S0967-0637(96)00069-6; LUYTEN JR, 1983, J PHYS OCEANOGR, V13, P292, DOI 10.1175/1520-0485(1983)013<0292:TVT>2.0.CO;2; Marsh R, 1996, J PHYS OCEANOGR, V26, P1059, DOI 10.1175/1520-0485(1996)026<1059:MWV>2.0.CO;2; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Rodwell MJ, 1999, NATURE, V398, P320, DOI 10.1038/18648; Sarmiento JL, 2002, SEA BIOL PHYSICAL IN, V12, P337; SPALL MA, 1992, J PHYS OCEANOGR, V22, P564, DOI 10.1175/1520-0485(1992)022<0564:CSARIT>2.0.CO;2; SPEER K, 1992, J PHYS OCEANOGR, V22, P93, DOI 10.1175/1520-0485(1992)022<0093:ROWMFI>2.0.CO;2; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Talley LD, 1982, J MAR RES, V40, P757; Wanninkhof R, 1999, GEOPHYS RES LETT, V26, P1889, DOI 10.1029/1999GL900363; Williams RG, 1995, J PHYS OCEANOGR, V25, P3089, DOI 10.1175/1520-0485(1995)025<3089:DSMLW>2.0.CO;2; WOODS JD, 1986, NATURE, V319, P574, DOI 10.1038/319574a0; WORTHINGTON LV, 1959, DEEP-SEA RES, V5, P297, DOI 10.1016/0146-6313(58)90026-1	30	86	87	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					489	493		10.1038/nature01253	http://dx.doi.org/10.1038/nature01253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12487116				2022-12-28	WOS:000179611600041
J	Green, RH; Brightling, CE; McKenna, S; Hargadon, B; Parker, D; Bradding, P; Wardlaw, AJ; Pavord, ID				Green, RH; Brightling, CE; McKenna, S; Hargadon, B; Parker, D; Bradding, P; Wardlaw, AJ; Pavord, ID			Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial	LANCET			English	Article							AIRWAY INFLAMMATION; HYPERRESPONSIVENESS	Background Treatment decisions in asthma are based on assessments of symptoms and simple measures of lung function, which do not relate closely to underlying eosinophilic airway inflammation. We aimed to assess whether a management strategy that minimises eosinophilic inflammation reduces asthma exacerbations compared with a standard management strategy. Methods We recruited 74 patients with moderate to severe asthma from hospital clinics and randomly allocated them to management either by standard British Thoracic Society asthma guidelines (BTS management group) or by normalisation of the induced sputum eosinophil count and reduction of symptoms (sputum management group). We assessed patients nine times over 12 months. The results were used to manage those in the sputum management group, but were not disclosed in the BTS group. The primary outcomes were the number of severe exacerbations and control of eosinophilic inflammation, measured by induced sputum eosinophil count. Analyses were by intention to treat. Findings The sputum eosinophil count was 63% (95% CI 24-100) lower over 12 months in the sputum management group than in the BTS management group (p=0.002). Patients in the sputum management group had significantly fewer severe asthma exacerbations than did patients in the BTS management group (35 vs 109; p=0.01) and significantly fewer patients were admitted to hospital with asthma (one vs six, p=0.047). The average daily dose of inhaled or oral corticosteroids did not differ between the two groups. Interpretation A treatment strategy directed at normalisation of the induced sputum eosinophil count reduces asthma exacerbations and admissions without the need for additional anti-inflammatory treatment.	Glenfield Hosp, Inst Lung Hlth, Dept Resp Med & Thorac Surg, Leicester LE3 9PQ, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Pavord, ID (corresponding author), Glenfield Hosp, Inst Lung Hlth, Dept Resp Med & Thorac Surg, Leicester LE3 9PQ, Leics, England.			Wardlaw, Andrew/0000-0001-6583-0791; Pavord, Ian/0000-0002-4288-5973; Bradding, Peter/0000-0001-8403-0319; brightling, chris/0000-0002-9345-4903				Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Campbell MJ, 1997, BRIT MED J, V314, P1439, DOI 10.1136/bmj.314.7092.1439; Carroll N, 1996, EUR RESPIR J, V9, P709, DOI 10.1183/09031936.96.09040709; Crimi E, 1998, AM J RESP CRIT CARE, V157, P4, DOI 10.1164/ajrccm.157.1.9703002; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; GREEN RH, 2000, EUR RESPIR J, V16, pS7; Hoskins G, 2000, THORAX, V55, P19, DOI 10.1136/thorax.55.1.19; Janson C, 1997, EUR RESPIR J, V10, P1795, DOI 10.1183/09031936.97.10081795; Jatakanon A, 2000, AM J RESP CRIT CARE, V161, P64, DOI 10.1164/ajrccm.161.1.9809100; Juniper E, 1994, HISTAMINE METHACHOLI; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; Kharitonov S, 1997, EUR RESPIR J, V10, P1683, DOI 10.1183/09031936.97.10071683; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Louis R, 2000, CLIN EXP ALLERGY, V30, P1151; NETTON A, 2001, UNIT COSTS HLTH SOCI; *NHS, 2001, NEW NHS 2001 REF COS; Parameswaran K, 2000, EUR RESPIR J, V15, P486, DOI 10.1034/j.1399-3003.2000.15.10.x; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Pavord ID, 1997, THORAX, V52, P498, DOI 10.1136/thx.52.6.498; Pizzichini E, 1999, EUR RESPIR J, V14, P12, DOI 10.1034/j.1399-3003.1999.14a04.x; Pizzichini MMM, 1999, EUR RESPIR J, V13, P15, DOI 10.1183/09031936.99.13101599; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Reddel H, 1999, LANCET, V353, P364, DOI 10.1016/S0140-6736(98)06128-5; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Treasure T, 1998, BRIT MED J, V317, P362; Turner M O, 1998, Can Respir J, V5, P261; Veen JCCMI, 1998, AM J RESP CRIT CARE, V158, P1134, DOI 10.1164/ajrccm.158.4.9710087; Wardlaw AJ, 2000, BRIT MED BULL, V56, P985, DOI 10.1258/0007142001903490; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	32	1328	1377	0	28	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1715	1721		10.1016/S0140-6736(02)11679-5	http://dx.doi.org/10.1016/S0140-6736(02)11679-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480423				2022-12-28	WOS:000179636800007
J	Hoermann, R				Hoermann, R			Thyroid-hormone suppressive therapy in benign thyroid nodules - is it effective?	LANCET			English	Editorial Material							MULTINODULAR GOITERS; LEVOTHYROXINE; PREVALENCE		Klinikum Luedenscheid, Dept Gen Internal Med Gastroenterol & Endocrinol, D-58515 Luedenscheid, Germany		Hoermann, R (corresponding author), Klinikum Luedenscheid, Dept Gen Internal Med Gastroenterol & Endocrinol, D-58515 Luedenscheid, Germany.			Hoermann, Rudolf/0000-0002-1326-4270				BURGI H, 1990, ACTA ENDOCRINOL-COP, V123, P577, DOI 10.1530/acta.0.1230577; Castro MR, 2002, J CLIN ENDOCR METAB, V87, P4154, DOI 10.1210/jc.2001-011762; HAMPEL R, 1995, MED KLIN, V90, P324; KOPP P, 1994, J CLIN ENDOCR METAB, V79, P134, DOI 10.1210/jc.79.1.134; Krohn K, 2002, MOL GENET METAB, V75, P202, DOI 10.1006/mgme.2001.3290; Lima N, 1997, THYROID, V7, P691, DOI 10.1089/thy.1997.7.691; Quadbeck B, 2002, EXP CLIN ENDOCR DIAB, V110, P348, DOI 10.1055/s-2002-34992; STUDER H, 1995, ENDOCR REV, V16, P411, DOI 10.1210/er.16.4.411; Zelmanovitz F, 1998, J CLIN ENDOCR METAB, V83, P3881, DOI 10.1210/jc.83.11.3881	9	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1899	1900		10.1016/S0140-6736(02)11934-9	http://dx.doi.org/10.1016/S0140-6736(02)11934-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493251				2022-12-28	WOS:000179870200003
J	Janata, P; Birk, JL; Van Horn, JD; Leman, M; Tillmann, B; Bharucha, JJ				Janata, P; Birk, JL; Van Horn, JD; Leman, M; Tillmann, B; Bharucha, JJ			The cortical topography of tonal structures underlying Western music	SCIENCE			English	Article							PREFRONTAL CORTICES; MEMORY; PITCH; EXPECTANCY; CONNECTIONS; MECHANISMS; CHORDS; CORTEX; TIME; ERP	Western tonal music relies on a formal geometric structure that determines distance relationships within a harmonic or tonal space. In functional magnetic resonance imaging experiments, we identified an area in the rostromedial prefrontal cortex that tracks activation in tonal space. Different voxels in this area exhibited selectivity for different keys. Within the same set of consistently activated voxels, the topography of tonality selectivity rearranged itself across scanning sessions. The tonality structure was thus maintained as a dynamic topography in cortical areas known to be at a nexus of cognitive, affective, and mnemonic processing.	Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA; Dartmouth Coll, Dartmouth Brain Imaging Ctr, Hanover, NH 03755 USA; State Univ Ghent, Inst Psychoacoust & Electron Music, B-9000 Ghent, Belgium	Dartmouth College; Dartmouth College; Dartmouth College; Ghent University	Janata, P (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.			Van Horn, John Darrell/0000-0003-1537-0816; Birk, Jeffrey/0000-0002-1313-0993	NINDS NIH HHS [P50 NS17778-18] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS017778] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; BESSON M, 1995, J EXP PSYCHOL HUMAN, V21, P1278, DOI 10.1037/0096-1523.21.6.1278; BHARUCHA JJ, 1986, J EXP PSYCHOL HUMAN, V12, P403, DOI 10.1037/0096-1523.12.4.403; BIGAND E, IN PRESS J EXP PSYCH; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; Eggermont JJ, 1998, NEUROSCI BIOBEHAV R, V22, P355, DOI 10.1016/S0149-7634(97)00021-3; FRANCES R, 1958, PERCEPTION MUSIQUE; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gazzaniga M., 2000, NEW COGNITIVE NEUROS, P1047; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Huron D., 1993, PSYCHOMUSICOLOGY J R, V12, P154, DOI DOI 10.1037/H0094110; JANATA P, 1995, J COGNITIVE NEUROSCI, V7, P153, DOI 10.1162/jocn.1995.7.2.153; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; KRUMHANSL CL, 1982, PSYCHOL REV, V89, P334, DOI 10.1037/0033-295X.89.4.334; Leman M, 2000, MUSIC PERCEPT, V17, P481; Lerdahl F., 2001, TONAL PITCH SPACE; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Meyer L., 1956, EMOTION MEANING MUSI; ORAM N, 1995, PSYCHOL RES-PSYCH FO, V57, P103; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Peretz I, 2001, BRAIN, V124, P928, DOI 10.1093/brain/124.5.928; SHEPARD RN, 1982, PSYCHOL REV, V89, P305, DOI 10.1037/0033-295X.89.4.305; Tekman HG, 1998, J EXP PSYCHOL HUMAN, V24, P252, DOI 10.1037/0096-1523.24.1.252; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885; Tramo M J, 1990, J Cogn Neurosci, V2, P195, DOI 10.1162/jocn.1990.2.3.195; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	30	252	257	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2167	2170		10.1126/science.1076262	http://dx.doi.org/10.1126/science.1076262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	624RA	12481131				2022-12-28	WOS:000179773700040
J	Matter, N; Herrlich, P; Konig, H				Matter, N; Herrlich, P; Konig, H			Signal-dependent regulation of splicing via phosphorylation of Sam68	NATURE			English	Article							MESSENGER-RNA; CD44; KINASE; TRANSDUCTION; ACTIVATION; SELECTION; DOMAINS; BINDING; MITOSIS; VARIANT	Evolution of human organismal complexity from a relatively small number of genes(1,2-)only approximately twice that of worm or fly-is explained mainly by mechanisms generating multiple proteins from a single gene, the most prevalent of which is alternative pre-messenger-RNA splicing(1,3,4). Appropriate spatial and temporal generation of splice variants demands that alternative splicing be subject to extensive regulation, similar to transcriptional control. Activation by extracellular cues of several cellular signalling pathways can indeed regulate alternative splicing(5-8). Here we address the link between signal transduction and splice regulation. We show that the nuclear RNA-binding protein Sam68 is a new extracellular signal-regulated kinase (ERK) target. It binds exonic splice-regulatory elements of an alternatively spliced exon that is physiologically regulated by the Ras signalling pathway, namely exon v5 of CD44. Forced expression of Sam68 enhanced ERK-mediated inclusion of the v5-exon sequence in mRNA. This enhancement was impaired by mutation of ERK-phosphorylation sites in Sam68, whereas ERK phosphorylation of Sam68 stimulated splicing of the v5 exon in vitro. Finally, Ras-pathway-induced alternative splicing of the endogenous CD44-v5 exon was abolished by suppression of Sam68 expression. Our data define Sam68 as a prototype regulator of alternative splicing whose function depends on protein modification in response to extracellular cues.	Forschungszentrum Karlsruhe, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; Univ Karlsruhe, Inst Genet, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Konig, H (corresponding author), Forschungszentrum Karlsruhe, Inst Toxicol & Genet, Postfach 3640, D-76021 Karlsruhe, Germany.	harald.koenig@itg.fzk.de		Konig, Harald/0000-0002-0117-0939				ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; COOPER DL, 1995, NAT MED, V1, P635, DOI 10.1038/nm0795-635; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; MERMOUD JE, 1992, NUCLEIC ACIDS RES, V20, P5263, DOI 10.1093/nar/20.20.5263; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Reddy TR, 2000, ONCOGENE, V19, P3570, DOI 10.1038/sj.onc.1203676; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; Sherman L, 1996, CURR TOP MICROBIOL, V213, P249; Stoss O, 2001, J BIOL CHEM, V276, P8665, DOI 10.1074/jbc.M006851200; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593	26	355	366	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					691	695		10.1038/nature01153	http://dx.doi.org/10.1038/nature01153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478298				2022-12-28	WOS:000179751800051
J	Unutzer, J; Katon, W; Callahan, CM; Williams, JW; Hunkeler, E; Harpole, L; Hoffing, M; Della Penna, RD; Noel, PH; Lin, EHB; Arean, PA; Hegel, MT; Tang, LQ; Belin, TR; Oishi, S; Langston, C				Unutzer, J; Katon, W; Callahan, CM; Williams, JW; Hunkeler, E; Harpole, L; Hoffing, M; Della Penna, RD; Noel, PH; Lin, EHB; Arean, PA; Hegel, MT; Tang, LQ; Belin, TR; Oishi, S; Langston, C		IMPACT Investigators	Collaborative care management of late-life depression in the primary care setting - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MENTAL-HEALTH-SERVICES; PATIENTS AGED 65; MAJOR DEPRESSION; OLDER-ADULTS; QUALITY IMPROVEMENT; COST-EFFECTIVENESS; MINOR DEPRESSION; SYMPTOMS; DISORDERS; GUIDELINES	Context Few depressed older adults receive effective treatment in primary care settings. Objective To determine the effectiveness of the Improving Mood-Promoting Access to Collaborative Treatment (IMPACT) collaborative care management program for late-life depression. Design Randomized controlled trial with recruitment from July 1999 to August 2001. Setting Eighteen primary care clinics from 8 health care organizations in 5 states. Participants A total of 1801 patients aged 60 years or older with major depression (17%), dysthymic disorder (30%), or both (53%). Intervention Patients were randomly assigned to the IMPACT intervention (n=906) or to usual care (n=895). Intervention patients had access for up to 12 months to a depression care manager who was supervised by a psychiatrist and a primary care expert and who offered education, care management, and support of antidepressant management by the patient's primary care physician or a brief psychotherapy for depresssion, Problem Solving Treatment in Primary Care. Main Outcome Measures Assessments at baseline and at 3, 6, and 12 months for depression, depression treatments, satisfaction with care, functional impairment, and quality of life. Results At 12 months, 45% of intervention patients had a 50% or greater reduction in depressive symptoms from baseline compared with 19% of usual care participants (odds ratio [OR], 3.45; 95% confidence interval [CI], 2.71-4.38; P<.001). Intervention patients also experienced greater rates of depression treatment (OR, 2.98; 95% CI, 2.34-3.79; P<.001), more satisfaction with depression care (OR, 3.38; 95% CI, 2.66-4.30; P<.001), lower depression severity (range, 0-4; between-group difference, -0.4; 95% CI, -0.46 to -0.33; P<.001), less functional impairment (range, 0-10; between-group difference, -0.91; 95% CI, -1.19 to -0.64; P<.001), and greater quality of life (range, 0-10; between-group difference, 0.56; 95% CI, 0.32-0.79; P<.001) than participants assigned to the usual care group. Conclusion The IMPACT collaborative care model appears to be feasible and significantly more effective than usual care for depression in a wide range of primary care practices.	Univ Calif Los Angeles, Inst Neuropsychiat, Ctr Hlth Serv Res, Los Angeles, CA 90024 USA; Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Indiana Univ, Ctr Aging Res, Regenstrief Inst Hlth Care, Indianapolis, IN 46204 USA; Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Kaiser Permanente No Calif, Div Res, Oakland, CA USA; Desert Med Grp, Palm Springs, CA USA; Kaiser Permanente So Calif, San Diego, CA USA; Univ Texas, Hlth Sci Ctr, S Texas Vet Hlth Care Syst, San Antonio, TX USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Dartmouth Coll Sch Med, Dept Psychiat, Hanover, NH USA; John A Hartford Fdn, New York, NY USA	University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Group Health Cooperative; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Kaiser Permanente; Kaiser Permanente; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of California System; University of California San Francisco; Dartmouth College	Unutzer, J (corresponding author), Univ Calif Los Angeles, Inst Neuropsychiat, Ctr Hlth Serv Res, 10920 Wilshire Blvd,Suite 300, Los Angeles, CA 90024 USA.	unutzer@ucla.edu	Arean, Patricia/GLR-1550-2022; Unutzer, Jurgen/N-4048-2018; Williams, John W/A-3696-2008; Williams, John/AAM-4572-2020	Williams, John W/0000-0002-5267-5558; Williams, John/0000-0002-5267-5558; Noel, Polly/0000-0002-1519-7489				Alexopoulos G S, 1992, Clin Geriatr Med, V8, P363; Arean P., 1999, PROBLEM SOLVING THER; BELL R, 1999, PRESENTATION DEPRESS; Blazer DG, 2000, AM J PSYCHIAT, V157, P1089, DOI 10.1176/appi.ajp.157.7.1089; BRUCE ML, 1994, AM J PSYCHIAT, V151, P716; Callahan CM, 2001, MED CARE, V39, P772, DOI 10.1097/00005650-200108000-00004; CALLAHAN CM, 1994, J AM GERIATR SOC, V42, P839, DOI 10.1111/j.1532-5415.1994.tb06555.x; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; CALLAHAN CM, 1994, J AM GERIATR SOC, V42, P833, DOI 10.1111/j.1532-5415.1994.tb06554.x; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Cole MG, 1996, INT J GERIATR PSYCH, V11, P157, DOI 10.1002/(SICI)1099-1166(199602)11:2<157::AID-GPS304>3.0.CO;2-S; Cole MG, 1997, AM J GERIAT PSYCHIAT, V5, P4; Conwell Y, 1996, AM J PSYCHIAT, V153, P1001; Coyne J, 2001, MED CARE, V39, P756, DOI 10.1097/00005650-200108000-00002; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; First M.B., 2014, STRUCTURED CLIN INTE; FRIEDHOFF AJ, 1992, JAMA-J AM MED ASSOC, V268, P1018, DOI 10.1001/jama.1992.03490080092032; GANGULI M, 1995, AM J GERIAT PSYCHIAT, V3, P144, DOI 10.1097/00019442-199500320-00006; Geerlings SW, 2000, PSYCHOL MED, V30, P369, DOI 10.1017/S0033291799001890; Gill D, 1999, J PSYCHOSOM RES, V47, P131, DOI 10.1016/S0022-3999(99)00020-3; GOLDSTROM ID, 1987, J GERONTOL, V42, P147, DOI 10.1093/geronj/42.2.147; Gurland BJ, 1996, AM J GERIAT PSYCHIAT, V4, pS7; HARPOLE L, 1999, MAKING IMPACT IMPROV; Hegel M, 1999, PROBLEM SOLVING TREA; Hegel M. T., 2000, FAMILIES SYSTEMS HLT, V18, P423, DOI DOI 10.1037/H0091866; Hegel M. T., 2002, FAM SYST HEALTH, V20, P265, DOI DOI 10.1037/H0089475; Hunkeler EM, 2000, ARCH FAM MED, V9, P700, DOI 10.1001/archfami.9.8.700; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LAVORI PW, 1995, STAT MED, V14, P1913, DOI 10.1002/sim.4780141707; Lebowitz BD, 1996, AM J GERIAT PSYCHIAT, V4, pS3; Lin EHB, 1997, MED CARE, V35, P831, DOI 10.1097/00005650-199708000-00008; Lin EHB, 2000, ARCH FAM MED, V9, P1052, DOI 10.1001/archfami.9.10.1052; LITTELL RC, 1996, SAS SYSTEM MIXED MOD, pCH3; LITTLE RJA, 1988, J BUS ECON STAT, V6, P287, DOI 10.2307/1391878; Luber MP, 2000, INT J PSYCHIAT MED, V30, P1, DOI 10.2190/YTRY-E86M-G1VC-LC79; Luber MP, 2001, AM J GERIAT PSYCHIAT, V9, P169, DOI 10.1176/appi.ajgp.9.2.169; Lyness JM, 1999, J GEN INTERN MED, V14, P249, DOI 10.1046/j.1525-1497.1999.00326.x; Mamdani MM, 2000, AM J PSYCHIAT, V157, P360, DOI 10.1176/appi.ajp.157.3.360; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; MEYERS BS, 1997, NAT I MENT HLTH C IM; Mynors-Wallis LM, 2000, BMJ-BRIT MED J, V320, P26, DOI 10.1136/bmj.320.7226.26; OISHI S, 1999, MAKING IMPACT LATE L; OISHI SM, IN PRESS PSYCHIAT Q; Olfson M, 2002, JAMA-J AM MED ASSOC, V287, P203, DOI 10.1001/jama.287.2.203; OXMAN TE, 1990, PSYCHOSOMATICS, V31, P174, DOI 10.1016/S0033-3182(90)72191-3; Penninx BWJH, 2001, ARCH GEN PSYCHIAT, V58, P221, DOI 10.1001/archpsyc.58.3.221; Penninx BWJH, 1999, ARCH GEN PSYCHIAT, V56, P889, DOI 10.1001/archpsyc.56.10.889; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Reynolds CF, 1999, JAMA-J AM MED ASSOC, V281, P39, DOI 10.1001/jama.281.1.39; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Saunders K, 1998, J CLIN EPIDEMIOL, V51, P883; Saur CD, 2002, J AM PSYCHIAT NURSES, V8, P159; Schoenbaum M, 2001, JAMA-J AM MED ASSOC, V286, P1325, DOI 10.1001/jama.286.11.1325; Schulberg HC, 1999, J CLIN PSYCHIAT, V60, P19; Schulberg HC, 1998, INT J PSYCHIAT MED, V28, P421, DOI 10.2190/G23R-NGGN-K1P1-MQ8N; SHAPIRO S, 1984, ARCH GEN PSYCHIAT, V41, P971; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Simon GE, 2001, AM J PSYCHIAT, V158, P1638, DOI 10.1176/appi.ajp.158.10.1638; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Swartz MS, 1998, COMMUNITY MENT HLT J, V34, P133, DOI 10.1023/A:1018736917761; Unutzer J, 1997, JAMA-J AM MED ASSOC, V277, P1618, DOI 10.1001/jama.277.20.1618; Unutzer J, 1999, MILBANK Q, V77, P225, DOI 10.1111/1468-0009.00132; Unutzer J, 1999, AM J GERIAT PSYCHIAT, V7, P235; Unutzer J, 2002, PSYCHIATR SERV, V53, P671, DOI 10.1176/appi.ps.53.6.671; Unutzer J, 2001, MED CARE, V39, P785, DOI 10.1097/00005650-200108000-00005; Unutzer J, 2001, ARCH GEN PSYCHIAT, V58, P935, DOI 10.1001/archpsyc.58.10.935; Unutzer J, 2000, J AM GERIATR SOC, V48, P871; Unutzer J, 2000, INT PSYCHOGERIATR, V12, P15, DOI 10.1017/S1041610200006177; UNUTZER J, IN PRESS J AM GERIAT; Unutzer J, 1999, IMPACT INTERVENTION; Von Korff M, 2002, BRIT MED J, V325, P92, DOI 10.1136/bmj.325.7355.92; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; WAXMAN HM, 1984, GERONTOLOGIST, V24, P593, DOI 10.1093/geront/24.6.593; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Williams JW, 2000, JAMA-J AM MED ASSOC, V284, P1519, DOI 10.1001/jama.284.12.1519; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55; 2001, HLTH CARE FINANC JUN, P104	80	1711	1719	1	124	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2836	2845		10.1001/jama.288.22.2836	http://dx.doi.org/10.1001/jama.288.22.2836			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	623YM	12472325				2022-12-28	WOS:000179732600028
J	Collins, S; Sadler, K				Collins, S; Sadler, K			Outpatient care for severely malnourished children in emergency relief programmes: a retrospective cohort study	LANCET			English	Article							SEVERE MALNUTRITION; MORTALITY	Background In emergency nutritional relief programmes, therapeutic feeding centres are the accepted intervention for the treatment of severely malnourished people. These centres often cannot treat all the people requiring care. Consequently, coverage of therapeutic feeding centre programmes can be low, reducing their effectiveness. We aimed to assess the effectiveness of outpatient treatment for severe malnutrition in an emergency relief programme. Methods We did a retrospective cohort study in an outpatient therapeutic feeding programme in Ethiopia from September, 2000, to January, 2001. We assessed clinical records for 170 children aged 6-120 months. The children had either marasmus, kwashiorkor, or marasmic kwashiorkor. Outcomes were mortality, default from programme, discharge from programme, rate of weight gain, and length of stay in programme. Findings 144 (85%) patients recovered, seven (4%) died, 11 (6%) were transferred, and eight (5%) defaulted. Median time to discharge was 42 days (IQR 28-56), days to death 14 (7-26), and days to default 14 (7-28). Median rate of weight gain was 3.16 g kg(-1) day(-1) (1.86-5.60). In patients who recovered, median rates of weight gain were 4.80 g kg(-1) day(-1) (2.95-8.07) for marasmic patients, 4.03 g kg(-1) day(-1) (2.68-4.29) for marasmic kwashiorkor patients, and 2.70 g kg(-1) day(-1) (0.00-4.76) for kwashiorkor patients. Interpretation Outpatient treatment exceeded internationally accepted minimum standards for recovery, default, and mortality rates. Time spent in the programme and rates of weight gain did not meet these standards. Outpatient care could provide a complementary treatment strategy to therapeutic feeding centres. Further research should compare the effectiveness of outpatient and centre-based treatment of severe malnutrition in emergency nutritional interventions.	Valid Int, London, England; Inst Child Hlth, Ctr Int Child Hlth, London, England; Concern Worldwide, Dublin, Ireland	University of London; University College London	Collins, S (corresponding author), 37 Squires Court,Binfield Rd, London SW4 6TD, England.							Ashworth A, 1997, HEALTH POLICY PLANN, V12, P115, DOI 10.1093/heapol/12.2.115; BEATON GH, 1982, AM J CLIN NUTR, V35, P864, DOI 10.1093/ajcn/35.4.864; BOELAERT M, 1995, NUTR GUIDELINES; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Collins S, 1998, AM J CLIN NUTR, V68, P193, DOI 10.1093/ajcn/68.1.193; Collins S, 2001, LANCET, V358, P498, DOI 10.1016/S0140-6736(01)05630-6; de Waal A., 1989, FAMINE KILLS DARFUR; DEGOYET CV, 2000, MANAGEMENT NUTR EMER; GOLDEN MHN, 1993, LANCET, V342, P360, DOI 10.1016/0140-6736(93)91491-4; Gomez Federico, 1956, J Trop Pediatr (Lond), V2, P77; Khanum S, 1998, AM J CLIN NUTR, V67, P940, DOI 10.1093/ajcn/67.5.940; KHANUM S, 1994, LANCET, V344, P1728; *NAT CTR HLTH STAT, 1979, NCHS GROWTH CURV CHI; Prudhon C, 1997, EUR J CLIN NUTR, V51, P771, DOI 10.1038/sj.ejcn.1600483; *SPHER PROJ, 2000, PROJ TEAM SPHER PROJ; WATERLOW JC, 1993, PROTEIN ENERGY MALNU; *WHO UN HIGH COMM, 2000, MAN NUTR MAJ EM; *WORLD FOOD PROGR, 2000, FOOD NUTR HDB; World Health Organization, 1998, MAN SEV MALN MAN PHY	19	91	92	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1824	1830		10.1016/S0140-6736(02)11770-3	http://dx.doi.org/10.1016/S0140-6736(02)11770-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480359				2022-12-28	WOS:000179706100009
J	Dickey, JO; Marcus, SL; de Viron, O; Fukumori, I				Dickey, JO; Marcus, SL; de Viron, O; Fukumori, I			Recent Earth oblateness variations: Unraveling climate and postglacial rebound effects	SCIENCE			English	Article							NCEP-NCAR REANALYSIS; MASS-BALANCE; TEMPERATURE; ROTATION; TRENDS	Earth's dynamic oblateness (J(2)) has been decreasing due to postglacial rebound (PGR). However, J(2) began to increase in 1997, indicating a pronounced global-scale mass redistribution within Earth's system. We have determined that the observed increases in J(2) are caused primarily by a recent surge in subpolar glacial melting and by mass shifts in the Southern, Pacific, and Indian oceans. When these effects are removed, the residual trend in J(2) (-2.9 x 10(-11) year(-1)) becomes consistent with previous estimates of PGR from satellite and eclipse data. The climatic significance of these rapid shifts in glacial and oceanic mass, however, remains to be investigated.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Observ Royal Belgique, FNRS, B-1180 Brussels, Belgium	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Fonds de la Recherche Scientifique - FNRS	Dickey, JO (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	jean.o.dickey@jpl.nasa.gov	de Viron, Olivier/N-6647-2014; Fukumori, Ichiro/AAY-9005-2020	de Viron, Olivier/0000-0003-3112-9686; Fukumori, Ichiro/0000-0002-0882-6400; Marcus, Steven/0000-0002-5763-6961				Adam D, 2002, NATURE, V416, P10, DOI 10.1038/416010a; Cazenave A, 2002, SCIENCE, V297, P783, DOI 10.1126/science.1074593; Cox CM, 2002, SCIENCE, V297, P831, DOI 10.1126/science.1072188; Devoti R, 2001, GEOPHYS RES LETT, V28, P855, DOI 10.1029/2000GL011566; Dickey J O, 1997, SATELLITE GRAVITY GE; Dyurgerov MB, 2000, P NATL ACAD SCI USA, V97, P1406, DOI 10.1073/pnas.97.4.1406; Dyurgerov MB, 1997, ARCTIC ALPINE RES, V29, P379, DOI 10.2307/1551986; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hines KM, 2000, J CLIMATE, V13, P3940, DOI 10.1175/1520-0442(2000)013<3940:ASPTIT>2.0.CO;2; James TS, 1997, J GEOPHYS RES-SOL EA, V102, P605, DOI 10.1029/96JB02855; Johnston P, 1999, GEOPHYS J INT, V136, P537, DOI 10.1046/j.1365-246x.1999.00738.x; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Marshall GJ, 2002, J CLIMATE, V15, P659, DOI 10.1175/1520-0442(2002)015<0659:TIAGHA>2.0.CO;2; Oerlemans J, 2000, ANN GLACIOL-SER, V31, P39, DOI 10.3189/172756400781820246; Rignot E, 2002, SCIENCE, V297, P1502, DOI 10.1126/science.1073888; Sabadini R, 2002, GEODYNAMICS, V29, P51; STEPHENSON FR, 1995, PHILOS T R SOC A, V351, P165, DOI 10.1098/rsta.1995.0028; YODER CF, 1983, NATURE, V303, P757, DOI 10.1038/303757a0; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	20	79	84	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					1975	1977		10.1126/science.1077777	http://dx.doi.org/10.1126/science.1077777			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471253				2022-12-28	WOS:000179629200040
J	Kazmierczak, J; Kremer, B				Kazmierczak, J; Kremer, B			Palaeontology (Communication arising): Thermal alteration of the Earth's oldest fossils	NATURE			English	Article									Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences	Kazmierczak, J (corresponding author), Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland.		Kremer, Barbara/ABB-1201-2020	Kremer, Barbara/0000-0002-0464-1265				Aleksandrowski P, 2000, T ROY SOC EDIN-EARTH, V90, P127, DOI 10.1017/S0263593300007197; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; Dalton R, 2002, NATURE, V417, P782, DOI 10.1038/417782a; HORODYSKI RJ, 1975, J SEDIMENT PETROL, V45, P894; KOMAREK J, 1986, Archiv fuer Hydrobiologie Supplement, V73, P157; KREMER B, 2001, EARLY PALAEOZOIC PAL, P36; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; TISSOT BP, 1987, AAPG BULL, V71, P1445; Wyzga B, 1987, GEOL SUDETICA, V22, P119	9	27	28	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					477	478		10.1038/420477b	http://dx.doi.org/10.1038/420477b			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466835				2022-12-28	WOS:000179611600037
J	Ritchie, K; Lovestone, S				Ritchie, K; Lovestone, S			The dementias	LANCET			English	Article							CEREBRAL BLOOD-VOLUME; WHITE-MATTER LESIONS; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; ELDERLY-PEOPLE; LEWY BODIES; CHOLINESTERASE-INHIBITORS; VASCULAR DEMENTIA; PREVALENCE; BETA	Dementia affects about 5% of the elderly population over age 65 years and has an unexplained predominance in women and a low rate in some cultures. Different forms of dementia are now distinguished-Alzheimer's disease, dementia with Lewy bodies, frontotemporal dementia, and dementia secondary to disease, such as AIDS dementia. However, such nosological boundaries are being re-evaluated because different demential are believed to have common underlying neuropathology: Neurochemical and neurobiological research has led to advances in understanding causes of dementia, and functional imaging has allowed identification of possible biomarkers; from these, a range of potential treatment approaches have arisen that focus on enhancement of neurotransmitter function, intervention at the level of amyloid production and deposition, and reduction of secondary risk factors such as hypertension, depression, and hypolipidaemia. Molecular diagnostic testing and genetic counselling for families with autosomal dominant early-onset dementia are new developments; however, this approach is not useful for late-onset dementia, in which the identified candidate susceptibility genes have a relatively small effect on risk. While fundamental research works towards new biological treatment strategies, much remains to be done in the area of disease management and the development of appropriate models of long-term care.	Hop La Colombiere, INSERM, EMI 9930, Montpellier, France; Inst Psychiat, Old Age Psychiat Sect, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; University of London; King's College London	Ritchie, K (corresponding author), Hop La Colombiere, INSERM, EMI 9930, Montpellier, France.	ritchie@montp.inserm.fr	Ritchie, Karen/G-3571-2013	Ritchie, Karen/0000-0002-0688-8982; Lovestone, Simon/0000-0003-0473-4565				AKESSON HO, 1969, HUM HERED, V19, P546, DOI 10.1159/000152266; Allen NHP, 1996, BRIT J PSYCHIAT, V169, P293, DOI 10.1192/bjp.169.3.293; Alvarez G, 1999, FEBS LETT, V453, P260, DOI 10.1016/S0014-5793(99)00685-7; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Armstrong M, 2000, Nurs Stand, V14, P33; Auer S R, 1996, Int Psychogeriatr, V8, P247, DOI 10.1017/S1041610296002621; Avila J, 2000, FEBS LETT, V476, P89, DOI 10.1016/S0014-5793(00)01676-8; Barber R, 1999, ARCH NEUROL-CHICAGO, V56, P961, DOI 10.1001/archneur.56.8.961; BARCLAY LL, 1985, NEUROLOGY, V35, P834, DOI 10.1212/WNL.35.6.834; BRODATY H, 1990, AUST NZ J PSYCHIAT, V24, P351, DOI 10.3109/00048679009077702; Brodaty H, 1997, INT J GERIATR PSYCH, V12, P183; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Burns A, 1997, J NEURAL TRANSM-SUPP, P27; BURNS A, 1991, PSYCHOL MED, V21, P363, DOI 10.1017/S0033291700020468; Cahill S., 1993, AUSTR J AGEING, V12, P10, DOI DOI 10.1111/J.1741-6612.1993.TB00612.X; Chandra V, 1998, NEUROLOGY, V51, P1000, DOI 10.1212/WNL.51.4.1000; Chapman J, 1998, STROKE, V29, P1401, DOI 10.1161/01.STR.29.7.1401; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Davis KL, 1999, JAMA-J AM MED ASSOC, V281, P1401, DOI 10.1001/jama.281.15.1401; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; Dupuy AM, 2001, GERONTOLOGY, V47, P213, DOI 10.1159/000052801; Eastwood R, 1996, LANCET, V347, P1303; ERKINJUNTTI T, 2000, DEMENTIA; Finkel S I, 1996, Int Psychogeriatr, V8 Suppl 3, P497; FITZ AG, 1994, J AM GERIATR SOC, V42, P186, DOI 10.1111/j.1532-5415.1994.tb04950.x; Fox NC, 2000, ARCH NEUROL-CHICAGO, V57, P339, DOI 10.1001/archneur.57.3.339; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; HARDY J, 1995, AM J MED GENET, V60, P456, DOI 10.1002/ajmg.1320600519; HARPER S, 1990, INT J AGING HUM DEV, V30, P241, DOI 10.2190/9BLE-FED4-BRAC-RPX3; Harris GJ, 1996, AM J PSYCHIAT, V153, P721; Harris GJ, 1998, AM J NEURORADIOL, V19, P1727; HENDERSON AS, 1995, LANCET, V346, P1387, DOI 10.1016/S0140-6736(95)92405-1; Heutink P, 2000, HUM MOL GENET, V9, P979, DOI 10.1093/hmg/9.6.979; HOFMAN A, 1991, INT J EPIDEMIOL, V20, P736, DOI 10.1093/ije/20.3.736; HOMER AC, 1990, BRIT MED J, V301, P1359, DOI 10.1136/bmj.301.6765.1359; Huang W, 1999, AM J PSYCHIAT, V156, P1879; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; KIRBY M, 1995, J GERIATR PSYCH NEUR, V8, pS2, DOI 10.1177/089198879500800102; Laakso MP, 1996, NEUROLOGY, V46, P678, DOI 10.1212/WNL.46.3.678; LINDESAY J, 1991, INT J GERIATR PSYCH, V6, P727, DOI 10.1002/gps.930061007; Livingston G, 2000, INT J GERIATR PSYCH, V15, P203, DOI 10.1002/(SICI)1099-1166(200003)15:3<203::AID-GPS100>3.0.CO;2-9; Lovestone S, 1997, NEUROSCIENCE, V78, P309; Marshall W., 1997, STATE ART DEMENTIA C, V43, P556; MCCALLUM J, 1993, MODERN MED AUSTR, V9, P74; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Mega MS, 1996, NEUROLOGY, V46, P130, DOI 10.1212/WNL.46.1.130; MOLSA PK, 1982, ACTA NEUROL SCAND, V65, P541; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; MORTIMER JA, 1985, NEUROLOGY, V35, P1804, DOI 10.1212/WNL.35.12.1804-a; MORTIMER JA, 1992, NEUROLOGY, V42, P1689, DOI 10.1212/WNL.42.9.1689; Mudher A, 2002, TRENDS NEUROSCI, V25, P22, DOI 10.1016/S0166-2236(00)02031-2; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; NAGY Z, 1995, DEMENTIA, V6, P21, DOI 10.1159/000106918; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; Osuntokun B O, 1992, Afr J Med Med Sci, V21, P71; Paglini G, 2000, NEUROCHEM RES, V25, P37, DOI 10.1023/A:1007531230651; PILLEMER K, 1992, J GERONTOL, V47, pS165, DOI 10.1093/geronj/47.4.S165; Poirier J, 1996, J PSYCHIATR NEUROSCI, V21, P128; Reisberg B, 1992, Int Psychogeriatr, V4 Suppl 1, P9; RITCHIE K, 1995, LANCET, V346, P931, DOI 10.1016/S0140-6736(95)91556-7; Ritchie K, 1999, AGE AGEING, V28, P385, DOI 10.1093/ageing/28.4.385; RITCHIE K, 1992, INT J GERIATR PSYCH, V7, P549, DOI 10.1002/gps.930070804; RITCHIE K, 1992, INT J GERIATR PSYCH, V7, P5, DOI 10.1002/gps.930070103; ROCCA WA, 1991, ANN NEUROL, V30, P817, DOI 10.1002/ana.410300611; SCHELTENS P, 1992, BRAIN, V115, P735, DOI 10.1093/brain/115.3.735; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schulz R, 1997, ALZ DIS ASSOC DIS, V11, P117; Serby M, 2001, AM J GERIAT PSYCHIAT, V9, P212, DOI 10.1176/appi.ajgp.9.3.212; Skoog I, 1998, NEUROEPIDEMIOLOGY, V17, P2, DOI 10.1159/000026147; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Skoog I, 1998, J NEUROL NEUROSUR PS, V64, P37, DOI 10.1136/jnnp.64.1.37; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Steeman E, 1997, ARCH PSYCHIAT NURS, V11, P295, DOI 10.1016/S0883-9417(97)80002-7; STERN Y, 1987, NEUROLOGY, V37, P1649, DOI 10.1212/WNL.37.10.1649; STERN Y, 1992, ANN NEUROL, V32, P371, DOI 10.1002/ana.410320311; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Tariot P N, 1996, Int Psychogeriatr, V8 Suppl 3, P317; TARIOT PN, 1995, AM J PSYCHIAT, V152, P1349; Vandenberg CM, 2000, DRUG AGING, V16, P123, DOI 10.2165/00002512-200016020-00004; WADE JPH, 1987, ARCH NEUROL-CHICAGO, V44, P24, DOI 10.1001/archneur.1987.00520130016010; Wilcock DM, 2001, DNA CELL BIOL, V20, P731, DOI 10.1089/10445490152717596; Wilkinson D, 2001, INT J CLIN PRACT, V55, P129; ZHANG MY, 1990, ANN NEUROL, V27, P428, DOI 10.1002/ana.410270412; Zubenko GS, 1998, GENOMICS, V50, P121, DOI 10.1006/geno.1998.5306	94	328	347	1	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2002	360	9347					1759	1766		10.1016/S0140-6736(02)11667-9	http://dx.doi.org/10.1016/S0140-6736(02)11667-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622FU	12480441				2022-12-28	WOS:000179636800025
J	Gong, MN; Wittram, C; Mark, EJ				Gong, MN; Wittram, C; Mark, EJ			A 56-year-old man with rapidly worsening dyspnea - Usual interstitial pneumonitis (fibrosing alveolitis) entering the accelerated phase, consistent with the clinical diagnosis of acute exacerbation of idiopathic pulmonary fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OBLITERANS ORGANIZING PNEUMONIA; ACUTE EOSINOPHILIC PNEUMONIA; BRONCHIOLITIS OBLITERANS; CT FINDINGS; LUNG-DISEASE; RESPIRATORY BRONCHIOLITIS; PATHOLOGICAL FINDINGS; FEATURES		Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Gong, MN (corresponding author), Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA 02114 USA.				NHLBI NIH HHS [K23 HL067197] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL067197] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akira M, 1999, J THORAC IMAG, V14, P76, DOI 10.1097/00005382-199904000-00002; Akira M, 1997, AM J ROENTGENOL, V168, P79, DOI 10.2214/ajr.168.1.8976924; ALASALY K, 1995, MEDICINE, V74, P201, DOI 10.1097/00005792-199507000-00004; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; BATEMAN ED, 1983, THORAX, V38, P93, DOI 10.1136/thx.38.2.93; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BOUCHARDY LM, 1993, J COMPUT ASSIST TOMO, V17, P352, DOI 10.1097/00004728-199305000-00002; Bouros D, 2000, EUR RESPIR J, V15, P412, DOI 10.1034/j.1399-3003.2000.15b31.x; CARRINGTON CB, 1978, NEW ENGL J MED, V298, P801, DOI 10.1056/NEJM197804132981501; COHEN AJ, 1994, AM J RESP CRIT CARE, V149, P1670, DOI 10.1164/ajrccm.149.6.8004328; Colby TV, 1991, ATLAS PULMONARY SURG, P227; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Daniil ZD, 1999, AM J RESP CRIT CARE, V160, P899, DOI 10.1164/ajrccm.160.3.9903021; FLUSSER G, 1991, RESPIRATION, V58, P324; FOWLER AA, 1983, ANN INTERN MED, V98, P593, DOI 10.7326/0003-4819-98-5-593; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; GUERRYFORCE ML, 1987, AM REV RESPIR DIS, V135, P705; Hamman L, 1944, B JOHNS HOPKINS HOSP, V74, P177; HARTMAN TE, 1993, RADIOLOGY, V187, P787, DOI 10.1148/radiology.187.3.8497631; Heyneman LE, 1999, AM J ROENTGENOL, V173, P1617, DOI 10.2214/ajr.173.6.10584810; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Iwashita T, 2000, HUM PATHOL, V31, P1498, DOI 10.1053/hupa.2000.20378; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; King MA, 1997, RADIOLOGY, V203, P715, DOI 10.1148/radiology.203.3.9169693; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; MacDonald SLS, 2001, RADIOLOGY, V221, P600, DOI 10.1148/radiol.2213010158; MATTHAY RA, 1975, MEDICINE, V54, P397, DOI 10.1097/00005792-197509000-00003; Min JK, 1997, J RHEUMATOL, V24, P2254; Niimi H, 1996, J COMPUT ASSIST TOMO, V20, P305, DOI 10.1097/00004728-199603000-00026; Ohnishi H, 2002, AM J RESP CRIT CARE, V165, P378, DOI 10.1164/ajrccm.165.3.2107134; OLSON J, 1990, MAYO CLIN PROC, V65, P1538, DOI 10.1016/S0025-6196(12)62187-9; PATCHEFSKY AS, 1971, ANN INTERN MED, V74, P322, DOI 10.7326/0003-4819-74-3-322; PopeHarman AL, 1996, MEDICINE, V75, P334, DOI 10.1097/00005792-199611000-00004; PRIMACK SL, 1993, RADIOLOGY, V188, P817, DOI 10.1148/radiology.188.3.8351354; Ryu JH, 2001, EUR RESPIR J, V17, P122, DOI 10.1183/09031936.01.17101220; SCHWARZ MI, 1994, TXB RESP MED, V2, P1803; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; TURNERWARWICK M, 1980, THORAX, V35, P171, DOI 10.1136/thx.35.3.171; Vourlekis JS, 2000, MEDICINE, V79, P369, DOI 10.1097/00005792-200011000-00003; WU TR, 1991, NEW ENGL J MED, V324, P1345, DOI 10.1056/NEJM199105093241908; YOUSEM SA, 1989, MAYO CLIN PROC, V64, P1373, DOI 10.1016/S0025-6196(12)65379-8; Zamora MR, 1997, MEDICINE, V76, P192, DOI 10.1097/00005792-199705000-00005; 2001, N ENGL J MED, V345, P1193	44	6	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2149	2157		10.1056/NEJMcpc020028	http://dx.doi.org/10.1056/NEJMcpc020028			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501228	Green Accepted			2022-12-28	WOS:000180040900009
J	Horng, S; Emanuel, EJ; Wilfond, B; Rackoff, J; Martz, K; Grady, C				Horng, S; Emanuel, EJ; Wilfond, B; Rackoff, J; Martz, K; Grady, C			Descriptions of benefits and risks in consent forms for phase 1 oncology trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFORMED-CONSENT; CLINICAL-TRIALS; THERAPEUTIC RESPONSE; ETHICS; QUALITY; IMPACT	Background: Ethicists have suggested that written consent forms encourage participants in phase 1 cancer trials to expect benefit from the experimental agent and to overlook serious risks. Methods: To evaluate the written description of direct benefit as well as risk, all consent forms for 1999 phase 1 cancer trials were compiled from 80 percent of the National Cancer Institute-designated cancer centers and from six of eight large pharmaceutical developers of anticancer drugs. In each case, we evaluated the characteristics of the trial, the descriptions of the purpose and procedures of the research, the promise of benefit, the description of risks, and the description of alternatives. Results: Of 272 forms, 268 explicitly mentioned that the trial was research, and 249 stated that the purpose of the trial was testing for safety. Nearly all forms (269) mentioned the right to withdraw from the trial. Almost all forms (260) referred to the experimental agent as ``treatment'' or ``therapy.'' Only one consent form promised direct benefit to subjects. Most forms (181) mentioned death as a risk, and very few (14) mentioned cure as even a possible benefit. Most (229) stated that there was unknown risk involved and indicated that severe or permanent harms were possible (224). Conclusions: Consent forms for phase 1 oncology studies almost never promise direct benefit to subjects, rarely mention cure, and usually communicate the seriousness and unpredictability of risk. Although there is room for improvement, the substance of these forms is unlikely to be the primary source of misunderstanding by subjects in phase 1 oncology trials.	NIH, Warren G Magnuson Clin Ctr, Dept Clin Bioeth, Bethesda, MD 20892 USA; Emmes Corp, Rockville, MD USA	National Institutes of Health (NIH) - USA; Emmes Corporation	Grady, C (corresponding author), NIH, Warren G Magnuson Clin Ctr, Dept Clin Bioeth, Bldg 10,Rm 1C118, Bethesda, MD 20892 USA.	cgrady@nih.gov			CLINICAL CENTER [Z01CL010514] Funding Source: NIH RePORTER	CLINICAL CENTER		CASSEL C, 2001, REPORT J HOPKINS U E; CAVALLI F, 1990, ANN ONCOL S, V10, P147; Cheng, 2000, J CLIN ONCOL, V18, P1807; Cheng JD, 2000, J CLIN ONCOL, V18, P421, DOI 10.1200/JCO.2000.18.2.421; Cox K, 2002, PATIENT EDUC COUNS, V46, P31, DOI 10.1016/S0738-3991(01)00147-1; DAUGHERTY C, 1995, J CLIN ONCOL, V13, P1062, DOI 10.1200/JCO.1995.13.5.1062; Daugherty C K, 2000, IRB, V22, P6, DOI 10.2307/3564113; Daugherty CK, 1999, J CLIN ONCOL, V17, P1601, DOI 10.1200/JCO.1999.17.5.1601; DECOSTER G, 1990, ANN ONCOL, V1, P175, DOI 10.1093/oxfordjournals.annonc.a057716; EMANUEL EJ, 1995, J CLIN ONCOL, V13, P1049, DOI 10.1200/JCO.1995.13.5.1049; ESTEY E, 1986, CANCER TREAT REP, V70, P1105; Freedman Benjamin, 1990, IRB, V12, P5, DOI 10.2307/3563682; GROSSMAN SA, 1994, J CLIN ONCOL, V12, P2211, DOI 10.1200/JCO.1994.12.10.2211; ITOH K, 1994, CANCER CHEMOTH PHARM, V34, P451, DOI 10.1007/BF00685653; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; King NMP, 2000, J LAW MED ETHICS, V28, P332, DOI 10.1111/j.1748-720X.2000.tb00685.x; KODISH E, 1992, J CLIN ONCOL, V10, P1810, DOI 10.1200/JCO.1992.10.11.1810; LEVINTHAL BG, 1988, RES METHODS CLIN ONC, P41; LIPSETT MB, 1982, JAMA-J AM MED ASSOC, V248, P941, DOI 10.1001/jama.248.8.941; MARKMAN M, 1986, CA-CANCER J CLIN, V36, P367, DOI 10.3322/canjclin.36.6.367; MCNEILLY PJ, 2001, COMMUNICATION   0719; Miller M, 2000, HASTINGS CENT REP, V30, P34, DOI 10.2307/3527646; Miller M, 2001, Int Anesthesiol Clin, V39, P13; MORROW GR, 1980, JAMA-J AM MED ASSOC, V244, P56, DOI 10.1001/jama.244.1.56; *NAT CANC I, 2002, CAN CTR LIST; *PHARM RES MAN AM, 2001, NEW MED DEV CANC 200; SIMES RJ, 1986, BRIT MED J, V293, P1065, DOI 10.1136/bmj.293.6554.1065; STOLBERG SG, 2000, NY TIMES        0525, pA20; VONHOFF DD, 1991, INVEST NEW DRUG, V9, P115, DOI 10.1007/BF00194562; Yoder L H, 1997, Oncol Nurs Forum, V24, P891	30	75	78	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2134	2140		10.1056/NEJMsa021182	http://dx.doi.org/10.1056/NEJMsa021182			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501226	Bronze			2022-12-28	WOS:000180040900007
J	Leitch, EM; Kovac, JM; Pryke, C; Carlstrom, JE; Halverson, NW; Holzapfel, WL; Dragovan, M; Reddall, B; Sandberg, ES				Leitch, EM; Kovac, JM; Pryke, C; Carlstrom, JE; Halverson, NW; Holzapfel, WL; Dragovan, M; Reddall, B; Sandberg, ES			Measurement of polarization with the Degree Angular Scale Interferometer	NATURE			English	Article							PHOTODISSOCIATION REGIONS; NGC-6334	Measurements of the cosmic microwave background (CMB) radiation can reveal with remarkable precision the conditions of the Universe when it was,400,000 years old. The three most fundamental properties of the CMB are its frequency spectrum (which determines the temperature), and the fluctuations in both the temperature and polarization across a range of angular scales. The frequency spectrum has been well determined, and considerable progress has been made in measuring the power spectrum of the temperature fluctuations. But despite many efforts to measure the polarization, detection of this property of the CMB has hitherto been beyond the reach of even the most sensitive observations. Here we describe the Degree Angular Scale Interferometer (DASI), an array of radio telescopes, which for the past two years has conducted polarization-sensitive observations of the CMB from the Amundsen-Scott South Pole research station.	Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; Univ Chicago, Ctr Astrophys Res Antarctica, Chicago, IL 60637 USA; Univ Chicago, Ctr Cosmol Phys, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of California System; University of California Berkeley	Leitch, EM (corresponding author), Univ Chicago, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA.		Holzapfel, William L/I-4836-2015					Burton MG, 2000, ASTROPHYS J, V542, P359, DOI 10.1086/309510; Halverson NW, 2002, ASTROPHYS J, V568, P38, DOI 10.1086/338879; HASLAM CGT, 1981, ASTRON ASTROPHYS, V100, P209; Hogbom J. A., 1974, Astronomy and Astrophysics Supplement Series, V15, P417; Hu W, 1997, NEW ASTRON, V2, P323, DOI 10.1016/S1384-1076(97)00022-5; Jackson JM, 1999, ASTROPHYS J, V512, P260, DOI 10.1086/306760; Kamionkowski M, 1997, PHYS REV D, V55, P7368, DOI 10.1103/PhysRevD.55.7368; Kovac JM, 2002, NATURE, V420, P772, DOI 10.1038/nature01269; Leitch EM, 2002, ASTROPHYS J, V568, P28, DOI 10.1086/338878; MITCHISON NA, 1994, IMMUNOLOGIST, V2, P32; MOFFAT PH, 1972, MON NOT R ASTRON SOC, V160, P139, DOI 10.1093/mnras/160.2.139; Padin S, 2002, PUBL ASTRON SOC PAC, V114, P83, DOI 10.1086/324786; Padin S, 2001, IEEE T INSTRUM MEAS, V50, P1234, DOI 10.1109/19.963190; Poppi S, 2002, AIP CONF PROC, V609, P187, DOI 10.1063/1.1471845; Pryke C, 2002, ASTROPHYS J, V568, P46, DOI 10.1086/338880; WRIGHT AE, 1994, ASTROPHYS J SUPPL S, V91, P111, DOI 10.1086/191939; Zaldarriaga M, 1997, PHYS REV D, V55, P1830, DOI 10.1103/PhysRevD.55.1830	17	93	94	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					763	771		10.1038/nature01271	http://dx.doi.org/10.1038/nature01271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490940	Green Submitted			2022-12-28	WOS:000179897300047
J	Muntau, AC; Roschinger, W; Habich, M; Demmelmair, H; Hoffmann, B; Sommerhoff, CP; Roscher, AA				Muntau, AC; Roschinger, W; Habich, M; Demmelmair, H; Hoffmann, B; Sommerhoff, CP; Roscher, AA			Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHENYLALANINE-HYDROXYLASE DEFICIENCY; IN-VITRO EXPRESSION; STRUCTURAL BASIS; HYPERPHENYLALANINEMIA PHENOTYPES; CRYSTAL-STRUCTURE; RESPONSIVENESS; MUTATIONS; MUTAGENESIS; GENOTYPE; DOMAIN	Background: Hyperphenylalaninemia is a common inherited metabolic disease that is due to phenylalanine hydroxylase deficiency, and at least half the affected patients have mild clinical phenotypes. Treatment with a low-phenylalanine diet represents a substantial psychosocial burden, but alternative treatments have not been effective. Methods: To explore the therapeutic efficacy of tetrahydrobiopterin, we performed a combined phenylalanine-tetrahydrobiopterin loading test and analyzed the in vivo rates of [C-13]phenylalanine oxidation in 38 children with phenylalanine hydroxylase deficiency (age range, 1 day to 17 years). We assessed whether responsiveness to tetrahydrobiopterin was associated with specific genotypes, and we mapped mutations using a structural model of the phenylalanine hydroxylase monomer. Results: In 27 (87 percent) of 31 patients with mild hyperphenylalaninemia (10 patients) or mild phenylketonuria (21 patients), tetrahydrobiopterin significantly lowered blood phenylalanine levels. Phenylalanine oxidation was significantly enhanced in 23 of these 31 patients (74 percent). Conversely, none of the seven patients with classic phenylketonuria had a response to tetrahydrobiopterin as defined in this study. Long-term treatment with tetrahydrobiopterin in five children increased daily phenylalanine tolerance, allowing them to discontinue their restricted diets. Seven mutations (P314S, Y417H, V177M, V245A, A300S, E390G, and IVS4-5C(rightarrow)G) were classified as probably associated with responsiveness to tetrahydrobiopterin, and six mutations (A403V, F39L, D415N, S310Y, R158Q, and I65T) were classified as potentially associated. Four mutations (Y414C, L48S, R261Q, and I65V) were inconsistently associated with this phenotype. Mutations connected to tetrahydrobiopterin responsiveness were predominantly in the catalytic domain of the protein and were not directly involved in cofactor binding. Conclusions: Tetrahydrobiopterin responsiveness is common in patients with mild hyperphenylalaninemia phenotypes. Responsiveness cannot consistently be predicted on the basis of genotype, particularly in compound heterozygotes.	Univ Munich, Dr von Hauner Childrens Hosp, Res Ctr, Dept Biochem Genet & Mol Biol, D-80337 Munich, Germany; Univ Munich, Dr von Hauner Childrens Hosp, Res Ctr, Dept Metab Disorders & Nutr, D-80337 Munich, Germany; Univ Munich, Dept Clin Chem & Clin Biochem, Surg Clin, D-80337 Munich, Germany	University of Munich; University of Munich; University of Munich	Roscher, AA (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, Res Ctr, Dept Biochem Genet & Mol Biol, Lindwurmstr 2A, D-80337 Munich, Germany.	adelbert.roscher@kk-i.med.uni-muenchen.de						Ames BN, 2002, AM J CLIN NUTR, V75, P616, DOI 10.1093/ajcn/75.4.616; Blau N, 2002, MOL GENET METAB, V75, P186, DOI 10.1006/mgme.2001.3294; Blau N., 2001, METABOLIC MOL BASIS, P1725; Bowersox J, 2001, PEDIATRICS, V108, P972; DANKS DM, 1975, LANCET, V2, P1043; Erlandsen H, 2000, BIOCHEMISTRY-US, V39, P2208, DOI 10.1021/bi992531+; Erlandsen H, 2001, J INHERIT METAB DIS, V24, P213, DOI 10.1023/A:1010371002631; Erlandsen H, 1997, NAT STRUCT BIOL, V4, P995, DOI 10.1038/nsb1297-995; Erlandsen H, 1999, MOL GENET METAB, V68, P103, DOI 10.1006/mgme.1999.2922; FISHER DB, 1973, J BIOL CHEM, V248, P4345; Fusetti F, 1998, J BIOL CHEM, V273, P16962, DOI 10.1074/jbc.273.27.16962; Gjetting T, 2001, MOL GENET METAB, V72, P132, DOI 10.1006/mgme.2000.3118; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GULDBERG P, 1993, HUM MOL GENET, V2, P1703, DOI 10.1093/hmg/2.10.1703; Guldberg P, 1998, AM J HUM GENET, V63, P71, DOI 10.1086/301920; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KAUFMAN S, 1993, ADV ENZYMOL RAMB, V67, P77; Kaufman S, 1999, P NATL ACAD SCI USA, V96, P3160, DOI 10.1073/pnas.96.6.3160; Kaufman S, 1999, P NATL ACAD SCI USA, V96, P11687; Kayaalp E, 1997, AM J HUM GENET, V61, P1309, DOI 10.1086/301638; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Kure S, 1999, J PEDIATR-US, V135, P375, DOI 10.1016/S0022-3476(99)70138-1; Lassker U, 2002, J INHERIT METAB DIS, V25, P65, DOI 10.1023/A:1015194002487; Lindner M, 2001, MOL GENET METAB, V74, P500, DOI 10.1006/mgme.2001.3262; Lindner M, 2001, MOL GENET METAB, V73, P104, DOI 10.1006/mgme.2001.3168; Linscheid P, 1998, BIOCHEM BIOPH RES CO, V243, P137, DOI 10.1006/bbrc.1998.8072; OKANO Y, 1991, NEW ENGL J MED, V324, P1232, DOI 10.1056/NEJM199105023241802; Scriver CR, 2002, J PEDIATR-US, V140, P502, DOI 10.1067/mpd.2002.124316; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; Scriver CR, 2000, HUM MUTAT, V15, P99, DOI 10.1002/(SICI)1098-1004(200001)15:1<99::AID-HUMU18>3.0.CO;2-P; Scriver CR, 1998, J CLIN INVEST, V101, P2613, DOI 10.1172/JCI3928; SMITH I, 1990, J INHERIT METAB DIS, V13, P651, DOI 10.1007/BF01799520; SMITH I, 1985, J INHERIT METAB DIS, V8, P39, DOI 10.1007/BF01800658; Spaapen LJM, 2001, J INHERIT METAB DIS, V24, P352, DOI 10.1023/A:1010596317296; Steinfeld R, 2002, EUR J PEDIATR, V161, P403, DOI 10.1007/s00431-002-0966-0; *SUNT, 1997, BIOPT SAPR HYDR; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Treacy EP, 1997, PEDIATR RES, V42, P430, DOI 10.1203/00006450-199710000-00002; Trefz FK, 2001, EUR J PEDIATR, V160, P315, DOI 10.1007/PL00008436; VANTRAPPEN GR, 1989, GASTROENTEROLOGY, V96, P1126, DOI 10.1016/0016-5085(89)91632-6; Wang GA, 2001, P NATL ACAD SCI USA, V98, P1537, DOI 10.1073/pnas.031561698; Waters PJ, 1998, HUM MUTAT, V11, P4; Waters PJ, 2001, MOL GENET METAB, V73, P230, DOI 10.1006/mgme.2001.3198; Weglage J, 2001, PEDIATR RES, V49, P532, DOI 10.1203/00006450-200104000-00015	45	232	245	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2122	2132		10.1056/NEJMoa021654	http://dx.doi.org/10.1056/NEJMoa021654			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501224				2022-12-28	WOS:000180040900005
J	Waks, E; Inoue, K; Santori, C; Fattal, D; Vuckovic, J; Solomon, GS; Yamamoto, Y				Waks, E; Inoue, K; Santori, C; Fattal, D; Vuckovic, J; Solomon, GS; Yamamoto, Y			Secure communication: Quantum cryptography with a photon turnstile	NATURE			English	Article							KEY DISTRIBUTION		Univ Calif Los Angeles, EL Ginzton Labs, MURI, IST,ICORP,Quantum Entanglement Project, Los Angeles, CA 90024 USA; Stanford Univ, Solid State Photon Lab, Stanford, CA 94305 USA; NTT Corp, Basic Res Labs, Kanagawa 2430198, Japan	University of California System; University of California Los Angeles; Stanford University; Nippon Telegraph & Telephone Corporation	Waks, E (corresponding author), Univ Calif Los Angeles, EL Ginzton Labs, MURI, IST,ICORP,Quantum Entanglement Project, Los Angeles, CA 90024 USA.	edo@stanford.edu	Santori, Charles/A-7314-2009; Vuckovic, Jelena/A-7335-2019; Fattal, David A/A-8920-2013; Yamamoto, Yoshihisa/A-2811-2012; Waks, Edo/E-3982-2016	Vuckovic, Jelena/0000-0002-4603-9686; Fattal, David A/0000-0003-1902-6115; Yamamoto, Yoshihisa/0000-0002-4150-6804; Waks, Edo/0000-0003-0299-0784				Bennett CH., 1984, P IEEE INT C COMP SY, P175; Beveratos A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.187901; Brassard G, 2000, PHYS REV LETT, V85, P1330, DOI 10.1103/PhysRevLett.85.1330; Buttler WT, 2000, PHYS REV LETT, V84, P5652, DOI 10.1103/PhysRevLett.84.5652; Lutkenhaus N, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.052304; MARAND C, 1995, OPT LETT, V20, P1695, DOI 10.1364/OL.20.001695; Santori C, 2001, PHYS REV LETT, V86, P1502, DOI 10.1103/PhysRevLett.86.1502; Waks E, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.042315	10	250	253	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					762	762		10.1038/420762a	http://dx.doi.org/10.1038/420762a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490939	Bronze			2022-12-28	WOS:000179897300046
J	Zhu, M; Ahlberg, PE; Zhao, WJ; Jia, LT				Zhu, M; Ahlberg, PE; Zhao, WJ; Jia, LT			Palaeontology - First Devonian tetrapod from Asia	NATURE			English	Article							JAWS		Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Natural History Museum London	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.		Zhu, Min/E-8728-2012; min, zhu/AAL-6712-2021; Ahlberg, Per/E-8086-2013	Zhu, Min/0000-0002-4786-0898; Zhao, Wenjin/0000-0002-9649-2171; Ahlberg, Per/0000-0001-9054-2900				AHLBERG PE, 1995, NATURE, V373, P420, DOI 10.1038/373420a0; Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; Ahlberg PE, 2000, PALAEONTOLOGY, V43, P533, DOI 10.1111/j.0031-0239.2000.00138.x; Campbell KSW, 1977, ALCHERINGA, V1, P369, DOI 10.1080/03115517708527771; COATES MI, 1991, NATURE, V352, P234, DOI 10.1038/352234a0; Daeschler EB, 2000, J PALEONTOL, V74, P301, DOI 10.1666/0022-3360(2000)074<0301:ETJFTL>2.0.CO;2; Metcalfe Ian, 1998, P25; Milner A.R., 1993, P324; Pan J., 1987, CONTINENTAL DEVONIAN	10	39	47	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					760	761		10.1038/420760a	http://dx.doi.org/10.1038/420760a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490937				2022-12-28	WOS:000179897300044
J	Gladstone, IM; Katz, VL				Gladstone, IM; Katz, VL			A tale of two citations: counting on numeracy in the digital divide	BRITISH MEDICAL JOURNAL			English	Article								The BMJ (British Medical Journal) and JAMA (the Journal of the American Medical Association) are vanguard clarions of their respective medical communities. In 1999 the BMJ published an analysis of JAMA cover art that was critical of the choices made.(1) This criticism inflamed many post-colonial physicians, who rose to defend their homeland. With pride, those west of the Atlantic pointed to the technological advances, the rise of Silicon Valley, and the importance of numbers in the daily lives of Americans. To demonstrate this last item we evaluated whether numeracy in tides of articles in medical journals is more prevalent, and by inference more important to physicians, in the United States.	Sacred Heart Med Ctr, Div Neonatol, Eugene, OR 97401 USA; Sacred Heart Med Ctr, Div Perinatol, Eugene, OR 97401 USA		Gladstone, IM (corresponding author), Sacred Heart Med Ctr, Div Neonatol, Eugene, OR 97401 USA.							Barone JE, 2000, BRIT MED J, V321, P1569, DOI 10.1136/bmj.321.7276.1569; Bland M., 2000, INTRO MED STAT, V3rd; Clark JP, 1999, BRIT MED J, V319, P1603, DOI 10.1136/bmj.319.7225.1603; NAKAO MA, 1983, AM J MED, V74, P1061, DOI 10.1016/0002-9343(83)90819-7; ROCKER I, 1976, LANCET, V2, P1246	5	0	0	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1452	1453		10.1136/bmj.325.7378.1452	http://dx.doi.org/10.1136/bmj.325.7378.1452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493664	Green Published			2022-12-28	WOS:000180188600016
J	Round, JEC; Deheragoda, M				Round, JEC; Deheragoda, M			Sex - can you get it right?	BRITISH MEDICAL JOURNAL			English	Article									Guys Hosp, Neonatal Intens Care Unit, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Round, JEC (corresponding author), Guys Hosp, Neonatal Intens Care Unit, London SE1 9RT, England.			Round, Jonathan/0000-0002-7404-2006				PORTER RH, 1984, PEDIATRICS, V74, P501	1	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1446	1447		10.1136/bmj.325.7378.1446	http://dx.doi.org/10.1136/bmj.325.7378.1446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493659	Green Published			2022-12-28	WOS:000180188600011
J	Rosenberg, NA; Pritchard, JK; Weber, JL; Cann, HM; Kidd, KK; Zhivotovsky, LA; Feldman, MW				Rosenberg, NA; Pritchard, JK; Weber, JL; Cann, HM; Kidd, KK; Zhivotovsky, LA; Feldman, MW			Genetic structure of human populations	SCIENCE			English	Article							MULTILOCUS GENOTYPES; DIVERSITY; APPORTIONMENT; STRATIFICATION; PATTERNS; BIAS	We studied human population structure using genotypes at 377 autosomal microsatellite loci in 1056 individuals from 52 populations. Within-population differences among individuals account for 93 to 95% of genetic variation; differences among major groups constitute only 3 to 5%. Nevertheless, without using prior information about the origins of individuals, we identified six main genetic clusters, five of which correspond to major geographic regions, and subclusters that often correspond to individual populations. General agreement of genetic and predefined populations suggests that self-reported ancestry can facilitate assessments of epidemiological risks but does not obviate the need to use genetic information in genetic association studies.	Univ So Calif, Los Angeles, CA 90089 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Marshfield Med Res Fdn, Ctr Genet Med, Marshfield, WI 54449 USA; Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 117809, Russia; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Southern California; University of Chicago; Foundation Jean Dausset-CEPH; Yale University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Stanford University	Rosenberg, NA (corresponding author), Univ So Calif, 1042 W 36th Pl DRB 289, Los Angeles, CA 90089 USA.	noahr@usc.edu	Zhivotovsky, Lev A/A-1351-2012; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Rosenberg, Noah/0000-0002-1829-8664	NIGMS NIH HHS [GM28428] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brown RA, 2001, EVOL ANTHROPOL, V10, P34, DOI 10.1002/1520-6505(2001)10:1<34::AID-EVAN1011>3.0.CO;2-P; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cann HM, 2002, SCIENCE, V296, P261; DU R, 1996, ETHNIC GROUPS CHINA; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; Haywood John, 1995, PENGUIN HIST ATLAS V; JIN L, 1995, HEREDITY, V74, P274, DOI 10.1038/hdy.1995.41; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; LATTER BDH, 1980, AM NAT, V116, P220, DOI 10.1086/283624; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Ptak SE, 2002, TRENDS GENET, V18, P559, DOI 10.1016/S0168-9525(02)02781-6; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Rogers AR, 1996, AM J HUM GENET, V58, P1033; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2001, GENETICS, V159, P699; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Urbanek M, 1996, MOL BIOL EVOL, V13, P943, DOI 10.1093/oxfordjournals.molbev.a025662; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761	26	1911	1984	2	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2381	2385		10.1126/science.1078311	http://dx.doi.org/10.1126/science.1078311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493913				2022-12-28	WOS:000179915900054
J	Albert, MR; Ostheimer, KG; Liewehr, DJ; Steinberg, SM; Breman, JG				Albert, MR; Ostheimer, KG; Liewehr, DJ; Steinberg, SM; Breman, JG			Smallpox manifestations and survival during the Boston epidemic of 1901 to 1903	ANNALS OF INTERNAL MEDICINE			English	Article							MANAGEMENT	Clinical records of 243 patients with smallpox consecutively admitted to the Southampton Street smallpox hospital in Boston, Massachusetts, during the 1901-1903 epidemic were reviewed. Smallpox was divided into five categories of varying severity; 47% of patients had varioloid, a relatively mild form of the disease usually occurring in previously vaccinated individuals with incomplete immunity. Survival information is available for 206 patients, of whom 36 (17.5%) died. Vaccination status, disease severity, and age were associated with survival, whereas sex, birthplace, and race were not. While full recovery often took weeks, most deaths occurred 7 to 14 days after the onset of symptoms, and all deaths occurred within 18 days of symptom onset. Smallpox was eradicated worldwide in 1977, but knowledge of the disease is essential because its cause, variola. virus, is considered a potential biological weapon.	NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; NCI, Bethesda, MD 20892 USA; Yale New Haven Med Ctr, New Haven, CT 06504 USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yale University	Breman, JG (corresponding author), NIH, Fogarty Int Ctr, 16 Ctr Dr,MSC 6705,Bldg 16,Room 214, Bethesda, MD 20892 USA.	jbreman@nih.gov	Liewehr, David J/GWV-3570-2022					Albert MR, 2001, NEW ENGL J MED, V344, P375, DOI 10.1056/NEJM200102013440511; Alibek K., 2000, BIOHAZARD; Bancroft IR, 1904, J MED RES, V11, P322; BANCROFT IR, 1963, JAMA-J AM MED ASSOC, V186, P180; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; COX DR, 1972, J R STAT SOC B, V34, P187; DIXON C.W, 1962, SMALLPOX; Fenner F., 1988, SMALLPOX ITS ERADICA; Henderson DA, 1999, SCIENCE, V283, P1279, DOI 10.1126/science.283.5406.1279; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Hopkins D. R., 1983, PRINCES PEASANTS SMA; Rao AR, 1972, SMALLPOX; ROTHMAN KJ, 1978, J CHRON DIS, V31, P557, DOI 10.1016/0021-9681(78)90043-7; SOMMER A, 1974, AM J EPIDEMIOL, V99, P303, DOI 10.1093/oxfordjournals.aje.a121615; WEBB ME, 1873, BOSTON MED SURG J, V89, P201; 1901, BOSTON MED SURG J, V145, P632; 1902, 30 ANN REP HLTH DEP; 1901, BOSTON GLOBE    1126, P4; 1904, 32 ANN REP HLTH DEP; 1946, DIRECTORY MED SPECIA, V3; 1903, 31 ANN REP HLTH DEP	21	9	9	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2002	137	12					993	1000		10.7326/0003-4819-137-12-200212170-00013	http://dx.doi.org/10.7326/0003-4819-137-12-200212170-00013			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626DR	12484715				2022-12-28	WOS:000179857500008
J	Lorber, B				Lorber, B			Update in infectious diseases	ANNALS OF INTERNAL MEDICINE			English	Review							THERAPY		Temple Univ Hosp & Med Sch, Infect Dis Sect, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Lorber, B (corresponding author), Temple Univ Hosp & Med Sch, Infect Dis Sect, Broad & Ontario St, Philadelphia, PA 19140 USA.	lorberb@tuhs.temple.edu						Ascherio A, 2001, NEW ENGL J MED, V344, P327, DOI 10.1056/NEJM200102013440502; DERESINSKI S, 2001, INFECT DIS ALERT, V20, P97; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Ledergerber B, 2001, NEW ENGL J MED, V344, P168, DOI 10.1056/NEJM200101183440302; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; 2001, MED LETT DRUGS THER, V43, P58	7	4	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2002	137	12					974	980		10.7326/0003-4819-137-12-200212170-00011	http://dx.doi.org/10.7326/0003-4819-137-12-200212170-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626DR	12484713				2022-12-28	WOS:000179857500006
J	Hickman, SJ; Dalton, CM; Miller, DH; Plant, GT				Hickman, SJ; Dalton, CM; Miller, DH; Plant, GT			Management of acute optic neuritis	LANCET			English	Review							DEVELOPING MULTIPLE-SCLEROSIS; CLINICALLY ISOLATED SYNDROMES; VISUAL EVOKED-RESPONSE; TERM-FOLLOW-UP; TREATMENT TRIAL; RETROBULBAR NEURITIS; DIAGNOSTIC-CRITERIA; INTRAVENOUS IMMUNOGLOBULIN; INTERFERON BETA-1A; RECOVERY	Optic neuritis is a common condition that causes reversible loss of vision. It can be clinically isolated or can arise as one of the manifestations of multiple sclerosis. Occasional cases are due to other causes, and in these instances management can differ radically. The treatment of optic neuritis has been investigated in several trials, the results of which have shown that corticosteroids speed up the recovery of vision without affecting the final visual outcome. Other aspects of management, however, are controversial, and there is uncertainty about when to investigate and when to treat the condition. Here we review the diagnostic features of optic neuritis, its differential diagnosis, and give practical guidance about management of patients. The condition's association with multiple sclerosis will be considered in the light of studies that define the risk for development of multiple sclerosis and with respect to results of trials of disease-modifying drugs in these individuals.	Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; UCL, Inst Neurol, NMR Res Unit, London, England; Moorfields Eye Hosp, Neuroophthalmol Dept, London, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Plant, GT (corresponding author), Natl Hosp Neurol & Neurosurg, Box 111, London WC1N 3BG, England.	gordon@plant.globalnet.co.uk			Multiple Sclerosis Society [491] Funding Source: Medline	Multiple Sclerosis Society(National Multiple Sclerosis Society)		Acheson J, 2000, J NEUROL, V247, P587, DOI 10.1007/s004150070127; ADACHIUSAMI E, 2001, JPN J OPHTHALMOL, V45, P320; BARNES D, 2000, PRINCIPLES TREATMENT, P14; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; BECK RW, 1993, NEW ENGL J MED, V329, P1764, DOI 10.1056/NEJM199312093292403; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; BECK RW, 1993, ARCH OPHTHALMOL-CHIC, V111, P300, DOI 10.1001/archopht.1993.01090030018009; BECK RW, 1993, ARCH OPHTHALMOL-CHIC, V111, P773, DOI 10.1001/archopht.1993.01090060061023; Beck RW, 1997, ARCH OPHTHALMOL-CHIC, V115, P1545; BECK RW, 1995, ARCH OPHTHALMOL-CHIC, V113, P136, DOI 10.1001/archopht.1995.01100020014004; Beck RW, 1998, WALSH HOYTS CLIN NEU, P599; Biousse V, 1999, NEUROLOGY, V52, P179, DOI 10.1212/WNL.52.1.179; BOWDEN AN, 1974, J NEUROL NEUROSUR PS, V37, P869, DOI 10.1136/jnnp.37.8.869; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Brex PA, 1999, NEUROLOGY, V53, P1184, DOI 10.1212/WNL.53.6.1184; Brodsky M, 1997, NEUROLOGY, V49, P1404; Brusa A, 2001, BRAIN, V124, P468, DOI 10.1093/brain/124.3.468; Brusaferri F, 2000, J NEUROL, V247, P435, DOI 10.1007/s004150070172; CARMODY RF, 1994, AM J NEURORADIOL, V15, P775; Cole SR, 1998, NEUROLOGY, V51, P885, DOI 10.1212/WNL.51.3.885; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; *COMM SAF MED, 1994, SEV CHICK ASS SYST C, V20, P1; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; COX TA, 1981, AM J OPHTHALMOL, V92, P685, DOI 10.1016/S0002-9394(14)74662-8; Dalton CM, 2002, ANN NEUROL, V52, P47, DOI 10.1002/ana.10240; DAVIS FA, 1976, NEUROLOGY, V26, P1100, DOI 10.1212/WNL.26.11.1100; Dunya IM, 1996, OPHTHALMIC PLAST REC, V12, P171, DOI 10.1097/00002341-199609000-00003; Ebers GC, 2001, LANCET, V357, P1547, DOI 10.1016/S0140-6736(00)04778-4; Eggenberger E R, 2001, Ophthalmol Clin North Am, V14, P73; ENOCH JM, 1979, ARCH OPHTHALMOL-CHIC, V97, P76, DOI 10.1001/archopht.1979.01020010016003; FEINSOD M, 1975, J NEUROL NEUROSUR PS, V38, P1109, DOI 10.1136/jnnp.38.11.1109; Frederiksen JL, 1997, ACTA OPHTHALMOL SCAN, V75, P544; Gass A, 2000, J NEUROL SCI, V172, pS17, DOI 10.1016/S0022-510X(99)00272-5; Gass JDM, 2000, AM J OPHTHALMOL, V130, P655, DOI 10.1016/S0002-9394(00)00738-8; Ghezzi A, 1999, J NEUROL, V246, P770, DOI 10.1007/s004150050453; Ghosh A, 2002, J NEUROL NEUROSUR PS, V72, P119, DOI 10.1136/jnnp.72.1.119; GOULD ES, 1977, BRIT MED J, V1, P1495, DOI 10.1136/bmj.1.6075.1495; Guy J, 2000, Curr Opin Ophthalmol, V11, P421, DOI 10.1097/00055735-200012000-00007; HALLIDAY AM, 1973, BRIT MED J, V4, P661, DOI 10.1136/bmj.4.5893.661; HALLIDAY AM, 1972, LANCET, V1, P982; Hauser, 2000, Am J Ophthalmol, V130, P690, DOI 10.1016/S0002-9394(00)00761-3; HELMAN SE, 1998, WALSH HOYTS CLIN NEU, P549; Holder GE, 2001, PROG RETIN EYE RES, V20, P531, DOI 10.1016/S1350-9462(00)00030-6; Horton JC, 2002, ANN NEUROL, V52, P129, DOI 10.1002/ana.10269; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jin YP, 1999, ARCH NEUROL-CHICAGO, V56, P975, DOI 10.1001/archneur.56.8.975; Jin YP, 1998, J NEUROL SCI, V159, P107, DOI 10.1016/S0022-510X(98)00141-5; KANSU T, 1989, J CLIN NEURO-OPHTHAL, V9, P277; Kapoor R, 1998, NEUROLOGY, V50, P230, DOI 10.1212/WNL.50.1.230; Kaufman DI, 2000, NEUROLOGY, V54, P2039, DOI 10.1212/WNL.54.11.2039; KIDD D, IN PRESS BRAIN; KRISS A, 1988, J NEUROL NEUROSUR PS, V51, P1253, DOI 10.1136/jnnp.51.10.1253; Lee AG, 2000, CAN J OPHTHALMOL, V35, P325, DOI 10.1016/S0008-4182(00)80060-5; LEVATIN P, 1959, ARCH OPHTHALMOL-CHIC, V62, P768; LIGHTMAN S, 1987, BRAIN, V110, P405, DOI 10.1093/brain/110.2.405; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; MALINOWSKI SM, 1993, OPHTHALMOLOGY, V100, P818; McCluskey PJ, 1999, OPHTHALMOLOGY, V106, P2380, DOI 10.1016/S0161-6420(99)90543-2; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McKee MD, 2001, CAN MED ASSOC J, V164, P205; MILLER DH, 1992, J NEUROL NEUROSUR PS, V55, P450, DOI 10.1136/jnnp.55.6.450; Miller DH, 1998, BRAIN, V121, P3, DOI 10.1093/brain/121.1.3; Miller NR, 1995, J NEURO-OPHTHALMOL, V15, P212; Morales DS, 2000, J PEDIAT OPHTH STRAB, V37, P254; Noseworthy JH, 2001, NEUROLOGY, V56, P1514, DOI 10.1212/WNL.56.11.1514; PARKIN PJ, 1984, BRAIN, V107, P951, DOI 10.1093/brain/107.3.951; Perkin GD, 1979, OPTIC NEURITIS ITS D; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Poser CM, 2001, LANCET, V358, P1746, DOI 10.1016/S0140-6736(01)06842-8; Purvin V, 2001, ARCH OPHTHALMOL-CHIC, V119, P1299; Ramsaransing G, 2001, MULT SCLER, V7, P345, DOI 10.1177/135245850100700512; RAWSON MD, 1969, LANCET, V2, P222; RAWSON MD, 1966, LANCET, V2, P1044; Ray S, 2001, INT OPHTHALMOL CLIN, V41, P83, DOI 10.1097/00004397-200101000-00009; Reynolds J, 1996, BRIT MED J, V312, P1608, DOI 10.1136/bmj.312.7046.1608b; RIZZO JF, 1988, NEUROLOGY, V38, P185, DOI 10.1212/WNL.38.2.185; RODRIGUEZ M, 1995, NEUROLOGY, V45, P244, DOI 10.1212/WNL.45.2.244; ROSENBERG ML, 1984, J CLIN NEURO-OPHTHAL, V4, P181; SANDBERG-WOLLHEIM M, 1990, Annals of Neurology, V27, P386, DOI 10.1002/ana.410270406; SELHORST JB, 1995, J NEURO-OPHTHALMOL, V15, P63; Sellebjerg F, 1999, NEUROLOGY, V52, P1479, DOI 10.1212/WNL.52.7.1479; SLAGSVOLD JE, 1978, ACTA OPHTHALMOL, V56, P817; SLAMOVITS TL, 1991, AM J OPHTHALMOL, V111, P209, DOI 10.1016/S0002-9394(14)72261-5; Smith KJ, 1999, PHILOS T R SOC B, V354, P1649, DOI 10.1098/rstb.1999.0510; TRAUZETTELKLOSINSKI S, 1993, CLIN VISION SCI, V8, P385; Trobe JD, 1999, OPHTHALMOLOGY, V106, P2047, DOI 10.1016/S0161-6420(99)90482-7; VANENGELEN BGM, 1992, ANN NEUROL, V32, P834, DOI 10.1002/ana.410320624; VINE AK, 1992, AM J OPHTHALMOL, V113, P28, DOI 10.1016/S0002-9394(14)75748-4; Wakakura M, 1999, JPN J OPHTHALMOL, V43, P127, DOI 10.1016/S0021-5155(98)00072-0; Wakakura M, 1999, JPN J OPHTHALMOL, V43, P133, DOI 10.1016/S0021-5155(98)00071-9; Wall M, 1998, ARCH OPHTHALMOL-CHIC, V116, P53, DOI 10.1001/archopht.116.1.53; WENNING GK, 1994, ACTA NEUROL SCAND, V89, P270; Werring DJ, 2000, J NEUROL NEUROSUR PS, V68, P441, DOI 10.1136/jnnp.68.4.441; YOUL BD, 1991, BRAIN, V114, P2437, DOI 10.1093/brain/114.6.2437; Zacks DN, 2001, INT OPHTHALMOL CLIN, V41, P61, DOI 10.1097/00004397-200101000-00007; Zajicek JP, 1999, QJM-INT J MED, V92, P103, DOI 10.1093/qjmed/92.2.103; 2002, BRIT NATL FORMULARY	97	162	169	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2002	360	9349					1953	1962		10.1016/S0140-6736(02)11919-2	http://dx.doi.org/10.1016/S0140-6736(02)11919-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493277				2022-12-28	WOS:000179870200029
J	Hong, MK; Bero, LA				Hong, MK; Bero, LA			How the tobacco industry responded to an influential study of the health effects of secondhand smoke	BRITISH MEDICAL JOURNAL			English	Article							WILLIAMSON DOCUMENTS; PASSIVE SMOKING; LAWYER CONTROL; LUNG-CANCER; AUTHORSHIP; RISK		Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bero, LA (corresponding author), Univ Calif San Francisco, Dept Clin Pharm, Box 0613, San Francisco, CA 94143 USA.			Bero, Lisa/0000-0003-1893-6651	NCI NIH HHS [CA-87472, R01 CA087472] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087472] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barnes DE, 1996, J HEALTH POLIT POLIC, V21, P515, DOI 10.1215/03616878-21-3-515; BARNES DE, 1995, JAMA-J AM MED ASSOC, V274, P248, DOI 10.1001/jama.274.3.248; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P241, DOI 10.1001/jama.274.3.241; BERO LA, 1994, JAMA-J AM MED ASSOC, V271, P612, DOI 10.1001/jama.271.8.612; BERO LA, 1993, TOB CONTROL, V2, P103; BEROLA, 2001, TOBACCO CONTROL, V10, P329; Drope J, 2001, J EPIDEMIOL COMMUN H, V55, P588, DOI 10.1136/jech.55.8.588; GLATNZ S, 1996, CIGARETTE PAPERS; GREEN CR, 1991, ETS DIVISION WEEKLY; GREEN CR, 1991, CIAR; HANAUER P, 1995, JAMA-J AM MED ASSOC, V274, P234; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; *INT COMM MED J ED, 1993, JAMA-J AM MED ASSOC, V269, P2282; Lee P, 1994, LIMITATIONS STUDIES; LEE PN, 1995, INT ARCH OCC ENV HEA, V67, P287, DOI 10.1007/BF00385642; LEE PN, LIMITATIONS STUDIES; LEE PN, 1991, DRAFT PROPOSAL STUDY; LEE PN, 1993, PN LEE STAT COM 0815; LEE PN, 1994, IS ENV TOBACCO SMOKE; Malone RE, 2000, SOC STUD SCI, V30, P713, DOI 10.1177/030631200030005003; MARCOTULLIO RJ, 1991, INT ETS MANAGEMENT C; Misakian AL, 1998, JAMA-J AM MED ASSOC, V280, P250, DOI 10.1001/jama.280.3.250; MORRIS P, 1991, LIFESTYLE QUESTIONNA; MORRIS P, 1991, PROPOSAL APPL RES ST; Muggli ME, 2001, AM J PUBLIC HEALTH, V91, P1419, DOI 10.2105/AJPH.91.9.1419; OSDENE TS, 1991, INVESTIGATION EXPOSU; PAGES R, 1991, JAPAN EXPOSURE ASSES; PAGES R, 1991, COMMUNICATION   0415; PAGES R, 1991, COMMUNICATION   1108; PROCTOR C, 1993, COMMUNICATION   0726; PROCTOR C, 1991, STUDY RESULTS JAPANE; PROCTOR C, 1991, QUESTIONNAIRE DEV JA; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; SADLER PA, 1993, COMMUNICATION   1005; Schotland MS, 2002, RISK ANAL, V22, P131, DOI 10.1111/0272-4332.t01-1-00011; Smith R, 1997, BRIT MED J, V314, P992, DOI 10.1136/bmj.314.7086.992; YANO E, 1992, CONFOUNDING FACTORS; YANO E, 1992, LACK VALIDITY MARRIA; 1981, BMJ, V283, P1464; 1981, BMJ, V283, P914	40	59	59	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1413	1416		10.1136/bmj.325.7377.1413	http://dx.doi.org/10.1136/bmj.325.7377.1413			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CP	12480862	Green Published, Green Submitted			2022-12-28	WOS:000179975000030
J	Missinou, MA; Borrmann, S; Schindler, A; Issifou, S; Adegnika, AA; Matsiegui, PB; Binder, R; Lell, B; Wiesner, J; Baranek, T; Jomaa, H; Kremsner, PG				Missinou, MA; Borrmann, S; Schindler, A; Issifou, S; Adegnika, AA; Matsiegui, PB; Binder, R; Lell, B; Wiesner, J; Baranek, T; Jomaa, H; Kremsner, PG			Fosmidomycin for malaria	LANCET			English	Article								Safe and effective antimalarial drugs with new methods of action are urgently needed. Fosmidomycin inhibits the synthesis of isoprenoid by Plasmodium falciparum, and suppresses the growth of multidrug-resistant strains in vitro. Our aim was to assess the efficacy and tolerability of fosmidomycin in adults with malaria in Gabon. We administered the drug for 5, 4, or 3 days (1-2 g every 8 h), in nine, eight, and ten evaluable patients, respectively. All treatment regimens were well tolerated. Cure rates by day 14 were 89% (eight of nine), 88% (seven of eight), and 60% (six of ten), for treatment durations of 5, 4, and 3 days, respectively. These data suggest that fosmidomycin is a safe and effective treatment for uncomplicated malaria if given for 4 days or more.	Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; Univ Tubingen, Inst Trop Med, Dept Parasitol, D-72074 Tubingen, Germany; Jomaa Pharmaka GmbH, Giessen, Germany	Eberhard Karls University of Tubingen	Kremsner, PG (corresponding author), Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon.		Borrmann, Steffen/G-1838-2013; ADEGNIKA, Ayola Akim/AAK-7307-2020	Borrmann, Steffen/0000-0001-9189-4393; 				Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; KUEMMERLE HP, 1985, INT J CLIN PHARM TH, V23, P521; Mordmuller B, 1998, WIEN KLIN WOCHENSCHR, V110, P321; MURAKAWA T, 1982, ANTIMICROB AGENTS CH, V21, P224, DOI 10.1128/AAC.21.2.224; WINKLER S, 1994, TROP MED PARASITOL, V45, P214	5	183	191	143	680	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1941	1942		10.1016/S0140-6736(02)11860-5	http://dx.doi.org/10.1016/S0140-6736(02)11860-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493263				2022-12-28	WOS:000179870200015
J	Galil, K; Lee, B; Strine, T; Carraher, C; Baughman, AL; Eaton, M; Montero, J; Seward, J				Galil, K; Lee, B; Strine, T; Carraher, C; Baughman, AL; Eaton, M; Montero, J; Seward, J			Outbreak of varicella at a day-care center despite vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	41st Interscience Conference on Antimicrobial Agents and Chemotherapy	DEC 16-20, 2001	CHICAGO, ILLINOIS				HEALTHY-CHILDREN; FOLLOW-UP; EFFICACY; POSTLICENSURE; ADOLESCENTS; LICENSURE	Background: In seven studies of the effectiveness of the varicella vaccine conducted since it was licensed, the effectiveness was 71 to 100 percent against disease of any severity and 95 to 100 percent against moderate and severe disease. We investigated an outbreak of varicella in a population of children with a high proportion of vaccinees who were attending a day-care center in a small community in New Hampshire. Methods: Using standardized questionnaires, we collected information about the children's medical and vaccination history from parents and health care providers. The analysis of the effectiveness of the vaccine and of risk factors for vaccine failure was restricted to children who were enrolled in the day-care center continuously during the outbreak and attended for one week or more and who were cared for in the building that represented the epicenter of the outbreak, since transmission was not documented in a second building. Results: Varicella developed in 25 of 88 children (28.4 percent) between December 1, 2000, and January 11, 2001. The index case occurred in a healthy child who had been vaccinated three years previously and who infected more than 50 percent of his classmates who had no history of varicella. The effectiveness of the vaccine was 44.0 percent (95 percent confidence interval, 6.9 to 66.3 percent) against disease of any severity and 86.0 percent (95 percent confidence interval, 38.7 to 96.8 percent) against moderate or severe disease. Children who had been vaccinated three years or more before the outbreak were at greater risk for vaccine failure than those who had been vaccinated more recently (relative risk, 2.6 [95 percent confidence interval, 1.3 to 5.3]). Conclusions: In this outbreak, vaccination provided poor protection against varicella, although there was good protection against moderate or severe disease. A longer interval since vaccination was associated with an increased risk of vaccine failure. Breakthrough infections in vaccinated, healthy persons can be as infectious as varicella in unvaccinated persons.	Ctr Dis Control & Prevent, Atlanta, GA USA; New Hampshire Dept Hlth & Human Serv, Concord, NH 03301 USA; Washington State Univ, Coll Vet Med, Pullman, WA 99164 USA	Centers for Disease Control & Prevention - USA; Washington State University	Galil, K (corresponding author), 65 Hayden Ave, Lexington, MA 02421 USA.							[Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P637; ARBETER AM, 1986, PEDIATRICS, V78, P748; Buchholz U, 1999, PEDIATRICS, V104, P561, DOI 10.1542/peds.104.3.561; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; CLEMENTS DA, 1995, PEDIATR INFECT DIS J, V14, P874, DOI 10.1097/00006454-199510000-00011; Dworkin MS, 2002, CLIN INFECT DIS, V35, P102, DOI 10.1086/340868; FINE PEM, 1994, AM J EPIDEMIOL, V139, P77, DOI 10.1093/oxfordjournals.aje.a116937; Galil K, 2002, J INFECT DIS, V186, P102, DOI 10.1086/341089; Galil K, 2002, PEDIATR INFECT DIS J, V21, P931, DOI 10.1097/00006454-200210000-00009; Galil Karin, 2001, Pediatric Research, V49, p150A; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; JOHNSON C, 1989, PEDIATRICS, V84, P418; JOHNSON CE, 1988, PEDIATRICS, V81, P512; Johnson CE, 1997, PEDIATRICS, V100, P761, DOI 10.1542/peds.100.5.761; KUTER BJ, 1991, VACCINE, V9, P643, DOI 10.1016/0264-410X(91)90189-D; LARUSSA P, 1992, J VIROL, V66, P1016, DOI 10.1128/JVI.66.2.1016-1020.1992; Loparev VN, 2000, J CLIN MICROBIOL, V38, P3156, DOI 10.1128/JCM.38.9.3156-3160.2000; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Rothstein EP, 1997, J INFECT DIS, V175, P444, DOI 10.1093/infdis/175.2.444; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; WATSON BM, 1993, PEDIATRICS, V91, P17; WEIBEL RE, 1984, NEW ENGL J MED, V310, P1409, DOI 10.1056/NEJM198405313102201; WHITE CJ, 1991, PEDIATRICS, V87, P604	25	164	175	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1909	1915		10.1056/NEJMoa021662	http://dx.doi.org/10.1056/NEJMoa021662			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623ZX	12477940				2022-12-28	WOS:000179735800002
J	Sambrano, GR; Fraser, I; Han, HP; Ni, Y; O'Connell, T; Yan, Z; Stull, JT				Sambrano, GR; Fraser, I; Han, HP; Ni, Y; O'Connell, T; Yan, Z; Stull, JT			Navigating the signalling network in mouse cardiac myocytes	NATURE			English	Article							MYOCARDIAL-CONTRACTILITY; CELL-SIZE; PHOSPHOLAMBAN; MECHANISM; PATHWAYS; HEART	Cardiac myocytes have a complex network of signals that regulates their essential role in the rhythmic pumping of the heart. This network is an appealing model system in which to study the basic principles underlying cellular signalling mechanisms. Progress in this effort has come through the establishment of standardized myocyte isolation and culture procedures and characterization of important signalling responses.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; San Francisco Vet Adm Med Ctr, Dept Cardiol, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; California Institute of Technology; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Sambrano, GR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	sambrano@cmp.ucsf.edu	O'Connell, Timothy/D-5048-2013; Fraser, Iain DC/L-4735-2017	Fraser, Iain DC/0000-0003-2272-3907; Yan, Zhen/0000-0002-4826-9813				Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; BENNDORF K, 1985, PFLUG ARCH EUR J PHY, V404, P190, DOI 10.1007/BF00585418; Bers DM, 2001, EXCITATION CONTRACTI; Colan Steven D., 1997, Cardiology Clinics, V15, P355, DOI 10.1016/S0733-8651(05)70345-3; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Hagemann D, 2002, TRENDS CARDIOVAS MED, V12, P51, DOI 10.1016/S1050-1738(01)00145-1; Hilal-Dandan R, 2000, J MOL CELL CARDIOL, V32, P1211, DOI 10.1006/jmcc.2000.1156; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Koch WJ, 2000, ANNU REV PHYSIOL, V62, P237, DOI 10.1146/annurev.physiol.62.1.237; KRUPPENBACHER JP, 1993, NATURWISSENSCHAFTEN, V80, P132, DOI 10.1007/BF01131017; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; ROBISON GA, 1965, MOL PHARMACOL, V1, P168; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862; SELLIN LC, 1994, PHARMACOL TOXICOL, V74, P305, DOI 10.1111/j.1600-0773.1994.tb01365.x; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Thum T, 2001, Cardiovasc Toxicol, V1, P61, DOI 10.1385/CT:1:1:61; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250; XIAO RP, 2001, BETA ADRENERGIC SIGN; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	25	70	71	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					712	714		10.1038/nature01306	http://dx.doi.org/10.1038/nature01306			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478303				2022-12-28	WOS:000179751800056
J	Corwin, HL; Gettinger, A; Pearl, RG; Fink, MP; Levy, MM; Shapiro, MJ; Corwin, MJ; Colton, T				Corwin, HL; Gettinger, A; Pearl, RG; Fink, MP; Levy, MM; Shapiro, MJ; Corwin, MJ; Colton, T		EPO Critical Care Trials Grp	Efficacy of recombinant human erythropoietin in critically ill patients - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-TRANSFUSION; CRITICAL ILLNESS; CRITICAL CARE; DOUBLE-BLIND; HEMOGLOBIN; SURGERY; ANEMIA	Context Anemia is common in critically ill patients and results in a large number of red blood cell (RBC) transfusions. Recent data have raised the concern that RBC transfusions may be associated with worse clinical outcomes in some patients. Objective To assess the efficacy in critically ill patients of a weekly dosing schedule of recombinant human erythropoietin (rHuEPO) to decrease the occurrence of RBC transfusion. Design A prospective, randomized, double-blind, placebo-controlled, multicenter trial conducted between December 1998 and June 2001. Setting A medical, surgical, or a medical/surgical intensive care unit (ICU) in each of 65 participating institutions in the United States. Patients A total of 1302 patients who had been in the ICU for 2 days and were expected to be in the ICU at least 2 more days and who met eligibility criteria were enrolled in the study; 650 patients were randomized to rHuEPO and 652 to placebo. Intervention Study drug (40000 units of rHuEPO) or placebo was administered by subcutaneous injection on ICU day 3 and continued weekly for patients who remained in the hospital, for a total of 3 doses. Patients in the ICU on study day 21 received a fourth dose. Main Outcome Measures The primary efficacy end point was transfusion independence, assessed by comparing the percentage of patients in each treatment group who received any RBC transfusion between study days 1 and 28. Secondary efficacy end points identified prospectively included cumulative RBC units transfused per patient through study day 28; cumulative mortality through study day 28; change in hemoglobin from baseline; and time to first transfusion or death. Results Patients receiving rHuEPO were less likely to undergo transfusion (60.4% placebo vs 50.5% rHuEPO; P<.001; odds ratio, 0:67; 95% confidence interval [CI], 0.54-0.83). There was a 19% reduction in the total units of RBCs transfused in the rHuEPO group (1963 units for placebo vs 1590 units for rHuEPO) and reduction in RBC units transfused per day alive (ratio of transfusion rates, 0.81; 95% CI, 0.79-0.83; P=.04). Increase in hemoglobin from baseline to study end was greater in the rHuEPO group (mean [SD], 1.32 [2] g/dL vs 0:94 [1.9] g/dL; P<.001). Mortality (14% for rHuEPO and 15% for placebo) and adverse clinical events were not significantly different. Conclusions In critically ill patients, weekly administration of 40000 units of rHuEPO reduces allogeneic RBC transfusion and increases hemoglobin. Further study is needed to determine whether this reduction in RBC transfusion results in improved clinical outcomes.	Dartmouth Hitchcock Med Ctr, Dept Anesthesiol, Lebanon, NH 03756 USA; Stanford Univ, Med Ctr, Dept Anesthesia, Stanford, CA 94305 USA; Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Pittsburgh, PA USA; Rhode Isl Hosp, Providence, RI USA; St Louis Univ, Hlth Sci Ctr, St Louis, MO 63103 USA; Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; CareStat Inc, Boston, MA USA	Dartmouth College; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Lifespan Health Rhode Island; Rhode Island Hospital; Saint Louis University; Boston University; Boston University	Corwin, HL (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Anesthesiol, 1 Med Ctr Dr, Lebanon, NH 03756 USA.			Colton, Theodore/0000-0001-6329-0955; Corwin, Michael/0000-0002-6591-209X				BLUMBERG N, 1994, ARCH PATHOL LAB MED, V118, P371; Burck R, 2002, CRIT CARE MED, V30, P1180, DOI 10.1097/00003246-200205000-00049; CASADEVALL, 2002, NEPHROL DIAL TRAN S5, V17, P42; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Corwin HL, 2001, CRIT CARE MED, V29, pA2; CORWIN HL, 1995, CHEST, V108, P767, DOI 10.1378/chest.108.3.767; Corwin HL, 2000, CRIT CARE MED, V28, P3098, DOI 10.1097/00003246-200008000-00079; Corwin HL, 1999, CRIT CARE MED, V27, P2346, DOI 10.1097/00003246-199911000-00004; Fitzgerald RD, 1997, CRIT CARE MED, V25, P726, DOI 10.1097/00003246-199705000-00004; Frede S, 1997, AM J PHYSIOL-REG I, V273, pR1067, DOI 10.1152/ajpregu.1997.273.3.R1067; Gabrilove JL, 2001, J CLIN ONCOL, V19, P2875, DOI 10.1200/JCO.2001.19.11.2875; Goldberg M A, 1996, Am J Orthop (Belle Mead NJ), V25, P544; GOODNOUGH LT, 1991, JAMA-J AM MED ASSOC, V265, P86, DOI 10.1001/jama.265.1.86; Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606; GROEGER JS, 1993, CRIT CARE MED, V21, P279, DOI 10.1097/00003246-199302000-00022; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Jelkmann W, 1998, J INTERF CYTOK RES, V18, P555, DOI 10.1089/jir.1998.18.555; KRAFTEJACOBS B, 1994, CRIT CARE MED, V22, P821, DOI 10.1097/00003246-199405000-00018; Landers DF, 1996, ANESTH ANALG, V82, P187, DOI 10.1097/00000539-199601000-00035; Littenberg B, 1995, Immunohematology, V11, P88; MARIK PE, 1993, JAMA-J AM MED ASSOC, V269, P3024, DOI 10.1001/jama.269.23.3024; McRae AD, 2002, CRIT CARE MED, V30, P1146, DOI 10.1097/00003246-200205000-00032; MICKLER TA, 1992, J INTENSIVE CARE MED, V7, P176; Monk TG, 1999, ANESTHESIOLOGY, V91, P24, DOI 10.1097/00000542-199907000-00008; Myhre BA, 2000, TRANSFUSION, V40, P879, DOI 10.1046/j.1537-2995.2000.40070879.x; Qvist N, 1999, WORLD J SURG, V23, P30, DOI 10.1007/s002689900561; Rodriquez RM, 2001, J CRIT CARE, V16, P36, DOI 10.1053/jcrc.2001.21795; Rogiers P, 1997, INTENS CARE MED, V23, P159, DOI 10.1007/s001340050310; Spahn DR, 2000, ANESTHESIOLOGY, V93, P242, DOI 10.1097/00000542-200007000-00035; Spence R K, 1993, Curr Probl Surg, V30, P1101; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499	32	352	371	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2827	2835		10.1001/jama.288.22.2827	http://dx.doi.org/10.1001/jama.288.22.2827			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623YM	12472324				2022-12-28	WOS:000179732600027
J	Ahumada, A; Slusarski, DC; Liu, XX; Moon, RT; Malbon, CC; Wang, HY				Ahumada, A; Slusarski, DC; Liu, XX; Moon, RT; Malbon, CC; Wang, HY			Signaling of rat Frizzled-2 through phosphodiesterase and cyclic GMP	SCIENCE			English	Article							BETA-CATENIN; FUNCTIONAL INTERACTION; TERATOCARCINOMA CELLS; WNT; HOMOLOG; PATHWAY; FAMILY	The Frizzled-2 receptor (Rfz2) from rat binds Wnt proteins and can signal by activating calcium release from intracellular stores. We show that wildtype Rfz2 and a chimeric receptor consisting of the extracellular and transmembrane portions of the beta(2)-adrenergic receptor with cytoplasmic domains of Rfz2 also signaled through modulation of cyclic guanosine 3',5'-monophosphate (cGMP). Activation of either receptor led to a decline in the intracellular concentration of cGMP, a process that was inhibited in cells treated with pertussis toxin, reduced by suppression of the expression of the heterotrimeric GTP-binding protein (G protein) transducin, and suppressed through inhibition of cGMP-specific phosphodiesterase (PDE) activity. Moreover, PDE inhibitors blocked Rfz2-induced calcium transients in zebrafish embryos. Thus, Frizzled-2 appears to couple to PDEs and calcium transients through G proteins.	SUNY Stony Brook, Univ Med Ctr, Diabet & Metab Dis Res Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; SUNY Stony Brook, Univ Med Ctr, Diabet & Metab Dis Res Ctr, Dept Mol Pharmacol, Stony Brook, NY 11794 USA; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Ctr Dev Biol, Seattle, WA 98195 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; University of Iowa; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wang, HY (corresponding author), SUNY Stony Brook, Univ Med Ctr, Diabet & Metab Dis Res Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	wangh@pharm.sunysb.edu	Moon, Randall T/B-1743-2014; malbon, craig/ABF-3604-2020; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408	NIDDK NIH HHS [T32-DK07521] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007521] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHUMADA A, UNPUB; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; Cox RT, 1998, CURR BIOL, V8, pR140, DOI 10.1016/S0960-9822(98)70081-8; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; Malbon CC, 2001, BIOCHEM BIOPH RES CO, V287, P589, DOI 10.1006/bbrc.2001.5630; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; RAPORT CJ, 1989, J BIOL CHEM, V264, P7122; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; STRICKLAND S, 1981, CELL, V24, P277, DOI 10.1016/0092-8674(81)90313-5; Wang YS, 1996, J BIOL CHEM, V271, P4468; Weinberg ES, 1996, DEVELOPMENT, V122, P271; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	26	137	141	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					2006	2010		10.1126/science.1073776	http://dx.doi.org/10.1126/science.1073776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471263				2022-12-28	WOS:000179629200050
J	Pohl, MED; Pope, KO; von Nagy, C				Pohl, MED; Pope, KO; von Nagy, C			Olmec origins of Mesoamerican writing	SCIENCE			English	Article								A cylinder seal and carved greenstone plaque bearing glyphs dating to similar to650 B.C. have been uncovered near the Olmec center of La Venta in Tabasco, Mexico. These artifacts, which predate others containing writing, reveal that the key aspects of the Mesoamerican scripts were present in Olmec writing: the combination of pictographic and glyphic elements to represent speech; the use of the sacred 260-day calendar; and the connection between writing, the calendar, and kingship. They imply that Mesoamerican writing originated in the La Venta polity.	Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA; Geo Eco Arc Res, Aquasco, MD 20608 USA; Tulane Univ, Dept Anthropol, New Orleans, LA 70118 USA	State University System of Florida; Florida State University; Tulane University	Pohl, MED (corresponding author), Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA.							Agrinier Pierre, 1964, PAPERS NEW WORLD ARC, V12; BENSON E, 1996, OLMEC ART ANCIENT ME, P213; BERGER R, 1967, CONTRIBUTIONS U CALI, V3, P1; CAHN R, 1993, INDIANA, V13, P30; CAMPBELL L, 1976, AM ANTIQUITY, V41, P80, DOI 10.2307/279044; CLARK J, 2000, OLMEC ART ARCHAEOLOG, P225; Coe M., COMMUNICATION; Coe M. D., 1999, BREAKING MAYA CODE, V2nd; Coe MichaelD., 1968, AM 1 CIVILIZATION; DEMAREST A, 1984, MESOAMERICA, V5, P53; Drucker Philip, 1952, SMITHSONIAN I BUREAU, V153; Gonzalez Lauck R., 1996, OLMEC ART ANCIENT ME, P73; GRAHAM JA, 1990, ARQUEOLOGIA, V3, P77; JUSTESON JS, 1990, VISIBLE LANG, V24, P88; Lee Thomas A., 1969, PAPERS NEW WORLD ARC, V26; LOWE GW, 1964, PAPERS NEW WORLD ARC, V12; MACRI M, COMMUNICATION; Marcus Joyce, 1992, MESOAMERICAN WRITING; Meluzin Sylvia, 1995, PAPERS NEW WORLD ARC, V65; Pope KO, 2001, SCIENCE, V292, P1370, DOI 10.1126/science.292.5520.1370; Quirarte Jacinto, 1977, ORIGINS MAYA CIVILIZ, P249; RUST WF, 1988, SCIENCE, V242, P102, DOI 10.1126/science.242.4875.102; Schele Linda, 1986, BLOOD KINGS DYNASTY; Scott John F, 1978, STUDIES PRECOLUMBIAN, V19; Smith Virginia G., 1984, STUDIES PRECOLUMBIAN, V27; STROSS B, 1990, VISIBLE LANG, V24, P38; Urcid Serrano Javier, 2001, STUDIES PRECOLUMBIAN, V34; Whittaker Gordon, 1980, THESIS YALE U; Winfield Capitaine F., 1988, ESTELA 1 MOJARRA VER	29	34	34	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1984	1987		10.1126/science.1078474	http://dx.doi.org/10.1126/science.1078474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471256				2022-12-28	WOS:000179629200043
J	Shaw, MR; Zavaleta, ES; Chiariello, NR; Cleland, EE; Mooney, HA; Field, CB				Shaw, MR; Zavaleta, ES; Chiariello, NR; Cleland, EE; Mooney, HA; Field, CB			Grassland responses to global environmental changes suppressed by elevated CO2	SCIENCE			English	Article							PLANT-RESPONSES; CARBON; NITROGEN; ECOSYSTEM; CLIMATE; PRODUCTIVITY; ASSIMILATION; ENRICHMENT; BIOSPHERE; WHEAT	Simulated global changes, including warming, increased precipitation, and nitrogen deposition, alone and in concert, increased net primary production (NPP) in the third year of ecosystem-scale manipulations in a California annual grassland. Elevated carbon dioxide also increased NPP, but only as a single-factor treatment. Across all multifactor manipulations, elevated carbon dioxide suppressed root allocation, decreasing the positive effects of increased temperature, precipitation, and nitrogen deposition on NPP. The NPP responses to interacting global changes differed greatly from simple combinations of single-factor responses. These findings indicate the importance of a multifactor experimental approach to understanding ecosystem responses to global change.	Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Jasper Ridge Biol Preserve, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University; Stanford University	Shaw, MR (corresponding author), Nat Conservancy Calif, 201 Mission St,4th Floor, San Francisco, CA 94105 USA.	shaw@globalecology.stanford.edu						[Anonymous], 1996, CARBON DIOXIDE POPUL; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Cardon ZG, 2001, SOIL BIOL BIOCHEM, V33, P365, DOI 10.1016/S0038-0717(00)00151-6; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Diaz S, 1996, PLANT SOIL, V187, P309, DOI 10.1007/BF00017096; Drake B. G., 1996, CARBON DIOXIDE TERRE, P197; Easterling DR, 2000, J GEOPHYS RES-ATMOS, V105, P20101, DOI 10.1029/2000JD900166; Edwards NT, 1999, PLANT SOIL, V206, P85, DOI 10.1023/A:1004319109772; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FIELD CB, 2000, EARTH SYSTEMS PROCES, P297; Higgins PAT, 2002, GLOBAL CHANGE BIOL, V8, P841, DOI 10.1046/j.1365-2486.2002.00514.x; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Hungate BA, 2000, OECOLOGIA, V124, P589, DOI 10.1007/s004420000405; IDSO KE, 1994, AGR FOREST METEOROL, V69, P153, DOI 10.1016/0168-1923(94)90025-6; *INT PAN CLIM CHAN, 2001, WORK GROUP 1 3 ASS R; KARL TR, 1998, REGIONAL IMPACTS CLI, P412; Kimball BA, 1995, GLOB CHANGE BIOL, V1, P429, DOI 10.1111/j.1365-2486.1995.tb00041.x; KIMBALL BA, 1993, AGRON J, V85, P706, DOI 10.2134/agronj1993.00021962008500030035x; KIMBALL BA, 1983, AGRON J, V75, P779, DOI 10.2134/agronj1983.00021962007500050014x; Koch G.W., 1996, CARBON DIOXIDE TERRE, ppp 415, DOI DOI 10.1016/B978-012505295-5/50023-9; Koide RT, 1988, FUNCT ECOL, V2, P335, DOI 10.2307/2389406; Korner C, 1997, ACTA OECOL, V18, P165, DOI 10.1016/S1146-609X(97)80002-1; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; LUO Y, 1994, PLANT CELL ENVIRON, V17, P1195, DOI 10.1111/j.1365-3040.1994.tb02017.x; Luo YQ, 1996, OECOLOGIA, V108, P130, DOI 10.1007/BF00333224; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Mooney H.A., 1999, TERRESTRIAL BIOSPHER, P141; OECHEL WC, 1994, NATURE, V371, P500, DOI 10.1038/371500a0; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Owensby CE, 1999, GLOB CHANGE BIOL, V5, P497, DOI 10.1046/j.1365-2486.1999.00245.x; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Volk M, 2000, OECOLOGIA, V125, P380, DOI 10.1007/s004420000454; ZAVALETA ES, 2001, THESIS STANFORD U	38	410	453	15	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					1987	1990		10.1126/science.1075312	http://dx.doi.org/10.1126/science.1075312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471257				2022-12-28	WOS:000179629200044
J	Namork, E; Brandtzaeg, P				Namork, E; Brandtzaeg, P			Fatal meningococcal septicaemia with "blebbing" meningococcus	LANCET			English	Editorial Material									Natl Inst Publ Hlth, Dept Environm Med, Electron Microscopy Unit, Oslo, Norway; Univ Oslo, Ulleval Univ Hosp, Dept Paediat, Oslo, Norway	University of Oslo	Namork, E (corresponding author), Natl Inst Publ Hlth, Dept Environm Med, Electron Microscopy Unit, Oslo, Norway.			Brandtzaeg, Petter/0000-0002-0667-1097					0	72	74	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1741	1741		10.1016/S0140-6736(02)11721-1	http://dx.doi.org/10.1016/S0140-6736(02)11721-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480427				2022-12-28	WOS:000179636800011
J	Sepkowitz, KA				Sepkowitz, KA			How contagious is vaccinia?	NEW ENGLAND JOURNAL OF MEDICINE			English	Review									Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Sepkowitz, KA (corresponding author), Mem Sloan Kettering Canc Ctr, Infect Dis Serv, 1275 York Ave, New York, NY 10021 USA.				NIAID NIH HHS [K24 AI052239-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI052239] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		American Cancer Society, 2002, CANC FACTS FIG 2002; ANDREEV V C, 1969, Dermatologia Internationalis, V8, P5; Angulo J J, 1966, Hospital (Rio J), V69, P179; Ayo C, 1942, ARCHIV OTOLARYNGOL, V36, P556; Barton RL, 1944, ARCH DERMATOL SYPH, V50, P99, DOI 10.1001/archderm.1944.01510140022005; BERGMAN R, 1941, NORD HYG TIDSKR, V22, P257; BIRRER RB, 1981, NEW YORK STATE J MED, V81, P774; BRAIN RT, 1950, BRIT J DERMATOL SYPH, V62, P203, DOI 10.1111/j.1365-2133.1950.tb14373.x; BRAV A, 1945, ARCH OPHTHALMOL-CHIC, V33, P67; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; *CDCP, 2002, SUMM OCT 2002 ACIP S; *CDCP, 2001, HIV AIDS SURVEILLANC, V13, P7; CHAUDHURI AKR, 1981, BRIT MED J, V282, P1797, DOI 10.1136/bmj.282.6278.1797-a; CONYBEARE E T, 1964, Mon Bull Minist Health Public Health Lab Serv, V23, P126; COPEMAN PWM, 1964, BRIT MED J, V2, P906, DOI 10.1136/bmj.2.5414.906; DANZIGER F, 1907, MUNCHEN MED WCHNSCHR, V54, P1583; DIXON MF, 1970, J PATHOL, V100, P53, DOI 10.1002/path.1711000107; Ellis FA, 1935, J AMER MED ASSOC, V104, P1891, DOI 10.1001/jama.1935.02760210023007; ERICHSON RB, 1961, ANN INTERN MED, V55, P491, DOI 10.7326/0003-4819-55-3-491; FIUMARA NJ, 1973, NEW ENGL J MED, V288, P324; FRIES JH, 1948, J PEDIATR, V32, P532, DOI 10.1016/S0022-3476(48)80174-5; FULGINITI VA, 1968, BIRTH DEFECTS OAS, V4, P129; GRAY FG, 1948, B JOHNS HOPKINS HOSP, V82, P538; GREER KE, 1974, ARCH DERMATOL, V110, P107, DOI 10.1001/archderm.110.1.107; Haim M, 2000, MIL MED, V165, P287, DOI 10.1093/milmed/165.4.287; Haim S, 1976, Cutis, V17, P308; HALL GFM, 1953, J PATHOL BACTERIOL, V66, P25, DOI 10.1002/path.1700660105; Horgan ES, 1944, J HYG-CAMBRIDGE, V43, P273, DOI 10.1017/S0022172400012961; HORWITZ MS, 1966, J PEDIATR-US, V68, P308, DOI 10.1016/S0022-3476(66)80164-6; HUMPHREY DC, 1963, AM J OBSTET GYNECOL, V86, P460; JOHNSON RH, 1976, WESTERN J MED, V125, P266; KOZINN PJ, 1955, PEDIATRICS, V16, P600; LANDTMAN B, 1954, Ann Paediatr Fenn, V1, P61; LANE JM, 1970, J AMER MED ASSOC, V212, P441, DOI 10.1001/jama.212.3.441; Laughter D, 2000, J AM ACAD DERMATOL, V43, P649, DOI 10.1067/mjd.2000.107773; LUM GS, 1967, AM J TROP MED HYG, V16, P332, DOI 10.4269/ajtmh.1967.16.332; MAGALDIJORDAO FB, 1962, ARCH DERMATOL, V85, P533, DOI 10.1001/archderm.1962.01590040097017; Martin HA, 1882, MED REC, V21, P393; McLachlan AD, 1936, BRIT J DERMATOL SYPH, V48, P337, DOI 10.1111/j.1365-2133.1936.tb10356.x; *NAT HEART LUNG BL, 1999, DAT FACT SHEET ASTHM; *NAT I ARTHR MUSC, 2002, QUEST ANSW ARTHR RHE; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; Nimpfer T, 1936, ARCH DERMATOL SYPH-G, V174, P518, DOI 10.1007/BF02061362; OCONNELL CJ, 1964, ANN INTERN MED, V60, P282, DOI 10.7326/0003-4819-60-2-282; PIERRET R, 1956, B SOC FR DERMATOL SY, V63, P409; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; SOMMERVILLE J, 1951, BRIT J DERMATOL, V63, P203, DOI 10.1111/j.1365-2133.1951.tb13714.x; STRICKLER A., 1944, Urologic and Cutaneous Review, V48, P340; TOSCANO F, 1953, Minerva Pediatr, V5, P987; WADDINGTON E, 1964, Trans St Johns Hosp Dermatol Soc, V50, P22; WHITTLE C H, 1950, Br J Dermatol Syph, V62, P195, DOI 10.1111/j.1365-2133.1950.tb14372.x; WILLCOX R R, 1957, Br J Clin Pract, V11, P925; 1968, MMWR MORB MORTAL WKL, V17, P336; 1981, MMWR MORB MORTAL WKL, V30, P453; 1984, MMWR MORB MORTAL WKL, V33, P37; 1971, BMJ, V1, P121	56	82	86	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					439	446		10.1056/NEJMra022500	http://dx.doi.org/10.1056/NEJMra022500			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12496351				2022-12-28	WOS:000180643800011
J	Grutzendler, J; Kasthuri, N; Gan, WB				Grutzendler, J; Kasthuri, N; Gan, WB			Long-term dendritic spine stability in the adult cortex	NATURE			English	Article							VISUAL-CORTEX; MACACA-NEMESTRINA; OCULAR DOMINANCE; STRIATE CORTEX; LIVING MICE; PLASTICITY; NEURONS; SYNAPTOGENESIS; FILOPODIA; SYNAPSES	The structural dynamics of synapses probably has a crucial role in the development and plasticity of the nervous system. In the mammalian brain, the vast majority of excitatory axo-dendritic synapses occur on dendritic specializations called 'spines'. However, little is known about their long-term changes in the intact developing or adult animal. To address this question we developed a transcranial two-photon imaging technique to follow identified spines of layer-5 pyramidal neurons in the primary visual cortex of living transgenic mice expressing yellow fluorescent protein. Here we show that filopodia-like dendritic protrusions, extending and retracting over hours, are abundant in young animals but virtually absent from the adult. In young mice, within the 'critical period' for visual cortex development, similar to73% of spines remain stable over a one-month interval; most changes are associated with spine elimination. In contrast, in adult mice, the overwhelming majority of spines (similar to96%) remain stable over the same interval with a half-life greater than 13 months. These results indicate that spines, initially plastic during development, become remarkably stable in the adult, providing a potential structural basis for long-term information storage.	NYU, Sch Med, Dept Physiol & Neurosci, Skirball Inst,Mol Neurobiol Program, New York, NY 10016 USA	New York University	Gan, WB (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci, Skirball Inst,Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.		Grutzendler, Jaime/F-3691-2010					Antonini A, 1999, J NEUROSCI, V19, P4388; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BOOTHE RG, 1979, J COMP NEUROL, V186, P473, DOI 10.1002/cne.901860310; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; HUTTENLOCHER PR, 1987, HUM NEUROBIOL, V6, P1; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P274, DOI 10.1006/nlme.1998.3827; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; LUND JS, 1977, J COMP NEUROL, V176, P149, DOI 10.1002/cne.901760203; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; PURVES D, 1985, NATURE, V315, P404, DOI 10.1038/315404a0; RAKIC P, 1994, PROG BRAIN RES, V102, P227; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	29	865	884	4	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					812	816		10.1038/nature01276	http://dx.doi.org/10.1038/nature01276			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490949				2022-12-28	WOS:000179897300056
J	Tracey, KJ				Tracey, KJ			The inflammatory reflex	NATURE			English	Review							VAGUS NERVE-STIMULATION; NECROSIS-FACTOR-ALPHA; PITUITARY-ADRENAL AXIS; TO-BRAIN COMMUNICATION; GASTRIC-ACID-SECRETION; PROINFLAMMATORY CYTOKINES; NEUROENDOCRINE REGULATION; RHEUMATOID-ARTHRITIS; IMMUNE FUNCTION; LATE MEDIATOR	Inflammation is a local, protective response to microbial invasion or injury. It must be fine-tuned and regulated precisely, because deficiencies or excesses of the inflammatory response cause morbidity and shorten lifespan. The discovery that cholinergic neurons inhibit acute inflammation has qualitatively expanded our understanding of how the nervous system modulates immune responses. The nervous system reflexively regulates the inflammatory response in real time, just as it controls heart rate and other vital functions. The opportunity now exists to apply this insight to the treatment of inflammation through selective and reversible 'hard-wired' neural systems.	N Shore LIJ Res Inst, Lab Biomed Sci, Manhasset, NY 11030 USA	Northwell Health	Tracey, KJ (corresponding author), N Shore LIJ Res Inst, Lab Biomed Sci, 350 Community Dr, Manhasset, NY 11030 USA.	kjtracey@sprynet.com		Tracey, Kevin J/0000-0003-1884-6314				Ader R, 2001, PSYCHONEUROIMMUNOLOG, P3; Andersson L1992A, SCRIPTA BOT BELG, V1, P1; ARAI I, 1985, JPN J PHARMACOL, V37, P91, DOI 10.1254/jjp.37.91; BELLINGER DL, 2001, PSYCHONEUROIMMUNOLOG, P55; Ben-Menachem E, 2001, J CLIN NEUROPHYSIOL, V18, P415, DOI 10.1097/00004691-200109000-00005; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; BERTINI R, 1988, J EXP MED, V167, P1708, DOI 10.1084/jem.167.5.1708; BESEDOVSKY H, 1986, SCIENCE, V233, P652, DOI 10.1126/science.3014662; BESEDOVSKY H, 1977, EUR J IMMUNOL, V7, P323, DOI 10.1002/eji.1830070516; Bianchi M, 1996, J EXP MED, V183, P927, DOI 10.1084/jem.183.3.927; BIANCHI M, 1995, MOL MED, V1, P254, DOI 10.1007/BF03401550; BLACK S, 1963, BRIT MED J, P925, DOI 10.1136/bmj.1.5335.925; BLALOCK JE, 1989, PHYSIOL REV, V69, P1, DOI 10.1152/physrev.1989.69.1.1; BLALOCK JE, 1984, J IMMUNOL, V132, P1067; BLALOCK JE, 1994, ANN NY ACAD SCI, V741, P292; Bloom O, 1998, SHOCK, V10, P395, DOI 10.1097/00024382-199812000-00003; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Borovikova LV, 2000, AUTON NEUROSCI-BASIC, V85, P141, DOI 10.1016/S1566-0702(00)00233-2; BREDER CD, 1994, P NATL ACAD SCI USA, V91, P11393, DOI 10.1073/pnas.91.24.11393; BREDER CD, 1988, SCIENCE, V240, P321, DOI 10.1126/science.3258444; BUTLER LD, 1989, J NEUROIMMUNOL, V24, P143, DOI 10.1016/0165-5728(89)90108-2; CATANIA A, 1991, P NATL ACAD SCI USA, V88, P8544, DOI 10.1073/pnas.88.19.8544; CERIANI G, 1994, NEUROENDOCRINOLOGY, V59, P138, DOI 10.1159/000126650; Chrousos GP, 2000, ANN NY ACAD SCI, V917, P38, DOI 10.1111/j.1749-6632.2000.tb05371.x; Clark KB, 1999, NAT NEUROSCI, V2, P94, DOI 10.1038/4600; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; DELGADO HR, 1999, NEUROIMMUNOMODULAT, V6, P187; DIAS DS, 2002, AM J PHYSIOL-REG I, V283, pR543; EDMONDS ME, 1979, BRIT MED J, V2, P173, DOI 10.1136/bmj.2.6183.173; Emch GS, 2000, AM J PHYSIOL-GASTR L, V279, pG582, DOI 10.1152/ajpgi.2000.279.3.G582; Exton MS, 2000, BEHAV BRAIN RES, V110, P129, DOI 10.1016/S0166-4328(99)00191-6; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; Goehler LE, 1997, BRAIN RES BULL, V43, P357, DOI 10.1016/S0361-9230(97)00020-8; Gordon FJ, 2000, AUTON NEUROSCI-BASIC, V85, P102, DOI 10.1016/S1566-0702(00)00228-9; Hansen MK, 2001, AM J PHYSIOL-REG I, V280, pR929; Hansen MK, 2000, AUTON NEUROSCI-BASIC, V85, P119, DOI 10.1016/S1566-0702(00)00230-7; Hermann GE, 2001, AM J PHYSIOL-REG I, V280, pR289, DOI 10.1152/ajpregu.2001.280.1.R289; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Johansson ACM, 2001, J IMMUNOL, V167, P3505, DOI 10.4049/jimmunol.167.6.3505; Kawashima K, 2000, PHARMACOL THERAPEUT, V86, P29, DOI 10.1016/S0163-7258(99)00071-6; KOIZUMI K, 1982, P NATL ACAD SCI-BIOL, V79, P2116, DOI 10.1073/pnas.79.6.2116; LANTZ M, 1990, J CLIN INVEST, V86, P1396, DOI 10.1172/JCI114853; LUX G, 1994, GUT, V35, P1026, DOI 10.1136/gut.35.8.1026; Mabley JG, 2002, J PHARMACOL EXP THER, V300, P876, DOI 10.1124/jpet.300.3.876; MADDEN KS, 1995, PHYSIOL REV, V75, P77, DOI 10.1152/physrev.1995.75.1.77; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pharmtox.35.1.417; Matsumori A, 1997, CIRCULATION, V96, P1386, DOI 10.1161/01.CIR.96.5.1386; Metalnikov S., 1926, ANN I PASTEUR PARIS, V40, P893; Molina PE, 2001, NEUROIMMUNOMODULAT, V9, P125, DOI 10.1159/000049016; Molina PE, 2001, SHOCK, V16, P459, DOI 10.1097/00024382-200116060-00010; Noguchi E, 1996, JPN J PHYSIOL, V46, P53, DOI 10.2170/jjphysiol.46.53; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Romanovsky AA, 2000, AUTON NEUROSCI-BASIC, V85, P39, DOI 10.1016/S1566-0702(00)00218-6; Sato E, 1998, AM J PHYSIOL-LUNG C, V274, pL970, DOI 10.1152/ajplung.1998.274.6.L970; Sato KZ, 1999, NEUROSCI LETT, V266, P17, DOI 10.1016/S0304-3940(99)00259-1; Schachter SC, 2002, CURR OPIN NEUROL, V15, P201, DOI 10.1097/00019052-200204000-00013; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; STERNBERG EM, 1989, P NATL ACAD SCI USA, V86, P2374, DOI 10.1073/pnas.86.7.2374; TAN J, 1993, AM J PHYS MED REHAB, V72, P196, DOI 10.1097/00002060-199308000-00005; TOUSSIROT E, 1993, J RHEUMATOL, V20, P1508; Tracey KJ, 1999, SHOCK, V11, P224, DOI 10.1097/00024382-199903000-00012; TRACEY KJ, 1989, LANCET, V1, P1122; Tracey KJ, 2001, FASEB J, V15, P1575, DOI 10.1096/fj.01-0148hyp; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Tracey KJ, 1998, PROG CLIN BIOL RES, V397, P335; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; vanderPoll T, 1996, J CLIN INVEST, V97, P713, DOI 10.1172/JCI118469; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117; WATKINS LR, 1995, NEUROSCI LETT, V183, P27, DOI 10.1016/0304-3940(94)11105-R; Watkins LR, 1999, P NATL ACAD SCI USA, V96, P7710, DOI 10.1073/pnas.96.14.7710; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Wessler I, 1998, PHARMACOL THERAPEUT, V77, P59, DOI 10.1016/S0163-7258(97)00085-5; WEXLER BC, 1957, ENDOCRINOLOGY, V61, P300, DOI 10.1210/endo-61-3-300; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; ZACHARIAE R, 2001, PSYCHONEUROIMMUNOLOG, P133; Zhang MH, 1999, MOL MED, V5, P595, DOI 10.1007/BF03402072	81	2306	2529	13	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					853	859		10.1038/nature01321	http://dx.doi.org/10.1038/nature01321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490958				2022-12-28	WOS:000179897300066
J	Freedman, VA; Martin, LG; Schoeni, RF				Freedman, VA; Martin, LG; Schoeni, RF			Recent trends in disability and functioning among in the United States - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SEVERE COGNITIVE IMPAIRMENT; AGGREGATE CHANGES; ELDERLY POPULATION; OLDER AMERICANS; HEALTH; PREVALENCE; US; LIMITATIONS; DECLINE; INDEX	Context Several well-publicized recent studies have suggested that disability among older Americans has declined in the last decade. Objectives To assess the quality, quantity, and consistency of recent evidence on US trends in the prevalence of self-rated old age disability and physical, cognitive, and sensory. limitations during the late 1980s and 1990s and to evaluate the evidence on trends in disparities by major demographic groups. Data Sources We searched MEDLINE and AGELINE for relevant articles published from January 1990 through May 2002 and reviewed reference lists in published articles. Study Selection From more than 800 titles reviewed, we selected 16 articles based on 8 unique repeat cross-sectional and cohort surveys of US prevalence trends in disability or functioning among persons generally aged 65 or 70 years or older. Data Extraction We evaluated survey quality according to 10 criteria, ranked the surveys as good, fair, or poor, and calculated for each outcome the average annual percent change. Data Synthesis Among the 8 surveys, 2 were rated as good, 4 as fair, 1 as poor, and 1 as mixed (fair or poor, depending on the outcome) for assessing trends. Analyses of surveys rated fair or good showed consistency of declines in any disability (-1.55% to -0.92% per year), instrumental activities of daily living disability (-2.74% to -0.40% per year), and functional limitations. Surveys provided limited evidence on cognition and conflicting evidence on self - reported ADL (changes ranged from -1.38% to 1.53% per year) and vision trends. Evidence on trends in disparities by age, sex, race, and education was limited and mixed, with no consensus yet emerging. Conclusions Several measures of old age disability and limitations have shown improvements in the last decade. Research into the causes of these improvements is needed to understand the implications for the future demand for medical care.	Madlyn & Leonard Abramson Ctr Jewish Life, Polisher Res Inst, N Wales, PA 19454 USA; Populat Council, New York, NY 10021 USA; Univ Michigan, Inst Social Res, Ann Arbor, MI USA	Population Council; University of Michigan System; University of Michigan	Freedman, VA (corresponding author), Madlyn & Leonard Abramson Ctr Jewish Life, Polisher Res Inst, 1425 Horsham Rd, N Wales, PA 19454 USA.	vfreedman@abramsoncenter.org			NIA NIH HHS [K01AG00670, R01-AG14346] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG014346, K01AG000670] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allaire SH, 1999, AM J PUBLIC HEALTH, V89, P1678, DOI 10.2105/AJPH.89.11.1678; Bishop CE, 1999, HEALTH AFFAIR, V18, P146, DOI 10.1377/hlthaff.18.4.146; *C BUDG OFF, 1999, PROJ LONGT CAR SERV; Clark DO, 1997, AM J PUBLIC HEALTH, V87, P438, DOI 10.2105/AJPH.87.3.438; Costa DL, 2002, DEMOGRAPHY, V39, P119, DOI 10.1353/dem.2002.0003; Costa DL, 2000, DEMOGRAPHY, V37, P53, DOI 10.2307/2648096; Crimmins EM, 1997, J GERONTOL B-PSYCHOL, V52, pS59, DOI 10.1093/geronb/52B.2.S59; Crimmins EM, 1997, POPUL DEV REV, V23, P555, DOI 10.2307/2137572; Crimmins EM, 1996, J GERONTOL B-PSYCHOL, V51, pS223, DOI 10.1093/geronb/51B.5.S223; CRIMMINS EM, 2000, DEMOGR RES, V3, P1; Cutler DM, 2001, P NATL ACAD SCI USA, V98, P6546, DOI 10.1073/pnas.131201698; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; DESAI M, 2001, AGING TRENDS, V2; Ettner SL, 1996, J HUM RESOUR, V31, P189, DOI 10.2307/146047; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Freedman VA, 2000, AM J PUBLIC HEALTH, V90, P1755, DOI 10.2105/AJPH.90.11.1755; Freedman VA, 1999, DEMOGRAPHY, V36, P461, DOI 10.2307/2648084; Freedman VA, 2002, J GERONTOL B-PSYCHOL, V57, pS126, DOI 10.1093/geronb/57.2.S126; Freedman VA, 2001, J GERONTOL B-PSYCHOL, V56, pS100, DOI 10.1093/geronb/56.2.S100; Freedman VA, 1998, AM J PUBLIC HEALTH, V88, P1457, DOI 10.2105/AJPH.88.10.1457; FREEDMAN VA, 1994, FOR DIS WORKSH SUMM; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Kane R. L., 2000, ASSESSING OLDER PERS; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Lan TY, 2002, J GERONTOL A-BIOL, V57, pM294, DOI 10.1093/gerona/57.5.M294; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Liao YL, 2000, JAMA-J AM MED ASSOC, V283, P512, DOI 10.1001/jama.283.4.512; Liao YL, 2001, J AM GERIATR SOC, V49, P443, DOI 10.1046/j.1532-5415.2001.49089.x; Lubitz J, 2001, HEALTH AFFAIR, V20, P19, DOI 10.1377/hlthaff.20.2.19; MANTON KG, 1993, J GERONTOL, V48, pS153, DOI 10.1093/geronj/48.4.S153; Manton KG, 2001, P NATL ACAD SCI USA, V98, P6354, DOI 10.1073/pnas.111152298; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; McNeil J., 2001, AM DISABILITIES 1997, P70; Nagi SZ, 1965, SOCIOLOGY REHABILITA, P100; Ostchega Y, 2000, J AM GERIATR SOC, V48, P1132, DOI 10.1111/j.1532-5415.2000.tb04791.x; POPE AM, 1991, DISABILITY AM NATL A; RHOADES JA, 1999, 3 MEPS AG HLTH CAR P; SAYHOUN NR, 2001, AGING TRENDS     MAR, P1; Schoeni RF, 2001, J GERONTOL B-PSYCHOL, V56, pS206, DOI 10.1093/geronb/56.4.S206; Sherman SE, 1998, J GEN INTERN MED, V13, P817, DOI 10.1046/j.1525-1497.1998.00245.x; Shrestha LB, 1996, GERONTOLOGIST, V36, P106, DOI 10.1093/geront/36.1.106; Singer BH, 1998, P NATL ACAD SCI USA, V95, P15618, DOI 10.1073/pnas.95.26.15618; TRUPIN L, 1987, MED EXPENDITURES PEO; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; WAIDMANN T, 1995, MILBANK Q, V73, P253, DOI 10.2307/3350259; Waidmann T. A., 1998, INT EVIDENCE DISABIL; Waidmann TA, 2000, J GERONTOL B-PSYCHOL, V55, pS298, DOI 10.1093/geronb/55.5.S298; Wolf DA, 2001, HEALTH AFFAIR, V20, P28, DOI 10.1377/hlthaff.20.6.28	50	539	549	1	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2002	288	24					3137	3146		10.1001/jama.288.24.3137	http://dx.doi.org/10.1001/jama.288.24.3137			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628QQ	12495394				2022-12-28	WOS:000180008200024
J	Steinberg, AG; Iezzoni, LI; Conill, A; Stineman, M				Steinberg, AG; Iezzoni, LI; Conill, A; Stineman, M			Reasonable accommodations for medical faculty with disabilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACADEMIC MEDICINE; MINORITY FACULTY; HEALTH-CARE; WOMEN; PHYSICIAN; GENDER	An unknown number of medical school faculty have disabilities, and their experiences have generally escaped notice and scrutiny. Although most medical schools offer long-term insurance and extended leaves of absence for disability, relatively few have policies explicitly addressing accommodations for faculty with disabilities as they perform teaching, research, and clinical duties. We discuss accommodating active medical school faculty with disabilities, drawing on University of Pennsylvania School of Medicine initiatives exploring the concerns of faculty with sensory and physical disabilities. Anecdotal reports suggest that many faculty, fearing reprisals, resist seeking job accommodations such as those mandated in the 1990 Americans with Disabilities Act (ADA). Although some faculty with disabilities have found supportive academic mentors, others report that lax institutional enforcement of ADA requirements, including physical,access problems, demonstrates a tepid commitment to disabled staff. Potentially useful job accommodations include adjusting timelines for promotion decisions; reassessing promotions requirements that inherently require extensive travel; improving physical access to teaching, research, and clinical sites; and modifying clinical and teaching schedules. Faculty with disabilities bring identical intellectual and collegial benefits to medical schools as their nondisabled counterparts. In addition, they may offer special insights into how chronic illness and impairments affect daily life.	Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Internal Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Rehabil Med, Philadelphia, PA 19104 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gen Med & Primary Care, Boston, MA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Steinberg, AG (corresponding author), Childrens Hosp Philadelphia, 3535 Market St,9th Floor, Philadelphia, PA 19104 USA.							Americans with Disabilities Act, SPRINGER REFERENCE, DOI [10.1007/springerreference_44126, DOI 10.1007/SPRINGERREFERENCE_44126]; *ASS AM MED COLL, US MED SCH FAC ANN D; *ASS AM MED COLL, DIS STUD MED SCH OV; *ASS AM MED COLL D, 2001, FAC I POL ARCH VERS; Batavia A. I, 2000, AM DISABILITIES EXPL, P283; Blanck P. D, 2000, AM DISABILITIES EXPL, P209; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; CASSELL EJ, 1997, DOCTORING NATURE PRI; Charlton J.I., 2000, NOTHING US US DISABI; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Derose KP, 2001, J GEN INTERN MED, V16, P218, DOI 10.1046/j.1525-1497.2001.016004218.x; Evans R. G., 1994, WHY ARE SOME PEOPLE; FELDBLUM CR, 1991, AM DISABILITIES ACT, P81; Fleischer D., 2001, DISABILITY RIGHTS MO; Fox D., 1993, POWER ILLNESS FAILUR; Francis L., 2000, AM DISABILITIES EXPL; Gamble VN, 2000, HEALTH AFFAIR, V19, P164, DOI 10.1377/hlthaff.19.1.164; Gray B, 1997, J COMMUN HEALTH, V22, P247, DOI 10.1023/A:1025148302636; Heid IM, 1999, MAYO CLIN PROC, V74, P113, DOI 10.4065/74.2.113; IEZZONI L, IN PRESS WALKING FAI; Iezzoni LI, 2000, MED CARE, V38, P1051, DOI 10.1097/00005650-200010000-00009; Iezzoni LI, 2000, AM J PUBLIC HEALTH, V90, P955, DOI 10.2105/AJPH.90.6.955; ILLINGWORTH P, 2000, AM DISABILITIES EXPL, P3; Johnson JC, 1998, ACAD MED, V73, P237, DOI 10.1097/00001888-199803000-00011; JONES N, 1991, AM DISABILITIES ACT, P25; KANE RL, 2000, ASSESSING OLDER PERS, P1; Kavka G. S., 2000, AM DISABILITIES EXPL, P174; Kleinman A., 1988, ILLNESS NARRATIVES; LAVEIST TA, 1993, MILBANK Q, V71, P41, DOI 10.2307/3350274; LAWN BB, 1989, AM J PSYCHIAT, V146, P771; Lewis-Stevenson S, 2001, FAM MED, V33, P459; Longmore Paul K., 2001, NEW DISABILITY HIST; MARTIN L, 2000, ANN STAT REPORT SOCI; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; Murphy Robert, 1990, THE BODY SILENT; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Nonnemaker L, 2000, NEW ENGL J MED, V342, P399, DOI 10.1056/NEJM200002103420606; Oliver M., 1996, UNDERSTANDING DISABI; Olkin R, 1993, READINGS, V8, P13; PACHTER LM, 1994, JAMA-J AM MED ASSOC, V271, P690, DOI 10.1001/jama.271.9.690; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; ROCKOW K, 2001, WORKING DEAF HARD HE; Roetzheim RG, 2002, J HEALTH CARE POOR U, V13, P461, DOI 10.1177/104920802762475111; Saha S, 1999, ARCH INTERN MED, V159, P997, DOI 10.1001/archinte.159.9.997; Shapiro Joseph P., 1994, NO PITY PEOPLE DISAB; Social Security Administration Office of Disability, 1998, SSA PUBL; STEIN MA, 2000, AM DISABILITIES EXPL, P193; Stone D., 1984, DISABLED STATE; *U PA HLTH SYST ME, FAC 2000 PROJ; *US DEP LAB OFF DI, JOB ACC NETW; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; van Ryn M, 2002, MED CARE, V40, P140; WAINAPEL SF, 1987, JAMA-J AM MED ASSOC, V257, P2935, DOI 10.1001/jama.257.21.2935; WHO, 2001, WHO INT CLASS FUNCT; Williams G., 2001, HDB DISABILITY STUDI, P123, DOI DOI 10.4135/9781412976251.N5; Wong EY, 2001, J WOMEN HEALTH GEN-B, V10, P541, DOI 10.1089/15246090152543120; Yedidia MJ, 2001, ACAD MED, V76, P453, DOI 10.1097/00001888-200105000-00017; YELIN EH, 1991, AM DISABILITIES ACT, P129; Young Iris M., 2000, AM DISABILITIES EXPL, P169; Young Jonathan, 1997, EQUALITY OPPORTUNITY; Zola I. K., 2003, MISSING PIECES CHRON	61	23	23	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2002	288	24					3147	3154		10.1001/jama.288.24.3147	http://dx.doi.org/10.1001/jama.288.24.3147			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628QQ	12495395				2022-12-28	WOS:000180008200025
J	Arcus, KD; Kessel, AS				Arcus, KD; Kessel, AS			Are ethical principles relative to time and place? A Star Wars perspective on the Alder Hey affair	BRITISH MEDICAL JOURNAL			English	Article								The problems at Alder Hey Hospital around how, when, and why parents' consent should be sought for research on their dead children's tissues has raised some old philosophical questions. In particular, to what degree can practices be morally defended on the grounds of context? To help shed light on this, Kim D Arcus and Anthony S Kessel went to a different time and place and requested help from a galaxy far, far away-from Dr Luke Skywalker and his mentor, Obi-Wan Kenobi.	McMaster Univ, Ctr Hlth Econ & Policy Anal, Program Policy Decis Making, Hamilton, ON L8N 3Z5, Canada; Univ London London Sch Hyg & Trop Med, Int Programme Eth Publ Hlth & Human Rights, London WC1E 7HT, England	McMaster University; University of London; London School of Hygiene & Tropical Medicine	Arcus, KD (corresponding author), McMaster Univ, Ctr Hlth Econ & Policy Anal, Program Policy Decis Making, Hamilton, ON L8N 3Z5, Canada.							Andrews L, 1998, LANCET, V351, P53, DOI 10.1016/S0140-6736(05)78066-1; Annas George J., 1992, NAZI DOCTORS NUREMBE; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Bristol Royal Infirmary Inquiry, 2000, INQ MAN CAR CHILDR R; DAVIS RB, 1995, J MED PHILOS, V20, P85, DOI 10.1093/jmp/20.1.85; Evans HM, 2001, J CLIN PATHOL, V54, P824, DOI 10.1136/jcp.54.11.824; GILLON R, 1994, BRIT MED J, V309, P184, DOI 10.1136/bmj.309.6948.184; Hewson B, 2000, BRIT MED J, V321, P780, DOI 10.1136/bmj.321.7264.780; Hutchens M P, 1997, JAMA, V278, P1115, DOI 10.1001/jama.278.13.1115; LINDBLOM CE, 1959, PUBLIC ADMIN REV, V19, P79, DOI 10.2307/973677; Nuffield Council on Bioethics, 1995, HUM TISS ETH LEG ISS; Redfern Michael, 2001, ROYAL LIVERPOOL CHIL; *ROYAL COLL PATH, 2000, GUID RET TISS ORG PO; Russell B., 1991, HIST W PHILOS; SMART J, 1991, UTILITARIANISM FOR A; Veatch, 2000, CROSS CULTURAL PERSP; WARBURTON N, 1999, PHILOS BASICS, P45; Wong, 1991, COMPANION ETHICS, V29, P442; *WORLD MED ASS, 2000, WORLD MED ASS DECL H	19	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1493	1495		10.1136/bmj.325.7378.1493	http://dx.doi.org/10.1136/bmj.325.7378.1493			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493680	Green Accepted, Green Published			2022-12-28	WOS:000180188600032
J	Carroll, D; Ebrahim, S; Tilling, K; MacLeod, J; Smith, GD				Carroll, D; Ebrahim, S; Tilling, K; MacLeod, J; Smith, GD			Admissions for myocardial infarction and World Cup football: database survey	BRITISH MEDICAL JOURNAL			English	Article							EARTHQUAKE; DISEASE; STRESS; CIVILIANS; MORTALITY; TRIGGERS	Objectives To examine hospital admissions for a range of diagnoses on days surrounding England's 1998 World Cup football matches. Design Analysis of hospital admissions obtained from English hospital episode statistics. Setting England. Participants Population aged 15-64 years. Main outcome measures Ratio of number of admissions for acute myocardial infarction, stroke, deliberate self harm, and road traffic injuries on the day of and five days after England's World Cup matches, compared with admissions at die same time in previous and following years and in the month preceding the tournament. Results Risk of admission for acute myocardial infarction increased by 25% on 30 June 1998 (the day England lost to Argentina in a penalty shoot-out) and the following two days. No excess admissions occurred for other diagnoses or on the days of the other England matches. The effect was the same when only the two days after the match were treated as the exposed condition. Individual analyses of the day of and the two days after the Argentina match showed 55 extra admissions for myocardial infarctions compared with the number expected. Conclusion The increase in admissions suggests that myocardial infarction can be triggered by emotional upset, such as watching your football team lose an important match.	Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England; Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Bristol; University of Birmingham; University of Birmingham	Smith, GD (corresponding author), Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013; Tilling, Kate/AAY-1578-2021	Davey Smith, George/0000-0002-1407-8314; Tilling, Kate/0000-0002-1010-8926				BERGOVEC M, 1992, LANCET, V339, P303, DOI 10.1016/0140-6736(92)91370-N; BRODKIN J, 1998, GUARDIAN        0702, P3; Brunekreef B, 2002, EPIDEMIOLOGY, V13, P491, DOI 10.1097/00001648-200207000-00022; Harrison LK, 2000, BIOL PSYCHOL, V52, P113, DOI 10.1016/S0301-0511(99)00033-2; Heslop P, 2001, BRIT J HEALTH PSYCH, V6, P167, DOI 10.1348/135910701169133; KATSOUYANNI K, 1986, INT J EPIDEMIOL, V15, P326, DOI 10.1093/ije/15.3.326; Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846; Kondo N I, 1995, J Cardiovasc Risk, V2, P499, DOI 10.1097/00043798-199512000-00003; LEAR J, 1996, AM J CARDIOL, V77, P1230; Macleod J, 2002, BMJ-BRIT MED J, V324, P1247, DOI 10.1136/bmj.324.7348.1247; MEISEL SR, 1991, LANCET, V338, P660, DOI 10.1016/0140-6736(91)91234-L; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; SUZUKI S, 1995, LANCET, V345, P981, DOI 10.1016/S0140-6736(95)90727-0; *TEL AUD RES INF S, 1999, UK TEL VID YB; TOFLER GH, 1990, AM J CARDIOL, V66, P22, DOI 10.1016/0002-9149(90)90729-K; TRICHOPOULOS D, 1983, LANCET, V1, P441; WITTE DR, 2000, BRIT MED J, V321, P1332; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P87, DOI 10.1097/00001648-200201000-00014; 2002, GUARDIAN        0620, P11	19	142	147	0	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1439	1442		10.1136/bmj.325.7378.1439	http://dx.doi.org/10.1136/bmj.325.7378.1439			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493655	Green Published, Green Accepted			2022-12-28	WOS:000180188600007
J	Halm, EA; Teirstein, AS				Halm, EA; Teirstein, AS			Management of community-acquired pneumonia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL ANTIMICROBIAL THERAPY; IN-HOSPITAL OBSERVATION; LOW-RISK PATIENTS; PRACTICE GUIDELINE; EARLY SWITCH; INTRAVENOUS ANTIBIOTICS; INTERVENTIONAL TRIAL; ADMISSION DECISION; MEDICAL OUTCOMES; LENGTH		Mt Sinai Sch Med, Dept Hlth Policy, New York, NY 10029 USA; Mt Sinai Sch Med, Div Gen Internal Med, Dept Med, New York, NY 10029 USA; Mt Sinai Sch Med, Div Pulm & Crit Care Med, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Halm, EA (corresponding author), Mt Sinai Sch Med, Dept Hlth Policy, Box 1077,1 Gustave L Levy Pl, New York, NY 10029 USA.							*AG HLTH CAR POL R, 1999, AHCPR PUBL; Atlas SJ, 1998, ARCH INTERN MED, V158, P1350, DOI 10.1001/archinte.158.12.1350; Auble TE, 1998, INFECT DIS CLIN N AM, V12, P741, DOI 10.1016/S0891-5520(05)70208-7; Auble TE, 2000, INFECT DIS CLIN N AM, V14, pXI; BARTLETT JG, 1995, NEW ENGL J MED, V333, P1618, DOI 10.1056/NEJM199512143332408; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; BURNS LR, 1991, MED CARE, V29, P251, DOI 10.1097/00005650-199103000-00007; CHAN R, 1995, BRIT MED J, V310, P1360, DOI 10.1136/bmj.310.6991.1360; CLEARY PD, 1991, JAMA-J AM MED ASSOC, V266, P73, DOI 10.1001/jama.266.1.73; Coley CM, 1996, ARCH INTERN MED, V156, P1565, DOI 10.1001/archinte.156.14.1565; Dean NC, 2000, CHEST, V117, P1368, DOI 10.1378/chest.117.5.1368; Dunn AS, 1999, AM J MED, V106, P6, DOI 10.1016/S0002-9343(98)00359-3; Fine MJ, 2000, AM J MED, V109, P378, DOI 10.1016/S0002-9343(00)00500-3; Fine MJ, 1997, ARCH INTERN MED, V157, P36, DOI 10.1001/archinte.157.1.36; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; FINE MJ, 1993, MED CARE, V31, P371, DOI 10.1097/00005650-199304000-00008; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gleason PP, 1999, ARCH INTERN MED, V159, P2562, DOI 10.1001/archinte.159.21.2562; Halm EA, 2000, ARCH INTERN MED, V160, P98, DOI 10.1001/archinte.160.1.98; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; Halm EA, 2002, ARCH INTERN MED, V162, P1278, DOI 10.1001/archinte.162.11.1278; HENDRICKSON JR, 1995, ANN PHARMACOTHER, V29, P561, DOI 10.1177/106002809502900601; Houck PM, 2001, CHEST, V119, P1420, DOI 10.1378/chest.119.5.1420; Lave JR, 1999, SEM RESP CRIT CARE M, V20, P189, DOI 10.1055/s-2007-1021315; MARRIE TJ, 1994, CLIN INFECT DIS, V18, P501, DOI 10.1093/clinids/18.4.501; Marrie TJ, 2000, CLIN INFECT DIS, V31, P1362, DOI 10.1086/317495; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; McCormick D, 1999, AM J MED, V107, P5, DOI 10.1016/S0002-9343(99)00158-8; MCMAHON LF, 1989, MED CARE, V27, P623, DOI 10.1097/00005650-198906000-00005; Mehr DR, 2001, J FAM PRACTICE, V50, P931; Metlay JP, 1997, ARCH INTERN MED, V157, P1453, DOI 10.1001/archinte.157.13.1453; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; Metlay JP, 1997, J GEN INTERN MED, V12, P423, DOI 10.1046/j.1525-1497.1997.00074.x; Niederman MS, 1998, CLIN THER, V20, P820, DOI 10.1016/S0149-2918(98)80144-6; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Omidvari K, 1998, RESP MED, V92, P1032, DOI 10.1016/S0954-6111(98)90351-1; Ramirez JA, 1999, ARCH INTERN MED, V159, P2449, DOI 10.1001/archinte.159.20.2449; RAMIREZ JA, 1995, ARCH INTERN MED, V155, P1273, DOI 10.1001/archinte.155.12.1273; Rhew DC, 1998, CHEST, V113, P142, DOI 10.1378/chest.113.1.142; Rhew DC, 1998, CHEST, V114, P115, DOI 10.1378/chest.114.1.115; Rhew DC, 2001, ARCH INTERN MED, V161, P722, DOI 10.1001/archinte.161.5.722; SANDERS WE, 1991, AM J MED, V91, P261, DOI 10.1016/0002-9343(91)90125-H; Siegel RE, 1996, CHEST, V110, P965, DOI 10.1378/chest.110.4.965; Suchyta MR, 2001, AM J MED, V110, P306, DOI 10.1016/S0002-9343(00)00719-1; WEINGARTEN SR, 1994, CHEST, V105, P1109, DOI 10.1378/chest.105.4.1109; Weingarten SR, 1996, AM J RESP CRIT CARE, V153, P1110, DOI 10.1164/ajrccm.153.3.8630553; WENNBERG JE, 1987, LANCET, V1, P1185, DOI 10.1016/s0140-6736(87)92152-0; COMMUNITY ACQUIRED P; PNEUMONIA SEVERITY I	51	106	113	1	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2002	347	25					2039	2045		10.1056/NEJMcp020499	http://dx.doi.org/10.1056/NEJMcp020499			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626LT	12490686				2022-12-28	WOS:000179874500008
J	Ball, AM; Gillen, DL; Sherrard, D; Weiss, NS; Emerson, SS; Seliger, SL; Kestenbaum, BR; Stehman-Breen, C				Ball, AM; Gillen, DL; Sherrard, D; Weiss, NS; Emerson, SS; Seliger, SL; Kestenbaum, BR; Stehman-Breen, C			Risk of hip and renal fracture among dialysis transplant recipients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; KIDNEY-TRANSPLANTATION; INDUCED OSTEOPOROSIS; DISEASE; HYPERPARATHYROIDISM	Context Renal failure places people at particularly high risk of hip fracture. However, the possible differential impact of dialysis and renal transplantation on this risk is not well understood. Objective To determine if patients who receive kidney transplants are at greater risk of hip fracture compared with those who continue to undergo dialysis. Design, Setting, and Participants Cohort study of 101039 patients with end-stage renal disease placed on the renal transplant waiting list in the United States between January 1, 1990, and December 31, 1999. Main Outcome Measures I Hip fractures, identified from Medicare claims data. Results Among the patients included in this analysis, 971 hip fractures were observed during the follow-up period of 314767 person-years. The incidence rate of hip fracture in patients receiving dialysis was 2.9 per 1000 patients per year compared with 3.3 hip fractures per 1000 patients per year in those who had previously received a renal transplant. Initially, the relative risk (RR) of hip fracture associated with transplantation was 1.34-fold greater when compared with dialysis (adjusted RR, 1.34; 95 % confidence interval [CI], 1.12-1.61) but then decreased by 1 % per month (adjusted RR, 0.99; 95% Cl, 0.98-0.99) until the estimated risk became equal for dialysis and transplant recipients approximately 630 days after transplantation (adjusted RR, 1.00; 95 % Cl, 0.87-1-15). Among transplant recipients, risk of fracture was relatively higher in persons with a prolonged period of dialysis before transplantation. Conclusion The high risk of hi p fracture among dialysis patients is exceeded by that among renal, transplant patients during the first 1 to 3 years after transplantation.	Vet Affairs Pubet Sound Hlth Care Syst, Div Nephrol, Seattle, WA 98108 USA; Univ Washington, Sch Med, Div Nephrol, Seattle, WA USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Stehman-Breen, C (corresponding author), Vet Affairs Pubet Sound Hlth Care Syst, Div Nephrol, 1660 S Columbian Way,Mailstop 111A, Seattle, WA 98108 USA.							Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; ALMOND MK, 1994, NEPHRON, V66, P52, DOI 10.1159/000187765; Caglar M, 1999, ANN NUCL MED, V13, P141, DOI 10.1007/BF03164853; Canalis E, 1996, J CLIN ENDOCR METAB, V81, P3441, DOI 10.1210/jc.81.10.3441; Carlini RG, 2000, AM J KIDNEY DIS, V36, P160, DOI 10.1053/ajkd.2000.8289; Chevalley T, 1996, EUR J ENDOCRINOL, V134, P591, DOI 10.1530/eje.0.1340591; Coco M, 2000, AM J KIDNEY DIS, V36, P1115, DOI 10.1053/ajkd.2000.19812; CUNDY T, 1983, Q J MED, V52, P67; Dalen N, 1973, Clin Nephrol, V1, P338; Epstein Sol, 1995, Current Opinion in Rheumatology, V7, P255, DOI 10.1097/00002281-199505000-00018; FISHER ES, 1990, AM J PUBLIC HEALTH, V80, P1487, DOI 10.2105/AJPH.80.12.1487; GROTZ WH, 1995, NEPHROL DIAL TRANSPL, V10, P2096; HORBER FF, 1994, J BONE MINER RES, V9, P1; JULIAN BA, 1991, NEW ENGL J MED, V325, P544, DOI 10.1056/NEJM199108223250804; KWAN JTC, 1992, MINER ELECTROL METAB, V18, P166; Manolagas SC, 1999, J BONE MINER RES, V14, P1061, DOI 10.1359/jbmr.1999.14.7.1061; *NIH, 1999, US REN DAT SYST USRD; PARFITT AM, 1982, MINER ELECTROL METAB, V8, P92; Pichette V, 1996, AM J KIDNEY DIS, V28, P105, DOI 10.1016/S0272-6386(96)90138-9; Ramsey-Goldman R, 1999, J BONE MINER RES, V14, P456, DOI 10.1359/jbmr.1999.14.3.456; RIGGS BL, 1992, NEW ENGL J MED, V327, P620; Stehman-Breen CO, 2000, KIDNEY INT, V58, P2200, DOI 10.1046/j.1523-1755.2000.00394.x; Stein MS, 1996, AM J KIDNEY DIS, V28, P515, DOI 10.1016/S0272-6386(96)90461-8; *US C, 1994, HIP FRACT OUTC PEOPL; Weisinger JR, 1999, TRANSPLANT P, V31, P3033, DOI 10.1016/S0041-1345(99)00658-2; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	26	298	305	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2002	288	23					3014	3018		10.1001/jama.288.23.3014	http://dx.doi.org/10.1001/jama.288.23.3014			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CG	12479766	Bronze			2022-12-28	WOS:000179854200036
J	Weisfeldt, ML; Becker, LB				Weisfeldt, ML; Becker, LB			Resuscitation after cardiac arrest - A 3-phase time-sensitive model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AUTOMATED EXTERNAL DEFIBRILLATORS; VENTRICULAR-FIBRILLATION; CARDIOPULMONARY-RESUSCITATION; IMMEDIATE COUNTERSHOCK; COST-EFFECTIVENESS; SWINE MODEL; SURVIVAL; POLICE; REPERFUSION; COMMUNITY		Univ Chicago, Dept Med, Sect Emergency Med, Chicago, IL 60637 USA; Johns Hopkins Univ, Dept Med, Baltimore, MD USA	University of Chicago; Johns Hopkins University	Becker, LB (corresponding author), Univ Chicago, Dept Med, Sect Emergency Med, MC5068,5841 S Maryland Ave, Chicago, IL 60637 USA.	lbecker@medicine.bsd.uchicago.edu						Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; ALLEN BS, 1993, J THORAC CARDIOV SUR, V105, P864; Becker LB, 2002, CIRCULATION, V105, P2562, DOI 10.1161/01.CIR.0000017142.39991.C3; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BEYERSDORF F, 1992, J THORAC CARDIOV SUR, V104, P1141; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Callaway CW, 2001, CIRCULATION, V103, P1656, DOI 10.1161/01.CIR.103.12.1656; Capucci A, 2002, CIRCULATION, V106, P1065, DOI 10.1161/01.CIR.0000028148.62305.69; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; Forrer CS, 2002, RESUSCITATION, V52, P23, DOI 10.1016/S0300-9572(01)00430-0; Garcia LA, 2000, RESUSCITATION, V47, P301, DOI 10.1016/S0300-9572(00)00244-6; GAUSSORGUES P, 1988, INTENS CARE MED, V14, P575, DOI 10.1007/BF00263532; Groeneveld PW, 2001, JAMA-J AM MED ASSOC, V286, P1482, DOI 10.1001/jama.286.12.1482; Han BH, 2002, J BIOL CHEM, V277, P30128, DOI 10.1074/jbc.M202931200; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jekova I, 2002, PHYSIOL MEAS, V23, P337, DOI 10.1088/0967-3334/23/2/309; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; MacDonald Russell D, 2002, Prehosp Emerg Care, V6, P1; Menegazzi J J, 2000, Prehosp Emerg Care, V4, P31, DOI 10.1080/10903120090941614; MENEGAZZI JJ, 1993, ANN EMERG MED, V22, P235, DOI 10.1016/S0196-0644(05)80211-2; Mosesso VN, 1998, ANN EMERG MED, V32, P200, DOI 10.1016/S0196-0644(98)70137-4; Murrant CL, 2001, MICROSC RES TECHNIQ, V55, P236, DOI 10.1002/jemt.1173; Myerburg RJ, 2002, CIRCULATION, V106, P1058, DOI 10.1161/01.CIR.0000028147.92190.A7; Niemann JT, 2000, ANN EMERG MED, V36, P543, DOI 10.1067/mem.2000.109441; NIEMANN JT, 1992, CIRCULATION, V85, P281, DOI 10.1161/01.CIR.85.1.281; ORourke MF, 1997, CIRCULATION, V96, P2849, DOI 10.1161/01.CIR.96.9.2849; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Ping PP, 2002, J CLIN INVEST, V109, P499, DOI 10.1172/JCI200213200; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Valenzuela TD, 1997, CIRCULATION, V96, P3308; VANDEHOEK TL, 2002, AM J PHYSL HEART CIR; Vanden Hoek TL, 2000, CIRCULATION, V102, pA2765; VandenHoek TL, 1996, AM J PHYSIOL-HEART C, V270, pH1334, DOI 10.1152/ajpheart.1996.270.4.H1334; Weil M H, 2001, Circulation, V103, P1182; White RD, 1998, RESUSCITATION, V39, P145, DOI 10.1016/S0300-9572(98)00135-X; WIK L, 2002, CIRCULATION S2, V106, pA1823; YAKAITIS RW, 1980, CRIT CARE MED, V8, P157, DOI 10.1097/00003246-198003000-00014; Yu T, 2002, CIRCULATION, V106, P368, DOI 10.1161/01.CIR.0000021429.22005.2E; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; 2000, CIRCULATION S1, V102, P1	42	420	450	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2002	288	23					3035	3038		10.1001/jama.288.23.3035	http://dx.doi.org/10.1001/jama.288.23.3035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CG	12479769				2022-12-28	WOS:000179854200039
J	Graham, SM				Graham, SM			Prophylaxis against Pneumocystis carinii pneumonia for HIV-exposed infants in Africa	LANCET			English	Editorial Material							VIRUS-INFECTED CHILDREN; COTRIMOXAZOLE PROPHYLAXIS; TRIMETHOPRIM; RESISTANCE		Univ Malawi, Wellcome Trust Res Labs, Blantyre 3, Malawi; Univ Malawi, Coll Med, Dept Paediat, Blantyre 3, Malawi; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool	Graham, SM (corresponding author), Univ Malawi, Wellcome Trust Res Labs, POB 30096, Blantyre 3, Malawi.	sgraham@mlw.medcol.mw		Graham, Stephen/0000-0003-3525-2294				Abdel-Haq N, 1999, PEDIATR INFECT DIS J, V18, P647, DOI 10.1097/00006454-199907000-00017; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Chokephaibulkit K, 1999, PEDIATR INFECT DIS J, V18, P147, DOI 10.1097/00006454-199902000-00012; DOUNG T, 1999, BMJ-BRIT MED J, V319, P1227; Fisher RG, 2001, AIDS PATIENT CARE ST, V15, P263, DOI 10.1089/10872910152050784; GIBB DM, 1994, ARCH DIS CHILD, V70, P241, DOI 10.1136/adc.70.3.241; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Grimwade K, 2001, CURR OPIN INFECT DIS, V14, P507, DOI 10.1097/00001432-200110000-00002; Ikeogu MO, 1997, ARCH DIS CHILD, V76, P124, DOI 10.1136/adc.76.2.124; Iyer JK, 2001, LANCET, V358, P1066, DOI 10.1016/S0140-6736(01)06201-8; Jeena PM, 1996, ANN TROP PAEDIATR, V16, P361, DOI 10.1080/02724936.1996.11747852; JohannLiang R, 1997, PEDIATR INFECT DIS J, V16, P1145, DOI 10.1097/00006454-199712000-00009; Lucas SB, 1996, BRIT MED J, V312, P335, DOI 10.1136/bmj.312.7027.335; Ruffini DD, 2002, AIDS, V16, P105, DOI 10.1097/00002030-200201040-00013; SIMONDS RJ, 1993, JAMA-J AM MED ASSOC, V270, P470, DOI 10.1001/jama.270.4.470; *UNAIDS WHO, 2000, UNAIDS PROV WHO UNAI; Williams AJ, 2001, AIDS, V15, P335, DOI 10.1097/00002030-200102160-00006; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P202, DOI 10.1016/S0035-9203(02)90306-8; Zar HJ, 2000, PEDIATR INFECT DIS J, V19, P603, DOI 10.1097/00006454-200007000-00004	20	19	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2002	360	9349					1966	1968		10.1016/S0140-6736(02)11921-0	http://dx.doi.org/10.1016/S0140-6736(02)11921-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493279				2022-12-28	WOS:000179870200031
J	Kirwan, JF; Nightingale, JA; Bunce, C; Wormald, R				Kirwan, JF; Nightingale, JA; Bunce, C; Wormald, R			beta Blockers for glaucoma and excess risk of airways obstruction: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							TOPICAL TIMOLOL; PULMONARY		Inst Ophthalmol, Dept Epidemiol & Int Eye Hlth, London EC1V 9EL, England; Royal Brompton Hosp, London SW3 6LY, England; Moorfields Eye Hosp, London EC1V 2PD, England	University of London; University College London; Royal Brompton Hospital; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Kirwan, JF (corresponding author), Inst Ophthalmol, Dept Epidemiol & Int Eye Hlth, London EC1V 9EL, England.			Nightingale, Julia/0000-0002-8978-2840; Bunce, Catey/0000-0002-0935-3713	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bateman DN, 2001, BRIT MED J, V323, P1401, DOI 10.1136/bmj.323.7326.1401; CHARAN NB, 1980, ARCH INTERN MED, V140, P843, DOI 10.1001/archinte.140.6.843; DIGGORY P, 1995, LANCET, V345, P1604, DOI 10.1016/S0140-6736(95)90116-7; Quigley HA, 1996, AM J OPHTHALMOL, V122, P355, DOI 10.1016/S0002-9394(14)72062-8; Stewart WC, 2001, J GLAUCOMA, V10, P227, DOI 10.1097/00061198-200106000-00015	5	20	22	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1396	1397		10.1136/bmj.325.7377.1396	http://dx.doi.org/10.1136/bmj.325.7377.1396			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480856	Green Published			2022-12-28	WOS:000179975000025
J	Rutz, HP				Rutz, HP			Effects of corticosteroid use on treatment of solid tumours	LANCET			English	Editorial Material							IONIZING-RADIATION; GENE-EXPRESSION; DEXAMETHASONE; CELLS; RESISTANCE; AGENTS; RADIORESISTANCE; APOPTOSIS; INVITRO		Paul Scherrer Inst, Dept Life Sci, Div Radiat Med, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Rutz, HP (corresponding author), Paul Scherrer Inst, Dept Life Sci, Div Radiat Med, CH-5232 Villigen, Switzerland.							AAPRO MS, 1991, RECENT RESULTS CANC, P91; AMBRUS JL, 1985, LANCET, V2, P148; BANSAL N, 1991, FASEB J, V5, P211, DOI 10.1096/fasebj.5.2.2004665; Biswas T, 1999, ONCOGENE, V18, P525, DOI 10.1038/sj.onc.1202320; BRADY ME, 1987, EUR J CLIN PHARMACOL, V32, P593, DOI 10.1007/BF02455994; BROCK WA, 1984, INT J RADIAT ONCOL, V10, P2113, DOI 10.1016/0360-3016(84)90210-4; DEVITA D, 1993, CANC PRINCIPLES PRAC; FREI E, 1965, BLOOD, V26, P624; Ioannidis JPA, 2000, J CLIN ONCOL, V18, P3409, DOI 10.1200/JCO.2000.18.19.3409; KARIN M, 1979, SCIENCE, V204, P176, DOI 10.1126/science.432639; Mariotta M, 1999, STRAHLENTHER ONKOL, V175, P392, DOI 10.1007/s000660050027; MILLAR BC, 1985, INT J RADIAT BIOL, V47, P539, DOI 10.1080/09553008514550771; Nauck M, 1997, AM J RESP CELL MOL, V16, P398, DOI 10.1165/ajrcmb.16.4.9115750; Naumann U, 1998, ONCOGENE, V17, P1567, DOI 10.1038/sj.onc.1202071; ORTH DN, 1992, WILLIAMS TXB ENDOCRI, P513; Pruschy M, 1997, BIOCHEM BIOPH RES CO, V241, P519, DOI 10.1006/bbrc.1997.7846; RENAN MJ, 1989, RADIAT RES, V120, P442, DOI 10.2307/3577795; ROILA F, 1995, NEW ENGL J MED, V332, P1; Roila F, 2000, NEW ENGL J MED, V342, P1554; Rutz HP, 1998, STRAHLENTHER ONKOL, V174, P71, DOI 10.1007/BF03038478; ZHAO JY, 1993, ENDOCRINOLOGY, V133, P521, DOI 10.1210/en.133.2.521	21	96	100	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1969	1970		10.1016/S0140-6736(02)11922-2	http://dx.doi.org/10.1016/S0140-6736(02)11922-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493280				2022-12-28	WOS:000179870200032
J	Thio, CL; Seaberg, EC; Skolasky, R; Phair, J; Visscher, B; Munoz, A; Thomas, DL				Thio, CL; Seaberg, EC; Skolasky, R; Phair, J; Visscher, B; Munoz, A; Thomas, DL			HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; UNITED-STATES-ARMY; HOMOSEXUAL MEN; C VIRUS; AIDS COHORT; FOLLOW-UP; FIBROSIS PROGRESSION; PROTEASE INHIBITOR; 1942 EPIDEMIC	Background Although coinfection with HIV-1 and hepatitis B virus (HBV) is common, few long-term studies on liver-disease mortality in coinfected people have been undertaken. Our aim was to examine liver-related mortality among people at risk for HIV-1 and HBV infections. Methods We used data from a multicentre, prospective cohort study to classify 5293 men who had sex with men, according to their HIV-1 antibody status, ascertained semiannually, and their hepatitis-B surface antigen status (HBsAg), which we ascertained at baseline. Mortality rates were estimated in terms of person-years and Poisson regression methods were used to test for signifiance of relative risks. Findings 326 (6%) men were HBsAg positive, of whom 213 (65%) were HIV-1 positive. Of the 4967 HBsAg negative men, 2346 (47%) were infected with HIV-1. The liver-related mortality rate was 1.1/1000 person years, and was higher in men with HIV-1 and HBsAg (14.2/1000) than in those with only HIV-1 infection (1.7/1000, p<0.001) or only HBsAg (0.8/1000, p<0.001). In coinfected individuals, the liver related mortality rate was highest with lower nadir CD4+ cell counts and was twice as high after 1996, when highly active antiretroviral therapy (HAART) was introduced. Interpretation Individuals coinfected with HIV-1 and HBV, especially those with low CD4+ nadir counts, are at increased risk for liver-related mortality, underscoring the importance of prevention, identification, and comprehensive management of hepatitis B in people infected with HIV-1.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Northwestern University; University of California System; University of California Los Angeles	Thio, CL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 424 N Bond St, Baltimore, MD 21231 USA.	cthio@jhmi.edu	Franzeck, Fabian C/B-5055-2011	Skolasky, Richard/0000-0002-2598-4427	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035043, U01AI037613, U01AI035041, U01AI035042, U01AI035040, U01AI037984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013806] Funding Source: NIH RePORTER; NCRR NIH HHS [5-M01-RR-00722] Funding Source: Medline; NIAID NIH HHS [UO1-AI-35043, UO1-AI-37984, UO1-AI-35042, UO1-AI-37613, UO1-AI-35041, UO1-AI-35040] Funding Source: Medline; NIDA NIH HHS [R01DA13806, DA00441] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Ahdieh L, 2000, AM J EPIDEMIOL, V152, P923, DOI 10.1093/aje/152.10.923; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Behrens GMN, 2000, IMMUNOBIOLOGY, V202, P186, DOI 10.1016/S0171-2985(00)80065-0; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bessesen M, 1999, CLIN INFECT DIS, V28, P1032, DOI 10.1086/514750; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; BODSWORTH N, 1989, J INFECT DIS, V160, P577, DOI 10.1093/infdis/160.4.577; Breslow N E, 1987, IARC Sci Publ, P1; Carr A, 1997, LANCET, V349, P995, DOI 10.1016/S0140-6736(05)62892-9; CHMIEL JS, 1987, AM J EPIDEMIOL, V126, P568, DOI 10.1093/oxfordjournals.aje.a114696; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; den Brinker M, 2000, AIDS, V14, P2895, DOI 10.1097/00002030-200012220-00011; Detels R, 2001, AIDS, V15, P347, DOI 10.1097/00002030-200102160-00008; DONAHUE JG, 1991, AM J EPIDEMIOL, V134, P1206, DOI 10.1093/oxfordjournals.aje.a116023; Forrest DM, 1998, CLIN INFECT DIS, V27, P1379, DOI 10.1086/515030; GALBRAITH RM, 1975, LANCET, V2, P528; Gilson RJC, 1997, AIDS, V11, P597, DOI 10.1097/00002030-199705000-00007; HADLER SC, 1991, J INFECT DIS, V163, P454, DOI 10.1093/infdis/163.3.454; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; London WT, 1996, CLIN LAB MED, V16, P251, DOI 10.1016/S0272-2712(18)30268-3; Mai AL, 1996, J CLIN GASTROENTEROL, V22, P299, DOI 10.1097/00004836-199606000-00012; Mastroianni CM, 1998, AIDS, V12, P1939; MCMAHON BJ, 1990, ARCH INTERN MED, V150, P1051, DOI 10.1001/archinte.150.5.1051; MILLS CT, 1990, GASTROENTEROLOGY, V99, P519, DOI 10.1016/0016-5085(90)91035-5; MORIYAMA T, 1990, SCIENCE, V248, P361, DOI 10.1126/science.1691527; NORMAN JE, 1993, HEPATOLOGY, V18, P790, DOI 10.1002/hep.1840180407; Puoti M, 2001, J INFECT DIS, V183, P134, DOI 10.1086/317644; Puoti M, 2000, J ACQ IMMUN DEF SYND, V24, P211; RECTOR WG, 1988, AM J GASTROENTEROL, V83, P262; SEEFF LB, 1987, NEW ENGL J MED, V316, P965, DOI 10.1056/NEJM198704163161601; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; THOMAS DL, 1994, J INFECT DIS, V169, P990, DOI 10.1093/infdis/169.5.990; VILLENEUVE JP, 1994, GASTROENTEROLOGY, V106, P1000, DOI 10.1016/0016-5085(94)90760-9; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; Yamashita TE, 2001, AIDS, V15, P735, DOI 10.1097/00002030-200104130-00009; Yu MW, 1997, AM J EPIDEMIOL, V145, P1039, DOI 10.1093/oxfordjournals.aje.a009060	38	780	805	1	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2002	360	9349					1921	1926		10.1016/S0140-6736(02)11913-1	http://dx.doi.org/10.1016/S0140-6736(02)11913-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493258				2022-12-28	WOS:000179870200010
J	Becerra, SP; Amaral, J				Becerra, SP; Amaral, J			Erythropoietin - An endogenous retinal survival factor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									NEI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Becerra, SP (corresponding author), NEI, Bethesda, MD 20892 USA.			Amaral, Juan/0000-0001-8755-9170	NATIONAL EYE INSTITUTE [ZIAEY000306, Z01EY000306] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bocker-Meffert S, 2002, INVEST OPHTH VIS SCI, V43, P2021; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Jaquet K, 2002, MICROVASC RES, V64, P326, DOI 10.1006/mvre.2002.2426; Jelkmann W, 2001, ADV EXP MED BIOL, V502, P169; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399	5	76	85	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1968	1970		10.1056/NEJMcibr022629	http://dx.doi.org/10.1056/NEJMcibr022629			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623ZX	12477950				2022-12-28	WOS:000179735800012
J	Lahteenmaki, R				Lahteenmaki, R			Finnish biotechnology - built on solid foundations	NATURE			English	Article																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916		S			A34	+		10.1038/420a34a	http://dx.doi.org/10.1038/420a34a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625LG	12501125	Bronze			2022-12-28	WOS:000179817500007
J	Sherman, R				Sherman, R			To reconstruct or not to reconstruct?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ So Calif, Los Angeles, CA 90089 USA	University of Southern California	Sherman, R (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.								0	5	5	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1906	1907		10.1056/NEJMp020150	http://dx.doi.org/10.1056/NEJMp020150			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623ZX	12477939				2022-12-28	WOS:000179735800001
J	Orach, CG; Kolsteren, P				Orach, CG; Kolsteren, P			Outpatient care for severely malnourished children	LANCET			English	Editorial Material							SEVERE MALNUTRITION; MORTALITY; DISTRICT; REFUGEE		Makerere Univ, Inst Publ Hlth, Kampala, Uganda	Makerere University	Orach, CG (corresponding author), Makerere Univ, Inst Publ Hlth, Kampala, Uganda.	cgorach@hotmail.com						Ashworth A, 1997, HEALTH POLICY PLANN, V12, P115, DOI 10.1093/heapol/12.2.115; BENGOA JOSE M., 1967, J TROP PEDIAT, V13, P169; CALVALCANTE AAM, 1998, TROP DOCT, V28, P95; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; Collins S, 2001, LANCET, V358, P498, DOI 10.1016/S0140-6736(01)05630-6; FERNANDEZCONCHA D, 1991, T ROY SOC TROP MED H, V85, P809, DOI 10.1016/0035-9203(91)90465-B; Husaini Y. K., 1986, Food and Nutrition Bulletin, V8, P55; *INT COMM RED CROS, 1996, HDB WAR PUBL HLTH, P353; KHANUM S, 1994, LANCET, V344, P1728; King M, 1966, MED CARE DEV COUNTRI; Orach CG, 1999, E AFR MED J, V76, P195; Puoane T, 2001, S AFR MED J, V91, P137; ROEMER MI, 1991, NATL HLTH SYSTEMS WO, P31; Schofield C, 1997, Afr Health, V19, P17; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; *UN CHILDR FUND, 1998, STAT WORLDS CHILDR F, P9; Van Damme W, 1998, LANCET, V351, P1609, DOI 10.1016/S0140-6736(97)10348-8; Van Damme W, 2002, LANCET, V359, P260, DOI 10.1016/S0140-6736(02)07422-6; Waterlow J, 1999, LANCET, V354, P1142, DOI 10.1016/S0140-6736(99)00329-3; 1997, MED SANS FRONTIERES, P37	20	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1800	1801						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480354				2022-12-28	WOS:000179706100004
J	Pellettieri, J; Seydoux, G				Pellettieri, J; Seydoux, G			Anterior-posterior polarity in C-elegans and Drosophila - PARallels and differences	SCIENCE			English	Review							OSKAR MESSENGER-RNA; PROTEIN-KINASE-C; CAENORHABDITIS-ELEGANS; EMBRYONIC POLARITY; AXIS FORMATION; CYTOPLASMIC LOCALIZATION; OOCYTE DIFFERENTIATION; ANTEROPOSTERIOR AXIS; PAR-1; GENE	The eggs of Caenorhabditis elegans and Drosophila bear little similarity to each other, yet both depend on the par genes for control of anterior-posterior polarity. Here we explore possible common roles for the par genes (pars) in converting transient asymmetries into stably polarized axes. Although clear mechanistic parallels remain to be established, par-dependent regulation of microtubule dynamics and protein stability emerge as common themes.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Seydoux, G (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.		SEYDOUX, Geraldine/AAA-2005-2020	Pellettieri, Jason/0000-0002-7800-4904; Seydoux, Geraldine/0000-0001-8257-0493				Basham SE, 2001, DEVELOPMENT, V128, P4645; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Boyd L, 1996, DEVELOPMENT, V122, P3075; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; BRENWALD P, COMMUNICATION; Cha BJ, 2002, NAT CELL BIOL, V4, P592, DOI 10.1038/ncb832; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; Cox DN, 2001, CURR BIOL, V11, P75, DOI 10.1016/S0960-9822(01)00027-6; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; CUENCA AA, IN PRESS; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Dollar G, 2002, DEVELOPMENT, V129, P517; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hird SN, 1996, DEVELOPMENT, V122, P1303; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Hung TJ, 1999, DEVELOPMENT, V126, P127; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Huynh JR, 2001, CURR BIOL, V11, P901, DOI 10.1016/S0960-9822(01)00244-5; Jankovics F, 2001, GENETICS, V158, P1177; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; LIN HF, 1995, DEV GENET, V16, P6, DOI 10.1002/dvg.1020160104; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Navarro C, 2001, CURR BIOL, V11, pR162, DOI 10.1016/S0960-9822(01)00083-5; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; Pichler S, 2000, DEVELOPMENT, V127, P2063; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Rappleye CA, 2002, DEV CELL, V2, P195, DOI 10.1016/S1534-5807(02)00114-4; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Riechmann V, 2002, NAT CELL BIOL, V4, P337, DOI 10.1038/ncb782; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Sadler PL, 2000, DEVELOPMENT, V127, P355; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; STJOHNSTON D, COMMUNICATION; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tenenhaus C, 1998, DEV BIOL, V200, P212, DOI 10.1006/dbio.1998.8940; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; Vaccari T, 2002, CURR BIOL, V12, P1524, DOI 10.1016/S0960-9822(02)01079-5; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Watts JL, 2000, DEVELOPMENT, V127, P1467; Wilson EB, 1925, CELL DEV HEREDITY, P3; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128	55	104	118	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1946	1950		10.1126/science.1072162	http://dx.doi.org/10.1126/science.1072162			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471246				2022-12-28	WOS:000179629200033
J	Bradley, A				Bradley, A			Mining the mouse genome - We have the draft sequence - but how do we unlock its secrets?	NATURE			English	Editorial Material									Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Bradley, A (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.			Bradley, Allan/0000-0002-2349-8839				BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; 2002, NATURE, V420, P586	8	27	39	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					512	514		10.1038/420512a	http://dx.doi.org/10.1038/420512a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466846				2022-12-28	WOS:000179611600049
J	Berliner, HS; Ginzberg, E				Berliner, HS; Ginzberg, E			Why this hospital nursing shortage is different	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									New Sch Unit, Milano Grad Sch, New York, NY 10011 USA; Columbia Univ, Grad Sch Business, New York, NY 10027 USA	The New School; Columbia University	Berliner, HS (corresponding author), New Sch Unit, Milano Grad Sch, 72 5th Ave, New York, NY 10011 USA.							Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; American Hospital Association, 2002, OUR HANDS HOSP LEAD; Berliner Howard, 2002, Health Serv J, V112, P32; Flynn L, 2002, J NURS SCHOLARSHIP, V34, P67, DOI 10.1111/j.1547-5069.2002.00067.x; Gamble DA, 2002, J NURS ADMIN, V32, P175, DOI 10.1097/00005110-200204000-00002; GREENHOUSE S, 2002, NY TIMES        0217, P37; KIMBALL B, 2002, AM NURSING SHORTAGE; SPRATLEY E, 2000, REGISTERED NURSE POP; Zachary G. P., 2001, WALL STREET J, pA1; 2002, JAMA, V288, P1137	11	54	54	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2002	288	21					2742	2744		10.1001/jama.288.21.2742	http://dx.doi.org/10.1001/jama.288.21.2742			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620UA	12460099				2022-12-28	WOS:000179549800035
J	Udelson, JE; Beshansky, JR; Ballin, DS; Feldman, JA; Griffith, JL; Heller, GV; Hendel, RC; Pope, JH; Ruthazer, R; Spiegler, EJ; Woolard, RH; Handler, J; Selker, HP				Udelson, JE; Beshansky, JR; Ballin, DS; Feldman, JA; Griffith, JL; Heller, GV; Hendel, RC; Pope, JH; Ruthazer, R; Spiegler, EJ; Woolard, RH; Handler, J; Selker, HP			Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-CARE-UNIT; CONTROLLED CLINICAL-TRIAL; INSTRUMENT ACI-TIPI; ACUTE CHEST PAIN; PREDICTIVE INSTRUMENT; EMERGENCY ROOM; NONDIAGNOSTIC ELECTROCARDIOGRAMS; MISSED DIAGNOSES; TROPONIN-I; MULTICENTER	Context Observational studies of acute myocardial perfusion imaging in emergency department (ED) patients with chest pain have suggested high sensitivity and negative predictive value for acute cardiac ischemia, but use of this method has not been prospectively tested. Objective To assess whether incorporating acute resting perfusion imaging into an ED evaluation strategy for patients with suspected acute ischemia but no initial electrocardiogram (ECG) changes diagnostic of acute ischemia improves clinical decision making for initial ED triage. Design, Setting, and Patients Prospective, randomized controlled trial conducted at 7 academic medical centers and community hospitals between July 1997 and May 1999 among 2475 adult ED patients with chest pain or other symptoms suggestive of acute cardiac ischemia and with normal or nondiagnostic initial ECG results. Intervention Patients were randomly assigned to receive either the usual ED evaluation strategy (n=1260) or the usual strategy supplemented with results from acute resting myocardial perfusion imaging using single-photon emission computed tomography with injection of 20 to 30 mCi of Tc-99m sestamibi (n=1215), interpreted in real time by local staff physicians and with results provided to the ED physician for incorporation into clinical decision making. Main Outcome Measure Appropriateness of triage decision either to admit to hospital/observation or to discharge directly home from the ED. Results Among patients with acute cardiac ischemia (ie, acute myocardial infarction [MI] or unstable angina; n = 329), there were no differences in ED triage decisions between those receiving standard evaluation and those whose evaluation was supplemented by a sestamibi scan. Among patients with acute MI (n = 56), 97% vs 96% were hospitalized (relative risk [RR], 1.00; 95% confidence interval [CI], 0.89-1.12), and among those with unstable angina (n =273), 83% vs 81% were hospitalized (RR, 0.98; 95% Cl, 0.87-1.10). However, among patients without acute cardiac ischemia (n=2146), hospitalization was 52% with usual care vs 42% with sestamibi imaging (RR, 0.84; 95% Cl, 0.77-0.92). Conclusions Sestamibi perfusion imaging improves ED triage decision making for patients with symptoms suggestive of acute cardiac ischemia without obvious abnormalities on initial ECG. In this study, unnecessary hospitalizations were reduced among patients without acute ischemia, without reducing appropriate admission for patients with acute ischemia.	Tufts Univ New England Med Ctr, Div Clin Care Res, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Div Cardiol, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Dept Emergency Med, Boston, MA 02111 USA; Boston Med Ctr, Dept Emergency Med, Boston, MA USA; Hartford Hosp, Div Cardiol, Hartford, CT 06115 USA; NW Mem Hosp, Dept Emergency Med, Chicago, IL 60611 USA; NW Mem Hosp, Div Cardiol, Chicago, IL 60611 USA; Baystate Med Ctr, Dept Emergency Med, Springfield, MA USA; St Agnes Hlth Care Syst, Div Nucl Med, Baltimore, MD USA; Rhode Isl Hosp, Dept Emergency Med, Providence, RI USA	Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Boston Medical Center; Hartford Hospital; Northwestern Memorial Hospital; Northwestern Memorial Hospital; Baystate Medical Center; Lifespan Health Rhode Island; Rhode Island Hospital	Udelson, JE (corresponding author), Tufts Univ New England Med Ctr, Div Clin Care Res, 750 Washington St,Box 70, Boston, MA 02111 USA.	judelson@Lifespan.org		Feldman, James/0000-0003-3962-0189; Handler, Jonathan/0000-0002-0304-7539	AHRQ HHS [R01-HS09110] Funding Source: Medline; NCRR NIH HHS [M01-RR00054, M01-RR00533, M01-RR00048] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS009110] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000533, M01RR000048, M01RR000054] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ADAMS JE, 1993, CIRCULATION, V88, P101, DOI 10.1161/01.CIR.88.1.101; BELLER GA, 1995, CLIN NUCL CARDIOLOGY, P37; Braunwald E, 1994, UNSTABLE ANGINA DIAG; Duca MD, 1999, J NUCL CARDIOL, V6, P570, DOI 10.1016/S1071-3581(99)90092-2; Farkouh ME, 1998, NEW ENGL J MED, V339, P1882, DOI 10.1056/NEJM199812243392603; FINEBERG HV, 1984, NEW ENGL J MED, V310, P1301, DOI 10.1056/NEJM198405173102006; Heller GV, 1998, J AM COLL CARDIOL, V31, P1011, DOI 10.1016/S0735-1097(98)00057-6; Hilton TC, 1996, J NUCL CARDIOL, V3, P308, DOI 10.1016/S1071-3581(96)90090-2; HILTON TC, 1994, J AM COLL CARDIOL, V23, P1016, DOI 10.1016/0735-1097(94)90584-3; JAFARY F, 1999, CLIN GATED CARDIAC S; Kontos MC, 1999, CIRCULATION, V99, P2073, DOI 10.1161/01.CIR.99.16.2073; LEE TH, 1995, ANN INTERN MED, V122, P434, DOI 10.7326/0003-4819-122-6-199503150-00006; LEE TH, 1987, AM J CARDIOL, V60, P219, DOI 10.1016/0002-9149(87)90217-7; MCCARTHY BD, 1990, J GEN INTERN MED, V5, P365, DOI 10.1007/BF02600409; MCCARTHY BD, 1993, ANN EMERG MED, V22, P579, DOI 10.1016/S0196-0644(05)81945-6; Miller DD, 1996, J NUCL CARDIOL, V3, P546, DOI 10.1016/S1071-3581(96)90063-X; Newby LK, 1998, CIRCULATION, V98, P1853, DOI 10.1161/01.CIR.98.18.1853; Pope JH, 1998, J THROMB THROMBOLYS, V6, P63, DOI 10.1023/A:1008876322599; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; POZEN MW, 1984, NEW ENGL J MED, V310, P1273, DOI 10.1056/NEJM198405173102001; Roberts RR, 1997, JAMA-J AM MED ASSOC, V278, P1670, DOI 10.1001/jama.278.20.1670; SARASIN FP, 1994, J GEN INTERN MED, V9, P187, DOI 10.1007/BF02600122; Selker HP, 1997, ANN EMERG MED, V29, P13, DOI 10.1016/S0196-0644(97)70298-1; Selker HP, 1998, ANN INTERN MED, V129, P845, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00002; Tatum JL, 1997, ANN EMERG MED, V29, P116, DOI 10.1016/S0196-0644(97)70317-2; VARETTO T, 1993, J AM COLL CARDIOL, V22, P1804, DOI 10.1016/0735-1097(93)90761-O; WACKERS FJT, 1979, BRIT HEART J, V41, P111; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zimmerman J, 1999, CIRCULATION, V99, P1671, DOI 10.1161/01.CIR.99.13.1671	29	241	251	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2002	288	21					2693	2700		10.1001/jama.288.21.2693	http://dx.doi.org/10.1001/jama.288.21.2693			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620UA	12460092	Bronze			2022-12-28	WOS:000179549800028
J	Laifer, G; Marti, W; Wiesner, W; Fluckiger, U				Laifer, G; Marti, W; Wiesner, W; Fluckiger, U			Balancing on the edge	LANCET			English	Article							LIVER		Univ Basel Hosp, Div Infect Dis, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland; Univ Basel Hosp, Inst Diagnost Radiol, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel	Laifer, G (corresponding author), Univ Basel Hosp, Div Infect Dis, Petersgraben 4, CH-4031 Basel, Switzerland.							CRADDOCK PR, 1977, NEW ENGL J MED, V296, P769, DOI 10.1056/NEJM197704072961401; KOK AN, 1993, J FORENSIC SCI, V38, P978; LEE GR, 1999, WINTROBES CLIN HEMAT, V2; PAWLOWSKI ZS, COMPENDIUM CYSTIC EC, P119; Wellhoener P, 2000, INTENS CARE MED, V26, P1578, DOI 10.1007/s001340000631	5	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1746	1746		10.1016/S0140-6736(02)11684-9	http://dx.doi.org/10.1016/S0140-6736(02)11684-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480429				2022-12-28	WOS:000179636800013
J	Dreyfus, M; Regnier, P				Dreyfus, M; Regnier, P			The poly(A) tail of mRNAs: Bodyguard in eukaryotes, scavenger in bacteria	CELL			English	Review							MESSENGER-RNA DEGRADATION; ESCHERICHIA-COLI; POLYMERASE-I; PROTEINS; COMPONENTS	In eukaryotes, poly(A) tails usually act as stabilizers of intact mRNAs, whereas in E. coli they serve to accelerate the destruction of fragments. The mechanisms underlying these contrasting effects of the same RNA modification are discussed.	Ecole Normale Super, CNRS, UMR 8541, F-75230 Paris, France; Inst Biol Physicochim, CNRS, UPR 9073, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Dreyfus, M (corresponding author), Ecole Normale Super, CNRS, UMR 8541, F-75230 Paris, France.							Carpousis AJ, 1999, TRENDS GENET, V15, P24, DOI 10.1016/S0168-9525(98)01627-8; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; Feng Y, 2001, J BIOL CHEM, V276, P31651, DOI 10.1074/jbc.M102855200; Feng YN, 2000, P NATL ACAD SCI USA, V97, P6415, DOI 10.1073/pnas.120173797; Grunberg-Manago M, 1999, ANNU REV GENET, V33, P193, DOI 10.1146/annurev.genet.33.1.193; HaugelNielsen J, 1996, EMBO J, V15, P3144, DOI 10.1002/j.1460-2075.1996.tb00677.x; Li ZW, 2002, EMBO J, V21, P1132, DOI 10.1093/emboj/21.5.1132; Mohanty BK, 1999, MOL MICROBIOL, V34, P1094, DOI 10.1046/j.1365-2958.1999.01673.x; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Raynal LC, 1999, MOL MICROBIOL, V32, P765, DOI 10.1046/j.1365-2958.1999.01394.x; REGNIER P, 2002, TRANSLATION MECH; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; Sarkar N, 1997, ANNU REV BIOCHEM, V66, P173, DOI 10.1146/annurev.biochem.66.1.173; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; XU FF, 1995, NATURE, V374, P180, DOI 10.1038/374180a0	20	176	197	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 27	2002	111	5					611	613		10.1016/S0092-8674(02)01137-6	http://dx.doi.org/10.1016/S0092-8674(02)01137-6			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464173	Bronze			2022-12-28	WOS:000179594500003
J	Ogle, JM; Murphy, FV; Tarry, MJ; Ramakrishnan, V				Ogle, JM; Murphy, FV; Tarry, MJ; Ramakrishnan, V			Selection of tRNA by the ribosome requires a transition from an open to a closed form	CELL			English	Article							AMINOACYL-TRANSFER-RNA; THERMODYNAMIC PARAMETERS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; INDUCED FIT; FACTOR TU; SUBUNIT; BINDING; INSIGHTS; RECOGNITION	A structural and mechanistic explanation for the selection of tRNAs by the ribosome has been elusive. Here, we report crystal structures of the 30S ribosomal subunit with codon and near-cognate tRNA anticodon stem loops bound at the decoding center and compare affinities of equivalent complexes in solution. In ribosomal interactions with near-cognate tRNA, deviation from Watson-Crick geometry results in uncompensated desolvation of hydrogen-bonding partners at the codon-anticodon minor groove. As a result, the transition to a closed form of the 30S induced by cognate tRNA is unfavorable for near-cognate tRNA unless paromomycin induces part of the rearrangement. We conclude that stabilization of a closed 30S conformation is required for tRNA selection, and thereby structurally rationalize much previous data on translational fidelity.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ramak@mrc-imb.cam.ac.uk		Ramakrishnan, V/0000-0002-4699-2194	NIGMS NIH HHS [GM 44973] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTLETT PA, 1987, SCIENCE, V235, P569, DOI 10.1126/science.3810155; Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cheetham GMT, 2000, CURR OPIN STRUC BIOL, V10, P117, DOI 10.1016/S0959-440X(99)00058-5; Chen XY, 2000, BIOCHEMISTRY-US, V39, P8970, DOI 10.1021/bi992938e; Clemons WM, 2001, J MOL BIOL, V310, P827, DOI 10.1006/jmbi.2001.4778; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; FOUMY D, 1996, SCIENCE, V274, P1367; GLUKHOVA MA, 1975, EUR J BIOCHEM, V52, P197, DOI 10.1111/j.1432-1033.1975.tb03987.x; GROSJEAN HJ, 1978, P NATL ACAD SCI USA, V75, P610, DOI 10.1073/pnas.75.2.610; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kurland C.G., 1996, ESCHERICHIA COLI SAL, P979; Lim VI, 2001, RNA, V7, P942, DOI 10.1017/S135583820100214X; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; PONGS O, 1973, EUR J BIOCHEM, V32, P117, DOI 10.1111/j.1432-1033.1973.tb02586.x; POWERS T, 1994, J MOL BIOL, V235, P156, DOI 10.1016/S0022-2836(05)80023-3; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; THOMPSON RC, 1977, P NATL ACAD SCI USA, V74, P198, DOI 10.1073/pnas.74.1.198; THOMPSON RC, 1982, J BIOL CHEM, V257, P6677; UHLENBECK OC, 1971, J MOL BIOL, V57, P217, DOI 10.1016/0022-2836(71)90342-1; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; VanLoock MS, 2000, J MOL BIOL, V304, P507, DOI 10.1006/jmbi.2000.4213; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yarus Michael, 1995, P443; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	50	501	515	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	2002	111	5					721	732		10.1016/S0092-8674(02)01086-3	http://dx.doi.org/10.1016/S0092-8674(02)01086-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464183	Bronze			2022-12-28	WOS:000179594500013
J	Quay, P				Quay, P			Ups and downs of CO2 uptake	SCIENCE			English	Editorial Material							ATMOSPHERIC CO2; INTERANNUAL VARIABILITY; CARBON-DIOXIDE; DELTA-C-13; SINK		Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Quay, P (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	pdquay@u.washington.edu						Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; Feely RA, 1999, NATURE, V398, P597, DOI 10.1038/19273; FRANCEY RJ, 1995, NATURE, V373, P326, DOI 10.1038/373326a0; Gruber N, 2002, SCIENCE, V298, P2374, DOI 10.1126/science.1077077; Le Quere C, 2000, GLOBAL BIOGEOCHEM CY, V14, P1247, DOI 10.1029/1999GB900049; Lee K, 1998, NATURE, V396, P155, DOI 10.1038/24139; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; TANS P, 2002, CMDL REP, V26, P28	11	13	13	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2344	2344		10.1126/science.1079444	http://dx.doi.org/10.1126/science.1079444			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493904				2022-12-28	WOS:000179915900043
J	Erban, JK; Sahani, D; Harris, NL; Ryan, DP; Tang, Z; Roth, SI				Erban, JK; Sahani, D; Harris, NL; Ryan, DP; Tang, Z; Roth, SI			Weekly clinicopathological exercises: Case 38-2002 - Diffuse large-B-cell lymphoma, presenting in the liver.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HORMONE-RELATED PROTEIN; PRIMARY HEPATIC LYMPHOMA; NON-HODGKINS-LYMPHOMA; PROGNOSTIC-SIGNIFICANCE; HYPERCALCEMIA; EXPRESSION; BCL-2; GENE; CLASSIFICATION; REARRANGEMENT		Tufts Univ New England Med Ctr, Breast Canc Program, Div Hematol Oncol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Erban, JK (corresponding author), Tufts Univ New England Med Ctr, Breast Canc Program, Div Hematol Oncol, 750 Washington St, Boston, MA 02111 USA.							Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; ANDERSON T, 1982, CANCER-AM CANCER SOC, V50, P2708, DOI 10.1002/1097-0142(19821215)50:12<2708::AID-CNCR2820501203>3.0.CO;2-G; Avlonitis VS, 1999, EUR J SURG, V165, P725; Brittinger G, 1984, Hematol Oncol, V2, P269; BURTIS WJ, 1987, J BIOL CHEM, V262, P7151; Cabot RC, 1941, NEW ENGL J MED, V225, P789; CARBONE PP, 1971, CANCER RES, V31, P1860; Collaborative Ocular Melanoma Study Group, 2001, Arch Ophthalmol, V119, P670; DANKS J, 1908, J BONE MINER RES, V4, P273; Engelhard M, 1997, BLOOD, V89, P2291; Firkin F, 1996, BRIT J HAEMATOL, V94, P486, DOI 10.1046/j.1365-2141.1996.d01-1819.x; Frolich AF, 1998, DAN MED BULL, V45, P436; Gascoyne RD, 1997, BLOOD, V90, P244; GRECO F, 1997, PRINCIPLES PRACTICE, V2, P2424; HARRIS NL, 1994, BLOOD, V84, P1361; HAYWARD ML, 1981, CANCER-AM CANCER SOC, V48, P1643, DOI 10.1002/1097-0142(19811001)48:7<1643::AID-CNCR2820480728>3.0.CO;2-9; Hermine O, 1996, BLOOD, V87, P265, DOI 10.1182/blood.V87.1.265.bloodjournal871265; HOBBS RD, 1984, CANCER, V53, P1552, DOI 10.1002/1097-0142(19840401)53:7<1552::AID-CNCR2820530722>3.0.CO;2-S; JAFFE ES, 1987, SEMIN LIVER DIS, V7, P257, DOI 10.1055/s-2008-1040581; Kageshita T, 1999, MELANOMA RES, V9, P69, DOI 10.1097/00008390-199902000-00009; KAUFMAN SD, 1982, NEW ENGL J MED, V307, P41; Lei KIK, 1998, LEUKEMIA LYMPHOMA, V29, P293, DOI 10.3109/10428199809068566; Lossos IS, 2001, BLOOD, V98, P945, DOI 10.1182/blood.V98.4.945; MILLER TP, 1994, BLOOD, V83, P1460, DOI 10.1182/blood.V83.6.1460.1460; MOSELEY JM, 1987, P NATL ACAD SCI USA, V84, P5048, DOI 10.1073/pnas.84.14.5048; Mundy GR, 1997, AM J MED, V103, P134, DOI 10.1016/S0002-9343(97)80047-2; MUNDY GR, 1982, METABOLISM, V31, P1247, DOI 10.1016/0026-0495(82)90012-9; Murty VVVS, 1998, SEMIN ONCOL, V25, P133; OFFIT K, 1994, NEW ENGL J MED, V331, P74, DOI 10.1056/NEJM199407143310202; Page RD, 2001, CANCER, V92, P2023, DOI 10.1002/1097-0142(20011015)92:8<2023::AID-CNCR1540>3.0.CO;2-B; POSNER MR, 1994, HEMATOL ONCOL CLIN N, V8, P533, DOI 10.1016/S0889-8588(18)30167-9; ROSENBERG SA, 1977, CANCER TREAT REP, V61, P1023; SENBA M, 1992, EUR J HAEMATOL, V48, P278; SEYMOUR JF, 1994, ANN INTERN MED, V121, P633, DOI 10.7326/0003-4819-121-9-199411010-00001; STREWLER GJ, 1987, J CLIN INVEST, V80, P1803, DOI 10.1172/JCI113275; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; VASSILOPOULOUSELLIN R, 1993, CANCER, V71, P1309, DOI 10.1002/1097-0142(19930215)71:4<1309::AID-CNCR2820710423>3.0.CO;2-M; Wilson WH, 1997, BLOOD, V89, P601, DOI 10.1182/blood.V89.2.601; Xu Y, 2001, AM J CLIN PATHOL, V116, P183	40	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1952	1960		10.1056/NEJMcpc020023	http://dx.doi.org/10.1056/NEJMcpc020023			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623ZX	12477946				2022-12-28	WOS:000179735800008
J	Wood, WT; Gettrust, JF; Chapman, NR; Spence, GD; Hyndman, RD				Wood, WT; Gettrust, JF; Chapman, NR; Spence, GD; Hyndman, RD			Decreased stability of methane hydrates in marine sediments owing to phase-boundary roughness	NATURE			English	Article							GAS HYDRATE	Below water depths of about 300 metres, pressure and temperature conditions cause methane to form ice-like crystals of methane hydrate(1). Marine deposits of methane hydrate are estimated to be large, amassing about 10, 000 gigatonnes of carbon(2), and are thought to be important to global change(3,4) and seafloor stability(5,6), as well as representing a potentially exploitable energy resource(7). The extent of these deposits can usually be inferred from seismic imaging, in which the base of the methane hydrate stability zone is frequently identifiable as a smooth reflector that runs parallel to the sea floor. Here, using high-resolution seismic sections of seafloor sediments in the Cascadia margin off the coast of Vancouver Island, Canada, we observe lateral variations in the base of the hydrate stability zone, including gas-rich vertical intrusions into the hydrate stability zone. We suggest that these vertical intrusions are associated with upward flow of warmer fluids. Therefore, where seafloor fluid expulsion and methane hydrate deposits coincide, the base of the hydrate stability zone might exhibit significant roughness and increased surface area. Increased area implies that significantly more methane hydrate lies close to being unstable and hence closer to dissociation in the event of a lowering of pressure due to sea-level fall.	USN, Res Lab, Stennis Space Ctr, MS 39529 USA; Univ Victoria, Victoria, BC V8W 3P6, Canada; Pacific Geosci Ctr, Sydney, BC V8L 4B2, Canada	United States Department of Defense; United States Navy; Naval Research Laboratory; University of Victoria	Wood, WT (corresponding author), USN, Res Lab, Stennis Space Ctr, MS 39529 USA.	warren.wood@nrlssc.navy.mil						BOOTH JS, 1994, ANN NY ACAD SCI, V715, P487, DOI 10.1111/j.1749-6632.1994.tb38863.x; Brown KM, 1996, EARTH PLANET SC LETT, V139, P471, DOI 10.1016/0012-821X(95)00243-6; Chapman NR, 2002, GEOPHYSICS, V67, P1038, DOI 10.1190/1.1500364; Collett TS, 1998, OIL GAS J, V96, P90; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; Fisher CR, 2000, NATURWISSENSCHAFTEN, V87, P184, DOI 10.1007/s001140050700; Gettrust J.F., 1991, SEA TECHNOL, V32, P23; Heggland R., 2000, AM OIL GAS REPOR FEB; HOVLAND M, 1988, SEABED POCKMARKS SEE, P181; HYNDMAN RD, 1992, J GEOPHYS RES-SOL EA, V97, P6683, DOI 10.1029/92JB00234; Korenaga J, 1997, J GEOPHYS RES-SOL EA, V102, P15345, DOI 10.1029/97JB00725; Kvenvolden K. A., 2001, GEOPHYS MONOGR SER, DOI [DOI 10.1029/GM124P0003, 10.1029/ GM124p0003.]; Meldahl P., 2001, LEADING EDGE, V20, P474, DOI [DOI 10.1190/1.1438976, 10.1190/1.1438976]; PAULL CK, 1991, GEOPHYS RES LETT, V18, P432, DOI 10.1029/91GL00351; Paull CK, 1996, GEOLOGY, V24, P143, DOI 10.1130/0091-7613(1996)024<0143:ICMSFD>2.3.CO;2; PAULL CK, 1996, P ODP INIT REP, V164; PAULL CK, 2001, NATURAL GAS HYDRATES, V124; Voss C, 1984, 844369 USGS; WESTBROOK GK, 1994, P ODP INIT REP, V146; WOOD WT, 2001, AGU MONOGRAPH, V124, P165; Xu WY, 1999, J GEOPHYS RES-SOL EA, V104, P5081, DOI 10.1029/1998JB900092	21	174	192	6	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					656	660		10.1038/nature01263	http://dx.doi.org/10.1038/nature01263			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478290				2022-12-28	WOS:000179751800042
J	Di Blasi, Z; Kaptchuk, TJ; Weinman, J; Kleijnen, J				Di Blasi, Z; Kaptchuk, TJ; Weinman, J; Kleijnen, J			Informing participants of allocation to placebo at trial closure: postal survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIAL; CONSUMERS; CONSENT	Objectives To assess whether and how investigators of placebo controlled randomised trials inform participants of their treatment allocation at trial closure and to assess barriers to feedback. Design Postal survey With a semistructured questionnaire. Participants All investigators who published a placebo controlled randomised trial in 2000 in five leading medical journals, and a random sample of 120 trials listed in the national research register database. Main outcome measures Number of investigators who informed participants of their treatment allocation at trial closure, methods for delivering the information, and barriers to unmasking treatment. Results 45% of investigators informed either,all or most participants of their treatment allocation, and 55% did not inform any participant or only informed those who asked. The main reasons for not informing participants were that the investigators never considered this option (40%) or to avoid biasing results at study follow up (24%). Conclusion Further research is required to examine sensitive ways to communicate treatment information to trial participants.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Harvard Univ, Sch Med, Osher Inst, Boston, MA 02215 USA; Guys Kings & St Thomas Sch Med, Unit Psychol, London SE1 9RT, England; Univ York, NHS Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England	University of York - UK; Harvard University; Harvard Medical School; University of London; King's College London; University of York - UK	Di Blasi, Z (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	zdb1@york.ac.uk		Di Blasi, Zelda/0000-0001-8950-4958; Weinman, John Alfred/0000-0002-6786-0166				[Anonymous], 1986, HIST THEORY INFORM C; Armitage P, 1982, Stat Med, V1, P345, DOI 10.1002/sim.4780010412; BERGMANN JF, 1994, CLIN TRIAL META-ANAL, V29, P41; Chalmers I, 2001, INT J EPIDEMIOL, V30, P1156, DOI 10.1093/ije/30.5.1156; Crow R., 1999, HEALTH TECHNOL ASSES, V3, P1, DOI [DOI 10.3310/HTA3030, DOI 10.3310/hta3030]; DAHAN R, 1986, BRIT MED J, V293, P363, DOI 10.1136/bmj.293.6543.363; *DEP HLTH, 2001, RES GOV FRAM HLTH SO; *DEP HLTH, 2001, RES GOVT FRAM HLTH S; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; FOX M, 2002, BRAIN SCAN STUDY SHO; Hanley B, 2001, BRIT MED J, V322, P519, DOI 10.1136/bmj.322.7285.519; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Kaptchuk TJ, 1998, B HIST MED, V72, P389, DOI 10.1353/bhm.1998.0159; Leuchter AF, 2002, AM J PSYCHIAT, V159, P122, DOI 10.1176/appi.ajp.159.1.122; LUNDH LG, 1987, SCAND J PSYCHOL, V28, P128, DOI 10.1111/j.1467-9450.1987.tb00747.x; *NHS CTR REV DISS, 2001, 4 U YORK NHS CTR REV; RABKIN JG, 1990, AM J PSYCHIAT, V147, P1622; Royle J, 2001, BRIT MED J, V323, P48; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; 2001, NATL RES REGISTER	20	27	27	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2002	325	7376					1329	1331		10.1136/bmj.325.7376.1329	http://dx.doi.org/10.1136/bmj.325.7376.1329			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468480	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000179817100017
J	Bidle, KD; Manganelli, M; Azam, F				Bidle, KD; Manganelli, M; Azam, F			Regulation of oceanic silicon and carbon preservation by temperature control on bacteria	SCIENCE			English	Article							BIOGENIC SILICA; SOUTHERN-OCEAN; ORGANIC-CARBON; WATER-COLUMN; MARINE DIATOMS; ROSS SEA; DISSOLUTION; CYCLE; AVAILABILITY; CONSUMPTION	We demonstrated in laboratory experiments that temperature control of marine bacteria action on diatoms strongly influences the coupling of biogenic silica and organic carbon preservation. Low temperature intensified the selective regeneration of organic matter by marine bacteria as the silicon: carbon preservation ratio gradually increased from similar to1 at 33degreesC to similar to6 at -1.8degreesC. Temperature control of bacteria-mediated selective preservation of silicon versus carbon should help to interpret and model the variable coupling of silicon and carbon sinking fluxes and the spatial patterns of opal accumulation in oceanic systems with different temperature regimes.	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Bidle, KD (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.		Azam, Farooq/A-2306-2012; Manganelli, Maura/M-7103-2017	Manganelli, Maura/0000-0002-5650-8191				ALLDREDGE AL, 1989, DEEP-SEA RES, V36, P159, DOI 10.1016/0198-0149(89)90131-3; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Bidle KD, 2001, LIMNOL OCEANOGR, V46, P1606, DOI 10.4319/lo.2001.46.7.1606; BIDLE KD, UNPUB; BRZEZINSKI MA, 1989, DEEP-SEA RES, V36, P1009, DOI 10.1016/0198-0149(89)90075-7; Brzezinski MA, 1998, MAR ECOL PROG SER, V167, P89, DOI 10.3354/meps167089; BRZEZINSKI MA, 1990, MAR ECOL PROG SER, V67, P83, DOI 10.3354/meps067083; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; CHRISTIAN JR, 1995, LIMNOL OCEANOGR, V40, P1042, DOI 10.4319/lo.1995.40.6.1042; CHRISTIAN JR, 1993, ANTARCT J US, V28, P221; Christian JR, 1992, ANTARCT J US, V27, P170; DeMaster DJ, 2002, DEEP-SEA RES PT II, V49, P3155, DOI 10.1016/S0967-0645(02)00076-0; DEMASTER DJ, 1991, MAR CHEM, V35, P489, DOI 10.1016/S0304-4203(09)90039-1; DEMASTER DJ, 1992, OCEANOGRAPHY, V5, P146, DOI DOI 10.5670/OCEANOG.1992.03; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; HANSON R B, 1981, Antarctic Journal of the United States, V16, P130; HODSON RE, 1981, MAR BIOL, V61, P89, DOI 10.1007/BF00386648; HURD DC, 1983, AM J SCI, V283, P1, DOI 10.2475/ajs.283.1.1; KAMATANI A, 1979, MAR BIOL, V55, P29, DOI 10.1007/BF00391714; KAMATANI A, 1982, MAR BIOL, V68, P91, DOI 10.1007/BF00393146; KARL DM, 1993, ANTARCTIC MICROBIOLO, V1, P1; LEWIN JC, 1961, GEOCHIM COSMOCHIM AC, V21, P182, DOI 10.1016/S0016-7037(61)80054-9; LONGHURST AR, 1989, PROG OCEANOGR, V22, P47, DOI 10.1016/0079-6611(89)90010-4; MORITA RY, 1975, BACTERIOL REV, V39, P144, DOI 10.1128/MMBR.39.2.144-167.1975; NELSON DM, 1982, GEOCHIM COSMOCHIM AC, V46, P491, DOI 10.1016/0016-7037(82)90153-3; Nelson DM, 2002, DEEP-SEA RES PT II, V49, P1645, DOI 10.1016/S0967-0645(02)00005-X; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nelson DM, 1996, J GEOPHYS RES-OCEANS, V101, P18519, DOI 10.1029/96JC01573; NELSON DM, 1991, MAR CHEM, V35, P461, DOI 10.1016/S0304-4203(09)90037-8; PAASCHE E, 1973, MAR BIOL, V19, P117, DOI 10.1007/BF00353582; Pomeroy LR, 2001, AQUAT MICROB ECOL, V23, P187, DOI 10.3354/ame023187; POMEROY LR, 1986, SCIENCE, V233, P359, DOI 10.1126/science.233.4761.359; Pondaven P, 2000, NATURE, V405, P168, DOI 10.1038/35012046; Ragueneau O, 2002, DEEP-SEA RES PT II, V49, P3127, DOI 10.1016/S0967-0645(02)00075-9; Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; TREGUER P, 1989, POLAR BIOL, V9, P397, DOI 10.1007/BF00442531	40	87	88	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1980	1984		10.1126/science.1076076	http://dx.doi.org/10.1126/science.1076076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471255				2022-12-28	WOS:000179629200042
J	Sala, E; Aburto-Oropeza, O; Paredes, G; Parra, I; Barrera, JC; Dayton, PK				Sala, E; Aburto-Oropeza, O; Paredes, G; Parra, I; Barrera, JC; Dayton, PK			A general model for designing networks of marine reserves	SCIENCE			English	Article							CONNECTIVITY; POPULATION; RETENTION	There is debate concerning the most effective conservation of marine biodiversity, especially regarding the appropriate location, size, and connectivity of marine reserves. We describe a means of establishing marine reserve networks by using optimization algorithms and multiple levels of information on biodiversity, ecological processes (spawning, recruitment, and larval connectivity), and socioeconomic factors in the Gulf of California. A network covering 40% of rocky reef habitat can fulfill many conservation goals while reducing social conflict. This quantitative approach provides a powerful tool for decision-makers tasked with siting marine reserves.	Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; Univ Autonoma Baja California, La Paz, Baja Calif Sur, Mexico; World Wildlife Fund, Gulf Calif Program, Hermosillo, Sonora, Mexico	University of California System; University of California San Diego; Scripps Institution of Oceanography; Universidad Autonoma de Baja California	Sala, E (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.	esala@ucsd.edu		Aburto-Oropeza, Octavio/0000-0002-8173-1432				AIRAME S, IN PRESS ECOL APPL; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Botsford LW, 2001, ECOL LETT, V4, P144; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; CARR MH, 1993, CAN J FISH AQUAT SCI, V50, P2019, DOI 10.1139/f93-226; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Dayton PK, 2000, B MAR SCI, V66, P617; Hastings A, 1999, SCIENCE, V284, P1537, DOI 10.1126/science.284.5419.1537; KINLAN BP, IN PRESS ECOLOGY; Lauck T, 1998, ECOL APPL, V8, pS72, DOI 10.1890/1051-0761(1998)8[S72:ITPPIF]2.0.CO;2; LESLIE H, IN PRESS ECOL APPL; Lockwood DR, 2002, THEOR POPUL BIOL, V61, P297, DOI 10.1006/tpbi.2002.1572; LUBCHENCO J, IN PRESS ECOL APPL; Malakoff D, 2002, SCIENCE, V296, P245, DOI 10.1126/science.296.5566.245; Mangel M, 2000, ECOL LETT, V3, P15, DOI 10.1046/j.1461-0248.2000.00104.x; Musick JA, 2000, FISHERIES, V25, P6, DOI 10.1577/1548-8446(2000)025<0006:POMFSA>2.0.CO;2; National Research Council, 2001, MAR PROT AR TOOLS SU; Ogden JC, 1997, SCIENCE, V278, P1414, DOI 10.1126/science.278.5342.1414; Palumbi SR, 2001, MARINE COMMUNITY ECOLOGY, P509; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robertson DR, 2001, P NATL ACAD SCI USA, V98, P5667, DOI 10.1073/pnas.091367798; SALA E, UNPUB; SALA E, IN PRESS B MAR SCI; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Ward TJ, 1999, ECOL APPL, V9, P691; Warner RR, 2000, B MAR SCI, V66, P821	29	303	315	1	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					1991	1993		10.1126/science.1075284	http://dx.doi.org/10.1126/science.1075284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471258	Green Submitted			2022-12-28	WOS:000179629200045
J	Cain, ME				Cain, ME			Atrial fibrillation - Rhythm or rate control	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington Univ, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Cain, ME (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.								0	14	15	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2002	347	23					1822	1823		10.1056/NEJMp020134	http://dx.doi.org/10.1056/NEJMp020134			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NW	12466505				2022-12-28	WOS:000179596900001
J	Shan, H; Wang, JX; Ren, FR; Zhang, YZ; Zhao, HY; Gao, GJ; Ji, Y; Ness, PM				Shan, H; Wang, JX; Ren, FR; Zhang, YZ; Zhao, HY; Gao, GJ; Ji, Y; Ness, PM			Blood banking in China	LANCET			English	Article							INFECTION	While transfusion-transmissible diseases, including AIDS and viral hepatitis, continue to spread especially in developing countries, the issue of safeguarding the world's blood supply is of paramount importance. China houses more than 20% of the earth's population, and thus its blood supply has the potential to affect the global community. In recent years, Chinese blood centres have tried to improve the nation's blood safety. Although substantial progress has already been made, many daunting difficulties remain. Traditional cultural barriers need to be overcome to successfully mobilise volunteer blood donors. Gaps in information and technology still need to be closed. Insufficiency of economic resources also restrict the blood bank industry. Other developing countries face many of the same challenges as China.	Johns Hopkins Med Inst, Dept Pathol, Div Blood Transfus, HIV Specialty Testing Lab, Baltimore, MD 21287 USA; Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China; Beijing Red Cross Blood Ctr, Beijing, Peoples R China; Xinjiang Autonomous Reg Ctr Dis Control & Prevent, Urumqi, Xinjiang, Peoples R China	Johns Hopkins University; Johns Hopkins Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS	Shan, H (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Div Blood Transfus, HIV Specialty Testing Lab, Baltimore, MD 21287 USA.				FIC NIH HHS [5D43 TW00010] Funding Source: Medline; NIAID NIH HHS [U01 AI48011] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI048011] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAY F, 1998, WHY ITS REALLY DRAW; Beach MV, 2001, LANCET, V357, P49, DOI 10.1016/S0140-6736(05)71551-8; DAI ZC, 1999, VIRAL HEPATITIS CHIN; FENG G, 2001, CHIN J BLOOD TRANSFU, V14, P205; JANG T, 2000, CHIN J BLOOD TRANSFU, V13, P44; Ji Y, 1996, TRANSFUSION MED, V6, P291, DOI 10.1111/j.1365-3148.1996.tb00082.x; JI Y, 1998, ACTA ACAD MED, V20, P240; JI Y, 1992, CHIN J BLOOD TRANSFU, V4, P184; JI Y, 1995, VOX SANG, V9, P255; LEI W, 1999, CHIN J BLOOD TRANSFU, V12, P31; LIU Y, 1999, CHIN J BLOOD TRANSFU, V12, P33; LUI Z, 2000, CHIN J EPIDEMIOL, V21, P466; MA J, 1995, CHIN J LIVER DIS S, V3, P28; SHAN H, 1998, 51 ANN M AM ASS BLOO; Shi XL, 1999, TRANSFUSION, V39, P913, DOI 10.1046/j.1537-2995.1999.39080913.x; Weinberg PD, 2002, ANN INTERN MED, V136, P312, DOI 10.7326/0003-4819-136-4-200202190-00011; XIAO H, 2000, CHIN J BLOOD TRANS S, V13, P72; Xiwen Zheng, 2000, CHIN J EPIDEMIOL, V21; YAN J, 2000, CHIN J EPIDEMIOL, V21, P10; YANG C, 2001, 1 FOG WORKSH BLOOD S; Zhang Y, 2000, 53 ANN M AM ASS BLOO; ZHAO H, 1992, CHIN J BLOOD TRANSFU, V4, P176; ZHENG X, 2000, CHIN J EPIDEMIOL, V21, P13; ZHENG X, 2000, CHIN J EPIDEMIOL, V21, P253; ZHENG XW, 1999, CHINESE J EPIDEMIOLO, V20, P131; ZHU P, 2000, CHIN J EPIDEMIOL, V21, P140; 2000, PEOPLES DAILY   1101; 2002, NEW CHINA NEWS A APR; 1998, HEALTH          0922	29	117	123	2	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1770	1775		10.1016/S0140-6736(02)11669-2	http://dx.doi.org/10.1016/S0140-6736(02)11669-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480443				2022-12-28	WOS:000179636800027
J	Hochheimer, A; Zhou, S; Zheng, S; Holmes, MC; Tjian, R				Hochheimer, A; Zhou, S; Zheng, S; Holmes, MC; Tjian, R			TRF2 associates with DREF and directs promoter-selective gene expression in Drosophila	NATURE			English	Article							TBP-LIKE FACTOR; NUCLEOSOME REMODELING FACTOR; POLYMERASE-II TRANSCRIPTION; CELL NUCLEAR ANTIGEN; BINDING PROTEIN; MICE LACKING; C-ELEGANS; ISWI; SPERMIOGENESIS; ELEMENTS	Drosophila TATA-box-binding protein (TBP)-related factor 2 (TRF2) is a member of a family of TBP-related factors present in metazoan organisms. Recent evidence suggests that TRF2s are required for proper embryonic development and differentiation(1-5). However, true target promoters and the mechanisms by which TRF2 operates to control transcription remain elusive. Here we report the antibody affinity purification of a Drosophila TRF2-containing complex that contains components of the nucleosome remodelling factor (NURF) chromatin remodelling complex as well as the DNA replication-related element (DRE)-binding factor DREF. This latter finding led us to potential target genes containing TRF2-responsive promoters. We have used a combination of in vitro and in vivo assays to show that the DREF-containing TRF2 complex directs core promoter recognition of the proliferating cell nuclear antigen (PCNA) gene. We also identified additional TRF2-responsive target genes involved in DNA replication and cell proliferation. These data suggest that TRF2 functions as a core promoter-selectivity factor responsible for coordinating transcription of a subset of genes in Drosophila.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, 401 Barker Hall, Berkeley, CA 94720 USA.	jmlim@uclink4.berkeley.edu						Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Coligan JKA, 1991, CURRENT PROTOCOLS IM; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; DYNLACHT BD, 1994, P NATL ACAD SCI USA, V91, P6359, DOI 10.1073/pnas.91.14.6359; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Gdula DA, 1998, GENE DEV, V12, P3206, DOI 10.1101/gad.12.20.3206; GOODRICH LA, 1994, CURR OPIN CELL BIOL, V6, P403, DOI 10.1016/0955-0674(94)90033-7; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; HEBERLEIN U, 1988, NATURE, V331, P410, DOI 10.1038/331410a0; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Hirose F, 1996, J BIOL CHEM, V271, P3930; HIROSE F, 1993, J BIOL CHEM, V268, P2092; Holmes MC, 2000, SCIENCE, V288, P867, DOI 10.1126/science.288.5467.867; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; Lieb B, 1998, EXP CELL RES, V245, P272, DOI 10.1006/excr.1998.4249; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Yamaguchi M, 1996, GENES CELLS, V1, P47, DOI 10.1046/j.1365-2443.1996.03003.x; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	29	170	177	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2002	420	6914					439	445		10.1038/nature01167	http://dx.doi.org/10.1038/nature01167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12459787				2022-12-28	WOS:000179494700045
J	Bose, A; Guilherme, A; Robida, SI; Nicoloro, SMC; Zhou, QL; Jiang, ZY; Pomerleau, DP; Czech, MP				Bose, A; Guilherme, A; Robida, SI; Nicoloro, SMC; Zhou, QL; Jiang, ZY; Pomerleau, DP; Czech, MP			Glucose transporter recycling in response to insulin is facilitated by myosin Myo1c	NATURE			English	Article							3T3-L1 ADIPOCYTES; RAT ADIPOCYTES; ACTIN-FILAMENTS; PHOSPHATIDYLINOSITOL 3-KINASE; MAMMALIAN-CELLS; IN-VIVO; GLUT4; TRANSLOCATION; MEMBRANE; VESICLES	Insulin stimulates glucose uptake in muscle and adipocytes by signalling the translocation of GLUT4 glucose transporters from intracellular membranes to the cell surface(1,2). The translocation of GLUT4 may involve signalling pathways that are both independent of and dependent on phosphatidylinositol-3-OH kinase (PI(3) K)(3-5). This translocation also requires the actin cytoskeleton(6-8), and the rapid movement of GLUT4 along linear tracks may be mediated by molecular motors(9). Here we report that the unconventional myosin Myo1c is present in GLUT4-containing vesicles purified from 3T3-L1 adipocytes. Myo1c, which contains a motor domain, three IQ motifs and a carboxy-terminal cargo domain, is highly expressed in primary and cultured adipocytes. Insulin enhances the localization of Myo1c with GLUT4 in cortical tubulovesicular structures associated with actin filaments, and this colocalization is insensitive to wortmannin. Insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane is augmented by the expression of wild-type Myo1c and inhibited by a dominant-negative cargo domain of Myo1c. A decrease in the expression of endogenous Myo1c mediated by small interfering RNAs inhibits insulin-stimulated uptake of 2-deoxyglucose. Thus, myosin Myo1c functions in a PI(3) K-independent insulin signalling pathway that controls the movement of intracellular GLUT4-containing vesicles to the plasma membrane.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.			Nicoloro, Sarah/0000-0002-8638-4556				BARYLKO B, 1992, P NATL ACAD SCI USA, V89, P490, DOI 10.1073/pnas.89.2.490; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bose A, 2001, MOL CELL BIOL, V21, P5262, DOI 10.1128/MCB.21.15.5262-5275.2001; CAIN CC, 1992, J BIOL CHEM, V267, P11681; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Czech MP, 2000, NATURE, V407, P147, DOI 10.1038/35025183; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; DeOca GM, 1997, ARCH MED RES, V28, P321; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Emoto M, 2001, J BIOL CHEM, V276, P10677, DOI 10.1074/jbc.M010785200; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; JIANG ZY, UNPUB P NATL ACAD SC; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; LAURIE SM, 1993, J BIOL CHEM, V268, P19110; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Neuhaus EM, 2000, J CELL BIOL, V150, P1013, DOI 10.1083/jcb.150.5.1013; OKADA T, 1994, J BIOL CHEM, V269, P3568; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Patki V, 2001, MOL BIOL CELL, V12, P129, DOI 10.1091/mbc.12.1.129; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; REIZES O, 1994, P NATL ACAD SCI USA, V91, P6349, DOI 10.1073/pnas.91.14.6349; RUPPERT C, 1995, J CELL SCI, V108, P3775; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Wang QH, 1998, BIOCHEM J, V331, P917, DOI 10.1042/bj3310917; Wu XF, 2000, CURR OPIN CELL BIOL, V12, P42, DOI 10.1016/S0955-0674(99)00055-1; Wu XF, 1997, J CELL SCI, V110, P847; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899	30	202	207	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					821	824		10.1038/nature01246	http://dx.doi.org/10.1038/nature01246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490950				2022-12-28	WOS:000179897300058
J	Cyranoski, D				Cyranoski, D			Neutrino physics - Tanked up and ready for action	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					737	737		10.1038/420737b	http://dx.doi.org/10.1038/420737b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490914				2022-12-28	WOS:000179897300023
J							CRAP Writing Grp	EBM: unmasking the ugly truth	BMJ-BRITISH MEDICAL JOURNAL			English	Article									CRAP Writing Grp, London WC1H 9JR, England		CRAP Writing Grp (corresponding author), CRAP Writing Grp, Poste Restante, London WC1H 9JR, England.								0	29	32	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 21	2002	325	7378					1496	1498						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493681				2022-12-28	WOS:000180188600033
J	Weeks, WB; Wallace, AE				Weeks, WB; Wallace, AE			Readability of British and American medical prose at the start of the 21st century	BRITISH MEDICAL JOURNAL			English	Article								Articles published in the BMJ and JAMA are available on the internet, albeit for a fee in the case of JAMA. We wanted to determine whether the materials published by these two pre-eminent journals, while physically accessible to a broad population, are likely to be comprehensible to them.	Dartmouth Coll Sch Med, Dept Psychiat, Hanover, NH 03756 USA; Dartmouth Coll Sch Med, Dept Community & Family Med, Hanover, NH USA	Dartmouth College; Dartmouth College	Weeks, WB (corresponding author), Dartmouth Coll Sch Med, Dept Psychiat, Hanover, NH 03756 USA.		Weeks, WB/G-7436-2014					Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Gunning R., 1952, TECHNIQUE CLEAR WRIT; ROBERTS JC, 1994, JAMA-J AM MED ASSOC, V272, P119, DOI 10.1001/jama.272.2.119; Rochon PA, 2002, JAMA-J AM MED ASSOC, V287, P2853, DOI 10.1001/jama.287.21.2853; Severin W. J., 1992, COMMUNICATION THEORI	5	28	28	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1451	1452		10.1136/bmj.325.7378.1451	http://dx.doi.org/10.1136/bmj.325.7378.1451			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493663	Green Published			2022-12-28	WOS:000180188600015
J	Macgregor, S; Visscher, PM; Knott, S; Porteous, D; Muir, W; Millar, K; Blackwood, D				Macgregor, S; Visscher, PM; Knott, S; Porteous, D; Muir, W; Millar, K; Blackwood, D			Is schizophrenia linked to chromosome 1q?	SCIENCE			English	Editorial Material							LOCI		Univ Edinburgh, Inst Cell Anim & Populat Biol, Ashworth Lab, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Edinburgh, Mol Med Ctr, Dept Med Genet, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Macgregor, S (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, Ashworth Lab, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	stuart.macgregor@ed.ac.uk	Macgregor, Stuart/C-6442-2009; Knott, Sara A/H-2466-2013; Visscher, Peter/ABB-6151-2020; Porteous, David J/C-7289-2013; Porteous, David/AAA-3446-2021	Macgregor, Stuart/0000-0001-6731-8142; Knott, Sara A/0000-0002-4568-2928; Visscher, Peter/0000-0002-2143-8760; Porteous, David J/0000-0003-1249-6106; Porteous, David/0000-0003-1249-6106				Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Ekelund J, 2001, HUM MOL GENET, V10, P1611, DOI 10.1093/hmg/10.15.1611; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Hopper JL, 2001, SEMIN CANCER BIOL, V11, P367, DOI 10.1006/scbi.2001.0392; Levinson DF, 2002, SCIENCE, V296, P739, DOI 10.1126/science.1069914; Sham P., 1998, STAT HUMAN GENETICS; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Weeks DE., 1990, AM J HUM GENET, V47, pA203	10	9	9	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2277	2277						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493873				2022-12-28	WOS:000179915900001
J	Furberg, CD; Wright, JT; Davis, BR; Cutler, JA; Alderman, M; Black, H; Cushman, W; Grimm, R; Haywood, LJ; Leenen, F; Oparil, S; Probstfield, J; Whelton, P; Nwachuku, C; Gordon, D; Proschan, M; Einhorn, P; Ford, CE; Piller, LB; Dunn, JK; Goff, D; Pressel, S; Bettencourt, J; deLeon, B; Simpson, LM; Blanton, J; Geraci, T; Walsh, SM; Nelson, C; Rahman, M; Juratovac, A; Pospisil, R; Carroll, L; Sullivan, S; Russo, J; Barone, G; Christian, R; Feldman, S; Lucente, T; Calhoun, D; Jenkins, K; McDowell, P; Johnson, J; Kingry, C; Alzate, J; Margolis, KL; Holland-Klemme, LA; Jaeger, B; Williamson, J; Louis, G; Ragusa, P; Williard, A; Ferguson, RLS; Tanner, J; Eckfeldt, J; Crow, R; Pelosi, J				Furberg, CD; Wright, JT; Davis, BR; Cutler, JA; Alderman, M; Black, H; Cushman, W; Grimm, R; Haywood, LJ; Leenen, F; Oparil, S; Probstfield, J; Whelton, P; Nwachuku, C; Gordon, D; Proschan, M; Einhorn, P; Ford, CE; Piller, LB; Dunn, JK; Goff, D; Pressel, S; Bettencourt, J; deLeon, B; Simpson, LM; Blanton, J; Geraci, T; Walsh, SM; Nelson, C; Rahman, M; Juratovac, A; Pospisil, R; Carroll, L; Sullivan, S; Russo, J; Barone, G; Christian, R; Feldman, S; Lucente, T; Calhoun, D; Jenkins, K; McDowell, P; Johnson, J; Kingry, C; Alzate, J; Margolis, KL; Holland-Klemme, LA; Jaeger, B; Williamson, J; Louis, G; Ragusa, P; Williard, A; Ferguson, RLS; Tanner, J; Eckfeldt, J; Crow, R; Pelosi, J		ALLHAT Collaborative Res Grp	Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic - The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE; AFRICAN-AMERICAN; FAILURE; DISEASE; PROGRESSION; ANTAGONISTS; MORTALITY; THERAPY; CHLORTHALIDONE	Context Anti hypertensive therapy is well established to reduce hypertension-related morbidity and mortality, but the optimal first-step therapy is unknown. Objective To determine whether treatment with a calcium channel blocker or an angiotensin-converting enzyme inhibitor lowers the incidence of coronary heart disease (CHD) or other cardiovascular disease (CVD) events vs treatment with a diuretic. Design The Anti hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), a randomized, double-blind, active-controlled clinical trial conducted from February 1994 through March 2002. Setting and Participants A total of 33 357 participants aged 55 years or older with hypertension and at least 1 other CHD risk factor from 623 North American centers. Interventions Participants were randomly assigned to receive chlorthalidone, 12.5 to 25 mg/d (n= 15255); amlodipine, 2.5 to 10 mg/d (n =9048); or lisinopril, 10 to 40 mg/d (n=9054) for planned follow-up of approximately 4 to 8 years. Main Outcome Measures The primary outcome was combined fatal CHD or nonfatal myocardial infarction, analyzed by intent-to-treat. Secondary outcomes were all-cause mortality, stroke, combined CHD (primary outcome, coronary revascularization, or angina with hospitalization), and combined CVD (combined CHD, stroke, treated angina without hospitalization, heart failure [HF], and peripheral arterial disease). Results Mean follow-up was 4.9 years. The primary outcome occurred in 2956 participants, with no difference between treatments. Compared with chlorthaliclone (6-year rate, 11.5%), the relative risks (RRs) were 0.98 (95% Cl, 0.90-1.07) for amlodipine (6-year rate, 11.3%) and 0.99 (95% Cl, 0.91-1.08) for lisinopril (6-year rate, 11.4%). Likewise, all-cause mortality did not differ between groups. Five-year systolic blood pressures were significantly higher in the amlodipine (0.8 mm Hg, P=.03) and lisinopril (2 mm Hg, P<.001) groups compared with chlorthaliclone, and 5-year diastolic blood pressure was significantly lower with amlodipine (0.8 mm Hg, P<.001). For amlodipine vs chlorthaliclone, secondary outcomes were similar except for a higher 6-year rate of HF with amlodipine (10.2% vs 7.7%; RR, 1.38; 95% Cl, 1.25-1.52). For lisinopril vs chlorthaliclone, lisinopril had higher 6-year rates of combined CVD (33.3% vs 30.9%; RR, 1.10; 95% Cl, 1.05-1.16); stroke (6.3% vs 5.6%; RR, 1.15; 95% Cl, 1.02-1.30); and HF (8.7% vs 7.7%; RR, 1.19; 95% Cl, 1.07-1.31). Conclusion Thiazide-type diuretics are superior in preventing 1 or more major forms of CVD and are less expensive. They should be preferred for first-step antihypertensive therapy.	Case Western Reserve Univ, Gen Clin Res Ctr, Cleveland, OH 44106 USA	Case Western Reserve University	Wright, JT (corresponding author), Case Western Reserve Univ, Gen Clin Res Ctr, Suite 7311,Horvitz Tower,11000 Euclid Ave, Cleveland, OH 44106 USA.	jxw20@po.cwru.edu; bdavis@sph.uth.tmc.edu			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035130] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-35130] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Alderman M, 1997, J HYPERTENS, V15, P105; *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI DOI 10.1016/S1062-1458(03)00049-7; *AM HEART ASS, 2001, 2002 HEART STROK STA; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; Chalmers J, 1996, J HYPERTENS, V14, P929; COLLINS R, 1990, LANCET, V336, P370, DOI 10.1016/0140-6736(90)91908-S; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Cushman WC, 2000, ARCH INTERN MED, V160, P825, DOI 10.1001/archinte.160.6.825; CUTLER JA, 1989, HYPERTENSION S1, V13, P136; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Davis BR, 2002, ANN INTERN MED, V137, P313, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00006; DAVIS BR, 1990, COMMUN STAT THEORY, V19, P3571, DOI 10.1080/03610929008830398; Dries DL, 2002, J AM COLL CARDIOL, V40, P311, DOI 10.1016/S0735-1097(02)01943-5; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Franklin SS, 1999, PATHOL BIOL, V47, P594; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; FURBERG CD, 1995, CIRCULATION, V92, P1326, DOI 10.1161/01.CIR.92.5.1326; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; Grimm RH, 2001, HYPERTENSION, V37, P19, DOI 10.1161/01.HYP.37.1.19; GRIMM RH, 1991, AM HEART J, V122, P910, DOI 10.1016/0002-8703(91)90811-U; Hall WD, 1997, AM J KIDNEY DIS, V29, P720, DOI 10.1016/S0272-6386(97)90125-6; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; *HLTH CAR FIN ADM, 2001, DHHS PUBL; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Klein JP., 2003, SURVIVAL ANAL TECHNI; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LONN EM, 1994, CIRCULATION, V90, P2056, DOI 10.1161/01.CIR.90.4.2056; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; MacMahon S, 2000, LANCET, V356, P352, DOI 10.1016/S0140-6736(00)02521-6; MANOLIO TA, 1995, ARCH INTERN MED, V155, P829, DOI 10.1001/archinte.155.8.829; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; Neal B, 2000, LANCET, V356, P1955; NEATON JD, 1993, JAMA-J AM MED ASSOC, V270, P713, DOI 10.1001/jama.270.6.713; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Pahor M, 2000, LANCET, V356, P1949, DOI 10.1016/S0140-6736(00)03306-7; Piller LB, 2002, CURR CONTR TRIALS C, V3, DOI 10.1186/1468-6708-3-10; POULTER NR, 1991, J CARDIOVASC PHARM, V18, pS35, DOI 10.1097/00005344-199100182-00008; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Rahman M, 1997, ENDOCRIN METAB CLIN, V26, P125, DOI 10.1016/S0889-8529(05)70237-1; SAUNDERS E, 1990, ARCH INTERN MED, V150, P1707, DOI 10.1001/archinte.150.8.1707; Staessen JA, 1997, JAMA-J AM MED ASSOC, V278, P1065, DOI 10.1001/jama.278.13.1065; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; TERWEE PM, 1994, ARCH INTERN MED, V154, P1185, DOI 10.1001/archinte.154.11.1185; Weir MR, 1999, AM J HYPERTENS, V12, p205S; WHO Int Soc Hyperten Blood Press Lower, 1998, J HYPERTENS, V16, P127; Yusuf S, 2000, NEW ENGL J MED, V342, P145	55	1880	2038	0	156	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2002	288	23					2981	2997						17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CG	12479763				2022-12-28	WOS:000179854200033
J	Garcia-Mira, MM; Sadqi, M; Fischer, N; Sanchez-Ruiz, JM; Munoz, V				Garcia-Mira, MM; Sadqi, M; Fischer, N; Sanchez-Ruiz, JM; Munoz, V			Experimental identification of downhill protein folding	SCIENCE			English	Article							KINETICS; BINDING; DYNAMICS; COMPLEX; DOMAIN	Theory predicts the existence of barrierless protein folding. Without barriers, folding should be noncooperative and the degree of native structure should be coupled to overall protein stability. We investigated the thermal unfolding of the peripheral subunit binding domain from Escherichia coli's 2-oxoglutarate dehydrogenase multienzyme complex (termed BBL) with a combination of spectroscopic techniques and calorimetry. Each technique probed a different feature of protein structure. BBL has a defined three-dimensional structure at low temperatures. However, each technique showed a distinct unfolding transition. Global analysis with a statistical mechanical model identified BBL as a downhill-folding protein. Because of BBL's biological function, we propose that downhill folders may be molecular rheostats, in which effects could be modulated by altering the distribution of an ensemble of structures.	Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; Univ Maryland, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Granada	Garcia-Mira, MM (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	vm48@umail.umd.edu	Fischer, Niels/ABA-5342-2021; Sanchez-Ruiz, Jose/H-2849-2015; Sadqi, Mourad/J-3180-2018; Garcia-Mira, Maria del Mar/E-2623-2018	Fischer, Niels/0000-0002-4609-4052; Sanchez-Ruiz, Jose/0000-0002-9056-3928; Sadqi, Mourad/0000-0003-3553-3408; Garcia-Mira, Maria del Mar/0000-0003-0245-8093				ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chamberlain AK, 1998, BIOCHEMISTRY-US, V37, P1736, DOI 10.1021/bi972692i; Eaton WA, 1999, P NATL ACAD SCI USA, V96, P5897, DOI 10.1073/pnas.96.11.5897; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Freire E, 2000, P NATL ACAD SCI USA, V97, P11680, DOI 10.1073/pnas.97.22.11680; GARCIAMIRA MM, UNPUB; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Hardin C, 1999, PROTEINS, V34, P281; Huang CY, 2002, P NATL ACAD SCI USA, V99, P2788, DOI 10.1073/pnas.052700099; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Leeson DT, 2000, P NATL ACAD SCI USA, V97, P2527, DOI 10.1073/pnas.040580397; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Munoz V, 2002, INT J QUANTUM CHEM, V90, P1522, DOI 10.1002/qua.10384; Munoz V, 2001, CURR OPIN STRUC BIOL, V11, P212, DOI 10.1016/S0959-440X(00)00192-5; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; PACKMAN LC, 1986, FEBS LETT, V206, P193, DOI 10.1016/0014-5793(86)80979-6; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; ROBIEN MA, 1992, BIOCHEMISTRY-US, V31, P3463, DOI 10.1021/bi00128a021; Sabelko J, 1999, P NATL ACAD SCI USA, V96, P6031, DOI 10.1073/pnas.96.11.6031; SADQI M, UNPUB; Schulman BA, 1997, NAT STRUCT BIOL, V4, P630, DOI 10.1038/nsb0897-630; Socci ND, 1996, J CHEM PHYS, V104, P5860, DOI 10.1063/1.471317; Spector S, 1999, J MOL BIOL, V293, P763, DOI 10.1006/jmbi.1999.3189; Spector S, 1998, J MOL BIOL, V276, P479, DOI 10.1006/jmbi.1997.1522; Thirumalai D, 2002, ADV CHEM PHYS, V120, P35; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Young M, 1999, PROTEIN SCI, V8, P1752, DOI 10.1110/ps.8.9.1752	30	274	278	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2191	2195		10.1126/science.1077809	http://dx.doi.org/10.1126/science.1077809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481137				2022-12-28	WOS:000179773700048
J	Sun, YG; Xia, YN				Sun, YG; Xia, YN			Shape-controlled synthesis of gold and silver nanoparticles	SCIENCE			English	Article							METAL PARTICLES; COLLOIDS; NANOCRYSTALS; MECHANISM; MOLECULES; CLUSTERS	Monodisperse samples of silver nanocubes were synthesized in large quantities by reducing silver nitrate with ethylene glycol in the presence of poly( vinyl pyrrolidone) (PVP). These cubes were single crystals and were characterized by a slightly truncated shape bounded by {100}, {110}, and {111} facets. The presence of PVP and its molar ratio ( in terms of repeating unit) relative to silver nitrate both played important roles in determining the geometric shape and size of the product. The silver cubes could serve as sacrificial templates to generate single-crystalline nanoboxes of gold: hollow polyhedra bounded by six {100} and eight {111} facets. Controlling the size, shape, and structure of metal nanoparticles is technologically important because of the strong correlation between these parameters and optical, electrical, and catalytic properties.	Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Xia, YN (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.		bee, betty/G-1104-2011; Xia, Younan/E-8499-2011; Sun, Yugang/A-3683-2010	Sun, Yugang/0000-0001-6351-6977				Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924; ALLPRESS JG, 1967, SURF SCI, V7, P1, DOI 10.1016/0039-6028(67)90062-3; Bonet F, 2000, B MATER SCI, V23, P165, DOI 10.1007/BF02719903; BONNEMANN H, 2001, HDB SURFACE INTERFAC, P1; Bradley JS, 2000, J AM CHEM SOC, V122, P4631, DOI 10.1021/ja992409y; Cordente N, 2001, NANO LETT, V1, P565, DOI 10.1021/nl0100522; Cullity B D, 2001, ELEMENTS XRAY DIFFRA, V3rd, P402; Dick LA, 2002, J PHYS CHEM B, V106, P853, DOI 10.1021/jp013638l; DUCAMPSANGUESA C, 1992, J SOLID STATE CHEM, V100, P272, DOI 10.1016/0022-4596(92)90101-Z; El-Sayed MA, 2001, ACCOUNTS CHEM RES, V34, P257, DOI 10.1021/ar960016n; Fievet F., 1989, MRS BULL, V14, P29, DOI [DOI 10.1557/S0883769400060930, 10.1557/S0883769400060930]; Goia DV, 1998, NEW J CHEM, V22, P1203, DOI 10.1039/a709236i; HALPERIN WP, 1986, REV MOD PHYS, V58, P533, DOI 10.1103/RevModPhys.58.533; Jin RC, 2001, SCIENCE, V294, P1901, DOI 10.1126/science.1066541; Kamat PV, 2002, J PHYS CHEM B, V106, P7729, DOI 10.1021/jp0209289; KIRKLAND AI, 1993, P ROY SOC LOND A MAT, V440, P589, DOI 10.1098/rspa.1993.0035; LAM DMK, 1991, SCI AM, V265, P80; LEWIS LN, 1993, CHEM REV, V93, P2693, DOI 10.1021/cr00024a006; LIN WB, 1993, J AM CHEM SOC, V115, P11644, DOI 10.1021/ja00077a092; Maier SA, 2001, ADV MATER, V13, P1501, DOI 10.1002/1521-4095(200110)13:19<1501::AID-ADMA1501>3.0.CO;2-Z; Murray CB, 2001, MRS BULL, V26, P985, DOI 10.1557/mrs2001.254; Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Oldenburg SJ, 1998, CHEM PHYS LETT, V288, P243, DOI 10.1016/S0009-2614(98)00277-2; Pileni MP, 2001, ADV FUNCT MATER, V11, P323, DOI 10.1002/1616-3028(200110)11:5<323::AID-ADFM323>3.0.CO;2-J; Puntes VF, 2001, SCIENCE, V291, P2115, DOI 10.1126/science.1057553; SCHMID G, 1992, CHEM REV, V92, P1709, DOI 10.1021/cr00016a002; Sun YG, 2002, NANO LETT, V2, P481, DOI 10.1021/nl025531v; Sun YG, 2002, ADV MATER, V14, P833, DOI 10.1002/1521-4095(20020605)14:11<833::AID-ADMA833>3.0.CO;2-K; Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664; Wang ZL, 2000, J PHYS CHEM B, V104, P1153, DOI 10.1021/jp993593c; Zhang ZT, 1996, J SOLID STATE CHEM, V121, P105, DOI 10.1006/jssc.1996.0015	32	5838	6025	116	5631	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2176	2179		10.1126/science.1077229	http://dx.doi.org/10.1126/science.1077229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481134				2022-12-28	WOS:000179773700043
J	Frank, L				Frank, L			Biotechnology in the Medicon Valley	NATURE			English	Article																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916		S			A27	+		10.1038/420a27a	http://dx.doi.org/10.1038/420a27a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625LG	12501124				2022-12-28	WOS:000179817500006
J	Goldreich, P; Lithwick, Y; Sari, R				Goldreich, P; Lithwick, Y; Sari, R			Formation of Kuiper-belt binaries by dynamical friction and three-body encounters	NATURE			English	Article							FRAGMENTATION; ACCRETION; VELOCITY; OBJECTS	The Kuiper belt is a disk of icy bodies that orbit the Sun beyond Neptune(1); the largest known members are Pluto and its companion Charon. A few per cent of Kuiper-belt bodies have recently been found to be binaries with wide separations and mass ratios of the order of unity(2-8). Collisions were too infrequent to account for the observed number of binaries(9),implying that these binaries formed through collisionless interactions mediated by gravity. These interactions are likely to have been most effective during the period of runaway accretion, early in the Solar System's history. Here we show that a transient binary forms when two large bodies penetrate one another's Hill sphere (the region where their mutual forces are larger than the tidal force of the Sun). The loss of energy needed to stabilize the binary orbit can then occur either through dynamical friction from surrounding small bodies, or through the gravitational scattering of a third large body. Our estimates slightly favour the former mechanism. We predict that five per cent of Kuiper-belt objects are binaries with apparent separations greater than 0.2 arcsec, and that most are in tighter binaries or systems of higher multiplicity.	CALTECH 130 33, Pasadena, CA 91125 USA; Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	California Institute of Technology; Institute for Advanced Study - USA; University of California System; University of California Berkeley	Sari, R (corresponding author), CALTECH 130 33, Pasadena, CA 91125 USA.							BINNEY J, 1977, MON NOT R ASTRON SOC, V181, P735, DOI 10.1093/mnras/181.4.735; BROWN ME, 2002, 7807 IAU; Chiang EI, 1999, ASTRON J, V118, P1411, DOI 10.1086/301005; ELLIOT JL, 2001, 7733 IAU; Gladman B, 1998, ASTRON J, V116, P2042, DOI 10.1086/300573; HUT P, 1983, ASTROPHYS J, V268, P319, DOI 10.1086/160956; KAVELAARS J, 2001, 7749 IAU; Kenyon SJ, 1998, ASTRON J, V115, P2136, DOI 10.1086/300331; Kenyon SJ, 2002, PUBL ASTRON SOC PAC, V114, P265, DOI 10.1086/339188; Kenyon SJ, 1999, ASTRON J, V118, P1101, DOI 10.1086/300969; Luu JX, 2002, ANNU REV ASTRON ASTR, V40, P63, DOI 10.1146/annurev.astro.40.060401.093818; Morbidelli A, 2002, ICARUS, V157, P241, DOI 10.1006/icar.2002.6832; NOLL KS, 2002, 7857 IAU; NOLL KS, 2002, 7824 IAU; STERN SA, 2002, ASTROPH0206104; Trujillo CA, 2001, ASTRON J, V122, P457, DOI 10.1086/321117; TRUJILLO CA, 2002, 7787 IAU; Veillet C, 2002, NATURE, V416, P711, DOI 10.1038/416711a; Weidenschilling SJ, 2002, ICARUS, V160, P212, DOI 10.1006/icar.2002.6952; WETHERILL GW, 1989, ICARUS, V77, P330, DOI 10.1016/0019-1035(89)90093-6	21	156	157	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					643	646		10.1038/nature01227	http://dx.doi.org/10.1038/nature01227			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478286				2022-12-28	WOS:000179751800038
J	Weis, CP; Intrepido, AJ; Miller, AK; Cowin, PG; Durno, MA; Gebhardt, JS; Bull, R				Weis, CP; Intrepido, AJ; Miller, AK; Cowin, PG; Durno, MA; Gebhardt, JS; Bull, R			Secondary aerosolization of viable Bacillus anthracis spores in a contaminated US Senate Office	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PCR	Context Bioterrorist attacks involving letters and mail-handling systems in Washington, DC, resulted in Bacillus anthracis (anthrax) spore contamination in the Hart Senate Office Building and other facilities in the US Capitol's vicinity. Objective To provide information about the nature and extent of indoor secondary aerosolization of B anthracis spores. Design Stationary and personal air samples, surface dust, and swab samples were collected under semiquiescent (minimal activities) and then simulated active office conditions to estimate secondary aerosolization of B anthracis spores. Nominal size characteristics, airborne concentrations, and surface contamination of a anthracis particles (colony-forming units) were evaluated. Results Viable B anthracis spores reaerosolized under semiquiescent conditions, with a marked increase in reaerosolization during simulated active office conditions. Increases were observed for B anthracis collected on open sheep blood agar plates (P<.001) and personal air monitors (P=.01) during active office conditions. More than 80% of the B anthracis particles collected on stationary monitors were within an alveolar respirable size range of 0.95 to 3.5 &mu;m. Conclusions Bacillus anthracis spores used in a recent terrorist incident reaerosolized under common office activities. These findings have important implications for appropriate respiratory protection, remediation, and reoccupancy of contaminated office environments.	US EPA, Natl Enforcement Invest Ctr, Denver Fed Ctr, Denver, CO 80225 USA; USA, Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD USA; US PHS, Denver, CO USA; US EPA, Cleveland Off, Westlake, OH USA; Naval Med Res Ctr, Biol Def Directorate, Silver Spring, MD USA	United States Environmental Protection Agency; United States Public Health Service; United States Environmental Protection Agency; Naval Medical Research Center (NMRC)	Weis, CP (corresponding author), US EPA, Natl Enforcement Invest Ctr, Denver Fed Ctr, Bldg 53,POB 25227, Denver, CO 80225 USA.		Weis, Christopher/GWR-1351-2022					Barakat LA, 2002, JAMA-J AM MED ASSOC, V287, P863, DOI 10.1001/jama.287.7.863; Brachman P S, 1980, Ann N Y Acad Sci, V353, P83, DOI 10.1111/j.1749-6632.1980.tb18910.x; BRACHMAN PS, 1966, BACTERIOL REV, V30, P646, DOI 10.1128/MMBR.30.3.646-659.1966; CHINN KS, 1996, REAEROSOLIZATION HAZ; DAVIDS DE, 1981, 321 DEF RES EST SUFF; DRUETT HA, 1953, J HYG-CAMBRIDGE, V51, P359, DOI 10.1017/S0022172400015795; FELLER W, 1950, INTRO PROBABILITY TH, P324; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Keim M, 1999, ANN EMERG MED, V34, P177, DOI 10.1016/S0196-0644(99)70227-1; Linn William S., 1993, Journal of Occupational Medicine and Toxicology, V2, P1; LINN WS, 1993, J CLEAN TECHNOL ENV, V3, P101; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Marple V.A., 1986, CASCADE IMPACTOR SAM, P79; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; PARKER JS, 2001, TERRORISM MAIL PROTE; PATRICK WC, 1999, RISK ASSESSMENT BIOL; Peters CJ, 2002, LANCET, V359, P710, DOI 10.1016/S0140-6736(02)07792-9; Resnick IG, 1990, EVALUATION NEED DETE; WATSON A, 1994, EPIDEMIOL INFECT, V113, P47	21	91	97	2	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2853	2858		10.1001/jama.288.22.2853	http://dx.doi.org/10.1001/jama.288.22.2853			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623YM	12472327				2022-12-28	WOS:000179732600030
J	Galvao, J				Galvao, J			Access to antiretroviral drugs in Brazil	LANCET			English	Article								Since 1996, the Brazilian Ministry of Health has guaranteed free and universal access to antiretroviral treatment for people living with HIV/AIDS. Implementation of this policy has had political, financial, and logistical challenges. I have investigated the history and context of antiretroviral policy in Brazil, the logistics of the drugs' distribution, and the government's strategies for acquisition of the drugs. Many antiretrovirals used in Brazil are produced domestically; the remainder, including some of the most expensive drugs, are purchased from abroad. Although the Brazilian policy of antiretroviral distribution has had notable success, it remains threatened by the high cost of acquisition of drugs, which has led to disputes with international pharmaceutical companies over prices and patents. Whether or not the Brazilian model of guaranteeing access to antiretroviral treatment for people living with HIV/AIDS can be applied in other countries or regions, much can be learnt from the country's experience.	Univ Calif Berkeley, Sch Publ Hlth, Fogarty Int AIDS Training Programme, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Galvao, J (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Fogarty Int AIDS Training Programme, Berkeley, CA 94720 USA.			Galvao, Jane/0000-0003-1598-9125	FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER; FIC NIH HHS [1-D43-TW00003] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Ashraf H, 2001, LANCET, V357, P2112, DOI 10.1016/S0140-6736(00)05244-2; BIEHL J, 1999, THESIS U CALIFORNIA; *BRAZ MIN HLTH, 2002, AIDS 2 REL IMPL AV D; *BRAZ MIN HLTH, 2001, MIN HLTH ANN COMP LI; *BRAZ MIN HLTH, 2002, NAT AIDS DRUG POL; *BRAZ MIN HLTH, 2001, WTO PAN CALLS BRAZ P; *BRAZ MIN HLTH, 1999, DIR CENTR TEST AC; *BRAZ MIN HLTH, 2002, B EP AIDS; *BRAZ MIN HLTH, 2000, SUS PRINC CONQ; DANIEL H, 1989, VIDA ANTES MORTE LIF; FALCAO D, 1997, FOLHA S PAULO, P1; Galvão Jane, 2002, Cad. Saúde Pública, V18, P213, DOI 10.1590/S0102-311X2002000100022; GALVAO JANE, 2000, AIDS NO BRASIL AGEND, P256; LIMA RM, 2000, ACAO ANTI AIDS, V43, P6; Lima RM, 2000, 13 INT AIDS C DURB S; PASSARELLI C, 2001, B ABIA, V46, P8; RICH JL, 2001, NY TIMES        0901, pB1; ROSENBERG T, 2001, NY TIMES MAGAZI 0126; *UN, 2001, ACC MED CONTEXT PAND; VELOSO V, 2000, 13 INT AIDS C DURB; *WORLD TRAD ORG, 2001, UR ROUND FIN ACT; World Trade Organization, 2001, DECL TRIPS AGR PUBL; 2001, OXFAM DRUG CO VS BRA	23	110	114	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1862	1865		10.1016/S0140-6736(02)11775-2	http://dx.doi.org/10.1016/S0140-6736(02)11775-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480377				2022-12-28	WOS:000179706100027
J	Klotz, L				Klotz, L			Reactions	LANCET			English	Editorial Material									Sunnybrook & Womens Coll Hlth Sci Ctr, Div Urol, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Klotz, L (corresponding author), Sunnybrook & Womens Coll Hlth Sci Ctr, Div Urol, Toronto, ON M4N 3M5, Canada.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1869	1869		10.1016/S0140-6736(02)11777-6	http://dx.doi.org/10.1016/S0140-6736(02)11777-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480379				2022-12-28	WOS:000179706100029
J	Devlin, K				Devlin, K			Portraits of science: Kurt Godel - Separating truth from proof in mathematics	SCIENCE			English	Editorial Material									Stanford Univ, Ctr Study Language & Informat, Stanford, CA 94305 USA	Stanford University	Devlin, K (corresponding author), Stanford Univ, Ctr Study Language & Informat, Stanford, CA 94305 USA.								0	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1899	1900		10.1126/science.1079622	http://dx.doi.org/10.1126/science.1079622			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471237				2022-12-28	WOS:000179629200024
J	Huppert, HE; Woods, AW				Huppert, HE; Woods, AW			The role of volatiles in magma chamber dynamics	NATURE			English	Article							ERUPTION; PRESSURE; VOLCANO; WATER	Many andesitic volcanoes exhibit effusive eruption activity(1), with magma volumes as large as 10(7)-10(9) m(3) erupted at rates of 1-10 m(3) s(-1) over periods of years or decades. During such eruptions, many complex cycles in eruption rates have been observed, with periods ranging from hours to years(2-7). Longer-term trends have also been observed, and are thought to be associated with the continuing recharge of magma from deep in the crust and with waning of overpressure in the magma reservoir. Here we present a model which incorporates effects due to compressibility of gas in magma. We show that the eruption duration and volume of erupted magma may increase by up to two orders of magnitude if the stored internal energy associated with dissolved volatiles can be released into the magma chamber. This mechanism would be favoured in shallow chambers or volatile-rich magmas and the cooling of magma by country rock may enhance this release of energy, leading to substantial increases in eruption rate and duration.	Univ Cambridge, Dept Appl Math & Theoret Phys, Inst Theoret Geophys, Cambridge CB3 9EW, England; BP Inst Multiphase Flow, Cambridge CB3 0EZ, England	University of Cambridge; BP; University of Cambridge	Huppert, HE (corresponding author), Univ Cambridge, Dept Appl Math & Theoret Phys, Inst Theoret Geophys, Silver St, Cambridge CB3 9EW, England.	heh1@esc.cam.ac.uk						Barmin A, 2002, EARTH PLANET SC LETT, V199, P173, DOI 10.1016/S0012-821X(02)00557-5; Belousov A, 1999, B VOLCANOL, V61, P324, DOI 10.1007/s004450050300; BLAKE S, 1981, NATURE, V289, P783, DOI 10.1038/289783a0; BLAKE S, 1984, J GEOPHYS RES, V89, P8237, DOI 10.1029/JB089iB10p08237; BURNHAM CW, 1962, AM J SCI, V260, P721, DOI 10.2475/ajs.260.10.721; Couch S, 2001, NATURE, V411, P1037, DOI 10.1038/35082540; FLOCH A, 1997, EARTH PLANET SC LETT, V163, P301; HUPPERT HE, 1982, NATURE, V297, P554, DOI 10.1038/297554a0; HURWITZ S, 1994, EARTH PLANET SC LETT, V122, P267, DOI 10.1016/0012-821X(94)90001-9; JAUPART C, 1998, GEOL SOC, V289, P783; Massol H, 1999, EARTH PLANET SC LETT, V166, P57, DOI 10.1016/S0012-821X(98)00277-5; Melnik O, 1999, NATURE, V402, P37, DOI 10.1038/46950; MILLER TP, 1994, J VOLCANOL GEOTH RES, V62, P1, DOI 10.1016/0377-0273(94)90025-6; Nakada S, 1999, J VOLCANOL GEOTH RES, V89, P1, DOI 10.1016/S0377-0273(98)00118-8; Rose W.I., 1987, GEOL SOC AM SPEC PAP, V212, P17, DOI DOI 10.1130/SPE212-P17; ROSE WI, 1972, B VOLCANOL, V36, P73; Sparks RSJ, 2002, GEO SOC MEM, P45; SPARKS RSJ, 1978, J VOLCANOL GEOTH RES, V3, P1, DOI 10.1016/0377-0273(78)90002-1; STASIUK MV, 1993, EARTH PLANET SC LETT, V114, P505, DOI 10.1016/0012-821X(93)90079-O; SWANSON DA, 1990, IAVCEI VOLC, V2, P3; TAIT S, 1989, EARTH PLANET SC LETT, V92, P107, DOI 10.1016/0012-821X(89)90025-3; TOULOUKIAN YS, 1981, PHYSICAL PROPERTIES, V1	23	166	170	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					493	495		10.1038/nature01211	http://dx.doi.org/10.1038/nature01211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466839				2022-12-28	WOS:000179611600042
J	Okazaki, Y; Furuno, M; Kasukawa, T; Adachi, J; Bono, H; Kondo, S; Nikaido, I; Osato, N; Saito, R; Suzuki, H; Yamanaka, I; Kiyosawa, H; Yagi, K; Tomaru, Y; Hasegawa, Y; Nogami, A; Schonbach, C; Gojobori, T; Baldarelli, R; Hill, DP; Bult, C; Hume, DA; Quackenbush, J; Schriml, LM; Kanapin, A; Matsuda, H; Batalov, S; Beisel, KW; Blake, JA; Bradt, D; Brusic, V; Chothia, C; Corbani, LE; Cousins, S; Dalla, E; Dragani, TA; Fletcher, CF; Forrest, A; Frazer, KS; Gaasterland, T; Gariboldi, M; Gissi, C; Godzik, A; Gough, J; Grimmond, S; Gustincich, S; Hirokawa, N; Jackson, IJ; Jarvis, ED; Kanai, A; Kawaji, H; Kawasawa, Y; Kedzierski, RM; King, BL; Konagaya, A; Kurochkin, IV; Lee, Y; Lenhard, B; Lyons, PA; Maglott, DR; Maltais, L; Marchionni, L; McKenzie, L; Miki, H; Nagashima, T; Numata, K; Okido, T; Pavan, WJ; Pertea, G; Pesole, G; Petrovsky, N; Pillai, R; Pontius, JU; Qi, D; Ramachandran, S; Ravasi, T; Reed, JC; Reed, DJ; Reid, J; Ring, BZ; Ringwald, M; Sandelin, A; Schneider, C; Semple, CAM; Setou, M; Shimada, K; Sultana, R; Takenaka, Y; Taylor, MS; Teasdale, RD; Tomita, M; Verardo, R; Wagner, L; Wahlestedt, C; Wang, Y; Watanabe, Y; Wells, C; Wilming, LG; Wynshaw-Boris, A; Yanagisawa, M; Yang, I; Yang, L; Yuan, Z; Zavolan, M; Zhu, Y; Zimmer, A; Carninci, P; Hayatsu, N; Hirozane-Kishikawa, T; Konno, H; Nakamura, M; Sakazume, N; Sato, K; Shiraki, T; Waki, K; Kawai, J; Aizawa, K; Arakawa, T; Fukuda, S; Hara, A; Hashizume, W; Imotani, K; Ishii, Y; Itoh, M; Kagawa, I; Miyazaki, A; Sakai, K; Sasaki, D; Shibata, K; Shinagawa, A; Yasunishi, A; Yoshino, M; Waterston, R; Lander, ES; Rogers, J; Birney, E; Hayashizaki, Y				Okazaki, Y; Furuno, M; Kasukawa, T; Adachi, J; Bono, H; Kondo, S; Nikaido, I; Osato, N; Saito, R; Suzuki, H; Yamanaka, I; Kiyosawa, H; Yagi, K; Tomaru, Y; Hasegawa, Y; Nogami, A; Schonbach, C; Gojobori, T; Baldarelli, R; Hill, DP; Bult, C; Hume, DA; Quackenbush, J; Schriml, LM; Kanapin, A; Matsuda, H; Batalov, S; Beisel, KW; Blake, JA; Bradt, D; Brusic, V; Chothia, C; Corbani, LE; Cousins, S; Dalla, E; Dragani, TA; Fletcher, CF; Forrest, A; Frazer, KS; Gaasterland, T; Gariboldi, M; Gissi, C; Godzik, A; Gough, J; Grimmond, S; Gustincich, S; Hirokawa, N; Jackson, IJ; Jarvis, ED; Kanai, A; Kawaji, H; Kawasawa, Y; Kedzierski, RM; King, BL; Konagaya, A; Kurochkin, IV; Lee, Y; Lenhard, B; Lyons, PA; Maglott, DR; Maltais, L; Marchionni, L; McKenzie, L; Miki, H; Nagashima, T; Numata, K; Okido, T; Pavan, WJ; Pertea, G; Pesole, G; Petrovsky, N; Pillai, R; Pontius, JU; Qi, D; Ramachandran, S; Ravasi, T; Reed, JC; Reed, DJ; Reid, J; Ring, BZ; Ringwald, M; Sandelin, A; Schneider, C; Semple, CAM; Setou, M; Shimada, K; Sultana, R; Takenaka, Y; Taylor, MS; Teasdale, RD; Tomita, M; Verardo, R; Wagner, L; Wahlestedt, C; Wang, Y; Watanabe, Y; Wells, C; Wilming, LG; Wynshaw-Boris, A; Yanagisawa, M; Yang, I; Yang, L; Yuan, Z; Zavolan, M; Zhu, Y; Zimmer, A; Carninci, P; Hayatsu, N; Hirozane-Kishikawa, T; Konno, H; Nakamura, M; Sakazume, N; Sato, K; Shiraki, T; Waki, K; Kawai, J; Aizawa, K; Arakawa, T; Fukuda, S; Hara, A; Hashizume, W; Imotani, K; Ishii, Y; Itoh, M; Kagawa, I; Miyazaki, A; Sakai, K; Sasaki, D; Shibata, K; Shinagawa, A; Yasunishi, A; Yoshino, M; Waterston, R; Lander, ES; Rogers, J; Birney, E; Hayashizaki, Y		FANTOM Consurtium; RIKEN Genome Exploration Res Grp	Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs	NATURE			English	Article							HUMAN GENOME; GENE; SEQUENCE; PROTEIN; RNA; CLASSIFICATION; IDENTIFICATION; CHROMOSOME-21; EVOLUTION; DISCOVERY	Only a small proportion of the mouse genome is transcribed into mature messenger RNA transcripts. There is an international collaborative effort to identify all full-length mRNA transcripts from the mouse, and to ensure that each is represented in a physical collection of clones. Here we report the manual annotation of 60,770 full-length mouse complementary DNA sequences. These are clustered into 33,409 'transcriptional units', contributing 90.1% of a newly established mouse transcriptome database. Of these transcriptional units, 4,258 are new protein-coding and 11,665 are new non-coding messages, indicating that non-coding RNA is a major component of the transcriptome. 41% of all transcriptional units showed evidence of alternative splicing. In protein-coding transcripts, 79% of splice variations altered the protein product. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs. The present work, completely supported by physical clones, provides the most comprehensive survey of a mammalian transcriptome so far, and is a valuable resource for functional genomics.	RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Lab Genome Explorat Res Grp, Tsurumi KU, Yokohama, Kanagawa 2300045, Japan; Discovery & Res Inst, Genome Sci Lab, Wako, Saitama 3510198, Japan; NTT Software Corp, Naka Ku, Kanagawa 2318554, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Div Genom Informat Resources Sci Biol Supramol Sy, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058577, Japan; RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Bioinformat Grp, Biomed Knowledge Discovery Team, Kanagawa 2300045, Japan; Natl Inst Genet, DNA Data Bank Japan, Shizuoka 4118540, Japan; Natl Inst Genet, Ctr Informat Biol, Shizuoka 4118540, Japan; Jackson Lab, Mouse Genome Informat Grp, Bar Harbor, ME 04609 USA; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, ARC Special Res Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia; Inst Genom Res TIGR, Rockville, MD 20850 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; European Bioinformat Inst, Cambridge CB10 1SD, England; Osaka Univ, Grad Sch Informat Sci & Technol, Osaka 5608531, Japan; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Boys Town Natl Res Hosp, Omaha, NE 68131 USA; Labs Informat Technol, Singapore 119613, Singapore; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; LNCIB, Funct Genom, I-34012 Trieste, Italy; Ist Tumori Milano, I-20133 Milan, Italy; The Scripps Res Inst, Res Inst, La Jolla, CA 92037 USA; Univ Oregon, Zebrafish Int Resource Ctr, Eugene, OR 97403 USA; Rockefeller Univ, Lab Computat Genom, New York, NY 10021 USA; Univ Milan, I-20133 Milan, Italy; Burnham Inst, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Howard Hughes Med Inst, Dallas, TX 75390 USA; Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Addenbrookes Hosp, Cambridge Inst Med Res, JDRF WT Diabet & Inflammat Lab, Cambridge CB2 2XY, England; NHGRI, NIH, Bethesda, MD 20892 USA; Canberra Hosp, Autoimmun Res Unit, Woden, ACT 2606, Australia; Appl Genom Inc, Sunnyvale, CA 94085 USA; Hirakata Ryoikuen, Osaka 5650874, Japan; Hyogo Med Univ, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Whitehead Inst MIT Ctr Genome Res, Cambridge, MA 02141 USA	RIKEN; Yokohama City University; Keio University; University of Tsukuba; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Jackson Laboratory; University of Queensland; University of Queensland; J. Craig Venter Institute; National Institutes of Health (NIH) - USA; European Molecular Biology Laboratory (EMBL); Osaka University; Novartis; Boys Town National Research Hospital; MRC Laboratory Molecular Biology; Fondazione IRCCS Istituto Nazionale Tumori Milan; Scripps Research Institute; University of Oregon; Rockefeller University; University of Milan; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Harvard Medical School; University of Tokyo; University of Edinburgh; Duke University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Karolinska Institutet; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Australian National University; Canberra Hospital; Hyogo College of Medicine; University of Hyogo; Wellcome Trust Sanger Institute; University of California System; University of California San Diego; University of Bonn; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Whitehead Institute	Hayashizaki, Y (corresponding author), RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Lab Genome Explorat Res Grp, Tsurumi KU, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yosihide@gsc.riken.go.jp	Dalla, Emiliano/AAH-3039-2020; Nikaido, Itoshi/K-2058-2014; Itoh, Masayoshi/N-5363-2015; Schriml, Lynn/AFO-9472-2022; Dragani, Tommaso A./K-4493-2016; Carninci, Piero/K-1568-2014; Teasdale, Rohan D/B-2538-2009; Bono, Hidemasa/AAF-3649-2020; Brusic, Vladimir/B-1478-2008; Grimmond, Sean/K-3246-2019; Ravasi, Timothy/B-8777-2008; Petrovsky, Nikolai/P-1912-2017; Kawai, Jun/A-6451-2016; Semple, Colin A M/A-5613-2009; Kanapin, Alexander A/Q-7590-2016; Godzik, Adam/AAW-1467-2020; Hayashizaki, Yoshihide/N-6590-2015; Hume, David A/C-7695-2013; Schönbach, Christian/B-1998-2009; Reid, James/G-2496-2010; Pesole, Graziano/C-1408-2009; Sandelin, Albin/G-2881-2011; Pesole, Graziano/K-5283-2019; Grimmond, Sean M/J-5304-2016; Taylor, Martin S/C-3825-2009; Zavolan, Mihaela/S-3888-2016; Konno, Hideaki/A-9191-2012; Marchionni, Luigi/S-6774-2017; Zimmer, Andreas/B-8357-2009; Wahlestedt, Claes/A-7039-2009; Jarvis, Erich D/A-2319-2008; Kurochkin, Igor/Q-5646-2019; Kawaji, Hideya/N-5116-2015; Kanapin, Alexander/E-7632-2013; Godzik, Adam/A-7279-2009; Yang, Ivana V/P-3059-2018; Wells, Christine A/A-5071-2010; Pesole, Graziano/E-9051-2014; Teasdale, Rohan/AAD-6698-2019; Yuan, Zheng/A-1344-2008; Konagaya, Akihiko/F-9302-2014; Suzuki, Harukazu/N-9553-2015; King, Benjamin/AAI-1492-2019; Konno, Hideaki/N-4366-2014; Kanai, Akio/C-4921-2014; Forrest, Alistair/A-6597-2008; Kasukawa, Takeya/N-5070-2015; Gariboldi, Manuela/K-4744-2016; Waki, Kazunori/T-6444-2019	Dalla, Emiliano/0000-0002-4687-6011; Nikaido, Itoshi/0000-0002-7261-2570; Itoh, Masayoshi/0000-0002-1772-318X; Dragani, Tommaso A./0000-0001-5915-4598; Carninci, Piero/0000-0001-7202-7243; Teasdale, Rohan D/0000-0001-7455-5269; Bono, Hidemasa/0000-0003-4413-0651; Brusic, Vladimir/0000-0003-0523-5266; Grimmond, Sean/0000-0002-8102-7998; Petrovsky, Nikolai/0000-0002-1580-5245; Semple, Colin A M/0000-0003-1765-4118; Kanapin, Alexander A/0000-0001-9802-5297; Godzik, Adam/0000-0002-2425-852X; Schönbach, Christian/0000-0002-0693-7617; Pesole, Graziano/0000-0003-3663-0859; Sandelin, Albin/0000-0002-7109-7378; Grimmond, Sean M/0000-0002-8102-7998; Taylor, Martin S/0000-0001-7656-330X; Marchionni, Luigi/0000-0002-7336-8071; Jarvis, Erich D/0000-0001-8931-5049; Kawaji, Hideya/0000-0002-0575-0308; Godzik, Adam/0000-0002-2425-852X; Yang, Ivana V/0000-0002-1018-489X; Wells, Christine A/0000-0003-3133-3628; Pesole, Graziano/0000-0003-3663-0859; Teasdale, Rohan/0000-0001-7455-5269; Suzuki, Harukazu/0000-0002-8087-0836; Konno, Hideaki/0000-0002-8470-4835; Kanai, Akio/0000-0002-6362-2419; Forrest, Alistair/0000-0003-4543-1675; Kasukawa, Takeya/0000-0001-5085-0802; Lenhard, Boris/0000-0002-1114-1509; Reid, James/0000-0001-6997-2850; Wilming, Laurens/0000-0002-4154-7358; Ravasi, Timothy/0000-0002-9950-465X; Quackenbush, John/0000-0002-2702-5879; Jackson, Ian/0000-0001-6526-0688; King, Benjamin/0000-0001-6463-1336; Kurochkin, Igor V/0000-0002-6231-9004; Gariboldi, Manuela/0000-0001-8406-165X; Gustincich, Stefano/0000-0002-2749-2514; Batalov, Sergey/0000-0002-0925-0554; Schriml, Lynn/0000-0001-8910-9851; Matsuda, Hideo/0000-0002-4701-3779; Gissi, Carmela/0000-0002-2269-079X; Hume, David/0000-0002-2615-1478; Birney, Ewan/0000-0001-8314-8497; Waki, Kazunori/0000-0001-7311-7208; Osato, Naoki/0000-0002-7584-5388; Blake, Judith/0000-0001-8522-334X; Okazaki, Yasushi/0000-0003-3241-5502; Fukuda, Shiro/0000-0002-0065-662X; Osato, Naoki/0000-0001-9716-6725; Zavolan, Mihaela/0000-0002-8832-2041	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000136, Z01HG000136] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Camargo AA, 2001, P NATL ACAD SCI USA, V98, P12103, DOI 10.1073/pnas.201182798; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carninci P, 2002, BIOTECHNIQUES, V33, P306, DOI 10.2144/02332st01; Carninci P, 2002, BIOTECHNIQUES, V32, P984, DOI 10.2144/02325bm01; Carninci P, 2001, GENOMICS, V77, P79, DOI 10.1006/geno.2001.6601; Daly MJ, 2002, CELL, V109, P283, DOI 10.1016/S0092-8674(02)00742-0; Dreyer SD, 1999, GENOMICS, V62, P119, DOI 10.1006/geno.1999.5981; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Harrison PM, 2002, GENOME RES, V12, P272, DOI 10.1101/gr.207102; Hill DP, 2001, GENOMICS, V74, P121, DOI 10.1006/geno.2001.6513; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hogenesch JB, 2001, CELL, V106, P413, DOI 10.1016/S0092-8674(01)00467-6; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kawaji H, 2002, GENOME RES, V12, P367, DOI 10.1101/gr.193702; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Konno H, 2001, GENOME RES, V11, P281, DOI 10.1101/gr.GR-1457R; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Pesole G, 2000, BIOINFORMATICS, V16, P439, DOI 10.1093/bioinformatics/16.5.439; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Poirier GMC, 1999, J IMMUNOL, V163, P4960; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Schweighoffer F, 2000, Pharmacogenomics, V1, P187, DOI 10.1517/14622416.1.2.187; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563	52	1278	1465	3	179	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					563	573		10.1038/nature01266	http://dx.doi.org/10.1038/nature01266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466851	hybrid, Green Published			2022-12-28	WOS:000179611600054
J	Altfeld, M; Allen, TM; Yu, XG; Johnston, MN; Agrawal, D; Korber, BT; Montefiori, DC; O'Connor, DH; Davis, BT; Lee, PK; Maier, EL; Harlow, J; Goulder, PJR; Brander, C; Rosenberg, ES; Walker, BD				Altfeld, M; Allen, TM; Yu, XG; Johnston, MN; Agrawal, D; Korber, BT; Montefiori, DC; O'Connor, DH; Davis, BT; Lee, PK; Maier, EL; Harlow, J; Goulder, PJR; Brander, C; Rosenberg, ES; Walker, BD			HIV-1 superinfection despite broad CD8(+) T-cell responses containing replication of the primary virus	NATURE			English	Article							ANTIRETROVIRAL THERAPY; IMMUNE-RESPONSES; VIREMIA; INFECTION; AIDS; DISCONTINUATION; LYMPHOCYTES; PREVENTION; CHALLENGE; MACAQUES	Early treatment of acute HIV-1 infection followed by treatment interruptions has shown promise for enhancing immune control of infection(1-3). A subsequent loss of control, however, allows the correlates of protective immunity to be assessed. Here we show that sudden breakthrough of plasma viraemia occurred after prolonged immune containment in an individual infected with HIV-1 at a time when 25 distinct CD8(+) T-cell epitopes in the viral proteins Gag, RT, Integrase, Env, Nef, Vpr, Vif and Rev were being targeted. Sequencing of the virus in plasma and cells showed that superinfection with a second clade-B virus was coincident with the loss of immune control. This sudden increase in viraemia was associated with a decline in half of the CD8(+) T-cell responses. The declining CD8(+) T-cell responses were coupled with sequence changes relative to the initial virus that resulted in impaired recognition. Our data show that HIV-1 superinfection can occur in the setting of a strong and broadly directed virus-specific CD8(+) T-cell response. The lack of cross-protective immunity for closely related HIV-1 strains, despite persistent recognition of multiple CD8 epitopes, has important implications for public health and vaccine development.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02129 USA; Harvard Univ, Sch Med, Div AIDS, Boston, MA 02129 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; Univ Wisconsin, Wisconsin Reg Primate Res Ctr, Madison, WI 53715 USA; Nuffield Dept Med, Dept Pediat, Oxford OX3 7LJ, England	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Los Alamos National Laboratory; Duke University; University of Wisconsin System; University of Wisconsin Madison; University of Oxford	Walker, BD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA 02129 USA.	bwalker@partners.org	Allen, Todd/F-5473-2011; Altfeld, Marcus/AAE-7306-2019	Allen, Todd/0000-0002-6609-1318; Altfeld, Marcus/0000-0001-5972-2997; o'connor, david/0000-0003-2139-470X; Brander, Christian/0000-0002-0548-5778; Korber, Bette/0000-0002-2026-5757				Allen TM, 2002, J VIROL, V76, P4108, DOI 10.1128/JVI.76.8.4108-4112.2002; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Altfeld MA, 2000, J VIROL, V74, P8541, DOI 10.1128/JVI.74.18.8541-8549.2000; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BRANDER C, 1999, HIV MOL DATABASE, pI1; DEL VM, 1991, CELL, V66, P1145; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; Felsenstein J., 1989, PHYLIP PHYLOGENY INF; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lisziewicz J, 1999, NEW ENGL J MED, V340, P1683, DOI 10.1056/NEJM199905273402114; Malhotra U, 2000, J INFECT DIS, V181, P121, DOI 10.1086/315202; McCutchan FE, 2000, AIDS, V14, pS31; Montefiori DC, 2001, J VIROL, V75, P10200, DOI 10.1128/JVI.75.21.10200-10207.2001; Ortiz GM, 1999, J CLIN INVEST, V104, pR13, DOI 10.1172/JCI7371; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Ramos A, 2002, J VIROL, V76, P7444, DOI 10.1128/JVI.76.15.7444-7452.2002; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Yu XG, 2002, J VIROL, V76, P8690, DOI 10.1128/JVI.76.17.8690-8701.2002	27	256	268	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2002	420	6914					434	439		10.1038/nature01200	http://dx.doi.org/10.1038/nature01200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12459786				2022-12-28	WOS:000179494700044
J	Reader, JS; Joyce, GF				Reader, JS; Joyce, GF			A ribozyme composed of only two different nucleotides	NATURE			English	Article							RNA; CYTIDINE; DNA	RNA molecules are thought to have been prominent in the early history of life on Earth because of their ability both to encode genetic information and to exhibit catalytic function(1). The modern genetic alphabet relies on two sets of complementary base pairs to store genetic information. However, owing to the chemical instability of cytosine, which readily deaminates to uracil(2), a primitive genetic system composed of the bases A, U, G and C may have been difficult to establish. It has been suggested that the first genetic material instead contained only a single base-pairing unit(3-7). Here we show that binary informational macromolecules, containing only two different nucleotide sub-units, can act as catalysts. In vitro evolution was used to obtain ligase ribozymes composed of only 2,6-diaminopurine and uracil nucleotides, which catalyse the template-directed joining of two RNA molecules, one bearing a 5'-triphosphate and the other a 3'-hydroxyl. The active conformation of the fastest isolated ribozyme had a catalytic rate that was about 36,000-fold faster than the uncatalysed rate of reaction. This ribozyme is specific for the formation of biologically relevant 3',5'-phosphodiester linkages.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gjoyce@scripps.edu						Atkins J.F, 1999, RNA WORLD; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Joyce GF, 1997, SCIENCE, V276, P1658, DOI 10.1126/science.276.5319.1658; KIRNOS MD, 1977, NATURE, V270, P369, DOI 10.1038/270369a0; Levy M, 1998, P NATL ACAD SCI USA, V95, P7933, DOI 10.1073/pnas.95.14.7933; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; McGinness KE, 2002, CHEM BIOL, V9, P585, DOI 10.1016/S1074-5521(02)00136-9; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; ORO J, 1961, NATURE, V191, P1193, DOI 10.1038/1911193a0; Plaxco KW, 1998, CURR OPIN STRUC BIOL, V8, P80, DOI 10.1016/S0959-440X(98)80013-4; Rich A., 1962, HORIZONS BIOCH, P103; Rogers J, 1999, NATURE, V402, P323, DOI 10.1038/46335; Rogers J, 2001, RNA, V7, P395, DOI 10.1017/S135583820100228X; Rohatgi R, 1996, J AM CHEM SOC, V118, P3332, DOI 10.1021/ja953712b; SANCHEZ RA, 1968, J MOL BIOL, V38, P121, DOI 10.1016/0022-2836(68)90132-0; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Taylor SV, 2001, P NATL ACAD SCI USA, V98, P10596, DOI 10.1073/pnas.191159298; WACHTERSHAUSER G, 1988, P NATL ACAD SCI USA, V85, P1134, DOI 10.1073/pnas.85.4.1134; ZUBAY G, 1991, CHEMTRACTS, V2, P439	19	69	75	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					841	844		10.1038/nature01185	http://dx.doi.org/10.1038/nature01185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490955				2022-12-28	WOS:000179897300063
J	Bassett, AS; Chow, EWC; Vieland, VJ; Brzustowicz, L				Bassett, AS; Chow, EWC; Vieland, VJ; Brzustowicz, L			Is schizophrenia linked to chromosome 1q?	SCIENCE			English	Editorial Material							LINKAGE ANALYSIS; SUSCEPTIBILITY LOCUS; PEDIGREES		Univ Toronto, Dept Psychiat, Toronto, ON M6J 1H4, Canada; Ctr Addict & Mental Hlth, Clin Genet Res Program, Toronto, ON M6J 1H4, Canada; Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Coll Publ Hlth, Dept Biostat, Div Stat Genet, Iowa City, IA 52242 USA; Univ Med & Dent New Jersey, Dept Psychiat, Newark, NJ 07103 USA; Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Iowa; University of Iowa; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Bassett, AS (corresponding author), Univ Toronto, Dept Psychiat, 1001 Queen St W, Toronto, ON M6J 1H4, Canada.	anne.bassett@utoronto.ca	MacGregor, Stuart/C-6442-2009	MacGregor, Stuart/0000-0001-6731-8142	Canadian Institutes of Health Research [38099] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Camp NJ, 2001, AM J HUM GENET, V69, P1278, DOI 10.1086/324590; GREENBERG DA, 1992, ARCH GEN PSYCHIAT, V49, P745; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Levinson DF, 2002, SCIENCE, V296, P739, DOI 10.1126/science.1069914; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Terwilliger JD, 2000, HUM BIOL, V72, P63; Vieland VJ, 2001, NAT GENET, V29, P244, DOI 10.1038/ng1101-244; Vieland VJ, 2001, HUM HERED, V51, P199, DOI 10.1159/000053343	11	3	3	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2277	2277						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12494945				2022-12-28	WOS:000179915900002
J	Farquhar, J; Wing, BA; McKeegan, KD; Harris, JW; Cartigny, P; Thiemens, MH				Farquhar, J; Wing, BA; McKeegan, KD; Harris, JW; Cartigny, P; Thiemens, MH			Mass-independent sulfur of inclusions in diamond and sulfur recycling on early earth	SCIENCE			English	Article							ISOTOPIC COMPOSITION; SULFIDE INCLUSIONS; MANTLE; CARBON; S-33; KAAPVAAL; BENEATH; FRACTIONATION; HETEROGENEITY; KIMBERLITE	Populations of sulfide inclusions in diamonds from the Orapa kimberlite pipe in the Kaapvaal-Zimbabwe craton, Botswana, preserve mass-independent sulfur isotope fractionations. The data indicate that material was transferred from the atmosphere to the mantle in the Archean. The data also imply that sulfur is not well mixed in the diamond source regions, allowing for reconstruction of the Archean sulfur cycle and possibly offering insight into the nature of mantle convection through time.	Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; Univ Maryland, Dept Geol, College Pk, MD 20742 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Univ Glasgow, Div Earth Sci, Glasgow G12 8QQ, Lanark, Scotland; Univ Paris 07, Inst Phys Globe, Lab Geochim Isotopes Stables, F-75252 Paris 05, France; Univ Calif San Diego, Dept Biochem & Chem, La Jolla, CA 92093 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of California System; University of California Los Angeles; University of Glasgow; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Diego	Farquhar, J (corresponding author), Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA.		Cartigny, Pierre/A-6251-2011; McKeegan, Kevin D/A-4107-2008	McKeegan, Kevin D/0000-0002-1827-729X				ALBAREDE F, 1999, EOS T AM GEOPHYS UN, V80, P535; Aulbach S, 2002, CONTRIB MINERAL PETR, V143, P56, DOI 10.1007/s00410-001-0331-8; Bulanova GP, 1996, CONTRIB MINERAL PETR, V124, P111, DOI 10.1007/s004100050179; Cartigny P, 1998, SCIENCE, V280, P1421, DOI 10.1126/science.280.5368.1421; Cartigny P, 1998, CHEM GEOL, V147, P147, DOI 10.1016/S0009-2541(97)00178-2; Cartigny P, 1999, P 7 INT KIMB C CAP T, P117; CHAUSSIDON M, 1987, NATURE, V330, P242, DOI 10.1038/330242a0; Cooper GW, 1997, SCIENCE, V277, P1072, DOI 10.1126/science.277.5329.1072; DEINES P, 1987, GEOCHIM COSMOCHIM AC, V51, P1227, DOI 10.1016/0016-7037(87)90215-8; DEINES P, 1995, GEOCHIM COSMOCHIM AC, V59, P3173, DOI 10.1016/0016-7037(95)00205-E; DEINES P, 1993, GEOCHIM COSMOCHIM AC, V57, P2781, DOI 10.1016/0016-7037(93)90390-I; ELDRIDGE CS, 1991, NATURE, V353, P649, DOI 10.1038/353649a0; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2000, GEOCHIM COSMOCHIM AC, V64, P1819, DOI 10.1016/S0016-7037(00)00356-2; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; GAO X, 1993, GEOCHIM COSMOCHIM AC, V57, P3159, DOI 10.1016/0016-7037(93)90300-L; GAO X, 1993, GEOCHIM COSMOCHIM AC, V57, P3171, DOI 10.1016/0016-7037(93)90301-C; Gao X., 1991, GEOCHIM COSMOCHIM AC, V55, P2671, DOI DOI 10.1016/0016-7037(91)90381-E; GURNEY JJ, 1991, NATURE, V353, P601, DOI 10.1038/353601a0; Haggerty SE, 1999, SCIENCE, V285, P851, DOI 10.1126/science.285.5429.851; Heymann D, 1998, GEOCHIM COSMOCHIM AC, V62, P173, DOI 10.1016/S0016-7037(97)00330-X; HULSTON JR, 1965, J GEOPHYS RES, V70, P4435, DOI 10.1029/JZ070i018p04435; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; James DE, 2001, GEOPHYS RES LETT, V28, P2485, DOI 10.1029/2000GL012578; MATSUHISA Y, 1978, GEOCHIM COSMOCHIM AC, V42, P173, DOI 10.1016/0016-7037(78)90130-8; Miller MF, 2002, GEOCHIM COSMOCHIM AC, V66, P1881, DOI 10.1016/S0016-7037(02)00832-3; Nguuri TK, 2001, GEOPHYS RES LETT, V28, P2501, DOI 10.1029/2000GL012587; REES CE, 1977, GEOCHIM COSMOCHIM AC, V41, P1679, DOI 10.1016/0016-7037(77)90177-6; Richardson SH, 2001, EARTH PLANET SC LETT, V191, P257, DOI 10.1016/S0012-821X(01)00419-8; RUDNICK RL, 1993, GEOLOGY, V21, P13, DOI 10.1130/0091-7613(1993)021<0013:DGHFIS>2.3.CO;2; Shirey SB, 2002, SCIENCE, V297, P1683, DOI 10.1126/science.1072384; Shirey SB, 2001, GEOPHYS RES LETT, V28, P2509, DOI 10.1029/2000GL012589; SMITH CB, 1991, GEOCHIM COSMOCHIM AC, V55, P2579, DOI 10.1016/0016-7037(91)90374-E; SOBOLEV NV, 1979, DOKL AKAD NAUK SSSR+, V249, P1217; Stachel T, 2002, CONTRIB MINERAL PETR, V142, P465, DOI 10.1007/s004100100297; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; Young ED, 2002, GEOCHIM COSMOCHIM AC, V66, P1095, DOI 10.1016/S0016-7037(01)00832-8	37	223	230	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2369	2372		10.1126/science.1078617	http://dx.doi.org/10.1126/science.1078617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493909				2022-12-28	WOS:000179915900050
J	Friedman, MA				Friedman, MA			Strengthening the FDA	SCIENCE			English	Editorial Material									Pharmacia Corp, Peapack, NJ 07977 USA; US FDA, Rockville, MD 20857 USA	Pfizer; US Food & Drug Administration (FDA)	Friedman, MA (corresponding author), Pharmacia Corp, Peapack, NJ 07977 USA.	Michael.a.friedman@pharmacia.com						Chassy BN, 2002, J AM COLL NUTR, V21, p166S, DOI 10.1080/07315724.2002.10719261; Friedman MA, 1999, ACAD MED, V74, P176; Kleinke JD, 1998, BRIT MED J, V317, P899; LURIE P, 1999, MED CROSSFIRE; Miller HI, 2002, NAT REV DRUG DISCOV, V1, P642, DOI 10.1038/nrd874	5	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2332	2332		10.1126/science.1080416	http://dx.doi.org/10.1126/science.1080416			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493898				2022-12-28	WOS:000179915900035
J	Starai, VJ; Celic, I; Cole, RN; Boeke, JD; Escalante-Semerena, JC				Starai, VJ; Celic, I; Cole, RN; Boeke, JD; Escalante-Semerena, JC			Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine	SCIENCE			English	Article							SALMONELLA-TYPHIMURIUM LT2; LIFE-SPAN; SIR2; GENE	Acetyl-coenzyme A (CoA) synthetase (Acs) is an enzyme central to metabolism in prokaryotes and eukaryotes. Acs synthesizes acetyl CoA from acetate, adenosine triphosphate, and CoA through an acetyl-adenosine monophosphate (AMP) intermediate. Immunoblotting and mass spectrometry analysis showed that Salmonella enterica Acs enzyme activity is posttranslationally regulated by acetylation of lysine-609. Acetylation blocks synthesis of the adenylate intermediate but does not affect the thioester-forming activity of the enzyme. Activation of the acetylated enzyme requires the nicotinamide adenine dinucleotide-dependent protein deacetylase activity of the CobB Sir2 protein from S. enterica. We propose that acetylation modulates the activity of all the AMP-forming family of enzymes, including nonribosomal peptide synthetases, luciferase, and aryl- and acyl-CoA synthetases. These findings extend our knowledge of the roles of Sir2 proteins in gene silencing, chromosome stability, and cell aging and imply that lysine acetylation is a common regulatory mechanism in eukaryotes and prokaryotes.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; Johns Hopkins University	Escalante-Semerena, JC (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	escalante@bact.wisc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062385, R01GM062203] Funding Source: NIH RePORTER; NCRR NIH HHS [1S10-RR14702] Funding Source: Medline; NIGMS NIH HHS [GM62203, R01 GM062203, GM62385] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; BERG P, 1956, J BIOL CHEM, V222, P991; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; Horswill AR, 1999, MICROBIOL-UK, V145, P1381, DOI 10.1099/13500872-145-6-1381; LEE Y, 1981, BIOCHEMISTRY-US, V20, P1253, DOI 10.1021/bi00508a031; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; STARAI VJ, IN PRESS GENETICS; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsang AW, 1996, J BACTERIOL, V178, P7016, DOI 10.1128/jb.178.23.7016-7019.1996	15	445	468	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2390	2392		10.1126/science.1077650	http://dx.doi.org/10.1126/science.1077650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493915				2022-12-28	WOS:000179915900057
J	Shafer, MAB; Tebb, KP; Pantell, RH; Wibbelsman, CJ; Neuhaus, JM; Tipton, AC; Kunin, SB; Ko, TH; Schweppe, DM; Bergman, DA				Shafer, MAB; Tebb, KP; Pantell, RH; Wibbelsman, CJ; Neuhaus, JM; Tipton, AC; Kunin, SB; Ko, TH; Schweppe, DM; Bergman, DA			Effect of a clinical practice improvement intervention on chlamydial screening among adolescent girls	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIGASE CHAIN-REACTION; NEISSERIA-GONORRHOEAE; TRACHOMATIS INFECTIONS; PREVENTIVE SERVICES; CARE; URINE; PROGRAM; DISEASE; PREVALENCE; DIAGNOSIS	Context Chlamydia trachomatis infection is a serious public health concern that disproportionately affects adolescent girls. Although annual C trachomatis screening of sexually active adolescent girls is recommended by health professional organizations and is a Health Employer Data and Information Set (HEDIS) performance measure, this goal is not being met. Objective To test the effectiveness of a system-level, clinical practice improvement intervention designed to increase C trachomatis screening by using urine-based tests for sexually active adolescent girls identified during their routine checkups at a pediatric clinic. Design, Setting, and Participants A randomized cluster of 10 pediatric clinics in the Kaiser Permanente of Northern California health maintenance organization, where adolescent girls aged 14 to 18 years had a total of 7920 routine checkup visits from April 2000 through March 2002. Intervention Five clinics were randomly assigned to provide usual care and 5 to provide the intervention, which required that leadership be engaged by showing the gap between best practice and current practice; a team be assembled to champion the project; barriers be identified and solutions developed through monthly meetings; and progress be monitored with site-specific screening proportions. Main Outcome Measure Chlamydia trachomatis screening rate for sexually active 14- to 18-year-old girls during routine checkups at each participating clinic. Results The population of adolescents was ethnically diverse with an average age of 15.4 years. Twenty-four percent of girls in the experimental clinics and 23% in the control clinics were sexually active. Of the 1017 patients eligible for screening in the intervention clinic, 478 (47%) were screened; of 1194 eligible for screening in the control clinic, 203 (17%) were screened. At baseline, the proportion screened was 0.05 (95% confidence interval [CI], 0.00-0.17) in the intervention and 0.14 (95% CI, 0.01-0.26) in the control clinics. By months 16 to 18, screening rates were 0.65 (95% CI, 0.53-0.77) in the intervention and 0.21 (95% CI, 0.09-0.33) in the control clinics (time period by study group interaction, F-6.60=5.33; P<.001). The average infection rate for the experimental clinics was 5.8% (23 positive test results out of 393 total urine tests and a total of 3986 clinic visits) vs 7.6% in controls (12 positive test results out of 157 tests and 3934 clinic visits). Conclusions implementation of this clinical practice intervention in a large health maintenance organization system is feasible, and it significantly increased the C trachomatis screening rates for sexually active adolescent girls during routine checkups.	Univ Calif San Francisco, Sch Med, Dept Pediat, Div Adolescent Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Pediat, Div Gen Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Kaiser Permanente, San Francisco, CA USA; Kaiser Permanente, Oakland, CA USA; Stanford Med Ctr, Lucile Salter Packard Childrens Hosp, Dept Pediat, Stanford, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Kaiser Permanente; Lucile Packard Children's Hospital (LPCH); Stanford University	Shafer, MAB (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pediat, Div Adolescent Med, Box 0503, San Francisco, CA 94143 USA.	shafer@itsa.ucsf.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010537] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM COLL OBST GYN, 1996, GUID WOM HLTH CAR; [Anonymous], 1997, HIDD EP CONFR SEX TR; Bergman D A, 1999, Pediatrics, V103, P225; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Best D, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e103; Blum RW, 1996, AM J PUBLIC HEALTH, V86, P1767, DOI 10.2105/AJPH.86.12.1767; Bordley WC, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e41; BOYER C, 2001, INT C SEX TRANSM INF, P241; Brodine SK, 1998, J INFECT DIS, V178, P1202, DOI 10.1086/515685; Burstein GR, 1998, JAMA-J AM MED ASSOC, V280, P521, DOI 10.1001/jama.280.6.521; *CDCP, 2001, TRACK HIDD EP TRENDS, P1; *CDCP, 2001, SEX TRANSM DIS SURV, P7; Cheah T. S., 1998, Annals Academy of Medicine Singapore, V27, P533; CHIVALA C, 1999, HLTH PEOPL 2010; Clark KL, 2002, SEX TRANSM DIS, V29, P1, DOI 10.1097/00007435-200201000-00001; Cohen DA, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.1.e1; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cook RL, 2001, J ADOLESCENT HEALTH, V28, P204, DOI 10.1016/S1054-139X(00)00152-X; Diggle PJ, 1994, ANAL LONGITUDINAL DA; *DIV STD PREV, 2001, SEX TRANSM DIS SUR S, P1; ELSTER AB, 1994, AMA GUIDELINES ADOLE; Embling ML, 2000, ANN EMERG MED, V36, P28, DOI 10.1067/mem.2000.105930; FRAME PS, 1984, J FAM PRACTICE, V19, P341; GANN P, 1993, ANN INTERN MED, V118, P893, DOI 10.7326/0003-4819-118-11-199306010-00011; Gaydos CA, 1998, NEW ENGL J MED, V339, P739, DOI 10.1056/NEJM199809103391105; Halpern-Felsher BL, 2000, ARCH PEDIAT ADOL MED, V154, P173, DOI 10.1001/archpedi.154.2.173; Hayward RSA, 1997, CAN MED ASSOC J, V156, P1725; Heinrich P, 1999, PEDIATR ANN, V28, P64, DOI 10.3928/0090-4481-19990101-12; HILLIS SD, 1995, FAM PLANN PERSPECT, V27, P108, DOI 10.2307/2136107; *KAIS FAM FDN, 2001, SEX SMARTS SEX HLTH; Langley Gj., 1996, IMPROVEMENT GUIDE PR; Lifson AR, 2001, J ADOLESCENT HEALTH, V28, P190, DOI 10.1016/S1054-139X(00)00165-8; Millstein SG, 1996, J ADOLESCENT HEALTH, V19, P249, DOI 10.1016/S1054-139X(96)00092-4; *NAT COMM QUAL ASS, 2002, HEDIS 2002 TECHN SPE, V2; *NAT COMM QUAL ASS, 2001, STAT MAN CAR QUAL RE; *NHS CTR REV DISS, 1999, EFF HLTH CAR GETT EV; NOLAN T, 1996, BREAKTHROUGH SERIES; OCONNER HJ, 1999, EFF CLIN PRACT, V2, P272; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention, 1998, MMWR RECOMMENDATIONS, V47, P1; SCHACHTER J, 1995, J INFECT DIS, V172, P1411, DOI 10.1093/infdis/172.5.1411; Schachter J, 1999, J CLIN MICROBIOL, V37, P3668, DOI 10.1128/JCM.37.11.3668-3671.1999; Schachter J, 1997, IMMUNOL INVEST, V26, P157, DOI 10.3109/08820139709048923; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Serlin M, 2002, ARCH PEDIAT ADOL MED, V156, P588, DOI 10.1001/archpedi.156.6.588; Shafer MAB, 1999, ARCH PEDIAT ADOL MED, V153, P119; STEIN M, 1997, GUIDELINES HLTH SUPE; *US PREV SERV TASK, 2001, CHLAM INF SCREEN 200, P325; Van Dyck E, 2001, J CLIN MICROBIOL, V39, P1751, DOI 10.1128/JCM.39.5.1751-1756.2001; Welte R, 2000, SEX TRANSM DIS, V27, P518, DOI 10.1097/00007435-200010000-00005; 1985, MMWR MORB MORTAL  S3, V34, pS53	51	114	115	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2846	2852		10.1001/jama.288.22.2846	http://dx.doi.org/10.1001/jama.288.22.2846			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	623YM	12472326	Bronze			2022-12-28	WOS:000179732600029
J	Lambert, GW; Reid, C; Kaye, DM; Jennings, GL; Esler, MD				Lambert, GW; Reid, C; Kaye, DM; Jennings, GL; Esler, MD			Effect of sunlight and season on serotonin turnover in the brain	LANCET			English	Article							AFFECTIVE-DISORDER; LIGHT THERAPY	Alterations in monoaminergic neurotransmission in the brain are thought to underlie seasonal variations in mood, behaviour, and affective disorders. We took blood samples from internal jugular veins in 101 healthy men, to assess the relation between concentration of serotonin metabolite in these samples and weather conditions and season. We showed that turnover of serotonin by the brain was lowest in winter (p=0-013). Moreover, the rate of production of serotonin by the brain was directly related to the prevailing duration of bright sunlight (r=0.294, p=0.010), and rose rapidly with increased luminosity. Our findings are further evidence for the notion that changes in release of serotonin by the brain underlie mood seasonality and seasonal affective disorder.	Baker Heart Res Inst, Human Neurotransmitter Lab, Melbourne, Vic 8008, Australia; Baker Heart Res Inst, Alfred & Baker Med Unit, Melbourne, Vic 8008, Australia	Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute	Lambert, GW (corresponding author), Baker Heart Res Inst, Human Neurotransmitter Lab, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	gavin.lambert@baker.edu.au	Lambert, Gavin W/E-7384-2010; Kaye, David/AAF-1202-2021; Jennings, Garry/B-3914-2009; Reid, Christopher M/AAP-8135-2021; Lambert, Gavin/Q-4869-2017	Lambert, Gavin W/0000-0003-0315-645X; Lambert, Gavin/0000-0003-0315-645X; Kaye, David/0000-0003-4058-0372; Reid, Christopher/0000-0001-9173-3944; Jennings, Garry/0000-0002-7865-5483				CARLSSON A, 1980, ACTA PSYCHIAT SCAND, V61, P75, DOI 10.1111/acps.1980.61.s280.75; Lam RW, 1996, ARCH GEN PSYCHIAT, V53, P41; LAMBERT GW, 1995, LIFE SCI, V57, P255, DOI 10.1016/0024-3205(95)00269-C; RUDORFER MV, 1993, PSYCHIAT RES, V46, P19, DOI 10.1016/0165-1781(93)90004-Z; TORK I, 1990, ANN NY ACAD SCI, V600, P9	5	335	345	5	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1840	1842		10.1016/S0140-6736(02)11737-5	http://dx.doi.org/10.1016/S0140-6736(02)11737-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	623MB	12480364				2022-12-28	WOS:000179706100014
J	Oakeshott, P; Hay, P; Hay, S; Steinke, F; Rink, E; Kerry, S				Oakeshott, P; Hay, P; Hay, S; Steinke, F; Rink, E; Kerry, S			Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks' gestation: prospective community based cohort study	BRITISH MEDICAL JOURNAL			English	Article							SPONTANEOUS-ABORTION; PRETERM DELIVERY; GENERAL-PRACTICE; GENITAL-TRACT; PREVENTION; PREGNANCY; RISK	Objectives To assess whether bacterial vaginosis or chlamydial infection before 10 weeks' gestation is associated with miscarriage before 16 weeks. Design Prospective cohort study. Setting 32 general practices and five family planning clinics in south London. Participants 1216 pregnant women, mean age 31, presenting before 10 weeks' gestation. Main outcome measure Prevalence of miscarriage before 16 weeks' gestation. Results 121 of 1214 women (10.0%, 95% confidence interval 8.3% to 11.7%) miscarried before 16 weeks. 174 of 1201 women (14.5%, 12.5% to 16.5%) had bacterial vaginosis. Compared with women who were negative for bacterial vaginosis those who were positive had a relative risk of miscarriage before 16 weeks' gestation of 1.2 (0.7 to 1.9). Bacterial vaginosis was, however, associated with miscarriage in the second trimester at 13-15 weeks (3.5, 1.2 to 10.3). Only 29 women (2.4%, 1.5% to 3.3%) had chlamydial infection, of whom one miscarried (0.32, 0.04 to 2.30). Conclusion Bacterial vaginosis is not strongly predictive of early miscarriage but may be a predictor after 13 weeks' gestation. The prevalence of Chlamydia was too low to assess the risk, but it is unlikely to be a major risk factor in pregnant women.	St George Hosp, Sch Med, Dept Gen Practice & Primary Care, London SW17 0RE, England; St George Hosp, Sch Med, Dept Genitourinary Med, London, England	St Georges University London; St Georges University London	Oakeshott, P (corresponding author), St George Hosp, Sch Med, Dept Gen Practice & Primary Care, London SW17 0RE, England.			Oakeshott, Pippa/0000-0003-2568-8211				Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; *CMOS EXP ADV GROU, 1998, CHLAM TRACH SUMM CON; Donders GGG, 2000, AM J OBSTET GYNECOL, V183, P431, DOI 10.1067/mob.2000.105738; ESCHENBACH DA, 1990, CHLAMYDIAL INFECT, P329; Everett C, 1997, BRIT MED J, V315, P32, DOI 10.1136/bmj.315.7099.32; HARLAP S, 1980, LANCET, V2, P173, DOI 10.1016/S0140-6736(80)90061-6; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Liversedge NH, 1999, HUM REPROD, V14, P2411, DOI 10.1093/humrep/14.9.2411; Lockwood CJ, 2000, LANCET, V355, P1292, DOI 10.1016/S0140-6736(00)02108-5; MCGREGOR JA, 1995, AM J OBSTET GYNECOL, V173, P157, DOI 10.1016/0002-9378(95)90184-1; Mills JL, 1999, NEW ENGL J MED, V340, P380, DOI 10.1056/NEJM199902043400509; Morgan DJ, 1996, BRIT J OBSTET GYNAEC, V103, P1105, DOI 10.1111/j.1471-0528.1996.tb09591.x; Morris M, 2001, BRIT J OBSTET GYNAEC, V108, P439; Neugebauer R, 1997, JAMA-J AM MED ASSOC, V277, P383, DOI 10.1001/jama.277.5.383; Oakeshott P, 1998, BRIT MED J, V316, P351, DOI 10.1136/bmj.316.7128.351; Ralph SG, 1999, BRIT MED J, V319, P220, DOI 10.1136/bmj.319.7204.220; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; STEPHENS RC, 2000, ADV MED SOC, V7, P1	19	63	75	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2002	325	7376					1334	1336A		10.1136/bmj.325.7376.1334	http://dx.doi.org/10.1136/bmj.325.7376.1334			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468483	Bronze, Green Published			2022-12-28	WOS:000179817100021
J	Sheikh, A; Walker, S				Sheikh, A; Walker, S			10-minute consultation - Food allergy	BRITISH MEDICAL JOURNAL			English	Article									Univ London Imperial Coll Sci Technol & Med, Dept Gen Practice & Primary Hlth Care, London W6 8RP, England; Natl Resp Training Ctr, Warwick CV34 4AB, England	Imperial College London	Sheikh, A (corresponding author), St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England.		Walker, Samantha/B-9740-2013; Sheikh, Aziz/D-2818-2009	Walker, Samantha/0000-0001-5503-8258; Sheikh, Aziz/0000-0001-7022-3056				BINDSLEVJENSEN C, 1998, ABC ALLERGIES, P44; BRUIJNZEELKOOMEN C, 1995, ALLERGY, V50, P623, DOI 10.1111/j.1398-9995.1995.tb02579.x; DURHAM SR, 2001, ALLERGY, P3; RADCLIFFE MJ, 1997, ALLERGIC DISORDERS, P91; SAMPSON HA, 1997, ALLERGY ALLERGIC DIS, P1517	5	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2002	325	7376					1337	1337		10.1136/bmj.325.7376.1337	http://dx.doi.org/10.1136/bmj.325.7376.1337			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468484	Bronze, Green Published			2022-12-28	WOS:000179817100022
J	Greenbaum, DC; Baruch, A; Grainger, M; Bozdech, Z; Medzihradszky, KF; Engel, J; DeRisi, J; Holder, AA; Bogyo, M				Greenbaum, DC; Baruch, A; Grainger, M; Bozdech, Z; Medzihradszky, KF; Engel, J; DeRisi, J; Holder, AA; Bogyo, M			A role for the protease falcipain 1 in host cell invasion by the human malaria parasite	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; CYSTEINE PROTEASE; PROTEINASE; ERYTHROCYTE; HEMOGLOBINASE; MEROZOITES; EXPRESSION; INHIBITORS; SEQUENCE	Cysteine proteases of Plasmodium falciparum are required for survival of the malaria parasite, yet their specific cellular functions remain unclear. We used a chemical proteomic screen with a small-molecule probe to characterize the predominant cysteine proteases throughout the parasite life cycle. Only one protease, falcipain 1, was active during the invasive merozoite stage. Falcipain 1-specific inhibitors, identified by screening of chemical libraries, blocked parasite invasion of host erythrocytes, yet had no effect on normal parasite processes such as hemoglobin degradation. These results demonstrate a specific role for falcipain 1 in host cell invasion and establish a potential new target for antimalarial therapeutics.	Univ Calif San Francisco, Dept Biochem & Biophys, Vet Affairs Med Ctr, San Francisco, CA 94043 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94043 USA; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; MRC National Institute for Medical Research	Greenbaum, DC (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Vet Affairs Med Ctr, 513 Parnassus Ave, San Francisco, CA 94043 USA.		Holder, Anthony A/A-7554-2013; Bozdech, Zbynek/A-2205-2011	Holder, Anthony A/0000-0002-8490-6058; Bozdech, Zbynek/0000-0002-9830-8446; Bogyo, Matthew/0000-0003-3753-4412	Medical Research Council [MC_U117532067] Funding Source: Medline; MRC [MC_U117532067] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; BANNISTER LH, 1986, CELL TISSUE RES, V245, P281, DOI 10.1007/BF00213933; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Chitnis CE, 2000, PARASITOL TODAY, V16, P411, DOI 10.1016/S0169-4758(00)01756-7; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Greenbaum DC, 2002, CHEM BIOL, V9, P1085, DOI 10.1016/S1074-5521(02)00238-7; GREENBAUM DC, UNPUB; Hanspal M, 2002, MOL BIOCHEM PARASIT, V122, P227, DOI 10.1016/S0166-6851(02)00104-4; MAYER R, 1991, J MED CHEM, V34, P3029, DOI 10.1021/jm00114a011; McKerrow JH, 1999, BIOORGAN MED CHEM, V7, P639, DOI 10.1016/S0968-0896(99)00008-5; Que XC, 2002, J BIOL CHEM, V277, P25791, DOI 10.1074/jbc.M202659200; Raphael P, 2000, MOL BIOCHEM PARASIT, V110, P259, DOI 10.1016/S0166-6851(00)00283-8; ROSENTHAL PJ, 1992, MOL BIOCHEM PARASIT, V51, P143, DOI 10.1016/0166-6851(92)90209-3; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197; ROSENTHAL PJ, 1993, J CLIN INVEST, V91, P1052, DOI 10.1172/JCI116262; SALAS F, 1995, INFECT IMMUN, V63, P2120, DOI 10.1128/IAI.63.6.2120-2125.1995; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481	24	236	256	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					2002	2006		10.1126/science.1077426	http://dx.doi.org/10.1126/science.1077426			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471262				2022-12-28	WOS:000179629200049
J	Kennedy, ADM; Sculpher, MJ; Coulter, A; Dwyer, N; Rees, M; Abrams, KR; Horsley, S; Cowley, D; Kidson, C; Kirwin, C; Naish, C; Stirrat, G				Kennedy, ADM; Sculpher, MJ; Coulter, A; Dwyer, N; Rees, M; Abrams, KR; Horsley, S; Cowley, D; Kidson, C; Kirwin, C; Naish, C; Stirrat, G			Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRANSCERVICAL ENDOMETRIAL RESECTION; ABDOMINAL HYSTERECTOMY; PATIENTS PREFERENCES; PRIMARY-CARE; BACK	Context Decision aids can increase patient involvement in treatment decision making. However, questions remain regarding their effects and cost implications. Objective To evaluate the effects of information, with and without a structured preference elicitation interview, on treatment choices, health outcomes, and costs. Design, Setting, and Participants A randomized controlled trial with 2 years of follow-up. Between October 1996 and February 1998, 894 women with uncomplicated menorrhagia were recruited from 6 hospitals in southwest England. Women were randomized to the control group, information alone group (information), or information plus interview group (interview). Interventions Women in both intervention groups were sent an information pack (a booklet and complementary videotape) 6 weeks before their specialist consultation. Immediately before their consultation, women in the interview group underwent structured interview, to clarify and elicit their preferences. Main Outcome Measures Self-reported health status was the main outcome; secondary outcomes included treatments received and costs. Cost analyses adopted a UK health service (payer) perspective, and were based on patient-reported resource use data and are reported in 1999-2000 US dollars. Results The interventions had no consistent effect on health status. Hysterectomy rates were lower for women in the interview group (38%) (adjusted odds ratio [OR], 0.60; 95% confidence interval [Cl, 0.38-0.96) than in the control group (48%) and women who received the information alone (48%) (adjusted OR, 0.52; 95% Cl, 0.33-0.82). The interview group had lower mean costs ($1566) than the control group ($2751) (mean difference, $1184; 95% Cl, $684-$2110) and the information group $2026 (mean difference, $461; 95% Cl, $236-$696). Conclusions Neither intervention had an effect on health status. Providing women with information alone did not affect treatment choices; however, the addition of an interview to clarify values and elicit preferences had a significant effect on women's management and resulted in reduced costs.	Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England; Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England; Picker Inst Europe, Oxford, England; Weston Gen Hosp, Weston Super Mare, England; John Radcliffe Hosp, Oxford OX3 9DU, England; Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester, Leics, England; Princess Margaret Rose Hosp, Swindon, Wilts, England; St Michaels Hosp, Bristol, Avon, England; Taunton & Somerset Hosp, Taunton, Somerset, England; St Pauls Hosp, Cheltenham, Glos, England	Brunel University; University of York - UK; University of Oxford; University of Leicester	Kennedy, ADM (corresponding author), Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England.	andrew.kennedy@brunel.ac.uk	Coulter, Angela/N-6998-2019; Abrams, Keith/AAA-2557-2020	Coulter, Angela/0000-0002-6308-8375; Abrams, Keith/0000-0002-7557-1567; Sculpher, Mark/0000-0003-3746-9913				BARRY MJ, 1997, DIS MANAGEMENT CLIN, V1, P1; Bernstein Steven J., 1998, Health Expect, V1, P50, DOI 10.1046/j.1369-6513.1998.00007.x; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; *BRIT MED ASS ROYA, 1999, BRIT NAT FORM, V38; Brock D W, 1991, Kennedy Inst Ethics J, V1, P28; Brown H., 1999, APPL MIXED MODELS ME; CHARLES C, 1993, J HEALTH POLIT POLIC, V18, P881, DOI 10.1215/03616878-18-4-881; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Corrado M, 1990, WOMENS HLTH 1990; COULTER A, 1995, INT J TECHNOL ASSESS, V11, P456, DOI 10.1017/S0266462300008679; Coulter A, 1999, BRIT MED J, V319, P719, DOI 10.1136/bmj.319.7212.719; COULTER A, 1994, FAM PRACT, V11, P67, DOI 10.1093/fampra/11.1.67; *DEP HLTH, 2000, NEW NHS 2000 REF COS, V6; Deyo RA, 2000, MED CARE, V38, P959, DOI 10.1097/00005650-200009000-00009; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P441, DOI 10.1001/jama.263.3.441; *EFF HLTH CAR, 1995, EFF HLTH CAR B U LEE, V9; Efron B., 1994, MONOGRAPHS STAT APPL; FINCH H, 1993, SHARED DECISION MAKI; HAUG MR, 1981, J HEALTH SOC BEHAV, V22, P212, DOI 10.2307/2136517; Jenkinson C, 1996, UK SF 36 ANAL INTERP; Kaplan RM, 1999, ANN BEHAV MED, V21, P3, DOI 10.1007/BF02895027; KASSIRER JP, 1994, NEW ENGL J MED, V330, P1895, DOI 10.1056/NEJM199406303302611; Molenaar S, 2000, MED DECIS MAKING, V20, P112, DOI 10.1177/0272989X0002000114; Morgan MW, 2000, J GEN INTERN MED, V15, P685, DOI 10.1046/j.1525-1497.2000.91139.x; *NAT STAT, 2001, HTLH STAT Q; Netten A, 1999, UNIT COSTS HLTH SOCI; *NHS EX, 1999, NURS MIDW PAY 1999 0; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; OCONNOR AM, 2001, DECISION AIDS PEOPLE; *OFF NAT STAT, 2000, LAB FORC SURV; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Prentice A, 1999, BRIT MED J, V319, P1343, DOI 10.1136/bmj.319.7221.1343; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral research, 1982, MAK HLTH CAR DEC; Rothert ML, 1997, RES NURS HEALTH, V20, P377, DOI 10.1002/(SICI)1098-240X(199710)20:5<377::AID-NUR2>3.0.CO;2-L; Royal College of General Practitioners, 1986, MORB STAT GEN PRACT; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; RUTA DA, 1995, QUAL LIFE RES, V4, P33, DOI 10.1007/BF00434381; Sculpher M, 1998, INT J TECHNOL ASSESS, V14, P302, DOI 10.1017/S0266462300012277; Sculpher M, 2000, BRIT J OBSTET GYNAEC, V107, P340, DOI 10.1111/j.1471-0528.2000.tb13229.x; Sculpher Mark J, 1998, Health Expect, V1, P96, DOI 10.1046/j.1369-6513.1998.00006.x; SCULPHER MJ, 1993, BRIT J OBSTET GYNAEC, V100, P244, DOI 10.1111/j.1471-0528.1993.tb15238.x; Secretary of State for Health, 1999, SAV LIV OUR HLTH NAT; STREET RL, 1995, CANCER, V76, P2275, DOI 10.1002/1097-0142(19951201)76:11<2275::AID-CNCR2820761115>3.0.CO;2-S; Veatch R M, 1972, Hastings Cent Rep, V2, P5, DOI 10.2307/3560825; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	46	168	174	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2002	288	21					2701	2708		10.1001/jama.288.21.2701	http://dx.doi.org/10.1001/jama.288.21.2701			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620UA	12460093	Bronze			2022-12-28	WOS:000179549800029
J	Hogg, R; Cahn, P; Katabira, ET; Lange, J; Samuel, NM; O'Shaughnessy, M; Vella, S; Wainberg, MA; Montaner, J				Hogg, R; Cahn, P; Katabira, ET; Lange, J; Samuel, NM; O'Shaughnessy, M; Vella, S; Wainberg, MA; Montaner, J			Time to act: global apathy towards HIV/AIDS is a crime against humanity	LANCET			English	Editorial Material									Univ British Columbia, St Pauls Hosp, AIDS Res Program, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Fdn Huesped, Buenos Aires, DF, Argentina; Makerere Univ, Fac Med, Kampala, Uganda; Univ Amsterdam, Acad Med Ctr, IATEC, NL-1105 AZ Amsterdam, Netherlands; TN DR MGR Med Univ, Dept Expt Med, Chennai, India; Univ British Columbia, Fac Med, Vancouver, BC, Canada; Ist Super Sanita, HIV AIDS Clin Res, I-00161 Rome, Italy; McGill Univ, AIDS Ctr, AIDS Res Lab, Lady Davis Inst Med Res, Montreal, PQ, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Makerere University; University of Amsterdam; Academic Medical Center Amsterdam; University of British Columbia; Istituto Superiore di Sanita (ISS); Lady Davis Institute; McGill University	Montaner, J (corresponding author), Univ British Columbia, St Pauls Hosp, AIDS Res Program, Vancouver, BC V6Z 1Y6, Canada.		Montaner, Julio/K-7621-2012; VELLA, STEFANO/ABI-3368-2020; Hogg, Robert S/B-2783-2012; VELLA, STEFANO/V-8440-2019; Vella, Stefano/GZM-0519-2022	Hogg, Robert S/0000-0003-3463-5488; VELLA, STEFANO/0000-0003-2347-5984; 				BUMILLER E, 2002, LA DAILY NEWS   0826; CHANG GG, 2002, CHINA BRIEF, V2; Luo RF, 2002, JAMA-J AM MED ASSOC, V288, P1649, DOI 10.1001/jama.288.13.1649; MERCER M, 2002, GAINESVILLE SUN 0430; Ramasundaram S, 2002, BRIT MED J, V324, P182, DOI 10.1136/bmj.324.7331.182; Sleigh A, 1998, LANCET, V351, P1449, DOI 10.1016/S0140-6736(05)78866-8; Weber AE, 1999, AIDS, V13, P2481, DOI 10.1097/00002030-199912030-00024; 2002, BLOBE MAIL      1022, pA20	8	34	35	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1710	1711		10.1016/S0140-6736(02)11722-3	http://dx.doi.org/10.1016/S0140-6736(02)11722-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480418				2022-12-28	WOS:000179636800002
J	Jeong, JW; Bae, MK; Ahn, MY; Kim, SH; Sohn, TK; Bae, MH; Yoo, MA; Song, EJ; Lee, KJ; Kim, KW				Jeong, JW; Bae, MK; Ahn, MY; Kim, SH; Sohn, TK; Bae, MH; Yoo, MA; Song, EJ; Lee, KJ; Kim, KW			Regulation and destabilization of HIF-1 alpha by ARD1-mediated acetylation	CELL			English	Article							INDUCIBLE FACTOR 1-ALPHA; TRANSCRIPTION FACTOR GATA-1; O-2 HOMEOSTASIS; GENE-EXPRESSION; DNA-BINDING; HIF-ALPHA; PROTEIN; UBIQUITINATION; DEGRADATION; ACTIVATION	Hypoxia-inducible factor 1 (HIF-1) plays a central role in cellular adaptation to changes in oxygen availability. Recently, prolyl hydroxylation was identified as a key regulatory event that targets the HIF-1alpha subunit for proteasomal degradation via the pVHL ubiquitination complex. In this report, we reveal an important function for ARD1 in mammalian cells as a protein acetyltransferase by direct binding to HIF-1alpha to regulate its stability. We present further evidence showing that ARD1-mediated acetylation enhances interaction of HIF-1alpha with pVHL and HIF-1alpha ubiquitination, suggesting that the acetylation of HIF-1alpha by ARD1 is critical to proteasomal degradation. Therefore, we have concluded that the role of ARD1 in the acetylation of HIF-1alpha provides a key regulatory mechanism underlying HIF-1alpha stability.	Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; Pusan Natl Univ, Dept Mol Biol, Pusan 609735, South Korea; Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea; Ewha Womans Univ, Ctr Cell Signaling Res, Div Mol Life Sci, Seoul 120750, South Korea	Seoul National University (SNU); Pusan National University; Ewha Womans University; Ewha Womans University	Kim, KW (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea.	qwonkim@plaza.snu.ac.kr	Kim, Kyu Won/AAJ-7213-2020	Lee, Kong-Joo/0000-0001-7972-6020; Song, Eun Joo/0000-0002-2420-6666				Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Bannister AJ, 2000, CELL MOL LIFE SCI, V57, P1184, DOI 10.1007/PL00000758; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Braun H, 2001, NUCLEIC ACIDS RES, V29, P4994, DOI 10.1093/nar/29.24.4994; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gendron RL, 2000, DEV DYNAM, V218, P300, DOI 10.1002/(SICI)1097-0177(200006)218:2<300::AID-DVDY5>3.0.CO;2-K; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hara S, 2001, BIOCHEM BIOPH RES CO, V287, P808, DOI 10.1006/bbrc.2001.5659; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Hung HL, 1999, MOL CELL BIOL, V19, P3496; Ingram AK, 2000, MOL BIOCHEM PARASIT, V111, P309, DOI 10.1016/S0166-6851(00)00322-4; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; PARK EC, 1992, EMBO J, V11, P2087, DOI 10.1002/j.1460-2075.1992.tb05267.x; Ravi R, 2000, GENE DEV, V14, P34; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shuman JD, 1997, J BIOL CHEM, V272, P12793, DOI 10.1074/jbc.272.19.12793; Song EJ, 2000, BIOCHEMISTRY-US, V39, P10090, DOI 10.1021/bi000267a; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; TRIBIOLI C, 1994, HUM MOL GENET, V3, P1061, DOI 10.1093/hmg/3.7.1061; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855	49	558	594	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	2002	111	5					709	720		10.1016/S0092-8674(02)01085-1	http://dx.doi.org/10.1016/S0092-8674(02)01085-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464182	Bronze			2022-12-28	WOS:000179594500012
J	Phelps, CJ; Koike, C; Vaught, TD; Boone, J; Wells, KD; Chen, SH; Ball, S; Specht, SM; Polejaeva, IA; Monahan, JA; Jobst, PM; Sharma, SB; Lamborn, AE; Garst, AS; Moore, M; Demetris, AJ; Rudert, WA; Bottino, R; Bertera, S; Trucco, M; Starzl, TE; Dai, YF; Ayares, DL				Phelps, CJ; Koike, C; Vaught, TD; Boone, J; Wells, KD; Chen, SH; Ball, S; Specht, SM; Polejaeva, IA; Monahan, JA; Jobst, PM; Sharma, SB; Lamborn, AE; Garst, AS; Moore, M; Demetris, AJ; Rudert, WA; Bottino, R; Bertera, S; Trucco, M; Starzl, TE; Dai, YF; Ayares, DL			Production of alpha 1,3-galactosyltransferase-deficient pigs	SCIENCE			English	Article							CLOSTRIDIUM-DIFFICILE; TOXIN-A; XENOTRANSPLANTATION; GAL-ALPHA-1-3GAL-BETA-1-4GLCNAC-R; EXPRESSION; EPITOPES; CELLS; MOUSE	The enzyme alpha1,3-galactosyltransferase (alpha1,3GT or GGTA1) synthesizes alpha1,3-galactose (alpha1,3Gal) epitopes (Galbeta1,3Galbeta1,4GlcNac-R), which are the major xenoantigens causing hyperacute rejection in pig-to-human xenotransplantation. Complete removal of alpha1,3Gal from pig organs is the critical step toward the success of xenotransplantation. We reported earlier the targeted disruption of one allele of the alpha1,3GT gene in cloned pigs. A selection procedure based on bacterial toxin was used to select for cells in which the second allele of the gene was knocked out. Sequencing analysis demonstrated that knockout of the second allele of the alpha1,3GT gene was caused by T-to-G single point mutation at the second base of exon 9, which resulted in inactivation of the alpha1,3GT protein. Four healthy alpha1,3GT double-knockout female piglets were produced by three consecutive rounds of cloning. The piglets carrying point mutation in the alpha1,3GT gene hold significant value, as they would allow production of alpha1,3Gal-deficient pigs free of antibiotic-resistance genes and thus have the potential to make safer product for human use.	PPL Therapeut Inc, Blacksburg, VA 24060 USA; PPL Therapeut Ltd, Roslin EH25 9PP, Midlothian, Scotland; Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15213 USA; Childrens Hosp, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dai, YF (corresponding author), PPL Therapeut Inc, 1700 Kraft Dr, Blacksburg, VA 24060 USA.		Polejaeva, Irina/G-4881-2012	Yang, Haiyuan/0000-0001-5253-0079; Polejaeva, Irina/0000-0002-0858-5889; Bertera, Suzanne/0000-0002-9228-4279; Dai, Yifan/0000-0003-2872-8442	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029961, R37DK029961] Funding Source: NIH RePORTER; NIADDK NIH HHS [R01 AM007772] Funding Source: Medline; NIDDK NIH HHS [R01 DK029961-19, DK29961, R01 AM007772] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CLARK GF, 1987, ARCH BIOCHEM BIOPHYS, V257, P217, DOI 10.1016/0003-9861(87)90561-3; COOPER DKC, 1993, LANCET, V342, P682, DOI 10.1016/0140-6736(93)91791-J; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Drake JW, 1998, GENETICS, V148, P1667; GALILI U, 1988, J BIOL CHEM, V263, P17755; Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; GOOD AH, 1992, TRANSPL P, V24, P559; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; Koike C, 2002, J BIOL CHEM, V277, P10114, DOI 10.1074/jbc.M110527200; KUSHNARYOV VM, 1990, CYTOBIOS, V64, P181; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Logan JS, 2000, CURR OPIN IMMUNOL, V12, P563, DOI 10.1016/S0952-7915(00)00139-4; MOHAN R, 2001, PROTEIN, V44, P428; Sandrin MS, 1999, CURR OPIN IMMUNOL, V11, P527, DOI 10.1016/S0952-7915(99)00011-4; Tanemura M, 2000, TRANSPLANTATION, V69, P187, DOI 10.1097/00007890-200001150-00034; Tearle RG, 1996, TRANSPLANTATION, V61, P13, DOI 10.1097/00007890-199601150-00004	17	821	918	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					411	414		10.1126/science.1078942	http://dx.doi.org/10.1126/science.1078942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12493821	Green Accepted			2022-12-28	WOS:000180426800051
J	Benoist, C; Mathis, D				Benoist, C; Mathis, D			Mast cells in autoimmune disease	NATURE			English	Article							MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC NEURITIS; TUMOR-NECROSIS-FACTOR; MULTIPLE-SCLEROSIS; PROINFLAMMATORY CYTOKINE; NEUTROPHIL RECRUITMENT; INDUCED ARTHRITIS; MURINE MODEL; MECHANISMS; INNATE	Mast cells are known to be the primary responders in allergic reactions, orchestrating strong responses to minute amounts of allergens. Several recent observations indicate that they may also have a key role in coordinating the early phases of autoimmune diseases, particularly those involving auto-antibodies.	Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Benoist, C (corresponding author), Joslin Diabet Ctr, Sect Immunol & Immunogenet, 1 Joslin Pl, Boston, MA 02215 USA.	cbdm@joslin.harvard.edu						Applequist SE, 2002, INT IMMUNOL, V14, P1065, DOI 10.1093/intimm/dxf069; AUSTEN KF, 1966, J EXP MED, V124, P397, DOI 10.1084/jem.124.3.397; BABA T, 1976, J IMMUNOL, V116, P112; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; BRENNER T, 1994, J NEUROL SCI, V122, P210, DOI 10.1016/0022-510X(94)90300-X; BROSNAN CF, 1984, J NEUROPATH EXP NEUR, V43, P84, DOI 10.1097/00005072-198401000-00007; Brown MA, 2002, MOL IMMUNOL, V38, P1373, DOI 10.1016/S0161-5890(02)00091-3; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; CRISP AJ, 1984, ARTHRITIS RHEUM, V27, P845, DOI 10.1002/art.1780270802; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; DIETSCH GN, 1989, J IMMUNOL, V142, P1476; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; Galli SJ, 1999, CURR OPIN IMMUNOL, V11, P53, DOI 10.1016/S0952-7915(99)80010-7; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; KATAYAMA I, 1984, ARCH DERMATOL RES, V276, P126, DOI 10.1007/BF00511070; Kiely PDW, 1997, J IMMUNOL, V159, P5100; Konttinen YT, 2000, RHEUMATOL INT, V19, P141, DOI 10.1007/s002960050118; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lafaille JJ, 1997, J EXP MED, V186, P307, DOI 10.1084/jem.186.2.307; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; LIU Z, 1995, J CLIN INVEST, V95, P1539, DOI 10.1172/JCI117826; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Ludgate M, 2002, CLIN EXP IMMUNOL, V127, P193, DOI 10.1046/j.1365-2249.2002.01792.x; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Malfait AM, 1999, J IMMUNOL, V162, P6278; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Mekori YA, 1999, J ALLERGY CLIN IMMUN, V104, P517, DOI 10.1016/S0091-6749(99)70316-7; Napoli D C, 2001, Curr Allergy Asthma Rep, V1, P329, DOI 10.1007/s11882-001-0044-0; Okayama Y, 2001, J IMMUNOL, V166, P4705, DOI 10.4049/jimmunol.166.7.4705; Olsson N, 2001, ANN RHEUM DIS, V60, P187, DOI 10.1136/ard.60.3.187; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; Prodeus AP, 1997, NATURE, V390, P172, DOI 10.1038/36586; ROZNIECKI JJ, 1995, ANN NEUROL, V37, P63, DOI 10.1002/ana.410370112; SCHMITT E, 1990, Cytokine, V2, P407, DOI 10.1016/1043-4666(90)90049-Y; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; SEELDRAYERS PA, 1989, J NEUROIMMUNOL, V25, P221, DOI 10.1016/0165-5728(89)90140-9; STANLEY JR, 1999, FITZPATRICKS DERMATO, P666; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Sylvestre DL, 1996, IMMUNITY, V5, P387, DOI 10.1016/S1074-7613(00)80264-2; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; VANDENBROEK MF, 1988, J RHEUMATOL, V15, P544; Williams CMM, 2000, J ALLERGY CLIN IMMUN, V105, P847, DOI 10.1067/mai.2000.106485; WINTROUB BU, 1978, NEW ENGL J MED, V298, P417, DOI 10.1056/NEJM197802232980803; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Woolley DE, 2000, ARTHRITIS RES, V2, P65, DOI 10.1186/ar70; Yamada T, 1998, VIRCHOWS ARCH, V433, P567, DOI 10.1007/s004280050290; YOUNG JDE, 1987, P NATL ACAD SCI USA, V84, P9175, DOI 10.1073/pnas.84.24.9175; ZHANG Y, 1992, SCIENCE, V258, P1957, DOI 10.1126/science.1470922	55	239	294	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					875	878		10.1038/nature01324	http://dx.doi.org/10.1038/nature01324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490961				2022-12-28	WOS:000179897300069
J	Kovac, JM; Leitch, EM; Pryke, C; Carlstrom, JE; Halverson, NW; Holzapfel, WL				Kovac, JM; Leitch, EM; Pryke, C; Carlstrom, JE; Halverson, NW; Holzapfel, WL			Detection of polarization in the cosmic microwave background using DASI	NATURE			English	Article							POWER SPECTRUM; ANGULAR SCALES; GRAVITY-WAVES; RADIO-SOURCES; ANISOTROPY; RADIATION; SKY; GHZ; RESOLUTION; PRIMER	The past several years have seen the emergence of a standard cosmological model, in which small temperature differences in the cosmic microwave background (CMB) radiation on angular scales of the order of a degree are understood to arise from acoustic oscillations in the hot plasma of the early Universe, arising from primordial density fluctuations. Within the context of this model, recent measurements of the temperature fluctuations have led to profound conclusions about the origin, evolution and composition of the Universe. Using the measured temperature fluctuations, the theoretical framework predicts the level of polarization of the CMB with essentially no free parameters. Therefore, a measurement of the polarization is a critical test of the theory and thus of the validity of the cosmological parameters derived from the CMB measurements. Here we report the detection of polarization of the CMB with the Degree Angular Scale Interferometer (DASI). The polarization is deteced with high confidence, and its level and spatial distribution are in excellent agreement with the predictions of the standard theory.	Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Chicago, Ctr Astrophys Res Antarctica, Chicago, IL 60637 USA; Univ Chicago, Ctr Cosmol Phys, Chicago, IL 60637 USA; Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of California System; University of California Berkeley	Kovac, JM (corresponding author), Univ Chicago, Dept Phys, 5640 S Ellis Ave, Chicago, IL 60637 USA.		Holzapfel, William L/I-4836-2015	Pryke, Clement/0000-0003-3983-6668				BANDAY AJ, 1991, MON NOT R ASTRON SOC, V248, P705, DOI 10.1093/mnras/248.4.705; Bond JR, 1998, PHYS REV D, V57, P2117, DOI 10.1103/PhysRevD.57.2117; BOND JR, 1984, ASTROPHYS J LETT, V285, P45; Bucher M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.191301; CADERNI N, 1978, PHYS REV D, V17, P1908, DOI 10.1103/PhysRevD.17.1908; CARTWRIGHT JK, IN PRESS MOR WORKSH, V37; Christensen N, 2001, CLASSICAL QUANT GRAV, V18, P2677, DOI 10.1088/0264-9381/18/14/306; COULSON D, 1994, PHYS REV LETT, V73, P2390, DOI 10.1103/PhysRevLett.73.2390; CRITTENDEN R, 1993, ASTROPHYS J, V417, pL13, DOI 10.1086/187082; DEOLIVEIRACOSTA A, 2002, UNPUB PHYS REV D; Fixsen DJ, 1996, ASTROPHYS J, V473, P576, DOI 10.1086/178173; Gaensler BM, 2001, ASTROPHYS J, V549, P959, DOI 10.1086/319468; Giardino G, 2002, ASTRON ASTROPHYS, V387, P82, DOI 10.1051/0004-6361:20020285; Gray AD, 1999, ASTROPHYS J, V514, P221, DOI 10.1086/306934; Halverson NW, 2002, ASTROPHYS J, V568, P38, DOI 10.1086/338879; HALVERSON NW, 2002, THESIS CALTECH; HASLAM CGT, 1981, ASTRON ASTROPHYS, V100, P209; Hedman MM, 2002, ASTROPHYS J, V573, pL73, DOI 10.1086/342020; Hedman MM, 2001, ASTROPHYS J, V548, pL111, DOI 10.1086/319114; Hildebrand RH, 2000, PUBL ASTRON SOC PAC, V112, P1215, DOI 10.1086/316613; Hu W, 1997, PHYS REV D, V55, P3288, DOI 10.1103/PhysRevD.55.3288; Hu W, 2002, ASTROPHYS J, V574, P566, DOI 10.1086/341110; Hu W, 1997, NEW ASTRON, V2, P323, DOI 10.1016/S1384-1076(97)00022-5; Hu W, 2002, ANNU REV ASTRON ASTR, V40, P171, DOI 10.1146/annurev.astro.40.060401.093926; KAISER N, 1983, MON NOT R ASTRON SOC, V202, P1169, DOI 10.1093/mnras/202.4.1169; Kamionkowski M, 1997, PHYS REV LETT, V78, P2058, DOI 10.1103/PhysRevLett.78.2058; Kamionkowski M, 1999, ANNU REV NUCL PART S, V49, P77, DOI 10.1146/annurev.nucl.49.1.77; Kamionkowski M, 1997, PHYS REV D, V55, P7368, DOI 10.1103/PhysRevD.55.7368; Keating BG, 2001, ASTROPHYS J, V560, pL1, DOI 10.1086/324222; Kesden M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.011304; Kinney WH, 2001, PHYS REV D, V63, DOI 10.1103/PhysRevD.63.043001; Knox L, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.103516; Knox L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.011303; Kosowsky A., 1999, New Astronomy Reviews, V43, P157, DOI 10.1016/S1387-6473(99)00009-3; Lazarian A, 2002, AIP CONF PROC, V609, P32, DOI 10.1063/1.1471820; Lee AT, 2001, ASTROPHYS J, V561, pL1, DOI 10.1086/324437; Leitch EM, 2002, NATURE, V420, P763, DOI 10.1038/nature01271; Leitch EM, 2002, ASTROPHYS J, V568, P28, DOI 10.1086/338878; LUBIN P, 1983, ASTROPHYS J, V273, pL51, DOI 10.1086/184128; LUBIN PM, 1981, ASTROPHYS J, V245, P1, DOI 10.1086/158780; LUBIN PM, 1979, PHYS REV LETT, V42, P129, DOI 10.1103/PhysRevLett.42.129; Lyth DH, 1997, PHYS REV LETT, V78, P1861, DOI 10.1103/PhysRevLett.78.1861; MASON BS, 2002, UNPUB ASTROPHYS J; MATHER JC, 1994, ASTROPHYS J, V420, P439, DOI 10.1086/173574; Miller AD, 1999, ASTROPHYS J, V524, pL1, DOI 10.1086/312293; NANOS GP, 1979, ASTROPHYS J, V232, P341, DOI 10.1086/157293; Netterfield CB, 2002, ASTROPHYS J, V571, P604, DOI 10.1086/340118; Partridge RB, 1997, ASTROPHYS J, V483, P38, DOI 10.1086/304226; PEARSON TJ, 2002, UNPUB ASTROPHYS J; Platania P, 1998, ASTROPHYS J, V505, P473, DOI 10.1086/306175; Polnarev A. G., 1985, Soviet Astronomy, V29, P607; Pryke C, 2002, ASTROPHYS J, V568, P46, DOI 10.1086/338880; REES MJ, 1968, ASTROPHYS J, V153, pL1, DOI 10.1086/180208; SCOTT PF, 2002, UNPUB MON NOT R ASTR; Seljak U, 1996, ASTROPHYS J, V469, P437, DOI 10.1086/177793; Seljak U, 1997, PHYS REV LETT, V78, P2054, DOI 10.1103/PhysRevLett.78.2054; Seljak U, 1997, ASTROPHYS J, V482, P6, DOI 10.1086/304123; Simard-Normandin M., 1981, Astronomy & Astrophysics Supplement Series, V43, P19; SIMARDNORMANDIN M, 1981, ASTROPHYS J SUPPL S, V45, P97, DOI 10.1086/190709; Sironi G, 1997, NEW ASTRON, V3, P1; Smoot G.F., 1992, APJ, V396, pL1; Staggs ST, 1999, ASTR SOC P, V181, P299; Subrahmanyan R, 2000, MON NOT R ASTRON SOC, V315, P808, DOI 10.1046/j.1365-8711.2000.03444.x; Tegmark M, 2000, ASTROPHYS J, V530, P133, DOI 10.1086/308348; Tegmark M, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.063001; Wang XM, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.123001; White M, 1999, ASTROPHYS J, V514, P12, DOI 10.1086/306911; WOLLACK EJ, 1993, ASTROPHYS J, V419, pL49, DOI 10.1086/187134; WRIGHT AE, 1994, ASTROPHYS J SUPPL S, V91, P111, DOI 10.1086/191939; Zaldarriaga M, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.023003; Zaldarriaga M, 1997, PHYS REV D, V55, P1830, DOI 10.1103/PhysRevD.55.1830; ZALDARRIAGA M, 2001, UNPUB PHYS REV D; Zukowski ELH, 1999, ASTRON ASTROPHYS SUP, V135, P571, DOI 10.1051/aas:1999190	75	496	497	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					772	787		10.1038/nature01269	http://dx.doi.org/10.1038/nature01269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490941	Green Submitted			2022-12-28	WOS:000179897300048
J	Phornphutkul, C; Introne, WJ; Perry, MB; Bernardini, I; Murphey, MD; Fitzpatrick, DL; Anderson, PD; Huizing, M; Anikster, Y; Gerber, LH; Gahl, WA				Phornphutkul, C; Introne, WJ; Perry, MB; Bernardini, I; Murphey, MD; Fitzpatrick, DL; Anderson, PD; Huizing, M; Anikster, Y; Gerber, LH; Gahl, WA			Natural history of alkaptonuria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOMOGENTISIC ACID; MUTATIONS; IDENTIFICATION; DIOXYGENASE; OCHRONOSIS; INHIBITION; SLOVAKIA; GENE; NTBC	Background: Alkaptonuria, caused by mutations in the HGO gene and a deficiency of homogentisate 1,2-dioxygenase, results in an accumulation of homogentisic acid (HGA), ochronosis, and destruction of connective tissue. There is no effective therapy for this disorder, although nitisinone inhibits the enzyme that produces HGA. We performed a study to delineate the natural history of alkaptonuria. Methods: We evaluated 58 patients with alkaptonuria (age range, 4 to 80 years), using clinical, radiographic, biochemical, and molecular methods. A radiographic scoring system was devised to assess the severity of spinal and joint damage. Two patients were treated with nitisinone for 10 and 9 days, respectively. Results: Life-table analyses showed that joint replacement was performed at a mean age of 55 years and that renal stones developed at 64 years, cardiac-valve involvement at 54 years, and coronary-artery calcification at 59 years. Linear regression analysis indicated that the radiographic score for the severity of disease began increasing after the age of 30 years, with a more rapid increase in men than in women. Twenty-three new HGO mutations were identified. In a 51-year-old woman, urinary HGA excretion fell from 2.9 to 0.13 g per day after a 10-day course of nitisinone (7 days at a dose of 0.7 mg per day and 3 days at 2.8 mg per day). In a 59-year-old woman, urinary HGA fell from 6.4 g to 1.7 g per day after nine days of treatment with nitisinone (0.7 mg per day). Plasma tyrosine levels in these patients rose from approximately 1.1 mg per deciliter (60 micromol per liter) in both to approximately 12.8 mg per deciliter (700 micromol per liter) and 23.6 mg per deciliter (1300 micromol per liter), respectively, with no clinical signs or symptoms. Conclusions: The reported data on the natural history of alkaptonuria provide a basis for the evaluation of long-term therapies. Although nitisinone can reduce HGA production in humans with homogentisate 1,2-dioxygenase deficiency, the long-term safety and efficacy of this treatment require further evaluation.	NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, Bethesda, MD 20892 USA; Natl Inst Hlth Clin Ctr, Dept Rehabil Med, Bethesda, MD USA; Armed Forces Inst Pathol, Dept Radiol Pathol, Washington, DC 20306 USA; Univ Maryland, Med Ctr, Dept Radiol, Baltimore, MD 21201 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); United States Department of Defense; University System of Maryland; University of Maryland Baltimore; Uniformed Services University of the Health Sciences - USA	Gahl, WA (corresponding author), NHGRI, Med Genet Branch, NIH, 10 Ctr Dr,MSC 1851,Bldg 10,Rm 10C-103, Bethesda, MD 20892 USA.	bgahl@helix.nih.gov	Huizing, Marjan/AAR-8860-2020	Gerber, Lynn/0000-0001-7525-680X				Anikster Y, 1998, AM J HUM GENET, V63, P920, DOI 10.1086/302027; BAHN AK, 1972, BASIC MED STATISTICS, P154; Baumann E, 1891, Z PHYSL CHEM, V15, P228; Boedeker C., 1859, Z RATION MED, V7, P130; de Bernabe DBV, 1999, AM J HUM GENET, V64, P1316, DOI 10.1086/302376; de Bernabe DBV, 1998, AM J HUM GENET, V62, P776, DOI 10.1086/301805; Deutsch JC, 1996, J CHROMATOGR B, V677, P147, DOI 10.1016/0378-4347(95)00442-4; ELLIS MK, 1995, TOXICOL APPL PHARM, V133, P12, DOI 10.1006/taap.1995.1121; FernandezCanon JM, 1996, NAT GENET, V14, P19, DOI 10.1038/ng0996-19; Garrod AE, 1908, LANCET, V2, P73; Garrod AE, 1902, LANCET, V2, P1616; de Jorge EG, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.7.e40; Hall MG, 2001, BRIT J CLIN PHARMACO, V52, P169, DOI 10.1046/j.0306-5251.2001.01421.x; Introne WJ, 2002, MOL GENET METAB, V77, P136, DOI 10.1016/S1096-7192(02)00121-X; KHAN MA, 1984, SPONDYLARTHROPATHIES, P69; LADU BN, 1958, J BIOL CHEM, V230, P251; LADU BN, 2002, CONNECTIVE TISSUE IT, P809; LADU BN, 2001, METABOLIC MOL BASES, V2, P2109; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; LUSTBERG TJ, 1971, CLIN CHIM ACTA, V35, P325, DOI 10.1016/0009-8981(71)90202-6; MACRAE IF, 1969, ANN RHEUM DIS, V28, P584, DOI 10.1136/ard.28.6.584; MITCHELL GA, 2001, METABOLIC MOL BASES, P1777; MOLL JMH, 1971, ANN RHEUM DIS, V30, P381, DOI 10.1136/ard.30.4.381; MOTULSKY H, 1995, INTUITIVE BIOSTATIST, P55; NEUBAUER O, 1909, DTSCH ARCH KLIN MED, V95, P211; OBRIEN WM, 1963, AM J MED, V34, P813, DOI 10.1016/0002-9343(63)90089-5; Porfirio B, 2000, J MED GENET, V37, P309, DOI 10.1136/jmg.37.4.309; Rodriguez JM, 2000, HUM MOL GENET, V9, P2341, DOI 10.1093/oxfordjournals.hmg.a018927; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schober P.J., 1937, MUNCH MED WOCHENSCHR, V84, P336; SCHULZ A, 1993, FEBS LETT, V318, P162, DOI 10.1016/0014-5793(93)80013-K; Srsen S, 2002, MOL GENET METAB, V75, P353, DOI 10.1016/S1096-7192(02)00002-1; STENN FF, 1977, SCIENCE, V197, P566, DOI 10.1126/science.327549; Suzuki Y, 1999, J HUM GENET, V44, P79, DOI 10.1007/s100380050114; WARE JE, 1981, AM J PUBLIC HEALTH, V71, P620, DOI 10.2105/AJPH.71.6.620; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WOLFF JA, 1989, PEDIATR RES, V26, P140, DOI 10.1203/00006450-198908000-00015; Zatkova A, 2000, AM J HUM GENET, V67, P1333	38	363	380	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2111	2121		10.1056/NEJMoa021736	http://dx.doi.org/10.1056/NEJMoa021736			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501223				2022-12-28	WOS:000180040900004
J	Wilkoff, BL; Cook, JR; Epstein, AE; Greene, L; Hallstrom, AP; Hsia, H; Kutalek, SP; Sharma, A				Wilkoff, BL; Cook, JR; Epstein, AE; Greene, L; Hallstrom, AP; Hsia, H; Kutalek, SP; Sharma, A		DAVID Trial Investigators	Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator - The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED-TRIAL; SURVIVAL; DEATH	Context Implantable cardioverter defibrillator (ICD) therapy with backup ventricular pacing increase's survival in patients with life-threatening ventricular arrhythmias. Most currently implanted ICD devices provide dual-chamber pacing therapy. The most common comorbid cause for mortality in this population is congestive heart failure. Objective To determine the efficacy of dual-chamber pacing compared with backup ventricular pacing in patients with standard indications for ICD implantation but without indications for antibradycardia pacing. Design The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial, a single-blind, parallel-group, randomized clinical trial. Setting and Participants A total of 506 patients with indications for ICD therapy were enrolled between October 2000 and September 2002 at 37 US centers. All patients had a left ventricular ejection fraction (LVEF) of 40% or less, no indication for antibradycardia pacemaker therapy, and no persistent atrial arrhythmias. Interventions All patients had an ICD with dual-chamber, rate-responsive pacing capability implanted. Patients were randomly assigned to have the ICDS programmed to ventricular backup pacing at 40/min (VVI-40; n=256) or dual-chamber rate-responsive pacing at 70/min (DDDR-70; n=250). Maximal tolerated medical therapy for left ventricular dysfunction, including angiotensin-converting enzyme inhibitors and beta-blockers, was prescribed to all patients. Main Outcome Measure Composite end point of time to death or first hospitalization for congestive heart failure. Results One-year survival free of the composite end point was 83.9% for patients treated with VVI-40 compared with 73.3% for patients treated with DDDR-70 (relative hazard, 1.61; 95% confidence interval [CI], 1.06-2.44). The components of the composite end point, mortality of 6.5% for VVI-40 vs 10.1 % for DDDR-70 (relative hazard, 1.61; 95% Cl, 0.84-3.09) and hospitalization for congestive heart failure of 13.3% for VVI-40 vs 22.6% for DDDR-70 (relative hazard, 1.54; 95% Cl, 0.97-2.46), also trended in favor of VVI-40 programming. Conclusion For patients with standard indications for ICD therapy, no indication for cardiac pacing, and an LVEF of 40% or less, dual-chamber pacing offers no clinical advantage over ventricular backup pacing and may be detrimental by increasing the combined end point of death or hospitalization for heart failure.	Cleveland Clin Fdn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Wilkoff, BL (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave,Desk F-15, Cleveland, OH 44195 USA.	wilkofb@ccf.org	Greene, Lewis J/L-6098-2017	Greene, Lewis J/0000-0003-0144-9726; Sharma, Arjun/0000-0002-6484-1250; Wilkoff, Bruce/0000-0001-8905-9233				Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Adams KF, 1999, J CARD FAIL, V5, P357; Andersen HR, 1997, LANCET, V350, P1210, DOI 10.1016/S0140-6736(97)03425-9; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; *CYT SOFTW CORP, 2001, E 2000 SOFTW DES INT; ELLENBOGEN KA, 1990, AM J CARDIOL, V65, P53, DOI 10.1016/0002-9149(90)90025-V; *FOOD DRUG ADM CTR, 2001, FOOD DRUG ADM CTR DE; Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09; Hallstrom AP, 2001, J CARDIOVASC ELECTR, V12, P990, DOI 10.1046/j.1540-8167.2001.00990.x; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; KERR CR, 2002, PACE, V25, P553; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; Lamas GA, 1998, NEW ENGL J MED, V338, P1097, DOI 10.1056/NEJM199804163381602; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; *MEDTR INS ICD CAR, 2002, FOOD DRUG ADM CTR DE; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; NAMBI V, 2002, PACING CLIN ELECTROP, V25, P642; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Sweeney MO, 2002, PACE, V25, P1715, DOI 10.1046/j.1460-9592.2002.01715.x; Wilkoff BL, 2001, CURR CONTR TRIALS C, V2, P215, DOI 10.1186/CVM-2-5-215; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	23	1342	1396	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2002	288	24					3115	3123						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628QQ	12495391				2022-12-28	WOS:000180008200021
J	Atkin, PA				Atkin, PA			A paradigm shift in the medical literature	BRITISH MEDICAL JOURNAL			English	Article								Medical literature is expanding massively. More and more journals are appearing and an increasing amount of research and comment is being produced to appear in these journals. Funding for universities is decided on the amount and quality of research produced, and therefore more pressure is placed on researchers and clinicians to (publish or perish). A piece of research needs to be sound in method and results, but the title needs to be appealing to attract the attention of editors and catch the eye of the reader. Titles including words suggesting results of great impact will cause more interest and tempt journal subscribers to read beyond the title or abstract this one did, didn't it! Papers with catchy titles work best. Titles need to contain phrases that are in popular use and suggest innovation and exploration. I examined the use of two such phrases that are, or have been, in popular use: "paradigm shift" and "pushing the envelope".	Royal London Hosp, Inst Dent, Barts & London NHS Trust, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Atkin, PA (corresponding author), Royal London Hosp, Inst Dent, Barts & London NHS Trust, London E1 1BB, England.							Kuhn T. S., 1996, STRUCTURE SCI REVOLU	1	9	10	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1450	1451		10.1136/bmj.325.7378.1450	http://dx.doi.org/10.1136/bmj.325.7378.1450			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493662	Green Published			2022-12-28	WOS:000180188600014
J	LaPorte, RE; Linkov, F; Villasenor, T; Sauer, F; Gamboa, C; Lovalekar, M; Shubnikov, E; Sekikawa, A; Sa, FR				LaPorte, RE; Linkov, F; Villasenor, T; Sauer, F; Gamboa, C; Lovalekar, M; Shubnikov, E; Sekikawa, A; Sa, FR			Papyrus to PowerPoint (P 2 P): metamorphosis of scientific communication	BRITISH MEDICAL JOURNAL			English	Article							JOURNALS	Scientific communication is in the process of metamorphosis. Will it change into a dung beetle or into a beautiful butterfly? Here is one possibility that some might argue is as frightening as Kafka's story.	Univ Pittsburgh, Grad Sch Publ Hlth, Global Hlth Network, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	LaPorte, RE (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Global Hlth Network, 5th Ave, Pittsburgh, PA 15213 USA.			Sekikawa, Akira/0000-0002-7197-6321; Lovalekar, Mita/0000-0002-4536-8656				Delamothe T, 1999, BRIT MED J, V318, P1637, DOI 10.1136/bmj.318.7199.1637; *GLOB HLTH NETW GR, 1998, NAT MED, P4; Goldbeck-Wood S, 1999, BMJ-BRIT MED J, V318, P44; Grant EL, 1988, STAT QUALITY CONTROL; HARMON JE, 2002, SCI ARTICLE REPUBLIC; HESS KL, 1996, GROWTH AUTOMOBILE TE; LaPorte RE, 1996, BRIT MED J, V313, P1609, DOI 10.1136/bmj.313.7072.1609; LAPORTE RE, 1995, BRIT MED J, V310, P1387, DOI 10.1136/bmj.310.6991.1387; Laporte RE, 2002, BRIT MED J, V324, P99, DOI 10.1136/bmj.324.7329.99; PARKER R, 2001, NEW YORKER      0520, P76; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; VARMUS H, 2002, E BIOMED PROPOSAL EL; 2002, WHAT IS 6 SIGMA	13	24	27	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1478	1481		10.1136/bmj.325.7378.1478	http://dx.doi.org/10.1136/bmj.325.7378.1478			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493674	Green Published			2022-12-28	WOS:000180188600027
J	Rigby, WFC; Fan, CM; Colvin, RB; Ang, HTS; Mark, EJ				Rigby, WFC; Fan, CM; Colvin, RB; Ang, HTS; Mark, EJ			A 35-year-old man with headache, deviation of the tongue, and unusual radiographic abnormalities. Takayasu's arteritis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GIANT-CELL ARTERITIS; INTERNAL CAROTID-ARTERY; HYPOGLOSSAL NERVE PALSY; TEMPORAL ARTERITIS; DISEASE; PARALYSIS; AORTITIS; CLASSIFICATION; VASCULITIS; DISSECTION		Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Lebanon, NH 03766 USA	Dartmouth College	Rigby, WFC (corresponding author), Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Lebanon, NH 03766 USA.							AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; ASKUPMARK E, 1954, ACTA MED SCAND, V149, P161; BULKLEY BH, 1973, CIRCULATION, V48, P1014, DOI 10.1161/01.CIR.48.5.1014; CHERIN P, 1992, AM J MED, V93, P349, DOI 10.1016/0002-9343(92)90247-9; CHURG J, 1989, MODERN PATHOL, V2, P144; Dal Canto AJ, 2001, J CLIN INVEST, V107, pR15, DOI 10.1172/JCI11540; EWART JM, 1983, AM SURGEON, V49, P37; Fernandes SRM, 2000, SEMIN ARTHRITIS RHEU, V30, P33, DOI 10.1053/sarh.2000.8364; Gilkeson GS, 1996, RHEUM DIS CLIN N AM, V22, P23, DOI 10.1016/S0889-857X(05)70260-X; Goldman MH, 2000, CIRCULATION, V102, P3023; GRAVALLESE EM, 1989, MEDICINE, V68, P95, DOI 10.1097/00005792-198903000-00003; Gravanis MB, 2000, INT J CARDIOL, V75, pS21, DOI 10.1016/S0167-5273(00)00184-4; HAMILTON CR, 1971, MEDICINE, V50, P1, DOI 10.1097/00005792-197101000-00001; Hoffman G, 2000, ARTHRITIS RHEUM, V43, pS115; Horikoshi M, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34, P331; ISHIKAWA K, 1978, CIRCULATION, V57, P27, DOI 10.1161/01.CIR.57.1.27; ISHIKAWA K, 1986, J AM COLL CARDIOL, V8, P1041, DOI 10.1016/S0735-1097(86)80380-1; ISHIKAWA K, 1988, J AM COLL CARDIOL, V12, P964, DOI 10.1016/0735-1097(88)90462-7; Kagata Y, 1999, PATHOL INT, V49, P226, DOI 10.1046/j.1440-1827.1999.00851.x; KERR GS, 1994, ANN INTERN MED, V120, P919, DOI 10.7326/0003-4819-120-11-199406010-00004; KLEIN RG, 1976, MAYO CLIN PROC, V51, P504; KLEIN RG, 1975, ANN INTERN MED, V83, P806, DOI 10.7326/0003-4819-83-6-806; LANDE A, 1976, ARCH PATHOL LAB MED, V100, P437; Lemmerling M, 1996, CLIN NEUROL NEUROSUR, V98, P52, DOI 10.1016/0303-8467(95)00088-7; Lie JT, 1996, MODERN PATHOL, V9, P469; LIE JT, 1995, SEMIN ARTHRITIS RHEU, V24, P422, DOI 10.1016/S0049-0172(95)80010-7; LIESCHKE GJ, 1988, STROKE, V19, P1151, DOI 10.1161/01.STR.19.9.1151; LINDSAY J, 2001, HURSTS HEART, V2, P2375; MASSEY EW, 1984, STROKE, V15, P157, DOI 10.1161/01.STR.15.1.157; Matsubara O, 1992, Heart Vessels Suppl, V7, P26, DOI 10.1007/BF01744540; Matsubara O, 1992, Heart Vessels Suppl, V7, P18; MATSUMOTO T, 1991, HUM PATHOL, V22, P45, DOI 10.1016/0046-8177(91)90060-3; MCADAM LP, 1976, MEDICINE, V55, P193, DOI 10.1097/00005792-197605000-00001; NUSYNOWITZ RN, 1990, NEURORADIOLOGY, V32, P229, DOI 10.1007/BF00589118; Olin JW, 2000, NEW ENGL J MED, V343, P864, DOI 10.1056/NEJM200009213431207; OZ MC, 1989, J CARDIOVASC SURG, V30, P99; OZ MC, 1989, J VASC SURG, V10, P439; PARK JH, 1989, AM J ROENTGENOL, V153, P1069, DOI 10.2214/ajr.153.5.1069; Petursdottir V, 1999, RHEUMATOLOGY, V38, P1208, DOI 10.1093/rheumatology/38.12.1208; Savory W S, 1856, Med Chir Trans, V39, P205; SCOTTI G, 1978, NEURORADIOLOGY, V14, P263, DOI 10.1007/BF00418626; THOMPSON EO, 1994, RADIOGRAPHICS, V14, P939, DOI 10.1148/radiographics.14.5.7991825; TSUCHIYA M, 1976, Vascular Surgery, V10, P176, DOI 10.1177/153857447601000309; VOLLERTSEN RS, 1986, MAYO CLIN PROC, V61, P344, DOI 10.1016/S0025-6196(12)61951-X; Weyand CM, 2000, INT J CARDIOL, V75, pS9, DOI 10.1016/S0167-5273(00)00198-4; Willett W F 3rd, 1996, J La State Med Soc, V148, P55	46	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2002	347	25					2057	2065		10.1056/NEJMcpc020021	http://dx.doi.org/10.1056/NEJMcpc020021			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626LT	12490688				2022-12-28	WOS:000179874500010
J	van de Vijver, MJ; He, YD; van 't Veer, LJ; Dai, H; Hart, AAM; Voskuil, DW; Schreiber, GJ; Peterse, JL; Roberts, C; Marton, MJ; Parrish, M; Atsma, D; Witteveen, A; Glas, A; Delahaye, L; van der Velde, T; Bartelink, H; Rodenhuis, S; Rutgers, ET; Friend, SH; Bernards, R				van de Vijver, MJ; He, YD; van 't Veer, LJ; Dai, H; Hart, AAM; Voskuil, DW; Schreiber, GJ; Peterse, JL; Roberts, C; Marton, MJ; Parrish, M; Atsma, D; Witteveen, A; Glas, A; Delahaye, L; van der Velde, T; Bartelink, H; Rodenhuis, S; Rutgers, ET; Friend, SH; Bernards, R			A gene-expression signature as a predictor of survival in breast cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROGNOSTIC FACTORS; RESIDUALS; PATTERNS; PROFILES; MODELS	Background: A more accurate means of prognostication in breast cancer will improve the selection of patients for adjuvant systemic therapy. Methods: Using microarray analysis to evaluate our previously established 70-gene prognosis profile, we classified a series of 295 consecutive patients with primary breast carcinomas as having a gene-expression signature associated with either a poor prognosis or a good prognosis. All patients had stage I or II breast cancer and were younger than 53 years old; 151 had lymph-node-negative disease, and 144 had lymph-node-positive disease. We evaluated the predictive power of the prognosis profile using univariable and multivariable statistical analyses. Results: Among the 295 patients, 180 had a poor-prognosis signature and 115 had a good-prognosis signature, and the mean (+/-SE) overall 10-year survival rates were 54.6+/-4.4 percent and 94.5+/-2.6 percent, respectively. At 10 years, the probability of remaining free of distant metastases was 50.6+/-4.5 percent in the group with a poor-prognosis signature and 85.2+/-4.3 percent in the group with a good-prognosis signature. The estimated hazard ratio for distant metastases in the group with a poor-prognosis signature, as compared with the group with the good-prognosis signature, was 5.1 (95 percent confidence interval, 2.9 to 9.0; P<0.001). This ratio remained significant when the groups were analyzed according to lymph-node status. Multivariable Cox regression analysis showed that the prognosis profile was a strong independent factor in predicting disease outcome. Conclusions: The gene-expression profile we studied is a more powerful predictor of the outcome of disease in young patients with breast cancer than standard systems based on clinical and histologic criteria.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Diagnost Oncol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Radiotherapy, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Med Oncol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Biometr, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Surg Oncol, NL-1066 CX Amsterdam, Netherlands; Ctr Biomed Genet, Amsterdam, Netherlands; Rosetta Inpharmat, Kirkland, WA USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Merck & Company	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.		Rutgers, Emiel J T/C-5934-2015	Glas, Annuska/0000-0002-0775-138X; van de Vijver, Marc/0000-0002-0385-4787; Bernards, Rene/0000-0001-8677-3423				Abe O, 1998, LANCET, V352, P930; Ahr A, 2002, LANCET, V359, P131, DOI 10.1016/S0140-6736(02)07337-3; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Clarke M, 1998, LANCET, V351, P1451; COX DR, 1972, J R STAT SOC B, V34, P187; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gruvberger S, 2001, CANCER RES, V61, P5979; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Isaacs C, 2001, SEMIN ONCOL, V28, P53, DOI 10.1053/sonc.2001.20742; KLEIN JP, 1991, SCAND J STAT, V18, P333; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.2307/2336057; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	20	4679	4915	6	253	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2002	347	25					1999	2009		10.1056/NEJMoa021967	http://dx.doi.org/10.1056/NEJMoa021967			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626LT	12490681	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000179874500003
J	Furberg, CD; Wright, JT; Davis, BR; Cutler, JA; Alderman, M; Black, H; Cushman, W; Grimm, R; Haywood, LJ; Leenen, F; Oparil, S; Probstfield, J; Whelton, P; Nwachuku, C; Gordon, D; Proschan, M; Einhorn, P; Ford, CE; Piller, LB; Dunn, JK; Goff, D; Pressel, S; Bettencourt, J; deLeon, B; Simpson, LM; Blanton, J; Geraci, T; Walsh, SM; Nelson, C; Rahman, M; Juratovac, A; Pospisil, R; Carroll, L; Sullivan, S; Russo, J; Barone, G; Christian, R; Feldman, S; Lucente, T; Calhoun, D; Jenkins, K; McDowell, P; Johnson, J; Kingry, C; Alzate, J; Margolis, KL; Holland-Klemme, LA; Jaeger, B; Williamson, J; Louis, G; Ragusa, P; Williard, A; Ferguson, RLS; Tanner, J; Eckfeldt, J; Crow, R; Pelosi, J				Furberg, CD; Wright, JT; Davis, BR; Cutler, JA; Alderman, M; Black, H; Cushman, W; Grimm, R; Haywood, LJ; Leenen, F; Oparil, S; Probstfield, J; Whelton, P; Nwachuku, C; Gordon, D; Proschan, M; Einhorn, P; Ford, CE; Piller, LB; Dunn, JK; Goff, D; Pressel, S; Bettencourt, J; deLeon, B; Simpson, LM; Blanton, J; Geraci, T; Walsh, SM; Nelson, C; Rahman, M; Juratovac, A; Pospisil, R; Carroll, L; Sullivan, S; Russo, J; Barone, G; Christian, R; Feldman, S; Lucente, T; Calhoun, D; Jenkins, K; McDowell, P; Johnson, J; Kingry, C; Alzate, J; Margolis, KL; Holland-Klemme, LA; Jaeger, B; Williamson, J; Louis, G; Ragusa, P; Williard, A; Ferguson, RLS; Tanner, J; Eckfeldt, J; Crow, R; Pelosi, J		ALLHAT Officers Coordinators ALLHA	Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care - The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-DISEASE; CHOLESTEROL; EVENTS; RECRUITMENT; RISK; MEN	Context Studies have demonstrated that statins administered to individuals with risk factors for coronary heart disease (CHD) reduce CHD events. However, many of these studies were too small to assess all-cause mortality or Outcomes in important subgroups. Objective To determine whether pravastatin compared with usual care reduces all-cause mortality in older, moderately hypercholesterolemic, hypertensive participants with at least 1 additional CHD risk factor. Design and Setting Multicenter (513 primarily community-based North American clinical centers), randomized, nonblinded trial conducted from 1994 through March 2002 in a subset of participants from the Anti hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Participants Ambulatory persons (n = 10355), aged 55 years or older, with low-density lipoprotein cholesterol (LDL-C) of 120 to 189 mg/dL (100 to 129 mg/dL if known CHD) and triglycerides lower than 350 mg/dL, were randomized to pravastatin (n=5170) or to usual care (n =5185). Baseline mean total cholesterol was 224 mg dL, LDL-C, 146 mg/dL; high-density lipoprotein cholesterol, 48 mg/dL; and triglycerides, 152 mg/dL. Mean age was 66 years, 49% were women, 38% black and 23% Hispanic, 14% had a history of CHD, and 35% had type 2 diabetes. Intervention Pravastatin, 40 mg/d, vs usual care. Main Outcome Measures The primary outcome was all-cause mortality, with follow-up for up to 8 years. Secondary outcomes included nonfatal myocardial infarction or fatal CHD (CHD events) combined, cause-specific mortality, and cancer. Results Mean follow-up was 4.8 years. During the trial, 32% of usual care participants with and 29% without CHD started taking lipid-lowering drugs. At year 4, total cholesterol levels were reduced by 17% with pravastatin vs 8% with usual care; among the random sample who had LDL-C levels assessed, levels were reduced by 28% with pravastatin vs 11% with usual care. All-cause mortality was similar for the 2 groups (relative risk [RR], 0.99; 95% confidence interval [01, 0.89-1.11; P=.88), with 6-year mortality rates of 14.9% for pravastatin vs 15.3% with usual care. CHD event rates were not significantly different between the groups (RR, 0.91 95% Cl, 0.79-1.04; P=.16), with 6-year CHD event rates of 9.3% for pravastatin an 10.4% for usual care. Conclusions Pravastatin did not reduce either all-cause mortality or CHD significantly when compared with usual care in older participants with well-controlled hypertension and moderately elevated LDL-C. The results may be due to the Modest differential in total cholesterol (9.6%) and LDL-C(16.7%) between pravastatin and usual care compared with prior statin trials supporting cardiovascular disease prevention.	Univ Washington, Sch Med, Med Ctr, Seattle, WA 98195 USA; Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Probstfield, J (corresponding author), Univ Washington, Sch Med, Med Ctr, 1959 NE Pacific St,Box 356422, Seattle, WA 98195 USA.	bdavis@sph.uth.tmc.edu; jeffp@swog.fhcrc.org			NHLBI NIH HHS [N01-HC-35130] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035130] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		[Anonymous], 1988, INT CLASS DIS 9 REV; Campeau L, 1997, NEW ENGL J MED, V336, P153; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; DAVIS BR, 1990, COMMUN STAT THEORY, V19, P3571, DOI 10.1080/03610929008830398; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; GORDON D, 1995, CONT ISSUES CHOLESTE, P33; Gordon DJ, 2000, CHOLESTEROL-LOWERING THERAPY, P299; GORDON DJ, 2002, 6 INT S GLOB RISK CO; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Klein JP., 2003, SURVIVAL ANAL TECHNI; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; LAROSA JC, 1994, ARCH INTERN MED, V154, P529, DOI 10.1001/archinte.154.5.529; PEDERSEN TR, 1994, LANCET, V344, P1383; Pressel S, 2001, CONTROL CLIN TRIALS, V22, P674, DOI 10.1016/S0197-2456(01)00177-5; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sacks FM, 2000, CIRCULATION, V102, P1893, DOI 10.1161/01.CIR.102.16.1893; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Wright JT, 2001, CONTROL CLIN TRIALS, V22, P659, DOI 10.1016/S0197-2456(01)00176-3	27	529	550	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2002	288	23					2998	3007		10.1001/jama.288.23.2998	http://dx.doi.org/10.1001/jama.288.23.2998			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CG	12479764	Bronze			2022-12-28	WOS:000179854200034
J	Chaudhry, S; Schroter, S; Smith, R; Morris, J				Chaudhry, S; Schroter, S; Smith, R; Morris, J			Does declaration of competing interests affect readers' perceptions? A randomised trial	BRITISH MEDICAL JOURNAL			English	Article									BMJ Editorial, London WC1H 9JR, England; Wythenshawe Hosp, Educ & Res Ctr, Dept Med Stat, Manchester M23 9LT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Schroter, S (corresponding author), BMJ Editorial, BMA House, London WC1H 9JR, England.		Schroter, Sara/G-3427-2012	Schroter, Sara/0000-0002-8791-8564				Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; COPLAN PM, 2000, BMJ; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Lenzer J, 2002, BRIT MED J, V324, P723, DOI 10.1136/bmj.324.7339.723; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812	5	95	96	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1391	1392		10.1136/bmj.325.7377.1391	http://dx.doi.org/10.1136/bmj.325.7377.1391			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480854	Green Published			2022-12-28	WOS:000179975000023
J	Morgan, JA				Morgan, JA			Looking beneath the surface	SCIENCE			English	Editorial Material							ELEVATED ATMOSPHERIC CO2; RESPONSES; MODEL		ARS, USDA, Rangeland Resources Res Unit, Ft Collins, CO 80526 USA	United States Department of Agriculture (USDA)	Morgan, JA (corresponding author), ARS, USDA, Rangeland Resources Res Unit, 1701 Ctr Ave, Ft Collins, CO 80526 USA.							ACKERLY DD, 1995, GLOB CHANGE BIOL, V1, P199, DOI 10.1111/j.1365-2486.1995.tb00021.x; DIAZ S, 1993, NATURE, V364, P616, DOI 10.1038/364616a0; DRAKE BG, 1997, ANNU REV PLANT PHYS, V48, P607; Houghton J. T., 2001, CLIMATE CHANGE 2001; Newton PCD, 2001, ECOL LETT, V4, P344, DOI 10.1046/j.1461-0248.2001.00233.x; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Thornley JHM, 2000, PLANT SOIL, V224, P153, DOI 10.1023/A:1004640327512; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Zak DR, 2000, NEW PHYTOL, V147, P201, DOI 10.1046/j.1469-8137.2000.00687.x	9	22	31	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1903	1904		10.1126/science.1079808	http://dx.doi.org/10.1126/science.1079808			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471239				2022-12-28	WOS:000179629200026
J	Abbott, A				Abbott, A			Talkin' about regeneration	NATURE			English	Article																			0	0	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					456	457		10.1038/420456b	http://dx.doi.org/10.1038/420456b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466810	Bronze			2022-12-28	WOS:000179611600013
J	Phillips, MR; Yang, GH; Zhang, YP; Wang, LJ; Ji, HY; Zhou, MG				Phillips, MR; Yang, GH; Zhang, YP; Wang, LJ; Ji, HY; Zhou, MG			Risk factors for suicide in China: a national case-control psychological autopsy study	LANCET			English	Article								Background Suicide is the fifth most important cause of death in China, but the reasons for the high rate and unique pattern of characteristics of those who kill themselves are unknown. Methods We pretested, and then administered a comprehensive interview to family members and close associates of 519 people who committed suicide and of 536 people who died from other injuries (controls) randomly selected from 23 geographically representative sites in China. Findings After adjustment for sex, age, location of residence, and research site, eight significant predictors of suicide remained in the final unconditional logistic regression model. In order of importance they were: high depression symptom score, previous suicide attempt, acute stress at time of death, low quality of life, high chronic stress, severe interpersonal conflict in the 2 days before death, a blood relative with previous suicidal behaviour, and a friend or associate with previous suicidal behaviour. Suicide risk increased substantially with exposure to multiple risk factors: none of the 265 deceased people who were exposed to one or fewer of the eight risk factors died by suicide, but 30% (90/299) with two or three risk factors, 85% (320/377) with four or five risk factors, and 96% (109/114) with six or more risk factors died by suicide. Interpretation Despite substantial differences between characteristics of people who commit suicide in China and the west, risk factors for suicide do not differ greatly. Suicide prevention programmes that concentrate on a single risk factor are unlikely to reduce suicide rates substantially; preventive efforts should focus on individuals exposed to multiple risk factors.	Beijing Hui Long Guan Hosp, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China; Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Phillips, MR (corresponding author), Beijing Hui Long Guan Hosp, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China.		Zhou, Maigeng/HCH-7703-2022; Phillips, Michael Robert/AAE-7585-2021; Zhang, Xiao/V-9027-2017	Phillips, Michael Robert/0000-0002-5973-2439; Zhang, Xiao/0000-0002-2932-5875				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 2008, INT HDB SUICIDE ATTE; [Anonymous], 1999, WORLD HLTH REPORT 19; Appleby L, 1999, BRIT J PSYCHIAT, V175, P168, DOI 10.1192/bjp.175.2.168; Beautrais AL, 2001, PSYCHOL MED, V31, P837; BRENT DA, 1989, SUICIDE LIFE-THREAT, V19, P43; Cavanagh JTO, 1999, PSYCHOL MED, V29, P1141, DOI 10.1017/S0033291799001038; *CHIN SOC PSYCH, 2000, CHIN CLASS MENT DIS; CLARK D. C., 1992, ASSESSMENT PREDICTIO, P144; Cooper JE, 1996, MENTAL DISORDERS CHI; First M.B., 2014, STRUCTURED CLIN INTE; Fleiss J. L., 1981, STAT METHODS RATES P, V2; GURURAJ G, 2001, NAT I MENTAL HLTH NE, V43; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hawton K, 1998, J AFFECT DISORDERS, V50, P269; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; LI SR, 1998, CHIN J PSYCHIAT, V31, P80; Li X, 2001, CHIN J EPIDEMIOL, V22, P281; Lonnqvist J. K., 2000, INT HDB SUICIDE ATTE, P107, DOI [DOI 10.1002/9780470698976.CH7, 10.1002/9780470698976.ch7]; Ma C, 1999, CHIN MENT HLTH J, V13, P110; Mortensen PB, 2000, LANCET, V355, P9, DOI 10.1016/S0140-6736(99)06376-X; Moscicki EK, 1997, PSYCHIAT CLIN N AM, V20, P499, DOI 10.1016/S0193-953X(05)70327-0; Nagelkerle N, 1991, BIOMETRIKA, V78, P791; Parker G, 2001, AM J PSYCHIAT, V158, P857, DOI 10.1176/appi.ajp.158.6.857; Phillips MR, 1999, CULT MED PSYCHIAT, V23, P25, DOI 10.1023/A:1005462530658; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Qin P, 2001, ACTA PSYCHIAT SCAND, V103, P117, DOI 10.1034/j.1600-0447.2001.00008.x; United Nations, 1996, PREV SUIC GUID FORM; Vijayakumar L, 1999, ACTA PSYCHIAT SCAND, V99, P407, DOI 10.1111/j.1600-0447.1999.tb00985.x; *WHO, 2001, WORKSH SUIC PREV CHI; Yang GH., 1991, EXPLORING ADULT MORT; Zhang B, 2000, SHANGHAI J PREV MED, V12, P282; Zhang W.X., 1998, CHINESE J PSYCHIAT, V31, P69; Zhao M., 2000, SHANGHAI PSYCHIATRIC, V12, P222, DOI [10.3969/j.issn.1002-0829.2000.04.015, DOI 10.3969/J.ISSN.1002-0829.2000.04.015]	34	561	687	3	77	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1728	1736		10.1016/S0140-6736(02)11681-3	http://dx.doi.org/10.1016/S0140-6736(02)11681-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622FU	12480425				2022-12-28	WOS:000179636800009
J	Tao, YZ; Farsetta, DL; Nibert, ML; Harrison, SC				Tao, YZ; Farsetta, DL; Nibert, ML; Harrison, SC			RNA synthesis in a cage - Structural studies of reovirus polymerase lambda 3	CELL			English	Article							CRYSTAL-STRUCTURE; DNA-POLYMERASE; REVERSE-TRANSCRIPTASE; ANGSTROM RESOLUTION; ELONGATION COMPLEX; INITIATION; MICROSCOPY; PARTICLES; MECHANISM; HELICASE	The reovirus polymerase and those of other dsRNA viruses function within the confines of a protein capsid to transcribe the tightly packed dsRNA genome segments. The crystal structure of the reovirus polymerase, lambda3, determined at 2.5 Angstrom resolution, shows a fingers-palm-thumb core, similar to those of other viral polymerases, surrounded by major N- and C-terminal elaborations, which create a cage-like structure, with four channels leading to the catalytic site. This "caged" polymerase has allowed us to visualize the results of several rounds of RNA polymerization directly in the crystals. A 5' cap binding site on the surface of lambda3 suggests a template retention mechanism by which attachment of the 5' end of the plus-sense strand facilitates insertion of the 3' end of the minus-sense strand into the template channel.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Wisconsin, Inst Mol Virol, Mol & Cellular Biol Program, Madison, WI 53706 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School	Harrison, SC (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	harrison@crystal.harvard.edu			NATIONAL CANCER INSTITUTE [R37CA013202, R01CA013202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI039533, R01AI047904] Funding Source: NIH RePORTER; NCI NIH HHS [CA13202] Funding Source: Medline; NIAID NIH HHS [AI-47904, AI-39533] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Ahola T, 2000, J VIROL, V74, P8803, DOI 10.1128/JVI.74.19.8803-8811.2000; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bisaillon M, 1997, J BIOL CHEM, V272, P18298, DOI 10.1074/jbc.272.29.18298; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; BRUENN JA, 1991, NUCLEIC ACIDS RES, V19, P217, DOI 10.1093/nar/19.2.217; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 2000, CURR OPIN STRUC BIOL, V10, P117, DOI 10.1016/S0959-440X(99)00058-5; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Dryden KA, 1998, VIROLOGY, V245, P33, DOI 10.1006/viro.1998.9146; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; Farsetta DL, 2000, J BIOL CHEM, V275, P39693, DOI 10.1074/jbc.M004562200; GILLIES S, 1971, SCIENCE, V174, P694, DOI 10.1126/science.174.4010.694; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hakansson K, 1998, P NATL ACAD SCI USA, V95, P1505, DOI 10.1073/pnas.95.4.1505; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hu GH, 1999, P NATL ACAD SCI USA, V96, P7149, DOI 10.1073/pnas.96.13.7149; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuznedelov K, 2002, EMBO J, V21, P1369, DOI 10.1093/emboj/21.6.1369; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mindich L, 1999, MICROBIOL MOL BIOL R, V63, P149, DOI 10.1128/MMBR.63.1.149-160.1999; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nibert ML., 2001, FIELDS VIROLOGY, P1679; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Noble S, 1997, J VIROL, V71, P7728, DOI 10.1128/JVI.71.10.7728-7735.1997; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; SKEHEL JJ, 1969, VIROLOGY, V39, P822, DOI 10.1016/0042-6822(69)90019-1; STARNES MC, 1993, VIROLOGY, V193, P356, DOI 10.1006/viro.1993.1132; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328	48	265	278	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	2002	111	5					733	745		10.1016/S0092-8674(02)01110-8	http://dx.doi.org/10.1016/S0092-8674(02)01110-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464184	Bronze			2022-12-28	WOS:000179594500014
J	Mack, T				Mack, T			A different view of smallpox and vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESPONSES		Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA	University of Southern California	Mack, T (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA.							*ADV COMM IMM PRAC, 2002, SUMM OCT 2002 ACIP S; Alibek K, 1999, BIOHAZARD CHILLING T; *ANDR AIR FORC BAS, 2001, DARK WINT BIOT EX; ARITA I, 1970, AM J PUBLIC HEALTH N, V60, P1960, DOI 10.2105/AJPH.60.10.1960; Bicknell WJ, 2002, NEW ENGL J MED, V346, P1323, DOI 10.1056/NEJMsb020357; BROAD WJ, 2002, NY TIMES A      0615, P1; *BUR LAB STAT, 2002, 2000 NAT IND SPEC OC; COWLEY G, 2002, NEWSWEEK        1014; DERUGY V, 2002, 434 CAT I, P1; DIXON C.W, 1962, SMALLPOX; DOWNIE AW, 1965, B WORLD HEALTH ORGAN, V33, P615; DOWNIE AW, 1961, B WORLD HEALTH ORGAN, V25, P49; GELFAND HM, 1971, AM J EPIDEMIOL, V93, P234, DOI 10.1093/oxfordjournals.aje.a121251; HEINER GG, 1971, AM J EPIDEMIOL, V94, P435, DOI 10.1093/oxfordjournals.aje.a121340; IRONS JV, 1953, AM J PUBLIC HEALTH, V43, P25, DOI 10.2105/AJPH.43.1.25; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; Jezek Z, 1988, HUMAN MONKEYPOX; KEMPE CH, 1960, PEDIATRICS, V26, P176; KEMPE CH, 1961, B WORLD HEALTH ORGAN, V25, P41; LANE JM, 1970, J AMER MED ASSOC, V212, P441, DOI 10.1001/jama.212.3.441; Lane JM, 1972, SMALLPOX YUGOSLAVIA; MACK TM, 1970, J INFECT DIS, V122, P479, DOI 10.1093/infdis/122.6.479; MACK TM, 1972, J INFECT DIS, V125, P161, DOI 10.1093/infdis/125.2.161; MACK TM, 1972, AM J EPIDEMIOL, V95, P169, DOI 10.1093/oxfordjournals.aje.a121382; MARENNIKOVA SS, 1962, B WORLD HEALTH ORGAN, V27, P325; MAYHEW CJ, 1970, APPL MICROBIOL, V20, P313, DOI 10.1128/AEM.20.3.313-316.1970; MEIKLEJOHN G, 1961, B WORLD HEALTH ORGAN, V25, P63; Meltzer MI, 2001, EMERG INFECT DIS, V7, P959, DOI 10.3201/eid0706.010607; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; Palmquist Emil E., 1947, CANADIAN JOUR PUBL HEALTH, V38, P213; Rao AR, 1972, SMALLPOX; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; THOMAS DB, 1972, AM J EPIDEMIOL, V95, P178, DOI 10.1093/oxfordjournals.aje.a121383; THOMAS DB, 1971, AM J EPIDEMIOL, V93, P361, DOI 10.1093/oxfordjournals.aje.a121269; WEINSTEIN I, 1947, AM J PUBLIC HEALTH, V37, P1376	35	41	42	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					460	463		10.1056/NEJMsb022994	http://dx.doi.org/10.1056/NEJMsb022994			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12496354				2022-12-28	WOS:000180643800014
J	Glaser, R; Herrmann, HC; Murphy, SA; Demopoulos, LA; DiBattiste, PM; Cannon, CP; Braunwald, E				Glaser, R; Herrmann, HC; Murphy, SA; Demopoulos, LA; DiBattiste, PM; Cannon, CP; Braunwald, E			Benefit of an early invasive management strategy in women with acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WAVE MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; ARTERY DISEASE; CONSERVATIVE STRATEGIES; MEN; ANGIOPLASTY; MORTALITY; REGISTRY; SEX; ASSOCIATION	Context Women who present with acute coronary syndromes (ACSs) have different characteristics than men. Reports have conflicted about whether different outcomes exist for women with use of a routine invasive management strategy. However, these studies were performed prior to the widespread use of platelet glycoprotein IIb/IIIa inhibitors and intracoronary stents. Objective To determine sex differences in baseline characteristics and outcomes in ACS and whether women benefit from a contemporary early invasive management strategy. Design and Setting Prospective analysis of women and men enrolled in the TACTICS-TIMI 18 randomized trial, conducted December 1997 to December 1999 in 169 centers in 9 countries in North America and Europe, with follow-up at 1 and 6 months. Participants A total of 2220 patients (757 women and 1463 men) with ACS. Interventions All patients received aspirin, 325 mg/d; intravenous unfractionated heparin; and tirofiban for 48 hours or until revascularization, with tirofiban administered for at least 12 hours after percutaneous coronary revascularization. Patients assigned to the early invasive strategy (n=11 14) underwent coronary angiography 4 to 48 hours after randomization and revascularization when appropriate. Patients assigned to the early conservative strategy (n = 1106) were treated medically and underwent coronary angiography and appropriate revascularization only if they met specified criteria. Main Outcome Measures Baseline characteristics and the primary composite end point of death, myocardial infarction, or rehospitalization for ACS at 6 months in women and men assigned to early invasive vs conservative management. Results Women were older and more frequently had hypertension (P<.001 for both). Women less frequently had previous myocardial infarction, coronary artery bypass grafting, and elevations in cardiac markers (P<.001 for all), but there was no difference in distribution of TIMI risk scores (P=.76). Angiography and intervention rates were similar, but women had less severe coronary artery disease, including no critical lesions in 17% of women vs 9% of men (P<.001). Women had a 28% odds reduction in the primary end point with an early invasive strategy (adjusted odds ratio [OR], 0.72; 95% confidence interval [0], 0.47-1.11), similar to the benefit in men (adjusted OR, 0.64; 95% Cl, 0.47-0.88; P=.60 for sex interaction). When adjusted for baseline characteristics, the benefit of invasive therapy in women with elevated troponin T levels was further enhanced (adjusted OR, 0.47; 95% Cl, 0.26-0.83). Conclusions Despite differences between women and men in baseline characteristics, the benefit of an early invasive strategy incorporating tirofiban and intracoronary stents was similar in women and men and was enhanced in women presenting with markers of increased risk.	Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Merck Res Labs, Blue Bell, PA USA	University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Merck & Company	Herrmann, HC (corresponding author), Hosp Univ Penn, 9 Founders Pavil,3400 Spruce St, Philadelphia, PA 19104 USA.		Cannon, Christopher P/AAY-7644-2020	Cannon, Christopher P/0000-0003-4596-2791				Bazzino O, 1998, NEW ENGL J MED, V338, P1498; Boersma E, 1999, CIRCULATION, V100, P2045, DOI 10.1161/01.CIR.100.20.2045; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; Cannon CP, 1998, AM J CARDIOL, V82, P731, DOI 10.1016/S0002-9149(98)00540-2; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; DAVIS KB, 1995, J AM COLL CARDIOL, V25, P1000, DOI 10.1016/0735-1097(94)00518-U; DESANCTIS RW, 1994, CARDIOVASC REV REP, V15, P10; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; FISHER LD, 1982, J THORAC CARDIOV SUR, V84, P334; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1; Lagerqvist B, 2001, J AM COLL CARDIOL, V38, P41, DOI 10.1016/S0735-1097(01)01308-0; Malenka DJ, 1996, CIRCULATION, V94, P99; Maynard C, 1997, ARCH INTERN MED, V157, P1379, DOI 10.1001/archinte.157.12.1379; Mueller C, 2002, J AM COLL CARDIOL, V40, P245, DOI 10.1016/S0735-1097(02)01949-6; OCONNOR GT, 1993, CIRCULATION, V88, P2104, DOI 10.1161/01.CIR.88.5.2104; Philpott S, 2001, SOC SCI MED, V52, P1565, DOI 10.1016/S0277-9536(00)00269-0; Rankin JM, 1999, NEW ENGL J MED, V341, P1957, DOI 10.1056/NEJM199912233412602; Scirica BM, 1999, AM J CARDIOL, V84, P1145, DOI 10.1016/S0002-9149(99)00525-1; Shlipak MG, 2001, ANN INTERN MED, V134, P1043, DOI 10.7326/0003-4819-134-11-200106050-00010; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; Welty FK, 2001, AM J CARDIOL, V88, P473, DOI 10.1016/S0002-9149(01)01721-0	23	197	214	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2002	288	24					3124	3129		10.1001/jama.288.24.3124	http://dx.doi.org/10.1001/jama.288.24.3124			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628QQ	12495392	Bronze			2022-12-28	WOS:000180008200022
J	Madden, JM; Soumerai, SB; Lieu, TA; Mandl, KD; Zhang, F; Ross-Degnan, D				Madden, JM; Soumerai, SB; Lieu, TA; Mandl, KD; Zhang, F; Ross-Degnan, D			Effects of a law against early postpartum discharge on newborn follow-up, adverse events, and HMO expenditures.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Academy-of-Health-Services-Research-and-Health-Policy	JUN, 2002	WASHINGTON, D.C.	Acad Hlth Serv Res & Hlth Policy			HOSPITAL READMISSION; STAY; LENGTH; MORTALITY; MEDICAID; MOTHERS; PROGRAM; CARE	Background: Concern about harm to newborns from early postpartum discharges led to laws establishing minimum hospital stays in the mid-1990s. We evaluated the effects of an early-discharge protocol (a hospital stay of one postpartum night plus a home visit) in a health maintenance organization (HMO) and a subsequent state law guaranteeing a 48-hour hospital stay. Methods: Using interrupted-time-series analysis and data on 20,366 mother-infant pairs with normal vaginal deliveries, we measured changes in length of stay, newborn examinations on the third or fourth day of life, and office visits, emergency department visits, and hospital readmissions for newborns. We also examined expenditures for hospitalizations and home-based care. Results: The early-discharge program increased the rate of stays of less than two nights from 29.0 percent to 65.6 percent (P<0.001). The rate declined to 13.7 percent after the state mandate (P<0.001). The rate of newborn examinations on the third or fourth day of life increased from 24.5 percent to 64.4 percent with the program (P<0.001), then dropped to 53.0 percent after the mandate (P<0.001) -- changes that primarily reflected changes in the rate of home visits. The rate of nonurgent visits to a health center increased from 33.4 percent to 44.7 percent (P<0.001) after the reduced-stay program was implemented. There were no significant changes in the rate of emergency department visits (quarterly mean, 1.1 percent) or rehospitalizations (quarterly mean, 1.5 percent). Results were similar for a vulnerable subgroup with lower incomes, younger maternal age, a lower level of education, or some combination of these characteristics. Average HMO expenditures on hospital and home-based services decreased by $90 per delivery with the early-discharge program and increased by $100 after the mandate. Conclusions: Neither policy appears to have affected the health outcomes of newborns. After the mandate, newborns were less likely to be examined as recommended on day 3 or 4. Because of changes in hospital prices, the two policies had minimal effects on HMO expenditures for hospital and home-based services.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA 02215 USA; Childrens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital	Ross-Degnan, D (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Fl, Boston, MA 02215 USA.				AHRQ HHS [5R01HS10060] Funding Source: Medline; PHS HHS [H16MC00050] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010060] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], 2001, Jt Comm Perspect, V21, P10; Braveman P, 1997, JAMA-J AM MED ASSOC, V278, P334; BRAVEMAN P, 1995, PEDIATRICS, V96, P716; BRITTON JR, 1994, PEDIATRICS, V94, P291; Brumfield CG, 1998, CLIN OBSTET GYNECOL, V41, P611, DOI 10.1097/00003081-199809000-00016; CARTY EM, 1990, BIRTH-ISS PERINAT C, V17, P199, DOI 10.1111/j.1523-536X.1990.tb00021.x; CHARLES S, 1995, PEDIATRICS, V96, P746; Cook T.C., 1979, QUASIEXPERIMENTATION; Declercq E, 1997, MILBANK Q, V75, P175, DOI 10.1111/1468-0009.00051; Eaton AP, 2001, PEDIATRICS, V107, P400, DOI 10.1542/peds.107.2.400; Edmonson MB, 1997, JAMA-J AM MED ASSOC, V278, P299, DOI 10.1001/jama.278.4.299; Gagnon AJ, 1997, AM J OBSTET GYNECOL, V176, P205, DOI 10.1016/S0002-9378(97)80037-3; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; GILLINGS D, 1981, AM J PUBLIC HEALTH, V71, P38, DOI 10.2105/AJPH.71.1.38; Kotagal UR, 1999, JAMA-J AM MED ASSOC, V282, P1150, DOI 10.1001/jama.282.12.1150; LAWRENCE RA, 1999, BREASTFEEDING GUIDE; Liu LL, 1997, JAMA-J AM MED ASSOC, V278, P2067; MADDEN JM, 2000, 6 ANN HMO RES NETW C; Maisels MJ, 1998, PEDIATRICS, V101, P995, DOI 10.1542/peds.101.6.995; Malkin JD, 2000, OBSTET GYNECOL, V96, P183, DOI 10.1016/S0029-7844(00)00894-2; Mandl KD, 1997, ARCH PEDIAT ADOL MED, V151, P915, DOI 10.1001/archpedi.1997.02170460053009; Mandl KD, 2000, PEDIATRICS, V106, P937; Martin S, 2000, INDEX CENSORSHIP, V29, P72, DOI 10.1080/03064220008536766; OH W, 1995, PEDIATRICS, V96, P788; Platt R., 1994, PHARMACOEPIDEM DR S, P277; ROSSDEGNAN D, 1993, JAMA-J AM MED ASSOC, V270, P1937, DOI 10.1001/jama.270.16.1937; SAS Institute, 1993, SAS ETS US GUID VERS SAS ETS US GUID VERS, V2nd; SOUMERAI SB, 1987, NEW ENGL J MED, V317, P550, DOI 10.1056/NEJM198708273170906; Thilo EH, 1998, CLIN PERINATOL, V25, P257, DOI 10.1016/S0095-5108(18)30114-3; 1995, MMWR MORB MORTAL WKL, V44, P335	30	62	66	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2002	347	25					2031	2038		10.1056/NEJMsa020408	http://dx.doi.org/10.1056/NEJMsa020408			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626LT	12490685	Green Submitted, Green Published			2022-12-28	WOS:000179874500007
J	Chapman, RS; Smith, GE; Warburton, F; Mayon-White, RT; Fleming, DM				Chapman, RS; Smith, GE; Warburton, F; Mayon-White, RT; Fleming, DM			Impact of NHS Direct on general practice consultations during the winter of 1999-2000: analysis of routinely collected data	BRITISH MEDICAL JOURNAL			English	Article									Birmingham Heartlands Hosp, Publ Hlth Lab Serv, Communicable Dis Surveillance Ctr W Midlands, Birmingham B9 5SS, W Midlands, England; Publ Hlth Lab Serv, Stat Unit, London NW9 5EQ, England; Oxford City Primary Care Trust, Oxford OX3 7LG, England; Royal Coll Gen Practitioners, Birmingham Res Unit, Birmingham B17 9DB, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham; Public Health England	Smith, GE (corresponding author), Birmingham Heartlands Hosp, Publ Hlth Lab Serv, Communicable Dis Surveillance Ctr W Midlands, Lincoln House, Birmingham B9 5SS, W Midlands, England.			Chapman, Rachel/0000-0001-5786-1918				Dedman DJ, 1997, PHLS MICROBIOL DIGES, V14, P206; Fleming D M, 1999, Commun Dis Public Health, V2, P96; Goddard N L, 2000, Commun Dis Public Health, V3, P261; Munro J, 2000, BRIT MED J, V321, P150, DOI 10.1136/bmj.321.7254.150; Woodman R, 2000, BRIT MED J, V320, P138, DOI 10.1136/bmj.320.7228.138	5	10	10	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1397	1398		10.1136/bmj.325.7377.1397	http://dx.doi.org/10.1136/bmj.325.7377.1397			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480857	Green Published			2022-12-28	WOS:000179975000026
J	Musset, D; Parent, F; Meyer, G; Maitre, S; Girard, P; Leroyer, C; Revel, MP; Carette, MF; Laurent, M; Charbonnier, B; Laurent, F; Mal, H; Nonent, M; Lancar, R; Grenier, P; Simonneau, G				Musset, D; Parent, F; Meyer, G; Maitre, S; Girard, P; Leroyer, C; Revel, MP; Carette, MF; Laurent, M; Charbonnier, B; Laurent, F; Mal, H; Nonent, M; Lancar, R; Grenier, P; Simonneau, G		Evaluation Scanner Spirale l'Embol	Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study	LANCET			English	Article							HELICAL COMPUTED-TOMOGRAPHY; SPIRAL CT; CLINICAL-MODEL; ANGIOGRAPHY; THROMBOEMBOLISM; MANAGEMENT; AGREEMENT	Background We designed a prospective multicentre outcome study to evaluate a diagnostic strategy based on clinical probability, spiral CT, and venous compression ultrasonography of the legs in patients with suspected pulmonary embolism (PE). The main aim was to assess the safety of withholding anticoagulant treatment in patients with low or intermediate clinical probability of PE and negative findings on spiral CT and ultrasonography. Methods 1041 consecutive inpatients and outpatients with suspected PE were included. Patients with negative spiral CT and ultrasonography and clinically assessed as having a low or intermediate clinical probability were left untreated. Those with high clinical probability underwent lung scanning, pulmonary angiography, or both. All patients were followed up for 3 months. Findings PE was diagnosed in 360 (34.6%) patients; 55 had positive ultrasonography despite negative spiral CT. Of 601 patients with negative spiral CT and ultrasonography, 76 were clinically assessed as having a high probability of PE; lung scanning or angiography showed PE in four (5.3% [95% CI 1.5-13.1]). The remaining 525 patients were assessed as having low or intermediate clinical probability, and 507 of them were not treated. Of these patients, nine experienced venous thromboembolism during follow-up (1.8% [0.8-3.3]). The diagnostic strategy proved inconclusive in 95 (9.1%) patients, and pulmonary angiography was done in 74 (7.1%). Interpretation Withholding of anticoagulant therapy is safe when the clinical probability of PE is assessed as low or intermediate and spiral CT and ultrasonography are negative.	Hop Univ Antoine Beclere, Serv Radiol, Clamart, France; Hop Univ Antoine Beclere, Serv Pneumol, Clamart, France; Hop Univ Europeen Georges Pompidou, Serv Pneumol, Paris, France; Hop Univ Europeen Georges Pompidou, Serv Radiol, Paris, France; Inst Mutualiste Montsouris, Dept Thorac, Paris, France; Hop La Cavale Blanche, Serv Med Interne & Pneumol, Brest, France; Hop La Cavale Blanche, Serv Radiol, Brest, France; Hop Univ Tenon, Serv Radiol, Paris, France; Hop Univ Pontchaillou, Serv Cardiol, Rennes, France; Hop Univ Trousseau, Serv Cardiol, Tours, France; Hop Univ Haut Leveque, Serv Radiol, Bordeaux, France; Hop Univ Beaujon, Serv Pneumol, Paris, France; Hop Univ Pitie Salpetriere, Serv Radiol, Paris, France; Hop Univ Pitie Salpetriere, INSERM, EMI 0214, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Rennes; CHU Tours; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Simonneau, G (corresponding author), Hop Antoine Beclere, Div Resp Med, 157 Ave Porte Trivaux, F-92140 Clamart, France.	gerald.simonneau@abc.ap-hop-paris.fr	Simonneau, Gerald/ABE-6614-2020	leroyer, christophe/0000-0002-7601-1692; revel, marie-pierre/0000-0001-8213-7817; NONENT, Michel/0000-0002-1317-8997				Ferretti GR, 1997, RADIOLOGY, V205, P453, DOI 10.1148/radiology.205.2.9356628; Garg K, 1998, RADIOLOGY, V208, P201, DOI 10.1148/radiology.208.1.9646814; Hartmann IJC, 2001, THROMB HAEMOSTASIS, V85, P604; HULL RD, 1994, ARCH INTERN MED, V154, P289, DOI 10.1001/archinte.154.3.289; Hyers TM, 1999, AM J RESP CRIT CARE, V159, P1; Miron MJ, 1999, EUR RESPIR J, V13, P1365, DOI 10.1183/09031936.99.13613719; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Perrier A, 2001, ANN INTERN MED, V135, P88, DOI 10.7326/0003-4819-135-2-200107170-00008; Raptopoulos V, 2001, RADIOLOGY, V221, P606, DOI 10.1148/radiol.2213010473; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; RemyJardin M, 1996, RADIOLOGY, V200, P699, DOI 10.1148/radiology.200.3.8756918; REMYJARDIN M, 1992, RADIOLOGY, V185, P381, DOI 10.1148/radiology.185.2.1410342; STEIN PD, 1991, CHEST, V100, P598, DOI 10.1378/chest.100.3.598; STEIN PD, 1992, CIRCULATION, V85, P462, DOI 10.1161/01.CIR.85.2.462; Stein PD, 1999, RADIOLOGY, V210, P689, DOI 10.1148/radiology.210.3.r99mr41689; vanBeek EJR, 1996, RADIOLOGY, V198, P721, DOI 10.1148/radiology.198.3.8628860; vanErkel AR, 1996, RADIOLOGY, V201, P29, DOI 10.1148/radiology.201.1.8816516; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	20	311	323	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2002	360	9349					1914	1920		10.1016/S0140-6736(02)11914-3	http://dx.doi.org/10.1016/S0140-6736(02)11914-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493257				2022-12-28	WOS:000179870200009
J	Murphy, CJ				Murphy, CJ			Nanocubes and nanoboxes	SCIENCE			English	Editorial Material							NANOPARTICLES; CLUSTERS; SHAPES		Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Murphy, CJ (corresponding author), Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.		Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Murphy, Catherine/0000-0001-7066-5575				Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Dick K, 2002, J AM CHEM SOC, V124, P2312, DOI 10.1021/ja017281a; El-Sayed MA, 2001, ACCOUNTS CHEM RES, V34, P257, DOI 10.1021/ar960016n; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Filankembo A, 2000, J PHYS CHEM B, V104, P5865, DOI 10.1021/jp000268c; He L, 2000, J AM CHEM SOC, V122, P9071, DOI 10.1021/ja001215b; Jin RC, 2001, SCIENCE, V294, P1901, DOI 10.1126/science.1066541; Johnson CJ, 2002, J MATER CHEM, V12, P1765, DOI 10.1039/b200953f; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; Murphy CJ, 2002, ADV MATER, V14, P80, DOI 10.1002/1521-4095(20020104)14:1<80::AID-ADMA80>3.0.CO;2-#; Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137; Puntes VF, 2001, SCIENCE, V291, P2115, DOI 10.1126/science.1057553; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647	16	426	440	1	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2139	+		10.1126/science.1080007	http://dx.doi.org/10.1126/science.1080007			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481122				2022-12-28	WOS:000179773700031
J	Bosse, MJ; MacKenzie, EJ; Kellam, JF; Burgess, AR; Webb, LX; Swiontkowski, MF; Sanders, RW; Jones, AL; McAndrew, MP; Patterson, BM; McCarthy, ML; Travison, TG; Castillo, RC				Bosse, MJ; MacKenzie, EJ; Kellam, JF; Burgess, AR; Webb, LX; Swiontkowski, MF; Sanders, RW; Jones, AL; McAndrew, MP; Patterson, BM; McCarthy, ML; Travison, TG; Castillo, RC			An analysis of outcomes of reconstruction or amputation of leg-threatening injuries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SICKNESS IMPACT PROFILE; OPEN TIBIAL FRACTURES; LIMB SALVAGE; TRAUMA	Background: Limb salvage for severe trauma has replaced amputation as the primary treatment in many trauma centers. However, long-term outcomes after limb reconstruction or amputation have not been fully evaluated. Methods: We performed a multicenter, prospective, observational study to determine the functional outcomes of 569 patients with severe leg injuries resulting in reconstruction or amputation. The principal outcome measure was the Sickness Impact Profile, a multidimensional measure of self-reported health status (scores range from 0 to 100; scores for the general population average 2 to 3, and scores greater than 10 represent severe disability). Secondary outcomes included limb status and the presence or absence of major complications resulting in rehospitalization. Results: At two years, there was no significant difference in scores for the Sickness Impact Profile between the amputation and reconstruction groups (12.6 vs. 11.8, P=0.53). After adjustment for the characteristics of the patients and their injuries, patients who underwent amputation had functional outcomes that were similar to those of patients who underwent reconstruction. Predictors of a poorer score for the Sickness Impact Profile included rehospitalization for a major complication, a low educational level, nonwhite race, poverty, lack of private health insurance, poor social-support network, low self-efficacy (the patient's confidence in being able to resume life activities), smoking, and involvement in disability-compensation litigation. Patients who underwent reconstruction were more likely to be rehospitalized than those who underwent amputation (47.6 percent vs. 33.9 percent, P=0.002). Similar proportions of patients who underwent amputation and patients who underwent reconstruction had returned to work by two years (53.0 percent and 49.4 percent, respectively). Conclusions: Patients with limbs at high risk for amputation can be advised that reconstruction typically results in two-year outcomes equivalent to those of amputation.	Carolinas Med Ctr, Dept Orthoped Surg, Charlotte, NC 28203 USA; Johns Hopkins Univ, Bloomberg Sch Hyg & Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD USA; Univ Maryland, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; Wake Forest Univ, Baptist Med Ctr, Dept Orthoped Surg, Winston Salem, NC 27109 USA; Univ Washington, Harborview Med Ctr, Dept Orthoped Surg, Seattle, WA 98104 USA; Tampa Gen Hosp, Orthoped Trauma Serv, Tampa, FL 33606 USA; Univ Texas, SW Med Ctr, Dept Orthoped Surg, Dallas, TX USA; Vanderbilt Univ, Sch Med, Dept Orthoped & Rehabil, Nashville, TN 37212 USA; Cleveland MetroHlth Med Ctr, Dept Orthoped Surg, Cleveland, OH USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Carolinas Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore; Wake Forest University; Wake Forest Baptist Medical Center; Harborview Medical Center; University of Washington; University of Washington Seattle; Tampa General Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; MetroHealth System; Johns Hopkins University	Bosse, MJ (corresponding author), Carolinas Med Ctr, Dept Orthoped Surg, 1000 Blythe Blvd, Charlotte, NC 28203 USA.	mbosse@carolinas.org	Travison, Thomas/C-7098-2011; Jones, Alan/HHS-1717-2022	Patterson, Brendan/0000-0001-6373-2258; Swiontkowski, Marc/0000-0001-7036-1782	NIAMS NIH HHS [R01-AR42659] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042659] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Association for the Advancement of Automotive Medicine, 1998, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BANDURA A, 1987, J PERS SOC PSYCHOL, V53, P563, DOI 10.1037/0022-3514.53.3.563; BARRERA M, 1981, AM J COMMUN PSYCHOL, V9, P435, DOI 10.1007/BF00918174; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; BROM D, 1993, J CLIN PSYCHOL, V49, P131, DOI 10.1002/1097-4679(199303)49:2<131::AID-JCLP2270490202>3.0.CO;2-2; CAUDLE RJ, 1987, J BONE JOINT SURG AM, V69A, P801, DOI 10.2106/00004623-198769060-00002; Costa PT., 1992, NEO PI R NEO PERSONA; Dagum AB, 1999, PLAST RECONSTR SURG, V103, P1212, DOI 10.1097/00006534-199904040-00017; DEBRUIN AF, 1992, SOC SCI MED, V35, P1003, DOI 10.1016/0277-9536(92)90240-Q; *DEP LAB EMPL TRAI, 1991, DICT OCC TITL; FAIRHURST MJ, 1994, CLIN ORTHOP RELAT R, V301, P227; FISHER GM, 1992, SOC SECUR BULL, V55, P3; FRANCEL TJ, 1992, PLAST RECONSTR SURG, V89, P478, DOI 10.1097/00006534-199203000-00014; FRANCEL TJ, 1994, PLAST RECONSTR SURG, V93, P1028, DOI 10.1097/00006534-199404001-00019; GEORGIADIS GM, 1993, J BONE JOINT SURG AM, V75A, P1431, DOI 10.2106/00004623-199310000-00003; GODINA M, 1986, PLAST RECONSTR SURG, V78, P285, DOI 10.1097/00006534-198609000-00001; GUSTILO RB, 1984, J TRAUMA, V24, P742, DOI 10.1097/00005373-198408000-00009; HANSEN ST, 1987, J BONE JOINT SURG AM, V69A, P799, DOI 10.2106/00004623-198769060-00001; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; JOHANSEN K, 1990, J TRAUMA, V30, P568, DOI 10.1097/00005373-199005000-00007; JURKOVICH G, 1995, J TRAUMA, V39, P625, DOI 10.1097/00005373-199510000-00001; LANDO ME, 1982, SSA PUBLICATION; Lange RH, 1989, CLIN ORTHOP RELAT R, V243, P92; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; MacKenzie EJ, 2000, J ORTHOP TRAUMA, V14, P455, DOI 10.1097/00005131-200009000-00001; MACKENZIE EJ, 1993, J ORTHOP TRAUMA, V7, P393, DOI 10.1097/00005131-199310000-00001; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; MASSEY JT, 1989, VITAL HLTH STAT 2, V10; Matelic TM, 1996, J ORTHOP TRAUMA, V10, P1, DOI 10.1097/00005131-199601000-00001; Matsen SL, 2000, J BONE JOINT SURG AM, V82A, P1089, DOI 10.2106/00004623-200008000-00004; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Muller ME, 1991, MANUAL INTERNAL FIXA, V3rd; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; Shalev AY, 1996, AM J PSYCHIAT, V153, P219; STOKES JP, 1984, AM J COMMUN PSYCHOL, V12, P53, DOI 10.1007/BF00896928; SUEDKAMP NP, 1993, J ORTHOP TRAUMA, V7, P473, DOI 10.1097/00005131-199310000-00011; Swiontkowski MF, 2002, J TRAUMA, V52, P641, DOI 10.1097/00005373-200204000-00005; TEASDALE G, 1974, LANCET, V2, P81; Vaiana, 1991, COMPENSATION ACCIDEN	42	538	553	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1924	1931		10.1056/NEJMoa012604	http://dx.doi.org/10.1056/NEJMoa012604			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	623ZX	12477942	Bronze			2022-12-28	WOS:000179735800004
J	Jayaraman, KS				Jayaraman, KS			Syngenta ready to drop plans for Indian rice venture	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					596	596		10.1038/420596b	http://dx.doi.org/10.1038/420596b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478254	Bronze			2022-12-28	WOS:000179751800010
J	Brolin, RE				Brolin, RE			Bariatric surgery and long-term control of morbid obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VERTICAL BANDED GASTROPLASTY; INDUCED WEIGHT-LOSS; GASTRIC BYPASS; BILIOPANCREATIC DIVERSION; DIABETES-MELLITUS; HYPERTENSION; OPERATIONS; REDUCTION; QUALITY; COSTS		St Peters Univ Hosp, New Brunswick, NJ 08903 USA; Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA	Saint Peter's University Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brolin, RE (corresponding author), St Peters Univ Hosp, 254 Easton Ave, New Brunswick, NJ 08903 USA.							ALPERT MA, 1985, AM J CARDIOL, V55, P783, DOI 10.1016/0002-9149(85)90156-0; Balsiger BM, 2000, J GASTROINTEST SURG, V4, P598, DOI 10.1016/S1091-255X(00)80108-0; Brolin R E, 1998, J Gastrointest Surg, V2, P436, DOI 10.1016/S1091-255X(98)80034-6; BROLIN RE, 1989, SURGERY, V105, P337; BROLIN RE, 1992, ANN SURG, V215, P387, DOI 10.1097/00000658-199204000-00014; BROLIN RE, 1994, ANN SURG, V220, P782, DOI 10.1097/00000658-199412000-00012; Brolin RE, 2000, J GASTROINTEST SURG, V4, P464, DOI 10.1016/S1091-255X(00)80087-6; BUMP RC, 1992, AM J OBSTET GYNECOL, V167, P392, DOI 10.1016/S0002-9378(11)91418-5; CARSON JL, 1994, ARCH INTERN MED, V154, P193, DOI 10.1001/archinte.154.2.193; CHARUZI I, 1985, SURGERY, V97, P535; COLDITZ GA, 1992, AM J CLIN NUTR, V55, P5035; DEITEL M, 1988, J AM COLL NUTR, V7, P147, DOI 10.1080/07315724.1988.10720232; Deitel M, 2001, OBES SURG, V11, P659, DOI 10.1381/09608920160558524; DeMaria EJ, 2001, ANN SURG, V233, P809, DOI 10.1097/00000658-200106000-00011; DRENICK EJ, 1980, JAMA-J AM MED ASSOC, V243, P443, DOI 10.1001/jama.243.5.443; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; FOLEY EF, 1992, AM J SURG, V163, P294, DOI 10.1016/0002-9610(92)90005-C; GLEYSTEEN JJ, 1990, AM J CLIN NUTR, V51, P774, DOI 10.1093/ajcn/51.5.774; HALVERSON JD, 1981, SURGERY, V90, P446; Hess DS, 1998, OBES SURG, V8, P267, DOI 10.1381/096089298765554476; Hickey MS, 1998, ANN SURG, V227, P637, DOI 10.1097/00000658-199805000-00004; KUZMAK L, 1989, SURG MORBIDLY OBESE, P225; LAGACE M, 1995, OBES SURG, V5, P411, DOI 10.1381/096089295765557511; MACLEAN LD, 1990, SURGERY, V107, P20; MARTIN LF, 1995, SURGERY, V118, P599, DOI 10.1016/S0039-6060(05)80024-8; Nguyen NT, 2001, ANN SURG, V234, P279, DOI 10.1097/00000658-200109000-00002; NIH Consensus Development Conference Panel, 1992, AM J CLIN NUTR, V55, p615S; PORIES WJ, 1987, ANN SURG, V206, P316, DOI 10.1097/00000658-198709000-00009; PRINTEN KJ, 1982, AM SURGEON, V48, P363; Scopinaro N, 1996, SURGERY, V119, P261, DOI 10.1016/S0039-6060(96)80111-5; Sugerman H J, 1997, J Gastrointest Surg, V1, P517, DOI 10.1016/S1091-255X(97)80067-4; SUGERMAN H J, 1992, American Journal of Clinical Nutrition, V55, p560S, DOI 10.1093/ajcn/55.2.560s; SUGERMAN HJ, 1988, ANN SURG, V207, P604, DOI 10.1097/00000658-198805000-00015; Torgerson JS, 2001, INT J OBESITY, V25, pS2, DOI 10.1038/sj.ijo.0801687; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x	35	324	339	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2793	2796		10.1001/jama.288.22.2793	http://dx.doi.org/10.1001/jama.288.22.2793			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623YM	12472304				2022-12-28	WOS:000179732600002
J	McDonald, HP; Garg, AX; Haynes, RB				McDonald, HP; Garg, AX; Haynes, RB			Interventions to enhance patient adherence to medication prescriptions - Scientific review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; SELF-MANAGEMENT; BLOOD-PRESSURE; SCHIZOPHRENIC-PATIENTS; COMPLIANCE THERAPY; FOLLOW-UP; EDUCATION; HYPERTENSION; STRATEGIES; PUBLICATION	Context Low adherence with prescribed treatments is ubiquitous and undermines treatment benefits. Objective To systematically review published randomized controlled trials (RCTs) of interventions to assist patients' adherence to prescribed medications. Data Sources A search of MEDLINE, CINAHL, PSYCHLIT, SOCIOFILE, IPA, EMBASE, The Cochrane Library databases, and bibliographies was performed for records from 1967 through August 2001 to identify relevant articles of all RCTs of interventions intended to improve adherence to self-administered medications. Study Selection and Data Extraction Studies were included if they reported an unconfounded RCT of an intervention to improve adherence with prescribed medications for a medical or psychiatric disorder; both adherence and treatment outcome were measured; follow-up of at least 80% of each study group was reported; and the duration of follow-up for studies with positive initial findings was at least 6 months. Information on study design features, interventions, controls, and findings (adherence rates and patient outcomes) were extracted for each article. Data Synthesis Studies were too disparate to warrant meta-analysis. Forty-nine percent of the interventions tested (19 of 39 in 33 studies) were associated with statistically significant increases in medication adherence and only 17 reported statistically significant improvements in treatment outcomes. Almost all the interventions that were effective for long-term care were complex, including combinations of more convenient care, information, counseling, reminders, self-monitoring, reinforcement, family therapy, and other forms of additional supervision or attention. Even the most effective interventions had modest effects. Conclusions Current methods of improving medication adherence for chronic health problems are mostly complex, labor-intensive, and not predictably effective. The full benefits of medications cannot be realized at currently achievable levels of adherence; therefore, more studies of innovative approaches to assist patients to follow prescriptions for medications are needed.	McMaster Univ, Med Ctr, Dept Clin Epidemiol & Biostat, Fac Hlth Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Sch Grad Studies, Hlth Res Methodol Program, Hamilton, ON, Canada; McMaster Univ, Fac Hlth Sci, Dept Med, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University	Haynes, RB (corresponding author), McMaster Univ, Med Ctr, Dept Clin Epidemiol & Biostat, Fac Hlth Sci, Room 2C10B,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	bhaynes@mcmaster.ca	Garg, Amit X/G-3295-2011	Haynes, Robert Brian/0000-0002-1453-3196				BAILEY WC, 1990, ARCH INTERN MED, V150, P1664, DOI 10.1001/archinte.150.8.1664; BAIRD MG, 1984, CLIN INVEST MED, V7, P95; Bandura A., 1971, SOCIAL LEARNING THEO; BECKER LA, 1986, J FAM PRACTICE, V22, P357; Brown BG, 1997, AM J CARDIOL, V80, P111, DOI 10.1016/S0002-9149(97)00303-2; Brus HLM, 1998, ANN RHEUM DIS, V57, P146, DOI 10.1136/ard.57.3.146; Burke LE, 1997, ANN BEHAV MED, V19, P239, DOI 10.1007/BF02892289; Chaplin R, 1998, BRIT J PSYCHIAT, V172, P78, DOI 10.1192/bjp.172.1.78; COLCHER IS, 1972, J AMER MED ASSOC, V222, P657, DOI 10.1001/jama.222.6.657; Cote J, 1997, AM J RESP CRIT CARE, V155, P1509, DOI 10.1164/ajrccm.155.5.9154850; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Friedman RH, 1996, AM J HYPERTENS, V9, P285, DOI 10.1016/0895-7061(95)00353-3; Gallefoss F, 1999, AM J RESP CRIT CARE, V160, P2000, DOI 10.1164/ajrccm.160.6.9901028; Gallefoss F, 1999, AM J RESP CRIT CARE, V159, P812, DOI 10.1164/ajrccm.159.3.9804047; GIBSON PG, 1999, LTD PATIENT ED PROGR; Girvin B, 1999, J HYPERTENS, V17, P1627, DOI 10.1097/00004872-199917110-00017; Gordis L, 1979, COMPLIANCE HLTH CARE, P23; HARVEY EL, 1999, IMPROVING HLTH PROFE; Haynes R., 2002, INTERVENTIONS HELPIN; Haynes RB, 2001, AM HEART MONOGR S, P3; HAYNES RB, 1976, LANCET, V1, P1265; HAYNES RB, 1987, CONTROL CLIN TRIALS, V8, P12, DOI 10.1016/0197-2456(87)90021-3; Henry A, 1999, AM J GASTROENTEROL, V94, P811, DOI 10.1111/j.1572-0241.1999.00856.x; HOWLAND JS, 1990, J FAM PRACTICE, V31, P62; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Irvine J, 1999, PSYCHOSOM MED, V61, P566, DOI 10.1097/00006842-199907000-00023; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JOHNSON AL, 1978, CAN MED ASSOC J, V119, P1034; Katon W, 2001, ARCH GEN PSYCHIAT, V58, P241, DOI 10.1001/archpsyc.58.3.241; Kemp R, 1996, BRIT MED J, V312, P345; Kemp R, 1998, BRIT J PSYCHIAT, V172, P413, DOI 10.1192/bjp.172.5.413; Knobel H, 1999, Enferm Infecc Microbiol Clin, V17, P78; LANCASTER T, 1999, SELF HELP INTERVENTI; Levy ML, 2000, RESP MED, V94, P900, DOI 10.1053/rmed.2000.0861; LOGAN AG, 1981, HYPERTENSION, V3, P211, DOI 10.1161/01.HYP.3.2.211; LOGAN AG, 1979, LANCET, V2, P1175; LUMLEY J, 1999, INTERVENTIONS PROMOT; MACHARIA WM, 1992, JAMA-J AM MED ASSOC, V267, P1813, DOI 10.1001/jama.267.13.1813; Merinder LB, 1999, SOC PSYCH PSYCH EPID, V34, P287, DOI 10.1007/s001270050146; Miller NH, 1997, CIRCULATION, V95, P1085; PETERSON GM, 1984, EPILEPSIA, V25, P412, DOI 10.1111/j.1528-1157.1984.tb03436.x; Peveler R, 1999, BRIT MED J, V319, P612, DOI 10.1136/bmj.319.7210.612; Piette JD, 2000, AM J MED, V108, P20, DOI 10.1016/S0002-9343(99)00298-3; Razali SM, 2000, J MENT HEALTH, V9, P283, DOI DOI 10.1080/713680246; SACKETT DL, 1975, LANCET, V1, P1205; Sackett DL, 1979, COMPLIANCE HLTH CARE; SILAGY C, 1999, NICOTINE REPLACEMENT; STEPHENSON BJ, 1993, JAMA-J AM MED ASSOC, V269, P2779, DOI 10.1001/jama.269.21.2779; STRANG J S, 1981, Psychopharmacology Bulletin, V17, P87; Tuldra A, 2000, J ACQ IMMUN DEF SYND, V25, P221, DOI 10.1097/00126334-200011010-00003; van Es SM, 2001, PATIENT EDUC COUNS, V44, P193, DOI 10.1016/S0738-3991(00)00195-6; VOLMINK J, 1999, INTERVENTIONS PROMOT; Wysocki T, 2001, DIABETES CARE, V24, P441, DOI 10.2337/diacare.24.3.441; XIONG W, 1994, BRIT J PSYCHIAT, V165, P239, DOI 10.1192/bjp.165.2.239; ZHANG ML, 1994, BRIT J PSYCHIAT, V165, P96, DOI 10.1192/S0007125000293045; [No title captured]	58	825	843	0	91	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2868	2879		10.1001/jama.288.22.2868	http://dx.doi.org/10.1001/jama.288.22.2868			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623YM	12472329	Bronze			2022-12-28	WOS:000179732600032
J	Cheung, CY; Poon, LLM; Lau, AS; Luk, W; Lau, YL; Shortridge, KF; Gordon, S; Guan, Y; Peiris, JSM				Cheung, CY; Poon, LLM; Lau, AS; Luk, W; Lau, YL; Shortridge, KF; Gordon, S; Guan, Y; Peiris, JSM			Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?	LANCET			English	Article							HUMAN INFECTION; EXPRESSION; TRANSCRIPTION; PATHOGENESIS; INHIBITION; RESPONSES; POULTRY; BLOOD; LUNG	Background In 1997, the first documented instance of human respiratory disease and death associated with a purely avian H5N1 influenza virus resulted in an overall case-fatality rate of 33%. The biological basis for the severity of human H5N1 disease has remained unclear. We tested the hypothesis that virus-induced cytokine dysregulation has a role. Methods We used cDNA arrays and quantitative RT-PCR to, compare the profile of cytokine gene expression induced by viruses A/HK/486/97 and A/HK/483/97 (both H5N1/97) with that of human H3N2 and H1N1 viruses in human primary monocyte-derived macrophages in vitro. Secretion of tumour necrosis factor alpha (TNF alpha) from macrophages infected with the viruses was compared by ELISA. By use of naturally occurring viral reassortants and recombinant viruses generated by reverse genetic techniques, we investigated the viral genes associated with the TNF-alpha response. Findings The H5N1/97 viruses induced much higher gene transcription of proinflammatory cytokines than did H3N2 or H1N1 viruses, particularly TNF alpha. and interferon beta. The concentration of TNF-alpha. protein in culture supernatants of macrophages infected with these viruses was similar to that induced by stimulation with Escherichia coli lipopolysaccharide. The non-structural (NS) gene-segment of H5N1/97 viruses contributed to the increase in TNF alpha induced by the virus. Interpretation The H5N1/97 viruses are potent inducers of proinflammatory cytokines in macrophages, the most notable being TNF alpha. This characteristic may contribute to the unusual severity of human H5N1 disease.	Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Hong Kong; University of Hong Kong; University of Oxford	Peiris, JSM (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Univ Pathol Bldg, Pokfulam, Hong Kong, Peoples R China.	malik@hkucc.hku.hk	Cheung, Chung Yan/C-4233-2009; Poon, Leo/AAP-6887-2020; Lau, Yu Lung/C-4322-2009; Poon, Leo Lit Man/C-4382-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Poon, Leo Lit Man/0000-0002-9101-7953; Guan, Yi/0000-0001-6057-9243; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995				Aggarwal B., 2001, CYTOKINE REFERENCE C, V1, P413; Blaschke V, 2000, J IMMUNOL METHODS, V246, P79, DOI 10.1016/S0022-1759(00)00304-5; Cauthen AN, 2000, J VIROL, V74, P6592, DOI 10.1128/JVI.74.14.6592-6599.2000; Ciesielski CJ, 2002, EUR J IMMUNOL, V32, P2037, DOI 10.1002/1521-4141(200207)32:7<2037::AID-IMMU2037>3.0.CO;2-I; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; DEHOUX MS, 1994, AM J RESP CRIT CARE, V150, P710, DOI 10.1164/ajrccm.150.3.8087341; Fisman DN, 2000, EMERG INFECT DIS, V6, P601, DOI 10.3201/eid0606.000608; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; GORDON S, 1997, LUNG MACROPHAGES DEN, P3; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Headley AS, 1997, CHEST, V111, P1306, DOI 10.1378/chest.111.5.1306; Hirst GK, 1942, J EXP MED, V76, P195, DOI 10.1084/jem.76.2.195; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hofmann P, 1997, J LEUKOCYTE BIOL, V61, P408, DOI 10.1002/jlb.61.4.408; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P10096, DOI 10.1073/pnas.152327499; Liu EM, 2001, PEDIATR RES, V50, P184, DOI 10.1203/00006450-200108000-00004; Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542; MONTANER LJ, 1996, WEIRS HDB EXPT IMMUN, V4, P1; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Webby RJ, 2001, PHILOS T R SOC B, V356, P1817, DOI 10.1098/rstb.2001.0997; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	30	693	750	1	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1831	1837		10.1016/S0140-6736(02)11772-7	http://dx.doi.org/10.1016/S0140-6736(02)11772-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480361				2022-12-28	WOS:000179706100011
J	von Hertzen, H; Piaggio, G; Ding, JH; Chen, JL; Song, S; Bartfai, G; Ng, E; Gemzell-Danielsson, K; Oyunbileg, A; Wu, SC; Cheng, WY; Ludicke, F; Pretnar-Darovec, A; Kirkman, R; Mittal, S; Khomassuridze, A; Apter, D; Peregoudov, A				von Hertzen, H; Piaggio, G; Ding, JH; Chen, JL; Song, S; Bartfai, G; Ng, E; Gemzell-Danielsson, K; Oyunbileg, A; Wu, SC; Cheng, WY; Ludicke, F; Pretnar-Darovec, A; Kirkman, R; Mittal, S; Khomassuridze, A; Apter, D; Peregoudov, A		WHO Res Grp Post-ovulatory Methods	Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial	LANCET			English	Article							YUZPE REGIMEN	Background A single 10 mg dose of mifepristone, and two 0.75 mg doses of levonorgestrel 12 h apart, are effective for emergency contraception. Because no studies had compared the efficacies of both compounds, or investigated a single dose of 1.5 mg levonorgestrel, we undertook this three-arm trial. Methods We did a randomised, double-blind trial in 15 family-planning clinics in 10 countries. We randomly assigned 4136 healthy women with regular menstrual cycles, who requested emergency contraception within 120 h of one unprotected coitus, to one of three regimens: 10 mg single-dose mifepristone; 1.5 mg single-dose levonorgestrel; or two doses of 0.75 mg levonorgestrel given 12 h apart. The primary outcome was unintended pregnancy; other outcomes were side-effects and timing of next menstruation. Analysis was by intention to treat, but we did exclude some patients from the final analyses. Findings Of 4071 women with known outcome, pregnancy rates were 1.5% (21/1359) in those given mifepristone, 1.5% (20/1356) in those assigned single-dose levonorgestrel, and 1.8% (24/1356) in women assigned two-dose levonorgestrel. These proportions did not differ significantly (p=0.83). The relative risk of pregnancy for single-dose levonorgestrel compared with two-dose levonorgestrel was 0.83 (95% Cl 0.46-1.50), and that for levonorgestrel (the two regimens combined) compared with mifepristone, 1.05 ( 0.63-1.76). Side-effects were mild and did not differ greatly between groups, and most women menstruated within 2 days of the expected date. Women who took levonorgestrel had earlier menses than did those who took mifepristone. Interpretation The three regimens studied are very efficacious for emergency contraception and prevent a high proportion of pregnancies if taken within 5 days of unprotected coitus. Mifepristone and levonorgestrel do not differ in efficacy. A 1.5 mg single levonorgestrel dose can substitute two 0.75 mg doses 12 h apart.	WHO, Dept Reprod Hlth & Res, UNDP UNFPA WHO World Bank Special Programme Res D, CH-1211 Geneva 27, Switzerland; Jiangsu Family Planning Inst, Nanjing, Peoples R China; Inst Family Planning Tech Instruct, Shanghai, Peoples R China; Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China; Univ Szeged, Szeged, Hungary; Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; Karolinska Hosp, S-10401 Stockholm, Sweden; State Res Ctr Human Reprod & Maternal & Child Hlt, Ulaanbaatar, Mongolia; Natl Res Inst Family Planning, Beijing, Peoples R China; Tianjin Municipal Res Inst Family Planning, Tianjin, Peoples R China; Univ Geneva, Geneva, Switzerland; Univ Ljubljana, Dept Obstet & Gynaecol, Ljubljana, Slovenia; Univ Manchester, Manchester, Lancs, England; All India Inst Med Sci, New Delhi, India; Zhordania Inst Human Reprod, Tbilisi, Georgia; Family Federat Finland, Helsinki, Finland	United Nations Population Fund; World Health Organization; Szeged University; University of Hong Kong; Karolinska Institutet; Karolinska University Hospital; National Research Institute for Family Planning - China; University of Geneva; University of Ljubljana; University of Manchester; All India Institute of Medical Sciences (AIIMS) New Delhi; Family Federation of Finland	von Hertzen, H (corresponding author), WHO, Dept Reprod Hlth & Res, UNDP UNFPA WHO World Bank Special Programme Res D, CH-1211 Geneva 27, Switzerland.	vonhertzenh@who.int	Armah, Eni/H-2657-2013; Apter, Dan/D-6269-2017	Apter, Dan/0000-0002-5175-8845; Ng, Ernest/0000-0002-7688-4557				CHENG L, 2000, COCHRANE DB SYST REV, V2; CROXATTO HB, 1993, REFERENCES GYNECOL O, V1, P175; Grimes D, 1998, LANCET, V352, P428; HO PC, 1993, HUM REPROD, V8, P389, DOI 10.1093/oxfordjournals.humrep.a138057; Piaggio G, 1999, LANCET, V353, P721, DOI 10.1016/S0140-6736(98)05718-3; Piaggio G, 1999, LANCET, V353, P697; Rowe PJ, 1997, CONTRACEPTION, V56, P341; SANG GW, 1994, REPROD BIOL, P219; Trussell J, 1998, CONTRACEPTION, V57, P363, DOI 10.1016/S0010-7824(98)00042-0; Van Look PFA, 1999, FERTIL STERIL, V72, P431; Wu S, 1999, Zhonghua Fu Chan Ke Za Zhi, V34, P327	11	386	400	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1803	1810		10.1016/S0140-6736(02)11767-3	http://dx.doi.org/10.1016/S0140-6736(02)11767-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480356				2022-12-28	WOS:000179706100006
J	Lardner, B; bin Lakim, M				Lardner, B; bin Lakim, M			Tree-hole frogs exploit resonance effects	NATURE			English	Article							CALL DURATION; GRAY; ACOUSTICS; BURROW; CHOICE		Field Museum Nat Hist, Div Amphibians & Reptiles, Chicago, IL 60605 USA; Sabah Pk, Res & Educ Div, Kota Kinabalu 88806, Sabah, Malaysia	Field Museum of Natural History (Chicago)	Lardner, B (corresponding author), Field Museum Nat Hist, Div Amphibians & Reptiles, Chicago, IL 60605 USA.							BAILEY WJ, 1981, J NAT HIST, V15, P693, DOI 10.1080/00222938100770491; Bailey WJ, 2001, J EXP BIOL, V204, P2827; BENNETCLARK HC, 1987, J EXP BIOL, V128, P383; Daws A. G., 1996, Bioacoustics, V7, P81; Gerhardt HC, 1996, BEHAV ECOL, V7, P7, DOI 10.1093/beheco/7.1.7; Gerhardt HC, 2000, BEHAV ECOL, V11, P663, DOI 10.1093/beheco/11.6.663; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; KLUMP GM, 1987, NATURE, V326, P286, DOI 10.1038/326286a0; Penna M, 1996, ANIM BEHAV, V51, P255, DOI 10.1006/anbe.1996.0026; PROZESKYSCHULZE L, 1975, NATURE, V255, P142, DOI 10.1038/255142a0; Welch AM, 1998, SCIENCE, V280, P1928, DOI 10.1126/science.280.5371.1928; Wells Kentwood D., 2001, P45	12	73	75	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					475	475		10.1038/420475a	http://dx.doi.org/10.1038/420475a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466831	Bronze			2022-12-28	WOS:000179611600033
J	Wade, CM; Kulbokas, EJ; Kirby, AW; Zody, MC; Mullikin, JC; Lander, ES; Lindblad-Toh, K; Daly, MJ				Wade, CM; Kulbokas, EJ; Kirby, AW; Zody, MC; Mullikin, JC; Lander, ES; Lindblad-Toh, K; Daly, MJ			The mosaic structure of variation in the laboratory mouse genome	NATURE			English	Article							GENETIC-VARIATION; INBRED STRAINS; MICE; DNA	Most inbred laboratory mouse strains are known to have originated from a mixed but limited founder population in a few laboratories(1,2). However, the effect of this breeding history on patterns of genetic variation among these strains and the implications for their use are not well understood. Here we present an analysis of the fine structure of variation in the mouse genome, using single nucleotide polymorphisms (SNPs). When the recently assembled genome sequence from the C57BL/6J strain(3) is aligned with sample sequence from other strains, we observe long segments of either extremely high (similar to40 SNPs per 10 kb) or extremely low (similar to0.5 SNPs per 10 kb) polymorphism rates. In all strain-to-strain comparisons examined, only one-third of the genome falls into long regions (averaging >1 Mb) of a high SNP rate, consistent with estimated divergence rates between Mus musculus domesticus and either M. m. musculus or M. m. castaneus. These data suggest that the genomes of these inbred strains are mosaics with the vast majority of segments derived from domesticus and musculus sources. These observations have important implications for the design and interpretation of positional cloning experiments.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; Whitehead MIT Ctr Genome Res, Cambridge, MA 02139 USA; Univ Queensland, Sch Vet Sci, St Lucia, Qld 4067, Australia; Sanger Ctr, Hinxton CB10 1RQ, Cambs, England	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Queensland; Wellcome Trust Sanger Institute	Lindblad-Toh, K (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02139 USA.		Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Wade, Claire/0000-0003-3413-4771				Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BISHOP CE, 1985, NATURE, V315, P70, DOI 10.1038/315070a0; BONHOMME F, 1987, BIOL J LINN SOC, V30, P51, DOI 10.1111/j.1095-8312.1987.tb00288.x; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Paigen K, 2000, MAMM GENOME, V11, P715, DOI 10.1007/s003350010152; Prager EM, 1998, GENETICS, V150, P835; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Schalkwyk LC, 1999, GENOME RES, V9, P878, DOI 10.1101/gr.9.9.878; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Threadgill DW, 1997, MAMM GENOME, V8, P390, DOI 10.1007/s003359900453; Threadgill DW, 2002, MAMM GENOME, V13, P175, DOI 10.1007/s00335-001-4001-Y; YOKOYAMA T, 1990, NUCLEIC ACIDS RES, V18, P7293, DOI 10.1093/nar/18.24.7293; YONEKAWA H, 1980, JPN J GENET, V55, P289, DOI 10.1266/jjg.55.289	18	370	381	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					574	578		10.1038/nature01252	http://dx.doi.org/10.1038/nature01252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466852	Bronze			2022-12-28	WOS:000179611600055
J	Hartemann-Heurtier, A; Ha Van, G; Grimaldi, A				Hartemann-Heurtier, A; Ha Van, G; Grimaldi, A			The Charcot foot	LANCET			English	Article								A retired 62-year-old man, who has had type 2 diabetes for 5 years, presented at a specialist diabetic foot clinic with difficulty putting on his shoes. On examination he had signs of distal symmetrical neuropathy in the leg and a deformed right foot: the longitudinal arch had collapsed, resulting in a rocker-bottom deformity. He reported no pain. The patient had been to another clinic a month previously because of redness and swelling of his right foot, which had also been slightly painful at that time. A diagnosis of deep vein thrombosis had been considered, but doppler ultrasonography of the vein proved normal. The final diagnosis was gout, despite normal concentration of uric acid in the blood and of inflammatory markers. No radiography was done at this stage. He had been advised to avoid long walks and had been treated with colchicine and a hypouricaemic drug but without any obvious benefits. About 1 month later the right foot became deformed fairly abruptly after no relevant trauma (figure 1). Clinical diagnosis of Charcot foot was confirmed by radiography showing striking osteoarthropathy, with dislocation of the tarsus, bulging of the navicular bone and collapse of the arch. Immobilisation and avoidance of weight-bearing were advised to reduce inflammation and oedema. After 3 months the patient was provided with a pair of orthopaedic shoes that supported the arch.	Hop La Pitie Salpetriere, Dept Diabetol & Metab, F-75651 Paris 13, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Hartemann-Heurtier, A (corresponding author), Hop La Pitie Salpetriere, Dept Diabetol & Metab, F-75651 Paris 13, France.			HA VAN, GEORGES/0000-0002-8024-8385				BONDUELLE M, 1996, CHARCOT GRAND MED SO; Charcot J., 1883, ARCH NEUROLOGIE, V6, P305; Charcot JM, 1868, ARCH PHYSIOL NORM P, V1, P161; Charcot JM, 1883, B SOC ANATOM PARIS, V8, P324; DAUDET L, 1922, OEUVRES HOMMES, P205; FREUD S, 1984, RESULTATS IDEES PROB, P68; Jeffcoate W, 2000, DIABETIC MED, V17, P253, DOI 10.1046/j.1464-5491.2000.00233.x; JOHNSON JE, 2001, LEVIN ONEALS DIABETI, P587; Sanders LJ, 2001, LEVIN ONEALS DIABETI, P439; 1881, T INT MED C, V8, P128	10	26	28	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1776	1779		10.1016/S0140-6736(02)11671-0	http://dx.doi.org/10.1016/S0140-6736(02)11671-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480445				2022-12-28	WOS:000179636800029
J	Kundhal, KK; Kundhal, PS				Kundhal, KK; Kundhal, PS			Cultural diversity: An evolving challenge to physician-patient communication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									McMaster Univ, Hamilton, ON, Canada; Univ Toronto, Toronto, ON, Canada	McMaster University; University of Toronto	Kundhal, KK (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Brach C, 2000, MED CARE RES REV, V57, P181, DOI 10.1177/107755800773743655; Chavez L R, 1995, Arch Fam Med, V4, P145, DOI 10.1001/archfami.4.2.145; Cross T., 1989, CULTURALLY COMPETENC; Culhane-Pera K A, 1997, Fam Med, V29, P719; DAY JC, 1996, US BUR CENSUS CURREN; Dein S, 1997, BRIT MED J, V315, P473, DOI 10.1136/bmj.315.7106.473; Dogra N, 2001, MED EDUC, V35, P232, DOI 10.1046/j.1365-2923.2001.00734.x; Flores G, 2000, ACAD MED, V75, P451, DOI 10.1097/00001888-200005000-00015; Morgan C, 1995, J NATL CANC I MONOGR, V18, P57; TIRADO M, 1996, TOOLS MONITORING CUL; *US BUR CENS, 1998, CENS POP	11	27	30	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					94	94		10.1001/jama.289.1.94	http://dx.doi.org/10.1001/jama.289.1.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630XL	12503987	Bronze			2022-12-28	WOS:000180136600035
J	Check, E				Check, E			Biodefence - Ploughshares into swords	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					736	736		10.1038/420736a	http://dx.doi.org/10.1038/420736a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490912				2022-12-28	WOS:000179897300021
J	Morris, RM; Rappe, MS; Connon, SA; Vergin, KL; Siebold, WA; Carlson, CA; Giovannoni, SJ				Morris, RM; Rappe, MS; Connon, SA; Vergin, KL; Siebold, WA; Carlson, CA; Giovannoni, SJ			SAR11 clade dominates ocean surface bacterioplankton communities	NATURE			English	Article							16S RIBOSOMAL-RNA; IN-SITU HYBRIDIZATION; LABELED OLIGONUCLEOTIDE PROBES; PLANKTONIC BACTERIA; SARGASSO SEA; IDENTIFICATION; ACCESSIBILITY; SENSITIVITY; DIVERSITY; INCREASE	The most abundant class of bacterial ribosomal RNA genes detected in seawater DNA by gene cloning belongs to SAR11-an alpha-proteobacterial clade(1). Other than indications of their prevalence in seawater, little is known about these organisms. Here we report quantitative measurements of the cellular abundance of the SAR11 clade in northwestern Sargasso Sea waters to 3,000 m and in Oregon coastal surface waters. On average, the SAR11 clade accounts for a third of the cells present in surface waters and nearly a fifth of the cells present in the mesopelagic zone. In some regions, members of the SAR11 clade represent as much as 50% of the total surface microbial community and 25% of the subeuphotic microbial community. By extrapolation, we estimate that globally there are 2.4 x 10(28) SAR11 cells in the oceans, half of which are located in the euphotic zone. Although the biogeochemical role of the SAR11 clade remains uncertain, these data support the conclusion that this microbial group is among the most successful organisms on Earth.	Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	Oregon State University; University of California System; University of California Santa Barbara	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.		Connon, Stephanie A/K-1959-2012; Morris, Robert/C-5188-2012	VERGIN, KEVIN/0000-0002-8972-2813				AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; BUCK KR, 1996, AQUAT MICROB ECOL, V10, P238; Carlson CA, 1996, DEEP-SEA RES PT II, V43, P491, DOI 10.1016/0967-0645(95)00101-8; CHO BC, 1988, NATURE, V332, P441, DOI 10.1038/332441a0; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; Field KG, 1997, APPL ENVIRON MICROB, V63, P63, DOI 10.1128/AEM.63.1.63-70.1997; Frischer ME, 1996, CAN J MICROBIOL, V42, P1061, DOI 10.1139/m96-136; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; FUHRMAN JA, 1989, MAR ECOL PROG SER, V57, P207, DOI 10.3354/meps057207; Fuhrman Jed. A., 1998, Aquatic Ecology, V32, P3, DOI 10.1023/A:1009974817127; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Giovannoni SJ., 2000, MICROBIAL ECOLOGY OC, P47; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; HICKS RE, 1992, APPL ENVIRON MICROB, V58, P2158, DOI 10.1128/AEM.58.7.2158-2163.1992; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; KEMP PF, 1993, APPL ENVIRON MICROB, V59, P2594, DOI 10.1128/AEM.59.8.2594-2601.1993; LEE SH, 1993, MAR ECOL PROG SER, V101, P193, DOI 10.3354/meps101193; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P661, DOI 10.1128/AEM.68.2.661-667.2002; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Schonhuber W, 1997, APPL ENVIRON MICROB, V63, P3268; SIERACKI ME, 1985, APPL ENVIRON MICROB, V49, P799, DOI 10.1128/AEM.49.4.799-810.1985; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wintzingerode Friedrich V., 1997, FEMS Microbiology Reviews, V21, P213	27	790	811	4	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					806	810		10.1038/nature01240	http://dx.doi.org/10.1038/nature01240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490947				2022-12-28	WOS:000179897300054
J	Abbasi, K; Butterfield, M; Connor, J; Delamothe, T; Dutton, S; Hadridge, P; Horgan, A; Smith, J; Smith, R; Walford, E; Williamson, A				Abbasi, K; Butterfield, M; Connor, J; Delamothe, T; Dutton, S; Hadridge, P; Horgan, A; Smith, J; Smith, R; Walford, E; Williamson, A			Four futures for scientific and medical publishing	BRITISH MEDICAL JOURNAL			English	Article									BMJ Publishing Grp, London WC1H 9JR, England	BMJ Publishing Group Ltd	Smith, R (corresponding author), BMJ Publishing Grp, London WC1H 9JR, England.								0	20	22	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1472	1475		10.1136/bmj.325.7378.1472	http://dx.doi.org/10.1136/bmj.325.7378.1472			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493672	Green Published			2022-12-28	WOS:000180188600025
J	Glazier, AM; Nadeau, JH; Aitman, TJ				Glazier, AM; Nadeau, JH; Aitman, TJ			Finding genes that underlie complex traits	SCIENCE			English	Review							DEPENDENT DIABETES-MELLITUS; QUANTITATIVE TRAIT; HYPERTENSIVE RATS; DROSOPHILA-MELANOGASTER; PHOTOPERIOD SENSITIVITY; INSULIN-RESISTANCE; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; MOLECULAR-BASIS; CROHNS-DISEASE	Phenotypic variation among organisms is central to evolutionary adaptations underlying natural and artificial selection, and also determines individual susceptibility to common diseases. These types of complex traits pose special challenges for genetic analysis because of gene-gene and gene-environment interactions, genetic heterogeneity, low penetrance, and limited statistical power. Emerging genome resources and technologies are enabling systematic identification of genes underlying these complex traits. We propose standards for proof of gene discovery in complex traits and evaluate the nature of the genes identified to date. These proof-of-concept studies demonstrate the insights that can be expected from the accelerating pace of gene discovery in this field.	Hammersmith Hosp, Imperial Coll Fac Med, MRC Clin Sci Ctr, Physiol Genom & Med Grp, London W12 0NN, England; Case Western Reserve Univ, Ctr Computat Genom, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	Imperial College London; Case Western Reserve University; Case Western Reserve University	Aitman, TJ (corresponding author), Hammersmith Hosp, Imperial Coll Fac Med, MRC Clin Sci Ctr, Physiol Genom & Med Grp, Ducane Rd, London W12 0NN, England.	jhn4@po.cwru.edu; t.aitman@csc.mrc.ac.uk		Aitman, Timothy/0000-0002-7875-4502				Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Aitman TJ, 1997, NAT GENET, V16, P197, DOI 10.1038/ng0697-197; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Cassell PG, 2002, DIABETES, V51, P1622, DOI 10.2337/diabetes.51.5.1622; CHOUDHARY M, 1991, GENETICS, V129, P481; Coppieters W, 1998, MAMM GENOME, V9, P540, DOI 10.1007/s003359900815; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cormier RT, 1997, NAT GENET, V17, P88, DOI 10.1038/ng0997-88; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Doerge RW, 1996, GENETICS, V142, P285; Fingerlin TE, 2002, DIABETES, V51, P1644, DOI 10.2337/diabetes.51.5.1644; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glazier AN, 2002, MAMM GENOME, V13, P108, DOI 10.1007/s00335-001-2132-9; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hong KH, 2001, P NATL ACAD SCI USA, V98, P3935, DOI 10.1073/pnas.051635898; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ikeda S, 1999, INVEST OPHTH VIS SCI, V40, P2706; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Korstanje R, 2002, NAT GENET, V31, P235, DOI 10.1038/ng0702-235; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Legare ME, 2000, GENOME RES, V10, P42; LUND T, 1990, NATURE, V345, P727, DOI 10.1038/345727a0; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Matin A, 2001, TRENDS GENET, V17, P727, DOI 10.1016/S0168-9525(01)02528-8; MCKUSICK VA, COMMUNICATION; MIYAZAKI T, 1990, NATURE, V345, P722, DOI 10.1038/345722a0; Murillo L, 2002, IMMUNOGENETICS, V54, P59, DOI 10.1007/s00251-002-0440-1; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nebert D W, 2000, Ann N Y Acad Sci, V919, P148; NISHIMOTO H, 1987, NATURE, V328, P432, DOI 10.1038/328432a0; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Stam LF, 1996, GENETICS, V144, P1559; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Symula DJ, 1999, NAT GENET, V23, P241, DOI 10.1038/13880; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0; TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yokoi N, 1997, J CLIN INVEST, V100, P2015, DOI 10.1172/JCI119733; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927	57	636	661	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2345	2349		10.1126/science.1076641	http://dx.doi.org/10.1126/science.1076641			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493905				2022-12-28	WOS:000179915900044
J	Habicht, KS; Gade, M; Thamdrup, B; Berg, P; Canfield, DE				Habicht, KS; Gade, M; Thamdrup, B; Berg, P; Canfield, DE			Calibration of sulfate levels in the Archean Ocean	SCIENCE			English	Article							SULFUR CYCLE; ISOTOPE; ATMOSPHERE; REDUCTION; WATER; MODEL	The size of the marine sulfate reservoir has grown through Earth's history, reflecting the accumulation of oxygen into the atmosphere. Sulfur isotope fractionation experiments on marine and freshwater sulfate reducers, together with the isotope record, imply that oceanic Archean sulfate concentrations were <200 mu M, which is less than one-hundredth of present marine sulfate levels and one-fifth of what was previously thought. Such low sulfate concentrations were maintained by volcanic outgassing of SO2 gas, and severely suppressed sulfate reduction rates allowed for a carbon cycle dominated by methanogenesis.	Univ So Denmark, Danish Ctr Earth Syst Sci, DK-5230 Odense M, Denmark; Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	University of Southern Denmark; University of Southern Denmark; University of Virginia	Canfield, DE (corresponding author), Univ So Denmark, Danish Ctr Earth Syst Sci, Campusvej 55, DK-5230 Odense M, Denmark.		Canfield, Don/C-1735-2012; Thamdrup, Bo/F-3889-2016	Canfield, Don/0000-0001-7602-8366; Thamdrup, Bo/0000-0002-1221-7077				Berner R.A., 2012, GLOBAL ENV WATER AIR, Vsecond; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Cypionka H., 1995, BIOTECH HAN, V8, P151; de Hoog JCM, 2001, EARTH PLANET SC LETT, V189, P237, DOI 10.1016/S0012-821X(01)00355-7; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; HARRISON AG, 1958, T FARADAY SOC, V54, P84, DOI 10.1039/tf9585400084; Holland HD., 1984, CHEM EVOLUTION ATMOS; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; INGVORSEN K, 1984, ARCH MICROBIOL, V139, P61, DOI 10.1007/BF00692713; INGVORSEN K, 1984, APPL ENVIRON MICROB, V27, P1029; JORGENSEN BB, 1979, GEOCHIM COSMOCHIM AC, V43, P363, DOI 10.1016/0016-7037(79)90201-1; Kakegawa T, 1999, PRECAMBRIAN RES, V96, P209, DOI 10.1016/S0301-9268(99)00006-6; Kakegawa T, 2000, GEOCHEM J, V34, P121, DOI 10.2343/geochemj.34.121; Kasting JF, 2001, ORIGINS LIFE EVOL B, V31, P271, DOI 10.1023/A:1010600401718; MARTENS CS, 1980, GEOCHIM COSMOCHIM AC, V44, P471, DOI 10.1016/0016-7037(80)90045-9; Middelburg JJ, 1997, DEEP-SEA RES PT I, V44, P327, DOI 10.1016/S0967-0637(96)00101-X; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; REEBURGH WS, 1976, EARTH PLANET SC LETT, V28, P337, DOI 10.1016/0012-821X(76)90195-3; Roychoudhury AN, 1998, APPL GEOCHEM, V13, P269, DOI 10.1016/S0883-2927(97)00064-4; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; STOIBER RE, 1987, J VOLCANOL GEOTH RES, V33, P1, DOI 10.1016/0377-0273(87)90051-5; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2	26	569	595	5	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2372	2374		10.1126/science.1078265	http://dx.doi.org/10.1126/science.1078265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493910				2022-12-28	WOS:000179915900051
J	Lu, JR; Bassel-Duby, R; Hawkins, A; Chang, P; Valdez, R; Wu, H; Gan, L; Shelton, JM; Richardson, JA; Olson, EN				Lu, JR; Bassel-Duby, R; Hawkins, A; Chang, P; Valdez, R; Wu, H; Gan, L; Shelton, JM; Richardson, JA; Olson, EN			Control of facial muscle development by MyoR and capsulin	SCIENCE			English	Article							HELIX TRANSCRIPTION FACTOR; CRANIAL PARAXIAL MESODERM; SKELETAL-MUSCLE; GENE; MYF-5; MESENCHYME; EXPRESSION; UPSTREAM; KIDNEY; CELLS	Members of the MyoD family of basic helix-loop-helix (bHLH) transcription factors control the formation of all skeletal muscles in vertebrates, but little is known of the molecules or mechanisms that confer unique identities to different types of skeletal muscles. MyoR and capsulin are related bHLH transcription factors expressed in specific facial muscle precursors. We show that specific facial muscles are missing in mice lacking both MyoR and capsulin, reflecting the absence of MyoD family gene expression and ablation of the corresponding myogenic lineages. These findings identify MyoR and capsulin as unique transcription factors for the development of specific head muscles.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Rochester, Ctr Aging & Dev Biol, Rochester, NY 14642 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Rochester	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	eolson@hamon.swmed.edu	Lu, Jianrong/F-5240-2013	Lu, Jianrong/0000-0002-4969-6040				Brohmann H, 2000, DEVELOPMENT, V127, P437; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Chen JCJ, 2001, DEV DYNAM, V221, P274, DOI 10.1002/dvdy.1138; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Hacker A, 1998, DEVELOPMENT, V125, P3461; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hidai H, 1998, MECH DEVELOP, V73, P33, DOI 10.1016/S0925-4773(98)00031-8; Kablar B, 1999, DEV BIOL, V206, P219, DOI 10.1006/dbio.1998.9126; Lu J., UNPUB; Lu JR, 2000, P NATL ACAD SCI USA, V97, P9525, DOI 10.1073/pnas.97.17.9525; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Lu JR, 1998, MECH DEVELOP, V73, P23, DOI 10.1016/S0925-4773(98)00030-6; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; OTT MO, 1991, DEVELOPMENT, V111, P1097; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Rawls A, 1997, CELL, V89, P5, DOI 10.1016/S0092-8674(00)80175-0; Rawls A, 1998, DEVELOPMENT, V125, P2349; Robb L, 1998, MECH DEVELOP, V76, P197, DOI 10.1016/S0925-4773(98)00122-1; Robb L, 1998, DEV DYNAM, V213, P105, DOI 10.1002/(SICI)1097-0177(199809)213:1<105::AID-AJA10>3.0.CO;2-1; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; TRAINOR PA, 1994, DEVELOPMENT, V120, P2397	24	153	162	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2378	2381		10.1126/science.1078273	http://dx.doi.org/10.1126/science.1078273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493912				2022-12-28	WOS:000179915900053
J	El Setouhy, M; Agbenyega, T; Anto, F; Clerk, CA; Koram, KA; English, M; Molyneux, C; Peshu, N; English, M; Molyneux, C; Juma, R; Kumwend, N; Mfutso-Bengu, J; Molyneux, M; Taylor, T; Taylor, T; Diarra, DA; Maiga, S; Sylla, M; Youssouf, D; Falade, CO; Gbadegesin, S; Lie, R; Mugusi, F; Ngassapa, D; Ecuru, J; Talisuna, A; Emanuel, E; Grady, C; Wendler, D; Higgs, E; Plowe, C; Sugarman, J				El Setouhy, M; Agbenyega, T; Anto, F; Clerk, CA; Koram, KA; English, M; Molyneux, C; Peshu, N; English, M; Molyneux, C; Juma, R; Kumwend, N; Mfutso-Bengu, J; Molyneux, M; Taylor, T; Taylor, T; Diarra, DA; Maiga, S; Sylla, M; Youssouf, D; Falade, CO; Gbadegesin, S; Lie, R; Mugusi, F; Ngassapa, D; Ecuru, J; Talisuna, A; Emanuel, E; Grady, C; Wendler, D; Higgs, E; Plowe, C; Sugarman, J		2001 Conf Ethical Aspects Res Dev	Fair benefits for research in developing countries	SCIENCE			English	Editorial Material							CLINICAL RESEARCH; TRIALS; WORLD		Ain Shams Univ, Cairo, Egypt; Sch Med Sci, Kumasi, Ghana; Minist Hlth, Navrongo, Ghana; Univ Ghana, Legon, Ghana; Kenya Govt Med Res Ctr, Kilifi, Kenya; Wellcome Trust Res Labs, Kilifi, Kenya; KEMRI, Nairobi, Kenya; Univ Malawi, Coll Med, Blantyre, Malawi; Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; Univ Mali, Barnako, Mali; Eglise Protestante Barnako Coura, Barnako, Mali; Univ Ibadan, Coll Med, Ibadan, Nigeria; Howard Univ, Washington, DC 20059 USA; Univ Bergen, N-5020 Bergen, Norway; Muhimbili Univ, Coll Hlth Sci, Dar Es Salaam, Tanzania; Uganda Natl Council Sci & Technol, Kampala, Uganda; Minist Hlth, Kampala, Uganda; NIAID, Dept Clin Bioeth & Res, NIH, Bethesda, MD 20892 USA; NIAID, Div Microbiol & Infect Dis, NIH, Bethesda, MD 20892 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Duke Univ, Raleigh, NC USA	Egyptian Knowledge Bank (EKB); Ain Shams University; University of Ghana; Kenya Medical Research Institute; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine; University of Bamako; University of Ibadan; Howard University; University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore; Duke University	Emanuel, E (corresponding author), Ain Shams Univ, Cairo, Egypt.	EEmanuel@nih.gov	El-Setouhy, Maged/B-6021-2019	Sugarman, Jeremy/0000-0001-7022-8332; Molyneux, Catherine/0000-0001-9522-416X				Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Annas GJ, 1998, AM J PUBLIC HEALTH, V88, P560, DOI 10.2105/AJPH.88.4.560; Black N, 2001, BRIT MED J, V323, P275, DOI 10.1136/bmj.323.7307.275; *COUNC INT ORG MED, 1993, INT ETH GUID BIOM RE; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Glantz LH, 1998, HASTINGS CENT REP, V28, P38, DOI 10.2307/3528268; *JOINT UN PROGR HI, 2000, ETH CONS HIV PREV VA; National Bioethics Advisory Commission, 2001, ETH POL ISS INT RES; Shapiro HT, 2001, NEW ENGL J MED, V345, P139, DOI 10.1056/NEJM200107123450212; WERTHEIMER A, 1999, EXPLOITATION, pCH1; Wilmshurst P, 1997, BMJ-BRIT MED J, V314, P840	11	91	93	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2133	2134						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481120				2022-12-28	WOS:000179773700026
J	Blendon, RJ; DesRoches, CM; Brodie, M; Benson, JM; Rosen, AB; Schneider, E; Altman, DE; Zapert, K; Herrmann, MJ; Steffenson, AE				Blendon, RJ; DesRoches, CM; Brodie, M; Benson, JM; Rosen, AB; Schneider, E; Altman, DE; Zapert, K; Herrmann, MJ; Steffenson, AE			Patient safety: Views of practicing physicians and the public on medical errors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPINION; VOLUME; DEATHS	Background: In response to the report by the Institute of Medicine on medical errors, national groups have recommended actions to reduce the occurrence of preventable medical errors. What is not known is the level of support for these proposed changes among practicing physicians and the public. Methods: We conducted parallel national surveys of 831 practicing physicians, who responded to mailed questionnaires, and 1207 members of the public, who were interviewed by telephone after selection with the use of random-digit dialing. Respondents were asked about the causes of and solutions to the problem of preventable medical errors and, on the basis of a clinical vignette, were asked what the consequences of an error should be. Results: Many physicians (35 percent) and members of the public (42 percent) reported errors in their own or a family member's care, but neither group viewed medical errors as one of the most important problems in health care today. A majority of both groups believed that the number of in-hospital deaths due to preventable errors is lower than that reported by the Institute of Medicine. Physicians and the public disagreed on many of the underlying causes of errors and on effective strategies for reducing errors. Neither group believed that moving patients to high-volume centers would be a very effective strategy. The public and many physicians supported the use of sanctions against individual health professionals perceived as responsible for serious errors. Conclusions: Though substantial proportions of the public and practicing physicians report that they have had personal experience with medical errors, neither group has the sense of urgency expressed by many national organizations. To advance their agenda, national groups need to convince physicians, in particular, that the current proposals for reducing errors will be very effective.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Kaiser Family Fdn, Menlo Pk, CA USA; Harris Interact, Rochester, NY USA; Int Commun Res, Media, PA USA	Harvard University; Harvard T.H. Chan School of Public Health	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.		DesRoches, Catherine/ABC-9869-2020	DesRoches, Catherine/0000-0001-5373-855X; Schneider, Eric/0000-0002-1132-5084				ALEXANDER CS, 1978, PUBLIC OPIN QUART, V42, P93, DOI 10.1086/268432; *AM ASS PUBL OP RE, 2000, STAND DEF FIN DIS CA; Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Brennan TA, 2000, NEW ENGL J MED, V342, P1123, DOI 10.1056/NEJM200004133421510; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Epstein AM, 2002, NEW ENGL J MED, V346, P1161, DOI 10.1056/NEJM200204113461512; HARTLEY T, 1992, AM POLIT SCI REV, V86, P905, DOI 10.2307/1964343; *HARV SCH PUBL HLT, 2000, SURV HLTH CAR 2000 E; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; *LEAPFR GROUP, 2002, PAT SAF TIM LEAPS; McDonald CJ, 2000, JAMA-J AM MED ASSOC, V284, P93, DOI 10.1001/jama.284.1.93; PAGE BI, 1983, AM POLIT SCI REV, V77, P175, DOI 10.2307/1956018; Sox H C Jr, 2000, Eff Clin Pract, V3, P277; STAR P, 1982, SOCIAL TRANSFORMATIO; STIMSON JA, 1995, AM POLIT SCI REV, V89, P543, DOI 10.2307/2082973; Weaver D, 2002, INT J PUBLIC OPIN R, V14, P202, DOI 10.1093/ijpor/14.2.202; WLEZIEN C, 1995, AM J POLIT SCI, V39, P981, DOI 10.2307/2111666	20	504	513	0	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1933	1940		10.1056/NEJMsa022151	http://dx.doi.org/10.1056/NEJMsa022151			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	623ZX	12477944	Bronze			2022-12-28	WOS:000179735800006
J	Gee, H				Gee, H			Aspirational thinking	NATURE			English	Editorial Material														Gee, Henry/0000-0002-9363-7654				Huxley Thomas, 1869, NATURE, V1, P9, DOI [10.1038/001009a0, DOI 10.1038/001009A0]; Young JZ, 1981, LIFE VERTEBRATES	2	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					611	611		10.1038/420611a	http://dx.doi.org/10.1038/420611a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478269	Bronze			2022-12-28	WOS:000179751800022
J	Mani, RG; Smet, JH; von Klitzing, K; Narayanamurti, V; Johnson, WB; Umansky, V				Mani, RG; Smet, JH; von Klitzing, K; Narayanamurti, V; Johnson, WB; Umansky, V			Zero-resistance states induced by electromagnetic-wave excitation in GaAs/AlGaAs heterostructures	NATURE			English	Article							CYCLOTRON-RESONANCE; SUPERCONDUCTIVITY; PHOTOCONDUCTIVITY; OSCILLATIONS; MODEL	The observation of vanishing electrical resistance in condensed matter has led to the discovery of new phenomena such as, for example, superconductivity, where a zero-resistance state can be detected in a metal below a transition temperature T-c (ref. 1). More recently, quantum Hall effects were discovered from investigations of zero-resistance states at low temperatures and high magnetic fields in two-dimensional electron systems (2DESs)(2-4). In quantum Hall systems and superconductors, zero-resistance states often coincide with the appearance of a gap in the energy spectrum(1,2,4). Here we report the observation of zero-resistance states and energy gaps in a surprising setting(5) : ultrahigh-mobility GaAs/AlGaAs heterostructures that contain a 2DES exhibit vanishing diagonal resistance without Hall resistance quantization at low temperatures and low magnetic fields when the specimen is subjected to electromagnetic wave excitation. Zero-resistance states occur about magnetic fields B=4/5B(f) and B=4/9B(f), where B-f=2pifm*/e;m* is the electron mass, e is the electron charge, and f is the electromagnetic-wave frequency. Activated transport measurements on the resistance minima also indicate an energy gap at the Fermi level(6). The results suggest an unexpected radiation-induced, electronic-state-transition in the GaAs/AlGaAs 2DES.	Harvard Univ, Gordon McKay Lab Appl Sci, Cambridge, MA 02138 USA; Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; Harvard Univ, Cambridge, MA 02138 USA; Univ Maryland, Lab Phys Sci, College Pk, MD 20740 USA; Weizmann Inst Sci, Braun Ctr Submicron Res, IL-76100 Rehovot, Israel	Harvard University; Max Planck Society; Harvard University; University System of Maryland; University of Maryland College Park; Weizmann Institute of Science	Mani, RG (corresponding author), Harvard Univ, Gordon McKay Lab Appl Sci, 9 Oxford St, Cambridge, MA 02138 USA.	mani@deas.harvard.edu	von Klitzing, Klaus/AAH-2988-2022; von Klitzing, Klaus/AFM-0585-2022; Umansky, Vladimir/P-1334-2019	Umansky, Vladimir/0000-0001-5727-2064				ALLENDER D, 1973, PHYS REV B, V7, P1020, DOI 10.1103/PhysRevB.7.1020; ANDO T, 1982, REV MOD PHYS, V54, P437, DOI 10.1103/RevModPhys.54.437; ANDO T, 1976, PHYS REV LETT, V36, P1383, DOI 10.1103/PhysRevLett.36.1383; Bezryadin A, 2000, NATURE, V404, P971, DOI 10.1038/35010060; Butov LV, 2002, NATURE, V418, P751, DOI 10.1038/nature00943; BYCHKOV YA, 1995, SOLID STATE COMMUN, V94, P61, DOI 10.1016/0038-1098(95)00011-9; DAVIS D, 1976, PHYS REV B, V13, P4766, DOI 10.1103/PhysRevB.13.4766; ENGLERT T, 1983, SOLID STATE COMMUN, V46, P545, DOI 10.1016/0038-1098(83)90687-7; GINZBURG VL, 1970, SOV PHYS USPEKHI, V13, P335, DOI 10.1070/PU1970v013n03ABEH004256; HEITMANN D, 1986, SURF SCI, V170, P332, DOI 10.1016/0039-6028(86)90984-2; KALLIN C, 1984, PHYS REV B, V30, P5655, DOI 10.1103/PhysRevB.30.5655; Kellogg M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.126804; KLAHN S, 1987, P 18 INT C PHYS SEM, V2, P1161; KOHN W, 1961, PHYS REV, V123, P1242, DOI 10.1103/PhysRev.123.1242; LERNER IV, 1981, ZH EKSP TEOR FIZ, V53, P763; LITTLE WA, 1964, PHYS REV, V134, P1416, DOI 10.1103/PhysRev.134.A1416; Mani R. G., 2001, B AM PHYS SOC, V46, P972; MANI RG, 1988, PHYS REV B, V37, P4299, DOI 10.1103/PhysRevB.37.4299; NICHOLAS RJ, 1984, SPRINGER SERIES SOLI, V53, P69; PAQUET D, 1985, PHYS REV B, V32, P5208, DOI 10.1103/PhysRevB.32.5208; Prange R. E., 1990, QUANTUM HALL EFFECT; SCHLESINGER Z, 1984, PHYS REV B, V30, P435, DOI 10.1103/PhysRevB.30.435; Snoke D, 2002, NATURE, V418, P754, DOI 10.1038/nature00940; SZE SM, 1981, PHYSICS SEMICONDUCTO; THEIS TN, 1978, SOLID STATE COMMUN, V26, P603, DOI 10.1016/0038-1098(78)90773-1; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; TSUI DC, 1982, PHYS REV B, V25, P1405, DOI 10.1103/PhysRevB.25.1405; VASILIADOU E, 1993, PHYS REV B, V48, P17145, DOI 10.1103/PhysRevB.48.17145; VONKLITZING K, 1985, P 17 INT C PHYS SEM, P271; Zudov MA, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.201311	32	621	631	0	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					646	650		10.1038/nature01277	http://dx.doi.org/10.1038/nature01277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478287	Green Submitted			2022-12-28	WOS:000179751800039
J	Smaglik, P				Smaglik, P			Turning oil into science - Norway	NATURE			English	Article																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916		S			A13	+		10.1038/420a13a	http://dx.doi.org/10.1038/420a13a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625LG	12501121	Bronze			2022-12-28	WOS:000179817500003
J	Stewart, KJ; Hiatt, WR; Regensteiner, JG; Hirsch, AT				Stewart, KJ; Hiatt, WR; Regensteiner, JG; Hirsch, AT			Medical progress: Exercise training for claudication	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PERIPHERAL ARTERIAL-DISEASE; MUSCLE BLOOD-FLOW; INTERMITTENT CLAUDICATION; SKELETAL-MUSCLE; NITRIC-OXIDE; FUNCTIONAL STATUS; AEROBIC EXERCISE; ENDOTHELIAL REACTIVITY; VASCULAR REACTIVITY; RESISTANCE EXERCISE		Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; Univ Colorado, Hlth Sci Ctr, Sect Vasc Med, Div Cardiol, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Sect Vasc Med, Div Geriatr, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Sect Vasc Med, Dept Internal Med, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Colorado Prevent Ctr, Denver, CO USA; Univ Minnesota, Sch Med, Minnesota Vasc Dis Ctr, Cardiovasc Div,Vasc Med Program, Minneapolis, MN 55455 USA	Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Minnesota System; University of Minnesota Twin Cities	Stewart, KJ (corresponding author), Johns Hopkins Bayview Med Ctr, 4940 Eastern Ave, Baltimore, MD 21224 USA.	kstewart@mail.jhmi.edu						Albright A, 2000, MED SCI SPORT EXER, V32, P1345; ALPERT JS, 1969, CIRCULATION, V39, P353, DOI 10.1161/01.CIR.39.3.353; *AM ASS CARD PULM, 1999, GUID CARD REH SEC PR; [Anonymous], 2001, ACSMS RESOURCE MANUA; Arosio E, 2001, LIFE SCI, V69, P421, DOI 10.1016/S0024-3205(01)01134-1; Baron AD, 1999, AM J CARDIOL, V84, p25J; Beebe HG, 1999, ARCH INTERN MED, V159, P2041, DOI 10.1001/archinte.159.17.2041; Brass EP, 2001, AM J PHYSIOL-HEART C, V280, pH603, DOI 10.1152/ajpheart.2001.280.2.H603; Brass EP, 2000, VASC MED, V5, P225, DOI 10.1191/135886300701568513; Brass EP, 2000, VASC MED, V5, P55, DOI 10.1177/1358836X0000500109; Brendle DC, 2001, AM J CARDIOL, V87, P324, DOI 10.1016/S0002-9149(00)01367-9; BRUSH JE, 1992, J AM COLL CARDIOL, V19, P809, DOI 10.1016/0735-1097(92)90522-O; Caballero AE, 1999, DIABETES, V48, P1856, DOI 10.2337/diabetes.48.9.1856; Capecchi PL, 1997, ANGIOLOGY, V48, P469, DOI 10.1177/000331979704800601; Clarkson P, 1996, J AM COLL CARDIOL, V28, P573, DOI 10.1016/0735-1097(96)82380-1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; CLIFFORD PC, 1980, BRIT MED J, V280, P1503, DOI 10.1136/bmj.280.6230.1503; COFFMAN JD, 1991, NEW ENGL J MED, V325, P577, DOI 10.1056/NEJM199108223250810; Creager M A, 2001, Cardiol Rev, V9, P238, DOI 10.1097/00045415-200107000-00010; Creasy T S, 1990, Eur J Vasc Surg, V4, P135, DOI 10.1016/S0950-821X(05)80427-X; Criqui MH, 2001, VASC MED, V6, P3, DOI 10.1177/1358836X0100600i102; Crosby F E, 1993, J Vasc Nurs, V11, P5; Dawson DL, 2000, AM J MED, V109, P523, DOI 10.1016/S0002-9343(00)00569-6; Dawson DL, 1998, CIRCULATION, V98, P678, DOI 10.1161/01.CIR.98.7.678; de Vries SO, 2002, RADIOLOGY, V222, P25, DOI 10.1148/radiol.2221001743; Deschenes MR, 1999, MED SCI SPORT EXER, V31, P1599, DOI 10.1097/00005768-199911000-00016; DESPRES JP, 1993, NUTRITION, V9, P452; Dormer S, 2000, IIC-INT REV IND PROP, V31, P1; ENGLAND JD, 1995, MUSCLE NERVE, V18, P380, DOI 10.1002/mus.880180403; ERNST E, 1994, ANGIOLOGY, V45, P339, DOI 10.1177/000331979404500502; ERNST EEW, 1987, CIRCULATION, V76, P1110, DOI 10.1161/01.CIR.76.5.1110; Feinglass J, 2000, J VASC SURG, V31, P93, DOI 10.1016/S0741-5214(00)70071-1; Franklin BA, 2000, ACSMS GUIDELINES EXE; Gardner Andrew W, 2002, J Cardiopulm Rehabil, V22, P192, DOI 10.1097/00008483-200205000-00011; Gardner AW, 2001, J AM GERIATR SOC, V49, P755, DOI 10.1046/j.1532-5415.2001.49152.x; GARDNER AW, 1995, JAMA-J AM MED ASSOC, V274, P975, DOI 10.1001/jama.274.12.975; Gardner AW, 2001, VASC MED, V6, P31, DOI 10.1191/135886301677047365; Gardner AW, 2000, J GERONTOL A-BIOL, V55, pM570, DOI 10.1093/gerona/55.10.M570; Gavin TP, 2001, J APPL PHYSIOL, V90, P1219, DOI 10.1152/jappl.2001.90.4.1219; Gibellini R, 2000, INT ANGIOL, V19, P8; Girolami B, 1999, ARCH INTERN MED, V159, P337, DOI 10.1001/archinte.159.4.337; Gustafsson T, 1999, AM J PHYSIOL-HEART C, V276, pH679, DOI 10.1152/ajpheart.1999.276.2.H679; Gustafsson T, 2001, EUR J CLIN INVEST, V31, P362, DOI 10.1046/j.1365-2362.2001.00816.x; Gustafsson T, 2001, FRONT BIOSCI-LANDMRK, V6, pD75, DOI 10.2741/gustafss; Hagberg JM, 2000, SPORTS MED, V30, P193, DOI 10.2165/00007256-200030030-00004; Hambrecht R, 1998, CIRCULATION, V98, P2709, DOI 10.1161/01.CIR.98.24.2709; Hardman AE, 1999, INT J OBESITY, V23, pS64, DOI 10.1038/sj.ijo.0800886; HARRIS LM, 1995, AM J CARDIOL, V76, P207, DOI 10.1016/S0002-9149(99)80066-6; HIATT WR, 1994, CIRCULATION, V90, P1866, DOI 10.1161/01.CIR.90.4.1866; HIATT WR, 1990, CIRCULATION, V81, P602, DOI 10.1161/01.CIR.81.2.602; HIATT WR, 1992, J APPL PHYSIOL, V73, P346, DOI 10.1152/jappl.1992.73.1.346; Hiatt WR, 1996, J APPL PHYSIOL, V81, P780, DOI 10.1152/jappl.1996.81.2.780; HIATT WR, 1989, J CLIN INVEST, V84, P1167, DOI 10.1172/JCI114281; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Higashi Y, 1999, HYPERTENSION, V33, P591, DOI 10.1161/01.HYP.33.1.591; Higashi Y, 1999, CIRCULATION, V100, P1194, DOI 10.1161/01.CIR.100.11.1194; Hirsch AT, 2001, VASC MED, V6, P9, DOI 10.1177/1358836X0100600i103; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Hood SC, 1996, CAN MED ASSOC J, V155, P1053; Hooi JD, 1998, SCAND J PRIM HEALTH, V16, P177; John S, 2000, J HYPERTENS, V18, P363, DOI 10.1097/00004872-200018040-00002; JOHNSON EC, 1989, CIRCULATION, V80, P59; JOHNSTONE MT, 1993, CIRCULATION, V88, P2510, DOI 10.1161/01.CIR.88.6.2510; Kelley G A, 2001, Prev Cardiol, V4, P73, DOI 10.1111/j.1520-037X.2001.00529.x; Kelley GA, 2001, PREV MED, V33, P120, DOI 10.1006/pmed.2001.0860; Killewich LA, 1998, J VASC SURG, V27, P645, DOI 10.1016/S0741-5214(98)70229-0; Kingwell BA, 2000, CLIN EXP PHARMACOL P, V27, P239, DOI 10.1046/j.1440-1681.2000.03232.x; Lavrencic A, 2000, ARTERIOSCL THROM VAS, V20, P551, DOI 10.1161/01.ATV.20.2.551; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; LENG GC, 2000, COCHRANE DB SYST REV, V2; Libby P, 2000, INT J CARDIOL, V74, pS3, DOI 10.1016/S0167-5273(99)00105-9; Lloyd PG, 2001, AM J PHYSIOL-HEART C, V281, pH2528, DOI 10.1152/ajpheart.2001.281.6.H2528; LUNDGREN F, 1989, ANN SURG, V209, P346, DOI 10.1097/00000658-198903000-00016; LUNDGREN F, 1989, CLIN SCI, V77, P45; Maiorana A, 2001, J AM COLL CARDIOL, V38, P860, DOI 10.1016/S0735-1097(01)01439-5; MATHIEN GM, 1990, AM J PHYSIOL, V258, pH759, DOI 10.1152/ajpheart.1990.258.3.H759; Maxwell AJ, 2002, NITRIC OXIDE-BIOL CH, V6, P101, DOI 10.1006/niox.2001.0394; MCALLISTER RM, 1995, MED SCI SPORT EXER, V27, P1145; McCully K, 1999, J GERONTOL A-BIOL, V54, pB291, DOI 10.1093/gerona/54.7.B291; McDermott MM, 2001, J AM GERIATR SOC, V49, P747, DOI 10.1046/j.1532-5415.2001.49151.x; MCVEIGH GE, 1992, DIABETOLOGIA, V35, P771; Money SR, 1998, J VASC SURG, V27, P267, DOI 10.1016/S0741-5214(98)70357-X; Mustonen P, 1998, ARTERIOSCL THROM VAS, V18, P244, DOI 10.1161/01.ATV.18.2.244; *NAT COMM PREV DET, 1997, NIH PUBL; Nehler MR, 1999, ANN VASC SURG, V13, P109, DOI 10.1007/s100169900228; Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652, DOI 10.1016/S0735-1097(96)00393-2; NIEBAUER J, 1999, AM J PHYSL, V276; Ouriel K, 2001, LANCET, V358, P1257, DOI 10.1016/S0140-6736(01)06351-6; Paterick T E, 2001, Cardiol Rev, V9, P282, DOI 10.1097/00045415-200109000-00008; Patterson RB, 1997, J VASC SURG, V25, P312, DOI 10.1016/S0741-5214(97)70352-5; Pollock ML, 2000, CIRCULATION, V101, P828, DOI 10.1161/01.CIR.101.7.828; PRIEBE M, 1991, WESTERN J MED, V154, P598; RADACK K, 1990, ANN INTERN MED, V113, P135, DOI 10.7326/0003-4819-113-2-135; Regensteiner J G, 1997, Vasc Med, V2, P238; Regensteiner JG, 1996, J VASC SURG, V23, P104, DOI 10.1016/S0741-5214(05)80040-0; Regensteiner JG, 2002, AM J MED, V112, P49, DOI 10.1016/S0002-9343(01)01034-8; REGENSTEINER JG, 1993, ANGIOLOGY, V44, P1, DOI 10.1177/000331979304400101; Regensteiner JG, 1997, ANGIOLOGY, V48, P291, DOI 10.1177/000331979704800402; Robeer GG, 1998, EUR J VASC ENDOVASC, V15, P36, DOI 10.1016/S1078-5884(98)80070-1; RUDERMAN N, 2000, HDB EXERCISE DIABETE; Ryan AS, 2000, J GERONTOL A-BIOL, V55, pB302, DOI 10.1093/gerona/55.6.B302; Scherer SA, 1998, ARCH PHYS MED REHAB, V79, P529, DOI 10.1016/S0003-9993(98)90067-3; SCHWARTZ RS, 1991, METABOLISM, V40, P545, DOI 10.1016/0026-0495(91)90239-S; SCHWARTZ RS, 1992, METABOLISM, V41, P649, DOI 10.1016/0026-0495(92)90058-I; Sieminski D J, 1997, Vasc Med, V2, P286; STEWART KJ, 1990, MED SCI SPORT EXER, V22, P171; TERJUNG RL, 1988, AM J CARDIOL, V62, pE15, DOI 10.1016/S0002-9149(88)80004-3; Tisi PV, 1998, EUR J VASC ENDOVASC, V16, P169, DOI 10.1016/S1078-5884(98)80161-5; Tisi PV, 1997, EUR J VASC ENDOVASC, V14, P344, DOI 10.1016/S1078-5884(97)80283-3; Tisi PV, 1998, EUR J VASC ENDOVASC, V15, P7, DOI 10.1016/S1078-5884(98)80066-X; Tomoike H, 1996, DIABETES RES CLIN PR, V30, pS55, DOI 10.1016/S0168-8227(96)80038-6; Treat-Jacobson D, 2002, J NURS SCHOLARSHIP, V34, P55, DOI 10.1111/j.1547-5069.2002.00055.x; VOGT MT, 1994, J AM GERIATR SOC, V42, P923, DOI 10.1111/j.1532-5415.1994.tb06581.x; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; Whyman MR, 1997, J VASC SURG, V26, P551, DOI 10.1016/S0741-5214(97)70052-1; Williams SB, 1996, J AM COLL CARDIOL, V27, P567, DOI 10.1016/0735-1097(95)00522-6; Womack CJ, 2001, MED SCI SPORT EXER, V33, P214; Womack CJ, 1997, MED SCI SPORT EXER, V29, P1286, DOI 10.1097/00005768-199710000-00002; WOMACK CJ, 1997, FVASC MED, V2, P174; YANG HT, 1995, AM J PHYSIOL-HEART C, V268, pH1174, DOI 10.1152/ajpheart.1995.268.3.H1174; Yataco AR, 1999, AM J CARDIOL, V83, P754, DOI 10.1016/S0002-9149(98)00984-9	122	336	351	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1941	1951		10.1056/NEJMra021135	http://dx.doi.org/10.1056/NEJMra021135			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	623ZX	12477945				2022-12-28	WOS:000179735800007
J	Hall, P				Hall, P			Doctors urgently need education in human rights	LANCET			English	Editorial Material									Phys Human Rights UK, Abbots Langley WD5 0BE, Herts, England		Hall, P (corresponding author), Phys Human Rights UK, 91 Harlech Rd, Abbots Langley WD5 0BE, Herts, England.							Aggleton P, 2002, CONCEPTUAL FRAMEWORK; Bharat S, 2001, HIV AIDS RELATED DIS, P16; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; *PHR UK, 2002, RESP UK GOV 4 REP IN; WEATHERBURN P, 2002, WHAT DO YOU NEED FIN, P63	5	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1879	1879		10.1016/S0140-6736(02)11779-X	http://dx.doi.org/10.1016/S0140-6736(02)11779-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480382				2022-12-28	WOS:000179706100032
J	Moulik, PK; Nethaji, C; Khaleeli, AA				Moulik, PK; Nethaji, C; Khaleeli, AA			Lesson of the week - Misleading electrocardiographic results in patient with hyperkalaemia and diabetic ketoacidosis	BRITISH MEDICAL JOURNAL			English	Review							PATTERN		Halton Gen Hosp, Dept Med, Runcorn WA7 2DA, Cheshire, England		Moulik, PK (corresponding author), Univ Hosp, Flat 39,Coniston House, Liverpool L9 7AL, Merseyside, England.							BEIGELMAN PM, 1971, DIABETES, V20, P490, DOI 10.2337/diab.20.7.490; COHEN A, 1981, ANGIOLOGY, V32, P361, DOI 10.1177/000331978103200510; Delaney ME, 2000, ENDOCRIN METAB CLIN, V29, P683, DOI 10.1016/S0889-8529(05)70159-6; Johnson C D, 1983, Bol Asoc Med P R, V75, P288; KAMIMURA M, 1992, HOSP PRACT, V27, P28; KRENTZ AJ, 1997, TXB DIABETES, V39, P1; Lim Y. H., 1998, SMJ, V39, P504; Schamroth L., 1990, INTRO ELECTROCARDIOG; Sweterlitsch EM, 1996, AM HEART J, V132, P1086, DOI 10.1016/S0002-8703(96)90037-X; VANGAAL L, 1981, DIABETES CARE, V4, P576, DOI 10.2337/diacare.4.5.576	10	24	27	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2002	325	7376					1346	1347		10.1136/bmj.325.7376.1346	http://dx.doi.org/10.1136/bmj.325.7376.1346			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468487	Green Published			2022-12-28	WOS:000179817100025
J	Dehaene-Lambertz, G; Dehaene, S; Hertz-Pannier, L				Dehaene-Lambertz, G; Dehaene, S; Hertz-Pannier, L			Functional neuroimaging of speech perception in infants	SCIENCE			English	Article							CORTICAL REPRESENTATION; BRAIN; LANGUAGE; ACTIVATION; DISCRIMINATION; ACQUISITION; RETRIEVAL; MEMORY; CORTEX; HUMANS	Human infants begin to acquire their native language in the first months of life. To determine which brain regions support language processing at this young age, we measured with functional magnetic resonance imaging the brain activity evoked by normal and reversed speech in awake and sleeping 3-month-old infants. Left-lateralized brain regions similar to those of adults, including the superior temporal and angular gyri, were already active in infants. Additional activation in right prefrontal cortex was seen only in awake infants processing normal speech. Thus, precursors of adult cortical language areas are already active in infants, well before the onset of speech production.	CNRS, Lab Sci Cognit & Psycholinguist, F-75270 Paris 06, France; Ecole Hautes Etud Sci Sociales, F-75270 Paris, France; CEA, Unite Neuroanat Fonct, Serv Hosp Frederic Joliot, F-91401 Orsay, France; Hop Necker Enfants Malad, Assistance Publ Hop Paris, Serv Radiol Pediat, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Dehaene-Lambertz, G (corresponding author), CNRS, Lab Sci Cognit & Psycholinguist, 54 Blvd Raspail, F-75270 Paris 06, France.		Dehaene, Ghislaine/O-3633-2017	Dehaene, Ghislaine/0000-0003-2221-9081; Hertz-Pannier, Lucie/0000-0003-4952-7009				Altman NR, 2001, RADIOLOGY, V221, P56, DOI 10.1148/radiol.2211010074; Anderson AW, 2001, MAGN RESON IMAGING, V19, P1, DOI 10.1016/S0730-725X(00)00231-9; BERTONCINI J, 1989, BRAIN LANG, V37, P591, DOI 10.1016/0093-934X(89)90113-2; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Born AP, 2000, NEUROPEDIATRICS, V31, P24, DOI 10.1055/s-2000-15402; Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; Dehaene-Lambertz G, 1998, LANG SPEECH, V41, P21, DOI 10.1177/002383099804100102; Dehaene-Lambertz G, 1998, NEUROREPORT, V9, P1885, DOI 10.1097/00001756-199806010-00040; DEHAENELAMBERTZ G, 1994, NATURE, V370, P292, DOI 10.1038/370292a0; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Elman JL, 1996, RETHINKING INNATENES; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Krause BJ, 1999, BRAIN, V122, P255, DOI 10.1093/brain/122.2.255; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Moore RJ, 2001, HUM BRAIN MAPP, V12, P94, DOI 10.1002/1097-0193(200102)12:2<94::AID-HBM1006>3.0.CO;2-E; Morita T, 2000, NEUROSCI RES, V38, P63, DOI 10.1016/S0168-0102(00)00146-2; Perani D, 1996, NEUROREPORT, V7, P2439, DOI 10.1097/00001756-199611040-00007; PINKER S, 1994, LANGUAGE INSTINCT MI; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Vaissiere J., 1983, PROSODY MODELS MEASU, P53, DOI DOI 10.1007/978-3-642-69103-4_5; WADA JA, 1975, ARCH NEUROL-CHICAGO, V32, P239, DOI 10.1001/archneur.1975.00490460055007	27	666	682	4	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					2013	2015		10.1126/science.1077066	http://dx.doi.org/10.1126/science.1077066			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471265				2022-12-28	WOS:000179629200052
J	Jasmer, RM; Nahid, P; Hopewell, PC				Jasmer, RM; Nahid, P; Hopewell, PC			Latent tuberculosis infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVENTIVE THERAPY; UNITED-STATES; ANERGY; PYRAZINAMIDE; MORTALITY; RIFAMPIN; TRIAL		San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Jasmer, RM (corresponding author), San Francisco Gen Hosp, Div Pulm & Crit Care Med, Rm 5K-1,1001 Potrero Ave, San Francisco, CA 94110 USA.	rjasmer@itsa.ucsf.edu		Nahid, Payam/0000-0003-2811-1311	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034238, K08AI001549] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 34238, AI 01549] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		American Thoracic Society, 1999, TARG TUB TEST TREATM; [Anonymous], 2000, MMWR-MORBID MORTAL W, V51, P101; BYRD RB, 1979, JAMA-J AM MED ASSOC, V241, P1239, DOI 10.1001/jama.241.12.1239; CAIAFFA WT, 1995, ARCH INTERN MED, V155, P2111, DOI 10.1001/archinte.155.19.2111; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P733; Chin DP, 1996, AM J RESP CRIT CARE, V153, P1982, DOI 10.1164/ajrccm.153.6.8665065; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; HOLDEN M, 1971, NEW ENGL J MED, V285, P1506, DOI 10.1056/NEJM197112302852704; Jasmer RM, 2002, ANN INTERN MED, V137, P640, DOI 10.7326/0003-4819-137-8-200210150-00007; Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009; Khan K, 2002, NEW ENGL J MED, V347, P1850, DOI 10.1056/NEJMsa021099; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; MARKOWITZ N, 1993, ANN INTERN MED, V119, P185, DOI 10.7326/0003-4819-119-3-199308010-00002; MAZUREK GH, 1908, JAMA-J AM MED ASSOC, V286, P1740; MCKENNA MT, 1995, NEW ENGL J MED, V332, P1071, DOI 10.1056/NEJM199504203321606; MENZIES R, 1992, AM REV RESPIR DIS, V145, P621, DOI 10.1164/ajrccm/145.3.621; MENZIES RI, 2000, LUNG BIOL HEALTH DIS, V144, P279; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; Mwinga A, 1998, AIDS, V12, P2447, DOI 10.1097/00002030-199818000-00014; NASH DR, 1980, CHEST, V77, P32, DOI 10.1378/chest.77.1.32; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; OESTREICHER R, 1954, AM REV TUBERC PULM, V70, P504; ROTHEL JS, 1990, AUST VET J, V67, P134, DOI 10.1111/j.1751-0813.1990.tb07730.x; SLUTKIN G, 1986, AM REV RESPIR DIS, V134, P1048, DOI 10.1164/arrd.1986.134.5.1048; SNIDER DE, 1980, TUBERCLE, V61, P191, DOI 10.1016/0041-3879(80)90038-0; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; THOMPSON NJ, 1979, AM REV RESPIR DIS, V119, P587; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; World Health Organization, 2001, GLOBAL TUBERCULOSIS; 2000, ENDING NEGLECT ELIMI, P86	38	309	330	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2002	347	23					1860	1866		10.1056/NEJMcp021045	http://dx.doi.org/10.1056/NEJMcp021045			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NW	12466511				2022-12-28	WOS:000179596900008
J	Stathopoulos, A; Van Drenth, M; Erives, A; Markstein, M; Levine, M				Stathopoulos, A; Van Drenth, M; Erives, A; Markstein, M; Levine, M			Whole-genome analysis of dorsal-ventral patterning in the Drosophila embryo	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; CELL-SHAPE CHANGES; TRANSCRIPTION FACTOR; MORPHOGEN GRADIENTS; GASTRULATION GENE; COLUMN IDENTITY; EXPRESSION; MESODERM; POLARITY; TISSUE	The maternal Dorsal regulatory gradient initiates the differentiation of several tissues in the early Drosophila embryo. Whole-genome microarray assays identified as many as 40 new Dorsal target genes, which encode a broad spectrum of cell signaling proteins and transcription factors. Evidence is presented that a tissue-specific form of the NF-Y transcription complex is essential for the activation of gene expression in the mesoderm. Tissue-specific enhancers were identified for new Dorsal target genes, and bioinformatics methods identified conserved cis-regulatory elements for coordinately regulated genes that respond to similar thresholds of the Dorsal gradient. The new Dorsal target genes and enhancers represent one of the most extensive gene networks known for any developmental process.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet & Dev, Berkeley, CA 94720 USA; Auilix Biopharma Inc, Berkeley, CA 94710 USA; Univ Chicago, Comm Dev Biol, Cummings Life Sci Ctr, Chicago, IL 60637 USA	University of California System; University of California Berkeley; University of Chicago	Levine, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet & Dev, 401 Barker Hall, Berkeley, CA 94720 USA.			Markstein, Michele/0000-0003-2635-8118; Levine, Michael/0000-0001-7629-0081; Erives, Albert/0000-0001-7107-5518	NIGMS NIH HHS [GM20352, GM46638] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046638, R37GM046638] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoyagi N, 2000, J CELL BIOL, V150, pF45, DOI 10.1083/jcb.150.2.F45; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; BODMER R, 1990, DEVELOPMENT, V110, P661; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Casal J, 1996, P NATL ACAD SCI USA, V93, P10327, DOI 10.1073/pnas.93.19.10327; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; COUREY AJ, 1995, BBA-GENE STRUCT EXPR, V1261, P1, DOI 10.1016/0167-4781(94)00234-T; Cremazy F, 2000, MECH DEVELOP, V93, P215, DOI 10.1016/S0925-4773(00)00268-9; DOYLE HJ, 1989, GENE DEV, V3, P1518, DOI 10.1101/gad.3.10.1518; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Frank LH, 1996, DEVELOPMENT, V122, P1343; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; HOCH M, 1990, EMBO J, V9, P2587, DOI 10.1002/j.1460-2075.1990.tb07440.x; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; IP YT, 1991, CELL, V64, P439; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; Kasai Y, 1998, GENE EXPRESSION, V7, P171; KIROV N, 1994, MOL CELL BIOL, V14, P713, DOI 10.1128/MCB.14.1.713; Kosman D, 1997, DEVELOPMENT, V124, P1343; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; LAI ZC, 1991, MECH DEVELOP, V34, P123, DOI 10.1016/0925-4773(91)90049-C; LEPTIN M, 1994, DEVELOPMENT, V120, P853; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Martin G, 2001, BIOESSAYS, V23, P865, DOI 10.1002/bies.1126; McDonald JA, 1998, GENE DEV, V12, P3603, DOI 10.1101/gad.12.22.3603; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; Morisato D, 2001, DEVELOPMENT, V128, P2309; Morize P, 1998, DEVELOPMENT, V125, P589; NATZLE JE, 1984, DEV BIOL, V104, P187, DOI 10.1016/0012-1606(84)90047-2; Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; RiesgoEscovar JR, 1997, SCIENCE, V278, P669, DOI 10.1126/science.278.5338.669; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; ROTH S, 1994, CURR BIOL, V4, P755, DOI 10.1016/S0960-9822(00)00170-6; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Rusch J, 1997, DEVELOPMENT, V124, P303; Rusch J, 1996, CURR OPIN GENET DEV, V6, P416, DOI 10.1016/S0959-437X(96)80062-1; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Shao XP, 2002, P NATL ACAD SCI USA, V99, P113, DOI 10.1073/pnas.012584599; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; Stathopoulos A, 2002, DEVELOPMENT, V129, P3411; Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STJOHNSTON D, 1992, CELL, V68, P201; STJOHNSTON RD, 1987, EMBO J, V6, P2785, DOI 10.1002/j.1460-2075.1987.tb02574.x; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; SZYMANSKI P, 1995, EMBO J, V14, P2229, DOI 10.1002/j.1460-2075.1995.tb07217.x; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TAYLOR MV, 1995, MECH DEVELOP, V50, P29, DOI 10.1016/0925-4773(94)00323-F; Van Buskirk C, 1999, TRENDS CELL BIOL, V9, P1, DOI 10.1016/S0962-8924(98)01413-5; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; WINICK J, 1993, DEVELOPMENT, V119, P1055	66	229	245	1	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 27	2002	111	5					687	701		10.1016/S0092-8674(02)01087-5	http://dx.doi.org/10.1016/S0092-8674(02)01087-5			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464180	Bronze, Green Published			2022-12-28	WOS:000179594500010
J	Ben-Yehuda, S; Rudner, DZ; Losick, R				Ben-Yehuda, S; Rudner, DZ; Losick, R			RacA, a bacterial protein that anchors chromosomes to the cell poles	SCIENCE			English	Article							BACILLUS-SUBTILIS SPOIIIE; DIVISION SEPTUM; DNA SEGREGATION; SITE; LOCALIZATION; DIVIVA; SPORULATION; SELECTION	Eukaryotic chromosomes are anchored to a spindle apparatus during mitosis, but no such structure is known during chromosome segregation in bacteria. When sister chromosomes are segregated during sporulation in Bacillus subtilis, the replication origin regions migrate to opposite poles of the cell. If and how origin regions are fastened at the poles has not been determined. Here we describe a developmental protein, RacA, that acts as a bridge between the origin region and the cell poles. We propose that RacA assembles into an adhesive patch at a centromere-like element near the origin, causing chromosomes to stick at the poles.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.				NIGMS NIH HHS [GM18568] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018568, R01GM018568] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Cha JH, 1997, J BACTERIOL, V179, P1671, DOI 10.1128/jb.179.5.1671-1683.1997; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Gordon GS, 2000, ANNU REV MICROBIOL, V54, P681, DOI 10.1146/annurev.micro.54.1.681; Graumann PL, 2001, J BACTERIOL, V183, P4052, DOI 10.1128/JB.183.13.4052-4060.2001; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Lindow JC, 2002, MOL MICROBIOL, V46, P997, DOI 10.1046/j.1365-2958.2002.03235.x; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; PIGGOT PJ, 1976, BACTERIOL REV, V40, P908, DOI 10.1128/MMBR.40.4.908-962.1976; PIGGOT PJ, 2001, BACILLUS SUBTILIS IT, P483; RYTER A, 1966, ANN I PASTEUR PARIS, V110, P305; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Thomaides HB, 2001, GENE DEV, V15, P1662, DOI 10.1101/gad.197501; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 2002, EMBO J, V21, P4001, DOI 10.1093/emboj/cdf393	23	254	262	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					532	536		10.1126/science.1079914	http://dx.doi.org/10.1126/science.1079914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12493822				2022-12-28	WOS:000180559800039
J	Coussens, LM; Werb, Z				Coussens, LM; Werb, Z			Inflammation and cancer	NATURE			English	Review							MACROPHAGE INFILTRATION; HELICOBACTER-PYLORI; TUMOR STROMA; P-SELECTIN; MAST-CELLS; GROWTH; CARCINOGENESIS; ANGIOGENESIS; METASTASIS; EXPRESSION	Recent data have expanded the concept that inflammation is a critical component of tumour progression. Many cancers arise from sites of infection, chronic irritation and inflammation. It is now becoming clear that the tumour microenvironment, which is largely orchestrated by inflammatory cells, is an indispensable participant in the neoplastic process, fostering proliferation, survival and migration. In addition, tumour cells have co-opted some of the signalling molecules of the innate immune system, such as selectins, chemokines and their receptors for invasion, migration and metastasis. These insights are fostering new antiinflammatory therapeutic approaches to cancer development.	Univ Calif San Francisco, Canc Res Inst, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, UCSF Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Coussens, LM (corresponding author), Univ Calif San Francisco, Canc Res Inst, Dept Pathol, Box 0128, San Francisco, CA 94143 USA.	coussens@cc.ucsf.edu; zena@itsa.ucsf.edu	Coussens, Lisa/ABH-9834-2020; Sroka, Isis C/A-2949-2009		NATIONAL CANCER INSTITUTE [R01CA057621, P01CA072006] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA057621-07, R01 CA057621, P01 CA072006-08, P01 CA072006] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allavena P, 2000, IMMUNOL REV, V177, P141, DOI 10.1034/j.1600-065X.2000.17714.x; Arenberg DA, 1998, J CLIN INVEST, V102, P465, DOI 10.1172/JCI3145; BALENTIEN E, 1991, ONCOGENE, V6, P1115; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Baron JA, 2000, ANNU REV MED, V51, P511, DOI 10.1146/annurev.med.51.1.511; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; BLASER MJ, 1995, CANCER RES, V55, P562; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Borsig L, 2001, P NATL ACAD SCI USA, V98, P3352, DOI 10.1073/pnas.061615598; Brigati C, 2002, CLIN EXP METASTAS, V19, P247, DOI 10.1023/A:1015587423262; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; CHEDID M, 1994, J BIOL CHEM, V269, P10753; CHENSUE SW, 1995, J IMMUNOL, V155, P3546; Chettibi S., 1999, INFLAMMATION BASIC P, P865; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dalgleish AG, 2002, ADV CANCER RES, V84, P231, DOI 10.1016/S0065-230X(02)84008-8; Di Carlo E, 2001, BLOOD, V97, P339, DOI 10.1182/blood.V97.2.339; DIPIETRO LA, 1995, SHOCK, V4, P233, DOI 10.1097/00024382-199510000-00001; Dranoff G, 2002, CURR OPIN IMMUNOL, V14, P161, DOI 10.1016/S0952-7915(02)00315-1; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elder DJE, 1997, CLIN CANCER RES, V3, P1679; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4; FEIKEN E, 1995, J INVEST DERMATOL, V105, P120, DOI 10.1111/1523-1747.ep12313429; Fritsch C, 1997, GASTROENTEROLOGY, V112, P826, DOI 10.1053/gast.1997.v112.pm9041244; Grutzkau A, 1998, MOL BIOL CELL, V9, P875, DOI 10.1091/mbc.9.4.875; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Homey B, 2002, NAT REV IMMUNOL, V2, P175, DOI 10.1038/nri748; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jensen UB, 1999, DEVELOPMENT, V126, P2409; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Kim YJ, 1998, P NATL ACAD SCI USA, V95, P9325, DOI 10.1073/pnas.95.16.9325; Kleeff J, 1999, INT J CANCER, V81, P650, DOI 10.1002/(SICI)1097-0215(19990517)81:4<650::AID-IJC23>3.0.CO;2-#; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; MacKenzie I, 1941, J EXP MED, V73, P391, DOI 10.1084/jem.73.3.391; Maeda H, 1998, BIOCHEMISTRY-MOSCOW+, V63, P854; MAMYTBEKOVA A, 1986, NEOPLASMA, V33, P417; Mantovani A, 2001, NOVART FDN SYMP, V234, P120; MARTINSGREEN M, 1994, CANCER RES, V54, P4334; Moore MAS, 2001, BIOESSAYS, V23, P674, DOI 10.1002/bies.1095; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Norgauer J, 1996, J IMMUNOL, V156, P1132; Nowicki A, 1996, INT J CANCER, V65, P112, DOI 10.1002/(SICI)1097-0215(19960103)65:1<112::AID-IJC19>3.3.CO;2-R; Ono M, 1999, CANCER CHEMOTH PHARM, V43, pS69, DOI 10.1007/s002800051101; Osusky R, 1997, OPHTHALMIC RES, V29, P31, DOI 10.1159/000267988; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Owen JD, 1997, INT J CANCER, V73, P94, DOI 10.1002/(SICI)1097-0215(19970926)73:1<94::AID-IJC15>3.0.CO;2-5; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Qian F, 2001, P NATL ACAD SCI USA, V98, P3976, DOI 10.1073/pnas.061633698; RICHMOND A, 1986, J CELL PHYSIOL, V129, P375, DOI 10.1002/jcp.1041290316; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rous P, 1941, J EXP MED, V73, P365, DOI 10.1084/jem.73.3.365; SCHOLL SM, 1994, JNCI-J NATL CANCER I, V86, P120, DOI 10.1093/jnci/86.2.120; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Shanahan JC, 2002, CLIN IMMUNOL, V103, P231, DOI 10.1006/clim.2002.5191; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Talmor M, 1998, EUR J IMMUNOL, V28, P811, DOI 10.1002/(SICI)1521-4141(199803)28:03<811::AID-IMMU811>3.3.CO;2-J; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D; Tsung K, 2002, CANCER RES, V62, P5069; Vicari AP, 2002, CYTOKINE GROWTH F R, V13, P143, DOI 10.1016/S1359-6101(01)00033-8; Wahl LM, 1998, J NATL CANCER I, V90, P1583, DOI 10.1093/jnci/90.21.1583; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Yamanishi Y, 2002, P NATL ACAD SCI USA, V99, P10025, DOI 10.1073/pnas.152333199; Yoshida T, 2002, J EXP MED, V196, P641, DOI 10.1084/jem.20012127; Zhang JN, 2002, CANCER RES, V62, P4194	76	10480	10975	90	2436	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					860	867		10.1038/nature01322	http://dx.doi.org/10.1038/nature01322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490959	Green Accepted			2022-12-28	WOS:000179897300067
J	Yedid, G; Bell, G				Yedid, G; Bell, G			Macroevolution simulated with autonomously replicating computer programs	NATURE			English	Article							EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; POPULATIONS; ADAPTATION; DIVERGENCE; COMPLEXITY; RESISTANCE; DROSOPHILA; SELECTION; BACTERIA	The process of adaptation occurs on two timescales. In the short term, natural selection merely sorts the variation already present in a population, whereas in the longer term genotypes quite different from any that were initially present evolve through the cumulation of new mutations. The first process is described by the mathematical theory of population genetics. However, this theory begins by defining a fixed set of genotypes and cannot provide a satisfactory analysis of the second process because it does not permit any genuinely new type to arise. The evolutionary outcome of selection acting on novel variation arising over long periods is therefore difficult to predict. The classical problem of this kind is whether 'replaying the tape of life' would invariably lead to the familiar organisms of the modern biota(1,2). Here we study the long-term behaviour of populations of autonomously replicating computer programs and find that the same type, introduced into the same simple environment, evolves on any given occasion along a unique trajectory towards one of many well-adapted end points.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	McGill University; Michigan State University	Bell, G (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.							ADAMI C, 1995, PHYSICA D, V80, P154, DOI 10.1016/0167-2789(95)90073-X; Adami C, 2000, P NATL ACAD SCI USA, V97, P4463, DOI 10.1073/pnas.97.9.4463; ATWOOD KC, 1951, COLD SPRING HARB SYM, V16, P345, DOI 10.1101/SQB.1951.016.01.026; Bull JJ, 1997, GENETICS, V147, P1497; COHAN FM, 1986, GENETICS, V114, P145; DYKHUIZEN D, 1981, EVOLUTION, V35, P581, DOI 10.1111/j.1558-5646.1981.tb04919.x; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Fisher R.A., 1930, GENETICAL THEORY NAT; Gerrish P, 2001, NATURE, V413, P299, DOI 10.1038/35095046; Gould S. J., 1989, WONDERFUL LIFE BURGE; Hartley B.S., 1984, MICROORGANISMS MODEL, P23; Hoffmann AA, 1999, HEREDITY, V83, P637, DOI 10.1038/sj.hdy.6886490; JOHNSON PA, 1995, P ROY SOC B-BIOL SCI, V259, P125, DOI 10.1098/rspb.1995.0019; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; KRAMER FR, 1974, J MOL BIOL, V89, P719, DOI 10.1016/0022-2836(74)90047-3; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; MANI GS, 1990, PROC R SOC SER B-BIO, V240, P29, DOI 10.1098/rspb.1990.0025; Nakatsu CH, 1998, J BACTERIOL, V180, P4325, DOI 10.1128/JB.180.17.4325-4331.1998; Ray T.S., 1991, SANTA FE I STUDIES S, VXI, P371; SPIEGELMAN S, 1971, Quarterly Reviews of Biophysics, V4, P213; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Travisano M, 1997, GENETICS, V146, P471; Wahl LM, 2000, GENETICS, V156, P1437; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Yedid G, 2001, AM NAT, V157, P465, DOI 10.1086/319928; YIN J, 1993, J BACTERIOL, V175, P1272, DOI 10.1128/JB.175.5.1272-1277.1993	26	53	54	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					810	812		10.1038/nature01151	http://dx.doi.org/10.1038/nature01151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490948				2022-12-28	WOS:000179897300055
J	Bitsori, M; Galanakis, E				Bitsori, M; Galanakis, E			Doctors versus artists: Gustav Klimt's Medicine	BRITISH MEDICAL JOURNAL			English	Article								In 1893 Austria's ministry of culture commissioned the artists Gustav Klimt and Franz Matsch to decorate the Great Hall of the University of Vienna.(1) The Habsburg empire had entered its final phase, and Vienna, one of Europe's flourishing cultural and scientific centres, was under liberal rule and experiencing a period of industrial expansion and new ideas that was to become known as the Ringstrasse era.(1) Ringstrasse, an imposing avenue, encircled the old centre of Vienna, and grand buildings were erected along it(1).	Univ Crete, Dept Paediat, Iraklion 71500, Greece	University of Crete	Galanakis, E (corresponding author), Univ Crete, Dept Paediat, POB 1393, Iraklion 71500, Greece.							BAHR H, 1981, G KLIMT, P59; CONSTANTINO M, 1998, KLIMT; FLIEDL G, 1998, G KLIMT; Gay P., 1988, FREUD LIFE OUR TIMES; Grist NR, 1979, BRIT MED J, V20, P199; Hofmann Werner, 1972, GUSTAV KLIMT; KOSCHATZKY W, 1970, ALBERTINA WIEN; NEBEHAY C, 1969, G KLIMT ZEICHUNGEN D, P240; PIRCHAN E, 1956, G KLIMT KUNSTLER WIE; RUTLEDGE RH, 1995, SURGERY, V118, P36, DOI 10.1016/S0039-6060(05)80007-8; SCHORSKE CE, 1981, FIN SIECLE VIENNA CU; VERGO P, MITTEILUNGEN OSTERRE; Whitford Frank, 1990, KLIMT; WYKLICKY H, 1983, WIEN KLIN WOCHENSCHR, V95, P601	14	7	8	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1506	1508		10.1136/bmj.325.7378.1506	http://dx.doi.org/10.1136/bmj.325.7378.1506			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	631VX	12493684	Green Published			2022-12-28	WOS:000180188600036
J	Isaacs, D; Fitzgerald, D				Isaacs, D; Fitzgerald, D			A seasonal cost effectiveness analysis: the last Noel?	BRITISH MEDICAL JOURNAL			English	Article								Health economists are ideologically opposed to frivolity. It has come to our attention that an annual, quasi-religious festival has been held for some years without having been subjected to the rigours of a cost effectiveness analysis. In these sombre days of economic rationalism, such an oversight is unconscionable. The money spent on gifts and wrapping paper, tinsel and turkey is a significant opportunity cost, which might be better spent on improving the health care of the nation. We present a cost effectiveness analysis of Christmas.	Childrens Hosp Westmead, Dept Immunol & Infect Dis, Sydney, NSW 2145, Australia; Childrens Hosp Westmead, Dept Resp Med, Westmead, NSW, Australia	University of Sydney; University of Sydney	Isaacs, D (corresponding author), Childrens Hosp Westmead, Dept Immunol & Infect Dis, Sydney, NSW 2145, Australia.								0	4	4	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1456	1456		10.1136/bmj.325.7378.1456	http://dx.doi.org/10.1136/bmj.325.7378.1456			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493667	Green Published			2022-12-28	WOS:000180188600019
J	Macho, B; Brancorsini, S; Fimia, GM; Setou, M; Hirokawa, N; Sassone-Corsi, P				Macho, B; Brancorsini, S; Fimia, GM; Setou, M; Hirokawa, N; Sassone-Corsi, P			CREM-dependent transcription in male germ cells controlled by a kinesin	SCIENCE			English	Article							NUCLEAR EXPORT; LEPTOMYCIN-B; PROTEIN; CRM1; TRANSPORT; SIGNAL; ACTIVATION; INHIBITION; RECEPTOR; BINDING	ACT is a LIM-only protein expressed exclusively in round spermatids, where it cooperates with transcriptional activator CREM in regulating various postmeiotic genes. Targeted inactivation of CREM leads to a complete block of mouse spermiogenesis. We sought to identify the regulatory steps controlling the functional interplay between CREM and ACT. We found that ACT selectively associates with KIF17b, a kinesin highly expressed in male germ cells. The ACT-KIF17b interaction is restricted to specific stages of spermatogenesis and directly determines the intracellular localization of ACT. Sensitivity to leptomycin B indicates that KIF17b can be actively exported from the nucleus through the Crm1 receptor. Thus, a kinesin directly controls the activity of a transcriptional coactivator by a tight regulation of its intracellular localization.	Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Tokyo	Sassone-Corsi, P (corresponding author), Inst Genet & Biol Mol & Cellulaire, BP 10142, F-67404 Strasbourg, France.	paolosc@gbmc.u-strasbg.fr	Brancorsini, Stefano/L-8770-2015; Sassone-Corsi, Paolo/H-6182-2011; Fimia, Gian Maria/K-3232-2016	Brancorsini, Stefano/0000-0002-8410-7248; Fimia, Gian Maria/0000-0003-4438-3325				Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Endow SA, 1999, EUR J BIOCHEM, V262, P12, DOI 10.1046/j.1432-1327.1999.00339.x; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; PARVINEN M, 1993, METHODS TOXICOLOGY A, V3, P142; Russell L. D., 1990, HISTOLOGICAL HISTOPA, P41; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Ziegelbauer J, 2001, MOL CELL, V8, P339, DOI 10.1016/S1097-2765(01)00313-6	24	90	103	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2388	2390		10.1126/science.1077265	http://dx.doi.org/10.1126/science.1077265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493914				2022-12-28	WOS:000179915900056
J	Dixon, J				Dixon, J			Foundation hospitals	LANCET			English	Editorial Material									Kings Fund, London W1G 0AN, England		Dixon, J (corresponding author), Kings Fund, London W1G 0AN, England.							Baker CD, 2000, BRIT MED J, V321, P1152, DOI 10.1136/bmj.321.7269.1152; *DEP HLTH, 2002, REF NHS FIN FLOWS IN; Department of Health, 1997, NEW NHS MOD DEP; Giddens A., 2000, 3 WAY ITS CRITICS; MORRIS N, 2002, INDEPENDENT     1115, P10; TIMMINS N, 2002, FINANCIAL TIMES 1015	6	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1900	1901		10.1016/S0140-6736(02)11935-0	http://dx.doi.org/10.1016/S0140-6736(02)11935-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493252				2022-12-28	WOS:000179870200004
J	Fieggen, G; Peter, J; Millar, A; Rode, H				Fieggen, G; Peter, J; Millar, A; Rode, H			Conjoined spinal cords in pygopagus twins	LANCET			English	Editorial Material									Red Cross War Mem Childrens Hosp, Dept Neurosurg & Paediat Surg, Cape Town, South Africa		Fieggen, G (corresponding author), Red Cross War Mem Childrens Hosp, Dept Neurosurg & Paediat Surg, Cape Town, South Africa.		Fieggen, Anthony Graham/AAT-6510-2021	Fieggen, Anthony Graham/0000-0001-6541-8377					0	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1934	1934		10.1016/S0140-6736(02)11916-7	http://dx.doi.org/10.1016/S0140-6736(02)11916-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493260				2022-12-28	WOS:000179870200012
J	Stearns, V; Ullmer, L; Lopez, JF; Smith, Y; Isaacs, C; Hayes, DF				Stearns, V; Ullmer, L; Lopez, JF; Smith, Y; Isaacs, C; Hayes, DF			Hot flushes	LANCET			English	Review							ESTROGEN REPLACEMENT THERAPY; BREAST-CANCER; POSTMENOPAUSAL WOMEN; HORMONE-REPLACEMENT; MENOPAUSAL SYMPTOMS; DOUBLE-BLIND; VASOMOTOR SYMPTOMS; MEGESTROL-ACETATE; 5-HT1A RECEPTOR; MEDROXYPROGESTERONE ACETATE	Almost every woman and some men will encounter hot flushes during their lifetime. Despite the prevalence of the symptoms, the pathophysiology of hot flushes remains unknown. A decline in hormone concentrations might lead to alterations in brain neurotransmitters and to instability in the hypothalamic thermoregulatory setpoint. The most effective treatments for hot flushes include oestrogens and progestagens. However, many women and their physicians are reluctant to accept hormonal treatments. Women want non-pharmacological treatments but unfortunately such treatments are not very effective, and non-hormonal drugs are often associated with adverse effects. Results from recent studies showed that selective serotonin reuptake inhibitors and other similar compounds can safely reduce hot flushes. Moreover, the efficacy of these drugs provides new insight into the pathophysiology of hot flushes. In this critical review, we assess knowledge of the epidemiology, pathophysiology, and treatment of hot flushes.	Univ Michigan, Ctr Comprehens Canc, Dept Internal Med, Breast Oncol Program, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Comprehens Canc, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Comprehens Canc, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; Georgetown Univ, Sch Med, Lombardi Canc Ctr, Washington, DC 20057 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Georgetown University	Stearns, V (corresponding author), Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Bunting Blaustein Canc Res Bldg,Room 1M53, Baltimore, MD 21231 USA.	vstearnl@jhmi.edu	Hayes, Daniel/ABE-1129-2020					Albertazzi P, 1998, MATURITAS, V30, P295, DOI 10.1016/S0378-5122(98)00059-0; ANDERSEN O, 1986, ACTA OBSTET GYN SCAN, V65, P405, DOI 10.3109/00016348609157373; Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; Avis NE, 2001, SOC SCI MED, V52, P345, DOI 10.1016/S0277-9536(00)00147-7; Bachmann G A, 1995, Int J Fertil Menopausal Stud, V40 Suppl 1, P16; Bachmann GA, 1999, AM J OBSTET GYNECOL, V180, pS312, DOI 10.1016/S0002-9378(99)70725-8; Barton DL, 1998, J CLIN ONCOL, V16, P495, DOI 10.1200/JCO.1998.16.2.495; BEEBE K, 2002, US PSYCH MENT HLTH C; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Berendsen HHG, 2000, MATURITAS, V36, P155, DOI 10.1016/S0378-5122(00)00151-1; BERTELLI G, 1998, P AM SOC CLIN ONCOL, V18; Bethea C L, 2000, Novartis Found Symp, V230, P112, DOI 10.1002/0470870818.ch9; BLIER P, 1994, TRENDS PHARMACOL SCI, V15, P220, DOI 10.1016/0165-6147(94)90315-8; Bourin M, 1996, BIOMED PHARMACOTHER, V50, P7, DOI 10.1016/0753-3322(96)85091-8; Braunwald E., 2001, HARRISONS PRINCIPLES; BRESSLER LR, 1993, ANN PHARMACOTHER, V27, P182, DOI 10.1177/106002809302700210; Brewster WR, 1999, INT J FERTIL WOMEN M, V44, P186; BUCHHOLZ NP, 1994, EUR UROL, V26, P120; BULLOCK JL, 1975, OBSTET GYNECOL, V46, P165; *BUR USC, 2002, RES POP EST US AG SE; Burger HG, 2000, J CLIN ENDOCR METAB, V85, P2832, DOI 10.1210/jc.85.8.2832; Carpenter JS, 1999, MENOPAUSE, V6, P209, DOI 10.1097/00042192-199906030-00006; Carpenter JS, 1998, CANCER-AM CANCER SOC, V82, P1682, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.3.CO;2-8; CASPER RF, 1985, CLIN ENDOCRINOL, V22, P293, DOI 10.1111/j.1365-2265.1985.tb03243.x; Chiechi L. M., 1997, Clinical and Experimental Obstetrics and Gynecology, V24, P163; Chiechi L. M., 1997, Clinical and Experimental Obstetrics and Gynecology, V24, P158; Christe C, 1999, J AM GERIATR SOC, V47, P630, DOI 10.1111/j.1532-5415.1999.tb02584.x; CLARK WG, 1986, NEUROSCI BIOBEHAV R, V10, P153, DOI 10.1016/0149-7634(86)90025-4; Cleare AJ, 1998, INT CLIN PSYCHOPHARM, V13, P23, DOI 10.1097/00004850-199801000-00004; COBLEIGH MA, 1994, JAMA-J AM MED ASSOC, V272, P540, DOI 10.1001/jama.272.7.540; Cohen FJ, 2000, MATURITAS, V34, P65, DOI 10.1016/S0378-5122(99)00090-0; COUZI RJ, 1995, J CLIN ONCOL, V13, P2737, DOI 10.1200/JCO.1995.13.11.2737; CRUNDWELL JK, 1993, INT J NEUROSCI, V68, P73, DOI 10.3109/00207459308994262; Cryan JF, 1999, J PSYCHOPHARMACOL, V13, P278, DOI 10.1177/026988119901300310; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; CUNNINGHAM FG, 1996, WILLIAMS OBSTET; DAVID A, 1988, AM J OBSTET GYNECOL, V158, P1107, DOI 10.1016/0002-9378(88)90230-X; Davies GC, 1999, OBSTET GYNECOL, V93, P558, DOI 10.1016/S0029-7844(98)00476-1; Davis SR, 2001, MED J AUSTRALIA, V174, P68, DOI 10.5694/j.1326-5377.2001.tb143156.x; Drevets WC, 1999, BIOL PSYCHIAT, V46, P1375, DOI 10.1016/S0006-3223(99)00189-4; Edwards JG, 1999, DRUGS, V57, P507, DOI 10.2165/00003495-199957040-00005; ELLIS H, 2000, DIS BREAST, P749; Empson JAC, 1999, ANN MED, V31, P141, DOI 10.3109/07853899908998790; ERLIK Y, 1982, OBSTET GYNECOL, V59, P403; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fallowfield L, 2001, J CLIN ONCOL, V19, P1885, DOI 10.1200/JCO.2001.19.7.1885; FALLOWFIELD L, 2003, P AM SOC CLIN O 0518, pA40; Finck G, 1998, J PAIN SYMPTOM MANAG, V16, P327, DOI 10.1016/S0885-3924(98)00090-6; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fisher B, 1996, JNCI-J NATL CANCER I, V88, P1529, DOI 10.1093/jnci/88.21.1529; FLOCKHART DA, 2001, P ASCPT, V10, P38; FOSTER GV, 1985, FERTIL STERIL, V43, P401; Frazer A, 1997, J CLIN PSYCHIAT, V58, P9; Freedman RR, 1999, AM J OBSTET GYNECOL, V181, P66, DOI 10.1016/S0002-9378(99)70437-0; Freedman RR, 1998, FERTIL STERIL, V70, P332, DOI 10.1016/S0015-0282(98)00137-X; Fugh-Berman A, 2001, MENOPAUSE, V8, P333, DOI 10.1097/00042192-200109000-00007; Fuh JL, 2001, MATURITAS, V39, P117, DOI 10.1016/S0378-5122(01)00193-1; GANNON L, 1988, WOMEN HEALTH, V14, P105, DOI 10.1300/J013v14n02_07; Ganz PA, 1999, CANCER-AM CANCER SOC, V86, P814, DOI 10.1002/(SICI)1097-0142(19990901)86:5<814::AID-CNCR17>3.0.CO;2-D; Gardier AM, 2001, EUR J PHARMACOL, V421, P171, DOI 10.1016/S0014-2999(01)01037-8; Gelfand MM, 1999, AM J OBSTET GYNECOL, V180, pS325, DOI 10.1016/S0002-9378(99)70728-3; Gerber GS, 2000, UROLOGY, V55, P97, DOI 10.1016/S0090-4295(99)00370-2; Gillman PK, 1999, J PSYCHOPHARMACOL, V13, P100, DOI 10.1177/026988119901300111; Gold EB, 2000, AM J EPIDEMIOL, V152, P463, DOI 10.1093/aje/152.5.463; GOLDBERG RM, 1994, J CLIN ONCOL, V12, P155, DOI 10.1200/JCO.1994.12.1.155; Goodwin PJ, 1999, J CLIN ONCOL, V17, P2365, DOI 10.1200/JCO.1999.17.8.2365; GUDELSKY GA, 1986, NEUROPHARMACOLOGY, V25, P1307, DOI 10.1016/0028-3908(86)90101-2; Guttuso TJ, 2000, NEUROLOGY, V54, P2161, DOI 10.1212/WNL.54.11.2161; Haddad P, 1998, J PSYCHOPHARMACOL, V12, P305, DOI 10.1177/026988119801200311; Haddjeri N, 1998, J NEUROSCI, V18, P10150; Hammar M, 1999, J UROLOGY, V161, P853, DOI 10.1016/S0022-5347(01)61789-0; HAMMOND MG, 1984, J CLIN ENDOCR METAB, V58, P1158, DOI 10.1210/jcem-58-6-1158; Ho SC, 1999, MATURITAS, V33, P219, DOI 10.1016/S0378-5122(99)00056-0; Hoyer D, 1996, BEHAV BRAIN RES, V73, P263; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Israel D, 1997, PHARMACOTHERAPY, V17, P970; Jacobson JS, 2001, J CLIN ONCOL, V19, P2739, DOI 10.1200/JCO.2001.19.10.2739; KAGEE A, 2001, P AM SOC CLIN O 0512; KIMMICK GG, 2001, P ASCO; Koenig James I., 2001, Trends in Endocrinology and Metabolism, V12, P4, DOI 10.1016/S1043-2760(00)00354-4; KRONENBERG F, 1990, ANN NY ACAD SCI, V592, P52; KRONENBERG F, 1994, EXP GERONTOL, V29, P319, DOI 10.1016/0531-5565(94)90012-4; Lanfrey P, 1996, Prog Urol, V6, P17; LEBHERZ TB, 1969, OBSTET GYNECOL, V33, P795; LEIBENLUFT E, 1993, J AFFECT DISORDERS, V29, P175, DOI 10.1016/0165-0327(93)90031-E; Leonetti HB, 1999, OBSTET GYNECOL, V94, P225, DOI 10.1016/S0029-7844(99)00266-5; Lin MT, 1998, AM J PHYSIOL-REG I, V274, pR1260, DOI 10.1152/ajpregu.1998.274.5.R1260; Liske E, 1998, ADV THER, V15, P45; Lopez JF, 1998, BIOL PSYCHIAT, V43, P547, DOI 10.1016/S0006-3223(97)00484-8; Lopez JF, 1999, BIOL PSYCHIAT, V46, P1461, DOI 10.1016/S0006-3223(99)00266-8; Loprinzi CL, 2002, J CLIN ONCOL, V20, P1578, DOI 10.1200/JCO.20.6.1578; Loprinzi CL, 2000, LANCET, V356, P2059, DOI 10.1016/S0140-6736(00)03403-6; Loprinzi CL, 1998, J CLIN ONCOL, V16, P2377, DOI 10.1200/JCO.1998.16.7.2377; LOPRINZI CL, 1994, J UROLOGY, V151, P634, DOI 10.1016/S0022-5347(17)35034-6; LOPRINZI CL, 1994, NEW ENGL J MED, V331, P347, DOI 10.1056/NEJM199408113310602; LOPRINZI CL, 2002, P ASCO, pA362; Maclennan A H, 2004, Cochrane Database Syst Rev, pCD002978, DOI 10.1002/14651858.CD002978.pub2; MANN JJ, 1989, BRIT J PSYCHIAT, V155, P7, DOI 10.1192/S000712500029171X; Manson JE, 2001, NEW ENGL J MED, V345, P34, DOI 10.1056/NEJM200107053450106; McNagny SE, 1999, ANN INTERN MED, V131, P605, DOI 10.7326/0003-4819-131-8-199910190-00010; MELDRUM DR, 1984, OBSTET GYNECOL, V64, P752; MELDRUM DR, 1979, AM J OBSTET GYNECOL, V135, P713, DOI 10.1016/0002-9378(79)90380-6; Messina MJ, 2001, J NUTR, V131, p3095S, DOI 10.1093/jn/131.11.3095S; Mohyi D, 1997, MATURITAS, V27, P203, DOI 10.1016/S0378-5122(97)83974-6; MOLNAR GW, 1975, J APPL PHYSIOL, V38, P499, DOI 10.1152/jappl.1975.38.3.499; MONTGOMERY JC, 1991, BRIT J HOSP MED, V45, P300; MORRISON JC, 1980, AM J OBSTET GYNECOL, V138, P99, DOI 10.1016/0002-9378(80)90017-4; MURKIES AL, 1995, MATURITAS, V21, P189, DOI 10.1016/0378-5122(95)00899-V; MYERS RD, 1981, J PHYSIOLOGY PARIS, V77, P505; NESHEIM BI, 1981, EUR J CLIN PHARMACOL, V20, P413, DOI 10.1007/BF00542092; Nisijima K, 2001, BRAIN RES, V890, P23, DOI 10.1016/S0006-8993(00)03020-1; Oerther S, 2000, NEUROREPORT, V11, P3949, DOI 10.1097/00001756-200012180-00009; Oerther S, 2001, PSYCHOPHARMACOLOGY, V154, P429, DOI 10.1007/s002130000659; Pandya KJ, 2000, ANN INTERN MED, V132, P788, DOI 10.7326/0003-4819-132-10-200005160-00004; Pansini F., 1995, Clinical and Experimental Obstetrics and Gynecology, V22, P341; PEARCE J, 1995, BRIT J PSYCHIAT, V167, P163, DOI 10.1192/bjp.167.2.163; PEROUTKA SJ, 1980, SCIENCE, V210, P88, DOI 10.1126/science.6251550; POWLES TJ, 1993, LANCET, V342, P60, DOI 10.1016/0140-6736(93)91931-B; Presti JC, 1996, JAMA-J AM MED ASSOC, V275, P1153, DOI 10.1001/jama.275.15.1153; Quella SK, 1999, J UROLOGY, V162, P98, DOI 10.1097/00005392-199907000-00024; Quella SK, 1998, CANCER, V82, P1784, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1789::AID-CNCR27>3.0.CO;2-#; Quella SK, 2000, J CLIN ONCOL, V18, P1068, DOI 10.1200/JCO.2000.18.5.1068; Reynolds F, 1999, MATURITAS, V32, P25, DOI 10.1016/S0378-5122(99)00017-1; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Roth AJ, 1998, PSYCHO-ONCOL, V7, P129, DOI 10.1002/(SICI)1099-1611(199803/04)7:2<129::AID-PON294>3.0.CO;2-T; Rothschild AJ, 2000, J CLIN PSYCHIAT, V61, P28; Rubinow DR, 1998, BIOL PSYCHIAT, V44, P839, DOI 10.1016/S0006-3223(98)00162-0; Salmi P, 1998, PHARMACOL TOXICOL, V82, P122, DOI 10.1111/j.1600-0773.1998.tb01410.x; Sartor O, 1999, SOUTHERN MED J, V92, P415, DOI 10.1097/00007611-199904000-00013; Scambia G, 2000, MENOPAUSE, V7, P105, DOI 10.1097/00042192-200007020-00006; SCHIFF I, 1980, JAMA-J AM MED ASSOC, V244, P1443, DOI 10.1001/jama.244.13.1443; Schmidt PJ, 2000, AM J OBSTET GYNECOL, V183, P414, DOI 10.1067/mob.2000.106004; Schow DA, 1998, SOUTHERN MED J, V91, P855, DOI 10.1097/00007611-199809000-00010; SCHWINGL PJ, 1994, OBSTET GYNECOL, V84, P29; SHAVER J, 1988, SLEEP, V11, P556, DOI 10.1093/sleep/11.6.556; Shaver JLF, 2000, J WOMEN HEALTH GEN-B, V9, P109, DOI 10.1089/152460900318605; SHAVER JLF, 1994, EXP GERONTOL, V29, P469, DOI 10.1016/0531-5565(94)90027-2; SHEARD MH, 1967, NATURE, V216, P495, DOI 10.1038/216495a0; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Spetz AC, 2001, J UROLOGY, V166, P517, DOI 10.1016/S0022-5347(05)65973-3; St Germain A, 2001, MENOPAUSE, V8, P17, DOI 10.1097/00042192-200101000-00005; Stahl SM, 2001, J CLIN PSYCHIAT, V62, P317, DOI 10.4088/JCP.v62n0501; Stearns V, 2000, ANN ONCOL, V11, P17, DOI 10.1023/A:1008382706068; STEVENSON DW, 1983, J BEHAV THER EXP PSY, V14, P137, DOI 10.1016/0005-7916(83)90031-9; TATARYN IV, 1981, OBSTET GYNECOL, V57, P340; Taylor M, 2001, J REPROD MED, V46, P317; THUMMALA AR, 2002, P ASCO, pA362; Towlerton G, 1999, PALLIATIVE MED, V13, P445, DOI 10.1177/026921639901300516; Upmalis DH, 2000, MENOPAUSE, V7, P236, DOI 10.1097/00042192-200007040-00005; VANPATTEN CL, IN PRESS J CLIN ONCO; Vassilopoulou-Sellin R, 1999, J CLIN ONCOL, V17, P1482, DOI 10.1200/JCO.1999.17.5.1482; VassilopoulouSellin R, 1997, GYNECOL ONCOL, V65, P89, DOI 10.1006/gyno.1997.4621; VERCELLINI P, 1992, GYNECOL OBSTET INVES, V34, P102, DOI 10.1159/000292736; Waldinger MD, 2000, MATURITAS, V36, P165, DOI 10.1016/S0378-5122(00)00152-3; Washburn S, 1999, MENOPAUSE, V6, P7; Wijma K, 1997, J BEHAV THER EXP PSY, V28, P251, DOI 10.1016/S0005-7916(97)00030-X; WILE AG, 1993, AM J SURG, V165, P372, DOI 10.1016/S0002-9610(05)80848-7; WOODWARD S, 1994, SLEEP, V17, P497, DOI 10.1093/sleep/17.6.497; Wyon YAM, 2000, MENOPAUSE, V7, P25, DOI 10.1097/00042192-200007010-00005; YATES M, 1990, BIOL PSYCHIAT, V27, P489, DOI 10.1016/0006-3223(90)90440-D; YOUNG RL, 1990, DRUGS, V40, P220, DOI 10.2165/00003495-199040020-00004; 1999, ONCOLOGY HUNTINGT, V13, P859	163	301	325	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1851	1861		10.1016/S0140-6736(02)11774-0	http://dx.doi.org/10.1016/S0140-6736(02)11774-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	623MB	12480376				2022-12-28	WOS:000179706100026
J	Suckfull, M				Suckfull, M		Hearing Loss Study Grp	Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial	LANCET			English	Article							PRECIPITATION HELP; BLOOD-VISCOSITY; DOUBLE-BLIND; HYPERCHOLESTEROLEMIA; DEAFNESS; DISEASE; HYPERLIPIDEMIA; IMPROVEMENT; EXPERIENCE; THERAPY	Background Sudden sensorineural hearing loss (SSHL) is thought to have many different origins, including disturbances of microcirculation, autoimmune pathology, and viral infection. We aimed to determine whether acute reduction of plasma fibrinogen and serum LDL is effective for treatment of SSHL of suspected vascular origin. Methods Between January, 2000, and June, 2001, we recruited 201 patients with sudden hearing loss from four otorhinolaryngology clinics in Germany. Patients were randomly allocated to single fibrinogen/LDL apheresis or standard treatment (250 mg prednisolone reduced by 25 mg per day, 500 mL 6% hydroxyethyl starch, 400 mg pentoxifylline per day). The primary outcome was recovery of hearing as measured by pure-tone audiometry 48 h after the start of treatment. Secondary outcomes were recovery of hearing 6 weeks after treatment, improvement of speech audiometry, tinnitus, and frequency of side-effects. Analysis was done per protocol. Findings Overall improvement of pure-tone thresholds was slightly but not significantly better in patients given apheresis than in those given standard treatment (difference 7.7, 95% Cl -8.2 to 23.6). However, the mean sound level at which 50% of recorded digits were recognised was significantly lower after 48 h in the apheresis group (21.6 dB, SD 20.8) than in the standard group (29.3 dB, 29.4; p=0.034). After 6 weeks, the mean 50% speech perception was at 13.6 dB (SD 14.3) in the apheresis group and at 20.8 dB (25.4) in those on standard treatment (p=0.059). At 48 h, in patients with plasma fibrinogen concentrations of more than 295 mg/dL, speech perception was improved much more in those on apheresis (15.3 dB, 17.3) than in those on standard treatment (6.1 dB, 10.4; p=0.005). Interpretation A single fibrinogen/LDL apheresis lasting for 2 h could be used as an alternative to conventional infusion treatment and prednisolone for 10 days. Patients with a plasma fibrinogen of more than 8.68 mumol/L improve much better when treated with apheresis, especially if serum LDL concentrations are also raised.	Univ Munich, Klinikum Grosshadern, D-81377 Munich, Germany	University of Munich	Suckfull, M (corresponding author), Univ Munich, Klinikum Grosshadern, Marchioninistr 15, D-81377 Munich, Germany.	suckfuell@hno.med.uni-muenchen.de						Alexiou C, 2001, ARCH OTOLARYNGOL, V127, P253, DOI 10.1001/archotol.127.3.253; AXELSSON A, 1985, ACTA OTO-LARYNGOL, V100, P379, DOI 10.3109/00016488509126561; BYL FM, 1984, LARYNGOSCOPE, V94, P647; CIUFFETTI G, 1991, LARYNGOSCOPE, V101, P65; ERNST E, 1993, ANN INTERN MED, V118, P956, DOI 10.7326/0003-4819-118-12-199306150-00008; Fessenden JD, 1998, HEARING RES, V118, P168, DOI 10.1016/S0378-5955(98)00027-6; Fetterman BL, 1996, AM J OTOL, V17, P529; GATEHOUSE S, 1989, ARCH OTOLARYNGOL, V115, P1227; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; John S, 1998, CIRCULATION, V98, P211, DOI 10.1161/01.CIR.98.3.211; KAWAKAMI M, 1992, ACTA OTO-LARYNGOL, V112, P991, DOI 10.3109/00016489209137500; Kojima Y, 2001, ANN OTO RHINOL LARYN, V110, P105, DOI 10.1177/000348940111000202; MATTOX DE, 1977, ANN OTO RHINOL LARYN, V86, P463, DOI 10.1177/000348947708600406; Megighian D, 2000, GERONTOLOGY, V46, P199, DOI 10.1159/000022160; Mellwig KP, 1998, ATHEROSCLEROSIS, V139, P173, DOI 10.1016/S0021-9150(98)00055-0; MILLER JM, 1988, AM J OTOLARYNG, V9, P302, DOI 10.1016/S0196-0709(88)80038-3; MOSKOWITZ D, 1984, LARYNGOSCOPE, V94, P664; Nguyen TVN, 1998, OTOLARYNG HEAD NECK, V119, P14, DOI 10.1016/S0194-5998(98)70167-6; OHINATA Y, 1994, ACTA OTO-LARYNGOL, V114, P601, DOI 10.3109/00016489409126112; Pfefferkorn TK, 1999, STROKE, V30, P1802, DOI 10.1161/01.STR.30.9.1802; PROBST R, 1992, ACTA OTO-LARYNGOL, V112, P435, DOI 10.3109/00016489209137424; PYYKKO I, 1988, ACTA OTO-LARYNGOL, P155; SAITO T, 1994, ORL J OTO-RHINO-LARY, V56, P315, DOI 10.1159/000276683; SCHUFFWERNER P, 1989, EUR J CLIN INVEST, V19, P30, DOI 10.1111/j.1365-2362.1989.tb00303.x; Seidel D, 1996, ARTIF ORGANS, V20, P303, DOI 10.1111/j.1525-1594.1996.tb04449.x; SHIRAISHI T, 1993, ACTA OTO-LARYNGOL, P46; Suckfull M, 1999, ACTA OTO-LARYNGOL, V119, P763, DOI 10.1080/00016489950180397; Suzuki K, 2000, LARYNGOSCOPE, V110, P1736, DOI 10.1097/00005537-200010000-00033; WILSON WR, 1980, ARCH OTOLARYNGOL, V106, P772; ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634	30	136	144	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1811	1817		10.1016/S0140-6736(02)11768-5	http://dx.doi.org/10.1016/S0140-6736(02)11768-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480357				2022-12-28	WOS:000179706100007
J	Holzenberger, M; Dupont, J; Ducos, B; Leneuve, P; Geloen, A; Even, PC; Cervera, P; Le Bouc, Y				Holzenberger, M; Dupont, J; Ducos, B; Leneuve, P; Geloen, A; Even, PC; Cervera, P; Le Bouc, Y			IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice	NATURE			English	Article							INSULIN-RECEPTOR; GROWTH-HORMONE; DWARF MICE; LONGEVITY; GENE; MUTATIONS; EXTENSION; CANCER; TISSUE	Studies in invertebrates have led to the identification of a number of genes that regulate lifespan, some of which encode components of the insulin or insulin-like signalling pathways(1-3). Examples include the related tyrosine kinase receptors InR (Drosophila melanogaster) and DAF-2 (Caenorhabditis elegans) that are homologues of the mammalian insulin-like growth factor type 1 receptor (IGF-1R). To investigate whether IGF-1R also controls longevity in mammals, we inactivated the IGF-1R gene in mice (Igf1r). Here, using heterozygous knockout mice because null mutants are not viable, we report that Igf1r (+/-) mice live on average 26% longer than their wild-type littermates (P < 0.02). Female Igf1r (+/-) mice live 33% longer than wild-type females (P < 0.001), whereas the equivalent male mice show an increase in lifespan of 16%, which is not statistically significant. Long-lived Igf1r (+/-) mice do not develop dwarfism, their energy metabolism is normal, and their nutrient uptake, physical activity, fertility and reproduction are unaffected. The Igf1r (+/-) mice display greater resistance to oxidative stress, a known determinant of ageing. These results indicate that the IGF-1 receptor may be a central regulator of mammalian lifespan.	INSERM, U515, F-75571 Paris 12, France; Hop St Antoine, Serv Anat & Cytol Pathol, F-75571 Paris 12, France; INRA, F-37380 Nouzilly, France; Inst Natl Sci Appl, INSERM, U352, F-69621 Villeurbanne, France; INA PG, INRA, F-75231 Paris 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; INRAE	Holzenberger, M (corresponding author), INSERM, U515, F-75571 Paris 12, France.	holzenberger@st-antoine.inserm.fr	GELOEN, Alain/D-6725-2011; Holzenberger, Martin/N-9732-2018	Holzenberger, Martin/0000-0003-4869-725X; GELOEN, Alain/0000-0001-7921-1254; Ducos, Bertrand/0000-0002-5322-1339; Even, Patrick/0000-0001-5733-3023				Bartke A, 2001, TRENDS ENDOCRIN MET, V12, P233, DOI 10.1016/S1043-2760(01)00426-X; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Dupont J, 2000, J BIOL CHEM, V275, P35893, DOI 10.1074/jbc.M006741200; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Gems D, 2001, CURR OPIN GENET DEV, V11, P287, DOI 10.1016/S0959-437X(00)00192-1; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Holzenberger M, 2001, ENDOCRINOLOGY, V142, P4469, DOI 10.1210/en.142.10.4469; Holzenberger M, 2000, ENDOCRINOLOGY, V141, P2557, DOI 10.1210/en.141.7.2557; Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x; Hunter WS, 1999, PHYSIOL BEHAV, V67, P433, DOI 10.1016/S0031-9384(99)00098-0; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; Sun JT, 1999, MOL CELL BIOL, V19, P216; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tissenbaum HA, 1998, GENETICS, V148, P703; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	30	1512	1573	3	187	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					182	187		10.1038/nature01298	http://dx.doi.org/10.1038/nature01298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12483226	Green Submitted			2022-12-28	WOS:000180267200045
J	Coe, S; Woo, WK; Bawendi, M; Bulovic, V				Coe, S; Woo, WK; Bawendi, M; Bulovic, V			Electroluminescence from single monolayers of nanocrystals in molecular organic devices	NATURE			English	Article							LIGHT-EMITTING-DIODES	The integration of organic and inorganic materials at the nanometre scale into hybrid optoelectronic structures enables active devices(1-3) that combine the diversity of organic materials with the high-performance electronic and optical properties of inorganic nanocrystals(4). The optimization of such hybrid devices ultimately depends upon the precise positioning of the functionally distinct materials. Previous studies(5,6) have already emphasized that this is a challenge, owing to the lack of well-developed nanometre-scale fabrication techniques. Here we demonstrate a hybrid light-emitting diode (LED) that combines the ease of processability of organic materials with the narrow-band, efficient luminescence of colloidal quantum dots(7) (QDs). To isolate the luminescence processes from charge conduction, we fabricate a quantum-dot LED (QD-LED) that contains only a single monolayer of QDs, sandwiched between two organic thin films. This is achieved by a method that uses material phase segregation between the QD aliphatic capping groups and the aromatic organic materials. In our devices, where QDs function exclusively as lumophores, we observe a 25-fold improvement in luminescence efficiency (1.6 cd A(-1) at 2,000 cd m(-2)) over the best previous QD-LED results(5). The reproducibility and precision of our phase-segregation approach suggests that this technique could be widely applicable to the fabrication of other hybrid organic/ inorganic devices.	MIT, Dept Elect Engn & Comp Sci, Lab Organ Optoelect, Cambridge, MA 02139 USA; MIT, Ctr Mat Sci & Engn, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bulovic, V (corresponding author), MIT, Dept Elect Engn & Comp Sci, Lab Organ Optoelect, Cambridge, MA 02139 USA.	bulovic@mit.edu	Bulovic, Vladimir/U-5449-2019					Adachi C, 2001, J APPL PHYS, V90, P5048, DOI 10.1063/1.1409582; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; DABBOUSI BO, 1995, APPL PHYS LETT, V66, P1316, DOI 10.1063/1.113227; Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y; Dirr S, 1998, JPN J APPL PHYS 1, V37, P1457, DOI 10.1143/JJAP.37.1457; Empedocles SA, 1996, PHYS REV LETT, V77, P3873, DOI 10.1103/PhysRevLett.77.3873; ERA M, 1991, CHEM PHYS LETT, V178, P488, DOI 10.1016/0009-2614(91)87007-X; Hill IG, 1999, J APPL PHYS, V86, P4515, DOI 10.1063/1.371395; Hines MA, 1996, J PHYS CHEM-US, V100, P468, DOI 10.1021/jp9530562; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Kagan CR, 1999, SCIENCE, V286, P945, DOI 10.1126/science.286.5441.945; Kwong RC, 1999, CHEM MATER, V11, P3709, DOI 10.1021/cm9906248; Leatherdale CA, 2000, PHYS REV B, V62, P2669, DOI 10.1103/PhysRevB.62.2669; Liu J, 2001, APPL PHYS LETT, V79, P578, DOI 10.1063/1.1389324; Mattoussi H, 1998, J APPL PHYS, V83, P7965, DOI 10.1063/1.367978; Moller S, 2002, J APPL PHYS, V91, P3324, DOI 10.1063/1.1435422; Morgan NY, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075339; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Schlamp MC, 1997, J APPL PHYS, V82, P5837, DOI 10.1063/1.366452; Tamarat P, 2000, J PHYS CHEM A, V104, P1, DOI [10.1021/jp992505l, 10.1021/jp9925051]	21	2313	2436	22	1034	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					800	803		10.1038/nature01217	http://dx.doi.org/10.1038/nature01217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490945				2022-12-28	WOS:000179897300052
J	Shearman, D				Shearman, D			Time and tide wait for no man	BRITISH MEDICAL JOURNAL			English	Article								Global warming presents a new hazard to human health. Recognising the predominant human mechanisms for our failure to address this problem may help in formulating strategies for action.	Univ Adelaide, Dept Geog & Environm Studies, Adelaide, SA, Australia	University of Adelaide	Shearman, D (corresponding author), 2 Reynolds Dr, Crafers, SA 5152, Australia.							BEDER S, 1999, ECOLOGIST, V29, P119; Carroll John., 1998, EGO SOUL MODERN W SE; COHEN, 2001, STATES DENIAL KNOWIN; GORBACHEV M, 2002, GUARDIAN WEEKLY  AUG; *INT PAN CLIM CHAN, 2001, CLIM CHANG 2001 3 AS, V1; Klein N., 2001, NO LOGO; McMichael AJ, 1999, BMJ-BRIT MED J, V319, P977, DOI 10.1136/bmj.319.7215.977; SHEARMAN D, 1997, GREEN GONE HLTH ECOL; Smith R, 2001, BRIT MED J, V322, P690, DOI 10.1136/bmj.322.7288.690; STIGLITZ JE, 2002, GLOBALISATION IT DIS; Suzuki D., 2002, GOOD NEWS CHANGE HOP; WATKINS K, 2002, GUARDIAN WEEKLY 0815, P21; Wilson E., 2002, FUTURE LIFE	13	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1466	1468		10.1136/bmj.325.7378.1466	http://dx.doi.org/10.1136/bmj.325.7378.1466			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493670	Green Published			2022-12-28	WOS:000180188600023
J	Sauter, G; Simon, R				Sauter, G; Simon, R			Perspective - Predictive molecular pathology.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Basel, CH-4003 Basel, Switzerland	University of Basel	Sauter, G (corresponding author), Univ Basel, CH-4003 Basel, Switzerland.			Simon, Ronald/0000-0003-0158-4258					0	25	29	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2002	347	25					1995	1996		10.1056/NEJMp020155	http://dx.doi.org/10.1056/NEJMp020155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626LT	12490679				2022-12-28	WOS:000179874500001
J	Durodie, B; Wessely, S				Durodie, B; Wessely, S			Resilience or panic? The public and terrorist attack	LANCET			English	Editorial Material									GKT Sch Med, Dept Psychol Med, London SE5 8AF, England; Inst Psychiat, London SE5 8AF, England; Kings Coll London, Dept War Studies, War Studies Grp, Int Policy Inst, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Wessely, S (corresponding author), GKT Sch Med, Dept Psychol Med, London SE5 8AF, England.	s.wessely@iop.kcl.ac.uk	Wessely, Simon C/A-8713-2008; Durodie, Bill/AAJ-9645-2020	Durodie, Bill/0000-0002-9968-9551; Wessely, Simon Charles/0000-0002-6743-9929				Coia P, 1998, J PSYCHOSOM RES, V45, P377; CURADO MP, 1991, MED BASIS RAD ACCIDE, V3, P143; DURODIE W, IN PRESS RISK ANAL; FUREDI F, 2002, ASSESSMENT ASYMMETRI; Gearson J, 2002, SUPERTERRORISM: POLICY RESPONSES, P7, DOI 10.1111/1467-923X.73.s1.3; Glass TA, 2002, CLIN INFECT DIS, V34, P217, DOI 10.1086/338711; Hyams KC, 2002, J HEALTH POLIT POLIC, V27, P273, DOI 10.1215/03616878-27-2-273; Janis Irving, 1951, AIR WAR EMOTIONAL ST; Lucock MP, 1997, BRIT MED J, V315, P572; Pastel R H, 2001, Mil Med, V166, P44; SHALEV A, 1996, EMOTIONAL AFTERMATH; Wessely S, 2000, NEW ENGL J MED, V342, P129, DOI 10.1056/NEJM200001133420212	12	37	39	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2002	360	9349					1901	1902		10.1016/S0140-6736(02)11936-2	http://dx.doi.org/10.1016/S0140-6736(02)11936-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493253				2022-12-28	WOS:000179870200005
J	Moore, L; Campbell, R; Whelan, A; Mills, N; Lupton, P; Misselbrook, E; Frohlich, J				Moore, L; Campbell, R; Whelan, A; Mills, N; Lupton, P; Misselbrook, E; Frohlich, J			Self help smoking cessation in pregnancy: cluster randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							STOPPING SMOKING; INTERVENTION; WOMEN; PROGRAM; SMOKERS; CARE	Objectives To evaluate the effectiveness of a self help approach to smoking cessation in pregnancy. Design Pragmatic cluster randomised controlled trial with community midwife as the unit of randomisation. Setting Three NHS hospital trusts in England. Participants 1527 women who smoked at the start of pregnancy. Intervention A series of five self help booklets comprising a step by step programme to increase motivation for quitting smoking and to teach strategies for cessation and relapse prevention. The first booklet was given to the women by a midwife at the earliest opportunity in antenatal care, together with a booklet for partners, family members, and friends. The remaining four booklets were mailed directly to die women. Main outcome measures The primary outcome was smoking cessation validated by cotinine measurement at the end of the second trimester of pregnancy. Other outcomes were self reported smoking status and cigarette consumption among daily smokers. Qualitative data exploring the acceptability of the intervention and the way that smoking cessation advice was delivered in both trial arms were also collected. Results Smoking cessation rates were low: the cotinine validated rates were 18.8% (113/600) in the intervention group and 20.7% (144/695) in the normal care group (difference 1.9%, 95% confidence intervals -3.5% to 7.3%). Self reported quit rates were higher. In the intervention group, 156 (25.6%), women reported not smoking for at least seven days, compared with 207 (29.1%) in the normal care group. In both groups, median self reported daily cigarette consumption among daily smokers was 10 cigarettes per day. Pregnant women and midwives approved of the intervention, but the way in which it was delivered varied considerably. For the primary smoking outcome, the degree of clustering at the midwife level was non-trivial (intracluster correlation coefficient 0.031). Conclusion The self help intervention was acceptable but ineffective when implemented during routine antenatal care. More intensive and complex interventions, appropriately targeted and tailored, need to be developed and evaluated. Validated smoking cessation rates among pregnant women are substantially lower than the self reported rates on which current smoking policy is based.	Cardiff Univ, Sch Social Sci, Cardiff CF10 3WT, S Glam, Wales; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ W England, Ctr Res Innovat & Grad Studies, Bristol BS16 1QD, Avon, England; Poole Hosp NHS Trust, Poole BH15 2JB, Dorset, England; St Michaels Hosp, United Bristol Healthcare Trust, Bristol BS2 8EG, Avon, England; Southmead Gen Hosp, N Bristol NHS Trust, Bristol BS10 5NB, Avon, England	Cardiff University; University of Bristol; University of West England; North Bristol NHS Trust; Southmead Hospital	Moore, L (corresponding author), Cardiff Univ, Sch Social Sci, Cardiff CF10 3WT, S Glam, Wales.			Mills, Nicola/0000-0002-2960-2940; Moore, Laurence/0000-0003-2182-823X				ADAMS C, 2000, UNPUB LEADING WAY SM; [Anonymous], 2002, INFANT FEEDING 2000; DOLANMULLEN P, 1994, AM J OBSTET GYNECOL, V171, P1328, DOI 10.1016/0002-9378(94)90156-2; ERSHOFF DH, 1989, AM J PUBLIC HEALTH, V79, P182, DOI 10.2105/AJPH.79.2.182; Fitzmaurice DA, 2001, BRIT MED J, V322, P1193, DOI 10.1136/bmj.322.7296.1193; Gielen AC, 1997, HEALTH EDUC RES, V12, P247, DOI 10.1093/her/12.2.247; Hajek P, 2001, ADDICTION, V96, P485, DOI 10.1046/j.1360-0443.2001.96348511.x; HJALMARSON AIM, 1991, BRIT J OBSTET GYNAEC, V98, P260, DOI 10.1111/j.1471-0528.1991.tb13390.x; *HLTH ED AUTH, 1993, SMOK PREGN GUID PURC; KENDRICK JS, 1995, AM J PUBLIC HEALTH, V85, P217, DOI 10.2105/AJPH.85.2.217; LUMLEY J, 1998, COCHRANE LIB; LUMLEY J, 1994, PREGNANCY CHILDBIRTH; MANT D, 1996, SCI BASIS HLTH SERVI, P170; Owen L, 1998, BRIT MED J, V317, P728, DOI 10.1136/bmj.317.7160.728; Owen L, 2001, ADDICTION, V96, P1001, DOI 10.1046/j.1360-0443.2001.96710019.x; PETERSEN L, 1992, OBSTET GYNECOL, V79, P924; Secretary of State for Health, 1998, SMOK KILLS WHIT PAP; SEXTON M, 1984, JAMA-J AM MED ASSOC, V251, P911, DOI 10.1001/jama.251.7.911; WALSH R, 1993, HEALTH PROMOT INT, V8, P111; WINDSOR RA, 1985, AM J PUBLIC HEALTH, V75, P1389, DOI 10.2105/AJPH.75.12.1389; WINDSOR RA, 1993, AM J PUBLIC HEALTH, V83, P201, DOI 10.2105/AJPH.83.2.201; Wisborg K, 1998, BRIT J OBSTET GYNAEC, V105, P1171, DOI 10.1111/j.1471-0528.1998.tb09970.x; [No title captured]	23	49	51	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1383	1386A		10.1136/bmj.325.7377.1383	http://dx.doi.org/10.1136/bmj.325.7377.1383			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CP	12480850	Green Published			2022-12-28	WOS:000179975000016
J	Vera, A; Moledina, S; Gunson, B; Hubscher, S; Mirza, D; Olliff, S; Neuberger, J				Vera, A; Moledina, S; Gunson, B; Hubscher, S; Mirza, D; Olliff, S; Neuberger, J			Risk factors for recurrence of primary sclerosing cholangitis of liver allograft	LANCET			English	Article								Primary sclerosing cholangitis (PSC) is a disease of unknown cause that effects the biliary tree and is closely associated with inflammatory bowel disease. We did a retrospective analysis of the risk factors associated with recurrence of PSC in an allograft after liver transplantation. Recurrence of disease, assessed by liver histology or imaging the biliary tree, occurred in 56 of 152 patients (37%) at a median of 36 months (range 1.4-120 months). Multivariate analysis showed that being male (relative risk 1.2, 95% CI 0.73-2.15) and an intact colon before transplantation (8.7, 1.19-64.48) were associated with recurrence. These observations could help elucidate the pathogenesis of the disease.	Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Neuberger, J (corresponding author), Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England.	J.M.Neuberger@bham.ac.uk	Neuberger, James/ABG-3010-2020	Gunson, Bridget/0000-0001-6149-9915				Cullen S, 2001, BEST PRACT RES CL GA, V15, P577, DOI 10.1053/bega.2001.0206; Grant AJ, 2002, LANCET, V359, P150, DOI 10.1016/S0140-6736(02)07374-9; HARRISON RF, 1994, HEPATOLOGY, V20, P356, DOI 10.1002/hep.1840200214; Sheng R, 1996, AM J ROENTGENOL, V166, P1109, DOI 10.2214/ajr.166.5.8615253; Zein C O, 2001, Semin Gastrointest Dis, V12, P103	5	139	140	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2002	360	9349					1943	1944		10.1016/S0140-6736(02)11861-7	http://dx.doi.org/10.1016/S0140-6736(02)11861-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493264				2022-12-28	WOS:000179870200016
J	Pitaevskii, L; Stringari, S				Pitaevskii, L; Stringari, S			The quest for superfluidity in Fermi gases	SCIENCE			English	Editorial Material							BOSE-EINSTEIN CONDENSATION; SCATTERING		Univ Trent, Dipartimento Fis, I-38050 Trento, Italy; Univ Trent, Ist Nazl Fis Mat, I-38050 Trento, Italy; PL Kapitza Phys Problems Inst, Moscow 117334, Russia	University of Trento; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Padua; University of Trento; PL Kapitza Institute for Physical Problems of Russian Academy of Sciences	Pitaevskii, L (corresponding author), Univ Trent, Dipartimento Fis, I-38050 Trento, Italy.	lev@science.unitn.it; stringar@science.unitn.it		Stringari, Sandro/0000-0002-5960-0612				ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Chevy F, 2000, PHYS REV LETT, V85, P2223, DOI 10.1103/PhysRevLett.85.2223; Courteille P, 1998, PHYS REV LETT, V81, P69, DOI 10.1103/PhysRevLett.81.69; Cowell S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.210403; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Heiselberg H, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.043606; Holland M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.120406; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; MENOTTI C, IN PRESS PHYS REV LE, P63608; Modugno G, 2002, SCIENCE, V297, P2240, DOI 10.1126/science.1077386; O'Hara KM, 2002, SCIENCE, V298, P2179, DOI 10.1126/science.1079107; O'Hara KM, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.041401; Ohashi Y, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.130402; Roberts JL, 1998, PHYS REV LETT, V81, P5109, DOI 10.1103/PhysRevLett.81.5109; SHLYAPNIKOV G, P 19 INT C AT PHYS C; Timmermans E, 2001, PHYS LETT A, V285, P228, DOI 10.1016/S0375-9601(01)00346-2	17	28	28	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2144	2146		10.1126/science.1080087	http://dx.doi.org/10.1126/science.1080087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481125				2022-12-28	WOS:000179773700034
J	Check, E				Check, E			All mutants great and small	NATURE			English	Article																			0	1	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					457	457		10.1038/420457a	http://dx.doi.org/10.1038/420457a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466811				2022-12-28	WOS:000179611600014
J	Churchill, GC; Okada, Y; Thomas, JM; Genazzani, AA; Patel, S; Galione, A				Churchill, GC; Okada, Y; Thomas, JM; Genazzani, AA; Patel, S; Galione, A			NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs	CELL			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; PANCREATIC ACINAR-CELLS; INTRACELLULAR CALCIUM; INOSITOL TRISPHOSPHATE; RELEASE; STORES; THAPSIGARGIN; COORDINATION; INACTIVATION	Nicotinic acid adenine dinucleotide phosphate (NAADP) mobilizes Call in many cells and species. Unlike other Ca(2+)-mobilizing messengers, NAADP mobilizes Ca(2+) from an unknown store that is not the endoplasmic reticulum, the store traditionally associated with messenger-mediated Ca(2+) signaling. Here, we demonstrate the presence of a Ca(2+) store in sea urchin eggs mobilized by NAADP that is dependent on a proton gradient maintained by an ATP-dependent vacuolar-type proton pump. Moreover, we provide pharmacological and biochemical evidence that this Ca(2+) store is the reserve granule, the functional equivalent of a lysosome in the sea urchin egg. These findings represent an unsuspected mechanism for messenger-mediated Ca(2+) release from lysosome-related organelles.	Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; UCL, Dept Physiol, London WC1E 6BT, England	University of Oxford; University of Cambridge; University of London; University College London	Churchill, GC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	grant.churchill@pharm.ox.ac.uk	Galione, Antony/E-5884-2011; Genazzani, Armando/AAI-8280-2020; Patel, Sandip/O-9591-2015	Patel, Sandip/0000-0001-7247-2013; Genazzani, Armando/0000-0003-1923-7430; Galione, Antony/0000-0002-4132-7646				Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; ARMANT DR, 1986, DEV BIOL, V113, P342, DOI 10.1016/0012-1606(86)90169-7; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Christensen KA, 2002, J CELL SCI, V115, P599; Churchill GC, 2000, J BIOL CHEM, V275, P38687, DOI 10.1074/jbc.M005827200; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2001, J BIOL CHEM, V276, P11223, DOI 10.1074/jbc.M009335200; CLAPPER DL, 1985, J BIOL CHEM, V260, P3947; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Docampo R, 1999, PARASITOL TODAY, V15, P443, DOI 10.1016/S0169-4758(99)01531-8; Galione A, 2000, BIOL CELL, V92, P197, DOI 10.1016/S0248-4900(00)01070-4; GALIONE A, 2000, CYCLIC ADP RIBOSE CA; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Gonzalez A, 1997, PFLUG ARCH EUR J PHY, V434, P609, DOI 10.1007/s004240050443; GUSE AH, 1994, BIOCHEM J, V301, P83, DOI 10.1042/bj3010083; Haller T, 1996, CELL CALCIUM, V19, P157, DOI 10.1016/S0143-4160(96)90084-6; JADOT M, 1984, BIOCHEM J, V219, P965, DOI 10.1042/bj2190965; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J CELL SCI, V113, P4413; Lee HC, 1997, J BIOL CHEM, V272, P4172, DOI 10.1074/jbc.272.7.4172; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; McNeil PL, 2000, J CELL SCI, V113, P1891; Patel S, 2001, TRENDS BIOCHEM SCI, V26, P482, DOI 10.1016/S0968-0004(01)01896-5; Patel S, 2000, BIOCHEM J, V352, P725, DOI 10.1042/0264-6021:3520725; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; ROONEY EK, 1992, P NATL ACAD SCI USA, V89, P8025, DOI 10.1073/pnas.89.17.8025; SCHUEL H, 1975, DEV BIOL, V46, P404, DOI 10.1016/0012-1606(75)90116-5; SUGAYA E, 1978, SCIENCE, V202, P1195, DOI 10.1126/science.725594; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; WILLIAMS J, 1967, BIOCHEMISTRY ANIMAL, V2, P341; Yagodin S, 1999, CELL CALCIUM, V25, P429, DOI 10.1054/ceca.1999.0043	34	380	386	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 27	2002	111	5					703	708		10.1016/S0092-8674(02)01082-6	http://dx.doi.org/10.1016/S0092-8674(02)01082-6			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464181	Bronze			2022-12-28	WOS:000179594500011
J	Mokdad, AH; Ford, ES; Bowman, BA; Dietz, WH; Vinicor, F; Bales, VS; Marks, JS				Mokdad, AH; Ford, ES; Bowman, BA; Dietz, WH; Vinicor, F; Bales, VS; Marks, JS			Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WEIGHT-LOSS; LIFE-STYLE; US ADULTS; OVERWEIGHT; GLUCOSE	Context Obesity and diabetes are increasing in the United States. Objective To estimate the prevalence of obesity and diabetes among US adults in 2001. Design, Setting, and Participants Random-digit telephone survey of 195 005 adults aged 18 years or older residing in all states participating in the Behavioral Risk Factor Surveillance System in 2001. Main Outcome Measures Body mass index,based on self-reported weight and height and self-reported diabetes., Results In 2001 the prevalence of obesity (BMI greater than or equal to30) was 20.9% vs 19.8% in 2000, an increase of 5.6%. The prevalence of diabetes increased to 7.9% vs 7.3% in 2000, an increase of 8.2%. The prevalence of BMI of 40 or higher in 2001 was 2.3%. Overweight and obesity were significantly associated with diabetes, high blood pressure, high cholesterol, asthma, arthritis, and poor health status. Compared with adults with normal weight, adults with a BMI of 40 or higher had an odds ratio (OR) of 7.37 (95% confidence interval [CI], 6.39-8.50) for diagnosed diabetes, 6.38 (95% Cl, 5.67-7.17) for high blood pressure, 1.88 (95% CI,1.67-2.13) for high cholesterol levels, 2.72 (95% CI, 2.38-3.12) for asthma, 4.41 (95% CI, 3.91-4.97),for arthritis, and 4.19 (95% CI, 3.68-4.76) for fair or poor health. Conclusions Increases in obesity and diabetes among US adults continue in both sexes, all ages, all races, all educational levels, and all smoking levels. Obesity is strongly associated with several major health risk factors.	CDCP, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; CDCP, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; CDCP, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; CDCP, Off Director, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Mokdad, AH (corresponding author), CDCP, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K66, Atlanta, GA 30341 USA.	ahm1@cdc.gov	Adiels, Martin/C-9278-2011					ADAY LA, 1989, DESIGNING CONDUCTING, P79; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; *CDCP, 2000, NAT DIAB FACT SHEET; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Ford ES, 1998, J CLIN EPIDEMIOL, V51, P55, DOI 10.1016/S0895-4356(97)00225-4; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; NELSON DE, 1998, P SECT SURV METH AM; PALTA M, 1982, AM J EPIDEMIOL, V115, P223, DOI 10.1093/oxfordjournals.aje.a113294; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; Ray NF, 1998, DIABETES CARE, V21, P296; REMINGTON PL, 1988, PUBLIC HEALTH REP, V103, P366; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; *SAS I INC, 2001, SAS SYST VERS 8; SHAH BV, 2000, SUDAAN USERS MANUAL; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Will JC, 2002, AM J PUBLIC HEALTH, V92, P1245, DOI 10.2105/AJPH.92.8.1245	23	2980	3043	10	459	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					76	79		10.1001/jama.289.1.76	http://dx.doi.org/10.1001/jama.289.1.76			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630XL	12503980	Bronze			2022-12-28	WOS:000180136600029
J	Beall, EL; Manak, JR; Zhou, S; Bell, M; Lipsick, JS; Botchan, MR				Beall, EL; Manak, JR; Zhou, S; Bell, M; Lipsick, JS; Botchan, MR			Role for a Drosophila Myb-containing protein complex in site-specific DNA replication	NATURE			English	Article							CHORION GENE AMPLIFICATION; ORIGIN RECOGNITION COMPLEX; BINDING DOMAIN; IDENTIFICATION; ELEMENT; CELLS	There is considerable interest in the developmental, temporal and tissue-specific patterns of DNA replication in metazoans(1,2). Site-specific DNA replication at the chorion loci in Drosophila follicle cells leads to extensive gene amplification, and the organization of the cis-acting DNA elements that regulate this process may provide a model for how such regulation is achieved(3). Two elements important for amplification of the third chromosome chorion gene cluster, ACE3 and Ori-beta, are directly bound by Orc(4-6) (origin recognition complex), and two-dimensional gel analysis has revealed that the primary origin used is Ori-beta (refs 7-9). Here we show that the Drosophila homologue of the Myb (Myeloblastosis) oncoprotein family is tightly associated with four additional proteins, and that the complex binds site-specifically to these regulatory DNA elements. Drosophila Myb is required in trans for gene amplification, showing that a Myb protein is directly involved in DNA replication. A Drosophila Myb binding site, as well as the binding site for another Myb complex member (p120), is necessary in cis for replication of reporter transgenes. Chromatin immunoprecipitation experiments localize both proteins to the chorion loci in vivo. These data provide evidence that specific protein complexes bound to replication enhancer elements work together with the general replication machinery for site-specific origin utilization during replication.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Stanford University; Stanford University	Botchan, MR (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Manak, John/0000-0002-6562-7694				Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; BOSCH T, 1995, OPT REV, V2, P289, DOI 10.1007/s10043-995-0289-2; Calvi BR, 1999, METHODS, V18, P407, DOI 10.1006/meth.1999.0799; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; DELIDAKIS C, 1989, EMBO J, V8, P891, DOI 10.1002/j.1460-2075.1989.tb03450.x; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Fitzpatrick CA, 2002, DEVELOPMENT, V129, P4497; Ganter B, 1999, ADV CANCER RES, V76, P21, DOI 10.1016/S0065-230X(08)60773-3; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; Harlow E., 1989, ANTIBODIES LAB MANUA; HECK MMS, 1990, J CELL BIOL, V110, P903, DOI 10.1083/jcb.110.4.903; Lu L, 2001, GENE DEV, V15, P134, DOI 10.1101/gad.822101; Manak JR, 2002, P NATL ACAD SCI USA, V99, P7438, DOI 10.1073/pnas.122231599; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; ORRWEAVER TL, 1991, BIOESSAYS, V13, P97, DOI 10.1002/bies.950130302; PETERS CWB, 1987, EMBO J, V6, P3085, DOI 10.1002/j.1460-2075.1987.tb02616.x; RIO DC, 1988, P NATL ACAD SCI USA, V85, P8929, DOI 10.1073/pnas.85.23.8929; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; STOBERGRASSER U, 1992, ONCOGENE, V7, P589; Suzanne M, 2001, DEV BIOL, V237, P282, DOI 10.1006/dbio.2001.0384; Voitenleitner C, 2002, J VIROL, V76, P3440, DOI 10.1128/JVI.76.7.3440-3451.2002	26	184	188	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					833	837		10.1038/nature01228	http://dx.doi.org/10.1038/nature01228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490953				2022-12-28	WOS:000179897300061
J	Delamothe, T				Delamothe, T			Is that it? How online articles have changed over the past five years	BRITISH MEDICAL JOURNAL			English	Article								Five years ago BMJ readers responded to the challenge of predicting what online articles would look like in the future in five general medical journals. Has the development of electronic publishing lived up to their predictions?.										ARMS WY, 2002, QUALITY CONTROL SCHO; Bero L, 1997, BRIT MED J, V315, P1692, DOI 10.1136/bmj.315.7123.1692; *EJUST, 2002, EJ US STUD; Sellen A., 2002, MYTH PAPERLESS OFFIC; WEINBERGER W, 2002, SMALL PIECES LOOSELY; 2002, CHARLESTON REPORT, V7, P1	6	8	10	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1475	1478		10.1136/bmj.325.7378.1475	http://dx.doi.org/10.1136/bmj.325.7378.1475			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493673	Green Published			2022-12-28	WOS:000180188600026
J	Schmidt, PJ; Leacock, AG				Schmidt, PJ; Leacock, AG			Forgotten transfusion history: John Leacock of Barbados	BRITISH MEDICAL JOURNAL			English	Article								A sugar planter's son from Barbados who graduated at Edinburgh was one of the first people to experiment with transfusing blood, in the early 19th century, nearly 100 years before the discovery of blood groups made transfusion routinely practicable.	Florida Blood Serv, Transfus Med Acad Ctr, St Petersburg, FL 33742 USA		Schmidt, PJ (corresponding author), 913 Mooring Circle, Tampa, FL 33602 USA.							Blundell J, 1818, Med Chir Trans, V9, P56; Blundell J., 1825, RES PHYSL PATHOLOGIC, P63; CASTLE T, 1984, PRINCIPLES PRACTICE; Leacock JH, 1817, MED CHIR J REV, V3, P276; Porter R., 1998, GREATEST BENEFIT MAN, P291; Schmidt PJ, 2002, TRANSFUSION, V42, P275, DOI 10.1046/j.1537-2995.2002.00033.x; SCHMIDT PJ, 1968, NEW ENGL J MED, V279, P1319, DOI 10.1056/NEJM196812122792406	7	23	23	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1485	1487		10.1136/bmj.325.7378.1485	http://dx.doi.org/10.1136/bmj.325.7378.1485			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493676	Green Published			2022-12-28	WOS:000180188600029
J	Wiechert, UH				Wiechert, UH			Earth's early atmosphere	SCIENCE			English	Editorial Material							DIAMOND FORMATION; SULFUR CYCLE		ETH Zentrum NO, Dept Earth Sci, Inst Isotope Geol & Mineral Resources, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Wiechert, UH (corresponding author), ETH Zentrum NO, Dept Earth Sci, Inst Isotope Geol & Mineral Resources, CH-8092 Zurich, Switzerland.	wiechert@erdw.ethz.ch						BEKKER A, 2002, 12 VM GOLDSCHM C DAV, pA64; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Cartigny P, 1998, SCIENCE, V280, P1421, DOI 10.1126/science.280.5368.1421; Catling DC, 2001, SCIENCE, V293, P839, DOI 10.1126/science.1061976; CHAUSSIDON M, 1987, NATURE, V330, P242, DOI 10.1038/330242a0; ELDRIDGE CS, 1991, NATURE, V353, P649, DOI 10.1038/353649a0; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2002, SCIENCE, V298, P2369, DOI 10.1126/science.1078617; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; FARQUHAR J, 2001, 11 VM GOLDSCHM C HOT; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Holland HD., 1984, CHEM EVOLUTION ATMOS; Holland HD., 1999, GEOCHEM NEWS, V100, P20; Kasting JF, 2002, SCIENCE, V296, P1066, DOI 10.1126/science.1071184; MOJZSIS SJ, 2001, 11 VM GOLDSCHM C HOT; OHMOTO H, 1997, GEOCHEM NEWS, V93, P12; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; Sagan C, 1997, SCIENCE, V276, P1217, DOI 10.1126/science.276.5316.1217	19	21	21	5	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2341	2342		10.1126/science.1079894	http://dx.doi.org/10.1126/science.1079894			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493902				2022-12-28	WOS:000179915900041
J	Straus, SE				Straus, SE			Perspective - Herbal medicines - What's in the bottle?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Straus, SE (corresponding author), Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA.								0	54	55	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2002	347	25					1997	1998		10.1056/NEJMp020148	http://dx.doi.org/10.1056/NEJMp020148			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626LT	12490680				2022-12-28	WOS:000179874500002
J	Di Tanna, GL; Rosano, A; Mastroiacovo, P				Di Tanna, GL; Rosano, A; Mastroiacovo, P			Prevalence of gastroschisis at birth: retrospective study	BRITISH MEDICAL JOURNAL			English	Article							ABDOMINAL-WALL DEFECTS; ENGLAND		Int Ctr Birth Defects, I-00195 Rome, Italy; Italian Inst Social Med, I-00196 Rome, Italy		Mastroiacovo, P (corresponding author), Int Ctr Birth Defects, I-00195 Rome, Italy.		rosano, Aldo/T-7180-2019; Di Tanna, Gian Luca/AAF-2352-2019; Rosano, Aldo/G-6525-2012	Di Tanna, Gian Luca/0000-0002-5470-3567; Rosano, Aldo/0000-0002-5453-2294				Barisic I, 2001, ULTRASOUND OBST GYN, V18, P309, DOI 10.1046/j.0960-7692.2001.00534.x; Nichols C R, 1997, J Matern Fetal Med, V6, P225; Rankin J, 1999, PRENATAL DIAG, V19, P662, DOI 10.1002/(SICI)1097-0223(199907)19:7<662::AID-PD607>3.0.CO;2-C; Tan KH, 1996, BRIT MED J, V313, P903; TORFS CP, 1994, TERATOLOGY, V50, P44, DOI 10.1002/tera.1420500107	5	47	52	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1389	1390		10.1136/bmj.325.7377.1389	http://dx.doi.org/10.1136/bmj.325.7377.1389			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480852	Green Published			2022-12-28	WOS:000179975000021
J	Stephens, DW; McLinn, CM; Stevens, JR				Stephens, DW; McLinn, CM; Stevens, JR			Discounting and reciprocity in an iterated prisoner's dilemma	SCIENCE			English	Article							TIT-FOR-TAT; COOPERATION; GAME; EVOLUTION; CHOICE; MODELS; DELAYS	The Iterated Prisoner's Dilemma (IPD) is a central paradigm in the study of animal cooperation. According to the IPD framework, repeated play ( repetition) and reciprocity combine to maintain a cooperative equilibrium. However, experimental studies with animals suggest that cooperative behavior in IPDs is unstable, and some have suggested that strong preferences for immediate benefits (that is, temporal discounting) might explain the fragility of cooperative equilibria. We studied the effects of discounting and strategic reciprocity on cooperation in captive blue jays. Our results demonstrate an interaction between discounting and reciprocity. Blue jays show high stable levels of cooperation in treatments with reduced discounting when their opponent reciprocates, but their levels of cooperation decline in all other treatment combinations. This suggests that stable cooperation requires both reduced discounting and reciprocity, and it offers an explanation of earlier failures to find cooperation in controlled payoff games.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Stephens, DW (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.		Stevens, Jeffrey R/C-4619-2011	Stevens, Jeffrey R/0000-0003-2375-1360; Stephens, David/0000-0003-3720-5248				AINSLIE GW, 1974, J EXP ANAL BEHAV, V21, P485, DOI 10.1901/jeab.1974.21-485; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1980, J CONFLICT RESOLUT, V24, P3, DOI 10.1177/002200278002400101; CLEMENTS KC, 1995, ANIM BEHAV, V50, P527, DOI 10.1006/anbe.1995.0267; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; Dugatkin L.A., 1997, COOPERATION ANIMALS; DUGATKIN LA, 1992, TRENDS ECOL EVOL, V7, P202, DOI 10.1016/0169-5347(92)90074-L; FLOOD M, 1983, BEHAV SCI, V28, P65, DOI 10.1002/bs.3830280108; GARDNER RM, 1984, PSYCHOL REP, V55, P687, DOI 10.2466/pr0.1984.55.3.687; GODIN JGJ, 1995, P ROY SOC B-BIOL SCI, V259, P193, DOI 10.1098/rspb.1995.0028; GREEN L, 1995, J EXP ANAL BEHAV, V64, P1, DOI 10.1901/jeab.1995.64-1; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; Heinrich B., 1989, RAVENS WINTER; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; MAZUR JE, 1984, J EXP PSYCHOL ANIM B, V10, P426, DOI 10.1037/0097-7403.10.4.426; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Pusey Anne E., 1997, P254; RACHLIN H, 1972, J EXP ANAL BEHAV, V17, P15, DOI 10.1901/jeab.1972.17-15; Silverstein A, 1998, J BEHAV DECIS MAKING, V11, P123, DOI 10.1002/(SICI)1099-0771(199806)11:2<123::AID-BDM283>3.3.CO;2-X; STEPHENS DW, 1995, J THEOR BIOL, V176, P457, DOI 10.1006/jtbi.1995.0213; Stephens DW, 1997, ANIM BEHAV, V53, P113, DOI 10.1006/anbe.1996.0283; Stephens DW, 2000, J THEOR BIOL, V205, P1, DOI 10.1006/jtbi.2000.2041; Weitzman ML, 2001, AM ECON REV, V91, P260, DOI 10.1257/aer.91.1.260	24	138	144	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2216	2218		10.1126/science.1078498	http://dx.doi.org/10.1126/science.1078498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	624RA	12481142	Green Submitted			2022-12-28	WOS:000179773700056
J	Zatorre, RJ; Krumhansl, CL				Zatorre, RJ; Krumhansl, CL			Mental models and musical minds	SCIENCE			English	Editorial Material									McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	McGill University; Cornell University	Zatorre, RJ (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.							Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; TOIVIAINEN P, IN PRESS PERCEPTION; Zatorre RJ, 2001, ANN NY ACAD SCI, V930, P193, DOI 10.1111/j.1749-6632.2001.tb05734.x	5	17	19	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2138	2139		10.1126/science.1080006	http://dx.doi.org/10.1126/science.1080006			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481121				2022-12-28	WOS:000179773700030
J	Patz, JA; Hulme, M; Rosenzweig, C; Mitchell, TD; Goldberg, RA; Githeko, AK; Lele, S; McMichael, AJ; Le Sueur, D				Patz, JA; Hulme, M; Rosenzweig, C; Mitchell, TD; Goldberg, RA; Githeko, AK; Lele, S; McMichael, AJ; Le Sueur, D			Climate change - Regional warming and malaria resurgence	NATURE			English	Article							VARIABILITY		Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; Univ E Anglia, Sch Environm Sci, Tyndall Ctr Climate Change Res, Norwich NR4 7TJ, Norfolk, England; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Columbia Univ, New York, NY 10025 USA; Kenya Govt Med Res Ctr, Ctr Vector Biol & Control Res, Climate & Human Hlth Res Unit, Kisumu, Kenya; Univ Alberta, Dept Math & Stat Sci, Edmonton, AB T6G 2G1, Canada; Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; S Africa MRC, ZA-4013 Congella, Durban, South Africa	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of East Anglia; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University; Kenya Medical Research Institute; University of Alberta; Australian National University	Patz, JA (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA.		Goldberg, Robert/AAE-3046-2019; Hulme, Mike/F-9012-2010	Hulme, Mike/0000-0002-1273-7662; Mitchell, Tim/0000-0003-4071-1977				Cox J., 1999, MAPPING MALARIA RISK; Gilles HM, 1993, BRUCECHWATTS ESSENTI, P124; Githeko A.K., 2001, GLOB CHANGE HUM HLTH, V2, P54, DOI [10.1023/A:1011943131643, DOI 10.1023/A:1011943131643]; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Patz JA, 1998, TROP MED INT HEALTH, V3, P818, DOI 10.1046/j.1365-3156.1998.00309.x; PETERSON T, 1997, B AM METEOROL SOC; Pielke RA, 2002, INT J CLIMATOL, V22, P421, DOI 10.1002/joc.706	9	125	127	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					627	628		10.1038/420627a	http://dx.doi.org/10.1038/420627a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478282				2022-12-28	WOS:000179751800034
J	Debacker, M; Zinsou, C; Aguiar, J; Meyers, W; Portaels, F				Debacker, M; Zinsou, C; Aguiar, J; Meyers, W; Portaels, F			Mycobacterium ulcerans disease (Buruli ulcer) following human bite	LANCET			English	Editorial Material									Inst Trop Med, Div Microbiol, B-2000 Antwerp, Belgium; Ctr Sanit & Nutr, Zagnanado, Gbemoten, Benin; Armed Forces Inst Pathol, Washington, DC 20306 USA	Institute of Tropical Medicine (ITM); United States Department of Defense	Debacker, M (corresponding author), Inst Trop Med, Div Microbiol, Natl Str 155, B-2000 Antwerp, Belgium.								0	13	13	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1830	1830		10.1016/S0140-6736(02)11771-5	http://dx.doi.org/10.1016/S0140-6736(02)11771-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480360				2022-12-28	WOS:000179706100010
J	Watson, RDS; Chin, BSP; Lip, GYH				Watson, RDS; Chin, BSP; Lip, GYH			ABC of antithrombotic therapy - Antithrombotic therapy in acute coronary syndromes	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Univ Birmingham, City Hosp, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Watson, RDS (corresponding author), Univ Birmingham, City Hosp, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B15 2TT, W Midlands, England.							Anand SS, 1998, CIRCULATION, V98, P1064, DOI 10.1161/01.CIR.98.11.1064; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; British Cardiac Soc Guidelines Med, 2001, HEART, V85, P133; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; *NAT I CLIN EXC, 2000, 12 NAT I CLIN EXC; Simoons ML, 1997, LANCET, V349, P1429; Topol E, 1998, NEW ENGL J MED, V339, P436; Wallentin L, 1999, LANCET, V354, P701	9	22	22	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2002	325	7376					1348	1351		10.1136/bmj.325.7376.1348	http://dx.doi.org/10.1136/bmj.325.7376.1348			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468488	Green Published			2022-12-28	WOS:000179817100026
J	Segura, TL; Toon, OB; Colaprete, A; Zahnle, K				Segura, TL; Toon, OB; Colaprete, A; Zahnle, K			Environmental effects of large impacts on Mars	SCIENCE			English	Article							CLIMATE	The martian valley networks formed near the end of the period of heavy bombardment of the inner solar system, about 3.5 billion years ago. The largest impacts produced global blankets of very hot ejecta, ranging in thickness from meters to hundreds of meters. Our simulations indicated that the ejecta warmed the surface, keeping it above the freezing point of water for periods ranging from decades to millennia, depending on impactor size, and caused shallow subsurface or polar ice to evaporate or melt. Large impacts also injected steam into the atmosphere from the craters or from water innate to the impactors. From all sources, a typical 100-, 200-, or 250-kilometers asteroid injected about 2, 9, or 16 meters, respectively, of precipitable water into the atmosphere, which eventually rained out at a rate of about 2 meters per year. The rains from a large impact formed rivers and contributed to recharging aquifers.	Univ Colorado, Program Atmospher & Ocean Sci, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Segura, TL (corresponding author), NASA, Ames Res Ctr, MS 245-3, Moffett Field, CA 94035 USA.							Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; Carr M.H, 1996, WATER MARS; Carr MH, 2000, ICARUS, V146, P366, DOI 10.1006/icar.2000.6428; Christensen PR, 1998, SCIENCE, V279, P1692, DOI 10.1126/science.279.5357.1692; Cohen BA, 2000, SCIENCE, V290, P1754, DOI 10.1126/science.290.5497.1754; COLAPRETE A, IN PRESS J GEOPHYS R; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; FREY HV, 2002, GEOPHYS RES LETT, V29; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; Hartmann W. K., 2000, ORIGIN EARTH MOON, P493; JAKOSKY BM, 1983, ICARUS, V55, P1, DOI 10.1016/0019-1035(83)90046-5; KASTING JF, 1991, ICARUS, V91, P1; LEOVY CB, UNPUB; Lodders K., 1998, PLANETARY SCI COMPAN; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; MALIN MC, 1986, GEOPHYS RES LETT, V13, P444, DOI 10.1029/GL013i005p00444; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Pierazzo E, 1997, ICARUS, V127, P408, DOI 10.1006/icar.1997.5713; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; Sleep NH, 1998, J GEOPHYS RES-PLANET, V103, P28529, DOI 10.1029/98JE01809; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Tanaka K. L., 1992, MARS, P345; ZAHNLE K, 1990, GEOCHIM COSMOCHIM AC, V54, P2577, DOI 10.1016/0016-7037(90)90243-E; Zahnle K. J., 1990, GEOL SOC AM SPEC PAP, V247, P271, DOI DOI 10.1130/SPE247-P271	25	216	220	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1977	1980		10.1126/science.1073586	http://dx.doi.org/10.1126/science.1073586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471254				2022-12-28	WOS:000179629200041
J	Pichichero, ME; Cernichiari, E; Lopreiato, J; Treanor, J				Pichichero, ME; Cernichiari, E; Lopreiato, J; Treanor, J			Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study	LANCET			English	Article							METHYLMERCURY EXPOSURE; VACCINATION; SEYCHELLES; HAIR	Background Thiomersal is a preservative containing small amounts of ethylmercury that is used in routine vaccines for infants and children. The effect of vaccines containing thiomersal on concentrations of mercury in infants' blood has not been extensively assessed, and the metabolism of ethylmercury in infants is unknown. We aimed to measure concentrations of mercury in blood, urine, and stools of infants who received such vaccines. Methods 40 full-term infants aged 6 months and younger were given vaccines that contained thiomersal (diptheria-tetanus-acellular pertussis vaccine, hepatitis B vaccine, and in some children Haemophilus influenzae type B vaccine). 21 control infants received thiomersal-free vaccines. We obtained samples of blood, urine, and stools 3-28 days after vaccination. Total mercury (organic and inorganic) in the samples was measured by cold vapour atomic absorption. Findings Mean mercury doses in infants exposed to thiomersal were 45.6 mug (range 37.5-62.5) for 2-month-olds and 111.3 mug (range 87.5-175.0) for 6-month-olds. Blood mercury in thiomersal-exposed 2-month-olds ranged from less than 3.75 to 20.55 nmol/L (parts per billion); in 6-month-olds all values were lower than 7.50 nmol/L. Only one of 15 blood samples from controls contained quantifiable mercury. Concentrations of mercury were low in urine after vaccination but were high in stools of thiomersal-exposed 2-month-olds (mean 82 ng/g dry weight) and in 6-month-olds (mean 58 ng/g dry weight). Estimated blood half-life of ethylmercury was 7 days (95% CI 4-10 days). Interpretation Administration of vaccines containing thiomersal does not seem to raise blood concentrations of mercury above safe values in infants. Ethylmercury seems to be eliminated from blood rapidly via the stools after parenteral administration of thiomersal in vaccines.	Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; Univ Rochester, Dept Environm Med, Rochester, NY 14642 USA; Univ Rochester, Dept Med, Rochester, NY 14642 USA; Natl Naval Med Res Inst, Bethesda, MD USA	University of Rochester; University of Rochester; University of Rochester; Naval Medical Research Center (NMRC)	Pichichero, ME (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	michael_pichichero@urmc.rochester.edu	Pichichero, Michael E/AID-7886-2022		ACF HHS [1 AF-45248] Funding Source: Medline	ACF HHS		Abramson JS, 1999, PEDIATRICS, V104, P570, DOI 10.1542/peds.104.3.570; AXTON JH, 1972, POSTGRAD MED J, V561, P417; Ball LK, 2001, PEDIATRICS, V107, P1147, DOI 10.1542/peds.107.5.1147; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P705; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P613; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; Clements CJ, 2000, LANCET, V355, P1279, DOI 10.1016/S0140-6736(05)74714-0; COX NH, 1988, CONTACT DERMATITIS, V18, P229, DOI 10.1111/j.1600-0536.1988.tb02809.x; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; FAGAN DG, 1977, ARCH DIS CHILD, V52, P962, DOI 10.1136/adc.52.12.962; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Lowell J A, 1996, Liver Transpl Surg, V2, P475, DOI 10.1002/lt.500020612; MATHESON DS, 1980, J PEDIATR-US, V97, P153, DOI 10.1016/S0022-3476(80)80159-4; National Academy of Sciences, 2000, TOX EFF METH; NIELSEN JB, 1994, ARCH TOXICOL, V68, P317, DOI 10.1007/s002040050075; Pfab R, 1996, J TOXICOL-CLIN TOXIC, V34, P453, DOI 10.3109/15563659609013818; Shenker BJ, 1998, ENVIRON RES, V77, P149, DOI 10.1006/enrs.1997.3816; Stajich GV, 2000, J PEDIATR-US, V136, P679, DOI 10.1067/mpd.2000.105133; YESS NJ, 1993, J AOAC INT, V76, P36; [No title captured]	20	157	170	0	32	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1737	1741		10.1016/S0140-6736(02)11682-5	http://dx.doi.org/10.1016/S0140-6736(02)11682-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480426				2022-12-28	WOS:000179636800010
J	Howarth-Hockey, G; Stride, P				Howarth-Hockey, G; Stride, P			Can medical education be fun as well as educational?	BRITISH MEDICAL JOURNAL			English	Article								Today's challenge to medical educators is to provide continuing education that supports excellence in clinical practice while finding new approaches to make learning more stimulating, motivating, and entertaining. At our hospital we are experimenting with innovative teaching techniques, incorporating games and debate, which encapsulate core concepts of the theory of adult learning: active participation by learners, application of knowledge, informal presentation, and feedback(1).	Redcliffe Hosp, Redcliffe Caboolture Hlth Serv, Redcliffe, Qld 4020, Australia		Stride, P (corresponding author), Redcliffe Hosp, Redcliffe Caboolture Hlth Serv, Anzac Ave, Redcliffe, Qld 4020, Australia.		Stride, Peter J. O/I-2830-2012	Stride, Peter J. O/0000-0003-1654-4814				Bell E A, 1991, Nurse Educ, V16, P6, DOI 10.1097/00006223-199103000-00002; HANDFIELDJONES R, 1993, MED TEACH, V15, P3, DOI 10.3109/01421599309029005	2	9	11	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1453	1454		10.1136/bmj.325.7378.1453	http://dx.doi.org/10.1136/bmj.325.7378.1453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493665	Green Published			2022-12-28	WOS:000180188600017
J	Jansens, A; van Duijn, E; Braakman, I				Jansens, A; van Duijn, E; Braakman, I			Coordinated nonvectorial folding in a newly synthesized multidomain protein	SCIENCE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; DISULFIDE BOND FORMATION; LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; NMR STRUCTURE; BIOSYNTHESIS; CONCATEMER; ISOMERASE; PATHWAY; DOMAINS	The low-density lipoprotein receptor (LDL-R) is a typical example of a multidomain protein, for which in vivo folding is assumed to occur vectorially from the amino terminus to the carboxyl terminus. Using a pulse-chase approach in intact cells, we found instead that newly synthesized LDL-R molecules folded by way of "collapsed" intermediates that contained non-native disulfide bonds between distant cysteines. The most amino-terminal domain acquired its native conformation late in folding instead of during synthesis. Thus, productive LDL-R folding in a cell is not vectorial but is mostly posttranslational, and involves transient long-range non-native disulfide bonds that are isomerized into native short-range cysteine pairs.	Univ Utrecht, Dept Bioorgan Chem 1, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	Utrecht University	Braakman, I (corresponding author), Univ Utrecht, Dept Bioorgan Chem 1, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	i.braakman@chem.uu.nl	Jansens, A./L-4409-2015	Braakman, Ineke/0000-0003-1592-4364				BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; BIERI S, 1995, FEBS LETT, V371, P341, DOI 10.1016/0014-5793(95)00939-7; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CREIGHTON TE, 1993, J MOL BIOL, V232, P1176, DOI 10.1006/jmbi.1993.1470; CUMMINGS RD, 1983, J BIOL CHEM, V258, P5261; DANIEL TO, 1983, J BIOL CHEM, V258, P4606; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; EWBANK JJ, 1993, BIOCHEMISTRY-US, V32, P3677, DOI 10.1021/bi00065a022; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Jaenicke R, 1999, PROG BIOPHYS MOL BIO, V71, P155, DOI 10.1016/S0079-6107(98)00032-7; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Kurniawan ND, 2000, PROTEIN SCI, V9, P1282, DOI 10.1110/ps.9.7.1282; Kurniawan ND, 2001, J MOL BIOL, V311, P341, DOI 10.1006/jmbi.2001.4867; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; North CL, 2000, BIOCHEMISTRY-US, V39, P13127, DOI 10.1021/bi0015156; North CL, 1999, BIOCHEMISTRY-US, V38, P3926, DOI 10.1021/bi9821622; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; van den Berg P, 1999, EMBO J, V18, P4794, DOI 10.1093/emboj/18.17.4794; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679	26	136	138	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2401	2403		10.1126/science.1078376	http://dx.doi.org/10.1126/science.1078376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493918	Green Submitted			2022-12-28	WOS:000179915900061
J	Wright, PJ; English, PJ; Hungin, APS; Marsden, SNE				Wright, PJ; English, PJ; Hungin, APS; Marsden, SNE			Managing acute renal colic across the primary-secondary care interface: a pathway of care based on evidence and consensus	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIINFLAMMATORY DRUGS; CLINICAL GUIDELINES; STONE DISEASE; PETHIDINE; EFFICACY	Acute renal colic is a common, often recurrent condition with an annual incidence of 1-2 cases per 1000 and a lifetime risk of 10-20% for men and 3-5% for women.(1-3) Patients usually present with acute pain and pose management challenges for the general practitioner, who may be uncertain whether immediate hospital admission is needed and, if not, how and when patients should be followed up.(4) In many patients sent to hospital the pain remits on the way to hospital, or soon after admission, in response to the analgesia given by the general practitioner, making the admission perhaps unnecessary.(5) The majority of those calling NHS Direct with acute renal colic are advised to contact their general practitioners "urgently"; a small number are referred to the accident and emergency services; and some are advised how to treat themselves.(6)	Univ Durham, Wolfson Res Inst, Stockton On Tees TS17 6BH, England; Univ Hosp N Durham, Durham DH1 5TW, England	Durham University	Wright, PJ (corresponding author), Univ Durham, Wolfson Res Inst, Univ Blvd, Stockton On Tees TS17 6BH, England.	patwright@doctors.org.uk		hungin, amritpal Pali/0000-0001-7275-8927				Acheson AG, 1998, J ROY COLL SURG EDIN, V43, P182; AHLSTRAND C, 1981, SCAND J UROL NEPHROL, V15, P143, DOI 10.3109/00365598109179591; BANKS I, 2000, NHS DIRECT HEALTHCAR; CARTE RY, 1997, RES METHODS PRIMARY; Coffey A, 1996, MAKING SENSE QUALITA; Dawson C, 1996, BRIT MED J, V312, P838; Eccles M, 1996, BMJ-BRIT MED J, V312, P760; Eskelinen M, 1998, EUR UROL, V34, P467, DOI 10.1159/000019785; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; HETHERINGTON JW, 1986, BRIT MED J, V292, P237, DOI 10.1136/bmj.292.6515.237; LABRECQUE M, 1994, ARCH INTERN MED, V154, P1381, DOI 10.1001/archinte.154.12.1381; Lattimer V, 1998, BMJ-BRIT MED J, V317, P1054; Mant D, 1998, BRIT J GEN PRACT, V48, P871; MENON M, 1998, CAMPBELLS UROLOGY, P2661; MORRIS SB, 1995, ANN ROY COLL SURG, V77, P450; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; PRESS SM, 1995, UROLOGY, V45, P753, DOI 10.1016/S0090-4295(99)80078-8; *SCOTT INT GUID NE, 2002, SIGN 50 GUID DEV HDB; SCOTT R, 1985, BRIT J UROL, V57, P491, DOI 10.1111/j.1464-410X.1985.tb05853.x; SCOTT R, 1987, BRIT J UROL, V59, P111, DOI 10.1111/j.1464-410X.1987.tb04799.x; Segura JW, 1997, J UROLOGY, V158, P1915, DOI 10.1016/S0022-5347(01)64173-9; THOMPSON JF, 1989, BRIT MED J, V299, P1140, DOI 10.1136/bmj.299.6708.1140; Tramer MR, 1998, ACTA ANAESTH SCAND, V42, P71; Wensing M, 1998, BRIT J GEN PRACT, V48, P991	24	28	29	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2002	325	7377					1408	1412		10.1136/bmj.325.7377.1408	http://dx.doi.org/10.1136/bmj.325.7377.1408			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480861	Green Published			2022-12-28	WOS:000179975000029
J	Scott, IC; Stainier, DYR				Scott, IC; Stainier, DYR			Fishing out a new heart	SCIENCE			English	Editorial Material							REGENERATION; DEDIFFERENTIATION; ZEBRAFISH		Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Scott, IC (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Scott, Ian/0000-0001-6665-1410; Stainier, Didier/0000-0002-0382-0026				Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; JOHNSON SL, 1995, GENETICS, V141, P1583; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; McGann CJ, 2001, P NATL ACAD SCI USA, V98, P13699, DOI 10.1073/pnas.221297398; OBERPRILLER JO, 1995, ANN NY ACAD SCI, V752, P30, DOI 10.1111/j.1749-6632.1995.tb17404.x; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Poss KD, 2002, DEVELOPMENT, V129, P5141; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Rosania GR, 2000, NAT BIOTECHNOL, V18, P304, DOI 10.1038/73753; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220	10	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2141	2142		10.1126/science.1079821	http://dx.doi.org/10.1126/science.1079821			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481123				2022-12-28	WOS:000179773700032
J	Li, J; Ning, YH; Hedley, W; Saunders, B; Chen, YS; Tindill, N; Hannay, T; Subramaniam, S				Li, J; Ning, YH; Hedley, W; Saunders, B; Chen, YS; Tindill, N; Hannay, T; Subramaniam, S			The Molecule Pages database	NATURE			English	Article								The Alliance for Cellular Signaling (AfCS)-Nature Molecule Pages will be a comprehensive database of key facts about more than 3,000 proteins involved in cell signalling. Each entry will be created by invited experts and be peer-reviewed. Alongside the large-scale experiments being conducted by the AfCS scientists, the wealth of information contained in this database offers the potential of accelerating the pace of discovery in signal transduction research.	Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA; Nat Publishing Grp, London N1 9XW, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Subramaniam, S (corresponding author), Univ Calif San Diego, San Diego Supercomp Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Califano, Andrea/F-7239-2012	Hannay, Timo/0000-0002-5941-3390					0	50	52	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					716	717		10.1038/nature01307	http://dx.doi.org/10.1038/nature01307			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478304	Bronze			2022-12-28	WOS:000179751800057
J	Sambrano, GR; Chandy, G; Choi, S; Decamp, D; Hsueh, R; Lin, KM; Mock, D; O'Rourke, N; Roach, T; Shu, HJ; Sinkovits, B; Verghese, M; Bourne, H				Sambrano, GR; Chandy, G; Choi, S; Decamp, D; Hsueh, R; Lin, KM; Mock, D; O'Rourke, N; Roach, T; Shu, HJ; Sinkovits, B; Verghese, M; Bourne, H			Unravelling the signal-transduction network in B lymphocytes	NATURE			English	Article							LYMPHOMA-CELLS; WEHI-231; ACTIVATION; CHEMOKINES; EXPRESSION	The Alliance for Cellular Signaling has chosen the mouse B lymphocyte as a model system to understand basic principles that govern cellular signalling. Progress to that end has focused initially on establishing a reproducible experimental cell system and characterizing essential signalling responses. Although unravelling this complex network will take years, findings revealed in the interim will prove immensely useful to the scientific community at large.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; San Francisco Vet Adm Med Ctr, Dept Rheumatol, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; Stanford University; California Institute of Technology; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Sambrano, GR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	sambrano@cmp.ucsf.edu						BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630; Bishop GA, 2001, CURR OPIN IMMUNOL, V13, P278, DOI 10.1016/S0952-7915(00)00216-8; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Hasler P, 2001, FASEB J, V15, P2085, DOI 10.1096/fj.00-0860rev; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; IANNONE MA, 1989, J BIOL CHEM, V264, P20177; JAKWAY JP, 1986, J IMMUNOL, V137, P2225; Klaus G G, 1997, Int Rev Immunol, V15, P5, DOI 10.3109/08830189709068169; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560, DOI 10.1128/MCB.13.9.5560; Krebs Danielle L., 1999, Methods in Cell Science, V21, P57, DOI 10.1023/A:1009843325770; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Nisimoto Y, 2002, EUR J BIOCHEM, V269, P2622, DOI 10.1046/j.1432-1033.2002.02939.x; Reif K, 2000, J IMMUNOL, V164, P4720, DOI 10.4049/jimmunol.164.9.4720; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; SCOTT DW, 1986, J EXP MED, V164, P156, DOI 10.1084/jem.164.1.156; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tarakhovsky A, 1997, RES IMMUNOL, V148, P457, DOI 10.1016/S0923-2494(97)82670-3	22	21	21	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					708	710		10.1038/nature01305	http://dx.doi.org/10.1038/nature01305			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478302				2022-12-28	WOS:000179751800055
J	Movassaghi, M; Jacobsen, EN				Movassaghi, M; Jacobsen, EN			The simplest "enzyme"	SCIENCE			English	Editorial Material									Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Movassaghi, M (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.							Dalko PI, 2001, ANGEW CHEM INT EDIT, V40, P3726, DOI 10.1002/1521-3773(20011015)40:20<3726::AID-ANIE3726>3.0.CO;2-D; Danishefsky SJ, 1996, J AM CHEM SOC, V118, P2843, DOI 10.1021/ja952692a; EDER U, 1971, ANGEW CHEM INT EDIT, V10, P496, DOI 10.1002/anie.197104961; EDER U, 1971, Patent No. 2014857; Hajos Z.G., 1971, [No title captured], Patent No. [2102623, DE 2102623]; HAJOS ZG, 1974, J ORG CHEM, V39, P1615, DOI 10.1021/jo00925a003; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; List B, 2002, TETRAHEDRON, V58, P5573, DOI 10.1016/S0040-4020(02)00516-1; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Northrup AB, 2002, J AM CHEM SOC, V124, P6798, DOI 10.1021/ja0262378	11	233	234	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1904	1905		10.1126/science.1076547	http://dx.doi.org/10.1126/science.1076547			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471240				2022-12-28	WOS:000179629200027
J	Check, E				Check, E			Pathogen-tracking questioned	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					451	451		10.1038/420451b	http://dx.doi.org/10.1038/420451b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466803	Bronze			2022-12-28	WOS:000179611600007
J	Van Gelder, IC; Hagens, VE; Bosker, HA; Kingma, JH; Kamp, O; Kingma, T; Said, SA; Darmanata, JI; Timmermans, AJM; Tijssen, JGP; Crijns, HJGM				Van Gelder, IC; Hagens, VE; Bosker, HA; Kingma, JH; Kamp, O; Kingma, T; Said, SA; Darmanata, JI; Timmermans, AJM; Tijssen, JGP; Crijns, HJGM		Rate Control Versus Elect Cardiove	A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THERAPY; STROKE; CARDIOVERSION; PROGRESS; SAFETY	Background: Maintenance of sinus rhythm is the main therapeutic goal in patients with atrial fibrillation. However, recurrences of atrial fibrillation and side effects of antiarrhythmic drugs offset the benefits of sinus rhythm. We hypothesized that ventricular rate control is not inferior to the maintenance of sinus rhythm for the treatment of atrial fibrillation. Methods: We randomly assigned 522 patients who had persistent atrial fibrillation after a previous electrical cardioversion to receive treatment aimed at rate control or rhythm control. Patients in the rate-control group received oral anticoagulant drugs and rate-slowing medication. Patients in the rhythm-control group underwent serial cardioversions and received antiarrhythmic drugs and oral anticoagulant drugs. The end point was a composite of death from cardiovascular causes, heart failure, thromboembolic complications, bleeding, implantation of a pacemaker, and severe adverse effects of drugs. Results: After a mean (+/-SD) of 2.3+/-0.6 years, 39 percent of the 266 patients in the rhythm-control group had sinus rhythm, as compared with 10 percent of the 256 patients in the rate-control group. The primary end point occurred in 44 patients (17.2 percent) in the rate-control group and in 60 (22.6 percent) in the rhythm-control group. The 90 percent (two-sided) upper boundary of the absolute difference in the primary end point was 0.4 percent (the prespecified criterion for noninferiority was 10 percent or less). The distribution of the various components of the primary end point was similar in the rate-control and rhythm-control groups. Conclusions: Rate control is not inferior to rhythm control for the prevention of death and morbidity from cardiovascular causes and may be appropriate therapy in patients with a recurrence of persistent atrial fibrillation after electrical cardioversion.	Univ Groningen Hosp, Thoraxctr, Dept Cardiol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Trial Coordinat Ctr, NL-9700 RB Groningen, Netherlands; Rijnstate Hosp, Arnhem, Netherlands; St Antonius Hosp, Nieuwegein, Netherlands; Free Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; Hosp Midden Twente, Hengelo, Netherlands; Twenteborg Hosp, Almelo, Netherlands; Med Spectrum Twente, Enschede, Netherlands; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Groningen; University of Groningen; Rijnstate Hospital; St. Antonius Hospital Utrecht; Vrije Universiteit Amsterdam; Medical Spectrum Twente; University of Amsterdam; Academic Medical Center Amsterdam	Van Gelder, IC (corresponding author), Univ Groningen Hosp, Thoraxctr, Dept Cardiol, POB 30-001, NL-9700 RB Groningen, Netherlands.	i.c.van.gelder@thorax.azg.nl	Said, Salah Ali Mohamed/I-6656-2019	kamp, otto/0000-0003-2707-2090				ANDERSON DC, 1992, ANN INTERN MED, V116, P1, DOI 10.7326/0003-4819-116-1-1; ANDERSON DC, 1992, ANN INTERN MED, V116, P6; [Anonymous], 2001, CIRCULATION, V104, P2118; COPLEN SE, 1991, CIRCULATION, V83, P714; COPLEN SE, 1990, CIRCULATION, V82, P1106, DOI 10.1161/01.CIR.82.4.1106; Falk RH, 2001, NEW ENGL J MED, V344, P1067, DOI 10.1056/NEJM200104053441407; Gallagher MM, 1998, AM J CARDIOL, V82, p18N, DOI 10.1016/S0002-9149(98)00736-X; GROGAN M, 1992, AM J CARDIOL, V69, P1570, DOI 10.1016/0002-9149(92)90705-4; Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223; Hart RG, 1999, ANN INTERN MED, V131, P688, DOI 10.7326/0003-4819-131-9-199911020-00010; Hart RG, 2000, J AM COLL CARDIOL, V35, P183, DOI 10.1016/S0735-1097(99)00489-1; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; HOHNLOSER SH, 1995, J CARDIOVASC ELECTR, V6, P920, DOI 10.1111/j.1540-8167.1995.tb00368.x; Levy S, 1999, CIRCULATION, V99, P3028, DOI 10.1161/01.CIR.99.23.3028; PACKER DL, 1986, AM J CARDIOL, V57, P563, DOI 10.1016/0002-9149(86)90836-2; VanGelder IC, 1996, ARCH INTERN MED, V156, P2585, DOI 10.1001/archinte.156.22.2585; WELLENS HJJ, 1994, NEW ENGL J MED, V331, P944, DOI 10.1056/NEJM199410063311413; Wyse DG, 1997, AM J CARDIOL, V79, P1198	18	1596	1649	0	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2002	347	23					1834	1840		10.1056/NEJMoa021375	http://dx.doi.org/10.1056/NEJMoa021375			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NW	12466507				2022-12-28	WOS:000179596900003
J	Kalayoglu, MV; Libby, P; Byrne, GI				Kalayoglu, MV; Libby, P; Byrne, GI			Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-ARTERY-DISEASE; SECONDARY PREVENTION TRIAL; HUMAN ENDOTHELIAL-CELLS; HUMAN ATHEROSCLEROTIC PLAQUES; BLOOD MONONUCLEAR-CELLS; LOW-DENSITY-LIPOPROTEIN; VASCULAR SMOOTH-MUSCLE; REACTIVE T-LYMPHOCYTES; HELICOBACTER-PYLORI; HEART-DISEASE	Recent appreciation of atherosclerosis as a chronic, inflammatory disease has rekindled efforts to examine the role that infectious agents may play in atherogenesis. In particular, much interest has focused on infection with Chlamydia pneumoniae. The possibility that a prokaryote contributes to atherogenesis has high clinical interest, as C pneumoniae infection may be a treatable risk factor. To review the evidence implicating ( pneumoniae in the pathogenesis of atherosclerosis, we searched MEDLINE for articles published between January 1966 and October 2002 on the association of C pneumoniae and atherosclerosis. We also used online resources, texts, meeting abstracts, and expert opinion. We included 5 types of studies (epidemiological, pathology based, animal model, cell biology, and human antibiotic treatment trials) and extracted diagnostic, pathophysiologic, and therapeutic information from the selected literature; consensus was reached on interpretation discrepancies. Chlamydia pneumoniae is associated with atherosclerosis by epidemiological and pathology-based studies. Animal model and cell biology studies suggest that the pathogen can modulate atheroma biology, including lipid- and inflammatory-related processes. Although some preliminary antibiotic treatment trials in patients with coronary artery disease indicated a reduction in recurrent coronary events, larger studies have not shown benefits in individuals with stable coronary artery disease. It is unlikely that C pneumoniae infection is necessary to initiate atherosclerosis. Furthermore-conventional antibiotic therapy may not eradicate the organism or reduce mortality in individuals with atherosclerotic vascular disease. Nevertheless, the current body of evidence establishes this pathogen as a plausible, potentially modifiable risk factor in cardiovascular disease.	Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA	University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital	Byrne, GI (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, 858 Madison Ave,Suite 801, Memphis, TN 38163 USA.	gbyrne@utmem.edu	Eckhardt, Erik/G-1567-2010; Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071735] Funding Source: Medline; NIAID NIH HHS [R01 AI019782] Funding Source: Medline; NIGMS NIH HHS [T32 GM008692] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aalto-Setala K, 2001, ARTERIOSCL THROM VAS, V21, P578, DOI 10.1161/01.ATV.21.4.578; Anderson JL, 1999, CIRCULATION, V99, P1540, DOI 10.1161/01.CIR.99.12.1540; Anderson JL, 2000, J INFECT DIS, V181, pS569, DOI 10.1086/315635; [Anonymous], 1882, BERLINER KLIN WOCHEN, V19, P221; Apfalter P, 2000, EUR J CLIN MICROBIOL, V19, P305, DOI 10.1007/s100960050481; Apfalter P, 2001, J CLIN MICROBIOL, V39, P519, DOI 10.1128/JCM.39.2.519-524.2001; Bartels C, 1999, CIRCULATION, V99, P879, DOI 10.1161/01.CIR.99.7.879; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Boman J, 2000, J INFECT DIS, V181, pS452, DOI 10.1086/315609; Burnett MS, 2001, J INFECT DIS, V183, P226, DOI 10.1086/317938; Caligiuri G, 2001, CIRCULATION, V103, P2834; Campbell LA, 2000, J INFECT DIS, V181, pS508, DOI 10.1086/315629; CERCEK B, 2002, J AM COLL CARDIOL  S, V39, P405; CHI EY, 1987, J BACTERIOL, V169, P3757, DOI 10.1128/jb.169.8.3757-3763.1987; Chierichetti F, 2000, ANGIOLOGY, V51, P827, DOI 10.1177/000331970005101004; Chiu B, 1997, CIRCULATION, V96, P2144; Cook PJ, 1998, HYPERTENSION, V31, P589, DOI 10.1161/01.HYP.31.2.589; Coombes BK, 1999, INFECT IMMUN, V67, P2909, DOI 10.1128/IAI.67.6.2909-2915.1999; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danesh J, 2002, EUR HEART J, V23, P371, DOI 10.1053/euhj.2001.2801; Danesh J, 2000, BRIT MED J, V321, P208, DOI 10.1136/bmj.321.7255.208; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; de Boer OJ, 2000, CARDIOVASC RES, V48, P402, DOI 10.1016/S0008-6363(00)00195-4; Dechend R, 1999, CIRCULATION, V100, P1369, DOI 10.1161/01.CIR.100.13.1369; Dowell SF, 2001, CLIN INFECT DIS, V33, P492, DOI 10.1086/322632; Dunne MW, 2000, J INFECT DIS, V181, pS572, DOI 10.1086/315634; Ericson K, 2000, CIRCULATION, V101, P2568, DOI 10.1161/01.CIR.101.22.2568; Esposito G, 1999, ANN VASC SURG, V13, P421, DOI 10.1007/s100169900277; FABRICANT CG, 1978, J EXP MED, V148, P335, DOI 10.1084/jem.148.1.335; Farsak B, 2000, J CLIN MICROBIOL, V38, P4408, DOI 10.1128/JCM.38.12.4408-4411.2000; Fong IW, 1997, J CLIN MICROBIOL, V35, P48, DOI 10.1128/JCM.35.1.48-52.1997; Fong IW, 2002, ANTIMICROB AGENTS CH, V46, P2321, DOI 10.1128/AAC.46.8.2321-2326.2002; Fong IW, 2000, J INFECT DIS, V181, pS514, DOI 10.1086/315607; Frothingham C, 1911, ARCH INTERN MED, V8, P0153; Fryer RH, 1997, J INVEST MED, V45, P168; Gaydos CA, 1996, INFECT IMMUN, V64, P1614, DOI 10.1128/IAI.64.5.1614-1620.1996; Gaydos CA, 2000, J INFECT DIS, V181, pS473, DOI 10.1086/315612; Geng YM, 2000, J IMMUNOL, V164, P5522, DOI 10.4049/jimmunol.164.10.5522; Gibbs RGJ, 2000, STROKE, V31, P2930, DOI 10.1161/01.STR.31.12.2930; Gieffers J, 2001, CIRCULATION, V103, P351; GODZIK KL, 1995, J CLIN MICROBIOL, V33, P2411, DOI 10.1128/JCM.33.9.2411-2414.1995; GRAYSTON J, 1998, P 9 INT S HUM CHLAM, P187; GRAYSTON JT, 1992, CLIN INFECT DIS, V15, P757, DOI 10.1093/clind/15.5.757; GRAYSTON JT, 1995, CIRCULATION, V92, P3397, DOI 10.1161/01.CIR.92.12.3397; GRAYSTON JT, 1990, J INFECT DIS, V161, P618, DOI 10.1093/infdis/161.4.618; Gupta S, 1997, CIRCULATION, V96, P404; Gurfinkel E, 1997, LANCET, V350, P404, DOI 10.1016/S0140-6736(97)07201-2; Gutierrez J, 2001, INFECTION, V29, P196, DOI 10.1007/s15010-001-1180-0; HAHN DL, 1992, ARTERIOSCLER THROMB, V12, P945, DOI 10.1161/01.ATV.12.8.945; Halme S, 1999, EUR J CLIN INVEST, V29, P546, DOI 10.1046/j.1365-2362.1999.00463.x; Hu H, 1999, J CLIN INVEST, V103, P747, DOI 10.1172/JCI4582; Jackson LA, 1997, AM J PATHOL, V150, P1785; Jackson LA, 1997, J INFECT DIS, V176, P292, DOI 10.1086/517270; Jackson LA, 2000, J INFECT DIS, V181, pS579, DOI 10.1086/315628; Jantos CA, 1999, CLIN INFECT DIS, V28, P988, DOI 10.1086/514763; Juvonen JJ, 1997, J VASC SURG, V25, P499, DOI 10.1016/S0741-5214(97)70260-X; Kalayoglu MV, 1999, J INFECT DIS, V180, P780, DOI 10.1086/314931; Kalayoglu MV, 1998, INFECT IMMUN, V66, P5067, DOI 10.1128/IAI.66.11.5067-5072.1998; Kalayoglu MV, 1998, J INFECT DIS, V177, P725, DOI 10.1086/514241; Kalayoglu MV, 2001, MICROBES INFECT, V3, P963, DOI 10.1016/S1286-4579(01)01458-7; Kalayoglu MV, 2000, J INFECT DIS, V181, pS483, DOI 10.1086/315619; Kalayoglu MV, 1999, MICROBES INFECT, V1, P409, DOI 10.1016/S1286-4579(99)80044-6; KALAYOGLU MV, 1999, INFEC AGENT, P233; Karlsson L, 2000, EUR J VASC ENDOVASC, V19, P630, DOI 10.1053/ejvs.1999.1057; KARVONEN M, 1994, INT J EPIDEMIOL, V23, P1315, DOI 10.1093/ije/23.6.1315; KAUKORANTATOLVANEN SS, 1994, MICROB PATHOGENESIS, V16, P313, DOI 10.1006/mpat.1994.1032; KaukorantaTolvanen SSE, 1996, MICROB PATHOGENESIS, V21, P215, DOI 10.1006/mpat.1996.0056; KaukorantaTolvanen SSE, 1996, MICROB PATHOGENESIS, V21, P407, DOI 10.1006/mpat.1996.0071; Kaul R, 2000, CIRCULATION, V102, P2341, DOI 10.1161/01.CIR.102.19.2341; Khovidhunkit W, 2000, J INFECT DIS, V181, pS462, DOI 10.1086/315611; Kol A, 1998, CIRCULATION, V98, P300, DOI 10.1161/01.CIR.98.4.300; Kothe H, 2000, CIRCULATION, V101, P1760, DOI 10.1161/01.CIR.101.15.1760; KUO CC, 1993, J INFECT DIS, V167, P841, DOI 10.1093/infdis/167.4.841; KUO CC, 1995, P NATL ACAD SCI USA, V92, P6911, DOI 10.1073/pnas.92.15.6911; LaBiche R, 2001, STROKE, V32, P855, DOI 10.1161/01.STR.32.4.855; Laitinen K, 1997, INFECT IMMUN, V65, P4832, DOI 10.1128/IAI.65.11.4832-4835.1997; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liuba P, 2000, CIRCULATION, V102, P1039, DOI 10.1161/01.CIR.102.9.1039; Maass M, 1998, ATHEROSCLEROSIS, V140, pS25, DOI 10.1016/S0021-9150(98)00117-8; Maass M, 2000, J INFECT DIS, V181, pS449, DOI 10.1086/315610; Mach F, 2002, CIRC RES, V90, pE1, DOI 10.1161/hh0102.102270; Mahdi OS, 2002, CIRCULATION, V106, P1659, DOI 10.1161/01.CIR.0000031567.10814.D8; Mahony JB, 2000, J CLIN MICROBIOL, V38, P2622, DOI 10.1128/JCM.38.7.2622-2627.2000; Mayr M, 1999, CIRCULATION, V99, P1560, DOI 10.1161/01.CIR.99.12.1560; Mayr M, 2000, CIRCULATION, V102, P833; Meijer A, 1999, ARTERIOSCL THROM VAS, V19, P2680, DOI 10.1161/01.ATV.19.11.2680; Melissano G, 1999, EUR J VASC ENDOVASC, V18, P355, DOI 10.1053/ejvs.1999.0915; Miller SA, 2000, J SURG RES, V90, P76, DOI 10.1006/jsre.2000.5847; Moazed TC, 1997, J INFECT DIS, V175, P883, DOI 10.1086/513986; Molestina RE, 1999, INFECT IMMUN, V67, P1323, DOI 10.1128/IAI.67.3.1323-1330.1999; Mosorin M, 2000, ARTERIOSCL THROM VAS, V20, P1061, DOI 10.1161/01.ATV.20.4.1061; Muhlestein JB, 2000, CIRCULATION, V102, P1755; Muhlestein JB, 1998, CIRCULATION, V97, P633, DOI 10.1161/01.CIR.97.7.633; Muhlestein JB, 1996, J AM COLL CARDIOL, V27, P1555, DOI 10.1016/0735-1097(96)00055-1; Muhlestein JB, 2000, J INFECT DIS, V181, pS505, DOI 10.1086/315627; Netea MG, 2000, EUR J IMMUNOL, V30, P541, DOI 10.1002/1521-4141(200002)30:2<541::AID-IMMU541>3.0.CO;2-X; Ong G, 1996, J CLIN PATHOL, V49, P102, DOI 10.1136/jcp.49.2.102; Ouchi K, 1998, J MED MICROBIOL, V47, P907, DOI 10.1099/00222615-47-10-907; Paterson DL, 1998, PATHOLOGY, V30, P169, DOI 10.1080/00313029800169166; Peeling RW, 2000, J INFECT DIS, V181, pS426, DOI 10.1086/315603; Peeling RW, 1996, EMERG INFECT DIS, V2, P307, DOI 10.3201/eid0204.960406; Qavi H B, 2000, Cent Eur J Public Health, V8, P71; Quinn TC, 1998, CURR OPIN INFECT DIS, V11, P301, DOI 10.1097/00001432-199806000-00006; Ramirez JA, 1996, ANN INTERN MED, V125, P979, DOI 10.7326/0003-4819-125-12-199612150-00008; Rebic R, 1993, Med Pregl, V46 Suppl 1, P20; Richardson M, 1997, AM J PATHOL, V151, P1009; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSSEN RD, 1994, CIRC RES, V75, P546, DOI 10.1161/01.RES.75.3.546; Rothstein NM, 2001, J INFECT DIS, V183, P232, DOI 10.1086/317941; Rugonfalvi-Kiss S, 2002, CIRCULATION, V106, P1071, DOI 10.1161/01.CIR.0000027137.96791.6A; Sakash JB, 2002, INFECT IMMUN, V70, P3959, DOI 10.1128/IAI.70.7.3959-3961.2002; Schwartz B, 1997, JAMA-J AM MED ASSOC, V278, P944, DOI 10.1001/jama.278.11.944; SHOR A, 1992, S AFR MED J, V82, P158; Stone AFM, 2002, CIRCULATION, V106, P1219, DOI 10.1161/01.CIR.0000027820.66786.CF; Summersgill JT, 2000, J INFECT DIS, V181, pS479, DOI 10.1086/315620; Taylor-Robinson D, 1998, LANCET, V351, P1255, DOI 10.1016/S0140-6736(05)79322-3; Thomas M, 1999, CIRCULATION, V99, P2733, DOI 10.1161/01.CIR.99.21.2733; Vehmaan-Kreula P, 2001, ARTERIOSCL THROM VAS, V21, pE1, DOI 10.1161/01.ATV.21.1.e1; Vink A, 2001, CIRCULATION, V103, P1613, DOI 10.1161/01.CIR.103.12.1613; Ward ME, 1995, APMIS, V103, P769, DOI 10.1111/j.1699-0463.1995.tb01436.x; Weiss SM, 1996, J INFECT DIS, V173, P957, DOI 10.1093/infdis/173.4.957; Wiesli P, 2002, CIRCULATION, V105, P2646, DOI 10.1161/01.CIR.0000017862.08503.15; Wong YK, 1999, J AM COLL CARDIOL, V33, P152, DOI 10.1016/S0735-1097(98)00547-6; Wright SD, 2000, J EXP MED, V191, P1437, DOI 10.1084/jem.191.8.1437; Zhu JH, 2001, CIRCULATION, V103, P45; Zhu JH, 2000, AM J CARDIOL, V85, P140, DOI 10.1016/S0002-9149(99)00653-0	127	198	206	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2002	288	21					2724	2731		10.1001/jama.288.21.2724	http://dx.doi.org/10.1001/jama.288.21.2724			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620UA	12460096				2022-12-28	WOS:000179549800032
J	Markowitz, AJ; McPhee, SJ				Markowitz, AJ; McPhee, SJ			Adolescent grief - "It never really hit me ... until it actually happened"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article														Markowitz, Amy/0000-0001-9314-2814				Christ GH, 2002, JAMA-J AM MED ASSOC, V288, P1269, DOI 10.1001/jama.288.10.1269	1	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2002	288	21					2741	2741		10.1001/jama.288.21.2741	http://dx.doi.org/10.1001/jama.288.21.2741			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620UA	12460098				2022-12-28	WOS:000179549800034
J	Quirk, CM; Seykora, J; Wingate, BJ; Cotsarelis, G				Quirk, CM; Seykora, J; Wingate, BJ; Cotsarelis, G			Acrodermatitis enteropathica associated with anorexia nervosa	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Brown Univ, Dept Dermatol, Providence, RI 02912 USA; Hosp Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; Hosp Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	Brown University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Cotsarelis, G (corresponding author), M8 Stellar Chance Lab, 422 Curie Blvd, Philadelphia, PA 19104 USA.	cotsarel@mail.med.upenn.edu						DANBOLT N, 1942, ACTA DERM-VENEREOL, V23, P127; Goskowicz Maki, 1993, Current Opinion in Pediatrics, V5, P441; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; *NAT HEART LUNG BL, NIH PUBL NAT HEART L; NELDER K, 1999, FITZPATRICKS DERMATO, P1738; VANVOORHEES AS, 1992, PEDIATR DERMATOL, V9, P268, DOI 10.1111/j.1525-1470.1992.tb00345.x	6	20	20	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2002	288	21					2655	2656		10.1001/jama.288.21.2655	http://dx.doi.org/10.1001/jama.288.21.2655			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620UA	12460069				2022-12-28	WOS:000179549800001
J	Kehrer, M; Goelz, R; Krageloh-Mann, I; Schoning, M				Kehrer, M; Goelz, R; Krageloh-Mann, I; Schoning, M			Measurement of volume of cerebral blood flow in healthy preterm and term neonates with ultrasound	LANCET			English	Article							COLOR DUPLEX MEASUREMENT; REPRODUCIBILITY; ADULTS	Changes in cerebral blood flow are important in the pathogenesis of ischaemic brain damage, but standard methods cannot measure volume of cerebral blood flow quantitatively in neonates. We used colour duplex sonography of the extracranial cerebral arteries to measure volume of global cerebral blood flow in 67 healthy preterm and term neonates. Volume of cerebral blood flow increased between the postmenstrual ages of 34 weeks (median 33 mL/min [range 23-43]) and 42 weeks (85 mL/min [57-104]). However, intersession and interobserver variability was quite large. This non-invasive method will allow quantitative bedside monitoring of global brain perfusion in preterm and term neonates with pathological disorders, and could also be used to monitor effects of neuroprotective measures.	Univ Tubingen, Childrens Hosp, Dept Child Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Childrens Hosp, Dept Neonatol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Schoning, M (corresponding author), Univ Tubingen, Childrens Hosp, Dept Child Neurol, D-72076 Tubingen, Germany.		Schoening, Martin/H-7559-2012					ALTMAN DI, 1988, ANN NEUROL, V24, P218, DOI 10.1002/ana.410240208; MATTHEW E, 1993, J CEREBR BLOOD F MET, V13, P748, DOI 10.1038/jcbfm.1993.95; Scheel P, 2000, STROKE, V31, P147, DOI 10.1161/01.STR.31.1.147; Schoning M, 1996, J CEREBR BLOOD F MET, V16, P827, DOI 10.1097/00004647-199609000-00007; Schoning M, 1996, J CEREBR BLOOD F MET, V16, P523, DOI 10.1097/00004647-199605000-00020	5	34	40	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1749	1750		10.1016/S0140-6736(02)11720-X	http://dx.doi.org/10.1016/S0140-6736(02)11720-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480431				2022-12-28	WOS:000179636800015
J	Schaub, R; Wahlstrom, E; Ronnau, A; Laegsgaard, E; Stensgaard, I; Besenbacher, F				Schaub, R; Wahlstrom, E; Ronnau, A; Laegsgaard, E; Stensgaard, I; Besenbacher, F			Oxygen-mediated diffusion of oxygen vacancies on the TiO2(110) surface	SCIENCE			English	Article							INTRINSIC DEFECTS; METAL-OXIDES; CO; OXIDATION; ATOMS; SITE	Defects such as oxygen vacancies play a crucial role in the surface properties of transition metal oxides. By means of time-resolved, high-resolution scanning tunneling microscopy, we unraveled an adsorbate-mediated diffusion mechanism of oxygen vacancies on rutile TiO2(110). Adsorbed oxygen molecules mediate vacancy diffusion through the loss of an oxygen atom to a vacancy and the sequential capture of an oxygen atom from a neighboring bridging oxygen row, leading to an anisotropic oxygen vacancy diffusion pathway perpendicular to the bridging oxygen rows.	Aarhus Univ, Dept Phys & Astron, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark; Aarhus Univ, CAMP, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Besenbacher, F (corresponding author), Aarhus Univ, Dept Phys & Astron, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark.	fbe@phys.au.dk	Wahlström, Erik/B-6696-2009; Besenbacher, Flemming/A-9623-2010; Schaub, Renald/B-1283-2014; Schaub, Renald/O-7418-2019	Wahlström, Erik/0000-0003-1905-5880; Schaub, Renald/0000-0002-1712-3336; Schaub, Renald/0000-0002-1712-3336				Baumer M, 1999, PROG SURF SCI, V61, P127, DOI 10.1016/S0079-6816(99)00012-X; Besenbacher F, 1996, REP PROG PHYS, V59, P1737, DOI 10.1088/0034-4885/59/12/004; Chambers SA, 2002, SCIENCE, V297, P827, DOI 10.1126/science.1073404; Charlton G, 1997, PHYS REV LETT, V78, P495, DOI 10.1103/PhysRevLett.78.495; Diebold U, 1998, SURF SCI, V411, P137, DOI 10.1016/S0039-6028(98)00356-2; Diebold U, 1996, PHYS REV LETT, V77, P1322, DOI 10.1103/PhysRevLett.77.1322; Epling WS, 1998, SURF SCI, V412-13, P333, DOI 10.1016/S0039-6028(98)00446-4; GOPEL W, 1983, PHYS REV B, V28, P3427, DOI 10.1103/PhysRevB.28.3427; Hansen KH, 1999, PHYS REV LETT, V83, P4120, DOI 10.1103/PhysRevLett.83.4120; HARUTA M, 1989, J CATAL, V115, P301, DOI 10.1016/0021-9517(89)90034-1; Heller A, 1995, ACCOUNTS CHEM RES, V28, P503, DOI 10.1021/ar00060a006; Henderson MA, 1999, J PHYS CHEM B, V103, P5328, DOI 10.1021/jp990655q; Henrich V. E., 1994, SURFACE SCI METAL OX; Henry CR, 1998, SURF SCI REP, V31, P235; Horch S, 1999, NATURE, V398, P134, DOI 10.1038/18185; Kasemo B, 1999, Adv Dent Res, V13, P8; Laegsgaard E, 2001, REV SCI INSTRUM, V72, P3537, DOI 10.1063/1.1389497; Linderoth TR, 1997, PHYS REV LETT, V78, P4978, DOI 10.1103/PhysRevLett.78.4978; LINSEBIGLER A, 1995, J CHEM PHYS, V103, P9438, DOI 10.1063/1.470005; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; LU GQ, 1995, J CHEM PHYS, V102, P4657, DOI 10.1063/1.469513; Schaub R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.266104; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; van Gastel R, 2000, NATURE, V408, P665, DOI 10.1038/35047156	24	377	384	16	369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					377	379		10.1126/science.1078962	http://dx.doi.org/10.1126/science.1078962			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12481022				2022-12-28	WOS:000180426800040
J	Arcasoy, SM; Lanken, PN				Arcasoy, SM; Lanken, PN			Pulmonary alveolar proteinosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Columbia University; University of Pennsylvania	Arcasoy, SM (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.		Arcasoy, Selim M/AAR-6637-2020; campo, Ilaria/K-4129-2016	campo, Ilaria/0000-0002-4423-2482					0	5	6	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2133	2133		10.1056/NEJMicm990808	http://dx.doi.org/10.1056/NEJMicm990808			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501225				2022-12-28	WOS:000180040900006
J	Dalton, R				Dalton, R			Misconduct - The stars who fell to Earth	NATURE			English	Editorial Material																		Abbott A, 2002, NATURE, V418, P113, DOI 10.1038/418113a; HOFMANN S, 1995, Z PHYS A-HADRON NUCL, V350, P277, DOI 10.1007/BF01291181; Hofmann S, 1996, Z PHYS A-HADRON NUCL, V354, P229, DOI 10.1007/s002180050036; Hofmann S, 2002, EUR PHYS J A, V14, P147, DOI 10.1140/epja/i2001-10119-x; Ninov V, 1999, PHYS REV LETT, V83, P1104, DOI 10.1103/PhysRevLett.83.1104; Ninov V., 2002, PHYS REV LETT, V89; Schon JH, 2002, SCIENCE, V298, P961, DOI 10.1126/science.298.5595.961b	7	10	10	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					728	729		10.1038/420728a	http://dx.doi.org/10.1038/420728a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490902				2022-12-28	WOS:000179897300011
J	Giles, J				Giles, J			Attosecond science - The fast show	NATURE			English	Editorial Material																		Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Niikura H, 2002, NATURE, V417, P917, DOI 10.1038/nature00787; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413	4	7	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					737	737		10.1038/420737a	http://dx.doi.org/10.1038/420737a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490913	Bronze			2022-12-28	WOS:000179897300022
J	Irie, M; Fukaminato, T; Sasaki, T; Tamai, N; Kawai, T				Irie, M; Fukaminato, T; Sasaki, T; Tamai, N; Kawai, T			Organic chemistry: A digital fluorescent molecular photoswitch	NATURE			English	Article							SINGLE MOLECULES; ROOM-TEMPERATURE; SPECTROSCOPY		Kyushu Univ, Grad Sch Engn, Dept Chem & Biochem, Higashi Ku, Fukuoka 8128581, Japan; Japan Sci & Technol, CREST, Higashi Ku, Fukuoka 8128581, Japan; Kwansei Gakuin Univ, Sch Sci & Technol, Dept Chem, Sanda 6691337, Japan	Kyushu University; Japan Science & Technology Agency (JST); Kwansei Gakuin University	Irie, M (corresponding author), Kyushu Univ, Grad Sch Engn, Dept Chem & Biochem, Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	irie@cstf.kyushu-u.ac.jp	Fukaminato, Tuyoshi/A-5497-2012; Fukaminato, Tsuyoshi/AAH-2088-2020	Fukaminato, Tsuyoshi/0000-0001-5504-0964				Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Ha T, 1997, CHEM PHYS LETT, V271, P1, DOI 10.1016/S0009-2614(97)00440-5; HANAZAWA M, 1992, J CHEM SOC CHEM COMM, P206, DOI 10.1039/c39920000206; Hofkens J, 2000, J AM CHEM SOC, V122, P9278, DOI 10.1021/ja0012570; Irie M, 2001, SCIENCE, V291, P1769, DOI 10.1126/science.291.5509.1769; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Kawai T, 2001, CHEM COMMUN, P711, DOI 10.1039/b100330p; Lu HP, 1997, NATURE, V385, P143, DOI 10.1038/385143a0; NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650; Tamai N, 1996, J PHYS CHEM-US, V100, P4689, DOI 10.1021/jp953181d	10	995	1009	9	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					759	760		10.1038/420759a	http://dx.doi.org/10.1038/420759a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	626WR	12490936				2022-12-28	WOS:000179897300043
J	Stone, J; Wojcik, W; Durrance, D; Carson, A; Lewis, S; MacKenzie, L; Warlow, CP; Sharpe, M				Stone, J; Wojcik, W; Durrance, D; Carson, A; Lewis, S; MacKenzie, L; Warlow, CP; Sharpe, M			What should we say to patients with symptoms unexplained by disease? The "number needed to offend"	BRITISH MEDICAL JOURNAL			English	Article								Most doctors make a diagnosis and offer treatment to patients whose symptoms turn out to be unexplained by disease.(1) In such cases a diagnostic label is important in signifying to the patient and family that the doctor is taking the problem seriously and accepts the complaints as real. Some diagnostic labels, particularly those that sound "psychological," can be perceived by patients as offensive by implying that the patients are "putting on" or "imagining" their symptoms or that they are "mad."(2) Various potentially suitable diagnoses are available to doctors. "Hysteria" was the traditional term and is still sometimes used. "Functional nervous disorder" was used in the late 19th century to denote symptoms arising from disordered nervous functioning,(3) but in the 20th century this was superseded by terms that implied psychogenesis, such as psychosomatic.(4) In the past 20 years more neutral descriptive terms such as "medically unexplained symptoms" have gained in popularity.(1) Despite their importance in the doctor-patient relationship, the implications to patients of these labels have received remarkably little attention. We explored the differing connotations and potential offensiveness of 10 different medical labels for the symptom of weakness.	Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Stone, J (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.		Stone, Jon/C-3119-2014	Stone, Jon/0000-0001-9829-8092; sharpe, michael/0000-0002-6474-9980; Lewis, Steff/0000-0003-1210-2314				COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; MACE CJ, 1991, J ROY SOC MED, V84, P471, DOI 10.1177/014107689108400808; Reid S, 2001, BRIT MED J, V322, P767, DOI 10.1136/bmj.322.7289.767; Sharpe M, 2001, ANN INTERN MED, V134, P926, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00018; TRIMBLE MR, 1982, BMJ-BRIT MED J, V285, P1768, DOI 10.1136/bmj.285.6357.1768; Wessely S, 2000, ETHICAL DILEMMAS NEU, P41	6	195	200	1	19	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1449	1450		10.1136/bmj.325.7378.1449	http://dx.doi.org/10.1136/bmj.325.7378.1449			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493661	Green Published			2022-12-28	WOS:000180188600013
J	Eisenberg, DM; Cohen, MH; Hrbek, A; Grayzel, J; Van Rompay, MI; Cooper, RA				Eisenberg, DM; Cohen, MH; Hrbek, A; Grayzel, J; Van Rompay, MI; Cooper, RA			Credentialing complementary and alternative medical providers	ANNALS OF INTERNAL MEDICINE			English	Article							NONPHYSICIAN CLINICIAN; UNITED-STATES; THERAPIES; CARE; HOMEOPATHY; TRENDS	Since the late 19th century, state legislatures and professional medical organizations have developed mechanisms to license physicians and other conventional nonphysician providers, establish standards of practice, and protect health care consumers by establishing standardized credentials as markers of competence. The popularity of complementary and alternative medical (CAM) therapies presents new challenges. This article describes the current status of, and central issues in, efforts to create models for health care credentialing of chiropractors, acupuncturists, naturopaths, massage therapists, and other CAM practitioners. It also suggests a strategy of CAM provider credentialing for use by physicians, health care administrators, insurance companies, and national professional organizations. The credentialing debate reflects fundamental questions about who determines which providers and therapies will be accepted as safe, effective, appropriate, and reimbursable. More nationally uniform credentialing mechanisms are necessary to ensure high standards of care and more generalizable clinical research. However, the result of more uniform licensure and credentialing may be excessive standardization and a decrease in individualization of services. Thus, increased standardization of credentialing for CAM practitioners may alter CAM practice substantially. Furthermore, even credentialed providers can deliver ineffective therapy. The suggested framework balances the desire to protect the public from dangerous practices against the wish to grant patients access to reasonably safe and effective therapies.	Harvard Univ, Sch Med, Osher Inst, Div Res & Educ Complementary & Integrat Med Therap, Boston, MA 02215 USA; Univ Massachusetts, Med Ctr, Worcester, MA 01655 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA	Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Medical College of Wisconsin	Eisenberg, DM (corresponding author), Harvard Univ, Sch Med, Osher Inst, Div Res & Educ Complementary & Integrat Med Therap, Suite 22A,401 Pk Dr, Boston, MA 02215 USA.	Osher_Institute@hms.harvard.edu	Van Rompay, Maria/G-9452-2012		NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NCCIH NIH HHS [AT00144] Funding Source: Medline; NIAMS NIH HHS [U24 AR43441] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams KE, 2002, ANN INTERN MED, V137, P660, DOI 10.7326/0003-4819-137-8-200210150-00010; *AM ASS NAT PHYS, 1998, NAT MED WHAT IT IS W; *AM ASS NAT PHYS, 1989, 20 QUEST NAT MED; *AM ASS NAT PHYS, 1997, MEMB RES DIR; *AM CHIR ASS, 2002, HOT TOP; *AM MASS THER ASS, 2002, DEM MASS THER; [Anonymous], 2000, LANCET, V356, P2023; CHAPMAN EH, 1997, J AM I HOMEOPATH, V90, P5; COHEN M, 2000, COMPLEMENTARY MED LE; Cohen MH, 2002, ANN INTERN MED, V136, P596, DOI 10.7326/0003-4819-136-8-200204160-00009; Cohen Michael, 1998, COMPLEMENTARY ALTERN; Cooper RA, 1996, HEALTH AFFAIR, V15, P226, DOI 10.1377/hlthaff.15.3.226; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P788, DOI 10.1001/jama.280.9.788; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P795, DOI 10.1001/jama.280.9.795; COOPER RA, IN PRESS MILLBANK Q; Diehl D L, 1997, J Altern Complement Med, V3, P119, DOI 10.1089/acm.1997.3.119; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; ELLISON MS, 1999, PHYSICIANS FINANCE S, V17, pS30; Ernst E, 2002, ANN INTERN MED, V136, P42, DOI 10.7326/0003-4819-136-1-200201010-00010; Goldman P, 2001, ANN INTERN MED, V135, P594, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00010; Kaptchuk TJ, 1998, ANN INTERN MED, V129, P1061, DOI 10.7326/0003-4819-129-12-199812150-00011; Leake R, 1999, ALTERN THER HEALTH M, V5, P94; Lee ACC, 2000, ARCH PEDIAT ADOL MED, V154, P75; MITCHELL BB, 2001, ACUPUNCTURE ORIENTAL; MITCHELL BB, 1998, LEGISLATIVE UPDATE F; O'Neale J, 2000, BRIT MED J, V321, P1365, DOI 10.1136/bmj.321.7273.1365; ROBBINS DA, 2000, MANAGED HEALTHCARE, P38; Ullman D, 1999, J ALTERN COMPLEM MED, V5, P65, DOI 10.1089/acm.1999.5.65; ULLMAN D, 1995, CONSUMERS GUIDE HOME; WEEKS J, 1998, CHALLENGES CREDENTIA, P2; 1997, OFFICIAL DIRECTORY C; 1998, DICT HLTH CARE TERMS, P59; 1998, DICT HLTH CARE TERMS, P46; 1998, DICT HLTH CARE TERMS, P211; 2002, NCCAOM CERTIFICATION	35	90	91	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2002	137	12					965	973		10.7326/0003-4819-137-12-200212170-00010	http://dx.doi.org/10.7326/0003-4819-137-12-200212170-00010			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626DR	12484712				2022-12-28	WOS:000179857500005
J	Thunberg, U; Tobin, G; Johnson, A; Soderberg, O; Padyukov, L; Hultdin, M; Klareskog, L; Enblad, G; Sundstrom, C; Roos, G; Rosenquist, R				Thunberg, U; Tobin, G; Johnson, A; Soderberg, O; Padyukov, L; Hultdin, M; Klareskog, L; Enblad, G; Sundstrom, C; Roos, G; Rosenquist, R			Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia	LANCET			English	Article							CD38 EXPRESSION; ATP RECEPTOR; LEUKEMIA; P2X(7); CELLS	Background The P2X7 receptor is a ligand-gated cation channel that mediates ATP-induced apoptotic death in haemopoietic and chronic lymphocytic leukaemia (CLL) cells. We aimed to investigate the clinical effect of a single nucleotide polymorphism in the P2X7 receptor gene (1513A-->C) and correlate findings with the immunoglobulin heavy chain variable (V-H) gene mutation status, a prognostic marker in CLL. Methods We investigated tumour DNA in 170 patients with CLL using PCR-RFLP analysis with Hhal restriction enzyme cleavage to screen for the polymorphism in the P2X7 receptor gene. The V gene mutation status was assessed in 165 patients by PCR amplification and nucleotide sequencing. We correlated the findings of the P2X7 receptor genotype with the V-H gene mutation data and overall survival and screened for the P2X7 receptor polymorphism in 200 healthy controls. Findings Of the 170 patients, 35 (21%) were heterozygous and one (1%) homozygous for the 1513C allele; whereas 134 (79%) had the 1513A/A genotype of the P2X7 receptor gene. Overall survival was significantly longer for patients with CLL heterozygous for the 1513C allele than those with the 1513A/A genotype. Median survival for heterozygous patients was 104 months (range 33-467) and 72 months (1-190) for homozygous patients (p=0.009). Of the 165 patients with CLL in whom we assessed the V-H gene mutation status, the V-H genes were mutated in 71 (43%) patients and unmutated in 94; 18 (25%) of the 71 patients with mutated genes had 1513C allele compared with 17 (18%) of 94 who had unmutated genes. In patients with mutated V-H genes, those with CLL who were 1513C positive had 53 months' longer median survival than did those with the 1513A/A genotype (151 vs 98 months, p=0.011). Interpretation The P2X7 polymorphism could affect clinical outcome in CLL, especially in patients with mutated V-H genes. Studies are necessary to elucidate the biological role of the P2X7 polymorphism in CLL in vivo.	Univ Uppsala, Dept Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; Univ Uppsala, Dept Oncol, S-75185 Uppsala, Sweden; Univ Uppsala, Dept Radiol, S-75185 Uppsala, Sweden; Univ Uppsala, Dept Clin Immunol, S-75185 Uppsala, Sweden; Karolinska Inst, Ctr Mol Med, Dept Med, Rheumatol Unit, Stockholm, Sweden; Umea Univ, Dept Med Biosci, S-90187 Umea, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet; Umea University	Rosenquist, R (corresponding author), Univ Uppsala, Dept Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden.		Söderberg, Ola/O-5130-2017; Padyukov, Leonid/A-4890-2009	Söderberg, Ola/0000-0003-2883-1925; Padyukov, Leonid/0000-0003-2950-5670; Rosenquist, Richard/0000-0002-0211-8788; Klareskog, Lars/0000-0001-9601-6186				Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Bange J, 2002, CANCER RES, V62, P840; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Hamblin TJ, 2002, BLOOD, V99, P1023, DOI 10.1182/blood.V99.3.1023; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Jaffe ES, 2001, WHO CLASSIFICATION T; Krajinovic M, 2002, LANCET, V359, P1033, DOI 10.1016/S0140-6736(02)08065-0; Krober A, 2002, BLOOD, V100, P1410, DOI 10.1182/blood.V100.4.1410.h81602001410_1410_1416; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li AH, 1999, EUR J HAEMATOL, V63, P211; MATUTES E, 1994, LEUKEMIA, V8, P1640; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Shahbazi M, 2002, LANCET, V359, P397, DOI 10.1016/S0140-6736(02)07600-6; Thunberg U, 2001, BLOOD, V97, P1892, DOI 10.1182/blood.V97.6.1892; Tobin G, 2002, BLOOD, V99, P2262, DOI 10.1182/blood.V99.6.2262; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; Wiley JS, 1998, AM J PHYSIOL-CELL PH, V275, pC1224, DOI 10.1152/ajpcell.1998.275.5.C1224	24	78	80	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1935	1939		10.1016/S0140-6736(02)11917-9	http://dx.doi.org/10.1016/S0140-6736(02)11917-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493261				2022-12-28	WOS:000179870200013
J	Colegrave, N				Colegrave, N			Sex releases the speed limit on evolution	NATURE			English	Article							TERM EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; RECOMBINATION; SELECTION; ADAPTATION	Explaining the evolutionary maintenance of sex remains a key problem in evolutionary biology(1-3). One potential benefit of sex is that it may allow a more rapid adaptive response when environmental conditions change, by increasing the efficiency with which selection can fix beneficial mutations(4-7). Here I show that sex can increase the rate of adaptation in the facultatively sexual single-celled chlorophyte Chlamydomonas reinhardtii, but that the benefits of sex depend crucially on the size of the population that is adapting: sex has a marked effect in large populations but little effect in small populations. Several mechanisms have been proposed to explain the benefits of sex in a novel environment, including stochastic effects in small populations, clonal interference and epistasis between beneficial alleles. These results indicate that clonal interference is important in this system.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Colegrave, N (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		Colegrave, Nick/F-3916-2010					Bell G., 1982, MASTERPIECE NATURE; Burt A, 2000, EVOLUTION, V54, P337; Colegrave N, 2002, EVOLUTION, V56, P14; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Fisher, 1958, GENETICAL THEORY NAT; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Goho S, 2000, P ROY SOC B-BIOL SCI, V267, P123, DOI 10.1098/rspb.2000.0976; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; MAYNARD SMITH J., 1978, EVOLUTION SEX; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Otto SP, 1997, GENETICS, V147, P879; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; West SA, 1999, J EVOLUTION BIOL, V12, P1003	15	185	189	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					664	666		10.1038/nature01191	http://dx.doi.org/10.1038/nature01191			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478292	Green Published			2022-12-28	WOS:000179751800044
J	Kinley, H; Czoski-Murray, C; George, S; McCabe, C; Primrose, J; Reilly, C; Wood, R; Nicolson, P; Healy, C; Read, S; Norman, J; Janke, E; Alhameed, H; Fernandes, N; Thomas, E				Kinley, H; Czoski-Murray, C; George, S; McCabe, C; Primrose, J; Reilly, C; Wood, R; Nicolson, P; Healy, C; Read, S; Norman, J; Janke, E; Alhameed, H; Fernandes, N; Thomas, E		OpCheck Study Grp	Effectiveness of appropriately trained nurses in preoperative assessment: randomised controlled equivalence/non-inferiority trial	BRITISH MEDICAL JOURNAL			English	Article							PREADMISSION	Objective To determine whether preoperative assessments carried out by appropriately trained nurses are inferior in quality to those carried out by preregistration house officers. Design Randomised controlled equivalence/non-inferiority trial. Setting Four NHS hospitals in three trusts. Three of the four were teaching hospitals. Participants All patients attending for assessment before general anaesthesia for general, vascular, urological, or breast surgery between April 1998 and March 1999. Intervention Assessment by one of three appropriately trained nurses or by one of several preregistration house officers. Main outcome measures History taken, physical examination, and investigations ordered. Measures evaluated by a specialist registrar in anaesthetics and placed in four categories: correct, overassessment, underassessment not affecting management, and underassessment possibly affecting management (primary outcome). Results 1907 patients were randomised, and 1874 completed the study; 926 were assessed by house officers and 948 by nurses. Overall 121/948 (13%) assessments carried out by nurses were judged to have possibly affected management compared with 138/926 (15%) of those performed by house officers. Nurses were judged to be non-inferior to house officers in assessment, although there was variation among them in terms of the quality of history taking. The house officers ordered considerably more unnecessary tests than the nurses (218/926 (24%) v 129/948 (14%). Conclusions There is no reason to inhibit the development of nurse led preoperative assessment provided that the nurses involved receive adequate training. However, house officers will continue to require experience in preoperative assessment.	Univ Southampton, Sch Med, Southampton Gen Hosp, Univ Surg, Southampton SO16 6YD, Hants, England; Univ Southampton, Sch Med, Hlth Care Res Unit, Southampton SO9 5NH, Hants, England; Univ Southampton, Sch Med, Shackleton Dept Anaesthesia, Southampton SO9 5NH, Hants, England; Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; Univ Sheffield, Sch Med, Div Clin Sci, Dept Anaesthesia,Royal Hallamshire Hosp, Sheffield S10 2RX, S Yorkshire, England; Univ Sheffield, No Gen Hosp, Sch Med, Div Clin Sci,Sect Surg, Sheffield S5 7AU, S Yorkshire, England; Univ Sheffield, Sch Nursing & Midwifery, Sheffield S3 7ND, S Yorkshire, England; Portsmouth Hlth Care NHS Trust, Portsmouth PO3 8LD, Hants, England	University of Southampton; University of Southampton; University of Southampton; University of Sheffield; University of Sheffield; Northern General Hospital; University of Sheffield; University of Sheffield; Portsmouth Hospitals NHS Trust	Primrose, J (corresponding author), Univ Southampton, Sch Med, Southampton Gen Hosp, Univ Surg, Southampton SO16 6YD, Hants, England.			Primrose, John/0000-0002-2069-7605; Czoski Murray, Carolyn/0000-0001-7742-2883				*AM SOC AN, 1987, BAS STAND PREAN CAR; CALMAN K, 1993, HOSP DOCTORS TRAININ; Collins K, 2000, J Nurs Manag, V8, P3; GARDNER MJ, 1989, STAT CONFIDENCE CONF; Kirkpatrick S, 1984, AORN J, V40, P826, DOI 10.1016/S0001-2092(07)63545-5; Koay CB, 1996, ANN ROY COLL SURG, V78, P15; Machin D, 1997, SAMPLE SIZE TABLES C; MAKUCH R, 1978, CANCER TREAT REP, V62, P1037; *NHS MAN EX, 1991, JUN DOCT NEW DEAL; READ S, 1994, REDUCTION JUNIOR DOC; Reed M, 1997, J ROY COLL SURG EDIN, V42, P310; Richardson G., 1995, 135 U YORK CTR HLTH; RICHARDSON G, 1995, 135 U YORK CTR REV D; *UK GEN MED COUNC, 1995, NEW DOCT; Whiteley MS, 1997, ANN ROY COLL SURG, V79, P257	15	40	41	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2002	325	7376					1323	1326		10.1136/bmj.325.7376.1323	http://dx.doi.org/10.1136/bmj.325.7376.1323			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468478	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000179817100015
J	Woywodt, A; Merkel, S; Buth, W; Haller, H; Schwarz, A				Woywodt, A; Merkel, S; Buth, W; Haller, H; Schwarz, A			A swollen neck	LANCET			English	Article									Hannover Med Sch, Dept Med, Med Intens Care Unit, Div Nephrol, D-30625 Hannover, Germany	Hannover Medical School	Woywodt, A (corresponding author), Hannover Med Sch, Dept Med, Med Intens Care Unit, Div Nephrol, Carl Neuberg Str 1, D-30625 Hannover, Germany.		Woywodt, Alexander/ABD-2711-2020	Woywodt, Alexander/0000-0002-3825-6955				HAGELSKJAER KJ, 2000, CLIN INFECT DIS, V31, P524; Hagelskjaer LH, 1998, EUR J CLIN MICROBIOL, V17, P561, DOI 10.1007/BF01708619; Lemierre A, 1936, LANCET, V1, P701; MAALIKJY AN, 2001, NEUROL SCI, V22, P403; SINAVE CP, 1989, MEDICINE, V68, P85, DOI 10.1097/00005792-198903000-00002	5	3	3	1	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1838	1838		10.1016/S0140-6736(02)11773-9	http://dx.doi.org/10.1016/S0140-6736(02)11773-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480362				2022-12-28	WOS:000179706100012
J	Johnson, GL; Lapadat, R				Johnson, GL; Lapadat, R			Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases	SCIENCE			English	Article								Multicellular organisms have three well-characterized subfamilies of mitogen-activated protein kinases (MAPKs) that control a vast array of physiological processes. These enzymes are regulated by a characteristic phosphorelay system in which a series of three protein kinases phosphorylate and activate one another. The extracellular signal-regulated kinases (ERKs) function in the control of cell division, and inhibitors of these enzymes are being explored as anticancer agents. The c-Jun amino-terminal kinases (JNKs) are critical regulators of transcription, and JNK inhibitors may be effective in control of rheumatoid arthritis. The p38 MAPKs are activated by inflammatory cytokines and environmental stresses and may contribute to diseases like asthma and autoimmunity.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Johnson, GL (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA.			Lapadat, Razvan/0000-0002-3120-5506				Abe MK, 1999, MOL CELL BIOL, V19, P1301; English JM, 2002, TRENDS PHARMACOL SCI, V23, P40, DOI 10.1016/S0165-6147(00)01865-4; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; JOHNSON GL, 2002, SCI STKE; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	11	3269	3545	21	557	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1911	1912		10.1126/science.1072682	http://dx.doi.org/10.1126/science.1072682			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471242				2022-12-28	WOS:000179629200029
J	Sagata, N				Sagata, N			Untangling checkpoints	SCIENCE			English	Editorial Material							DNA-DAMAGE; REPLICATION CHECKPOINT; CDC25; CHK1; PATHWAY; ATR		Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan	Kyushu University	Sagata, N (corresponding author), Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan.							Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Eckstein J., 1997, BIOCHIM BIOPHYS ACTA, V1332, P53; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Liu QH, 2000, GENE DEV, V14, P1448; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Oe T, 2001, DEV BIOL, V229, P250, DOI 10.1006/dbio.2000.9968; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Walworth NC, 2001, CURR OPIN GENET DEV, V11, P78, DOI 10.1016/S0959-437X(00)00160-X; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	15	15	16	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1905	+		10.1126/science.1079225	http://dx.doi.org/10.1126/science.1079225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471241				2022-12-28	WOS:000179629200028
J	Birgens, H				Birgens, H			Clinical errors	LANCET			English	Editorial Material									Univ Copenhagen, Herlev Hosp, Dept Haematol L, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Birgens, H (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Haematol L, DK-2730 Herlev, Denmark.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1775	1775		10.1016/S0140-6736(02)11670-9	http://dx.doi.org/10.1016/S0140-6736(02)11670-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480444				2022-12-28	WOS:000179636800028
J	Fromm, RE; Weltge, A; Varon, J				Fromm, RE; Weltge, A; Varon, J			Public use of automatic defibrillators: a bolt from the blue	LANCET			English	Editorial Material									Univ Texas, Hlth Sci Ctr, Dept Emergency Med, Houston, TX 77225 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Fromm, RE (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Emergency Med, Houston, TX 77225 USA.		Varon, Joseph/R-5198-2019; Varon, Joseph/T-9481-2019	Varon, Joseph/0000-0002-7622-9974				[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P123; Becker LB, 1991, AM J EMERG MED, V20, P335; Bigger JT, 2002, NEW ENGL J MED, V346, P931, DOI 10.1056/NEJMe020011; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; CUMMINS RO, 1984, ANN EMERG MED, V13, P798, DOI 10.1016/S0196-0644(84)80441-2; DIACK AW, 1979, MED INSTRUM, V13, P78; Fromm RE, 1997, RESUSCITATION, V33, P219, DOI 10.1016/S0300-9572(96)01036-2; WALTERS G, 1994, RESUSCITATION, V27, P39, DOI 10.1016/0300-9572(94)90020-5; 2000, CIRCULATION S1, V102, P60	9	0	0	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1712	1712		10.1016/S0140-6736(02)11724-7	http://dx.doi.org/10.1016/S0140-6736(02)11724-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480420				2022-12-28	WOS:000179636800004
J	Abbott, A				Abbott, A			CERN collider project back on track	NATURE			English	News Item																		2001, NATURE, V413, P441	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					721	721		10.1038/420721b	http://dx.doi.org/10.1038/420721b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490894	Bronze			2022-12-28	WOS:000179897300004
J	Harrison, R				Harrison, R			Revalidation: the real life OSCE	BRITISH MEDICAL JOURNAL			English	Article								Consultants love a good OSCE, and if objective structured clinical examinations are good enough for assessing medical students then they should be good enough for assessing consultants, although they must reflect a typical working day. The OSCE outlined here is designed for the revalidation of middle aged, mate doctors, but it can easily be adjusted for age, sex, and specialty.	Univ Hosp N Tees, Stockton On Tees TS19 8PE, England	University Hospital of North Tees	Harrison, R (corresponding author), Univ Hosp N Tees, Stockton On Tees TS19 8PE, England.								0	2	2	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1454	1456		10.1136/bmj.325.7378.1454	http://dx.doi.org/10.1136/bmj.325.7378.1454			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493666	Green Published			2022-12-28	WOS:000180188600018
J	Southall, DP; O'Hare, BAM				Southall, DP; O'Hare, BAM			Empty arms: the effect of the arms trade on mothers and children	BRITISH MEDICAL JOURNAL			English	Article								Trading in arms, both legal and illegal, is highly detrimental to the health of mothers and children in the countries where armed conflict occurs. But do the powerful arms trading countries want to address the problems they are causing?.	Child Advocacy Int, Newcastle Under Lyme ST5 1ND, Staffs, England		Southall, DP (corresponding author), Child Advocacy Int, Newcastle Under Lyme ST5 1ND, Staffs, England.			O'Hare, Bernadette/0000-0003-1730-7941				AANDSTAD SA, 2002, SMALL ARMS DATABASE; *AMN INT, 2001, TERR TRAD TIM ARMS F; *AMN INT, 1999, FIR LIN WAR CHILDR R; Amnesty International, 1997, UG BREAK GODS COMM D; ANNAN K, 2002, SMALL ARMS SURVEY 20; ANNAN K, 2002, UN C ILL TRAD SMALL; ARIAS O, 1999, NY TIMES        0623; *ARMS TRANSF PROJ, 2002, SIPRI ARMS TRANSF PR; BACHELOR P, 2000, ARMS TRADE RESOURCE; BIGGS D, 2000, SMALL ARMS CONTROL N; Brett R., 1998, CHILDREN INVISIBLE S; *BUR INT RES, 1999, ARMS FLOWS CENTR AFR; *CAMP ARMS TRAD, 2001, ARMS TRAD INTR BRIEF; *CARN CORP NEW YOR, 1997, PREV DEAD CONFL EX S; *COAL STOP US CHIL, 1998, STOP US CHILD SOLD; *CONV ARMS BRANCH, 2002, SMALL ARMS LIGHT WEA; COOK R, 1997, GUARDIAN        0512; *DEF SEC COOP AG, 2002, EXC DEF ART; *FAO, 1996, NUTR IMP ARM CONFL C; *FED AM SCI, 2002, NOB LAUR INT COD CON; GEORGE S, 1988, FATE WORSE DEBT; GILSON D, 2002, UKRAINE CASHING ILLE; *GLOB WITN, ROL CO GOV ANG CONFL; *GOV PAK MIN FIN, 2002, EC SURV 2001 2002; *GRAD I INT STUD, 2002, SMALL ARMS SURV 2002, P173; *GRAD I INT STUD, 2002, SMALL ARMS SURV 2002; GREEN RH, 1994, WAR HUNGER; Grimmett R. F., 2001, CONVENTIONAL ARMS TR; HARTUNG WD, 2002, ARMS TRADE RESOURCE; HARTUNG WD, 2002, DEADLY LEGACY US ARM; *INT ACT NETW SMAL, 2002, FOUND DOC; *INT FED RED CROSS, 1997, WORLD DIS REP, P23; *INT REL SEC NETW, 2002, FACTS INT REL SEC TR; KLARE M, 1996, LIGHT WEAPONS INT SE, P1; KRUG E, 1999, WORLD REPORT VIOLENC; LOUISE C, 1994, SOC IMPACT LIGHT WEA; LUMPE L, 1998, ARMS TRADE REVEALED; Machel G., 1996, IMPACT ARMED CONFLIC; *MOZ NEWS AG, 1998, AIM REP WEAP DESTR; NORTONTAYLOR R, 2001, SPECIAL REPORT ARMS; OFCANSKY T, 2002, COMMUNICATION    MAY; *OXF RES GROUP SAF, 2001, SUBS TRAP; *OXFAM, 1997, SAF FUT RED HUM COST; *OXFAM, UK CONTR TRANSP ACC; PELEMAN J, 2002, COMMUNICATION    MAY; Plunkett MCB, 1998, ARCH DIS CHILD, V78, P72, DOI 10.1136/adc.78.1.72; RANA S, 1995, 34 UN I DIS RES; SOUTHALL D, 1995, INT CHILD HLTH, V6, P111; TAYLOR BS, 2002, SIPRI YB 2002 ARMAME; *UN HIGH COMM REF, 2001, ASYL SEEK REF OTH UN; *UN SEC COUNC, 2002, SMALL ARMS REP SECR; UNICEF, CONV RIGHTS CHILD; United Nations Children's Fund, 2000, STAT WORLDS CHILDR 2; United Nations High Commission for Refugees, 1997, STAT WORLDS REF HUM; *US GEN ASS, 2002, A55323 UN GEN ASS; *US MISS EUR UN, 1999, US EU STAT COMM PRIN; WALLENSTEEN P, 2001, UPPSALA CONFLICT DAT; *WHO UN UN POP FUN, 1995, MAT MORT STAT REG CO; 2002, SMALL ARMS BIG PROBL; 2002, STUDIES ENCOURAGE EC; US LAWS POLICIES REL	61	18	18	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1457	+		10.1136/bmj.325.7378.1457	http://dx.doi.org/10.1136/bmj.325.7378.1457			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493668	Green Published, Green Submitted			2022-12-28	WOS:000180188600020
J	Cobb, LA; Fahrenbruch, CE; Olsufka, M; Copass, MK				Cobb, LA; Fahrenbruch, CE; Olsufka, M; Copass, MK			Changing incidence,of out-of-hospital ventricular fibrillation. 1980-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; SUDDEN CARDIAC DEATH; ACUTE MYOCARDIAL-INFARCTION; UNITED-STATES; TRENDS; ARREST; DELAY; RESUSCITATION	Context Recent reports from 2 European cities and an earlier observation from Seattle, Wash, suggest that the number of patients treated for out-of-hospital ventricular fibrillation (VF) has declined. Objective To analyze the incidence of cardiac arrest and to examine relationships among incidence, sex, race, age, and first identified cardiac rhythm in Seattle. Design, Setting, and Patients Population-based study of all cardiac arrest cases with presumed cardiac etiology who received advanced life support from Seattle Fire Department emergency medical services during specified periods between 1979 and 2000 . United States Census data for Seattle in 1980, 1990, and 2000 were used to determine incidence rates for treated cardiac arrest with adjustments for age and sex. Main Outcome Measures Changes in incidence of cardiac arrest and initial recorded cardiac rhythm. Results The adjusted annual incidence of cardiac arrest with VF as the first identified rhythm decreased by about 56% from 1980 to 2000 (from 0.85 to 0.38 per 1000; relative risk [RR], 0.44; 95% confidence/interval [CI], 0.37-0.53). Similar reductions occurred in blacks (54%; RR, 0.45; 95% Cl, 0.26-0.79) and whites (53%; RR, 0.47; 95% Cl, 0.38-0.58) and was most evident in men (57%; RR, 0.43; 95% Cl, 0.35-0.53), in whom the baseline incidence was relatively high. When all treated arrests with presumed cardiac etiology were considered, that incidence decreased by 43% (RR, 0.58; 95 % Cl, 0.49-0.67) in men but negligibly in women, for whom a relatively low incidence of VF also declined but was offset by more cases with asystole or pulseless electrical activity. Conclusion We observed a major decline in the incidence of out-of-hospital VF and in all cases of treated cardiac arrest presumably due to heart disease in Seattle. These changes likely reflect the national decline in coronary heart disease mortality.	Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; Univ Washington, Dept Med, Seattle, WA USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cobb, LA (corresponding author), Univ Washington, Harborview Med Ctr, Box 359748,325 9th Ave, Seattle, WA 98104 USA.							Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; COBB LA, 1992, CIRCULATION, V85, P98; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; Cooper R, 2000, CIRCULATION, V102, P3137; Every NR, 1997, AM HEART J, V134, P1129, DOI 10.1016/S0002-8703(97)70035-8; Fox JP, 1970, EPIDEMIOLOGY MAN DIS; GILLUM RF, 1994, J AM COLL CARDIOL, V23, P1273, DOI 10.1016/0735-1097(94)90367-0; Goldberg RJ, 1999, ARCH INTERN MED, V159, P2141, DOI 10.1001/archinte.159.18.2141; Herlitz J, 2000, EUR HEART J, V21, P1251, DOI 10.1053/euhj.2000.2150; HO MT, 1989, ANN EMERG MED, V18, P727, DOI 10.1016/S0196-0644(89)80004-6; Iribarren C, 1998, AM J CARDIOL, V82, P50, DOI 10.1016/S0002-9149(98)00240-9; Kuisma M, 2001, LANCET, V358, P473, DOI 10.1016/S0140-6736(01)05634-3; Kurkciyan I, 2000, ARCH INTERN MED, V160, P1529, DOI 10.1001/archinte.160.10.1529; Kurkciyan I, 2001, RESUSCITATION, V51, P27, DOI 10.1016/S0300-9572(01)00381-1; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; SILFVAST T, 1991, J INTERN MED, V229, P331, DOI 10.1111/j.1365-2796.1991.tb00355.x; *SPSS INC, 2001, SPSS VERS 11 0 COMP; *US BUR CENS, 1990, 1990 CENS TRANSP PLA; *US BUR CENS, 1984, 1980 CENS POP SUBJ R; *US BUR CENS, 2000, CENS 2000 SUMM FIL 1, pCH8; US Census Bureau, 2001, QUEST ANSW CENS 2000; WEAVER WD, 1987, J AM COLL CARDIOL, V10, P1259, DOI 10.1016/S0735-1097(87)80128-6; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	24	469	500	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2002	288	23					3008	3013		10.1001/jama.288.23.3008	http://dx.doi.org/10.1001/jama.288.23.3008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CG	12479765	Bronze			2022-12-28	WOS:000179854200035
J	Wehrens, XHT; Vos, MA; Doevendans, PA; Wellens, HJJ				Wehrens, XHT; Vos, MA; Doevendans, PA; Wellens, HJJ			Novel insights in the congenital long QT syndrome	ANNALS OF INTERNAL MEDICINE			English	Review							TORSADE-DE-POINTES; ROMANO-WARD SYNDROME; Q-T INTERVAL; INHERITED CARDIAC-ARRHYTHMIA; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; LIFE-THREATENING ARRHYTHMIAS; LANGE-NIELSEN SYNDROME; VENTRICULAR REPOLARIZATION; NA+ CHANNEL; HEART-RATE	Background: The congenital long QT syndrome is a potentially fatal, inherited cardiac syndrome. Early diagnosis and preventive treatment are instrumental to prevent sudden cardiac death in patients with the congenital long QT syndrome. Purpose: To review new insights in genetics and cellular electrophysiology, as well as the current understanding of the clinical diagnosis and treatment of the congenital long QT syndrome. Data Sources: Authors' personal databases and search of PubMed database from 1966 to 2001. Study Selection: Experimental and clinical studies on the congenital long QT syndrome. Data Extraction: Data from peer-reviewed studies were manually extracted, classified, and summarized. Data Synthesis: The congenital long QT syndrome is characterized by abnormally prolonged ventricular repolarization, which predisposes patients to syncope, ventricular arrhythmias, and sudden cardiac death. The recent discovery of mutations in genes encoding ion channels has improved our understanding of the cellular origin of this condition. The congenital long QT syndrome may result from inherited defects in cardiac K+ and Na+ channels, which both result in prolongation of the ventricular action potential. The diagnosis is based on electrocardiographic and clinical criteria. Genetic screening of symptomatic patients or asymptomatic family members may identify patients at risk for life-threatening ventricular arrhythmias. beta-Blocking agents are the mainstay of treatment. Certain patients may also benefit from a pacemaker or implantable cardioverter defibrillator. Recent studies suggest that genotype-specific treatment of the congenital long QT syndrome will be feasible in the near future. Conclusions: The congenital long QT syndrome is a potentially life-threatening condition caused by mutations in genes encoding cardiac ion channels. Better understanding of the mechanisms responsible for this condition will guide genotype-specific therapy in the near future.	Univ Hosp Maastricht, Dept Cardiol, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Vos, MA (corresponding author), Univ Hosp Maastricht, Dept Cardiol, POB 5800, NL-6202 AZ Maastricht, Netherlands.	m.vos@cardio.azm.nl	Wehrens, Xander/AAQ-9574-2020	Wehrens, Xander/0000-0001-5044-672X				Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abriel H, 2001, CIRC RES, V88, P740, DOI 10.1161/hh0701.089668; Ackerman MJ, 1998, MAYO CLIN PROC, V73, P250, DOI 10.4065/73.3.250; Ackerman MJ, 1999, MAYO CLIN PROC, V74, P1088, DOI 10.4065/74.11.1088; Ali RHH, 2000, AM J CARDIOL, V85, P457, DOI 10.1016/S0002-9149(99)90772-5; An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; Atiga WL, 1998, J CARDIOVASC ELECTR, V9, P899, DOI 10.1111/j.1540-8167.1998.tb00130.x; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BARLOW JB, 1964, LANCET, V2, P531; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; BENHORIN J, 1990, CIRCULATION, V82, P521, DOI 10.1161/01.CIR.82.2.521; Benhorin J, 2000, CIRCULATION, V101, P1698; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; BHANDARI AK, 1985, CIRCULATION, V71, P63, DOI 10.1161/01.CIR.71.1.63; BRACHMANN J, 1983, CIRCULATION, V68, P846, DOI 10.1161/01.CIR.68.4.846; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Choy AM, 1997, CIRCULATION, V96, P2149; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Compton SJ, 1996, CIRCULATION, V94, P1018, DOI 10.1161/01.CIR.94.5.1018; COUMEL P, 1985, EUR HEART J, V6, P115, DOI 10.1093/eurheartj/6.suppl_D.115; COWAN JC, 1988, AM J CARDIOL, V61, P83, DOI 10.1016/0002-9149(88)91309-4; CRANEFIELD PF, 1988, PACE, V11, P670, DOI 10.1111/j.1540-8159.1988.tb06016.x; CURTISS EI, 1978, AM HEART J, V95, P420, DOI 10.1016/0002-8703(78)90232-6; DAVIGNON A, 1980, PEDIATR CARDIOL, V1, P123, DOI 10.1007/BF02083144; DAY CP, 1990, BRIT HEART J, V63, P342; de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276; deJager T, 1996, J MED GENET, V33, P567, DOI 10.1136/jmg.33.7.567; Dessertenne F, 1966, Arch Mal Coeur Vaiss, V59, P263; DISEGNI E, 1980, J ELECTROCARDIOL, V13, P189, DOI 10.1016/S0022-0736(80)80053-7; DOEVENDANS PA, 2001, CARDIOVASCULAR GENET; Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Dorostkar PC, 1999, CIRCULATION, V100, P2431, DOI 10.1161/01.CIR.100.24.2431; Dumaine R, 1996, CIRC RES, V78, P916, DOI 10.1161/01.RES.78.5.916; EGGELING T, 1992, CARDIOLOGY, V81, P107, DOI 10.1159/000175784; ELDAR M, 1987, J AM COLL CARDIOL, V10, P600, DOI 10.1016/S0735-1097(87)80203-6; GARSON A, 1993, AM J CARDIOL, V72, pB14, DOI 10.1016/0002-9149(93)90034-A; GARZA LA, 1970, CIRCULATION, V41, P39, DOI 10.1161/01.CIR.41.1.39; Geelen JLMC, 1998, EUR HEART J, V19, P1427, DOI 10.1053/euhj.1998.0873; Gorgels APM, 1998, J CARDIOVASC ELECTR, V9, P1225, DOI 10.1111/j.1540-8167.1998.tb00096.x; Groh WJ, 1996, AM J CARDIOL, V78, P703, DOI 10.1016/S0002-9149(96)00403-3; GRUBB BP, 1991, CHEST, V100, P1724, DOI 10.1378/chest.100.6.1724; HASHIBA K, 1978, JPN CIRC J, V42, P1133, DOI 10.1253/jcj.42.1133; HIEJIMA K, 1981, CHEST, V79, P446, DOI 10.1378/chest.79.4.446; HIEJIMA K, 1976, BRIT HEART J, V38, P767; HII JTY, 1992, CIRCULATION, V86, P1376, DOI 10.1161/01.CIR.86.5.1376; JACKMAN WM, 1988, PROG CARDIOVASC DIS, V31, P115, DOI 10.1016/0033-0620(88)90014-X; JAMES TN, 1967, AM J CARDIOL, V19, P627, DOI 10.1016/0002-9149(67)90467-5; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; JIANG CA, 1994, NAT GENET, V8, P141, DOI 10.1038/ng1094-141; JOHANSSON BW, 1972, BRIT HEART J, V34, P744; Kass RS, 1997, CIRCULATION, V96, P1720; KEATING M, 1991, AM J HUM GENET, V49, P1335; KEATING M, 1991, SCIENCE, V252, P704, DOI 10.1126/science.1673802; Kubota T, 2000, J CARDIOVASC ELECTR, V11, P1048, DOI 10.1111/j.1540-8167.2000.tb00178.x; KUGLER JD, 1991, AM HEART J, V121, P1132, DOI 10.1016/0002-8703(91)90673-6; LEHMANN MH, 1994, J AM COLL CARDIOL, V24, P746, DOI 10.1016/0735-1097(94)90024-8; Lehmann MH, 1997, J AM COLL CARDIOL, V29, P93, DOI 10.1016/S0735-1097(96)00454-8; Lehmann MH, 1996, CIRCULATION, V94, P2535, DOI 10.1161/01.CIR.94.10.2535; LINKER NJ, 1992, AM J CARDIOL, V69, P634, DOI 10.1016/0002-9149(92)90155-R; Locati EH, 1998, CIRCULATION, V97, P2237, DOI 10.1161/01.CIR.97.22.2237; MALFATTO G, 1994, J AM COLL CARDIOL, V23, P296, DOI 10.1016/0735-1097(94)90410-3; Malik M, 2000, J CARDIOVASC ELECTR, V11, P835, DOI 10.1111/j.1540-8167.2000.tb00061.x; Maron BJ, 1998, CIRCULATION, V98, P1460, DOI 10.1161/01.CIR.98.14.1460; MEDINARAVELL V, 1983, PACE, V6, P333, DOI 10.1111/j.1540-8159.1983.tb04370.x; MERRI M, 1992, CIRCULATION, V85, P1816, DOI 10.1161/01.CIR.85.5.1816; MERRI M, 1989, CIRCULATION, V80, P1301, DOI 10.1161/01.CIR.80.5.1301; Molnar J, 1996, J AM COLL CARDIOL, V27, P76, DOI 10.1016/0735-1097(95)00426-2; MORGANROTH J, 1993, AM J CARDIOL, V72, pB26, DOI 10.1016/0002-9149(93)90037-D; Moss AJ, 1999, AM J CARDIOL, V84, P876, DOI 10.1016/S0002-9149(99)00458-0; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; MOSS AJ, 1995, CIRCULATION, V92, P2929, DOI 10.1161/01.CIR.92.10.2929; NAKAJIMA T, 1995, JPN CIRC J, V59, P241, DOI 10.1253/jcj.59.241; Napolitano C, 2000, J CARDIOVASC ELECTR, V11, P691, DOI 10.1111/j.1540-8167.2000.tb00033.x; NEARING BD, 1991, SCIENCE, V252, P437, DOI 10.1126/science.2017682; Pham TV, 2001, CIRCULATION, V103, P2207; PHILLIPS J, 1970, CHEST, V58, P236, DOI 10.1378/chest.58.3.236; Piippo K, 2001, AM J CARDIOL, V87, P909, DOI 10.1016/S0002-9149(00)01538-1; Priori SG, 2000, CIRCULATION, V102, P945, DOI 10.1161/01.CIR.102.9.945; Priori SG, 1999, CIRCULATION, V99, P518, DOI 10.1161/01.CIR.99.4.518; PRIORI SG, 1994, CIRCULATION, V89, P1681, DOI 10.1161/01.CIR.89.4.1681; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; Priori SG, 1998, CIRCULATION, V97, P2420, DOI 10.1161/01.CIR.97.24.2420; Rashba EJ, 1998, CIRCULATION, V97, P451; RATSHIN RA, 1971, ANN INTERN MED, V75, P919, DOI 10.7326/0003-4819-75-6-919; RAUTAHARJU PM, 1992, CAN J CARDIOL, V8, P690; Roden DM, 2000, J CARDIOVASC ELECTR, V11, P938, DOI 10.1111/j.1540-8167.2000.tb00077.x; Roden DM, 1998, AM J CARDIOL, V82, p49I, DOI 10.1016/S0002-9149(98)00472-X; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; ROMANO C, 1963, Clin Pediatr (Bologna), V45, P656; ROSERO SZ, 1997, ANN NONINVAS ELECTRO, V2, P274, DOI DOI 10.1111/j.1542-474X.1997.tb00336.x; ROY PR, 1976, AM J CARDIOL, V37, P237, DOI 10.1016/0002-9149(76)90318-0; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SANGUINETTI MC, 1992, PFLUG ARCH EUR J PHY, V420, P180, DOI 10.1007/BF00374988; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; SCHOTT JJ, 1995, AM J HUM GENET, V57, P1114; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; SchulzeBahr E, 1997, HUM GENET, V100, P573, DOI 10.1007/s004390050554; SCHWARTZ PJ, 1975, AM HEART J, V89, P378, DOI 10.1016/0002-8703(75)90089-7; SCHWARTZ PJ, 1985, EUR HEART J, V6, P103, DOI 10.1093/eurheartj/6.suppl_D.103; SCHWARTZ PJ, 1995, CIRCULATION, V92, P3381, DOI 10.1161/01.CIR.92.12.3381; Schwartz PJ, 2001, CIRCULATION, V103, P89; SCHWARTZ PJ, 1983, EUR HEART J, V4, P529, DOI 10.1093/oxfordjournals.eurheartj.a061517; SCHWARTZ PJ, 1982, J CARDIOVASC MED, V7, P1317; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; SCHWARTZ PJ, 1975, AM HEART J, V89, P45, DOI 10.1016/0002-8703(75)90008-3; SCHWARTZ PJ, 1985, AM HEART J, V109, P399, DOI 10.1016/0002-8703(85)90626-X; SCHWARTZ PJ, 1997, LONG QT SYNDROME; SCHWARTZ PJ, 1995, CARDIAC ELECTROPHYSI, V5, P778; SCHWARTZ SP, 1950, AM HEART J, V39, P361, DOI 10.1016/0002-8703(50)90336-X; SCOTT WA, 1987, AM J CARDIOL, V60, P1409, DOI 10.1016/0002-9149(87)90634-5; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Shimizu W, 1998, CIRCULATION, V97, P1581, DOI 10.1161/01.CIR.97.16.1581; Shimizu W, 1998, CIRCULATION, V98, P2314, DOI 10.1161/01.CIR.98.21.2314; SHIMIZU W, 1991, PACE, V14, P1966, DOI 10.1111/j.1540-8159.1991.tb02799.x; Sicouri S, 1997, J CARDIOVASC ELECTR, V8, P1280, DOI 10.1111/j.1540-8167.1997.tb01019.x; SILKA MJ, 1993, CIRCULATION, V87, P800, DOI 10.1161/01.CIR.87.3.800; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; STRAMBABADIALE M, 1995, AM J CARDIOL, V75, P1277, DOI 10.1016/S0002-9149(99)80781-4; Swan H, 1999, J AM COLL CARDIOL, V34, P823, DOI 10.1016/S0735-1097(99)00255-7; SYLVEN JC, 1984, J ELECTROCARDIOL, V17, P179, DOI 10.1016/S0022-0736(84)81093-6; Tan HL, 1999, J CARDIOVASC ELECTR, V10, P229, DOI 10.1111/j.1540-8167.1999.tb00665.x; Tanabe S, 1999, AM J PHYSIOL-HEART C, V277, pH826, DOI 10.1152/ajpheart.1999.277.2.H826; van den Berg MP, 2001, J CARDIOVASC ELECTR, V12, P630; VASSALLO JA, 1988, CIRCULATION, V78, P1365, DOI 10.1161/01.CIR.78.6.1365; Vincent G M, 1999, Cardiol Rev, V7, P44, DOI 10.1097/00045415-199901000-00014; VINCENT GM, 1991, AM J CARDIOL, V68, P498, DOI 10.1016/0002-9149(91)90785-J; Vincent GM, 1998, ANNU REV MED, V49, P263; VINCENT GM, 1992, NEW ENGL J MED, V327, P846, DOI 10.1056/NEJM199209173271204; Vincent GM, 1999, CIRCULATION, V100, P245; VINCENT GM, 1986, AM HEART J, V112, P61, DOI 10.1016/0002-8703(86)90678-2; Viskin S, 1996, J AM COLL CARDIOL, V28, P1262, DOI 10.1016/S0735-1097(96)00311-7; Viskin S, 2000, J CARDIOVASC ELECTR, V11, P593, DOI 10.1111/j.1540-8167.2000.tb00015.x; Viswanathan PC, 1999, CARDIOVASC RES, V42, P530, DOI 10.1016/S0008-6363(99)00035-8; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; WARD O C, 1964, J Ir Med Assoc, V54, P103; Wehrens XHT, 2000, CIRCULATION, V102, P584; Wei J, 1999, CIRCULATION, V100, P495; Wellens, 1980, SUDDEN DEATH, P358; WELLENS HJJ, 1972, CIRCULATION, V46, P661, DOI 10.1161/01.CIR.46.4.661; WELLENS HJJ, 1975, CARDIAC ARRHYTHMIAS, P182; Wilde AAM, 2000, CIRCULATION, V102, P2796; Wilde AAM, 1999, J AM COLL CARDIOL, V33, P327, DOI 10.1016/S0735-1097(98)00578-6; WILMER CI, 1987, AM J CARDIOL, V59, P171, DOI 10.1016/S0002-9149(87)80098-X; Wilson FN, 1935, AM HEART J, V10, P46; Zareba W, 1998, NEW ENGL J MED, V339, P960, DOI 10.1056/NEJM199810013391404; Zhang L, 2000, CIRCULATION, V102, P2849	151	41	45	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2002	137	12					981	992		10.7326/0003-4819-137-12-200212170-00012	http://dx.doi.org/10.7326/0003-4819-137-12-200212170-00012			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626DR	12484714	Green Published, Green Submitted			2022-12-28	WOS:000179857500007
J	Nathan, C				Nathan, C			Catalytic antibody bridges innate and adaptive immunity	SCIENCE			English	Editorial Material							NITRIC-OXIDE SYNTHASE; MACROPHAGES; DISEASE		Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Grad Program Immunol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Grad Program Mol Biol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Nathan, C (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.				NIAID NIH HHS [AI46382] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046382] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; Ganz T, 1997, Curr Opin Hematol, V4, P53; Lambeth JD, 2002, CURR OPIN HEMATOL, V9, P11, DOI 10.1097/00062752-200201000-00003; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Van Deventer SJH, 2001, GASTROENTEROLOGY, V121, P1242; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2002, SCIENCE, V298, P2195, DOI 10.1126/science.1077642; Yoshimaru T, 2002, CLIN EXP ALLERGY, V32, P612, DOI 10.1046/j.0954-7894.2002.01263.x	12	25	28	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2143	2144		10.1126/science.1080005	http://dx.doi.org/10.1126/science.1080005			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481124				2022-12-28	WOS:000179773700033
J	Banavar, JR; Damuth, J; Maritan, A; Rinaldo, A				Banavar, JR; Damuth, J; Maritan, A; Rinaldo, A			Ontogenetic growth - Modelling universality and scaling	NATURE			English	Article									Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Scuola Int Super Studi Avanzati, I-34014 Trieste, Italy; INFM, I-34014 Trieste, Italy; Abdus Salam Int Ctr Theoret Phys, I-34014 Trieste, Italy; Univ Padua, Dipartimento Ingn Idraul Marittima & Geotecn, I-35100 Padua, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Santa Barbara; International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Abdus Salam International Centre for Theoretical Physics (ICTP); University of Padua	Banavar, JR (corresponding author), Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA.			Damuth, John/0000-0002-1635-9726; Maritan, Amos/0000-0002-3535-7873				VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076	2	45	45	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					626	626		10.1038/420626a	http://dx.doi.org/10.1038/420626a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478280				2022-12-28	WOS:000179751800032
J	Chelur, DS; Ernstrom, GG; Goodman, MB; Yao, CA; Chen, L; O'Hagan, R; Chalfie, M				Chelur, DS; Ernstrom, GG; Goodman, MB; Yao, CA; Chen, L; O'Hagan, R; Chalfie, M			The mechanosensory protein MEC-6 is a subunit of the C-elegans touch-cell degenerin channel	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; MEMBER; FAMILY; PARAOXONASE; UNC-8	Mechanosensory transduction in touch receptor neurons is believed to be mediated by DEG/ENaC (degenerin/epithelial Na+ channel) proteins in nematodes and mammals(1). In the nematode Caenorhabditis elegans, gain-of-function mutations in the degenerin genes mec-4 and mec-10 (denoted mec-4(d) and mec-10(d), respectively) cause degeneration of the touch cells(2,3). This phenotype is completely suppressed by mutation in a third gene, mec-6 (refs 3, 4), that is needed for touch sensitivity. This last gene is also required for the function of other degenerins(4-8). Here we show that mec-6 encodes a single-pass membrane-spanning protein with limited similarity to paraoxonases, which are implicated in human coronary heart disease(9). This gene is expressed in muscle cells and in many neurons, including the six touch receptor neurons. MEC-6 increases amiloride-sensitive Na+ currents produced by MEC-4(d)/MEC-10(d) by similar to30-fold, and functions synergistically with MEC-2 (a stomatin-like protein(10) that regulates MEC-4(d)/MEC-10(d) channel activity(11)) to increase the currents by 200-fold. MEC-6 physically interacts with all three channel proteins. In vivo, MEC-6 colocalizes with MEC-4, and is required for punctate MEC-4 expression along touch-neuron processes. We propose that MEC-6 is a part of the degenerin channel complex that may mediate mechanotransduction in touch cells.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Columbia University; Stanford University	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu	O'Hagan, Robert/AAE-9789-2020; Goodman, Miriam B./H-3036-2019	Goodman, Miriam B./0000-0002-5810-1272; O'Hagan, Robert/0000-0001-7580-1441	NIGMS NIH HHS [R37 GM030997] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030997] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; ERNSTROM GG, IN PRESS ANN REV GEN; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; SHREFFLER W, 1995, GENETICS, V139, P1261; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7	26	122	138	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					669	673		10.1038/nature01205	http://dx.doi.org/10.1038/nature01205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478294				2022-12-28	WOS:000179751800046
J	Etienne-Manneville, S; Hall, A				Etienne-Manneville, S; Hall, A			Rho GTPases in cell biology	NATURE			English	Review							STIMULATED GLUT4 TRANSLOCATION; ACTIN STRESS FIBERS; PROTEIN-KINASE; CDC42 GTPASES; RAC; POLARITY; ACTIVATION; GROWTH; PHAGOCYTOSIS; MIGRATION		UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Canc Res UK Incogene & Signaal Transduct Grp, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Hall, A (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	alan.hall@ucl.ac.uk	Etienne-Manneville, Sandrine/C-5879-2015	Etienne-Manneville, Sandrine/0000-0001-6651-3675				Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Bokoch GM, 2000, IMMUNOL RES, V21, P139, DOI 10.1385/IR:21:2-3:139; Brock J, 1996, J CELL BIOL, V135, P1097, DOI 10.1083/jcb.135.4.1097; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Cantrell D, 1998, CURR BIOL, V8, pR535, DOI 10.1016/S0960-9822(07)00341-7; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Caron E, 2000, CURR BIOL, V10, pR489, DOI 10.1016/S0960-9822(00)00555-8; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Glassford J, 2001, J BIOL CHEM, V276, P41040, DOI 10.1074/jbc.M105305200; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Gupta T, 2001, DEV CELL, V1, P443, DOI 10.1016/S1534-5807(01)00062-4; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Knust E, 1997, CURR BIOL, V7, pR558, DOI 10.1016/S0960-9822(06)00281-8; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Nobes C, 2000, CURR BIOL, V10, pR739, DOI 10.1016/S0960-9822(00)00736-3; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Ozdinler PH, 2001, J COMP NEUROL, V438, P377; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Pinxteren JA, 2000, BIOCHIMIE, V82, P385, DOI 10.1016/S0300-9084(00)00197-8; Pruyne D, 2000, J CELL SCI, V113, P365; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Raich WB, 1999, CURR BIOL, V9, P1139, DOI 10.1016/S0960-9822(00)80015-9; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Sakurada S, 2001, AM J PHYSIOL-CELL PH, V281, pC571, DOI 10.1152/ajpcell.2001.281.2.C571; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Stronach BE, 1999, ONCOGENE, V18, P6172, DOI 10.1038/sj.onc.1203125; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Wittmann T, 2001, J CELL SCI, V114, P3795; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Wong WT, 2000, J NEUROSCI, V20, P5024; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	77	3662	3819	9	370	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					629	635		10.1038/nature01148	http://dx.doi.org/10.1038/nature01148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478284				2022-12-28	WOS:000179751800036
J	Hunt, P				Hunt, P			The right to health: from the margins to the mainstream	LANCET			English	Editorial Material									Univ Essex, Human Rights Ctr, Colchester CO4 3SQ, Essex, England	University of Essex	Hunt, P (corresponding author), Univ Essex, Human Rights Ctr, Colchester CO4 3SQ, Essex, England.								0	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1878	1878		10.1016/S0140-6736(02)11778-8	http://dx.doi.org/10.1016/S0140-6736(02)11778-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480381				2022-12-28	WOS:000179706100031
J	Kuijpers, MWA; van Eck, D; Kemmere, MF; Keurentjes, JTF				Kuijpers, MWA; van Eck, D; Kemmere, MF; Keurentjes, JTF			Cavitation-induced reactions in high-pressure carbon dioxide	SCIENCE			English	Article							SONOLUMINESCENCE THRESHOLD; BUBBLE DYNAMICS; SONOCHEMISTRY; ULTRASOUND	The feasibility of ultrasound-induced in situ radical formation in liquid carbon dioxide was demonstrated. The required threshold pressure for cavitation could be exceeded at a relatively low acoustic intensity, as the high vapor pressure of CO2 counteracts the hydrostatic pressure. With the use of a dynamic bubble model, the formation of hot spots upon bubble collapse was predicted. Cavitation-induced radical formation was used for the polymerization of methyl methacrylate in CO2, yielding high-molecular-weight polymers. These results show that sonochemical reactions can be performed in dense-phase fluids, which allows the environmentally benign CO2 to replace conventional organic solvents in many reaction systems.	Eindhoven Univ Technol, Proc Dev Grp, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology	Keurentjes, JTF (corresponding author), Eindhoven Univ Technol, Proc Dev Grp, POB 513, NL-5600 MB Eindhoven, Netherlands.							Abraham M. A., 2002, CLEAN SOLVENTS ALTER, V819, DOI [10.1021/bk-2002-0819, DOI 10.1021/BK-2002-0819]; BERLAN J, 1994, ULTRASON SONOCHEM, V1, pS97, DOI 10.1016/1350-4177(94)90005-1; Didenko YT, 2002, NATURE, V418, P394, DOI 10.1038/nature00895; Goldfarb DL, 1998, J PHYS CHEM A, V102, P8888, DOI 10.1021/jp9815964; Hilgenfeldt S, 1998, J FLUID MECH, V365, P171, DOI 10.1017/S0022112098001207; JESSOP PG, 1999, CHEM SYNTHESIS USING; Kuijpers MWA, 2002, ULTRASONICS, V40, P675, DOI 10.1016/S0041-624X(02)00197-X; Leighton T.G., 1994, ACOUSTIC BUBBLE, DOI DOI 10.1121/1.410082; Lora M, 1999, FLUID PHASE EQUILIBR, V157, P285, DOI 10.1016/S0378-3812(99)00043-6; LORIMER JP, 1987, CHEM SOC REV, V16, P239, DOI 10.1039/cs9871600239; Luche J. L., 1998, SYNTHETIC ORGANIC SO; Price GJ, 1996, ULTRASON SONOCHEM, V3, pS229, DOI 10.1016/S1350-4177(96)00031-4; SHAFFER KA, 1995, TRENDS POLYM SCI, V3, P146; Singh D. P., 1992, Acoustics Letters, V15, P235; SUSLICK KS, 1989, SCI AM, V260, P80, DOI 10.1038/scientificamerican0289-80; SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439; Thompson LH, 1999, IND ENG CHEM RES, V38, P1215, DOI 10.1021/ie9804172; Yasui K, 1998, ULTRASONICS, V36, P575, DOI 10.1016/S0041-624X(97)00107-8; YASUI K, 1995, J ACOUST SOC AM, V98, P2772, DOI 10.1121/1.413242	19	90	99	7	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1969	1971		10.1126/science.1078022	http://dx.doi.org/10.1126/science.1078022			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471251				2022-12-28	WOS:000179629200038
J	Levine, JD; Funes, P; Dowse, HB; Hall, JC				Levine, JD; Funes, P; Dowse, HB; Hall, JC			Resetting the circadian clock by social experience in Drosophila melanogaster	SCIENCE			English	Article							MUTANT DROSOPHILA; COURTSHIP; OLFACTION; RHYTHMS; ENTRAINMENT; SYSTEM	Circadian clocks are influenced by social interactions in a variety of species, but little is known about the sensory mechanisms underlying these effects. We investigated whether social cues could reset circadian rhythms in Drosophila melanogaster by addressing two questions: Is there a social influence on circadian timing? If so, then how is that influence communicated? The experiments show that in a social context Drosophila transmit and receive cues that influence circadian time and that these cues are likely olfactory.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Icosyst Corp, Cambridge, MA 02138 USA; Univ Maine, Dept Math & Stat, Orono, ME 04469 USA; Univ Maine, Dept Biol Sci, Orono, ME 04469 USA	Brandeis University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Hall, JC (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-33205] Funding Source: Medline; NINDS NIH HHS [NS-44232] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; AVERHOFF WW, 1974, BEHAV GENET, V4, P207, DOI 10.1007/BF01074155; Batschelet E., 1981, CIRCULAR STAT BIOL; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; GAILEY DA, 1986, BEHAV GENET, V16, P375, DOI 10.1007/BF01071319; Hall JC, 1998, ADV GENET, V38, P135, DOI 10.1016/S0065-2660(08)60143-1; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; KAVALIERS M, 1980, BIOL BULL, V158, P69, DOI 10.2307/1540759; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; LEVINE JH, UNPUB; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; LILLY M, 1990, GENETICS, V124, P293; Moore-Ede MC., 1982, CLOCKS TIME US; MROSOVSKY N, 1988, J COMP PHYSIOL A, V162, P35, DOI 10.1007/BF01342701; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Saunders DS, 1982, INSECT CLOCKS; SHOREY HH, 1970, ANIM BEHAV, V18, P159, DOI 10.1016/0003-3472(70)90085-0; SIDDIQI O, 1987, TRENDS GENET, V3, P137, DOI 10.1016/0168-9525(87)90204-6; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Toma DP, 2000, P NATL ACAD SCI USA, V97, P6914, DOI 10.1073/pnas.97.12.6914; TOMPKINS L, 1980, J INSECT PHYSIOL, V26, P689, DOI 10.1016/0022-1910(80)90042-6; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135	25	179	179	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					2010	2012		10.1126/science.1076008	http://dx.doi.org/10.1126/science.1076008			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471264				2022-12-28	WOS:000179629200051
J	Khan, WA; Saha, D; Rahman, A; Salam, MA; Bogaerts, J; Bennish, ML				Khan, WA; Saha, D; Rahman, A; Salam, MA; Bogaerts, J; Bennish, ML			Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial	LANCET			English	Article							CIPROFLOXACIN; TETRACYCLINE; DOXYCYCLINE; SHIGELLOSIS; SUSPENSION; CHILDREN; FURAZOLIDONE; EFFICACY; ADULTS	Background Cholera is a major public-health problem, with children most affected. However, effective single-dose antimicrobial regimens have been identified only for adults. Our aim was to compare the efficacy of azithromycin and erythromycin regimens in the treatment of children. Methods We did a double-blind, randomised study of 128 severely dehydrated children (age 1-15 years) with cholera, treated at one of two treatment centres in Bangladesh in 1999. Children were assigned single-dose azithromycin (20 mg/kg bodyweight, maximum individual dose 1 g; n=65) or 12.5 mg/kg erythromycin (maximum dose 500 mg; n=63) every 6 h for 3 days. Patients stayed in hospital for 5 days. We measured fluid balance every 6 h, and obtained a rectal swab or stool sample for culture daily. Our primary outcome measures were clinical success of treatment-ie, cessation of watery diarrhoea within 48 hand bacteriological success-ie, absence of Vibrio cholerae 01 or 0139 from cultures of stool or rectal swab samples after study day 2. Analysis was per protocol. Findings Two children in both groups withdrew from the study, and we excluded one child in the erythromycin group. Treatment was clinically successful in 48 (76%) patients who received azithromycin and 39 (65%) who received erythromycin (difference 11%, 95% CI -5 to 27, p=0.244); and bacteriologically successful in 45 (71%) and 49 (82%) patients, respectively (10%, -5 to 25, p=0.261). Patients treated with azithromycin had a shorter duration of diarrhoea (median 24 h vs 42 h; difference 12 h, 0-18 h, p=0.019) and fewer episodes of vomiting (1 vs 4; difference 1 episode, 0-3 episodes, p=0.023). Interpretation Single-dose azithromycin is as effective for treatment of cholera in children as standard erythromycin therapy, but is associated with less vomiting.	Int Ctr Diarrhoeal Dis Res, Div Clin Sci, Ctr Hlth & Populat Res, Dhaka 1000, Bangladesh; Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; Tufts Univ, Sch Med, New England Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA; Univ Oxford, Nuffield Dept Clin Med, Oxford, England	International Centre for Diarrhoeal Disease Research (ICDDR); University of Kwazulu Natal; Tufts Medical Center; Tufts University; University of Oxford	Khan, WA (corresponding author), Int Ctr Diarrhoeal Dis Res, Div Clin Sci, Ctr Hlth & Populat Res, GPO Box 128, Dhaka 1000, Bangladesh.	wakhan@icddrb.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI001671] Funding Source: NIH RePORTER; NIAID NIH HHS [1 K24 AI/HDO01671] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALAM AN, 1990, BRIT MED J, V300, P1619, DOI 10.1136/bmj.300.6740.1619; BAILEY RL, 1993, LANCET, V342, P453, DOI 10.1016/0140-6736(93)91591-9; Bennish Michael L., 1994, P229; Bennish Michael L., 1995, P1499; Bonetta L, 2000, NAT MED, V6, P1069, DOI 10.1038/80367; Foulds G, 1996, J ANTIMICROB CHEMOTH, V37, P37, DOI 10.1093/jac/37.suppl_C.37; GREENOUGH WB, 1964, LANCET, V1, P355; ISLAM MR, 1987, GUT, V28, P1029, DOI 10.1136/gut.28.8.1029; Kabir I, 1996, J DIARRHOEAL DIS RES, V14, P243; KARCHMER A W, 1970, Bulletin of the World Health Organization, V43, P373; KHAN WA, 1995, T ROY SOC TROP MED H, V89, P103, DOI 10.1016/0035-9203(95)90675-4; Khan WA, 1996, LANCET, V348, P296, DOI 10.1016/S0140-6736(96)01180-4; Khan WA, 1997, ANN INTERN MED, V126, P697, DOI 10.7326/0003-4819-126-9-199705010-00004; LINDENBAUM J, 1967, B WORLD HEALTH ORGAN, V37, P529; LINDENBAUM J, 1966, LANCET, V1, P1066; MAKUCH RW, 1986, ARCH INTERN MED, V146, P986, DOI 10.1001/archinte.146.5.986; MARTIN DH, 1992, NEW ENGL J MED, V327, P921, DOI 10.1056/NEJM199209243271304; NAHATA MC, 1993, ANTIMICROB AGENTS CH, V37, P314, DOI 10.1128/AAC.37.2.314; RABBANI GH, 1989, ANTIMICROB AGENTS CH, V33, P1447, DOI 10.1128/AAC.33.9.1447; RABBANI GH, 1991, ANTIMICROB AGENTS CH, V35, P1864, DOI 10.1128/AAC.35.9.1864; Roy SK, 1998, T ROY SOC TROP MED H, V92, P460, DOI 10.1016/S0035-9203(98)91094-X; Ryan ET, 2000, AM J TROP MED HYG, V63, P12, DOI 10.4269/ajtmh.2000.63.12; SACK DA, 1978, ANTIMICROB AGENTS CH, V14, P462, DOI 10.1128/AAC.14.3.462; SALAM MA, 1988, J PEDIATR-US, V113, P901, DOI 10.1016/S0022-3476(88)80029-5; Salam MA, 1998, LANCET, V352, P522, DOI 10.1016/S0140-6736(97)11457-X; SIDDIQUE AK, 1995, LANCET, V345, P359, DOI 10.1016/S0140-6736(95)90344-5; SIMON HJ, 1970, APPL MICROBIOL, V19, P573, DOI 10.1128/AEM.19.4.573-579.1970; Treadway G, 1996, J ANTIMICROB CHEMOTH, V37, P143, DOI 10.1093/jac/37.suppl_C.143; *WHO, 1991, MAN PAT CHOL, P1; *WORLD BANK, 2002, DAT STAT; 2001, WKLY EPIDEMIOL REC, V76, P233	31	41	43	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2002	360	9347					1722	1727		10.1016/S0140-6736(02)11680-1	http://dx.doi.org/10.1016/S0140-6736(02)11680-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480424				2022-12-28	WOS:000179636800008
J	Sampson, B; Fagerhol, MK; Sunderkotter, C; Golden, BE; Richmond, P; Klein, N; Kovar, IZ; Beattie, JH; Wolska-Kusnierz, B; Saito, Y; Roth, J				Sampson, B; Fagerhol, MK; Sunderkotter, C; Golden, BE; Richmond, P; Klein, N; Kovar, IZ; Beattie, JH; Wolska-Kusnierz, B; Saito, Y; Roth, J			Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism	LANCET			English	Article							CALCIUM-BINDING PROTEINS; MYELOID DIFFERENTIATION; IMMUNE-RESPONSE; S100 PROTEIN; CALPROTECTIN; CELLS; PLASMA; FAMILY; MRP14; NEUTROPHILS	Background Calprotectin (complex of S100A8 and S100A9) is the major calcium and zinc-binding protein of phagocytes. We report a new syndrome with recurrent infections, inflammation, and hyperzincaemia associated with excessively high plasma concentrations of calprotectin. Methods We measured calprotectin in plasma and protein fractions by ELISA assay and zinc by atomic absorption spectrometry. Plasma proteins were fractionated by size exclusion chromatography and electrophoresis. Mass spectra of purified proteins were determined by MALDI-TOFMS. Findings We assessed five patients, two of whom are related. All patients had much the same biochemical findings of hyperzincaemia (77-200 mumol/L, reference range 11-18 mumol/L) and raised plasma calprotectin concentrations (1.4-6.5 g/L, reference range <1 mg/L). All patients presented with recurrent infections, hepatosplenomegaly, anaemia, and evidence of systemic inflammation. Three patients had cutaneous inflammation and three presented in infancy with severe growth failure. Size exclusion chromatography showed that zinc and calprotectin were associated in a broad fraction with molecular weight range 100-300 kDa. Analysis by electrophoresis and mass spectrometry showed that the patients' protein contained normal S100A8 and S100A9 subunits. Interpretation Dysregulation of zinc metabolism associated with accumulation in plasma of S100A8 and S100A9 defines a new disease, which encompasses a pathological role for dysregulation of two members of the large S100 protein family.	Charing Cross Hosp, Dept Clin Chem, London W6 8RF, England; Ullevaal Univ Hosp, Dept Immunol & Transfus Med, Oslo, Norway; Univ Munster, Dept Dermatol, D-4400 Munster, Germany; Univ Munster, Inst Expt Dermatol, D-4400 Munster, Germany; Univ Aberdeen, Dept Child Hlth, Aberdeen, Scotland; Inst Child Hlth, Immunobiol Unit, London, England; Chelsea & Westminster Hosp, Dept Paediat, London, England; Rowett Res Inst, Aberdeen, Scotland; Childrens Mem Hlth Inst, Dept Immunol, Warsaw, Poland; Tokyo Womens Med Univ, Dept Paediat, Tokyo, Japan	Imperial College London; University of Oslo; University of Munster; University of Munster; University of Aberdeen; University of London; University College London; Imperial College London; University of Aberdeen; Children's Memorial Health Institute; Tokyo Women's Medical University	Sampson, B (corresponding author), Charing Cross Hosp, Dept Clin Chem, London W6 8RF, England.		Richmond, Peter C/G-3379-2012	Richmond, Peter C/0000-0001-7562-7228; Wolska-Kusnierz, Beata/0000-0003-4863-4443; Fagerhol, Magne Kristoffer/0000-0002-5103-6981; Klein, Nigel/0000-0003-3925-9258; Sunderkotter, Cord/0000-0002-2929-145X				BRANDTZAEG P, 1987, AM J CLIN PATHOL, V87, P700, DOI 10.1093/ajcp/87.6.700; CHANDRA RK, 1984, JAMA-J AM MED ASSOC, V252, P1443, DOI 10.1001/jama.252.11.1443; Clohessy PA, 1996, J LEUKOCYTE BIOL, V60, P674, DOI 10.1002/jlb.60.5.674; DANKS DM, 1985, CLIN ENDOCRINOL META, V14, P591, DOI 10.1016/S0300-595X(85)80008-6; EVERSOLE LR, 1992, ARCH ORAL BIOL, V37, P963, DOI 10.1016/0003-9969(92)90068-J; FAILLA ML, 1982, J LAB CLIN MED, V100, P943; HAMBIDGE KM, 1985, J PEDIATR-US, V106, P450, DOI 10.1016/S0022-3476(85)80677-6; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Johne B., 1997, Molecular Pathology, V50, P113, DOI 10.1136/mp.50.3.113; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; LAGASSE E, 1988, MOL CELL BIOL, V8, P2402, DOI 10.1128/MCB.8.6.2402; Loomans HJ, 1998, J INFECT DIS, V177, P812, DOI 10.1086/517816; Mikami M, 1998, MICROBIOL IMMUNOL, V42, P211, DOI 10.1111/j.1348-0421.1998.tb02273.x; MYERS MA, 1984, J CLIN PATHOL, V37, P862, DOI 10.1136/jcp.37.8.862; Neves I, 1998, CLIN EXP IMMUNOL, V111, P264; Newton RA, 1998, J IMMUNOL, V160, P1427; PRASAD AS, 1978, JAMA-J AM MED ASSOC, V240, P2166, DOI 10.1001/jama.240.20.2166; Rammes A, 1997, J BIOL CHEM, V272, P9496; RICHMOND P, 1999, ARCH DIS CHILD, V80, pA67; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; ROTH J, 1993, BLOOD, V82, P1875; Saito Y, 2002, J PEDIATR-US, V140, P267, DOI 10.1067/mpd.2002.121699; Sampson B, 1997, PEDIATR RES, V42, P219, DOI 10.1203/00006450-199708000-00015; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SMITH JC, 1983, SCIENCE, V193, P496; Sohnle PG, 1997, REV MED MICROBIOL, V8, P217; Sorg C, 1992, Behring Inst Mitt, P126; Srikrishna G, 2001, J IMMUNOL, V166, P4678, DOI 10.4049/jimmunol.166.7.4678; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; Unoshima M, 2001, J LAB CLIN MED, V137, P28, DOI 10.1067/mlc.2001.111514; Vogl T, 1999, J AM SOC MASS SPECTR, V10, P1124; YUI S, 1995, J LEUKOCYTE BIOL, V58, P307, DOI 10.1002/jlb.58.3.307	32	93	97	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1742	1745		10.1016/S0140-6736(02)11683-7	http://dx.doi.org/10.1016/S0140-6736(02)11683-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480428				2022-12-28	WOS:000179636800012
J	Weiner, HL; Selkoe, DJ				Weiner, HL; Selkoe, DJ			Inflammation and therapeutic vaccination in CNS diseases	NATURE			English	Review							CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA-PEPTIDE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CD4(+) T-CELLS; MULTIPLE-SCLEROSIS; MOUSE MODEL; DNA VACCINATION; IFN-GAMMA; PROTEIN; INDUCTION	The spectrum of inflammatory diseases of the central nervous system has been steadily expanding from classical autoimmune disorders such as multiple sclerosis to far more diverse diseases. Evidence now suggests that syndromes such as Alzheimer's disease and stroke have important inflammatory and immune components and may be amenable to treatment by anti-inflammatory and immunotherapeutic approaches. The notion of 'vaccinating' individuals against a neurodegenerative disorder such as Alzheimer's disease is a marked departure from classical thinking about mechanism and treatment, and yet therapeutic vaccines for both Alzheimer's disease and multiple sclerosis have been validated in animal models and are in the clinic. Such approaches, however, have the potential to induce unwanted inflammatory responses as well as to provide benefit.	Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Weiner, HL (corresponding author), Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.							Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Balashov KE, 1997, P NATL ACAD SCI USA, V94, P599, DOI 10.1073/pnas.94.2.599; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Becker KJ, 1997, P NATL ACAD SCI USA, V94, P10873, DOI 10.1073/pnas.94.20.10873; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; CANNELLA B, 1995, ANN NEUROL, V37, P424, DOI 10.1002/ana.410370404; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Comabella M, 1998, J CLIN INVEST, V102, P671, DOI 10.1172/JCI3125; Cook S, 1996, HDB MULTIPLE SCLEROS, P97; Cooper NR, 2000, NEUROBIOL AGING, V21, P451, DOI 10.1016/S0197-4580(00)00148-2; Cuzner ML, 1996, J NEUROPATH EXP NEUR, V55, P1194, DOI 10.1097/00005072-199612000-00002; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Edan G, 1997, J NEUROL NEUROSUR PS, V62, P112, DOI 10.1136/jnnp.62.2.112; El Khoury J, 1998, NEUROBIOL AGING, V19, pS81, DOI 10.1016/S0197-4580(98)00036-0; FURLAN R, IN PRESS BRAIN; Garren H, 2001, IMMUNITY, V15, P15, DOI 10.1016/S1074-7613(01)00171-6; Gobbini MI, 1999, J NEUROIMMUNOL, V99, P142, DOI 10.1016/S0165-5728(99)00039-9; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Jansson M, 2002, J IMMUNOL, V168, P2096, DOI 10.4049/jimmunol.168.5.2096; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Karni A, 2002, J NEUROIMMUNOL, V125, P134, DOI 10.1016/S0165-5728(02)00018-8; Kumar Vipin, 2001, Trends in Immunology, V22, P539, DOI 10.1016/S1471-4906(01)02020-8; Lafaille JJ, 1997, J EXP MED, V186, P307, DOI 10.1084/jem.186.2.307; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; LININGTON C, 1992, J NEUROIMMUNOL, V40, P219, DOI 10.1016/0165-5728(92)90136-9; Makhlouf K, 2001, J NEUROIMMUNOL, V119, P145, DOI 10.1016/S0165-5728(01)00371-X; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Maron R, 1999, INT IMMUNOL, V11, P1573, DOI 10.1093/intimm/11.9.1573; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; MEDAER R, 1995, LANCET, V346, P807, DOI 10.1016/S0140-6736(95)91622-9; MILLER A, 1991, J EXP MED, V174, P791, DOI 10.1084/jem.174.4.791; Miller DH, 1998, BRAIN, V121, P3, DOI 10.1093/brain/121.1.3; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Monsonego A, 2001, P NATL ACAD SCI USA, V98, P10273, DOI 10.1073/pnas.191118298; MONSONEGO A, 2002, P 8 INT C ALZH DIS R; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Neuhaus O, 2001, NEUROLOGY, V56, P702, DOI 10.1212/WNL.56.6.702; OLSSON T, 1990, J CLIN INVEST, V86, P981, DOI 10.1172/JCI114800; PANITCH HS, 1987, LANCET, V1, P893; PRINEAS JW, 1996, HDB MULTIPLE SCLEROS, P223; ROMINE JS, 1983, MULT SCLER, P621; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SCHENK D, IN PRESS IMMUNIZATIO; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SIBLEY WA, 1985, LANCET, V1, P1313; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Trieb K, 1996, NEUROBIOL AGING, V17, P541; Vandenbark AA, 2001, NEUROCHEM RES, V26, P713, DOI 10.1023/A:1010951706830; Weiner HL, 1998, CAN J NEUROL SCI, V25, P93, DOI 10.1017/S0317167100033680; Weiner HL, 2002, MULT SCLER J, V8, P142, DOI 10.1191/1352458502ms790oa; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; Weiner HL, 2000, J NEUROIMMUNOL, V104, P164, DOI 10.1016/S0165-5728(99)00273-8; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; Weissert R, 2000, P NATL ACAD SCI USA, V97, P1689, DOI 10.1073/pnas.030390097; Wildbaum G, 2000, J CLIN INVEST, V106, P671, DOI 10.1172/JCI8759; Wildbaum G, 2002, J IMMUNOL, V168, P5885, DOI 10.4049/jimmunol.168.11.5885; WINDHAGEN A, 1995, J EXP MED, V182, P1985, DOI 10.1084/jem.182.6.1985; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; ZHANG JW, 1994, J EXP MED, V179, P973, DOI 10.1084/jem.179.3.973	67	197	249	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					879	884		10.1038/nature01325	http://dx.doi.org/10.1038/nature01325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490962				2022-12-28	WOS:000179897300070
J	Elliott, C; Brodwin, P				Elliott, C; Brodwin, P			Identity and genetic ancestry tracing	BRITISH MEDICAL JOURNAL			English	Article							SOUTHERN AFRICA; BLACK JEWS; ORIGINS; LEMBA	Tracing genetic identity can lead to resolution of uncertainty but can cause more problems than it solves. Will establishment of genetic identity be cohesive or divisive?.	Univ Minnesota, Ctr Bioeth, Minneapolis, MN 55455 USA; Univ Wisconsin, Dept Anthropol, Milwaukee, WI 53201 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Milwaukee	Elliott, C (corresponding author), Univ Minnesota, Ctr Bioeth, N504 Boynton,410 Church St SE, Minneapolis, MN 55455 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002196] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01-HG02196-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BALLOCH J, 2002, KNOXVILLE NEWS  0621, pA1; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; BRADMAN N, 1998, SCI SPECTRA, V14, P32; Brodwin P, 2002, ANTHROPOL QUART, V75, P323, DOI 10.1353/anq.2002.0027; Brown K, 2002, SCIENCE, V295, P1634, DOI 10.1126/science.295.5560.1634; Brownwell Margo S., 2000, U MICH J L REFORM, V34, P275; ELLIOTT C, IN PRESS WILSON Q; Foster EA, 1998, NATURE, V396, P27, DOI 10.1038/23835; GLABERSON W, 2001, NY TIMES        0621, pA1; JOHNSTON J, IN PRESS J LAW MED E; Price ET, 1951, GEOGR REV, V41, P256, DOI 10.2307/211022; REED JS, 1997, SO CULTURES, V3, P25; SAULNY S, 2002, NY TIMES        0226, pB1; Spurdle AB, 1996, AM J HUM GENET, V59, P1126; TALLBEAR K, 2002, WICAZO SA REV, V17, P2; Thomas MG, 2000, AM J HUM GENET, V66, P674, DOI 10.1086/302749; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; WRIGHT G, 2000, SEATTLE TIMES   0405; [No title captured]	19	44	45	2	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1469	1471		10.1136/bmj.325.7378.1469	http://dx.doi.org/10.1136/bmj.325.7378.1469			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493671	Green Published			2022-12-28	WOS:000180188600024
J	Winfree, AT				Winfree, AT			On emerging coherence	SCIENCE			English	Editorial Material									Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona								BASAR E, 1980, EEG BRAIN DYNAMICS, P176; GHOSH AK, 1971, ARCH BIOCHEM BIOPHYS, V145, P319, DOI 10.1016/0003-9861(71)90042-7; Glass L, 1988, CLOCKS CHAOS RHYTHMS; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; STROGATZ SH, UNPUB; TYSON J, 1978, J THEOR BIOL, V73, P723, DOI 10.1016/0022-5193(78)90133-9; Vanag VK, 2001, SCIENCE, V294, P835, DOI 10.1126/science.1064167; Wiesenfeld K, 1996, PHYS REV LETT, V76, P404, DOI 10.1103/PhysRevLett.76.404; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; WINFREE AT, 1966, PROGRESS REPORT; WINFREE AT, 2001, GEOMETRY BIOL TIME, P119	13	54	54	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2336	2337		10.1126/science.1072560	http://dx.doi.org/10.1126/science.1072560			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493899				2022-12-28	WOS:000179915900038
J	Mayanja, BN; Kambugu, FSK; Mbulaiteye, SM; Whitworth, JAG				Mayanja, BN; Kambugu, FSK; Mbulaiteye, SM; Whitworth, JAG			Chronic facial crusts	LANCET			English	Editorial Material									MRC, Uganda Virus Res Inst, Entebbe, Uganda; Mulago Hosp, Dermatol & Venereol Dept, Kampala, Uganda	Uganda Virus Research Institute; Mulago National Referral Hospital	Mayanja, BN (corresponding author), MRC, Uganda Virus Res Inst, POB 49, Entebbe, Uganda.		Mayanja, Billy/AAL-5087-2021; Mbulaiteye, Sam/O-3056-2019	Mbulaiteye, Sam/0000-0002-8273-9831				CANIZARES O, 1982, OTHER BACTERIAL INFE, P71; Favre E., 1998, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V99, P70; Jain S, 1998, Australas J Dermatol, V39, P183, DOI 10.1111/j.1440-0960.1998.tb01279.x; KIRBY JDT, 1994, CLIN MED, P1013; Orem J, 1998, E AFR MED J, V75, P436	5	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1940	1940		10.1016/S0140-6736(02)11918-0	http://dx.doi.org/10.1016/S0140-6736(02)11918-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493262				2022-12-28	WOS:000179870200014
J	Spiegel, P; Sheik, M; Gotway-Crawford, C; Salama, P				Spiegel, P; Sheik, M; Gotway-Crawford, C; Salama, P			Health programmes and policies associated with decreased mortality in displaced people in postemergency phase camps: a retrospective study	LANCET			English	Article							HUMANITARIAN RESPONSE; DEVELOPING-COUNTRIES; PUBLIC-HEALTH; REFUGEE CAMPS; EASTERN SUDAN; INTERVENTIONS; POPULATIONS; BANGLADESH; SANITATION	Background An estimated 35 million people have been displaced by complex humanitarian emergencies. International humanitarian organisations define policies and provide basic health and nutrition programmes to displaced people in postemergency phase camps. However, many policies and programmes are not based on supporting data. We aimed to identify associations between age-specific mortality and health indicators in displaced people in postemergency phase camps and to define the programme and policy implications of these data. Methods In 1998-2000, we obtained and analysed retrospective mortality data for the previous 3 months in 51 postemergency phase camps in seven countries. We did multivariate regression with 18 independent variables that affect crude mortality rates (CMRs) and mortality rates in children younger than 5 years (<5 MRs) in complex emergencies. We compared these results with recommended emergency phase minimum indicators. Findings Recently established camps had higher CMRs and <5 MRs and fewer local health workers per person than did camps that had been established earlier. Camps that were close to the border or region of conflict or had longer travel times to referral hospitals had higher CMRs than did those located further away or with shorter travel times, and camps with less water per person and high rates of diarrhoea had higher <5 MRs than did those with more water and lower rates of diarrhoea. Distance to border or area of conflict, water quantity, and the number of local health workers per person exceeded the minimum indicators recommended in the emergency phase. Interpretation Health and nutrition policies and programmes for displaced people in postemergency phase camps should be evidence-based. Programmes in complex emergencies should focus on indicators proven to be associated with mortality. Minimum indicators should be developed for programmes targeting displaced people in postemergency phase camps.	CDCP, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Atlanta, GA USA; CDCP, Off Director, Environm Hazards & Hlth Effects Div, Natl Ctr Environm Hlth, Atlanta, GA USA; Johns Hopkins Sch Hyg & Publ Hlth, Ctr Refugee & Disaster Studies, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Johns Hopkins University	Spiegel, P (corresponding author), DOS HCDS, Case Postale 2500,2 Depot, CH-1211 Geneva, Switzerland.	spiegel@unhcr.ch	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				Banatvala N, 2000, BMJ-BRIT MED J, V321, P101, DOI 10.1136/bmj.321.7253.101; Bartlett LA, 2002, LANCET, V359, P643, DOI 10.1016/S0140-6736(02)07808-X; Becker S, 1998, INT J EPIDEMIOL, V27, P814, DOI 10.1093/ije/27.5.814; BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; *CDCP, 2002, JAMA-J AM MED ASSOC, V287, P182; Cosgrave J, 1996, DISASTERS, V20, P261, DOI 10.1111/j.1467-7717.1996.tb01038.x; ESREY SA, 1986, EPIDEMIOL REV, V8, P117, DOI 10.1093/oxfordjournals.epirev.a036290; Garenne M, 1997, Afr J Reprod Health, V1, P14, DOI 10.2307/3583271; JACOBSEN K, 2000, REFUG SURV Q, V19, P3; MACARTHUR J, 2000, REFUGE, V18, P4; MERCER A, 1992, DISASTERS, V16, P28, DOI 10.1111/j.1467-7717.1992.tb00373.x; RAHMAN M, 1985, LANCET, V2, P28, DOI 10.1016/S0140-6736(85)90068-6; Robinson C., 2000, REFUGEE SURVEY Q, V19, P23; Ronald C, 1999, BMJ, V318; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P531, DOI 10.1001/jama.286.5.531; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; Spiegel P B, 2001, Prehosp Disaster Med, V16, P281; Spiegel PB, 2001, DISASTERS, V25, P172, DOI 10.1111/1467-7717.00169; *STEER COMM HUM RE, 1998, SPHER PROJ HUM CHART; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1988, J TROP PEDIATRICS, V34, P218, DOI 10.1093/tropej/34.5.218; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; UN. High Commission for Refugees, 1999, HDB EM; US Committee for Refugees, 2001, WORLD REF SURV 2001; Van Damme W, 1998, LANCET, V351, P1609, DOI 10.1016/S0140-6736(97)10348-8; Waldman R, 1999, AM J PUBLIC HEALTH, V89, P1483, DOI 10.2105/AJPH.89.10.1483; *WHO, 1999, WHO REC SURV STAND, P157	29	47	47	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2002	360	9349					1927	1934		10.1016/S0140-6736(02)11915-5	http://dx.doi.org/10.1016/S0140-6736(02)11915-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493259				2022-12-28	WOS:000179870200011
J	Bernasconi, NL; Traggiai, E; Lanzavecchia, A				Bernasconi, NL; Traggiai, E; Lanzavecchia, A			Maintenance of serological memory by polyclonal activation of human memory B cells	SCIENCE			English	Article							PLASMA-CELLS; IMMUNOLOGICAL MEMORY; HUMORAL IMMUNITY; BONE-MARROW; ANTIGEN; DIFFERENTIATION; LYMPHOCYTES	Production of antibodies can last for a lifetime, through mechanisms that remain poorly understood. Here, we show that human memory B lymphocytes proliferate and differentiate into plasma cells in response to polyclonal stimuli, such as bystander T cell help and CpG DNA. Furthermore, plasma cells secreting antibodies to recall antigens are produced in vivo at levels proportional to the frequency of specific memory B cells, even several years after antigenic stimulation. Although antigen boosting leads to a transient increase in specific antibody levels, ongoing polyclonal activation of memory B cells offers a means to maintain serological memory for a human lifetime.	Inst Biomed Res, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Lanzavecchia, A (corresponding author), Inst Biomed Res, Via Vela 6, CH-6500 Bellinzona, Switzerland.	lanzavecchia@irb.unisi.ch	traggiai, elisabetta/A-2316-2009					Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BERNASCONI NL, UNPUB; CELADA F, 1967, J EXP MED, V125, P199, DOI 10.1084/jem.125.2.199; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; LANZAVECCHIA A, 1983, EUR J IMMUNOL, V13, P820, DOI 10.1002/eji.1830131008; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2002, CURR OPIN IMMUNOL, V14, P517, DOI 10.1016/S0952-7915(02)00356-4; Manz RA, 2002, EUR J IMMUNOL, V32, P923, DOI 10.1002/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; O'Connor BP, 2002, J EXP MED, V195, P737, DOI 10.1084/jem.20011626; Ochsenbein AF, 2000, P NATL ACAD SCI USA, V97, P13263, DOI 10.1073/pnas.230417497; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Paramithiotis E, 1997, P NATL ACAD SCI USA, V94, P208, DOI 10.1073/pnas.94.1.208; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Uhr J W, 1968, Adv Immunol, V8, P81, DOI 10.1016/S0065-2776(08)60465-4; Zinkernagel RM, 2002, CURR OPIN IMMUNOL, V14, P523, DOI 10.1016/S0952-7915(02)00367-9	28	1005	1062	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2199	2202		10.1126/science.1076071	http://dx.doi.org/10.1126/science.1076071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481138				2022-12-28	WOS:000179773700050
J	Shaye, DD; Greenwald, I				Shaye, DD; Greenwald, I			Endocytosis-mediated downregulation of LIN-12/Notch upon Ras activation in Caenorhabditis elegans	NATURE			English	Article							CELL FATE DECISIONS; C-ELEGANS; NEGATIVE REGULATOR; RECEPTOR; EXPRESSION; DROSOPHILA; NOTCH; DELTA; GENE; INDUCTION	The coordination of signals from different pathways is important for cell fate specification during animal development. Here, we define a novel mode of crosstalk between the epidermal growth factor receptor/Ras/mitogen-activated protein kinase cascade and the LIN-12/Notch pathway during Caenorhabditis elegans vulval development. Six vulval precursor cells (VPCs) are initially equivalent but adopt different fates as a result of an inductive signal mediated by the Ras pathway and a lateral signal mediated by the LIN-12/Notch pathway(1). One consequence of activating Ras is a reduction of LIN-12 protein in P6.p (ref. 2), the VPC believed to be the source of the lateral signal. Here we identify a 'downregulation targeting signal' (DTS) in the LIN-12 intracellular domain, which encompasses a di-leucine-containing endocytic sorting motif. The DTS seems to be required for internalization of LIN-12, and on Ras activation it might mediate altered endocytic routing of LIN-12, leading to downregulation. We also show that if LIN-12 is stabilized in P6.p, lateral signalling is compromised, indicating that LIN-12 downregulation is important in the appropriate specification of cell fates in vivo.	Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Greenwald, I (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.		Shaye, Daniel/AAY-5351-2020	Shaye, Daniel/0000-0002-3962-6903				Ambros V, 1999, DEVELOPMENT, V126, P1947; Burdine RD, 1998, DEVELOPMENT, V125, P1083; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Dietrich J, 1996, J BIOL CHEM, V271, P11441, DOI 10.1074/jbc.271.19.11441; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Ehrlich M, 2001, J CELL SCI, V114, P1777; Fares H, 2001, GENETICS, V159, P133; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FITZGERALD K, 1993, DEVELOPMENT, V119, P1019; Grant B, 1997, DEVELOPMENT, V124, P637; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Greenwald Iva, 1997, Cold Spring Harbor Monograph Series, V33, P519; HEITZLER P, 1993, DEVELOPMENT, V117, P1113; Heitzler P, 1996, DEVELOPMENT, V122, P161; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; Kil SJ, 2000, J CELL PHYSIOL, V185, P47, DOI 10.1002/1097-4652(200010)185:1<47::AID-JCP4>3.3.CO;2-F; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Levitan D, 1998, DEVELOPMENT, V125, P3101; Mello C, 1995, CAENORHABDITIS ELEGA, P451; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; SINGH N, 1995, GENE DEV, V9, P2251, DOI 10.1101/gad.9.18.2251; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; WILKINSON HA, 1994, CELL, V79, P1187, DOI 10.1016/0092-8674(94)90010-8; WILKINSON HA, 1995, GENETICS, V141, P513	30	113	117	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					686	690		10.1038/nature01234	http://dx.doi.org/10.1038/nature01234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478297				2022-12-28	WOS:000179751800050
J	Way, J; Back, AL; Curtis, JR				Way, J; Back, AL; Curtis, JR			Withdrawing life support and resolution of conflict with families	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INTENSIVE-CARE-UNIT; MEDICAL FUTILITY RATIONALE; CRITICALLY ILL PATIENTS; SUSTAINING TREATMENT; RESUSCITATION PREFERENCES; MECHANICAL VENTILATION; PATIENTS EXPERIENCE; END; DECISIONS; COMMUNICATION		Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Curtis, JR (corresponding author), Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Box 359762,325 9th Ave, Seattle, WA 98104 USA.	jrc@u.washington.edu			NINR NIH HHS [R01 NR005226, R01 NR-05226-01] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR005226] Funding Source: NIH RePORTER	NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; American Thoracic Society, 1991, Ann Intern Med, V115, P478; Asch DA, 1996, MED CARE, V34, P103, DOI 10.1097/00005650-199602000-00002; ASCH DA, 1995, AM J RESP CRIT CARE, V151, P288, DOI 10.1164/ajrccm.151.2.7842181; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; BERGBOMENGBERG I, 1989, CRIT CARE MED, V17, P1068, DOI 10.1097/00003246-198910000-00021; Breen CM, 2001, J GEN INTERN MED, V16, P283, DOI 10.1046/j.1525-1497.2001.00419.x; Brody H, 1997, NEW ENGL J MED, V336, P652, DOI 10.1056/NEJM199702273360910; CAMPBELL ML, 1992, AM J CRIT CARE, V1, P152; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; *COUNC ETH JUD AFF, 1989, PRINC MED ETH; Covinsky KE, 2000, J AM GERIATR SOC, V48, pS187, DOI 10.1111/j.1532-5415.2000.tb03131.x; CURTIS J, 2001, MANAGING DEATH ICU T; CURTIS JR, 1995, JAMA-J AM MED ASSOC, V273, P124, DOI 10.1001/jama.273.2.124; Curtis JR, 2000, ARCH INTERN MED, V160, P1597, DOI 10.1001/archinte.160.11.1597; Curtis JR, 2002, J CRIT CARE, V17, P147, DOI 10.1053/jcrc.2002.35929; Daly B J, 1996, Am J Crit Care, V5, P331; Danis M, 1997, CRIT CARE MED, V25, P887; Eidelman LA, 1998, INTENS CARE MED, V24, P162, DOI 10.1007/s001340050539; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; FaberLangendoen K, 1996, ARCH INTERN MED, V156, P2130, DOI 10.1001/archinte.156.18.2130; FABERLANGENDOEN K, 1994, CHEST, V106, P880, DOI 10.1378/chest.106.3.880; FABERLANGENDOEN.K, 1996, AM J RESP CRIT CARE, V109, P852; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Fetters MD, 2001, CRIT CARE MED, V29, P921, DOI 10.1097/00003246-200105000-00001; Goold SD, 2000, JAMA-J AM MED ASSOC, V283, P909, DOI 10.1001/jama.283.7.909; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; Helft PR, 2000, NEW ENGL J MED, V343, P293, DOI 10.1056/NEJM200007273430411; HICKEY M, 1990, HEART LUNG, V19, P401; Kagawa-Singer M, 2001, JAMA-J AM MED ASSOC, V286, P2993, DOI 10.1001/jama.286.23.2993; Keenan SP, 1998, CRIT CARE MED, V26, P245, DOI 10.1097/00003246-199802000-00018; KIRKLAND L, 1994, J CLIN ETHIC, V5, P38; LANTOS JD, 1989, AM J MED, V87, P81; Lilly CM, 2000, AM J MED, V109, P469, DOI 10.1016/S0002-9343(00)00524-6; Luce JM, 1997, AM J RESP CRIT CARE, V156, P1715, DOI 10.1164/ajrccm.156.6.9705004; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; MOLTER NC, 1979, HEART LUNG, V8, P332; Nelson JE, 2001, CRIT CARE MED, V29, P277, DOI 10.1097/00003246-200102000-00010; Plows CW, 1999, JAMA-J AM MED ASSOC, V281, P937; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Puchalski CM, 2000, J AM GERIATR SOC, V48, pS84, DOI 10.1111/j.1532-5415.2000.tb03146.x; Rushton C H, 1995, Am J Crit Care, V4, P112; Schneiderman LJ, 1996, ANN INTERN MED, V125, P669, DOI 10.7326/0003-4819-125-8-199610150-00007; SCHNEIDERMAN LJ, 1990, ANN INTERN MED, V112, P949, DOI 10.7326/0003-4819-112-12-949; SCHNEIDERMAN LJ, 1993, J CLIN ETHIC, V4, P28; SECKLER AB, 1991, ANN INTERN MED, V115, P92, DOI 10.7326/0003-4819-115-2-92; SOLOMON MZ, 1993, AM J PUBLIC HEALTH, V83, P14, DOI 10.2105/AJPH.83.1.14; Somogyi-Zalud E, 2000, J AM GERIATR SOC, V48, pS140, DOI 10.1111/j.1532-5415.2000.tb03123.x; Sulmasy DP, 1998, ANN INTERN MED, V128, P621, DOI 10.7326/0003-4819-128-8-199804150-00002; *SUPPORT PRINC INV, 1996, JAMA-J AM MED ASSOC, V274, P1591; TRUOG RD, 1992, NEW ENGL J MED, V327, P1678, DOI 10.1056/NEJM199212033272311; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; Truog RD, 2000, NEW ENGL J MED, V342, P508, DOI 10.1056/NEJM200002173420712; TRUOG RD, 1992, NEW ENGL J MED, V326, P1560, DOI 10.1056/NEJM199206043262310; TULSKY JA, 1995, J GEN INTERN MED, V10, P436, DOI 10.1007/BF02599915; UHLMANN RF, 1988, J GERONTOL, V43, pM115, DOI 10.1093/geronj/43.5.M115; UHLMANN RF, 1989, WESTERN J MED, V150, P705; Vincent JL, 1999, CRIT CARE MED, V27, P1626, DOI 10.1097/00003246-199908000-00042; Wenger NS, 2000, J AM GERIATR SOC, V48, pS44, DOI 10.1111/j.1532-5415.2000.tb03140.x; WILSON WC, 1992, JAMA-J AM MED ASSOC, V267, P949	61	77	80	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2002	325	7376					1342	1345		10.1136/bmj.325.7376.1342	http://dx.doi.org/10.1136/bmj.325.7376.1342			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	625LC	12468486	Green Published			2022-12-28	WOS:000179817100024
J	Keller, R				Keller, R			Shaping the vertebrate body plan by polarized embryonic cell movements	SCIENCE			English	Review							CONVERGENT EXTENSION MOVEMENTS; UNDERLYING NOTOCHORD FORMATION; AVIAN PRIMITIVE STREAK; XENOPUS-LAEVIS; NEURAL PLATE; MORPHOGENETIC MOVEMENTS; GASTRULATION MOVEMENTS; PROTRUSIVE ACTIVITY; SIGNALING PATHWAYS; CULTURED EXPLANTS	Polarized cell movements shape the major features of the vertebrate body plan during development. The head-to-tail body axis of vertebrates is elongated in embryonic stages by "convergent extension" tissue movements. During these movements cells intercalate between one another transverse to the elongating body axis to form a narrower, longer array. Recent discoveries show that these polarized cell movements are controlled by homologs of genes that control the polarity of epithelial cells in the developing wing and eye of the fruit fly, Drosophila.	Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA	University of Virginia	Keller, R (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.							Adler PN, 2000, MECH DEVELOP, V96, P197, DOI 10.1016/S0925-4773(00)00392-0; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Choi SC, 2002, DEV BIOL, V244, P342, DOI 10.1006/dbio.2002.0602; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; Djiane A, 2000, DEVELOPMENT, V127, P3091; Elul T, 2000, DEV BIOL, V224, P3, DOI 10.1006/dbio.2000.9746; GLICKMAN N, IN PRESS DEVELOPMENT; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; HARDIN JD, 1986, DEV BIOL, V115, P490, DOI 10.1016/0012-1606(86)90269-1; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Katoh K, 2001, J CELL BIOL, V153, P569, DOI 10.1083/jcb.153.3.569; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; KELLER R, 1989, J EXP ZOOL, V251, P134, DOI 10.1002/jez.1402510204; KELLER R, 1988, DEVELOPMENT, V103, P193; KELLER R, 1989, DEV BIOL, V131, P539, DOI 10.1016/S0012-1606(89)80024-7; KELLER R, 1992, DEV DYNAM, V195, P162, DOI 10.1002/aja.1001950303; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kim SH, 1998, DEVELOPMENT, V125, P4681; KIMMEL CB, 1994, DEVELOPMENT, V120, P265; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; KOLEGA J, 1986, J CELL BIOL, V102, P1400, DOI 10.1083/jcb.102.4.1400; Lawson A, 2001, GENESIS, V29, P188, DOI 10.1002/gene.1023; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Marsden M, 2001, DEVELOPMENT, V128, P3635; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; MOON RT, 1993, DEVELOPMENT, V119, P97; MOORE SW, 1995, DEVELOPMENT, V121, P3131; Munro EM, 2002, DEVELOPMENT, V129, P13; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; RAUCH G, COLD SPRING HARBOR S, V62, P227; SAUSEDO RA, 1993, ANAT REC, V237, P58, DOI 10.1002/ar.1092370107; SAUSEDO RA, 1994, ANAT REC, V239, P103, DOI 10.1002/ar.1092390112; Schechtman A Mandel, 1942, UNIV CALIFORNIA PUBL ZOOL, V51, P1; SCHOENWOLF GC, 1989, DEVELOPMENT, V106, P427; Sepich DS, 2000, GENESIS, V27, P159, DOI 10.1002/1526-968X(200008)27:4<159::AID-GENE50>3.0.CO;2-T; Settleman J, 2001, DEV CELL, V1, P321, DOI 10.1016/S1534-5807(01)00053-3; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; SHIH J, 1992, DEVELOPMENT, V116, P901; SHIH J, 1992, DEVELOPMENT, V116, P915; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Tada M, 2000, DEVELOPMENT, V127, P2227; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Vogt Walther, 1929, Wilhelm Roux Arch Entwickl Mech Org, V120, P384, DOI 10.1007/BF02109667; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wei Y, 2000, DEVELOPMENT, V127, P87; WILSON P, 1991, DEVELOPMENT, V112, P289; WILSON PA, 1989, DEVELOPMENT, V105, P155; WINKBAUER R, NATURE, V413, P856; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; ZHONG Y, 1997, CELL BIOL, V144, P351	57	534	541	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					1950	1954		10.1126/science.1079478	http://dx.doi.org/10.1126/science.1079478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471247				2022-12-28	WOS:000179629200034
J	Dermitzakis, ET; Reymond, A; Lyle, R; Scamuffa, N; Ucla, C; Deutsch, S; Stevenson, BJ; Flegel, V; Bucher, P; Jongeneel, CV; Antonarakis, SE				Dermitzakis, ET; Reymond, A; Lyle, R; Scamuffa, N; Ucla, C; Deutsch, S; Stevenson, BJ; Flegel, V; Bucher, P; Jongeneel, CV; Antonarakis, SE			Numerous potentially functional but non-genic conserved sequences on human chromosome 21	NATURE			English	Article							NONCODING SEQUENCES; REGULATORY ELEMENTS; PLACENTAL MAMMALS; HUMAN-CHROMOSOME-21; DNA; PHYLOGENETICS	The use of comparative genomics to infer genome function relies on the understanding of how different components of the genome change over evolutionary time(1-3). The aim of such comparative analysis is to identify conserved, functionally transcribed sequences such as protein-coding genes and non-coding RNA genes, and other functional sequences such as regulatory regions(4,5), as well as other genomic features. Here, we have compared the entire human chromosome 21 with syntenic regions of the mouse genome, and have identified a large number of conserved blocks of unknown function. Although previous studies have made similar observations(6,7), it is unknown whether these conserved sequences are genes or not. Here we present an extensive experimental and computational analysis of human chromosome 21 in an effort to assign function to sequences conserved between human chromosome 21 (ref. 8) and the syntenic mouse regions. Our data support the presence of a large number of potentially functional non-genic sequences, probably regulatory and structural. The integration of the properties of the conserved components of human chromosome 21 to the rapidly accumulating functional data for this chromosome 9,10 will improve considerably our understanding of the role of sequence conservation in mammalian genomes.	Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, CH-1211 Geneva, Switzerland; Ludwig Inst Canc Res, Off Informat Technol, CH-1066 Epalinges, Switzerland; Ludwig Inst Canc Res, Swiss Inst Bioinformat, CH-1066 Epalinges, Switzerland; Ludwig Inst Canc Res, Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland	University of Geneva; University of Geneva; Ludwig Institute for Cancer Research; Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; Ludwig Institute for Cancer Research; Swiss Institute Experimental Cancer Research	Antonarakis, SE (corresponding author), Univ Geneva, Sch Med, Div Med Genet, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.		Kutalik, Zoltan/HHZ-5697-2022; Dermitzakis, Emmanouil/B-7687-2013; Antonarakis, Stylianos E/N-8866-2014; Jongeneel, Cornelis V/B-2135-2012	Kutalik, Zoltan/0000-0001-8285-7523; Antonarakis, Stylianos E/0000-0001-8907-5823; Jongeneel, Cornelis Victor/0000-0002-3922-1906; Reymond, Alexandre/0000-0003-1030-8327; Deutsch, Samuel/0000-0001-9456-7101				Antonarakis SE, 2002, INT J DEV BIOL, V46, P89; Davisson MT, 2001, GENOMICS, V78, P99, DOI 10.1006/geno.2001.6639; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Frazer KA, 2001, GENOME RES, V11, P1651, DOI 10.1101/gr.198201; Gardiner K, 2002, GENOMICS, V79, P833, DOI 10.1006/geno.2002.6782; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Novichkov PS, 2001, BIOINFORMATICS, V17, P1011, DOI 10.1093/bioinformatics/17.11.1011; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; OBRIEN SJ, 1999, SCIENCE, V286, P479; Reymond A, 2002, GENOMICS, V79, P824, DOI 10.1006/geno.2002.6781; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Reymond A, 2001, GENOMICS, V78, P46, DOI 10.1006/geno.2001.6640; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shabalina SA, 2001, TRENDS GENET, V17, P373, DOI 10.1016/S0168-9525(01)02344-7; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	30	184	187	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					578	582		10.1038/nature01251	http://dx.doi.org/10.1038/nature01251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466853	Green Published, hybrid			2022-12-28	WOS:000179611600056
J	Iyasu, S; Randall, LL; Welty, TK; Hsia, J; Kinney, HC; Mandell, F; McClain, M; Randall, B; Habbe, D; Wilson, H; Willinger, M				Iyasu, S; Randall, LL; Welty, TK; Hsia, J; Kinney, HC; Mandell, F; McClain, M; Randall, B; Habbe, D; Wilson, H; Willinger, M			Risk factors for sudden infant death syndrome among Northern Plains Indians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONFIDENTIAL INQUIRY; RANDOMIZED-TRIAL; ALCOHOL; STILLBIRTHS; ENVIRONMENT; PREGNANCY; OUTCOMES; SMOKING; GROWTH	Context Sudden infant death syndrome (SIDS) is a leading cause of postneonatal mortality among American Indians, a group whose infant death rate is consistently above the US national average. Objective To determine Prenatal and postnatal risk factors for SIDS among American Indians. Design, Setting, and Participants Population-based case-control study of 33 SIDS infants and 66 matched living controls among American Indians in South Dakota, North Dakota, Nebraska, and Iowa enrolled from December 1992 to November 1996 and investigated using standardized parental interview, medical record abstraction', autopsy protocol, and infant death review. Main Outcome Measures Association of SIDS with maternal socioeconomic and behavioral factors, health care utilization, and infant care practices. Results The proportions of case and control infants who were usually placed prone to sleep (15.2% and 13.6%, respectively), who shared a bed with parents (59.4% and 55.4%), or whose mothers smoked during pregnancy (69.7% and 54.6%) were similar. However, mothers of 72.7% of case infants and 45.5% of control infants engaged in binge drinking during pregnancy. Conditional logistic regression revealed significant associations between SIDS and 2 or more layers of clothing on the infant (adjusted odds ratio [aOR], 6.2; 95% confidence interval [CI], 1.4-26.5), any visits by a public health nurse (aOR, 0.2; 95% Cl, 0.1-0.8), periconceptional maternal alcohol use (aOR, 6.2; 95% Cl, 1.6-23.3), and maternal first-trimester binge drinking (aOR, 8.2; 95% Cl, 1.9-35.3). Conclusions Public health nurse visits, maternal alcohol use during the periconceptional period and first trimester, and layers of clothing are important risk factors for SIDS among Northern Plains Indians. Strengthening public health nurse visiting programs and programs to reduce alcohol consumption among women of childbearing age could potentially reduce the high rate of SIDS.	Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Aberdeen Area Indian Hlth Serv, Rapid City, SD USA; Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Massachusetts SIDS Ctr, Boston, MA USA; LCM Pathologists PC, Sioux Falls, SD USA; Clin Lab Black Hills, Rapid City, SD USA; Providence Mem Hosp, Dept Pathol, El Paso, TX USA; NICHHD, NIH, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Iyasu, S (corresponding author), US FDA, Div Pediat, Off Counter Terrorism & Pediat Drug Dev, Ctr Drug Evaluat & Res, 5A-33,HFD-960,5600 Fishers Ln, Rockville, MD 20857 USA.	IyasuS@cder.fda.gov		Randall, Leslie L/0000-0002-4960-9541				Alm B, 1999, ARCH DIS CHILD, V81, P107, DOI 10.1136/adc.81.2.107; Blair PS, 1996, BRIT MED J, V313, P195, DOI 10.1136/bmj.313.7051.195; Blair PS, 1999, BRIT MED J, V319, P1457, DOI 10.1136/bmj.319.7223.1457; Braveman P, 1996, J Am Board Fam Pract, V9, P254; Brooke H, 1997, BMJ-BRIT MED J, V314, P1516, DOI 10.1136/bmj.314.7093.1516; Bull LBH, 1999, AM J PREV MED, V16, P240; DAY NL, 1989, PEDIATRICS, V84, P536; DREWS CD, 1990, INT J EPIDEMIOL, V19, P405, DOI 10.1093/ije/19.2.405; ERNHART CB, 1985, ALCOHOL CLIN EXP RES, V9, P447, DOI 10.1111/j.1530-0277.1985.tb05581.x; Fleming PJ, 1996, BMJ-BRIT MED J, V313, P191, DOI 10.1136/bmj.313.7051.191; GIBBONS LE, 1993, AM J EPIDEMIOL, V137, P654, DOI 10.1093/oxfordjournals.aje.a116723; GILBERT R, 1992, ARCH DIS CHILD, V67, P171, DOI 10.1136/adc.67.2.171; Gomby DS, 1999, FUTURE CHILD, V9, P4, DOI 10.2307/1602719; *IND HLTH SERV, 1998, REG DIFF IND HLTH 19; *IND HLTH SERV, REG DIFF IND HLTH DE; Indian Health Service, 2000, REG DIFF IND HLTH 19; Kitzman H, 1997, JAMA-J AM MED ASSOC, V278, P644, DOI 10.1001/jama.278.8.644; Kleinman J C, 1990, MMWR CDC Surveill Summ, V39, P31; MacDonald CB, 1999, INT J PEDIATR OTORHI, V47, P23, DOI 10.1016/S0165-5876(98)90152-5; MACDORMAN MF, 2002, INFANT MORTALITY STA; Mathews TJ, 2002, NATL VITAL STAT REPO; OLDS DL, 1986, PEDIATRICS, V77, P16; OLDS DL, 1986, PEDIATRICS, V78, P65; PONSONBY AL, 1992, BRIT MED J, V304, P277, DOI 10.1136/bmj.304.6822.277; Randall L L, 2001, Am Indian Alsk Native Ment Health Res, V10, P1; SAS Institute Inc, 1997, SAS STAT SOFTW CHANG; SCRAGG R, 1993, BMJ-BRIT MED J, V307, P1312, DOI 10.1136/bmj.307.6915.1312; Shaw GM, 1999, J PEDIATR-US, V134, P298, DOI 10.1016/S0022-3476(99)70453-1; Williams SM, 1996, INT J EPIDEMIOL, V25, P366, DOI 10.1093/ije/25.2.366; WILLINGER M, 1991, Pediatric Pathology, V11, P677	30	132	135	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2002	288	21					2717	2723		10.1001/jama.288.21.2717	http://dx.doi.org/10.1001/jama.288.21.2717			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620UA	12460095	Bronze			2022-12-28	WOS:000179549800031
J	Henderson, DC				Henderson, DC			Mercury in vaccines - reassuring news	LANCET			English	Editorial Material							GLUTATHIONE		Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Fac Med, Dept Immunol, London SW10 9NH, England	Imperial College London	Henderson, DC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Fac Med, Dept Immunol, London SW10 9NH, England.							Henderson DC, 2001, J DENT, V29, P469, DOI 10.1016/S0300-5712(01)00025-2; LORSCHEIDER FL, 1995, FASEB J, V9, P504, DOI 10.1096/fasebj.9.7.7737458; MAGOS L, 1978, BIOCHEM PHARMACOL, V27, P1373, DOI 10.1016/0006-2952(78)90122-3; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; NAGANUMA A, 1990, BIOCHEM PHARMACOL, V40, P693; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038	6	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1711	1712		10.1016/S0140-6736(02)11723-5	http://dx.doi.org/10.1016/S0140-6736(02)11723-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480419				2022-12-28	WOS:000179636800003
J	Blendon, RJ; DesRoches, CM; Benson, JM; Herrmann, MJ; Taylor-Clark, K; Weldon, KJ				Blendon, RJ; DesRoches, CM; Benson, JM; Herrmann, MJ; Taylor-Clark, K; Weldon, KJ			The public and the smallpox threat	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIOTERRORISM	BACKGROUND: The potential for a bioterrorist attack involving smallpox has led to a debate about what national precautions should be taken. What is unclear is the public's knowledge of smallpox and views about precautions. METHODS: We conducted a national survey of 1006 adults selected by means of random-digit dialing. Respondents were asked about their knowledge of and beliefs about the smallpox virus and the vaccine, their possible reactions to a bioterrorist attack involving smallpox, and a number of proposed state emergency powers. RESULTS: The majority of the respondents have a number of beliefs about smallpox and smallpox vaccination that are false. The majority believe that there is an effective treatment for smallpox, that there have been cases of smallpox in the past five years, and that there is not enough smallpox vaccine to vaccinate everyone in the United States. Thirty percent believe that vaccination earlier in their lives would protect them from the disease. The majority of respondents said they wanted to be vaccinated; however, only 21 percent would want to be vaccinated if physicians declined vaccination. There was strong support among the respondents for several proposed state emergency powers. CONCLUSIONS: Our results suggest the need for public education about smallpox. These data also point to the importance of a discussion in the medical community about the advisability of vaccination of individual physicians at this time.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Int Commun Res, Media, PA USA	Harvard University; Harvard T.H. Chan School of Public Health	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.		DesRoches, Catherine/ABC-9869-2020	DesRoches, Catherine/0000-0001-5373-855X; Weldon, Kathleen/0000-0001-5884-6947				ALTMAN LK, 2002, NY TIMES        1012, P20; *AM ASS PUBL OP RE, 2000, STAND DEF FIN DISP C; Annas GJ, 2002, NEW ENGL J MED, V346, P1337, DOI 10.1056/NEJM200204253461722; [Anonymous], 2002, SMALLP FACT SHEET SM; Barbera J, 2001, JAMA-J AM MED ASSOC, V286, P2711, DOI 10.1001/jama.286.21.2711; Bicknell WJ, 2002, NEW ENGL J MED, V346, P1323, DOI 10.1056/NEJMsb020357; BLENDON RJ, 2002, MEDSCAPE GEN MED, V4; *CDCP, 2002, SMALLP VACC VACC MET; *CDCP, 2002, MOD STAT EM HLTH POW; Cohen J, 2001, SCIENCE, V294, P985, DOI 10.1126/science.294.5544.985; Fauci AS, 2002, NEW ENGL J MED, V346, P1319, DOI 10.1056/NEJM200204253461711; FLAHERTY T, 2002, AMA ANSWERS NEEDED W; Gostin LO, 2002, JAMA-J AM MED ASSOC, V288, P622, DOI 10.1001/jama.288.5.622; Henderson DA, 1998, EMERG INFECT DIS, V4, P488, DOI 10.3201/eid0403.980340; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Meltzer MI, 2001, EMERG INFECT DIS, V7, P959, DOI 10.3201/eid0706.010607; MILLER J, 2002, NY TIMES        1203, pA18; Miller Judith, 2002, NEW YORK TIMES  1112, pA1; O'Toole T, 2002, CLIN INFECT DIS, V34, P972, DOI 10.1086/339909; PAGE BI, 1983, AM POLIT SCI REV, V77, P175, DOI 10.2307/1956018; Sepkowitz KA, 2003, NEW ENGL J MED, V348, P439, DOI 10.1056/NEJMra022500; STIMSON JA, 1995, AM POLIT SCI REV, V89, P543, DOI 10.2307/2082973; STOLBERG SG, 2002, NY TIMES        1128, pA22; TANNER L, 2002, 434 CAT I; WLEZIEN C, 1995, AM POLIT SCI REV, V89, P981; 2002, NY TIMES        1214, pA14	26	62	66	1	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					426	432		10.1056/NEJMsa023184	http://dx.doi.org/10.1056/NEJMsa023184			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12496352				2022-12-28	WOS:000180643800009
J	Naimi, TS; Brewer, RD; Mokdad, A; Denny, C; Serdula, MK; Marks, JS				Naimi, TS; Brewer, RD; Mokdad, A; Denny, C; Serdula, MK; Marks, JS			Binge drinking among US adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK FACTOR SURVEILLANCE; REPORTED ALCOHOL-USE; HARVARD-SCHOOL; CONSUMPTION; ENFORCEMENT; VALIDITY; TRENDS; PERIOD; SALES; DEATH	Context Binge drinking (consuming greater than or equal to5 alcoholic drinks on 1 occasion) generally results in acute impairment and has numerous adverse health consequences. Reports indicate that binge drinking may be increasing in the United States. Objectives To quantify episodes of binge drinking among US adults in 1993-2001, to characterize adults who engage in binge drinking, and to describe state and regional differences in binge drinking. Design, Setting, and Participants The Behavioral Risk Factor Surveillance System, a random-digit telephone survey of adults aged 18 years or older that is conducted annually in all states. The sample size ranged from 102263 in 1993 to 212 510 in 2001. Main Outcome Measures Binge-drinking prevalence, episodes, and episodes per person per year. Results Between 1993 and 2001, the total number of binge-drinking episodes among US adults increased from approximately 1.2 billion to 1.5 billion; during this time, binge-drinking episodes per person per year increased by 17% (from 6.3 to 7.4, P for trend = .03). Between 1995 and 2001, binge-drinking episodes per person per year increased by 35% (P for trend = .005). Men accounted for 81% of binge-drinking episodes in the study years. Although rates of binge-drinking episodes were highest among those aged 18 to 25 years, 69% of binge-drinking episodes during the study period occurred among those aged 26 years or older. Overall, 47% of binge-drinking episodes occurred among otherwise moderate (ie, non-heavy) drinkers, and 73% of all binge drinkers were moderate drinkers. Binge drinkers were 14 times more likely to drive while impaired by alcohol compared with non-binge drinkers. There were substantial state and regional differences in per capita binge-drinking episodes. Conclusions Binge drinking is common among most strata of US adults, including among those aged 26 years or older. Per capita binge-drinking episodes have increased, particularly since 1995. Binge drinking is strongly associated with alcohol-impaired driving. Effective interventions to prevent the mortality and morbidity associated with binge drinking should be widely adopted, including screening patients for alcohol abuse in accordance with national guidelines.	Ctr Dis Control & Prevent, Alcohol Team, Analyt Methods Branch, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA USA; Ctr Dis Control & Prevent, Behav Surveillance Branch, Div Adult & Community Hlth, Atlanta, GA USA; Ctr Dis Control & Prevent, Chron Dis Nutr Branch, Div Nutr & Phys Act, Atlanta, GA USA; Ctr Dis Control & Prevent, Off Director, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Ctr Dis Control & Prevent, Alcohol Team, Emerging Invest Branch, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Naimi, TS (corresponding author), CDC, Alcohol Team, MS K-67,4770 Buford Hwy NE, Atlanta, GA 30341 USA.	tbn7@cdc.gov		Naimi, Timothy/0000-0001-9849-4413				*ALC EP PROGR, 2000, ALC POL US HIGHL 50; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P173; Center for Disease Control and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P1064; Center on Alcohol Marketing and Youth, 2002, OV YOUTH TARG ALC AD; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P273; CHALOUPKA FJ, 1993, J LEGAL STUD, V22, P161, DOI 10.1086/468161; Chaloupka FJ, 2002, ALCOHOL RES HEALTH, V26, P22; Chikritzhs TN, 2001, MED J AUSTRALIA, V174, P281, DOI 10.5694/j.1326-5377.2001.tb143269.x; Coffield AB, 2001, AM J PREV MED, V21, P1, DOI 10.1016/S0749-3797(01)00308-7; Cook PJ, 2002, HEALTH AFFAIR, V21, P120, DOI 10.1377/hlthaff.21.2.120; *FED TRAD COMM, 2002, SELF REG ALC IND; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8; Gentry E M, 1985, Am J Prev Med, V1, P9; Gladstone J, 1996, REPROD TOXICOL, V10, P3, DOI 10.1016/0890-6238(95)02024-1; Gmel G, 2001, ADDICTION, V96, P273, DOI 10.1046/j.1360-0443.2001.96227311.x; Greenfield TK, 2000, AM J PUBLIC HEALTH, V90, P47, DOI 10.2105/AJPH.90.1.47; Holder HD, 2000, JAMA-J AM MED ASSOC, V284, P2341, DOI 10.1001/jama.284.18.2341; Iyasu S, 2002, JAMA-J AM MED ASSOC, V288, P2717, DOI 10.1001/jama.288.21.2717; Jacobs EA, 2001, PEDIATRICS, V108, P185, DOI 10.1542/peds.108.1.185; Jacobson Joseph L, 1994, Alcohol Health Res World, V18, P30; LENDER ME, 1987, DRINKING AM; Liu S, 1997, JAMA-J AM MED ASSOC, V277, P122, DOI 10.1001/jama.277.2.122; Maier SE, 1997, ALCOHOL CLIN EXP RES, V21, P1418; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; MCKNIGHT AJ, 1994, ACCIDENT ANAL PREV, V26, P79, DOI 10.1016/0001-4575(94)90070-1; MIDANIK LT, 1988, BRIT J ADDICT, V83, P1019; MORSE J, 2002, TIME, V159, P56; Nelson DE, 2002, JAMA-J AM MED ASSOC, V287, P2659, DOI 10.1001/jama.287.20.2659; Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3; *PARTN PREV, 2002, ALC HLTH RISK US MEA; RAE S, 1991, DRINK DRINKERS DRINK; REMINGTON PL, 1988, PUBLIC HEALTH REP, V103, P366; Rogers JD, 1999, J STUD ALCOHOL, V60, P732, DOI 10.15288/jsa.1999.60.732; SAFFER H, 1987, J LEGAL STUD, V16, P351, DOI 10.1086/467834; Shah BV, 1997, SUDAAN USERS MANUAL; SHULTZ JM, 1991, PUBLIC HEALTH REP, V106, P443; SMITH PF, 1990, AM J PUBLIC HEALTH, V80, P309, DOI 10.2105/AJPH.80.3.309; Stout EM, 2000, J STUD ALCOHOL, V61, P402, DOI 10.15288/jsa.2000.61.402; *SUBST AB MENT HLT, 2002, NAT HOUS DRUG AB SUM; U. S. Department of Health and Human Services, 2000, HLTH PEOPL 2010, V1; *US DEP HLTH HUM S, 2000, HOM GARD B, V232; US Department of Health and Human Services, 2000, SAYING IT CLEARL; *US PREV SERV TASK, 1996, SCREEN PROBL DRINK G, P567; WAGENAAR AC, 1995, PUBLIC HEALTH REP, V110, P419; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; Wechsler H, 1998, J STUD ALCOHOL, V59, P122, DOI 10.15288/jsa.1998.59.122; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713; Wechsler H, 2001, PSYCHOL ADDICT BEHAV, V15, P287, DOI 10.1037/0893-164X.15.4.287; Wechsler H, 1998, J AM COLL HEALTH, V47, P57, DOI 10.1080/07448489809595621; World Health Organization, 2000, INT GUID MON ALC CON	53	723	742	0	80	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					70	75		10.1001/jama.289.1.70	http://dx.doi.org/10.1001/jama.289.1.70			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630XL	12503979				2022-12-28	WOS:000180136600028
J	Yeargin-Allsopp, M; Rice, C; Karapurkar, T; Doernberg, N; Boyle, C; Murphy, C				Yeargin-Allsopp, M; Rice, C; Karapurkar, T; Doernberg, N; Boyle, C; Murphy, C			Prevalence of autism in a US metropolitan area	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; DIAGNOSTIC INTERVIEW; CHILDREN; SURVEILLANCE; EPIDEMIOLOGY; POPULATION	Context Concern has been raised about possible increases in the prevalence of autism. However, few population-based studies have been conducted in the United States. Objectives To determine the prevalence of autism among children in a major US metropolitan area and to describe characteristics of the study population. Design, Setting, and Population Study of the prevalence of autism among children aged 3 to 10 years in the 5 counties of metropolitan Atlanta, Ga, in 1996. Cases were identified through screening and abstracting records at multiple medical and educational sources, with case status determined by expert review. Main Outcome. Measures Autism prevalence by demographic factors, levels of cognitive functioning, previous autism diagnoses, special education eligibility categories, and sources of identification. Results A total of 987 children displayed behaviors consistent with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for autistic disorder, pervasive developmental disorder-not otherwise specified, or Asperger disorder. The prevalence for autism was 3.4 per 1000 (95% confidence interval [CI], 3.2-3.6) (male-female ratio,.4:1). Overall, the prevalence was comparable for black and white children (black, 3.4 per 1000 [95% CI, 3.0-3.7] and white, 3.4 per 1000 [95% CI, 3.2-3.7]). Sixty-eight percent of children with IQ or developmental test results (N = 880) had cognitive impairment. As severity of cognitive impairment increased from mild to profound, the male-female ratio decreased from 4.4 to 1.3. Forty percent of children with autism were identified only at educational sources. Schools were the most important source for information on black children, children of younger mothers, and children of mothers with less than 12 years of education. Conclusion The rate of autism found in this study was higher than the rates from studies conducted in the United States during the 1980s and early 1990s, but it was consistent with those of more recent studies.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Battelle Mem Inst, Ctr Publ Hlth Res & Evaluat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Yeargin-Allsopp, M (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Hwy NE, Atlanta, GA 30341 USA.	mxy1@cdc.gov	Rice, Catherine E/D-6305-2016; Fahimifar, Sepideh/M-5303-2019					American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Arvidsson T., 1997, AUTISM, V2, P163; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; Baird G, 2000, J AM ACAD CHILD PSY, V39, P694, DOI 10.1097/00004583-200006000-00007; Baird G, 2001, ARCH DIS CHILD, V84, P468, DOI 10.1136/adc.84.6.468; BARONCOHEN S, 1992, BRIT J PSYCHIAT, V161, P839, DOI 10.1192/bjp.161.6.839; Berney TP, 2000, BRIT J PSYCHIAT, V176, P20, DOI 10.1192/bjp.176.1.20; Bertrand J, 2001, PEDIATRICS, V108, P1155, DOI 10.1542/peds.108.5.1155; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Blaxill MF, 2002, BRIT MED J, V324, P296; BRASK BH, 1972, NORD S COMPR CAR PSY, P145; BURD L, 1987, J AM ACAD CHILD PSY, V26, P700, DOI 10.1097/00004583-198709000-00014; California Department of Developmental Services, 1999, CHANG POP PERS AUT P; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Comi AM, 1999, J CHILD NEUROL, V14, P388, DOI 10.1177/088307389901400608; COWLEY G, 2000, NEWSWEEK        0731, P46; Croen LA, 2002, J AUTISM DEV DISORD, V32, P207, DOI 10.1023/A:1015453830880; EDMONDS LD, 1981, INT J EPIDEMIOL, V10, P247, DOI 10.1093/ije/10.3.247; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Fombonne E, 2001, J AM ACAD CHILD PSY, V40, P820, DOI 10.1097/00004583-200107000-00017; Fombonne E, 2001, PEDIATRICS, V107, P411, DOI 10.1542/peds.107.2.411; GILLBERG C, 1984, J CHILD PSYCHOL PSYC, V25, P35, DOI 10.1111/j.1469-7610.1984.tb01717.x; Gillberg C, 1999, ACTA PSYCHIAT SCAND, V99, P399, DOI 10.1111/j.1600-0447.1999.tb00984.x; Heussler H, 2001, BRIT MED J, V323, P633, DOI 10.1136/bmj.323.7313.633; Hillman R E, 2000, Mo Med, V97, P159; HOSHINO Y, 1982, FOLIA PSYCHIAT NEU J, V36, P115; Howlin P., 1997, AUTISM, V1, P135, DOI [DOI 10.1177/1362361397012003, 10.1177/1362361397012003]; Kadesjo B, 1999, J AUTISM DEV DISORD, V29, P327, DOI 10.1023/A:1022115520317; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; KIRBY RS, 1995, J DEV BEHAV PEDIATR, V16, P318; London E, 2000, ENVIRON HEALTH PERSP, V108, P401, DOI 10.1289/ehp.00108s3401; Lord C, 2000, COMM LANG INTERVEN, V9, P11; LORD C, 1985, J AUTISM DEV DISORD, V15, P185, DOI 10.1007/BF01531604; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 1999, AUTISM DIAGNOSTIC OB, DOI DOI 10.1037/T17256-000; Lotter V., 1966, SOC PSYCHIATR, V1, P124, DOI [10.1007/BF00584048, https://doi.org/10.1007/BF00584048]; National Research Council Committee on Educational Interventions for Children with Autism, 2001, ED CHILDR AUT; *NIH INT AUT COORD, 2001, 2001 SCI C SEPT 6 7; *PHS US DEP HLTH H, 1988, INT CLASS DIS 9 REV; RITVO ER, 1989, AM J PSYCHIAT, V146, P194; Robins DL, 2001, J AUTISM DEV DISORD, V31, P131, DOI 10.1023/A:1010738829569; Sandler AD, 2001, PEDIATRICS, V107, P1221; Schopler E, 1998, CHILDHOOD AUTISM RAT; Selvin S., 1996, STAT ANAL EPIDEMIOLO; SIEGEL B, 1988, J DEV BEHAV PEDIATR, V9, P199; SIEGEL B, 1999, BIENN M SOC RES CHIL; *US DEP ED, 2000, 22 ANN REP C IMPL IN, P20; *US DEP ED OFF SPE, NUMB CHILDR SERV IDE; Wing L, 1993, Eur Child Adolesc Psychiatry, V2, P61, DOI 10.1007/BF02098832; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; World Health Organization, 1992, INT CLASS DIS 10 REV; YEARGINALLSOPP M, 1992, PEDIATRICS, V89, P624; 1977, FED REG         0823, V42, P42474	56	806	839	0	97	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					49	55		10.1001/jama.289.1.49	http://dx.doi.org/10.1001/jama.289.1.49			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630XL	12503976	Bronze			2022-12-28	WOS:000180136600025
J	Smith, G				Smith, G			Scared to death?	BRITISH MEDICAL JOURNAL			English	Article									Pomona Coll, Dept Econ, Claremont, CA 91711 USA	Claremont Colleges; Pomona College	Smith, G (corresponding author), Pomona Coll, Dept Econ, Claremont, CA 91711 USA.			Smith, Gary/0000-0002-5173-2741				Glaser JH, 2002, BRIT MED J, V324, P1098, DOI 10.1136/bmj.324.7345.1098; PHILLIPS DP, 1988, LANCET, V2, P728; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; Phillips DP, 2001, BRIT MED J, V323, P1443, DOI 10.1136/bmj.323.7327.1443; PHILLIPS DP, 1993, LANCET, V342, P1142, DOI 10.1016/0140-6736(93)92124-C	5	9	9	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1442	1443		10.1136/bmj.325.7378.1442	http://dx.doi.org/10.1136/bmj.325.7378.1442			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493656	Green Published			2022-12-28	WOS:000180188600008
J	Dillin, A; Hsu, AL; Arantes-Oliveira, NA; Lehrer-Graiwer, J; Hsin, H; Fraser, AG; Kamath, RS; Ahringer, J; Kenyon, C				Dillin, A; Hsu, AL; Arantes-Oliveira, NA; Lehrer-Graiwer, J; Hsin, H; Fraser, AG; Kamath, RS; Ahringer, J; Kenyon, C			Rates of behavior and aging specified by mitochondrial function during development	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; RNA INTERFERENCE; EXTENDS LIFE; GENE; LONGEVITY; NEMATODE; MUTANTS	To explore the role of mitochondrial activity in the aging process, we have lowered the activity of the electron transport chain and adenosine 5'-triphosphate (ATP) synthase with RNA interference (RNAi) in Caenorhabditis elegans. These perturbations reduced body size and behavioral rates and extended adult life-span. Restoring messenger RNA to near-normal levels during adulthood did not elevate ATP levels and did not correct any of these phenotypes. Conversely, inhibiting respiratory-chain components during adulthood only did not reset behavioral rates and did not affect life-span. Thus, the developing animal appears to contain a regulatory system that monitors mitochondrial activity early in life and, in response, establishes rates of respiration, behavior, and aging that persist during adulthood.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England	University of California System; University of California San Francisco; University of Cambridge	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu	Hsu, Ao-Lin Allen/AAX-1856-2020	Kenyon, Cynthia/0000-0003-3446-2636; Ahringer, Julie/0000-0002-7074-4051; Hsu, Ao-Lin/0000-0002-2864-3134; Hsin, Honor/0000-0002-0510-7494; Fraser, Andrew/0000-0001-9939-6014	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Braeckman BP, 1999, CURR BIOL, V9, P493, DOI 10.1016/S0960-9822(99)80216-4; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; DILLIN A, UNPUB; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gems D, 1998, GENETICS, V150, P129; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; MEANS LW, 1993, PHYSIOL BEHAV, V54, P503, DOI 10.1016/0031-9384(93)90243-9; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; SLATER EC, 1983, TRENDS BIOCHEM SCI, V8, P239, DOI 10.1016/0968-0004(83)90348-1; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; WONG A, 1995, GENETICS, V139, P1247	22	746	784	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2398	2401		10.1126/science.1077780	http://dx.doi.org/10.1126/science.1077780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12471266				2022-12-28	WOS:000179915900060
J	Knapp, AK; Fay, PA; Blair, JM; Collins, SL; Smith, MD; Carlisle, JD; Harper, CW; Danner, BT; Lett, MS; McCarron, JK				Knapp, AK; Fay, PA; Blair, JM; Collins, SL; Smith, MD; Carlisle, JD; Harper, CW; Danner, BT; Lett, MS; McCarron, JK			Rainfall variability, carbon cycling, and plant species diversity in a mesic grassland	SCIENCE			English	Article							CLIMATE VARIABILITY; EXTREMES; FIRE	Ecosystem responses to increased variability in rainfall, a prediction of general circulation models, were assessed in native grassland by reducing storm frequency and increasing rainfall quantity per storm during a 4-year experiment. More extreme rainfall patterns, without concurrent changes in total rainfall quantity, increased temporal variability in soil moisture and plant species diversity. However, carbon cycling processes such as soil CO2 flux, CO2 uptake by the dominant grasses, and aboveground net primary productivity (ANPP) were reduced, and ANPP was more responsive to soil moisture variability than to mean soil water content. Our results show that projected increases in rainfall variability can rapidly alter key carbon cycling processes and plant community composition, independent of changes in total precipitation.	Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Natl Sci Fdn, Ecol Studies Program, Arlington, VA 22230 USA; Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA	Kansas State University; National Science Foundation (NSF); National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Knapp, AK (corresponding author), Kansas State Univ, Div Biol, Manhattan, KS 66506 USA.	aknapp@ksu.edu	Fay, Philip A./I-1853-2012; Blair, John M/I-4082-2014; Knapp, Alan K/A-2931-2008; Smith, Melinda D/J-8987-2014; Noojipady, Praveen/B-2511-2010; Collins, Scott L/P-7742-2014	Fay, Philip A./0000-0002-8291-6316; Blair, John M/0000-0003-0072-0721; Collins, Scott L/0000-0002-0193-2892				Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fay PA, 2000, ECOSYSTEMS, V3, P308, DOI 10.1007/s100210000028; Gates D.M., 1993, CLIMATE CHANGE ITS B; GORDON HB, 1992, CLIM DYNAM, V8, P83, DOI 10.1007/BF00209165; Groisman PY, 1999, CLIMATIC CHANGE, V42, P243, DOI 10.1023/A:1005432803188; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SYNT; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Johnson LC, 2001, ECOLOGY, V82, P3377, DOI 10.1890/0012-9658(2001)082[3377:FAGRBP]2.0.CO;2; KARL TR, 1995, NATURE, V377, P217, DOI 10.1038/377217a0; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Knapp A.K., 1998, GRASSLAND DYNAMICS L, V1st; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 1998, ECOL APPL, V8, P760, DOI 10.2307/2641264; KNAPP AK, 1993, ECOLOGY, V74, P549, DOI 10.2307/1939315; Koch G, 1996, CARBON DIOXIDE TERRE; Ludwig J. A., 1988, STAT ECOLOGY; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; MEARNS LO, 1990, J GEOPHYS RES-ATMOS, V95, P20469, DOI 10.1029/JD095iD12p20469; Mearns LO, 1997, CLIMATIC CHANGE, V35, P367, DOI 10.1023/A:1005358130291; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Plummer N, 1999, CLIMATIC CHANGE, V42, P183, DOI 10.1023/A:1005472418209; RICKLEFS RE, 1977, AM NAT, V111, P376, DOI 10.1086/283169; RIND D, 1989, CLIMATIC CHANGE, V14, P5, DOI 10.1007/BF00140173; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; SCHIMEL DS, 1991, ECOLOGY, V72, P672, DOI 10.2307/2937207; Schlesinger WH., 1997, BIOGEOCHEMISTRY; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257	27	819	914	46	687	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2202	2205		10.1126/science.1076347	http://dx.doi.org/10.1126/science.1076347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481139				2022-12-28	WOS:000179773700051
J	Hadden, PW; Barry, CJ				Hadden, PW; Barry, CJ			Herpetic encephalitis and acute retinal necrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Lions Eye Inst, Perth, WA 6009, Australia	Lions Eye Institute; University of Western Australia	Hadden, PW (corresponding author), Lions Eye Inst, Perth, WA 6009, Australia.		Hadden, Peter/AAH-5861-2021	Hadden, Peter/0000-0003-0352-5286					0	5	6	1	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1932	1932		10.1056/NEJMicm010938	http://dx.doi.org/10.1056/NEJMicm010938			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623ZX	12477943				2022-12-28	WOS:000179735800005
J	Stensmyr, MC; Urru, I; Collu, I; Celander, M; Hansson, BS; Angioy, AM				Stensmyr, MC; Urru, I; Collu, I; Celander, M; Hansson, BS; Angioy, AM			Rotting smell of dead-horse arum florets - These blooms chemically fool flies into pollinating them.	NATURE			English	Article							DECEPTION; MIMICRY		Swedish Univ Agr Sci, Dept Crop Sci, S-23053 Alnarp, Sweden; Univ Cagliari, Dept Expt Biol, I-4500 Monserrato, Italy	Swedish University of Agricultural Sciences; University of Cagliari	Stensmyr, MC (corresponding author), Swedish Univ Agr Sci, Dept Crop Sci, POB 44, S-23053 Alnarp, Sweden.		Hansson, Bill/G-2774-2013	Hansson, Bill/0000-0002-4811-1223; Stensmyr, Marcus/0000-0003-4009-9212; Celander, Malin/0000-0002-4350-751X				ARN H, 1975, Z NATURFORSCH C, V30, P722; BROWN MH, 1982, MEAT MICROBIOLOGY; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; Fridlender Alain, 2000, Webbia, V55, P7; Kite Geoffrey C., 2000, Kew Bulletin, V55, P237, DOI 10.2307/4117785; Linnaeus C., 1745, C LINNAEI OLANDSKA G; Rosello JA, 1997, ACTA BOT BARC, V44, P169; Roy BA, 1999, TRENDS PLANT SCI, V4, P325, DOI 10.1016/S1360-1385(99)01445-4; Schiestl FP, 1999, NATURE, V399, P421, DOI 10.1038/20829; Schiestl FP, 2000, J COMP PHYSIOL A, V186, P567, DOI 10.1007/s003590000112	10	157	159	4	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					625	626		10.1038/420625a	http://dx.doi.org/10.1038/420625a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478279				2022-12-28	WOS:000179751800031
J	Fritsche, L; Greenhalgh, T; Falck-Ytter, Y; Neumayer, HH; Kunz, R				Fritsche, L; Greenhalgh, T; Falck-Ytter, Y; Neumayer, HH; Kunz, R			Do short courses in evidence based medicine improve knowledge and skills? Validation of Berlin questionnaire and before and after study of courses in evidence based medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CRITICAL-APPRAISAL SKILLS; TEACHING RESIDENTS; CONTROLLED-TRIAL; EDUCATION; READ	Objective To develop and validate an instrument for measuring knowledge and skills in evidence based medicine and to investigate whether short courses in evidence based medicine lead to a meaningful increase in knowledge and skills. Design Development and validation of an assessment instrument and before and after study. Setting Various postgraduate short courses in evidence based medicine in Germany. Participants The instrument was validated with experts in evidence based medicine, postgraduate doctors, and medical students. The effect of courses was assessed by postgraduate doctors from medical and surgical backgrounds. Intervention Intensive 3 day courses in evidence based medicine delivered through tutor facilitated small groups. Main outcome measure Increase in knowledge and skills. Results The questionnaire distinguished reliably between groups with different expertise in evidence based medicine. Experts attained a threefold higher average score than students. Postgraduates who had not attended a course performed better than students but significantly worse than experts. Knowledge and skills in evidence based medicine increased after the course by 57% (mean score before course 6.3 (SD 2.9) v 9.9 (SD 2.8), P < 0.001). No difference was found among experts or students in absence of an intervention. Conclusions The instrument reliably assessed knowledge and skills in evidence based medicine. An intensive 3 day course in evidence based medicine led to a significant increase in knowledge and skills.	Charite, Dept Nephrol, D-10117 Berlin, Germany; UCL, Dept Primary Hlth Care, London N19 3UA, England; Univ Freiburg, Inst Med Biometry & Med Informat, German Cochrane Ctr, D-7800 Freiburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; University College London; University of Freiburg	Kunz, R (corresponding author), Charite, Dept Nephrol, Campus Mitte, D-10117 Berlin, Germany.	regina.kunz@charite.de	Falck-Ytter, Yngve/GZH-0993-2022; Greenhalgh, Trisha/B-1825-2015; Yngve Falck-Ytter, AGAF/AAC-5362-2019	Greenhalgh, Trisha/0000-0003-2369-8088; Yngve Falck-Ytter, AGAF/0000-0002-4688-3211				Alguire PC, 1998, J GEN INTERN MED, V13, P347, DOI 10.1046/j.1525-1497.1998.00102.x; *AM COLL PHYS, 2001, BEST EV, V5; [Anonymous], 2001, CLIN EVIDENCE; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; GEHLBACH SH, 1980, J MED EDUC, V55, P362; Green ML, 1999, ACAD MED, V74, P686, DOI 10.1097/00001888-199906000-00017; Green ML, 2000, J EVAL CLIN PRACT, V6, P121, DOI 10.1046/j.1365-2753.2000.00239.x; Guyatt GH, 2000, BRIT MED J, V320, P954, DOI 10.1136/bmj.320.7240.954; GUYATT GH, 2002, USERS GUIDE MED LIT; Khan KS, 2001, MED TEACH, V23, P92, DOI 10.1080/01421590150214654; Kirkpatrick DL, 1967, TRAINING DEV HDB; KITCHENS JM, 1989, J GEN INTERN MED, V4, P384, DOI 10.1007/BF02599686; Kunz R, 2001, Z Arztl Fortbild Qualitatssich, V95, P371; LIENERT GA, 1995, TESTAUFBAU TESTANALY; LINZER M, 1988, JAMA-J AM MED ASSOC, V260, P2537, DOI 10.1001/jama.260.17.2537; Norman GR, 1998, CAN MED ASSOC J, V158, P177; Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd; PARKES J, 2001, COCHRANE LIB; Smith CA, 2000, J GEN INTERN MED, V15, P710, DOI 10.1046/j.1525-1497.2000.91026.x; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; Taylor R, 2000, MED EDUC, V34, P120, DOI 10.1046/j.1365-2923.2000.00574.x; *UPD SOFTW, 2002, COCHR LIB	22	220	228	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2002	325	7376					1338	1341		10.1136/bmj.325.7376.1338	http://dx.doi.org/10.1136/bmj.325.7376.1338			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468485	Green Published, Bronze			2022-12-28	WOS:000179817100023
J	Dickson, BJ				Dickson, BJ			Molecular mechanisms of axon guidance	SCIENCE			English	Review							GROWTH CONE GUIDANCE; GANGLION-CELL AXONS; C-ELEGANS; NERVE GROWTH; SEMAPHORIN RECEPTOR; NEURONAL MIGRATION; TYROSINE KINASE; DROSOPHILA CNS; IN-VIVO; CHEMOATTRACTANT NETRIN-1	Axons are guided along specific pathways by attractive and repulsive cues in the extracellular environment. Genetic and biochemical studies have led to the identification of highly conserved families of guidance molecules, including netrins, Slits, semaphorins, and ephrins. Guidance cues steer axons by regulating cytoskeletal dynamics in the growth cone through signaling pathways that are still only poorly understood. Elaborate regulatory mechanisms ensure that a given cue elicits the right response from the right axons at the right time but is otherwise ignored. With such regulatory mechanisms in place, a relatively small number of guidance factors can be used to generate intricate patterns of neuronal wiring.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	dickson@nt.imp.univie.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X				Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Battye R, 1999, DEVELOPMENT, V126, P2475; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bossing T, 2002, DEVELOPMENT, V129, P4205; BOYLE M, COMMUNICATION; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Erskine L, 2000, J NEUROSCI, V20, P4975; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Fujii T, 2002, DEVELOPMENT, V129, P2053; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Ginzburg VE, 2002, DEVELOPMENT, V129, P2065; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HEIDEMANN SR, 1990, J CELL BIOL, V111, P1949, DOI 10.1083/jcb.111.5.1949; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Isbister CM, 2000, J NEUROBIOL, V44, P271, DOI 10.1002/1097-4695(200008)44:2<271::AID-NEU15>3.3.CO;2-1; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kishore RS, 2002, DEV BIOL, V241, P339, DOI 10.1006/dbio.2001.0513; Knoll B, 2001, DEVELOPMENT, V128, P895; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Murray MJ, 1998, J NEUROBIOL, V37, P607, DOI 10.1002/(SICI)1097-4695(199812)37:4<607::AID-NEU9>3.3.CO;2-H; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; MYERS PZ, 1993, J NEUROSCI, V13, P127; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Niclou SP, 2000, J NEUROSCI, V20, P4962; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; OKABE S, 1991, J NEUROSCI, V11, P1918; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Roy PJ, 2000, DEVELOPMENT, V127, P755; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wong JTW, 1999, NAT NEUROSCI, V2, P798, DOI 10.1038/12168; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	114	1088	1156	2	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					1959	1964		10.1126/science.1072165	http://dx.doi.org/10.1126/science.1072165			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471249				2022-12-28	WOS:000179629200036
J	Holmberg, SD; Moorman, AC; Williamson, JM; Tong, TC; Ward, DJ; Wood, KC; Greenberg, AE; Janssen, RS				Holmberg, SD; Moorman, AC; Williamson, JM; Tong, TC; Ward, DJ; Wood, KC; Greenberg, AE; Janssen, RS		HOPS Investigators	Protease inhibitors and cardiovascular outcomes in patients with HIV-1	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; CORONARY-ARTERY DISEASE	Protease inhibitors for treatment of HIV-1 have been linked with increased risk of hyperlipidaemia and hyperglycaemia. In a cohort of 5672 outpatients with HIV-1 seen at nine US HIV clinics between January, 1993, and January, 2002, the frequency of myocardial infarctions increased after the introduction of protease inhibitors in 1996 (test for trend, p=0.0125). We noted that 19 of 3247 patients taking, but only two of 2425 who did not take, protease inhibitors had a myocardial infarction (odds ratio 7.1, 95% CI 1.6-44.3; Cox proportional hazards model-adjusted for smoking, sex, age, diabetes, hyperlipidaemia, and hypertension-hazard ratio 6.5, 0.9-47.8). Our findings suggest that, although infrequent, use of protease inhibitors is associated with increased risk of myocardial infarction in patients with HIV-1.	Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; Dupont Circle Phys Grp, Washington, DC USA; Cerner Corp, McLean, VA USA	Centers for Disease Control & Prevention - USA	Holmberg, SD (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.			Moorman, Anne/0000-0003-2411-2798				BARBARO G, 2002, 14 INT C AIDS BARC J; BOZZETTE SA, 2002, 9 C RETR OPP INF SEA; Henry K, 1998, LANCET, V351, P1328, DOI 10.1016/S0140-6736(05)79053-X; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Passalaris JD, 2000, CLIN INFECT DIS, V31, P787	5	362	380	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1747	1748		10.1016/S0140-6736(02)11672-2	http://dx.doi.org/10.1016/S0140-6736(02)11672-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480430				2022-12-28	WOS:000179636800014
J	Nurnberg, HG; Hensley, PL; Gelenberg, AJ; Fava, M; Lauriello, J; Paine, S				Nurnberg, HG; Hensley, PL; Gelenberg, AJ; Fava, M; Lauriello, J; Paine, S			Treatment of antidepressant-associated sexual dysfunction with sildenafil - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEROTONIN REUPTAKE INHIBITORS; SPINAL-CORD INJURY; ERECTILE DYSFUNCTION; ORAL SILDENAFIL; PRIMARY-CARE; RADICAL PROSTATECTOMY; DEPRESSIVE SYMPTOMS; INTERNATIONAL INDEX; SUSTAINED-RELEASE; MEN	Context Sexual dysfunction is a common adverse effect of antidepressants that frequently results in treatment noncompliance. Objective To assess the efficacy of sildenafil citrate in men with sexual dysfunction associated with the use of selective and nonselective serotonin reuptake inhibitor (SRI) antidepressants. Design, Setting, and Patients Prospective, parallel-group, randomized, double-blind, placebo-controlled trial conducted between November 1, 2000, and January 1, 2001, at 3 US university medical centers among 90 male outpatients (mean [SD] age, 45 [8] years) with major depression in remission and sexual dysfunction associated with SRI antidepressant treatment. Intervention Patients were randomly assigned to take sildenafil (n=45) or placebo (n=45) at a flexible dose starting at 50 mg and adjustable to 100 mg before sexual activity for 6 weeks. Main Outcome Measures The primary outcome measure was score on the Clinical Global Impression-Sexual Function (CGI-SF); secondary measures were scores on the International index of Erectile Function, Arizona Sexual Experience Scale, Massachusetts General Hospital-Sexual Functioning Questionnaire, and Hamilton Rating Scale for Depression (HAM-D). Results Among the 90 randomized patients, 93% (83/89) of patients treated per protocol took at least 1 dose of study drug and 85% (76/89) completed week 6 end-point assessments with last observation carried forward analyses. At a CGI-SF score of 2 or lower, 54.5% (24/44) of sildenafil compared with 4.4% (2/45) of placebo patients were much or very much improved (P<.001). Erectile function, arousal, ejaculation, orgasm, and overall satisfaction domain measures improved significantly in sildenafil compared with placebo patients. Mean depression scores remained consistent with remission (HAM-D score <= 10) in both groups for the study duration. Conclusion In our study, sildenafil effectively improved erectile function and other aspects of sexual function in men with sexual dysfunction associated with the use of SRI antidepressants. These improvements may allow patients to maintain adherence with effective antidepressant treatment.	Univ New Mexico, Sch Med, Dept Psychiat, Hlth Sci Ctr, Albuquerque, NM 87131 USA; Arizona Hlth Sci Ctr, Dept Psychiat, Tucson, AZ 85724 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of Arizona Health Sciences; Harvard University; Massachusetts General Hospital	Nurnberg, HG (corresponding author), Univ New Mexico, Sch Med, Dept Psychiat, Hlth Sci Ctr, 2400 Tucker NE, Albuquerque, NM 87131 USA.	geon@unm.edu	Fava, Maurizio/AAH-3548-2020					ABRAM HS, 1975, J NERV MENT DIS, V160, P220, DOI 10.1097/00005053-197503000-00007; American Psychiatric Association, 2002, PRACT GUID TREATM PA; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANDERSSON KE, 1995, PHYSIOL REV, V75, P191, DOI 10.1152/physrev.1995.75.1.191; Araujo AB, 1998, PSYCHOSOM MED, V60, P458, DOI 10.1097/00006842-199807000-00011; Ashton AK, 1999, J CLIN PSYCHIAT, V60, P194, DOI 10.4088/JCP.v60n0309a; BAKER BO, 1966, EDUC PSYCHOL MEAS, V26, P291, DOI 10.1177/001316446602600204; Ballard SA, 1998, J UROLOGY, V159, P2164, DOI 10.1016/S0022-5347(01)63299-3; Balon R, 1998, J SEX MARITAL THER, V24, P313, DOI 10.1080/00926239808403967; Bogenschutz MP, 2000, HARVARD REV PSYCHIAT, V8, P18, DOI 10.1093/hrp/8.1.18; Boolell M, 1996, Int J Impot Res, V8, P47; Clayton AH, 2002, J CLIN PSYCHIAT, V63, P357, DOI 10.4088/JCP.v63n0414; CLAYTON AH, 2000, NEW CLIN DRUG EV UN; Croft H, 1999, CLIN THER, V21, P643, DOI 10.1016/S0149-2918(00)88317-4; Derry FA, 1998, NEUROLOGY, V51, P1629, DOI 10.1212/WNL.51.6.1629; Dinsmore WW, 1999, UROLOGY, V53, P800, DOI 10.1016/S0090-4295(98)00586-X; Ekselius L, 2001, J CLIN PSYCHOPHARM, V21, P154, DOI 10.1097/00004714-200104000-00006; Fava M, 1998, Ann Clin Psychiatry, V10, P145; Fava M, 1998, PSYCHOTHER PSYCHOSOM, V67, P328, DOI 10.1159/000012299; Fava M, 2002, J CLIN PSYCHIAT, V63, P13; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; FOWLER C, 2000, AM J PSYCHIAT, V157, P497; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Giuliano F, 1999, ANN NEUROL, V46, P15, DOI 10.1002/1531-8249(199907)46:1<15::AID-ANA5>3.0.CO;2-U; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Greden JF, 2001, J CLIN PSYCHIAT, V62, pS26; GUY W, 1976, ECDEU ASS MAN PSYCHO; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HARRISON WM, 1986, J CLIN PSYCHOPHARM, V6, P144; Hultling C, 2000, SPINAL CORD, V38, P363, DOI 10.1038/sj.sc.3101011; KATON W, 1992, MED CARE, V30, P67, DOI 10.1097/00005650-199201000-00007; Kavoussi RJ, 1997, J CLIN PSYCHIAT, V58, P532, DOI 10.4088/JCP.v58n1204; Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001; Kennedy SH, 1999, J AFFECT DISORDERS, V56, P201, DOI 10.1016/S0165-0327(99)00050-6; Kloner RA, 2001, AM J HYPERTENS, V14, P70, DOI 10.1016/S0895-7061(00)01177-8; Labbate LA, 1998, J SEX MARITAL THER, V24, P3, DOI 10.1080/00926239808414663; Labbate LA, 2001, PSYCHOTHER PSYCHOSOM, V70, P221, DOI 10.1159/000056257; Landen M, 1999, J CLIN PSYCHOPHARM, V19, P268, DOI 10.1097/00004714-199906000-00012; LIN EHB, 1995, MED CARE, V33, P67, DOI 10.1097/00005650-199501000-00006; MATHEW RJ, 1982, ARCH SEX BEHAV, V11, P323, DOI 10.1007/BF01541593; McGahuey CA, 2000, J SEX MARITAL THER, V26, P25, DOI 10.1080/009262300278623; Michelson D, 2001, J SEX MARITAL THER, V27, P289, DOI 10.1080/009262301750257146; Montejo AL, 2001, J CLIN PSYCHIAT, V62, P10; *NAT DEPR MAN DEPR, 2000, DIAGN LANDM SURV DEP; Nelson EB, 2001, J CLIN PSYCHIAT, V62, P469, DOI 10.4088/JCP.v62n0611; Nurnberg H G, 2001, J Psychiatr Pract, V7, P92, DOI 10.1097/00131746-200103000-00003; Nurnberg HG, 2000, CNS DRUGS, V13, P321, DOI 10.2165/00023210-200013050-00003; Nurnberg HG, 1999, J CLIN PSYCHIAT, V60, P33, DOI 10.4088/JCP.v60n0107; Nurnberg HG, 2001, AM J PSYCHIAT, V158, P1926, DOI 10.1176/appi.ajp.158.11.1926; Pelliccia F, 2000, J AM COLL CARDIOL, V35, p339A; Price D, 1999, INT J CLIN PRACT, P21; Price DE, 1998, DIABETIC MED, V15, P821, DOI 10.1002/(SICI)1096-9136(199810)15:10<821::AID-DIA697>3.0.CO;2-P; Rendell MS, 1999, JAMA-J AM MED ASSOC, V281, P421, DOI 10.1001/jama.281.5.421; ROOSE SP, 1982, NEUROPSYCHOBIOLOGY, V8, P284, DOI 10.1159/000117913; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rosen RC, 1999, J CLIN PSYCHOPHARM, V19, P67, DOI 10.1097/00004714-199902000-00013; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Rothschild AJ, 2000, CLIN THER, V22, pA42, DOI 10.1016/S0149-2918(00)80072-7; Schaller JL, 1999, AM J PSYCHIAT, V156, P156; Scholz M, 1999, J UROLOGY, V161, P1914, DOI 10.1016/S0022-5347(05)68849-0; Seidman SN, 2001, AM J PSYCHIAT, V158, P1623, DOI 10.1176/appi.ajp.158.10.1623; Snedecor GW, 1980, STAT METHODS, V7th; STEELE TE, 1986, J CLIN PSYCHOPHARM, V6, P326; THASE ME, 1987, AM J PSYCHIAT, V144, P89; TIGNOL JL, 2001, AM PSYCH ASS ANN M M; Zagaja GP, 2000, UROLOGY, V56, P631, DOI 10.1016/S0090-4295(00)00659-2; Zajecka J, 2001, J CLIN PSYCHIAT, V62, P35; Zippe CD, 2000, UROLOGY, V55, P241, DOI 10.1016/S0090-4295(99)00441-0; Zusman RM, 2000, J HYPERTENS, V18, P1865, DOI 10.1097/00004872-200018120-00022; 1999, ADV DATA, V305, P1	71	145	149	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					56	64		10.1001/jama.289.1.56	http://dx.doi.org/10.1001/jama.289.1.56			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630XL	12503977	Bronze			2022-12-28	WOS:000180136600026
J	Mariner, WK				Mariner, WK			Independent external review of health maintenance organizations' medical-necessity decisions.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INCOME SECURITY ACT; MANAGED-CARE DECISIONS; RETIREMENT; LIABILITY; REFORM; ERISA		Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA	Boston University	Mariner, WK (corresponding author), Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA.		reddy, indra p/C-5363-2011	Mariner, Wendy/0000-0001-5176-5917				BUTLER P, 2001, KEY CHARACTERISTICS; CHIRBAMARTIN MA, 1994, HEALTH AFFAIR, V13, P142, DOI 10.1377/hlthaff.13.2.142; COPELAND C, 2000, EBRI NOTES, V21, P3; COUCH G, 1995, CYCLOPEDIA INSURAN S; DALLEK G, 2000, KAISER FAMILY FDN PU, V3020; FRONSTIN P, 2001, SOURCES HLTH INSURAN; JORDAN KA, 2000, MO L REV, V65, P405; *KAIS FAM FDN HARV, 1999, HJ KAIS FAM FDN PUBL, V1502; Kinney ED, 2000, AM J LAW MED, V26, P335; Mariner WK, 1996, AM J PUBLIC HEALTH, V86, P863, DOI 10.2105/AJPH.86.6.863; Mariner WK, 2001, J LAW MED ETHICS, V29, P253, DOI 10.1111/j.1748-720X.2001.tb00347.x; MARINER WK, 1992, NEW ENGL J MED, V327, P1682, DOI 10.1056/NEJM199212033272312; Mariner WK, 2000, NEW ENGL J MED, V343, P592, DOI 10.1056/NEJM200008243430823; Mariner WK, 1996, NEW ENGL J MED, V335, P1986, DOI 10.1056/NEJM199612263352610; STEMPEL JW, 1999, LAW INSURANCE CONTRA	15	5	5	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2178	2182		10.1056/NEJMlim021769	http://dx.doi.org/10.1056/NEJMlim021769			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	629FZ	12501237	Green Published			2022-12-28	WOS:000180040900033
J	Wolpert, L; Szathmary, E				Wolpert, L; Szathmary, E			Multicellularity: Evolution and the egg	NATURE			English	Editorial Material									UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Eotvos Lorand Univ, Dept Plant Taxon & Ecol, H-1014 Budapest, Hungary; Collegium Budapest, Inst Adv Study, H-1014 Budapest, Hungary	University of London; University College London; Eotvos Lorand University	Wolpert, L (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.		Szathmary, Eors/AAS-1202-2021; Szathmáry, Eörs/A-5007-2011	Szathmary, Eors/0000-0001-5227-2997; 				BONNER JT, 2002, 1 SIGNALS EVOLUTION; HAMMERSTEIN P, IN PRESS DAHL WORKSH, V90; Kaiser D, 2001, ANNU REV GENET, V35, P103, DOI 10.1146/annurev.genet.35.102401.090145; Kerszberg M, 1998, J THEOR BIOL, V193, P535, DOI 10.1006/jtbi.1998.0714; Szathmary E, 1995, MAJOR TRANSITIONS EV	5	59	59	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					745	745		10.1038/420745a	http://dx.doi.org/10.1038/420745a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490925	Bronze			2022-12-28	WOS:000179897300033
J	Ostapowicz, G; Fontana, RJ; Schiodt, FV; Larson, A; Davern, TJ; Han, SHB; McCashland, TM; Shakil, AO; Hay, JE; Hynan, L; Crippin, JS; Blei, AT; Samuel, G; Reisch, J; Lee, WM				Ostapowicz, G; Fontana, RJ; Schiodt, FV; Larson, A; Davern, TJ; Han, SHB; McCashland, TM; Shakil, AO; Hay, JE; Hynan, L; Crippin, JS; Blei, AT; Samuel, G; Reisch, J; Lee, WM		US Acute Liver Failure Study Grp	Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							FULMINANT HEPATIC-FAILURE; PARACETAMOL OVERDOSE; CLINICAL-FEATURES; TRANSPLANTATION; EXPERIENCE; ETIOLOGY; HEPATOTOXICITY	Background: Because acute liver failure is rare, related data have been sparse. Studies have suggested that viral hepatitis is the most common underlying cause of this condition. Objective: To describe the clinical features, presumed causes, and short-term outcomes of acute liver failure. Design: Prospective cohort study. Setting: 17 tertiary care centers participating in the U.S. Acute Liver Failure Study Group. Patients: 308 consecutive patients with acute liver failure, admitted over a 41-month period. Measurements: Detailed clinical and laboratory data collected during hospitalization, including outcome 3 weeks after study admission. Results: 73% of patients were women; median age was 38 years. Acetaminophen overdose was the most common apparent cause of acute liver failure, accounting for 39% of cases. idiosyncratic drug reactions were the presumptive cause in 13% of cases, viral hepatitis A and B combined were implicated in 12% of cases, and 17% of cases were of indeterminate cause. Overall patient survival at 3 weeks was 67%. Twenty-nine percent of patients had liver transplantation, and 43% survived without transplantation. Short-term transplant-free survival varied greatly, from 68% for patients with acetaminophen-related liver failure to 25% and 17% for those with other drug reactions and liver failure of indeterminate cause, respectively. Coma grade at admission appeared to be associated with outcome, but age and symptom duration did not. Conclusions: Acetaminophen overdose and idiosyncratic drug reactions have replaced viral hepatitis as the most frequent apparent causes of acute liver failure. Apparent cause and coma grade at admission were associated with outcome. Although transplantation may improve patient survival, it was unavailable or unnecessary for most patients.	Univ Texas, SW Med Ctr, Div Digest & Liver Dis, Dallas, TX 75235 USA; Gold Coast Hosp, Southport, Qld, Australia; Univ Michigan, Ann Arbor, MI 48109 USA; Baylor Univ, Med Ctr, Dallas, TX 75246 USA; Univ Washington, Seattle, WA 98195 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; Univ Nebraska, Omaha, NE 68182 USA; Univ Pittsburgh, Pittsburgh, PA 15260 USA; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA; Northwestern Univ, Chicago, IL 60611 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Gold Coast University Hospital; University of Michigan System; University of Michigan; Baylor University; Baylor University Medical Center; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of Nebraska System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; Northwestern University	Lee, WM (corresponding author), Univ Texas, SW Med Ctr, Div Digest & Liver Dis, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.		Shaikh, Obaid/AAL-5339-2021; Larson, Anne/I-2087-2019; Hynan, Linda S/P-6473-2016	Shaikh, Obaid/0000-0002-4955-9222; Hynan, Linda/0000-0002-4642-7769	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058369, R03DK052827] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK58369, R03 DK52827] Funding Source: Medline; FDA HHS [FD-R-001661] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FDA HHS		Acharya SK, 1996, HEPATOLOGY, V23, P1448, DOI 10.1053/jhep.1996.v23.pm0008675163; BENHAMOU JP, 1991, ACUTE LIVER FAILURE, P6; ELLIS AJ, 1995, J HEPATOL, V23, P363, DOI 10.1016/0168-8278(95)80193-6; Fontana RJ, 1999, LIVER TRANSPLANT SUR, V5, P480, DOI 10.1002/lt.500050607; GIMSON AES, 1986, HEPATOLOGY, V6, P288, DOI 10.1002/hep.1840060222; Hamid SS, 1996, J HEPATOL, V25, P20, DOI 10.1016/S0168-8278(96)80323-0; Hawton K, 2001, BMJ-BRIT MED J, V322, P1203, DOI 10.1136/bmj.322.7296.1203; Hay JE, 2001, GASTROENTEROLOGY, V120, pA542; HOOFNAGLE JH, 1995, HEPATOLOGY, V21, P240, DOI 10.1002/hep.1840210137; Larsen FS, 1995, TRANSPLANT P, V27, P3519; LEE WM, 1993, NEW ENGL J MED, V329, P1862, DOI 10.1056/NEJM199312163292508; LEE WM, 1999, SCHIFFS DIS LIVER, P879; MAKIN AJ, 1995, GASTROENTEROLOGY, V109, P1907, DOI 10.1016/0016-5085(95)90758-0; McCashland TM, 1996, SEMIN LIVER DIS, V16, P427, DOI 10.1055/s-2007-1007255; Murphy EJ, 2000, DIGEST DIS SCI, V45, P549, DOI 10.1023/A:1005405526283; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Prince MI, 2000, LANCET, V355, P2047, DOI 10.1016/S0140-6736(00)02354-0; RAKELA J, 1991, DIGEST DIS SCI, V36, P1223, DOI 10.1007/BF01307513; RAKELA J, 1985, MAYO CLIN PROC, V60, P289, DOI 10.1016/S0025-6196(12)60534-5; RITT DJ, 1969, MEDICINE, V48, P151, DOI 10.1097/00005792-196903000-00003; Schiodt FV, 1999, LIVER TRANSPLANT SUR, V5, P29, DOI 10.1002/lt.500050102; Schiodt FV, 1999, SCAND J GASTROENTERO, V34, P723; SCHMIDT LE, 2002, HEPATOLOGY, V16, P707; Shakil AO, 2000, LIVER TRANSPLANT, V6, P163, DOI 10.1016/S1527-6465(00)80005-2; TREY C, 1970, Progress in Liver Diseases, P282; Trigo PL, 2001, HEPATOLOGY, V34, p657A; Turvill JL, 2000, LANCET, V355, P2048, DOI 10.1016/S0140-6736(00)02355-2; Uemoto S, 2000, TRANSPLANTATION, V70, P152; WHITCOMB DC, 1994, JAMA-J AM MED ASSOC, V272, P1845, DOI 10.1001/jama.272.23.1845; Williams R, 1996, SEMIN LIVER DIS, V16, P343, DOI 10.1055/s-2007-1007247; 1998, 3 NAT HLTH NUTR EXAM	32	1404	1492	0	63	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2002	137	12					947	954		10.7326/0003-4819-137-12-200212170-00007	http://dx.doi.org/10.7326/0003-4819-137-12-200212170-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626DR	12484709				2022-12-28	WOS:000179857500002
J	Di Virgilio, F; Wiley, JS				Di Virgilio, F; Wiley, JS			The P2X7 receptor of CLL lymphocytes - a molecule with a split personality	LANCET			English	Editorial Material							ATP RECEPTOR; P2X(7); EXPRESSION; LEUKEMIA; CELLS		Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; Univ Sydney, Nepean Hosp, Dept Med, Penrith, NSW, Australia	University of Ferrara; Nepean Hospital; University of Sydney	Di Virgilio, F (corresponding author), Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy.		Di Virgilio, Francesco/J-3754-2018; DI VIRGILIO, Francesco/O-4634-2019	Di Virgilio, Francesco/0000-0003-3566-1362; DI VIRGILIO, Francesco/0000-0003-3566-1362; Wiley, James/0000-0001-9421-4154				Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Rawstron AC, 2002, BLOOD, V100, P635, DOI 10.1182/blood.V100.2.635; Wickremasinghe RG, 1999, BLOOD, V93, P3587, DOI 10.1182/blood.V93.11.3587.411k46_3587_3600; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; WILEY JS, 1989, BLOOD, V73, P1316	12	16	16	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1898	1899		10.1016/S0140-6736(02)11933-7	http://dx.doi.org/10.1016/S0140-6736(02)11933-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493250				2022-12-28	WOS:000179870200002
J	Peterson, BJ; Holmes, RM; McClelland, JW; Vorosmarty, CJ; Lammers, RB; Shiklomanov, AI; Shiklomanov, IA; Rahmstorf, S				Peterson, BJ; Holmes, RM; McClelland, JW; Vorosmarty, CJ; Lammers, RB; Shiklomanov, AI; Shiklomanov, IA; Rahmstorf, S			Increasing river discharge to the Arctic Ocean	SCIENCE			English	Article							ATLANTIC THERMOHALINE CIRCULATION; RECENT CLIMATE-CHANGE; MASS-BALANCE; FRESH-WATER; ICE SHEETS; RUNOFF; MODEL; VARIABILITY; DYNAMICS; IMPACT	Synthesis of river-monitoring data reveals that the average annual discharge of fresh water from the six largest Eurasian rivers to the Arctic Ocean increased by 7% from 1936 to 1999. The average annual rate of increase was 2.0 +/- 0.7 cubic kilometers per year. Consequently, average annual discharge from the six rivers is now about 128 cubic kilometers per year greater than it was when routine measurements of discharge began. Discharge was correlated with changes in both the North Atlantic Oscillation and global mean surface air temperature. The observed large-scale change in freshwater flux has potentially important implications for ocean circulation and climate.	Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Water Syst Anal Grp, Durham, NH 03824 USA; State Hydrol Inst, St Petersburg 199053, Russia; Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany	Marine Biological Laboratory - Woods Hole; University System Of New Hampshire; University of New Hampshire; Potsdam Institut fur Klimafolgenforschung	Peterson, BJ (corresponding author), Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA.	peterson@mbl.edu	Rahmstorf, Stefan/A-8465-2010; Shiklomanov, Alexander I/C-5521-2014; McClelland, James W/C-5396-2008	Rahmstorf, Stefan/0000-0001-6786-7723; McClelland, James W/0000-0001-9619-8194; Shiklomanov, Alexander/0000-0001-9790-3510; Holmes, Robert Max/0000-0002-6413-9154				Broecker WS, 1997, SCIENCE, V278, P1582, DOI 10.1126/science.278.5343.1582; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Dickson RR, 2000, J CLIMATE, V13, P2671, DOI 10.1175/1520-0442(2000)013<2671:TAORTT>2.0.CO;2; Dowdeswell JA, 1997, QUATERNARY RES, V48, P1, DOI 10.1006/qres.1997.1900; Huybrechts P, 1999, J CLIMATE, V12, P2169, DOI 10.1175/1520-0442(1999)012<2169:TDROTG>2.0.CO;2; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Lammers R., 2002, EOS T AM GEOPHYS UNI, V83, P13, DOI [10.1029/2002EO000007, DOI 10.1029/2002EO000007]; Lammers RB, 2001, J GEOPHYS RES-ATMOS, V106, P3321, DOI 10.1029/2000JD900444; MANABE S, 1994, J CLIMATE, V7, P5, DOI 10.1175/1520-0442(1994)007<0005:MCROAC>2.0.CO;2; Miller JR, 2000, GEOPHYS RES LETT, V27, P1183, DOI 10.1029/1999GL007001; MILLER JR, 1992, J GEOPHYS RES-ATMOS, V97, P2757, DOI 10.1029/91JD01700; Moritz RE, 2002, SCIENCE, V297, P1497, DOI 10.1126/science.1076522; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Nijssen B, 2001, CLIMATIC CHANGE, V50, P143, DOI 10.1023/A:1010616428763; Prowse TD, 2000, HYDROL PROCESS, V14, P3185, DOI 10.1002/1099-1085(200011/12)14:16/17<3185::AID-HYP170>3.0.CO;2-S; Rahmstorf S, 1996, CLIM DYNAM, V12, P799, DOI 10.1007/s003820050144; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Rahmstorf S, 1999, CLIMATIC CHANGE, V43, P353, DOI 10.1023/A:1005474526406; Savelieva NI, 2000, PROG OCEANOGR, V47, P279, DOI 10.1016/S0079-6611(00)00039-2; Semiletov IP, 2000, NATO SCI S PRT 2 ENV, V70, P323; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Shiklomanov IA, 2000, NATO SCI S PRT 2 ENV, V70, P281; Stieglitz M, 2000, GLOBAL BIOGEOCHEM CY, V14, P1123, DOI 10.1029/1999GB001214; VANBLARCUM SC, 1995, CLIMATIC CHANGE, V30, P7, DOI 10.1007/BF01093223; Vinnikov KY, 1999, SCIENCE, V286, P1934, DOI 10.1126/science.286.5446.1934; VOROSMARTY C, 2002, EOS, V83, P241; Wild M, 2000, ANN GLACIOL, V30, P197, DOI 10.3189/172756400781820741	28	1059	1114	11	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2171	2173		10.1126/science.1077445	http://dx.doi.org/10.1126/science.1077445			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481132	Green Submitted			2022-12-28	WOS:000179773700041
J	Cyranoski, D				Cyranoski, D			Radar array tests the atmosphere at pole position	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					594	594		10.1038/420594b	http://dx.doi.org/10.1038/420594b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478250	Bronze			2022-12-28	WOS:000179751800006
J	Pendleton, D; King, J				Pendleton, D; King, J			Values and leadership	BRITISH MEDICAL JOURNAL			English	Article																		*BRIT MED ASS, 2001, NAT SURV GP OP; Clever LH, 1999, BRIT MED J, V319, P1587, DOI 10.1136/bmj.319.7225.1587; COLLINS JC, 1996, HARVARD BUSINESS SEP, P65; FLETCHER C, 1997, APPRAISAL; General Medical Council, 2001, GOOD MED PRACT; Gray DP, 2002, BRIT MED J, V324, P627; Jones R, 2002, BRIT MED J, V324, P624, DOI 10.1136/bmj.324.7338.624; MARTIN M, 2002, BR J GEN PRACT, V52, P243; OREILLY C, 2000, HIDDEN POWER; Porras JI., 1994, BUILT LAST SUCCESSFU; *ROYAL COLL GEN PR, 1985, WHAT SORT DOCT; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Waterman R. H., 1990, ADHOCRACY POWER CHAN	13	38	38	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2002	325	7376					1352	1355		10.1136/bmj.325.7376.1352	http://dx.doi.org/10.1136/bmj.325.7376.1352			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468489	Green Published			2022-12-28	WOS:000179817100027
J	Kaplan, J				Kaplan, J			Mechanisms of cellular iron acquisition: Another iron in the fire	CELL			English	Review							HEPCIDIN; GENE; TRANSPORTER; OVERLOAD; CLONING; ANEMIA; LIVER; MOUSE; MICE	Iron transport occurs by the Well-known transferrin (Tf)-transferrin receptor (Tf receptor) system and by a second as yet uncharacterized system. Two reports in the current issue of Molecular Cell suggest an unexpected candidate for the Tf-independent system.	Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.							Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Jurado RL, 1997, CLIN INFECT DIS, V25, P888, DOI 10.1086/515549; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4	19	98	101	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 27	2002	111	5					603	606		10.1016/S0092-8674(02)01164-9	http://dx.doi.org/10.1016/S0092-8674(02)01164-9			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464171	Bronze			2022-12-28	WOS:000179594500001
J	Loudon, JC; Mathur, ND; Midgley, PA				Loudon, JC; Mathur, ND; Midgley, PA			Charge-ordered ferromagnetic phase in La0.5Ca0.5MnO3	NATURE			English	Article							THIN-FILMS; SEPARATION; MANGANITES; LA1-XCAXMNO3; STRIPES	Mixed-valent manganites are noted for their unusual magnetic, electronic and structural phase transitions. For example, the La1-xCaxMnO3 phase diagram(1) shows that below transition temperatures in the range 100-260 K, compounds with 0.2 < x < 0.5 are ferromagnetic and metallic, whereas those with 0.5 < x < 0.9 are antiferromagnetic and charge ordered. In a narrow region around x 5 0.5, these totally dissimilar ground states are thought to coexist(2,3). It has been shown 4 that charge order and charge disorder can coexist in the related compound, La0.25Pr0.375Ca0.375MnO3. Here we present electron microscopy data for La0.5Ca0.5MnO3 that shed light on the distribution of these coexisting phases, and uncover an additional, unexpected phase. Using electron holography and Fresnel imaging, we find micrometre-sized ferromagnetic regions spanning several grains coexisting with similar-sized regions with no local magnetization. Holography shows that the ferromagnetic regions have a local magnetization of 3.4 +/- 0.2 Bohr magnetons per Mn atom (the spin-aligned value is 3.5 mu(B) per Mn). We use electron diffraction and dark-field imaging to show that charge order exists in regions with no net magnetization and, surprisingly, can also occur in ferromagnetic regions.	Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	University of Cambridge	Loudon, JC (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.			Midgley, Paul/0000-0002-6817-458X				Chen CH, 1997, J APPL PHYS, V81, P4326, DOI 10.1063/1.364758; Cheong S.W., 2000, MONOGRAPHS CONDENSED; DEGENNES PG, 1960, PHYS REV, V118, P141, DOI 10.1103/PhysRev.118.141; Dunin-Borkowski RE, 1998, ULTRAMICROSCOPY, V74, P61, DOI 10.1016/S0304-3991(98)00023-0; GOODENOUGH JB, 1955, PHYS REV, V100, P564, DOI 10.1103/PhysRev.100.564; Hirsh P., 1977, ELECT MICROSCOPY THI; Levy P, 2000, PHYS REV B, V62, P6437, DOI 10.1103/PhysRevB.62.6437; Lloyd SJ, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.172407; Mathur ND, 2001, SOLID STATE COMMUN, V119, P271, DOI 10.1016/S0038-1098(01)00112-0; Moreo A, 1999, SCIENCE, V283, P2034, DOI 10.1126/science.283.5410.2034; Mori S, 2002, J ELECTRON MICROSC, V51, P225, DOI 10.1093/jmicro/51.4.225; Mori S, 1998, NATURE, V392, P473, DOI 10.1038/33105; Radaelli PG, 1999, PHYS REV B, V59, P14440, DOI 10.1103/PhysRevB.59.14440; Radaelli PG, 1997, PHYS REV B, V55, P3015, DOI 10.1103/PhysRevB.55.3015; REZ D, 1994, ACTA CRYSTALLOGR A, V50, P481, DOI 10.1107/S0108767393013200; Roy M, 1998, PHYS REV B, V58, P5185, DOI 10.1103/PhysRevB.58.5185; Suzuki Y, 1998, J APPL PHYS, V83, P7064, DOI 10.1063/1.367570; Uehara M, 1999, NATURE, V399, P560, DOI 10.1038/21142; Yunoki S, 2000, PHYS REV LETT, V84, P3714, DOI 10.1103/PhysRevLett.84.3714; ZENER C, 1951, PHYS REV, V82, P403, DOI 10.1103/PhysRev.82.403; Zuo JM, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.060407	21	266	267	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					797	800		10.1038/nature01299	http://dx.doi.org/10.1038/nature01299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490944	Green Submitted			2022-12-28	WOS:000179897300051
J	Trachtenberg, JT; Chen, BE; Knott, GW; Feng, GP; Sanes, JR; Welker, E; Svoboda, K				Trachtenberg, JT; Chen, BE; Knott, GW; Feng, GP; Sanes, JR; Welker, E; Svoboda, K			Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex	NATURE			English	Article							RAT BARREL CORTEX; PRIMARY SOMATOSENSORY CORTEX; DENDRITIC SPINES; VISUAL-CORTEX; FUNCTIONAL REORGANIZATION; PYRAMIDAL CELLS; IN-VIVO; SYNAPSES; MEMORY; CA1	Do new synapses form in the adult cortex to support experience-dependent plasticity? To address this question, we repeatedly imaged individual pyramidal neurons in the mouse barrel cortex over periods of weeks. We found that, although dendritic structure is stable, some spines appear and disappear. Spine lifetimes vary greatly: stable spines, about 50% of the population, persist for at least a month, whereas the remainder are present for a few days or less. Serial-section electron microscopy of imaged dendritic segments revealed retrospectively that spine sprouting and retraction are associated with synapse formation and elimination. Experience-dependent plasticity of cortical receptive fields was accompanied by increased synapse turnover. Our measurements suggest that sensory experience drives the formation and elimination of synapses and that these changes might underlie adaptive remodelling of neural circuits.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Lausanne; Washington University (WUSTL)	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.		Feng, Guoping/Y-2827-2019	Knott, Graham W/0000-0002-2956-9052				ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HUTTENLOCHER PR, 1982, NEUROSCI LETT, V33, P247, DOI 10.1016/0304-3940(82)90379-2; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Ramon y Cajal S, 1893, ARCH ANAT PHYSL, P319; SANDISON DR, 1994, 3 DIMENSIONAL CONFOC, P29; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tanzi E., 1893, RIV SPER FRENIAT MED, V19, P419; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; VAUGHAN DW, 1973, J COMP NEUROL, V149, P355, DOI 10.1002/cne.901490305; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	43	1397	1421	4	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					788	794		10.1038/nature01273	http://dx.doi.org/10.1038/nature01273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490942				2022-12-28	WOS:000179897300049
J	Fludger, S; Turner, AM; Harvey, RF; Haslam, N				Fludger, S; Turner, AM; Harvey, RF; Haslam, N			Controlled prospective study of faecal occult blood screening for colorectal cancer in Bury, black pudding capital of the world	BRITISH MEDICAL JOURNAL			English	Article									Fairfield Hosp, Bury BL9 7TD, England; Royal Liverpool Univ Hosp, Liverpool L7 8XP, Merseyside, England; Royal Preston Hosp, Preston PR2 4HT, Lancs, England; Frenchay Hosp, Bristol BS16 1LE, Avon, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Preston Hospital	Haslam, N (corresponding author), Fairfield Hosp, Bury BL9 7TD, England.							Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Pignone M, 2001, Eff Clin Pract, V4, P150	4	5	5	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1444	1445		10.1136/bmj.325.7378.1444	http://dx.doi.org/10.1136/bmj.325.7378.1444			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493657	Green Published			2022-12-28	WOS:000180188600009
J	Le Fanu, J				Le Fanu, J			The case of the missing data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; RISK-FACTORS; MORTALITY		Mawbey Brough Hlth Ctr, London SW8 2UD, England		Le Fanu, J (corresponding author), Mawbey Brough Hlth Ctr, 39 Wilcox Close, London SW8 2UD, England.							ARMSTRONG B, 1975, INT J CANCER, V15, P617, DOI 10.1002/ijc.2910150411; BARKER DJP, 1986, J EPIDEMIOL COMMUN H, V40, P37, DOI 10.1136/jech.40.1.37; BRISSON G, 1982, LIPIDS HUMAN NUTR, P98; BRULL D, 2000, BR J CARDIOL, V7, P681; Conan Doyle A., 1981, PENGUIN COMPLETE SHE, P635; CORNFIELD J, 1969, ARCH ENVIRON HEALTH, V19, P382, DOI 10.1080/00039896.1969.10666860; Department of Health, 1992, HLTH NAT STRAT HLTH; Ebrahim S, 1997, BMJ-BRIT MED J, V314, P1666, DOI 10.1136/bmj.314.7095.1666; GROVE RD, 1968, STAT RATES US 1940 1; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Le Fanu J., 2014, RISE FALL MODERN MED; MARMOT MG, 1975, AM J EPIDEMIOL, V102, P514, DOI 10.1093/oxfordjournals.aje.a112189; *NAT ADV COMM NUTR, 1983, PROP NUTR GUID HLTH; PEESE DH, 1972, 6 TOB RES COUNC; Shepherd E, 1999, MED SCI LAW, V39, P138, DOI 10.1177/002580249903900208; SIGFUSSON N, 1991, BRIT MED J, V302, P1371, DOI 10.1136/bmj.302.6789.1371; SMITH GD, 1992, BMJ-BRIT MED J, V304, P431, DOI 10.1136/bmj.304.6824.431; *US PHS, 1976, USPHS PUBL, V1696; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; *WHO, 1977, HLTH STAT ANN; *WHO, 1951, WORLD HLTH STAT ANN	22	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 21	2002	325	7378					1490	1493		10.1136/bmj.325.7378.1490	http://dx.doi.org/10.1136/bmj.325.7378.1490			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493679	Green Published			2022-12-28	WOS:000180188600031
J	Demmig-Adams, B; Adams, WW				Demmig-Adams, B; Adams, WW			Antioxidants in photosynthesis and human nutrition	SCIENCE			English	Review							XANTHOPHYLL CYCLE; BETA-CAROTENE; ENERGY-DISSIPATION; GENE-EXPRESSION; PROTECTIVE ROLE; PHOTOSYSTEM-II; LIGHT; ZEAXANTHIN; DISEASE; LUTEIN		Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Demmig-Adams, B (corresponding author), Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA.	barbara.demmig-adams@colorado.edu	Adams, William/R-2772-2019					Adams WW, 1999, PLANT CELL ENVIRON, V22, P125, DOI 10.1046/j.1365-3040.1999.00369.x; Adams WW, 2001, PHOTOSYNTH RES, V67, P51, DOI 10.1023/A:1010688528773; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Basu HN, 2001, J AM OIL CHEM SOC, V78, P665, DOI 10.1007/s11746-001-0324-x; Battaini F, 2001, PHARMACOL RES, V44, P353, DOI 10.1006/phrs.2001.0893; Bernstein PS, 1997, INVEST OPHTH VIS SCI, V38, P167; Connor WE, 2000, AM J CLIN NUTR, V71, p171S, DOI 10.1093/ajcn/71.1.171S; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Davison PA, 2002, NATURE, V418, P203, DOI 10.1038/nature00861; Demmig-Adams B, 1999, ADV PHOTOSYNTH, V8, P245; Demmig-Adams B, 2000, NATURE, V403, P371, DOI 10.1038/35000315; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; Denys A, 2001, J LIPID RES, V42, P2015; Dharmapuri S, 2002, FEBS LETT, V519, P30, DOI 10.1016/S0014-5793(02)02699-6; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; GYORGYPAL Z, 1991, MOL GEN GENET, V226, P337, DOI 10.1007/BF00273624; Hammond BR, 2001, ARCH BIOCHEM BIOPHYS, V385, P41, DOI 10.1006/abbi.2000.2184; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2000, PLANT PHYSIOL, V124, P273, DOI 10.1104/pp.124.1.273; Hieber AD, 2000, BBA-PROTEIN STRUCT M, V1482, P84, DOI 10.1016/S0167-4838(00)00141-2; Ho E, 1999, P SOC EXP BIOL MED, V222, P205, DOI 10.1046/j.1525-1373.1999.d01-137.x; Josue JS, 2002, J PHYS CHEM A, V106, P4815, DOI 10.1021/jp014150n; Krinsky NI, 2002, J NUTR, V132, p540S, DOI 10.1093/jn/132.3.540S; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Logdberg L, 2000, BBA-PROTEIN STRUCT M, V1482, P284, DOI 10.1016/S0167-4838(00)00164-3; Lomnitski L, 1997, INT J VITAM NUTR RES, V67, P407; Maccarrone M, 2001, CELL DEATH DIFFER, V8, P776, DOI 10.1038/sj.cdd.4400908; Maher P, 2000, CELL MOL LIFE SCI, V57, P1287, DOI 10.1007/PL00000766; Mares-Perlman JA, 2002, J NUTR, V132, p518S, DOI 10.1093/jn/132.3.518S; Muller K, 2002, FREE RADICAL RES, V36, P791, DOI 10.1080/10715760290032539; Mullineaux P, 2002, CURR OPIN PLANT BIOL, V5, P43, DOI 10.1016/S1369-5266(01)00226-6; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Nose K, 2000, BIOL PHARM BULL, V23, P897; Paolini M, 2001, CARCINOGENESIS, V22, P1483, DOI 10.1093/carcin/22.9.1483; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Pogson BJ, 2000, PHILOS T ROY SOC B, V355, P1395, DOI 10.1098/rstb.2000.0701; Rao AVR, 2000, J AM COLL NUTR, V19, P563, DOI 10.1080/07315724.2000.10718953; Reinbothe C, 1997, PLANTA, V201, P281, DOI 10.1007/s004250050067; Sahu SC, 2002, J ENVIRON SCI HEAL C, V20, P61, DOI 10.1081/GNC-120005388; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Siddiqui RA, 2000, CURR ORG CHEM, V4, P1145, DOI 10.2174/1385272003375833; Solomons NW, 2000, ASIA PAC J CLIN NUTR, V9, pS41, DOI 10.1046/j.1440-6047.2000.00165.x; Sumantran VN, 2000, CANCER EPIDEM BIOMAR, V9, P257; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Trono D, 1999, J CEREAL SCI, V29, P99, DOI 10.1006/jcrs.1998.0215; Vershinin A, 1999, BIOFACTORS, V10, P99, DOI 10.1002/biof.5520100203; Williams SN, 2000, CHEM-BIOL INTERACT, V128, P211, DOI 10.1016/S0009-2797(00)00204-0; Yang CS, 2001, ANNU REV NUTR, V21, P381, DOI 10.1146/annurev.nutr.21.1.381	54	479	505	1	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2149	2153		10.1126/science.1078002	http://dx.doi.org/10.1126/science.1078002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481128				2022-12-28	WOS:000179773700037
J	Melillo, JM; Steudler, PA; Aber, JD; Newkirk, K; Lux, H; Bowles, FP; Catricala, C; Magill, A; Ahrens, T; Morrisseau, S				Melillo, JM; Steudler, PA; Aber, JD; Newkirk, K; Lux, H; Bowles, FP; Catricala, C; Magill, A; Ahrens, T; Morrisseau, S			Soil warming and carbon-cycle feedbacks to the climate system	SCIENCE			English	Article							TRACE GAS FLUXES; ORGANIC-CARBON; AVAILABILITY; TEMPERATURE; RESPIRATION; NITROGEN; FORESTS; PRAIRIE	In a decade-long soil warming experiment in a mid-latitude hardwood forest, we documented changes in soil carbon and nitrogen cycling in order to investigate the consequences of these changes for the climate system. Here we show that whereas soil warming accelerates soil organic matter decay and carbon dioxide fluxes to the atmosphere, this response is small and short-lived for a mid-latitude forest, because of the limited size of the labile soil carbon pool. We also show that warming increases the availability of mineral nitrogen to plants. Because plant growth in many mid-latitude forests is nitrogen-limited, warming has the potential to indirectly stimulate enough carbon storage in plants to at least compensate for the carbon losses from soils. Our results challenge assumptions made in some climate models that lead to projections of large long-term releases of soil carbon in response to warming of forest ecosystems.	Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Univ New Hampshire, Complex Syst Res Ctr, Durham, NH 03824 USA; Res Designs, Woods Hole, MA 02543 USA	Marine Biological Laboratory - Woods Hole; University System Of New Hampshire; University of New Hampshire	Melillo, JM (corresponding author), Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA.							Bergh J, 1999, FOREST ECOL MANAG, V119, P51, DOI 10.1016/S0378-1127(98)00509-X; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; FRIEDLINGSTEIN P, IN PRESS TELLUS; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; HARTE J, 1995, ECOL APPL, V5, P132, DOI 10.2307/1942058; Houghton J. T., 2001, CLIMATE CHANGE 2001; Jarvis P, 2000, NATURE, V405, P904, DOI 10.1038/35016154; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Magill AH, 2000, ECOSYSTEMS, V3, P238, DOI 10.1007/s100210000023; Merriam J, 1996, SOIL SCI SOC AM J, V60, P1050, DOI 10.2136/sssaj1996.03615995006000040013x; PETERJOHN WT, 1994, ECOL APPL, V4, P617, DOI 10.2307/1941962; PETERJOHN WT, 1993, OECOLOGIA, V93, P18, DOI 10.1007/BF00321185; Rustad L, 2001, NATURE, V413, P578, DOI 10.1038/35098162; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Woodwell GM, 1995, BIOTIC FEEDBACKS GLO, P3	17	931	1157	30	734	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2173	2176		10.1126/science.1074153	http://dx.doi.org/10.1126/science.1074153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481133				2022-12-28	WOS:000179773700042
J	Corezzi, S; Fioretto, D; Rolla, P				Corezzi, S; Fioretto, D; Rolla, P			Bond-controlled configurational entropy reduction in chemical vitrification	NATURE			English	Article							MOLECULAR-DYNAMICS; TEMPERATURE-DEPENDENCE; DIELECTRIC-RELAXATION; SUPERCOOLED LIQUIDS; ENERGY LANDSCAPE; POLYMERIZATION; THERMODYNAMICS; FRAGILITY	Glass formation is usually viewed in terms of physical vitrification: a liquid in a metastable state(1) is cooled or compressed so as to avoid crystallization. However, glasses may also be formed by chemical vitrification, a process involving progressive polymerization of the constituent molecules via the formation of irreversible chemical bonds. The formation of most of the materials used in engineering plastics and the hardening of natural and synthetic resins are based on chemical vitrification. Despite the differences in the molecular processes involved in chemical and physical vitrification, surprising similarities(2-9) are observed in the slowing down of the dynamics and in the thermodynamical properties of the resulting glasses. Explaining such similarities would improve general understanding of the glass transition and may disclose its universal nature. Here we report dielectric and photon-correlation measurements that reveal the origin of the similarity in the dynamical behaviour of physical and chemical glass formers. We find that the evolution of their configurational restrictions proceeds in a similar manner. In particular, we make a connection between the reduction in configurational entropy and the number of chemical bonds, a quantity that can be controlled in experiments.	Univ Perugia, Ist Nazl Fis Mat, I-06123 Perugia, Italy; Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; Univ Pisa, Ist Nazl Fis Mat, I-56127 Pisa, Italy; Univ Pisa, Dipartimento Fis, I-56127 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Padua; University of Perugia; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Pisa; University of Pisa	Corezzi, S (corresponding author), Univ Perugia, Ist Nazl Fis Mat, Via A Pascoli, I-06123 Perugia, Italy.	Silvia.Corezzi@fisica.unipg.it	Corezzi, Silvia/B-9035-2016	Corezzi, Silvia/0000-0002-3437-5949				ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; ANGELL CA, 1991, J NON-CRYST SOLIDS, V131, P13, DOI 10.1016/0022-3093(91)90266-9; [Anonymous], 1991, INTRO POLYM; Casalini R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.031207; Casalini R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041504; Casalini R, 1996, CHEM PHYS LETT, V258, P470, DOI 10.1016/0009-2614(96)00654-9; CASSETTARI M, 1994, J NON-CRYST SOLIDS, V172, P554, DOI 10.1016/0022-3093(94)90487-1; Debenedetti P.G., 1996, METASTABLE LIQUIDS C; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; DENG Y, 1994, J POLYM SCI POL PHYS, V32, P2115, DOI 10.1002/polb.1994.090321218; Gallone G, 2001, POLYM INT, V50, P545, DOI 10.1002/pi.663; Johari GP, 1999, PHYS CHEM CHEM PHYS, V1, P2997, DOI 10.1039/a901865d; Johari GP, 1999, J CHEM PHYS, V110, P11592, DOI 10.1063/1.479098; KAUZMANN W, 1948, CHEM REV, V43, P219, DOI 10.1021/cr60135a002; Kumar SK, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.188301; La Nave E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.225701; LUNAK S, 1975, J POLYM SCI POL SYM, P45; MACOSKO CW, 1976, MACROMOLECULES, V9, P199, DOI 10.1021/ma60050a003; Martinez LM, 2001, NATURE, V410, P663, DOI 10.1038/35070517; MATSUOKA S, 1989, MACROMOLECULES, V22, P4093, DOI 10.1021/ma00200a048; PARTHUN MG, 1995, J CHEM PHYS, V103, P440, DOI 10.1063/1.469610; Richert R, 1998, J CHEM PHYS, V108, P9016, DOI 10.1063/1.476348; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; Sastry S, 2001, NATURE, V409, P164, DOI 10.1038/35051524; Scala A, 2000, NATURE, V406, P166, DOI 10.1038/35018034; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; Tombari E, 1997, J PHYS-CONDENS MAT, V9, P7017, DOI 10.1088/0953-8984/9/33/006; Vogel H, 1921, PHYS Z, V22, P645; Xia XY, 2000, P NATL ACAD SCI USA, V97, P2990, DOI 10.1073/pnas.97.7.2990	29	75	75	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					653	656		10.1038/nature01261	http://dx.doi.org/10.1038/nature01261			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478289				2022-12-28	WOS:000179751800041
J	Lambert, JD; Nagy, LM				Lambert, JD; Nagy, LM			Asymmetric inheritance of centrosomally localized mRNAs during embryonic cleavages	NATURE			English	Article							C-ELEGANS EMBRYOS; ILYANASSA-OBSOLETA; ASCIDIAN EMBRYO; MESSENGER-RNA; PIE-1 PROTEIN; DROSOPHILA; SPECIFICATION; CELLS; GENE; CENTRIOLES	During development, different cell fates are generated by cell-cell interactions or by the asymmetric distribution of patterning molecules. Asymmetric inheritance is known to occur either through directed transport along actin microfilaments into one daughter cell(1,2) or through capture of determinants by a region of the cortex inherited by one daughter(3-5). Here we report a third mechanism of asymmetric inheritance in a mollusc embryo. Different messenger RNAs associate with centrosomes in different cells and are subsequently distributed asymmetrically during division. The segregated mRNAs are diffusely distributed in the cytoplasm and then localize, in a microtubule-dependent manner, to the pericentriolar matrix. During division, they dissociate from the core mitotic centrosome and move by means of actin filaments to the presumptive animal daughter cell cortex. In experimental cells with two interphase centrosomes, mRNAs accumulate on the correct centrosome, indicating that differences between centrosomes control mRNA targeting. Blocking the accumulation of mRNAs on the centrosome shows that this event is required for subsequent cortical localization. These events produce a complex pattern of mRNA localization, in which different messages distinguish groups of cells with the same birth order rank and similar developmental potentials.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Nagy, LM (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.			Lambert, J. David/0000-0002-7005-0244				Bonaccorsi S, 2000, NAT CELL BIOL, V2, P54, DOI 10.1038/71378; Boyd L, 1996, DEVELOPMENT, V122, P3075; CLEMENT AC, 1962, J EXP ZOOL, V149, P193, DOI 10.1002/jez.1401490304; CLEMENT AC, 1976, AM ZOOL, V16, P447; CLEMENT AC, 1952, J EXP ZOOL, V132, P427; Conklin Edwin G., 1902, Journal of the Academy of Natural Sciences of Philadelphia Ser 2, V12; Crampton HE, 1896, ROUXS ARCH ENTW MECH, V3, P1; Goto S, 1997, DEV GENES EVOL, V207, P194, DOI 10.1007/s004270050107; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; Lambert JD, 2001, DEVELOPMENT, V128, P45; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; MACDONALD PM, 1986, CELL, V47, P721, DOI 10.1016/0092-8674(86)90515-5; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Nishikata T, 1999, DEV BIOL, V209, P72, DOI 10.1006/dbio.1999.9244; Paoletti A, 1996, J CELL SCI, V109, P3089; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Render J, 1997, DEV BIOL, V189, P301, DOI 10.1006/dbio.1997.8654; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; SHIMELL MJ, 1991, CELL, V67, P469, DOI 10.1016/0092-8674(91)90522-Z; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Sweet HC, 1998, DEVELOPMENT, V125, P4033; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Wilson EB, 1904, J EXP ZOOL, V1, P197, DOI 10.1002/jez.1400010202; Wu XY, 1999, P NATL ACAD SCI USA, V96, P1397, DOI 10.1073/pnas.96.4.1397; Yoshida S, 1996, DEVELOPMENT, V122, P2005	28	170	178	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					682	686		10.1038/nature01241	http://dx.doi.org/10.1038/nature01241			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478296				2022-12-28	WOS:000179751800049
J	Temelkuran, B; Hart, SD; Benoit, G; Joannopoulos, JD; Fink, Y				Temelkuran, B; Hart, SD; Benoit, G; Joannopoulos, JD; Fink, Y			Wavelength-scalable hollow optical fibres with large photonic bandgaps for CO2 laser transmission	NATURE			English	Article							LIGHT; CORE	Conventional solid-core optical fibres require highly transparent materials. Such materials have been difficult to identify owing to the fundamental limitations associated with the propagation of light through solids, such as absorption, scattering and nonlinear effects. Hollow optical fibres offer the potential to minimize the dependence of light transmission on fibre material transparency(1-3). Here we report on the design and drawing of a hollow optical fibre lined with an interior omnidirectional dielectric mirror(4). Confinement of light in the hollow core is provided by the large photonic bandgaps(5-7) established by the multiple alternating submicrometre-thick layers of a high-refractive-index glass and a low-refractive-index polymer. The fundamental and high-order transmission windows are determined by the layer dimensions and can be scaled from 0.75 to 10.6 mum in wavelength. Tens of metres of hollow photonic bandgap fibres for transmission of carbon dioxide laser light at 10.6 mum wavelength were drawn. The transmission losses are found to be less than 1.0 dB m(-1), orders of magnitude lower than those of the intrinsic fibre material, thus demonstrating that low attenuation can be achieved through structural design rather than high-transparency material selection.	MIT, Elect Res Lab, Cambridge, MA 02139 USA; MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Fink, Y (corresponding author), MIT, Elect Res Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	yoel@mit.edu	Joannopoulos, John D/E-6401-2013	Temelkuran, Burak/0000-0003-2390-5091				Allan DC, 2001, NATO SCI SER II-MATH, V563, P305; Bormashenko E, 2001, OPT ENG, V40, P661, DOI 10.1117/1.1360241; BORNSTEIN A, 1985, J NON-CRYST SOLIDS, V77-8, P1277, DOI 10.1016/0022-3093(85)90891-9; Broeng J, 2000, OPT LETT, V25, P96, DOI 10.1364/OL.25.000096; Cregan RF, 1999, SCIENCE, V285, P1537, DOI 10.1126/science.285.5433.1537; Eggleton BJ, 2001, OPT EXPRESS, V9, P698, DOI 10.1364/OE.9.000698; Fink Y, 1998, SCIENCE, V282, P1679, DOI 10.1126/science.282.5394.1679; Fink Y, 1999, J LIGHTWAVE TECHNOL, V17, P2039, DOI 10.1109/50.802992; Fitt AD, 2001, J LIGHTWAVE TECHNOL, V19, P1924, DOI 10.1109/50.971686; Harrington JA, 2000, FIBER INTEGRATED OPT, V19, P211, DOI 10.1080/01468030050058794; HARRINGTON JA, 2001, HDB OPTICS; Hart SD, 2002, SCIENCE, V296, P510, DOI 10.1126/science.1070050; Hilton A. R., 1970, Journal of Non-Crystalline Solids, V2, P28, DOI 10.1016/0022-3093(70)90118-3; HONGO A, 1992, APPL OPTICS, V31, P5114, DOI 10.1364/AO.31.005114; Ibanescu M, 2000, SCIENCE, V289, P415, DOI 10.1126/science.289.5478.415; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Johnson SG, 2001, OPT EXPRESS, V9, P748, DOI 10.1364/OE.9.000748; KECK DB, 1973, APPL PHYS LETT, V22, P307, DOI 10.1063/1.1654649; MARCATILI EAJ, 1964, AT&T TECH J, V43, P1783, DOI 10.1002/j.1538-7305.1964.tb04108.x; Matsuura Y, 2002, OPT EXPRESS, V10, P488, DOI 10.1364/OE.10.000488; Maurer R.D., 1972, Google Patents, Patent No. [US3659915A, 3659915]; Mitra PP, 2001, NATURE, V411, P1027, DOI 10.1038/35082518; MIYAGI M, 1984, J LIGHTWAVE TECHNOL, V2, P116, DOI 10.1109/JLT.1984.1073590; Ouyang G, 2001, OPT EXPRESS, V9, P733, DOI 10.1364/OE.9.000733; RENN MJ, 1995, PHYS REV LETT, V75, P3253, DOI 10.1103/PhysRevLett.75.3253; Rundquist A, 1998, SCIENCE, V280, P1412, DOI 10.1126/science.280.5368.1412; Sanghera JS, 1999, J NON-CRYST SOLIDS, V256, P6, DOI 10.1016/S0022-3093(99)00484-6; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; YEH P, 1978, J OPT SOC AM, V68, P1196, DOI 10.1364/JOSA.68.001196	30	496	532	4	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					650	653		10.1038/nature01275	http://dx.doi.org/10.1038/nature01275			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478288				2022-12-28	WOS:000179751800040
J	Haynes, RB; McDonald, HP; Garg, AX				Haynes, RB; McDonald, HP; Garg, AX			Helping patients follow prescribed treatment - Clinical applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADHERENCE	Low adherence to prescribed medical regimens is a ubiquitous problem. Typical adherence rates are about 50% for medications and are much lower for lifestyle prescriptions and other more behaviorally demanding regimens. In addition, many patients with medical problems do not seek care or drop out of care prematurely. Although accurate measures of low adherence are lacking for many regimens, simple measures, such as directly asking patients and watching for appointment nonattendance and treatment nonresponse, will detect most problems. For short-term regimens (less than or equal to2 weeks), adherence to medications is readily achieved by giving clear instructions. On the other hand, improving adherence to long-term regimens requires combinations of information about the regimen, counseling about the importance of adherence and how to organize medication taking, reminders about appointments and adherence, rewards and recognition for the patient's efforts to follow the regimen, and enlisting social support from family and friends. Successful interventions for long-term regimens are all labor-intensive but ultimately can be cost-effective.	McMaster Univ, Med Ctr, Dept Clin Epidemiol & Biostat, Fac Hlth Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Fac Hlth Sci, Dept Med, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Sch Grad Studies, Hlth Res Methodol Program, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Haynes, RB (corresponding author), McMaster Univ, Med Ctr, Dept Clin Epidemiol & Biostat, Fac Hlth Sci, Room 2C10B,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.		Garg, Amit X/G-3295-2011	Haynes, Robert Brian/0000-0002-1453-3196				BOWEN RG, 1961, NURS RES, V10, P151, DOI 10.1097/00006199-196101030-00005; DICKEY FF, 1975, HOSPITALS, V49, P85; GILBERT JR, 1980, CAN MED ASSOC J, V123, P119; Girvin B, 1999, J HYPERTENS, V17, P1627, DOI 10.1097/00004872-199917110-00017; GORDIS L, 1969, PEDIATRICS, V43, P173; Haynes RB, 2001, AM HEART MONOGR S, P3; Holmboe ES, 2002, JAMA-J AM MED ASSOC, V287, P373, DOI 10.1001/jama.287.3.373; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; JONSEN AR, 1979, COMPLIANCE HLTH CARE, P113; LEVINE RJ, 1994, AM J RESP CRIT CARE, V149, P287, DOI 10.1164/ajrccm.149.2.8306018; LINKEWICH JA, 1974, DRUG INTEL CLIN PHAR, V8, P10, DOI 10.1177/106002807400800102; LOGAN AG, 1981, HYPERTENSION, V3, P211, DOI 10.1161/01.HYP.3.2.211; MACHARIA WM, 1992, JAMA-J AM MED ASSOC, V267, P1813, DOI 10.1001/jama.267.13.1813; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; SACKETT DL, 1979, ADHERENCE HLTH CARE, P11; SHARPE TR, 1974, AM J HOSP PHARM, V31, P479, DOI 10.1093/ajhp/31.5.479; STEPHENSON BJ, 1993, JAMA-J AM MED ASSOC, V269, P2779, DOI 10.1001/jama.269.21.2779; Wright A, 1998, ANN INTERN MED, V128, P165, DOI 10.7326/0003-4819-128-3-199802010-00001; Yusuf S, 2000, NEW ENGL J MED, V342, P145; [No title captured]	20	560	593	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2880	2883		10.1001/jama.288.22.2880	http://dx.doi.org/10.1001/jama.288.22.2880			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623YM	12472330	Bronze			2022-12-28	WOS:000179732600033
J	Gruskin, S; Loff, B				Gruskin, S; Loff, B			Do human rights have a role in public health work?	LANCET			English	Editorial Material									Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; Harvard Univ, Sch Publ Hlth, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02115 USA	Monash University; Harvard University; Harvard T.H. Chan School of Public Health	Loff, B (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.		Loff, Bebe/G-9241-2014	Loff, Bebe/0000-0003-1963-6503				De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; *ECOSOC, 1985, SIR PRINC LIM DER PR; TARANTOLA D, 1997, POLICIES PROGRAMS SE; UN-OHCHR (United Nations Office of the High Commissioner for Human Rights), 2000, CESCR GEN COMM 14 RI	4	20	20	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1880	1880		10.1016/S0140-6736(02)11780-6	http://dx.doi.org/10.1016/S0140-6736(02)11780-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480383				2022-12-28	WOS:000179706100033
J	Reid, VA; Keane, J				Reid, VA; Keane, J			Tuberculous mastoiditis and cerebral tuberculoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Boston City Hosp, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston, MA 02118 USA	Boston Medical Center; Boston University	Reid, VA (corresponding author), Boston City Hosp, Boston, MA 02118 USA.								0	3	3	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2002	347	23					E6	E6		10.1056/ENEJMicm010554	http://dx.doi.org/10.1056/ENEJMicm010554			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NW	12466523				2022-12-28	WOS:000179596900006
J	Titus, TN; Kieffer, HH; Christensen, PR				Titus, TN; Kieffer, HH; Christensen, PR			Exposed water ice discovered near the south pole of Mars	SCIENCE			English	Article							THERMAL MAPPER OBSERVATIONS; GROUND ICE; SUMMER TEMPERATURES; LAYERED DEPOSITS; CARBON-DIOXIDE; NEAR-SURFACE; BEHAVIOR; VAPOR; ALBEDO; SUBSURFACE	The Mars Odyssey Thermal Emission Imaging System (THEMIS) has discovered water ice exposed near the edge of Mars' southern perennial polar cap. The surface H2O ice was first observed by THEMIS as a region that was cooler than expected for dry soil at that latitude during the summer season. Diurnal and seasonal temperature trends derived from Mars Global Surveyor Thermal Emission Spectrometer observations indicate that there is H2O ice at the surface. Viking observations, and the few other relevant THEMIS observations, indicate that surface H2O ice may be widespread around and under the perennial CO2 cap.	US Geol Survey, Branch Astrogeol, Flagstaff, AZ 86001 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA	United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe	Titus, TN (corresponding author), US Geol Survey, Branch Astrogeol, 2255 N Gemini Dr, Flagstaff, AZ 86001 USA.	ttitus@usgs.gov						BARKER ES, 1970, SCIENCE, V170, P1308, DOI 10.1126/science.170.3964.1308; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; CUTTS JA, 1973, J GEOPHYS RES, V78, P4231, DOI 10.1029/JB078i020p04231; FARMER CB, 1979, J GEOPHYS RES, V84, P2881, DOI 10.1029/JB084iB06p02881; FARMER CB, 1976, SCIENCE, V194, P1339, DOI 10.1126/science.194.4271.1339; Forget F, 1998, ASTROPHYS SPACE SC L, V227, P477, DOI 10.1007/978-94-011-5252-5_20; HERKENHOFF KE, 1990, J GEOPHYS RES-SOLID, V95, P1343, DOI 10.1029/JB095iB02p01343; HERKENHOFF KE, 2001, USGS MISC INV SERI I, V2686; HOFSTADTER MD, 1990, ICARUS, V84, P352, DOI 10.1016/0019-1035(90)90043-9; JAKOSKY BM, 1990, J GEOPHYS RES-SOLID, V95, P1359, DOI 10.1029/JB095iB02p01359; JAKOSKY BM, 1982, J GEOPHYS RES, V87, P2999, DOI 10.1029/JB087iB04p02999; JAKOSKY BM, 1992, MARS, pCH28; JAMES PB, 1992, MARS, pCH27; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; Kieffer HH, 2000, J GEOPHYS RES-PLANET, V105, P9653, DOI 10.1029/1999JE001136; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; MELLON MT, 1993, J GEOPHYS RES-PLANET, V98, P3345, DOI 10.1029/92JE02355; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P19357, DOI 10.1029/97JE01346; MOROZ VI, 1964, SOV ASTRON, V8, P273; PAIGE DA, 1990, J GEOPHYS RES-SOLID, V95, P1319, DOI 10.1029/JB095iB02p01319; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25993, DOI 10.1029/93JE03429; PAIGE DA, 1992, NATURE, V356, P43, DOI 10.1038/356043a0; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25959, DOI 10.1029/93JE03428; SMITH MD, 2002, ANN M DIV PLAN SCI B; THOMAS P, 1992, MARS, pCH23; TILLMAN JE, 1993, J GEOPHYS RES-PLANET, V98, P10963, DOI 10.1029/93JE01084; ZENT AP, 1986, ICARUS, V67, P19, DOI 10.1016/0019-1035(86)90171-5	31	164	167	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2003	299	5609					1048	1051		10.1126/science.1080497	http://dx.doi.org/10.1126/science.1080497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12471268				2022-12-28	WOS:000180960000042
J	Etchegaray, JP; Lee, C; Wade, PA; Reppert, SM				Etchegaray, JP; Lee, C; Wade, PA; Reppert, SM			Rhythmic histone acetylation underlies transcription in the mammalian circadian clock	NATURE			English	Article							GENE-EXPRESSION; MECHANISMS; MOUSE; COMPONENTS; HDA1; LIMB	In the mouse circadian clock, a transcriptional feedback loop is at the centre of the clockwork mechanism. Clock and Bmal1 are essential transcription factors that drive the expression of three period genes (Per1-3) and two cryptochrome genes (Cry1 and Cry2)(1-5). The Cry proteins feedback to inhibit Clock/Bmal1-mediated transcription by a mechanism that does not alter Clock/Bmal1 binding to DNA(6). Here we show that transcriptional regulation of the core clock mechanism in mouse liver is accompanied by rhythms in H3 histone acetylation, and that H3 acetylation is a potential target of the inhibitory action of Cry. The promoter regions of the Per1, Per2 and Cry1 genes exhibit circadian rhythms in H3 acetylation and RNA polymerase II binding that are synchronous with the corresponding steady-state messenger RNA rhythms. The histone acetyltransferase p300 precipitates together with Clock in vivo in a time-dependent manner. Moreover, the Cry proteins inhibit a p300-induced increase in Clock/Bmal1-mediated transcription. The delayed timing of the Cry1 mRNA rhythm, relative to the Per rhythms, is due to the coordinated activities of Rev-Erbalpha and Clock/Bmal1, and defines a new mechanism for circadian phase control.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	University of Massachusetts System; University of Massachusetts Worcester; Emory University	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, LRB-728,364 Plantat St, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Guschin D, 2000, BIOCHEMISTRY-US, V39, P5238, DOI 10.1021/bi000421t; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pfeifer GP, 1999, METHOD ENZYMOL, V304, P548; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takahata S, 2000, GENES CELLS, V5, P739, DOI 10.1046/j.1365-2443.2000.00363.x; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wade PA, 1999, METHOD ENZYMOL, V304, P715; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542	23	517	536	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					177	182		10.1038/nature01314	http://dx.doi.org/10.1038/nature01314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12483227				2022-12-28	WOS:000180267200044
J	Check, E				Check, E			Gene therapy - Shining hopes dented - but not dashed	NATURE			English	Editorial Material																			0	17	18	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					735	735		10.1038/420735b	http://dx.doi.org/10.1038/420735b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490910	Bronze			2022-12-28	WOS:000179897300020
J	Clarfield, AM				Clarfield, AM			The Soviet "Doctors' Plot" - 50 years on	BRITISH MEDICAL JOURNAL			English	Article									Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel	Ben Gurion University	Clarfield, AM (corresponding author), Soroka Hosp, Dept Geriatr, POB 151, IL-84101 Beer Sheva, Israel.							ABELES W, 1953, JAMA-J AM MED ASSOC, V151, P939; Amis Martin, 2002, KOBA DREAD LAUGHTER; Cohn Norman, 1970, WARRANT GENOCIDE; CUNNINGHAM HS, 2002, ARTICLE PRAVDA DOCTO; Heynick Frank, 2002, JEWS MED EPIC SAGA; NIREL N, 1998, BITACHON SOZIALI, V51, P96; Rapoport Louis, 1990, STALINS WAR JEWS DOC; SHAPIRO H, 2002, JERUSALEM POST  1025, pA5; Ulam Adam B, 1973, STALIN MAN HIS ERA; VOLKOV S, 1979, TESTIMONY MEMOIRS SH; *WORLD MED ASS, 1953, BRIT MED J, V1, pS136; 1953, PRAVDA          0113, P1; 1953, BMJ, V1, P824	13	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1487	1489		10.1136/bmj.325.7378.1487	http://dx.doi.org/10.1136/bmj.325.7378.1487			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493677	Green Published			2022-12-28	WOS:000180188600030
J	Zheng, NF; Bu, XG; Wang, B; Feng, PY				Zheng, NF; Bu, XG; Wang, B; Feng, PY			Microporous and photoluminescent chalcogenide zeolite analogs	SCIENCE			English	Article							SULFIDE; CLUSTERS	Crystalline semiconducting sulfide and selenide zeolite analogs were synthesized that possess four-connected, three-dimensional tetrahedral networks built from tetravalent (M4+=Ge4+ or Sn4+, where M=meta) and trivalent (M3+=Ga3+ or In3+) cations. Microporous materials were obtained in all four combinations of M4+ and M3+, and some of them were thermally stable up to at least 380degreesC. These materials exhibit framework topologies with pore size ranging from 12 to 24 tetrahedral atoms, high surface area, high framework charge density and ion exchange capacity, and tunable electronic and optical properties.	Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA	University of California System; University of California Riverside; University of California System; University of California Santa Barbara	Feng, PY (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	pingyun.feng@ucr.edu	Zheng, Nanfeng/G-4613-2010	Zheng, Nanfeng/0000-0001-9879-4790				Ahari H, 1999, J MATER CHEM, V9, P1263, DOI 10.1039/a807660j; Baerlocher C., 2007, ATLAS ZEOLITE FRAMEW, DOI [10.1016/B978-0-444-53064-6.X5186-X, DOI 10.1016/B978-044453064-6/50201-2]; BEDARD RL, 1989, STUD SURF SCI CATAL, V49, P375; Bowes CL, 1996, CHEM MATER, V8, P2147, DOI 10.1021/cm960280a; BRUNNER GO, 1989, NATURE, V337, P146, DOI 10.1038/337146a0; Bu XH, 1997, SCIENCE, V278, P2080, DOI 10.1126/science.278.5346.2080; Bu XH, 2002, J AM CHEM SOC, V124, P12646, DOI 10.1021/ja021009z; Cahill CL, 2000, J CHEM SOC DALTON, P1475, DOI 10.1039/a909005c; Cheetham AK, 1999, ANGEW CHEM INT EDIT, V38, P3268, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3268::AID-ANIE3268>3.0.CO;2-U; Corma A, 2002, NATURE, V418, P514, DOI 10.1038/nature00924; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; DHINGRA S, 1992, SCIENCE, V258, P1769, DOI 10.1126/science.258.5089.1769; Feng PY, 1997, NATURE, V388, P735, DOI 10.1038/41937; Flanigen E. M., 1991, INTRO ZEOLITE SCI PR, P13; Li HL, 1999, SCIENCE, V283, P1145, DOI 10.1126/science.283.5405.1145; Li HL, 2001, J AM CHEM SOC, V123, P4867, DOI 10.1021/ja010413f; O'Keeffe M, 2000, J SOLID STATE CHEM, V152, P3, DOI 10.1006/jssc.2000.8723; Scott RWJ, 1999, CURR OPIN SOLID ST M, V4, P113, DOI 10.1016/S1359-0286(99)00014-5; TAN KM, 1995, J AM CHEM SOC, V117, P7039, DOI 10.1021/ja00131a042; Wang C, 2002, J AM CHEM SOC, V124, P10268, DOI 10.1021/ja020735z; Wang C, 2001, J AM CHEM SOC, V123, P11506, DOI 10.1021/ja011739r; YAGHI OM, 1994, J AM CHEM SOC, V116, P807, DOI 10.1021/ja00081a067	22	363	380	3	290	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2366	2369		10.1126/science.1078663	http://dx.doi.org/10.1126/science.1078663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493908				2022-12-28	WOS:000179915900049
J	Adelman, S				Adelman, S			Lessons in friendship	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2002	288	23					2937	2938		10.1001/jama.288.23.2937	http://dx.doi.org/10.1001/jama.288.23.2937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CG	12479738				2022-12-28	WOS:000179854200001
J	Free, C; Lee, RM; Ogden, J				Free, C; Lee, RM; Ogden, J			Young women's accounts of factors influencing their use and non-use of emergency contraception: in-depth interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							KNOWLEDGE	Objectives To explore young women's accounts of their use and non-use of emergency contraception. Design Qualitative study using in-depth interviews. Participants 30 women aged 16-25; participants from socially deprived inner city areas were specifically included. Setting Community, service, and educational settings in the London area. Results Young women's accounts of their non-use of emergency contraception principally concerned evaluations of the risk conferred by different contraceptive behaviours, their evaluations of themselves in needing emergency contraception, and personal difficulties in asking for emergency contraception. Conclusions The attitudes and concerns of young women, especially those from disadvantaged backgrounds, may make them less able or willing than others to take advantage of recent increases in access to emergency contraception. Interventions that aim to increase the use of emergency contraception need to address the factors that influence young women's non-use of emergency contraception.	Guys Kings & St Thomas Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England; Royal Holloway Univ London, Dept Social & Polit Sci, Egham TW20 0EX, Surrey, England	University of London; King's College London; University of London; Royal Holloway University London	Free, C (corresponding author), Guys Kings & St Thomas Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England.	caroline.free@kcl.ac.uk		Ogden, Jane/0000-0003-4271-5621; Free, Caroline/0000-0003-1711-0006				ANDERSON C, 2001, LAMBETH SOUTHWORK LE; Barrett G, 2000, SOCIOL HEALTH ILL, V22, P197, DOI 10.1111/1467-9566.00199; Beck Ulrich., 1992, RISK SOC NEW MODERNI; Crosier A, 1996, BRIT J FAM PLAN, V22, P87; Crosier A., 1997, EMERGENCY CONTRACEPT; Department of the Environment Transport and the Regions, 2000, IND DEPR 2000 REG RE; Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101; Graham A, 1996, BRIT MED J, V312, P1567, DOI 10.1136/bmj.312.7046.1567; HALPER C, 1995, FAM PLANN PERSPECT, V27, P149, DOI 10.2307/2136258; Harrison-Woolrych M, 2001, BRIT MED J, V322, P186; Irwin MR, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; TRUSSELL J, 1992, FAM PLANN PERSPECT, V24, P269, DOI 10.2307/2135857; Trussell J, 1998, J Am Med Womens Assoc (1972), V53, P247; WEINSTEIN ND, 1984, HEALTH PSYCHOL, V3, P431, DOI 10.1037/0278-6133.3.5.431; Ziebland S, 1996, BRIT J FAM PLAN, V22, P84	15	75	77	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2002	325	7377					1393	1396		10.1136/bmj.325.7377.1393	http://dx.doi.org/10.1136/bmj.325.7377.1393			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CP	12480855	Green Published, Green Accepted			2022-12-28	WOS:000179975000024
J	Mesterton-Gibbons, M; Adams, ES				Mesterton-Gibbons, M; Adams, ES			The economics of animal cooperation	SCIENCE			English	Editorial Material									Florida State Univ, Dept Math, Tallahassee, FL 32306 USA; Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	State University System of Florida; Florida State University; University of Connecticut	Mesterton-Gibbons, M (corresponding author), Florida State Univ, Dept Math, Tallahassee, FL 32306 USA.							Ainslie G.W., 1992, PICOECONOMICS STRATE; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; CLEMENTS KC, 1995, ANIM BEHAV, V50, P527, DOI 10.1006/anbe.1995.0267; Dugatkin L.A., 1997, COOPERATION ANIMALS; FRANK RH, 1993, J ECON PERSPECT, V7, P159, DOI 10.1257/jep.7.2.159; Hammerstein Peter, 2001, P1, DOI 10.1017/CBO9780511752421.002; Mesterton-Gibbons M, 1998, AM SCI, V86, P334, DOI 10.1511/1998.31.814; Noe Ronald, 2001, P93, DOI 10.1017/CBO9780511752421.008; Stephens DW, 2002, SCIENCE, V298, P2216, DOI 10.1126/science.1078498	9	6	7	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2146	2147		10.1126/science.1080051	http://dx.doi.org/10.1126/science.1080051			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	624RA	12481126				2022-12-28	WOS:000179773700035
J	Gilman, AG; Simon, MI; Bourne, HR; Harris, BA; Long, R; Ross, EM; Stull, JT; Taussig, R; Bourne, HR; Arkin, AP; Cobb, MH; Cyster, JG; Devreotes, PN; Ferrell, JE; Fruman, D; Gold, M; Weiss, A; Stull, JT; Berridge, MJ; Cantley, LC; Catterall, WA; Coughlin, SR; Olson, EN; Smith, TF; Brugge, JS; Botstein, D; Dixon, JE; Hunter, T; Lefkowitz, RJ; Pawson, AJ; Sternberg, PW; Varmus, H; Subramaniam, S; Sinkovits, RS; Li, J; Mock, D; Ning, YH; Saunders, B; Sternweis, PC; Hilgemann, D; Scheuermann, RH; DeCamp, D; Hsueh, R; Lin, KM; Ni, Y; Seaman, WE; Simpson, PC; O'Connell, TD; Roach, T; Simon, MI; Choi, S; Eversole-Cire, P; Fraser, I; Mumby, MC; Zhao, YM; Brekken, D; Shu, HJ; Meyer, T; Chandy, G; Do Heo, W; Liou, J; O'Rourke, N; Verghese, M; Mumby, SM; Han, HP; Brown, HA; Forrester, JS; Ivanova, P; Milne, SB; Casey, PJ; Harden, TK; Arkin, AP; Doyle, J; Gray, ML; Meyer, T; Michnick, S; Schmidt, MA; Toner, M; Tsien, RY; Natarajan, M; Ranganathan, R; Sambrano, GR				Gilman, AG; Simon, MI; Bourne, HR; Harris, BA; Long, R; Ross, EM; Stull, JT; Taussig, R; Bourne, HR; Arkin, AP; Cobb, MH; Cyster, JG; Devreotes, PN; Ferrell, JE; Fruman, D; Gold, M; Weiss, A; Stull, JT; Berridge, MJ; Cantley, LC; Catterall, WA; Coughlin, SR; Olson, EN; Smith, TF; Brugge, JS; Botstein, D; Dixon, JE; Hunter, T; Lefkowitz, RJ; Pawson, AJ; Sternberg, PW; Varmus, H; Subramaniam, S; Sinkovits, RS; Li, J; Mock, D; Ning, YH; Saunders, B; Sternweis, PC; Hilgemann, D; Scheuermann, RH; DeCamp, D; Hsueh, R; Lin, KM; Ni, Y; Seaman, WE; Simpson, PC; O'Connell, TD; Roach, T; Simon, MI; Choi, S; Eversole-Cire, P; Fraser, I; Mumby, MC; Zhao, YM; Brekken, D; Shu, HJ; Meyer, T; Chandy, G; Do Heo, W; Liou, J; O'Rourke, N; Verghese, M; Mumby, SM; Han, HP; Brown, HA; Forrester, JS; Ivanova, P; Milne, SB; Casey, PJ; Harden, TK; Arkin, AP; Doyle, J; Gray, ML; Meyer, T; Michnick, S; Schmidt, MA; Toner, M; Tsien, RY; Natarajan, M; Ranganathan, R; Sambrano, GR		Alliance Cellular Signaling	Overview of the Alliance for Cellular Signaling	NATURE			English	Editorial Material								The Alliance for Cellular Signaling is a large-scale collaboration designed to answer global questions about signalling networks. Pathways will be studied intensively in two cells-B lymphocytes (the cells of the immune system) and cardiac myocytes-to facilitate quantitative modelling. One goal is to catalyse complementary research in individual laboratories; to facilitate this, all alliance data are freely available for use by the entire research community.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, Dallas, TX 75390 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Dept Biol, Pasadena, CA 91125 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; Aventis Pharmaceut, Bridgewater, NJ 08807 USA; NIGMS, Pharmacol Physiol & Biol Chem Div, NIH, Bethesda, MD 20892 USA; Univ Calif Berkeley, EO Lawrence Berkeley Natl Lab, Dept Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, EO Lawrence Berkeley Natl Lab, Dept Chem, Berkeley, CA 94720 USA; Johns Hopkins Univ, Dept Cell Biol & Anat, Baltimore, MD 21205 USA; Stanford Univ, Sch Med, Ctr Clin Sci Res, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Babraham Inst, Cambridge CB2 4AT, England; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Cell Biol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Boston Univ, BMERC, Boston, MA 02215 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Salk Inst Biol Studies, San Diego, CA 92186 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92037 USA; Vet Affairs Med Ctr, Dept Rheumatol, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, Dept Cardiol, San Francisco, CA 94121 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; MIT, Harvard MIT Div Hlth Sci & Technol, Dept Elect & Med Engn, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Dept Elect & Med Engn, Cambridge, MA 02139 USA; Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; Shriners Burn Hosp, Boston, MA 02114 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Sanofi-Aventis; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Johns Hopkins University; Stanford University; Stanford University; Stanford University; University of California System; University of California Irvine; University of British Columbia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Boston University; University of Michigan System; University of Michigan; Salk Institute; Duke University; Howard Hughes Medical Institute; Duke University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Universite de Montreal; Howard Hughes Medical Institute; University of California System; University of California San Diego	Gilman, AG (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA.		Cantley, Lewis C/D-1800-2014; Lefkowitz, Robert/AAW-2649-2021; O'Connell, Timothy/D-5048-2013; Brekken, Deirdre/I-7999-2012; Arkin, Adam P/A-6751-2008; Arkin, Adam/M-9941-2019; Ivanova, Pavlina/K-8307-2012; Fraser, Iain DC/L-4735-2017; Gold, Michael/AAF-2081-2021	Cantley, Lewis C/0000-0002-1298-7653; Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931; Fraser, Iain DC/0000-0003-2272-3907; Gold, Michael/0000-0003-1222-3191; Casey, Patrick/0000-0002-7366-9309; Meyer, Tobias/0000-0003-4339-3804; Cobb, Melanie/0000-0003-0833-5473; Natarajan, Madhusudan/0000-0003-1607-2917; Brekken, Deirdre/0000-0003-2790-0108; Sinkovits, Robert/0000-0001-7377-9762	NCI NIH HHS [T32 CA121938] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA121938] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	89	92	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					703	706		10.1038/nature01304	http://dx.doi.org/10.1038/nature01304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478301	Bronze, Green Published			2022-12-28	WOS:000179751800054
J	Buckley, NA; McManus, PR				Buckley, NA; McManus, PR			Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data	BRITISH MEDICAL JOURNAL			English	Article							OVERDOSE		Canberra Hosp, Dept Clin Pharmacol & Therapeut, Woden, ACT 2606, Australia; Canberra Hosp, Dept Pharm, Woden, ACT, Australia	Australian National University; Canberra Hospital; Australian National University; Canberra Hospital	Buckley, NA (corresponding author), Canberra Hosp, Dept Clin Pharmacol & Therapeut, POB 11, Woden, ACT 2606, Australia.		Buckley, Nicholas A/D-4030-2012	Buckley, Nicholas A/0000-0002-6326-4711				Buckley NA, 1998, DRUG SAFETY, V18, P369, DOI 10.2165/00002018-199818050-00006; HENRY JA, 1995, BRIT MED J, V310, P221, DOI 10.1136/bmj.310.6974.221; ISACSSON G, 1994, BRIT MED J, V309, P1546, DOI 10.1136/bmj.309.6968.1546; OWENS D, 1994, BRIT J PSYCHIAT, V165, P797, DOI 10.1192/bjp.165.6.797; Sarko J, 2000, EMERG MED CLIN N AM, V18, P637, DOI 10.1016/S0733-8627(05)70151-6	5	122	123	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2002	325	7376					1332	1333		10.1136/bmj.325.7376.1332	http://dx.doi.org/10.1136/bmj.325.7376.1332			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468481	Bronze, Green Published			2022-12-28	WOS:000179817100019
J	Belkaid, Y; Piccirillo, CA; Mendez, S; Shevach, EM; Sacks, DL				Belkaid, Y; Piccirillo, CA; Mendez, S; Shevach, EM; Sacks, DL			CD4(+)CD25(+) regulatory T cells control Leishmania major persistence and immunity	NATURE			English	Article							AZAR DERMAL LEISHMANIASIS; INTERFERON-GAMMA; KALA-AZAR; DENDRITIC CELLS; ACTIVATION; INTERLEUKIN-10; IL-10; SKIN; EXPRESSION; DISEASE	The long-term persistence of pathogens in a host that is also able to maintain strong resistance to reinfection, referred to as concomitant immunity, is a hallmark of certain infectious diseases, including tuberculosis and leishmaniasis. The ability of pathogens to establish latency in immune individuals often has severe consequences for disease reactivation(1-3). Here we show that the persistence of Leishmania major in the skin after healing in resistant C57BL/6 mice is controlled by an endogenous population of CD4(+)CD25(+) regulatory T cells. These cells constitute 5-10% of peripheral CD4(+) T cells in naive mice and humans, and suppress several potentially pathogenic responses in vivo, particularly T-cell responses directed against self-antigens(4). During infection by L. major, CD4(+)CD25(+) T cells accumulate in the dermis, where they suppress-by both interleukin-10-dependent and interleukin-10-independent mechanisms-the ability of CD4(+)CD25(-) effector T cells to eliminate the parasite from the site. The sterilizing immunity achieved in mice with impaired IL-10 activity is followed by the loss of immunity to reinfection, indicating that the equilibrium established between effector and regulatory T cells in sites of chronic infection might reflect both parasite and host survival strategies.	NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), Childrens Hosp, Div Mol Immunol, Res Fdn, 3333 Burnet Ave,MLC 7021, Cincinnati, OH 45229 USA.			Belkaid, Yasmine/0000-0001-9962-3571	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000494, ZIAAI000224, Z01AI000494, Z01AI000224] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; ELHASSAN AM, 1992, T ROY SOC TROP MED H, V86, P245, DOI 10.1016/0035-9203(92)90294-M; Gasim S, 1998, CLIN EXP IMMUNOL, V111, P64; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mendez S, 2001, J IMMUNOL, V166, P5122, DOI 10.4049/jimmunol.166.8.5122; MOMENI AZ, 1994, INT J DERMATOL, V33, P260, DOI 10.1111/j.1365-4362.1994.tb01039.x; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Ostrowski MA, 2001, J INFECT DIS, V184, P1268, DOI 10.1086/324005; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Plebanski M, 1999, IMMUNITY, V10, P651, DOI 10.1016/S1074-7613(00)80064-3; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Uzonna JE, 2001, J IMMUNOL, V167, P6967, DOI 10.4049/jimmunol.167.12.6967; von Stebut E, 1998, J EXP MED, V188, P1547, DOI 10.1084/jem.188.8.1547	26	1348	1429	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					502	507		10.1038/nature01152	http://dx.doi.org/10.1038/nature01152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466842				2022-12-28	WOS:000179611600045
J	Gitton, Y; Dahmane, N; Baik, S; Altaba, ARI; Neidhardt, L; Scholze, M; Herrmann, BG; Kahlem, P; Benkahla, A; Schrinner, S; Yildirimman, R; Herwig, R; Lehrach, H; Yaspo, ML				Gitton, Y; Dahmane, N; Baik, S; Altaba, ARI; Neidhardt, L; Scholze, M; Herrmann, BG; Kahlem, P; Benkahla, A; Schrinner, S; Yildirimman, R; Herwig, R; Lehrach, H; Yaspo, ML		HSA21 expression map initiative	A gene expression map of human chromosome 21 orthologues in the mouse	NATURE			English	Article							DOWN-SYNDROME; CRITICAL REGION; TREFOIL FACTOR; EMBRYOGENESIS; HEART; MICE	The DNA sequence of human chromosome 21 (HSA21)(1) has opened the route for a systematic molecular characterization of all of its genes. Trisomy 21 is associated with Down's syndrome, the most common genetic cause of mental retardation in humans. The phenotype includes various organ dysmorphies, stereotypic craniofacial anomalies and brain malformations(2). Molecular analysis of congenital aneuploidies poses a particular challenge because the aneuploid region contains many protein-coding genes whose function is unknown. One essential step towards understanding their function is to analyse mRNA expression patterns at key stages of organism development. Seminal works in flies, frogs and mice showed that genes whose expression is restricted spatially and/or temporally are often linked with specific ontogenic processes. Here we describe expression profiles of mouse orthologues to HSA21 genes by a combination of large-scale mRNA in situ hybridization at critical stages of embryonic and brain development and in silico (computed) mining of expressed sequence tags. This chromosome-scale expression annotation associates many of the genes tested with a potential biological role and suggests candidates for the pathogenesis of Down's syndrome.	NYU, Sch Med, Skirball Inst, Dev Genet Program, New York, NY 10016 USA; Univ Mediterranee, CNRS, UMR 6156, Inst Dev Biol, F-13288 Marseille 09, France; Max Planck Inst Immunol, Dept Dev Biol, D-79108 Freiburg, Germany; Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany	New York University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Max Planck Society; Max Planck Society	Altaba, ARI (corresponding author), NYU, Sch Med, Skirball Inst, Dev Genet Program, 540 1st Ave, New York, NY 10016 USA.	ria@saturn.med.nyu.edu; herrmann@immunbio.mpg.de; yaspo@molgen.mpg.de	GITTON, Yorick/A-3876-2009; GITTON, Yorick/M-8524-2019	GITTON, Yorick/0000-0002-6808-6010; GITTON, Yorick/0000-0002-6808-6010; Kahlem, Pascal/0000-0002-8810-444X; Benkahla, Alia/0000-0001-9988-3250; Herwig, Ralf/0000-0002-9335-1760; Ruiz i Altaba, Ariel/0000-0003-2292-3933				Altman J. B. S., 1995, ATLAS PRENATAL RAT B; Casas C, 2001, MECH DEVELOP, V101, P289, DOI 10.1016/S0925-4773(00)00583-9; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Egeo A, 2000, MECH DEVELOP, V90, P313, DOI 10.1016/S0925-4773(99)00253-1; Epstein C.J., 1995, METABOLIC MOL BASES, P749; Epstein DJ, 2000, DEVELOPMENT, V127, P4701; Ewing RM, 1999, GENOME RES, V9, P950, DOI 10.1101/gr.9.10.950; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; KAHLEM P, 2000, GENE FUNCT DIS, V1, P175; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Krause A, 2002, NUCLEIC ACIDS RES, V30, P299, DOI 10.1093/nar/30.1.299; Lin BY, 1999, CANCER RES, V59, P4180; MAROULAKOU IG, 1994, ONCOGENE, V9, P1551; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Neidhardt L, 2000, MECH DEVELOP, V98, P77, DOI 10.1016/S0925-4773(00)00453-6; Orti R, 2000, GENOMICS, V64, P203, DOI 10.1006/geno.1999.6109; Otto WR, 1999, ANAT EMBRYOL, V199, P499, DOI 10.1007/s004290050247; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Saito T, 2001, MOL PSYCHIATR, V6, P387, DOI 10.1038/sj.mp.4000871; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Scheurle D, 2000, CANCER RES, V60, P4037; Schmitt AO, 1999, NUCLEIC ACIDS RES, V27, P4251, DOI 10.1093/nar/27.21.4251; Sumarsono SH, 1996, NATURE, V379, P534, DOI 10.1038/379534a0; SYLVESTER PE, 1983, J MENT DEFIC RES, V27, P227; Taketo MM, 1997, GENOMICS, V46, P138, DOI 10.1006/geno.1997.5014; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Vingron M, 1999, J MOL MED-JMM, V77, P3, DOI 10.1007/s001090050290; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227	30	96	99	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					586	590		10.1038/nature01178	http://dx.doi.org/10.1038/nature01178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466855	Bronze, Green Published			2022-12-28	WOS:000179611600058
J	Piskorowski, R; Aldrich, RW				Piskorowski, R; Aldrich, RW			Calcium activation of BKCa potassium channels lacking the calcium bowl and RCK domains	NATURE			English	Article							ALLOSTERIC GATING MECHANISM; CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; CA CHANNELS; HAIR-CELLS; VOLTAGE; SENSITIVITY; CURRENTS; IDENTIFICATION; SUBUNIT	In many physiological systems such as neurotransmitter release, smooth muscle relaxation and frequency tuning of auditory hair cells, large-conductance calcium-activated potassium (BKCa) channels create a connection between calcium signalling pathways and membrane excitability(1-4). BKCa channels are activated by voltage and by micromolar concentrations of intracellular calcium. Although it is possible to open BKCa channels in the absence of calcium(5-9), calcium binding is essential for their activation under physiological conditions. In the presence of intracellular calcium, BKCa channels open at more negative membrane potentials(5,10-14). Many experiments investigating the molecular mechanism of calcium activation of the BKCa channel have focused on the large intracellular carboxy terminus, and much evidence supports the hypothesis that calcium-binding sites are located in this region of the channel. Here we show that BKCa channels that lack the whole intracellular C terminus retain wild-type calcium sensitivity. These results show that the intracellular C terminus, including the 'calcium bowl' and the RCK domain, is not necessary for the calcium-activated opening of these channels.	Stanford Univ, Dept Cellular & Mol Physiol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Aldrich, RW (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Sch Med, Stanford, CA 94305 USA.		Piskorowski, Rebecca Ann/G-6610-2017	Piskorowski, Rebecca Ann/0000-0003-0120-2360				Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; Braun AP, 2001, J PHYSIOL-LONDON, V533, P681, DOI 10.1111/j.1469-7793.2001.00681.x; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; CRAWFORD AC, 1981, J PHYSIOL-LONDON, V312, P377, DOI 10.1113/jphysiol.1981.sp013634; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Krauss J K, 1996, Parkinsonism Relat Disord, V2, P35, DOI 10.1016/1353-8020(95)00018-6; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; MARTY A, 1981, NATURE, V291, P597; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Niu XW, 2002, P NATL ACAD SCI USA, V99, P11441, DOI 10.1073/pnas.172254699; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Quirk JC, 2001, NEURON, V32, P13, DOI 10.1016/S0896-6273(01)00444-5; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Rothberg BS, 1999, J GEN PHYSIOL, V114, P93, DOI 10.1085/jgp.114.1.93; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; Talukder G, 2000, BIOPHYS J, V78, P761, DOI 10.1016/S0006-3495(00)76634-3; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Zhu GY, 1998, J NEUROSCI METH, V81, P73, DOI 10.1016/S0165-0270(98)00019-3	30	56	57	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					499	502		10.1038/nature01199	http://dx.doi.org/10.1038/nature01199			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466841				2022-12-28	WOS:000179611600044
J	Weber, U; Scherubl, H				Weber, U; Scherubl, H			Tuberculosis with atlantoaxial and craniovertebral Pott's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Free Univ Berlin, D-12200 Berlin, Germany	Free University of Berlin	Weber, U (corresponding author), Free Univ Berlin, D-12200 Berlin, Germany.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2002	347	23					1849	1849		10.1056/NEJMicm010634	http://dx.doi.org/10.1056/NEJMicm010634			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NW	12466509				2022-12-28	WOS:000179596900005
J	Hogg, PJ; McLachlan, EM				Hogg, PJ; McLachlan, EM			Blood vessels and nerves: together or not?	LANCET			English	Editorial Material							GROWTH-FACTOR; ENDOTHELIAL-CELLS; BIOLOGY; PROLIFERATION; ANGIOGENESIS; REGENERATION; EXPRESSION		Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; Prince Wales Med Res Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Prince Wales Medical Research Institute	Hogg, PJ (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia.		McLachlan, Elspeth M/A-1844-2013	McLachlan, Elspeth M/0000-0003-0755-8747; Hogg, Philip/0000-0001-6486-2863				Hobson MI, 2000, J ANAT, V197, P591, DOI 10.1046/j.1469-7580.2000.19740591.x; Jackman A, 2000, J COMP NEUROL, V418, P281; MITCHELL BS, 1994, TUMOR BIOL, V15, P269, DOI 10.1159/000217901; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Pincelli C, 2000, EUR J DERMATOL, V10, P85; Raychaudhuri SK, 2001, ARCH DERMATOL RES, V293, P291, DOI 10.1007/s004030100224; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Shima DT, 2000, CURR OPIN GENET DEV, V10, P536, DOI 10.1016/S0959-437X(00)00124-6; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Smith PG, 2002, CELL TISSUE RES, V307, P281, DOI 10.1007/s00441-001-0477-8; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TERENGHI G, 1995, HISTOL HISTOPATHOL, V10, P709	14	6	9	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1714	1714		10.1016/S0140-6736(02)11726-0	http://dx.doi.org/10.1016/S0140-6736(02)11726-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480422				2022-12-28	WOS:000179636800006
J	Liu, CW; Corboy, MJ; DeMartino, GN; Thomas, PJ				Liu, CW; Corboy, MJ; DeMartino, GN; Thomas, PJ			Endoproteolytic activity of the proteasome	SCIENCE			English	Article							HIGH-MOLECULAR-WEIGHT; TRANSCRIPTION FACTOR; 26S PROTEASOME; 20S PROTEASOME; CORE PARTICLE; UBIQUITIN; DEGRADATION; ACTIVATION; CHAPERONE; PROTEINS	The proteasome plays a central role in the degradation of regulatory and misfolded proteins. Current models suggest that substrates access the internal catalytic sites by processively threading their termini through the gated substrate channel. Here, we found that latent (closed) and activated (open) proteasomes degraded two natively disordered substrates at internal peptide bonds even when they lacked accessible termini, suggesting that these substrates themselves promoted gating of the proteasome. This endoproteolysis provides a molecular mechanism for regulated release of transcription factors from inactive precursors as well as a means of accessing internal folding defects of misfolded multidomain proteins.	Univ Texas, SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.		Thomas, Philip J/F-7115-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049835, R01DK049835] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK49835, DK46818, R37 DK049835, R01 DK049835] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Evans TC, 1999, J BIOL CHEM, V274, P18359, DOI 10.1074/jbc.274.26.18359; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee C, 2002, J BIOL CHEM, V277, P34760, DOI 10.1074/jbc.M204750200; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MA CP, 1994, J BIOL CHEM, V269, P3539; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	30	315	320	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					408	411		10.1126/science.1079293	http://dx.doi.org/10.1126/science.1079293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12481023	Green Accepted			2022-12-28	WOS:000180426800050
J	Abbott, A				Abbott, A			Genomics - Sorry, dogs - man's got a new best friend	NATURE			English	Editorial Material																		Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	2	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					729	729		10.1038/420729a	http://dx.doi.org/10.1038/420729a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490903	Bronze			2022-12-28	WOS:000179897300012
J	Clarke, T				Clarke, T			Sustainable development - Now we're talking	NATURE			English	Editorial Material																		Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GORDON D, 2002, 200204D ICA NAT INT; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181	3	3	4	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					733	734		10.1038/420733a	http://dx.doi.org/10.1038/420733a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490908				2022-12-28	WOS:000179897300017
J	Voracek, M; Fisher, ML				Voracek, M; Fisher, ML			Shapely centrefolds? Temporal change in body measures: trend analysis	BRITISH MEDICAL JOURNAL			English	Article							ATTRACTIVENESS		Univ Vienna, Sch Med, AKH,Stat & Documentat Branch, Dept Psychoanal & Psychotherapy, A-1090 Vienna, Austria; York Univ, Dept Psychol, N York, ON M3J 1P3, Canada	University of Vienna; York University - Canada	Voracek, M (corresponding author), Univ Vienna, Sch Med, AKH,Stat & Documentat Branch, Dept Psychoanal & Psychotherapy, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.		Voracek, Martin/S-5865-2016	Voracek, Martin/0000-0001-6109-6155; Fisher, Maryanne/0000-0002-7804-8544				MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; RINTALA M, 1992, BRIT MED J, V305, P1575, DOI 10.1136/bmj.305.6868.1575; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Tovee MJ, 1997, LANCET, V350, P1474, DOI 10.1016/S0140-6736(05)64238-9; Tovee MJ, 1998, LANCET, V352, P548, DOI 10.1016/S0140-6736(05)79257-6	5	58	59	0	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1447	1448		10.1136/bmj.325.7378.1447	http://dx.doi.org/10.1136/bmj.325.7378.1447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493660	Green Published			2022-12-28	WOS:000180188600012
J	Connolly, DL; Lip, GYH; Chin, BSP				Connolly, DL; Lip, GYH; Chin, BSP			ABC of antithrombotic therapy - Antithrombotic strategies in acute coronary syndromes and percutaneous coronary interventions	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ELEVATION MYOCARDIAL-INFARCTION; UNSTABLE ANGINA		Sandwell & W Birmingham Hosp NHS Trust, Dept Cardiol & Vasc Med, Birmingham, W Midlands, England		Connolly, DL (corresponding author), Sandwell & W Birmingham Hosp NHS Trust, Dept Cardiol & Vasc Med, Birmingham, W Midlands, England.							Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Roffi M, 2002, CIRCULATION, V105, P2730, DOI 10.1161/01.CIR.0000018123.02672.C7	5	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2002	325	7377					1404	1407		10.1136/bmj.325.7377.1404	http://dx.doi.org/10.1136/bmj.325.7377.1404			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480860	Green Published			2022-12-28	WOS:000179975000028
J	Crowcroft, NS; Catchpole, M				Crowcroft, NS; Catchpole, M			Mortality from methicillin resistant Staphylococcus aureus in England and Wales: analysis of death certificates	BRITISH MEDICAL JOURNAL			English	Article									Off Natl Stat, London SW1V 2QQ, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England	Public Health England	Crowcroft, NS (corresponding author), Off Natl Stat, London SW1V 2QQ, England.							*DEP HLTH STAT HEA, HOSP ACQ INF; PRATT SJ, 2001, J HOSP INFECT S, V47, pS3; Reacher MH, 2000, BMJ-BRIT MED J, V320, P213, DOI 10.1136/bmj.320.7229.213; Rooney C, 1999, HLTH STAT Q, P21; Speller DCE, 1997, LANCET, V350, P323, DOI 10.1016/S0140-6736(97)12148-1	5	44	45	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1390	1391		10.1136/bmj.325.7377.1390	http://dx.doi.org/10.1136/bmj.325.7377.1390			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480853	Green Published			2022-12-28	WOS:000179975000022
J	Funes, S; Davidson, E; Reyes-Prieto, A; Magallon, S; Herion, P; King, MP; Gonzalez-Halphen, D				Funes, S; Davidson, E; Reyes-Prieto, A; Magallon, S; Herion, P; King, MP; Gonzalez-Halphen, D			A green algal apicoplast ancestor	SCIENCE			English	Article							MITOCHONDRIAL GENOME; PARASITES; NUCLEAR; GENES; APICOMPLEXAN; EVOLUTION; PLASTIDS; ORIGIN; DNA		Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA; Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Jefferson University; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Gonzalez-Halphen, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.		Funes, Soledad/A-1278-2010; Gonzalez-Halphen, Diego/C-2664-2013	Funes, Soledad/0000-0003-1815-1977; Gonzalez-Halphen, Diego/0000-0003-0654-655X; Magallon, Susana/0000-0002-6838-7497	FIC NIH HHS [TW01176] Funding Source: Medline; NHLBI NIH HHS [HL59646] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059646] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Feagin JE, 2000, INT J PARASITOL, V30, P371, DOI 10.1016/S0020-7519(99)00190-3; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; McFadden GI, 1997, BIOESSAYS, V19, P1033, DOI 10.1002/bies.950191114; Nedelcu AM, 2000, GENOME RES, V10, P819, DOI 10.1101/gr.10.6.819; Perez-Martinez X, 2001, J BIOL CHEM, V276, P11302, DOI 10.1074/jbc.M010244200; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449	9	105	116	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2155	2155		10.1126/science.1076003	http://dx.doi.org/10.1126/science.1076003			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481129				2022-12-28	WOS:000179773700038
J	Chantler, C				Chantler, C			The second greatest benefit to mankind?	LANCET			English	Article							DOCTORS; CYSTINOSIS; PROFESSIONALISM; PERFORMANCE; UROKINASE; MEDICINE; WORLD; DEATH; CARE		Kings Fund, London, England		Chantler, C (corresponding author), 22 Benbow House,New Globe Walk, London SE1 9DS, England.	cyril.chantler@kcl.ac.uk						*AC MED SCI, 2002, CLIN AC MED JEOP REC; Academy of Medical Sciences, 2000, TEN TRACK CLIN SCI N; [Anonymous], 2001, BMJ-BRIT MED J, V323, P651; Berwick DM, 2002, BRIT MED J, V324, P142; Boyd R, 1997, LANCET, V350, P595, DOI 10.1016/S0140-6736(05)63190-X; Brearley M, 2000, BRIT MED J, V321, P1141, DOI 10.1136/bmj.321.7269.1141; Bunker JP, 2001, INT J EPIDEMIOL, V30, P1260, DOI 10.1093/ije/30.6.1260; CALMAN K, 1994, BRIT MED J, V309, P1140, DOI 10.1136/bmj.309.6962.1140; Catto G, 2002, CLIN MED, V2, P212, DOI 10.7861/clinmedicine.2-3-212; Chadwick J., 2005, HIPPOCRATIC WRITINGS; Chantler C, 1998, J ROY SOC MED, V91, P317, DOI 10.1177/014107689809100610; Chantler C, 2002, BRIT MED J, V325, P388; Chantler C, 1998, BRIT MED J, V316, P1731; CHANTLER C, 1988, J ROY COLL PHYS LOND, V22, P69; Chantler C, 1999, LANCET, V353, P1178, DOI 10.1016/S0140-6736(99)01075-2; CHANTLER C, 2002, J HLTH SERV RES POLI, V7, P118; Chantler C., 1994, TREAT DOCTORS ROLE C; CHANTLER C, 2001, POTENTIAL COMMUNITY; Cochrane A. L, 1972, PUBLIC HEALTH, DOI DOI 10.1016/S0033-3506(73)80082-4; Colver AF, 2000, ARCH DIS CHILD-FETAL, V83, pF7, DOI 10.1136/fn.83.1.F7; Committee on Quality of Healthcare in America, 2001, CROSS QUAL CHASM NEW; Coulter A, 2002, BMJ-BRIT MED J, V324, P648, DOI 10.1136/bmj.324.7338.648; *COUNC HEADS MED S, 2002, STAFF MED SCH ENGL; Cruess RL, 2000, LANCET, V356, P156, DOI 10.1016/S0140-6736(00)02458-2; DAMIANI M, 2001, MANAGING PRESSURE EM; DAVIES R, 1998, MERRY HEART DOCTOR H; de Leval MR, 2000, J THORAC CARDIOV SUR, V119, P661, DOI 10.1016/S0022-5223(00)70006-7; *DEP HLTH, 2001, COP LETT PAT IN INV; *DEP PUBL HLTH, 2002, ALL NHS DOCT GLANC; DOYAL L, IN PRESS OXFORD TXB; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; FOLLETT B, 2001, REV APPRAISAL DISCIP; Garattini S, 2002, BMJ-BRIT MED J, V325, P269, DOI 10.1136/bmj.325.7358.269; *GEN MED COUNC, 1999, MAN HLTH CAR ROL DOC; *GEN MED COUNC, 2002, WITHH WITHDR TREATM; General Medical Council, 2001, GOOD MED PRACT; General Medical Council, 1999, SEEK PAT CONS ETH CO; General Medical Council, 1993, TOM DOCT; Goldacre MJ, 2001, MED EDUC, V35, P337, DOI 10.1046/j.1365-2923.2001.00939.x; Gray JAM, 1999, BRIT MED J, V319, P1476, DOI 10.1136/bmj.319.7223.1476; GRIFFITHS R, 1992, J ROY SOC MED, V85, P663; Ham C, 2002, BRIT MED J, V324, P838, DOI 10.1136/bmj.324.7341.838; HAYCOCK GB, 1982, ARCH DIS CHILD, V57, P934, DOI 10.1136/adc.57.12.934; *HIGH ED FUND COUN, 2002, COUNC BRIEF; *HIGH ED FUND COUN, 2002, RES REL HIGH ED I CH; HILL AP, 2000, WHATS GONE WRONG HLT; Illich I, 1995, BRIT MED J, V311, P1652, DOI 10.1136/bmj.311.7021.1652; Irvine D, 1997, BRIT MED J, V314, P1540, DOI 10.1136/bmj.314.7093.1540; *JOINT WORK PART B, 1998, PROV AC HOSP SERV; JONES FE, 1975, BRIT MED J, V4, P547, DOI 10.1136/bmj.4.5996.547; JONES RWA, 1981, KIDNEY INT, V20, P723, DOI 10.1038/ki.1981.202; *KING FUND, 2002, FUT NHS FRAM DEB; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, DOI 10.17226/9728; KROGSTAD V, 2002, BMJ-BRIT MED J, V324, P36; Le Fanu J., 1999, RISE FALL MODERN MED; MARINKER M, 1995, END GEN PRACTICE; MCCAGUE K, 2001, BMJ-BRIT MED J, V322, P1062; McCormick J, 1996, LANCET, V348, P667, DOI 10.1016/S0140-6736(96)03512-X; MINTZBERG H, 1983, STRUCTURE FIVES DESI; *MORI, 2002, PUBL TRUST DOCT RIS; NEUBERGER J, 2000, CLIN MANAGE, V9, P197; ONEILL O, 2002, BBC REITH LECT RADIO; PARSLEY K, 2002, MOL THERAPY, V5, pS26; PORTER R, 1997, GREATEST BENEFIT MAN, P246; Posnett J, 1999, BRIT MED J, V319, P1063, DOI 10.1136/bmj.319.7216.1063; Powell JE., 1966, NEW LOOK MED POLITIC; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; RICHARDS R, 1997, CLIN ACAD CAREERS; Rivett Geoffrey, 1998, CRADLE GRAVE 50 YEAR; ROLAND M, 1998, WHAT PATIENTS VALUE; SHINE KI, 2002, PRESIDENTS REPORT ME; SKRABANEK P, 1989, FOLLIES FALLACIES ME; Smith R, 2001, BMJ-BRIT MED J, V322, P1073, DOI 10.1136/bmj.322.7294.1073; Smith R, 2002, BMJ-BRIT MED J, V324, P923; SMITH T, 2001, SURVEY CLIN ACAD STA; *STAND MED ADV COM, 2001, DOCT FUT SMAC ADV; Stevens Rosemary, 1966, MED PRACTICE MODERN; SYKES R, 2000, NEW MED PRACTICE MED; The Bristol Royal Infirmary Inquiry, 2001, LEARN BRIST REP PUBL; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; VANTHOFF WG, 1991, ARCH DIS CHILD, V66, P1434, DOI 10.1136/adc.66.12.1434; Walshe K, 2002, BRIT MED J, V324, P967, DOI 10.1136/bmj.324.7343.967; WEINER JP, 2001, US MANAGED CARE PCTS; WEST MA, IN PRESS INT J HUM R	84	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1870	1877		10.1016/S0140-6736(02)11787-9	http://dx.doi.org/10.1016/S0140-6736(02)11787-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480380	Green Published			2022-12-28	WOS:000179706100030
J	Lawlor, DA; Smith, GD; Leon, DA; Sterne, JAC; Ebrahim, S				Lawlor, DA; Smith, GD; Leon, DA; Sterne, JAC; Ebrahim, S			Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis	LANCET			English	Article							ACUTE CEREBROVASCULAR-DISEASE; CORONARY HEART-DISEASE; CIGARETTE-SMOKING; PROJECT 1981-86; ISCHEMIC STROKE; COMMUNITY; WOMEN; RISK; RENFREW/PAISLEY; POPULATIONS	Background Since both cerebral infarction and coronary heart disease are caused by atherosclerosis, they would be expected to have similar secular trends in mortality. Because differential diagnosis of stroke subtype on routine death certificates is inaccurate, we aimed to estimate secular trends in cerebral infarct and haemorrhage throughout the 20th century, for England and Wales, with data from autopsy studies. Methods We calculated the ratio of cerebral infarct to cerebral haemorrhage from all available sources of autopsy data from the 20th century. These data were used to estimate the ratio of cerebral infarct to haemorrhage for every year, and hence to estimate rates of cerebral infarct and cerebral haemorrhage from the total stroke mortality rate, obtained from the UK Office for National Statistics. Findings Data about stroke subtypes from autopsies were available from 1932 to 1999. The ratio of cerebral infarct to cerebral haemorrhage increased fourfold from 0.5 in the 1930s to 2.0 by the 1990s; most of the increase took place between the 1930s and the 1970s. Estimated secular trends suggested that there was a steady fall in mortality from cerebral haemorrhage throughout the 20th century, whereas mortality from cerebral infarct increased to a peak in the 1970s and then fell. Trends in estimated cerebral infarct mortality closely matched those for coronary heart disease mortality. Interpretation The closely related trends in cerebral infarct and coronary heart disease suggest common causes, but the very different trend in cerebral haemorrhage shows that its cause probably differs importantly from these conditions.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; London Sch Hyg & Trop Med, London WC1, England	University of Bristol; University of London; London School of Hygiene & Tropical Medicine	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall,Whiteladies Rd, Bristol BS8 2PR, Avon, England.	D.A.Lawlor@bristol.ac.uk	Davey Smith, George/A-7407-2013; Sterne, Jonathan/Z-3106-2019; Leon, David A/G-2195-2010	Davey Smith, George/0000-0002-1407-8314; Sterne, Jonathan/0000-0001-8496-6053; Leon, David A/0000-0001-9747-1762; Lawlor, Debbie A/0000-0002-6793-2262				ALLEN CMC, 1983, Q J MED, V52, P515; ANDERSON TW, 1968, LANCET, V1, P1137; BAMFORD J, 1988, J NEUROL NEUROSUR PS, V51, P1373, DOI 10.1136/jnnp.51.11.1373; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Charlton J., 1997, HLTH ADULT BRITAIN 1, VVolume 2, P60; CROFTON E, 1963, BRIT MED J, P1161, DOI 10.1136/bmj.2.5366.1161; Eriksson JG, 2000, STROKE, V31, P869, DOI 10.1161/01.STR.31.4.869; Falkeborn M, 1996, EPIDEMIOLOGY, V7, P67, DOI 10.1097/00001648-199601000-00012; Gale CR, 1997, J ROY SOC MED, V90, P138, DOI 10.1177/014107689709000307; Hart CL, 2000, J EPIDEMIOL COMMUN H, V54, P874, DOI 10.1136/jech.54.11.874; HART CL, IN PRESS J EPIDEMIOL; *HER MAJ STAT OFF, 1956, REG GEN STAT REV ENG; Hypponen E, 2001, BRIT MED J, V323, P1033, DOI 10.1136/bmj.323.7320.1033; Kodama K, 1993, Ann Epidemiol, V3, P524; KULLER L, 1971, AM J EPIDEMIOL, V93, P1; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; McCarron P, 2001, J EPIDEMIOL COMMUN H, V55, P404, DOI 10.1136/jech.55.6.404; MITCHINSON MJ, 1980, LANCET, V1, P244; Newson R., 2000, STATA TECHNICAL B, V57, P20; REED DM, 1990, AM J EPIDEMIOL, V131, P579, DOI 10.1093/oxfordjournals.aje.a115542; SAKUGAWA H, 1999, J CLIN PATHOL, V47, P31; SANDERCOCK P, 1985, BRIT MED J, V290, P193, DOI 10.1136/bmj.290.6463.193; Shinton R, 1997, J EPIDEMIOL COMMUN H, V51, P138, DOI 10.1136/jech.51.2.138; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Smith GD, 1997, J EPIDEMIOL COMMUN H, V51, P134, DOI 10.1136/jech.51.2.134; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; TERENT A, 1988, STROKE, V19, P598, DOI 10.1161/01.STR.19.5.598; YATES PO, 1964, LANCET, V1, P65; YATES PO, 1961, MED RES COUNCIL SPEC, V300; [No title captured]	30	97	105	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1818	1823		10.1016/S0140-6736(02)11769-7	http://dx.doi.org/10.1016/S0140-6736(02)11769-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480358				2022-12-28	WOS:000179706100008
J	Cotton, FA; Gruhn, NE; Gu, JD; Huang, P; Lichtenberger, DL; Murillo, CA; Van Dorn, LO; Wilkinson, CC				Cotton, FA; Gruhn, NE; Gu, JD; Huang, P; Lichtenberger, DL; Murillo, CA; Van Dorn, LO; Wilkinson, CC			Closed-shell molecules that ionize more readily than cesium	SCIENCE			English	Article							PHOTOELECTRON-SPECTROSCOPY; ELECTRONIC-STRUCTURE; COMPLEXES	We report a class of molecules with extremely low ionization enthalpies, one member of which has been determined to have a gas-phase ionization energy (onset, 3.51 electron volts) lower than that of the cesium atom (which has the lowest gas-phase ionization energy of the elements) or of any other known closed-shell molecule or neutral transient species reported. The molecules are dimetal complexes with the general formula M-2(hpp)(4) (where M is Cr, Mo, or W, and hpp is the anion of 1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidine), structurally characterized in the solid state, spectroscopically characterized in the gas phase, and modeled with theoretical computations. The low-energy ionization of each molecule corresponds to the removal of an electron from the delta bonding orbital of the quadruple metal-metal bond, and a strong interaction of this orbital with a filled orbital on the hpp ligands largely accounts for the low ionization energies.	Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA; Texas A&M Univ, Mol Struct & Bonding Lab, College Stn, TX 77842 USA; Univ Arizona, Dept Chem, Tucson, AZ 85721 USA; Univ Arizona, Lab Gas Phase Electron Spect, Tucson, AZ 85721 USA; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, State Key Lab Drug Res,Drug Design & Discovery Ct, Shanghai 200031, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Arizona; University of Arizona; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS	Cotton, FA (corresponding author), Texas A&M Univ, Dept Chem, POB 30012, College Stn, TX 77842 USA.			Lichtenberger, Dennis/0000-0002-9271-0311				BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; CAULETTI C, 1980, J ELECTRON SPECTROSC, V19, P327, DOI 10.1016/0368-2048(80)80058-2; Cotton F. A., 1999, ADV INORGANIC CHEM; Cotton FA, 2002, J AM CHEM SOC, V124, P9249, DOI 10.1021/ja0266464; Cotton FA, 1998, POLYHEDRON, V17, P179; Cotton FA, 2002, INORG CHEM, V41, P2466, DOI 10.1021/ic025508c; Cotton FA, 2002, INORG CHEM COMMUN, V5, P501, DOI 10.1016/S1387-7003(02)00449-5; COTTON FA, 1992, MULTIPLE BONDS METAL; COTTON FA, UNPUB; COTTON FA, IN PRESS INORG CHEM; DAVIES CE, 1992, INORG CHEM, V31, P3779, DOI 10.1021/ic00044a021; Frisch M.J., 2016, GAUSSIAN 16 REVISION; GREEN JC, 1983, ORGANOMETALLICS, V2, P211, DOI 10.1021/om00074a002; GUTSEV GL, 1982, CHEM PHYS LETT, V92, P262, DOI 10.1016/0009-2614(82)80272-8; Hehre W. J., 1986, AB INITIO MOL ORBITA; Huzinaga S., 1984, GAUSSIAN BASIS SETS; JATCKO ME, 1989, THESIS U ARIZONA TUC; KAPPES MM, 1985, J PHYS CHEM-US, V89, P1499, DOI 10.1021/j100254a038; KAPPES MM, 1985, CHEM PHYS LETT, V113, P243, DOI 10.1016/0009-2614(85)80252-9; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LICHTENBERGER DL, 1990, J ELECTRON SPECTROSC, V50, P335, DOI 10.1016/0368-2048(90)87076-Z; Lichtenberger DL, 1999, J AM CHEM SOC, V121, P12167, DOI 10.1021/ja993065e; Lin C, 1996, INORG CHEM, V35, P6422, DOI 10.1021/ic960555o; Martin WC, 1996, ATOMIC MOL OPTICAL P, P135; MARTIN WC, GROUND LEVELS IONIZA; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Moore C. E., 1970, 34 NSRDSNBS; Moran D, 2002, J PHYS CHEM A, V106, P5144, DOI 10.1021/jp014471z; Novak I, 2001, J PHYS CHEM A, V105, P1783, DOI 10.1021/jp003430k; OHARE D, 1992, ORGANOMETALLICS, V11, P48, DOI 10.1021/om00037a016; Westcott BL, 1998, J AM CHEM SOC, V120, P3382, DOI 10.1021/ja972674o	31	113	127	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1971	1974		10.1126/science.1078721	http://dx.doi.org/10.1126/science.1078721			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471252				2022-12-28	WOS:000179629200039
J	Fitzsimons, EJ; Sturrock, RD				Fitzsimons, EJ; Sturrock, RD			The chronic anaemia of rheumatoid arthritis: iron banking or blocking?	LANCET			English	Editorial Material							CHRONIC DISEASE		Univ Glasgow, Dept Haematol, Glasgow G11 6NT, Lanark, Scotland; Univ Glasgow, Fac Med, Ctr Rheumat Dis, Div Immunol Infect & Inflammat, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow; University of Glasgow	Fitzsimons, EJ (corresponding author), Univ Glasgow, Dept Haematol, Glasgow G11 6NT, Lanark, Scotland.	ejf1s@clinmed.gla.ac.uk						Davis D, 1997, BRIT J RHEUMATOL, V36, P950; DROSOS AA, 1990, CLIN RHEUMATOL, V9, P333, DOI 10.1007/BF02114393; Fitzsimons EJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P166, DOI 10.1002/art.10247; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; KONIJN AM, 1977, BRIT J HAEMATOL, V37, P7, DOI 10.1111/j.1365-2141.1977.tb08806.x; Leandro MJ, 2002, ANN RHEUM DIS, V61, P883, DOI 10.1136/ard.61.10.883; Papadaki HA, 2002, BLOOD, V99, P1610, DOI 10.1182/blood.V99.5.1610; Papadaki HA, 2002, BLOOD, V100, P474, DOI 10.1182/blood-2002-01-0136; Suominen P, 2000, ARTHRITIS RHEUM, V43, P1016, DOI 10.1002/1529-0131(200005)43:5<1016::AID-ANR9>3.0.CO;2-3	9	13	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2002	360	9347					1713	1714		10.1016/S0140-6736(02)11725-9	http://dx.doi.org/10.1016/S0140-6736(02)11725-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480421				2022-12-28	WOS:000179636800005
J	Li, QL; Park, PW; Wilson, CL; Parks, WC				Li, QL; Park, PW; Wilson, CL; Parks, WC			Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury	CELL			English	Article							MACROPHAGE-INFLAMMATORY PROTEIN-2; HEPARAN-SULFATE PROTEOGLYCANS; MEDIATED HOST-DEFENSE; CXC CHEMOKINE; METALLOPROTEINASE MATRILYSIN; RECEPTOR-2 LIGANDS; FAS LIGAND; MATRIX METALLOPROTEINASE-7; INCREASED SUSCEPTIBILITY; PULMONARY-FIBROSIS	The influx of inflammatory cells to sites of injury is largely directed by signals from the epithelium, but how these cells form chemotactic gradients is not known. In matrilysin null mice, neutrophils remained confined in the interstitium of injured lungs and did not advance into the alveolar space. Impaired transepithelial migration was accompanied by a lack of both shed syndecan-1, a heparan sulfate proteoglycan, and KC, a CXC chemokine, in the alveolar fluid. KC was bound to shed syndecan-1, and it was not detected in the lavage of syndecan-1 null mice. In vitro, matrilysin cleaved syndecan-1 from the surface of cells. Thus, matrilysin-mediated shedding of syndecan-1/KC complexes from the mucosal surface directs and confines neutrophil influx to sites of injury.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Baylor College of Medicine	Parks, WC (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	parks_w@kids.wustl.edu	Sawant, Kirti V/H-3778-2013; Parks, William C./AAH-6786-2021	Park, Pyong Woo/0000-0002-7979-4979	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594, R01HL069050] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL069050, HL69050, HL29594, HL54619] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Aoshiba K, 2000, AM J RESP CRIT CARE, V162, P695, DOI 10.1164/ajrccm.162.2.9907012; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Corry DB, 2002, NAT IMMUNOL, V3, P347, DOI 10.1038/ni773; Cosgrove GP, 2002, CHEST, V121, p25S, DOI 10.1378/chest.121.3_suppl.25S-a; Crawford HC, 2002, J CLIN INVEST, V109, P1437, DOI 10.1172/JCI200215051; Del Rio L, 2001, J IMMUNOL, V167, P6503, DOI 10.4049/jimmunol.167.11.6503; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Endlich B, 2002, J IMMUNOL, V168, P3586, DOI 10.4049/jimmunol.168.7.3586; Fingleton B, 2001, NEOPLASIA, V3, P459, DOI 10.1038/sj.neo.7900190; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Godaly G, 2000, J IMMUNOL, V165, P5287, DOI 10.4049/jimmunol.165.9.5287; Hall LR, 2001, J IMMUNOL, V166, P4035, DOI 10.4049/jimmunol.166.6.4035; Haro H, 2000, J CLIN INVEST, V105, P143, DOI 10.1172/JCI7091; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Keane MP, 1999, J IMMUNOL, V162, P5511; Kielian T, 2001, J IMMUNOL, V166, P4634, DOI 10.4049/jimmunol.166.7.4634; Kuwano K, 1999, J CLIN INVEST, V104, P13, DOI 10.1172/JCI5628; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; Mehrad B, 1999, J IMMUNOL, V163, P6086; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mitsiades N, 2001, CANCER RES, V61, P577; Moore TA, 2000, J IMMUNOL, V164, P908, DOI 10.4049/jimmunol.164.2.908; Olszyna DP, 2001, J INFECT DIS, V184, P301, DOI 10.1086/322030; Ortiz LA, 1998, EXP LUNG RES, V24, P721, DOI 10.3109/01902149809099592; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; Parks WC, 2001, RESP RES, V2, P10, DOI 10.1186/rr33; Parks WC, 1999, WOUND REPAIR REGEN, V7, P423, DOI 10.1046/j.1524-475X.1999.00423.x; Piccolo MTS, 1999, EXP MOL PATHOL, V66, P220, DOI 10.1006/exmp.1999.2263; PIGUET PF, 1989, J EXP MED, V170, P655, DOI 10.1084/jem.170.3.655; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; SaarialhoKere UK, 1996, AM J PATHOL, V148, P519; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; Wiekowski MT, 2001, J IMMUNOL, V167, P7102, DOI 10.4049/jimmunol.167.12.7102; WILSON CL, 1995, MOL BIOL CELL, V6, P851, DOI 10.1091/mbc.6.7.851; Wilson CL, 1998, BIOL EXTRAC, P149; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yoshidome H, 1999, J SURG RES, V81, P33, DOI 10.1006/jsre.1998.5490; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	49	611	631	6	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	2002	111	5					635	646		10.1016/S0092-8674(02)01079-6	http://dx.doi.org/10.1016/S0092-8674(02)01079-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464176	Bronze			2022-12-28	WOS:000179594500006
J	Taniuchi, I; Osato, M; Egawa, T; Sunshine, MJ; Bae, SC; Komori, T; Ito, Y; Littman, DR				Taniuchi, I; Osato, M; Egawa, T; Sunshine, MJ; Bae, SC; Komori, T; Ito, Y; Littman, DR			Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development	CELL			English	Article							MULTIPLE CHROMOSOMAL TRANSLOCATIONS; ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; TRANSCRIPTION FACTOR; CELL DEVELOPMENT; NERVOUS-SYSTEM; BINDING-FACTOR; AML1	T lymphocytes differentiate in discrete stages within the thymus. Immature thymocytes lacking CD4 and CD8 coreceptors differentiate into double-positive cells (CD4(+)CD8(+)), which are selected to become either CD4(+)CD8(-)helper cells or CD4(-)CD8(+) cytotoxic cells. A stage-specific transcriptional silencer regulates expression of CD4 in both immature and CD4(-)CD8(+) thymocytes. We show here that binding sites for Runt domain transcription factors are essential for CD4 silencer function at both stages, and that different Runx family members are required to fulfill unique functions at each stage. Runxi is required for active repression in CD4(-)CD8(-) thymocytes whereas Runx3 is required for establishing epigenetic silencing in cytotoxic lineage thymocytes. Runx3-deficient cytotoxic T cells, but not helper cells, have defective responses to antigen, suggesting that Runx proteins have critical functions in lineage specification and homeostasis of CD8lineage T lymphocytes.	NYU, Sch Med, Howard Hughes Med Inst, Mol Pathogenesis Program,Skirball Inst Biomol Med, New York, NY 10016 USA; Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 6068507, Japan; Chungbuk Natl Univ, Inst Tumor Res, Sch Med, Dept Biochem, Cheongju 361763, South Korea; Osaka Univ, Sch Med, Dept Mol Med, Osaka 5650871, Japan	Howard Hughes Medical Institute; New York University; Kyoto University; Chungbuk National University; Osaka University	Taniuchi, I (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 8128582, Japan.	taniuchi@bioreg.kyushu-u.ac.jp; littman@saturn.med.nyu.edu	Osato, Motomi/N-5056-2014; Taniuchi, Ichiro/N-6399-2015	Osato, Motomi/0000-0003-3982-9054; Taniuchi, Ichiro/0000-0002-9853-9068; Sunshine, Mary Jean/0000-0002-2188-7881				Akasaka T, 2001, DEVELOPMENT, V128, P1587; Allen RD, 2001, MOL CELL BIOL, V21, P3071, DOI 10.1128/MCB.21.9.3071-3082.2001; Bae SC, 1999, HISTOL HISTOPATHOL, V14, P1213, DOI 10.14670/HH-14.1213; Canon J, 2000, SEMIN CELL DEV BIOL, V11, P327, DOI 10.1006/scdb.2000.0185; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Donda A, 1996, EUR J IMMUNOL, V26, P493, DOI 10.1002/eji.1830260232; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Garefalaki A, 2002, IMMUNITY, V16, P635, DOI 10.1016/S1074-7613(02)00308-4; GROETTRUP M, 1993, IMMUNOL TODAY, V14, P610, DOI 10.1016/0167-5699(93)90201-U; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hedrick SM, 2002, IMMUNITY, V16, P619, DOI 10.1016/S1074-7613(02)00316-3; INOUE KI, 2002, IN PRESS NAT NEUROSC; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; KANIA MA, 1990, GENE DEV, V4, P1701, DOI 10.1101/gad.4.10.1701; Karsenty G, 2000, SEMIN CELL DEV BIOL, V11, P343, DOI 10.1006/scdb.2000.0188; Killeen N, 1996, CURR TOP MICROBIOL, V205, P89; Kim HK, 1998, MOL CELL BIOL, V18, P7166, DOI 10.1128/MCB.18.12.7166; Kim WWS, 1999, J EXP MED, V190, P281, DOI 10.1084/jem.190.2.281; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Lewin B, 1998, CELL, V93, P301, DOI 10.1016/S0092-8674(00)81154-X; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lutterbach B, 2000, J BIOL CHEM, V275, P651, DOI 10.1074/jbc.275.1.651; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Srivastava M, 2000, GENE DEV, V14, P1186; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Tracey WD, 2000, SEMIN CELL DEV BIOL, V11, P337, DOI 10.1006/scdb.2000.0186; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; Wakimoto BT, 1998, CELL, V93, P321, DOI 10.1016/S0092-8674(00)81159-9; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WEE HJ, 2002, IN PRESS EMBO REP; Wheeler JC, 2000, SEMIN CELL DEV BIOL, V11, P369, DOI 10.1006/scdb.2000.0184; Wheeler JC, 2002, NAT GENET, V32, P206, DOI 10.1038/ng942; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	56	587	602	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	2002	111	5					621	633		10.1016/S0092-8674(02)01111-X	http://dx.doi.org/10.1016/S0092-8674(02)01111-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464175	Bronze			2022-12-28	WOS:000179594500005
J	Bozzette, SA; Boer, R; Bhatnagar, V; Brower, JL; Keeler, EB; Morton, SC; Stoto, MA				Bozzette, SA; Boer, R; Bhatnagar, V; Brower, JL; Keeler, EB; Morton, SC; Stoto, MA			A model for a smallpox-vaccination policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND: The new reality of biologic terrorism and warfare has ignited a debate about whether to reintroduce smallpox vaccination. METHODS: We developed scenarios of smallpox attacks and built a stochastic model of outcomes under various control policies. We conducted a systematic literature review and estimated model parameters on the basis of European and North American outbreaks since World War II. We assessed the trade-offs between vaccine-related harms and benefits. RESULTS: Nations or terrorists possessing a smallpox weapon could feasibly mount attacks that vary with respect to tactical complexity and target size, and patterns of spread can be expected to vary according to whether index patients are hospitalized early. For acceptable results, vaccination of contacts must be accompanied by effective isolation. Vaccination of contacts plus isolation is expected to result in 7 deaths (from vaccine or smallpox) in a scenario involving the release of variola virus from a laboratory, 19 deaths in a human-vector scenario, 300 deaths in a building-attack scenario, 2735 deaths in a scenario involving a low-impact airport attack, and 54,729 deaths in a scenario involving a high-impact airport attack. Immediate vaccination of the public in an attacked region would provide little additional benefit. Prior vaccination of health care workers, who would be disproportionately affected, would save lives in large local or national attacks but would cause 25 deaths nationally. Prior vaccination of health care workers and the public would save lives in a national attack but would cause 482 deaths nationally. The expected net benefits of vaccination depend on the assessed probability of an attack. Prior vaccination of health care workers would be expected to save lives if the probability of a building attack exceeded 0.22 or if the probability of a high-impact airport attack exceeded 0.002. The probability would have to be much higher to make vaccination of the public life-saving. CONCLUSIONS: The analysis favors prior vaccination of health care workers unless the likelihood of any attack is very low, but it favors vaccination of the public only if the likelihood of a national attack or of multiple attacks is high.	RAND Corp, Hlth Care, Ctr Domest & Int Hlth Secur, Santa Monica, CA 90407 USA; RAND Corp, Ctr Domest & Int Hlth Secur, Arlington, VA USA; Vet Affairs San Diego Healthcare Syst, Ctr Res Patient Oriented Care, San Diego, CA USA; Univ Calif San Diego, San Diego, CA 92103 USA; Erasmus Univ, Rotterdam, Netherlands	RAND Corporation; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Erasmus University Rotterdam	Bozzette, SA (corresponding author), RAND Corp, Hlth Care, Ctr Domest & Int Hlth Secur, 1700 Main St, Santa Monica, CA 90407 USA.		Boer, Rob/E-6473-2015; Boer, Robert/AFM-0525-2022; Boer, Robert/AAH-2901-2022	Boer, Rob/0000-0003-0680-001X; Boer, Robert/0000-0003-0680-001X; Boer, Robert/0000-0003-0680-001X; Stoto, Michael/0000-0001-8293-471X				[Anonymous], 1980, REPORT INVESTIGATION; [Anonymous], 1996, MMWR-MORBID MORTAL W, V45, P538; [Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P1; BAUER DJ, 1974, BRIT MED J, V1, P576, DOI 10.1136/bmj.1.5907.576; BEHBEHANI AM, 1988, SMALLPOX STORY WORDS; *BRIT MED ASS, FACTS SMALL POX VACC; COPEMAN PWM, 1964, BRIT MED J, V2, P906, DOI 10.1136/bmj.2.5414.906; COX P, 1974, COMMITTEE INQUIRY SM; Dick G, 1966, Prog Med Virol, V8, P1; DIXON C.W, 1962, SMALLPOX; FALKENRATH RA, 1998, AM ACHILLES HEEL NUC, P94; FENNER F, 1997, CLIN VIROLOGY, P357; Fenner F.H.D., 1988, SMALLPOX ITS ERADICA; GELFAND HM, 1971, AM J EPIDEMIOL, V93, P234, DOI 10.1093/oxfordjournals.aje.a121251; GOLDSTEIN JA, 1975, PEDIATRICS, V55, P342; *GREAT BRIT MIN HL, 1963, 109 GREAT BRIT MIN H; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Henderson DA, 1999, EMERG INFECT DIS, V5, P537, DOI 10.3201/eid0504.990415; HENDERSON DA, 1999, VACCINES, P74; Kaplan EH, 2002, P NATL ACAD SCI USA, V99, P10935, DOI 10.1073/pnas.162282799; KEMPE CH, 1960, PEDIATRICS, V26, P176; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1220, DOI 10.1056/NEJM196911272812205; LEROUX M, 1956, SMALLPOX EPIDEMIC VA; Mafart B, 1999, SEM HOP PARIS, V75, P1265; *OCC EMPL STAT PRO, 2000, 2000 NAT IND SPEC OC; POLLOCK TM, 1969, BRIT MED BULL, V25, P202, DOI 10.1093/oxfordjournals.bmb.a070693; SARKAR JK, 1974, INDIAN J MED RES, V62, P1800; SARKAR JK, 1973, B WORLD HEALTH ORGAN, V48, P517; SCHMEMANN S, 2002, NY TIMES        0713, pA3; SHARP JCM, 1973, LANCET, V1, P656; STROM JUSTUS, 1966, ACTA MED SCAND SUPPL, V464, P57; TIGNOR GH, 1992, ANN NY ACAD SCI, V653, P334, DOI 10.1111/j.1749-6632.1992.tb19660.x; TUDOR V, 1977, SMALLPOX CHOLERA TUN; WEHRLE PF, 1978, JAMA-J AM MED ASSOC, V240, P1977, DOI 10.1001/jama.240.18.1977	36	113	120	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					416	425		10.1056/NEJMsa025075	http://dx.doi.org/10.1056/NEJMsa025075			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12496353	Bronze, Green Published			2022-12-28	WOS:000180643800008
J	Brown, ME; Bouchez, AH; Griffith, CA				Brown, ME; Bouchez, AH; Griffith, CA			Direct detection of variable tropospheric clouds near Titan's south pole	NATURE			English	Article							VOYAGER-1 RADIO-OCCULTATION; ATMOSPHERE; TELESCOPE; METHANE; IMAGES	Atmospheric conditions on Saturn's largest satellite, Titan, allow the possibility that it could possess a methane condensation and precipitation cycle with many similarities to Earth's hydrological cycle. Detailed imaging studies(1-4) of Titan have hitherto shown no direct evidence for tropospheric condensation clouds, although there has been indirect spectroscopic evidence for transient clouds(5,6). Here we report images and spectra of Titan that show clearly transient clouds, concentrated near the south pole, which is currently near the point of maximum solar heating. The discovery of these clouds demonstrates the existence of condensation and localized moist convection in Titan's atmosphere. Their location suggests that methane cloud formation is controlled seasonally by small variations in surface temperature, and that the clouds will move from the south to the north pole on a 15-year timescale.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	California Institute of Technology; University of Arizona	Brown, ME (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.			Brown, Michael E./0000-0002-8255-0545				AWAL M, 1994, GEOPHYS RES LETT, V21, P2491, DOI 10.1029/94GL01707; BOUCHEZ AH, 2000, B AM ASTRON SOC, V32, P1702; BOUCHEZ AH, UNPUB ICARUS; Combes M, 1997, ICARUS, V129, P482, DOI 10.1006/icar.1997.5772; Coustenis A, 2001, ICARUS, V154, P501, DOI 10.1006/icar.2001.6643; Gibbard SG, 1999, ICARUS, V139, P189, DOI 10.1006/icar.1999.6095; Griffith CA, 2000, SCIENCE, V290, P509, DOI 10.1126/science.290.5491.509; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; GRIFFITH CA, IN PRESS ICARUS; Hunten D.M, 1984, SATURN, P671; LELLOUCH E, 1989, ICARUS, V79, P328, DOI 10.1016/0019-1035(89)90081-X; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; Lorenz RD, 2001, GEOPHYS RES LETT, V28, P4453, DOI 10.1029/2001GL013728; McKay CP, 1997, ICARUS, V129, P498, DOI 10.1006/icar.1997.5751; McLean IS, 1998, P SOC PHOTO-OPT INS, V3354, P566, DOI 10.1117/12.317283; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023; Tokano T, 2001, ICARUS, V153, P130, DOI 10.1006/icar.2001.6659; Wizinowich P, 2000, P SOC PHOTO-OPT INS, V4007, P2, DOI 10.1117/12.390368	18	153	153	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					795	797		10.1038/nature01302	http://dx.doi.org/10.1038/nature01302			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490943				2022-12-28	WOS:000179897300050
J	Morrow, DS				Morrow, DS			Not guilty	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Benson H., 2000, RELAXATION RESPONSE; GUNDERT B, 2000, SOMA PSYCHE; Seyle H., 1976, STRESS LIFE; Sontag Susan, 2001, ILLNESS METAPHOR	4	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2002	288	24					3084	3085		10.1001/jama.288.24.3084	http://dx.doi.org/10.1001/jama.288.24.3084			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628QQ	12495378				2022-12-28	WOS:000180008200001
J	Wakabayashi, C; Adachi, T; Wienands, R; Tsubata, T				Wakabayashi, C; Adachi, T; Wienands, R; Tsubata, T			A distinct signaling pathway used by the IgG-containing B cell antigen receptor	SCIENCE			English	Article							CO-RECEPTORS; CD22; ACTIVATION; LYMPHOCYTES; CD72; ASSOCIATION; RESPONSES; COMPLEX; ROLES; MICE	The immunoglobulin G (IgG)-containing B lymphocyte antigen receptor (IgG-BCR) transmits a signal distinct from that of IgM-BCR or IgD-BCR, although all three use the same signal-transducing component, Igalpha/Igbeta. Here we demonstrate that the inhibitory coreceptor CD22 down-modulates signaling through IgM-BCR and IgD-BCR, but not that through IgG-BCR, because of the IgG cytoplasmic tail, which prevents CD22 phosphorylation. These results suggest that the cytoplasmic tail of IgG specifically enhances IgG-BCR signaling by preventing CD22-mediated signal inhibition. Enhanced signaling through IgG-BCR may be involved in efficient IgG production, which is crucial for immunity to pathogens.	Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo 1138510, Japan; Univ Freiburg, Dept Mol Immunol Biol 3, D-79108 Freiburg, Germany; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	Tokyo Medical & Dental University (TMDU); University of Freiburg; Max Planck Society	Tsubata, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo 1138510, Japan.	tsubata.imm@mri.tmd.ac.jp	Tsubata, Takeshi/AAI-7489-2021	Tsubata, Takeshi/0000-0003-0760-1258				Adachi T, 2000, J IMMUNOL, V164, P1223, DOI 10.4049/jimmunol.164.3.1223; Adachi T, 1998, J IMMUNOL, V160, P4662; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; ORourke L, 1997, CURR OPIN IMMUNOL, V9, P324, DOI 10.1016/S0952-7915(97)80077-5; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; PEAKER CJG, 1993, EUR J IMMUNOL, V23, P1358, DOI 10.1002/eji.1830230626; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; Tooze RM, 1997, IMMUNITY, V7, P59, DOI 10.1016/S1074-7613(00)80510-5; Tsubata T, 1999, CURR OPIN IMMUNOL, V11, P249, DOI 10.1016/S0952-7915(99)80041-7; WAKABAYASHI C, UNPUB; WEISER P, 1994, EUR J IMMUNOL, V24, P665, DOI 10.1002/eji.1830240327; WIENANDS J, 1990, EMBO J, V9, P449, DOI 10.1002/j.1460-2075.1990.tb08130.x	23	139	145	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2392	2395		10.1126/science.1076963	http://dx.doi.org/10.1126/science.1076963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493916				2022-12-28	WOS:000179915900058
J	Willner, I				Willner, I			Biomaterials for sensors, fuel cells, and circuitry	SCIENCE			English	Article							GLUCOSE-OXIDASE; DNA; IMMUNOSENSOR; ELECTRODES		Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Willner, I (corresponding author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.	willnea@vms.huji.ac.il						Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; Caruana DJ, 1999, J AM CHEM SOC, V121, P769, DOI 10.1021/ja983328p; Chen T, 2001, J AM CHEM SOC, V123, P8630, DOI 10.1021/ja0163164; DIGLERIA K, 1986, ANAL CHEM, V58, P1203, DOI 10.1021/ac00297a050; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; HELLER A, 1992, J PHYS CHEM-US, V96, P3579, DOI 10.1021/j100188a007; Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8; Katz E, 2001, J AM CHEM SOC, V123, P10752, DOI 10.1021/ja0167102; KONIG B, 1993, ANAL CHIM ACTA, V280, P37, DOI 10.1016/0003-2670(93)80238-G; Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S; Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003; Patolsky F, 2002, ANGEW CHEM INT EDIT, V41, P2323, DOI 10.1002/1521-3773(20020703)41:13<2323::AID-ANIE2323>3.0.CO;2-H; Patolsky F, 2002, J AM CHEM SOC, V124, P770, DOI 10.1021/ja0119752; Patolsky F, 2002, ANGEW CHEM INT EDIT, V41, P3398, DOI 10.1002/1521-3773(20020916)41:18<3398::AID-ANIE3398>3.0.CO;2-W; Patolsky F, 2001, ANGEW CHEM INT EDIT, V40, P2261, DOI 10.1002/1521-3773(20010618)40:12<2261::AID-ANIE2261>3.0.CO;2-P; Patolsky F, 2001, NAT BIOTECHNOL, V19, P253, DOI 10.1038/85704; RISHPON J, 1989, BIOSENSORS, V4, P61, DOI 10.1016/0265-928X(89)80023-9; SCHUHMANN W, 1991, J AM CHEM SOC, V113, P1394, DOI 10.1021/ja00004a048; Takenaka S, 2000, ANAL CHEM, V72, P1334, DOI 10.1021/ac991031j; Wang LM, 2000, J AM CHEM SOC, V122, P7435, DOI 10.1021/ja0010195; Weizmann Y, 2001, ANALYST, V126, P1502, DOI 10.1039/b106613g; Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611; Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E; Willner I, 2001, TRENDS BIOTECHNOL, V19, P222, DOI 10.1016/S0167-7799(01)01634-1; Willner I, 2001, ANGEW CHEM INT EDIT, V40, P1861; Zeck G, 2001, P NATL ACAD SCI USA, V98, P10457, DOI 10.1073/pnas.181348698	26	280	290	0	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2407	2408		10.1126/science.298.5602.2407	http://dx.doi.org/10.1126/science.298.5602.2407			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493919				2022-12-28	WOS:000179915900062
J	De Smet, PAGM				De Smet, PAGM			Drug therapy - Herbal remedies.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ST-JOHNS-WORT; GINKGO-BILOBA EXTRACT; BENIGN PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIAL; PLACEBO-CONTROLLED TRIALS; HYPERICUM-PERFORATUM; DOUBLE-BLIND; INTERMITTENT CLAUDICATION; MAJOR DEPRESSION; CLINICAL-TRIALS		Sci Inst Dutch Pharmacists, NL-2514 JL The Hague, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Clin Pharm, Nijmegen, Netherlands	Radboud University Nijmegen	De Smet, PAGM (corresponding author), Sci Inst Dutch Pharmacists, Alexanderstr 11, NL-2514 JL The Hague, Netherlands.	pdesmet@winap.nl	Smet, P.A.G.M./L-4654-2015					Ackermann RT, 2001, ARCH INTERN MED, V161, P813, DOI 10.1001/archinte.161.6.813; AMMON HPT, 1981, PLANTA MED, V43, P209, DOI 10.1055/s-2007-971502; Ang-Lee MK, 2001, JAMA-J AM MED ASSOC, V286, P208, DOI 10.1001/jama.286.2.208; Arenz A, 1996, PLANTA MED, V62, P548, DOI 10.1055/s-2006-957967; Behnke K, 2002, ADV THER, V19, P43, DOI 10.1007/BF02850017; Benjamin J, 2001, POSTGRAD MED J, V77, P112, DOI 10.1136/pmj.77.904.112; Benninger J, 1999, GASTROENTEROLOGY, V117, P1234, DOI 10.1016/S0016-5085(99)70410-5; Bhattacharya SK, 1998, PHARMACOPSYCHIATRY, V31, P22, DOI 10.1055/s-2007-979342; Blumenthal M., 1998, COMPLETE GERMAN COMM; Bove GM, 1998, LANCET, V352, P1121, DOI 10.1016/S0140-6736(05)79763-4; BRAQUET P, 1991, J ETHNOPHARMACOL, V32, P135, DOI 10.1016/0378-8741(91)90111-P; BRAQUET P, 1993, AM J GASTROENTEROL, V88, P2138; Brenner R, 2000, CLIN THER, V22, P411, DOI 10.1016/S0149-2918(00)89010-4; Brown TM, 2000, AM J EMERG MED, V18, P231, DOI 10.1016/S0735-6757(00)90030-5; Budeiri D, 1996, CONTROL CLIN TRIALS, V17, P60, DOI 10.1016/0197-2456(95)00082-8; Burkard G, 1991, MUNCH MED WSCHR S1, V133, P38; Burstein AH, 2000, CLIN PHARMACOL THER, V68, P605, DOI 10.1067/mcp.2000.111530; Carraro JC, 1996, PROSTATE, V29, P231, DOI 10.1002/(SICI)1097-0045(199610)29:4&lt;231::AID-PROS4&gt;3.0.CO;2-E; Chatterjee SS, 1998, LIFE SCI, V63, P499, DOI 10.1016/S0024-3205(98)00299-9; Chatterjee SS, 1997, ARZNEIMITTEL-FORSCH, V47, P821; Cheema P, 2001, J INTERN MED, V250, P167, DOI 10.1046/j.1365-2796.2001.00851.x; Crowe S, 2002, ANESTHESIOLOGY, V96, P1025, DOI 10.1097/00000542-200204000-00035; Davidson JRT, 2001, J CLIN PSYCHOPHARM, V21, P635, DOI 10.1097/00004714-200112000-00026; Davidson JRT, 2002, JAMA-J AM MED ASSOC, V287, P1807, DOI 10.1001/jama.287.14.1807; Davydov Liya, 2001, Journal of Herbal Pharmacotherapy, V1, P65, DOI 10.1080/J157v01n03_06; De Backer TL, 2000, EUR J CLIN PHARMACOL, V56, P199, DOI 10.1007/s002280000114; Debruyne F, 2002, EUR UROL, V41, P497, DOI 10.1016/S0302-2838(02)00066-0; DESMET PAG, 1992, ADVERSE EFFECTS HERB, V1, P1; DESMET PAG, 1999, ESSENTIALS COMPLEMEN, P108; DESMET PAGM, 1995, DRUG SAFETY, V13, P81, DOI 10.2165/00002018-199513020-00003; DeSmet PAGM, 1996, BMJ-BRIT MED J, V313, P241, DOI 10.1136/bmj.313.7052.241; Di Silverio F, 1998, PROSTATE, V37, P77, DOI 10.1002/(SICI)1097-0045(19981001)37:2<77::AID-PROS3>3.0.CO;2-I; DISILVERIO F, 1992, EUR UROL, V21, P309; Drew S, 2001, BRIT MED J, V322, P73, DOI 10.1136/bmj.322.7278.73; Drieu K., 2000, GINKGO BILOBA, P303; Durr D, 2000, CLIN PHARMACOL THER, V68, P598, DOI 10.1067/mcp.2000.112240; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 2000, BRIT J ANAESTH, V84, P367, DOI 10.1093/oxfordjournals.bja.a013442; Ernst E, 1997, NATURE, V385, P480, DOI 10.1038/385480c0; Ernst E, 2000, Public Health Nutr, V3, P509, DOI 10.1017/S1368980000000598; Ernst E, 1998, EUR J CLIN PHARMACOL, V54, P589, DOI 10.1007/s002280050519; Ernst E, 1999, CLIN DRUG INVEST, V17, P301, DOI 10.2165/00044011-199917040-00006; Ernst E, 1999, CLIN OTOLARYNGOL, V24, P164, DOI 10.1046/j.1365-2273.1999.00243.x; Ernst E, 2002, COCHRANE DATABASE SY, V2; Escher M, 2001, BRIT MED J, V322, P139, DOI 10.1136/bmj.322.7279.139; ESCHER M, 2001, BRIT MED J, V322, P1097; *EUR HERB PRACT AS, 2002, PROV MCA ASS REL STR; Felker GM, 2001, AM HEART J, V142, P393, DOI 10.1067/mhj.2001.117606; Ferko N, 2001, PHARMACOTHERAPY, V21, P1574, DOI 10.1592/phco.21.20.1574.34483; Flausino OA, 2002, PHARMACOL BIOCHEM BE, V71, P251, DOI 10.1016/S0091-3057(01)00665-7; Fornal CA, 2001, NEUROPSYCHOPHARMACOL, V25, P858, DOI 10.1016/S0893-133X(01)00297-4; Galluzzi S, 2000, J NEUROL NEUROSUR PS, V68, P679; Gaster B, 2000, ARCH INTERN MED, V160, P152, DOI 10.1001/archinte.160.2.152; Gerber GS, 2000, J UROLOGY, V163, P1408, DOI 10.1016/S0022-5347(05)67631-8; Gerber GS, 2001, UROLOGY, V58, P960, DOI 10.1016/S0090-4295(01)01442-X; Gilbert GJ, 1997, NEUROLOGY, V48, P1137, DOI 10.1212/WNL.48.4.1137; Giles JT, 2000, PHARMACOTHERAPY, V20, P690, DOI 10.1592/phco.20.7.690.35173; Gobbi M, 2001, PHARMACOPSYCHIATRY, V34, pS45, DOI 10.1055/s-2001-15458; Golsch S, 1997, HAUTARZT, V48, P249, DOI 10.1007/s001050050578; Granger AS, 2001, AGE AGEING, V30, P523, DOI 10.1093/ageing/30.6.523; Gregory PJ, 2001, ANN INTERN MED, V134, P344, DOI 10.7326/0003-4819-134-4-200102200-00026; Gundling K, 1999, WESTERN J MED, V171, P191; Gurley BJ, 2000, AM J HEALTH-SYST PH, V57, P963, DOI 10.1093/ajhp/57.10.963; Harrer G, 1999, ARZNEIMITTELFORSCH, V49, P289; Holubarsch CJ, 2000, EUR J HEART FAIL, V2, P431, DOI 10.1016/S1388-9842(00)00109-4; Irefin S, 2000, J CLIN ANESTH, V12, P498, DOI 10.1016/S0952-8180(00)00199-9; Joseph G, 1995, ARZNEIMITTEL-FORSCH, V45-2, P1261; Kajiyama Y, 2002, PEDIATRICS, V109, P325, DOI 10.1542/peds.109.2.325; Kanowski S, 1996, PHARMACOPSYCHIATRY, V29, P47, DOI 10.1055/s-2007-979544; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kitts D, 2000, Public Health Nutr, V3, P473, DOI 10.1017/S1368980000000550; Lacaille-Dubois MA, 2001, PHYTOMEDICINE, V8, P47, DOI 10.1078/0944-7113-00003; Lal S, 2000, CAN MED ASSOC J, V163, P262; Lane-Brown MM, 2000, MED J AUSTRALIA, V172, P302, DOI 10.5694/j.1326-5377.2000.tb123965.x; Le Bars PL, 2000, DEMENT GERIATR COGN, V11, P230, DOI 10.1159/000017242; LeBars PL, 1997, JAMA-J AM MED ASSOC, V278, P1327, DOI 10.1001/jama.278.16.1327; LINDE K, 2000, COCHRANE DB SYST REV, V2; Lord GM, 1999, LANCET, V354, P481, DOI 10.1016/S0140-6736(99)03380-2; Lord GM, 2001, LANCET, V358, P1515, DOI 10.1016/S0140-6736(01)06576-X; *MED CONTR AG, 2002, HERB SAF NEWS; Melchart D., 2000, COCHRANE DB SYST REV; Miwa H, 2001, EPILEPSIA, V42, P280, DOI 10.1046/j.1528-1157.2001.33100.x; Moher D, 2000, DRUGS, V59, P1057, DOI 10.2165/00003495-200059050-00003; Moses EL, 2000, J CLIN PSYCHOPHARM, V20, P115, DOI 10.1097/00004714-200002000-00027; Mossabeb R, 2001, WIEN KLIN WOCHENSCHR, V113, P580; MULROW C, 2000, AHRQ PUBLICATION; Nahrstedt A, 1997, PHARMACOPSYCHIATRY, V30, P129, DOI 10.1055/s-2007-979533; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; OYAMA Y, 1994, BRAIN RES, V635, P125, DOI 10.1016/0006-8993(94)91431-1; Parker V, 2001, CAN J PSYCHIAT, V46, P77, DOI 10.1177/070674370104600112; Patel S, 2002, AM J MED, V112, P507, DOI 10.1016/S0002-9343(01)01134-2; Perloff MD, 2001, BRIT J PHARMACOL, V134, P1601, DOI 10.1038/sj.bjp.0704399; Peters H, 1998, VASA-J VASCULAR DIS, V27, P106; *PHARM CONV, 2002, SAW PALM; Philipp M, 1999, BRIT MED J, V319, P1534, DOI 10.1136/bmj.319.7224.1534; PHILIPP M, 2000, BMJ-BRIT MED J, V320, P361; Pittler MH, 2000, J CLIN EPIDEMIOL, V53, P485, DOI 10.1016/S0895-4356(99)00220-6; Pittler MH, 2000, AM J MED, V108, P276, DOI 10.1016/S0002-9343(99)00454-4; Roby CA, 2000, CLIN PHARMACOL THER, V67, P451, DOI 10.1067/mcp.2000.106793; Rothfuss MA, 2001, ARZNEIMITTEL-FORSCH, V51, P24; Schempp CM, 2001, ARCH DERMATOL, V137, P512; Schmidt U., 1998, Z PHYTOTHER, V19, P22; Schrader E, 2000, INT CLIN PSYCHOPHARM, V15, P61, DOI 10.1097/00004850-200015020-00001; Schulz V., 2004, RATIONAL PHYTOTHERAP, P1; Schwinger RHG, 2000, J CARDIOVASC PHARM, V35, P700, DOI 10.1097/00005344-200005000-00004; Shelton RC, 2001, JAMA-J AM MED ASSOC, V285, P1978, DOI 10.1001/jama.285.15.1978; Sherwin BB, 2000, J AM GERIATR SOC, V48, P431, DOI 10.1111/j.1532-5415.2000.tb04703.x; Snow V, 2000, ANN INTERN MED, V132, P738, DOI 10.7326/0003-4819-132-9-200005020-00010; Steuer-Vogt MK, 2001, EUR J CANCER, V37, P23, DOI 10.1016/S0959-8049(00)00360-9; Stevinson C, 2000, SLEEP MED, V1, P91, DOI 10.1016/S1389-9457(99)00015-5; Tauchert M, 2002, AM HEART J, V143, P910, DOI 10.1067/mhj.2002.121463; TAUCHERT M, 1999, HERZ, V24, P586; Tauchert R, 1999, HERZ, V24, P465; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Vacherot F, 2000, PROSTATE, V45, P259, DOI 10.1002/1097-0045(20001101)45:3<259::AID-PROS9>3.0.CO;2-G; Vale S, 1998, LANCET, V352, P36, DOI 10.1016/S0140-6736(05)79516-7; van Dongen MCJM, 2000, J AM GERIATR SOC, V48, P1183, DOI 10.1111/j.1532-5415.2000.tb02589.x; van Gurp G, 2002, CAN FAM PHYSICIAN, V48, P905; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Vorbach EU, 1997, PHARMACOPSYCHIATRY, V30, P81, DOI 10.1055/s-2007-979524; Wang ZQ, 2001, CLIN PHARMACOL THER, V70, P317, DOI 10.1067/mcp.2001.118522; Weihmayr T, 1996, Fortschr Med, V114, P27; Wentworth JM, 2000, J ENDOCRINOL, V166, pR11, DOI 10.1677/joe.0.166R011; Wheatley D, 1997, PHARMACOPSYCHIATRY, V30, P77, DOI 10.1055/s-2007-979523; Whiskey E, 2001, INT CLIN PSYCHOPHARM, V16, P239, DOI 10.1097/00004850-200109000-00001; Williams JW, 2000, ANN INTERN MED, V132, P743, DOI 10.7326/0003-4819-132-9-200005020-00011; WILT T, 2001, COCHRANE DATABASE SY, V2; Woelk H, 2000, BMJ-BRIT MED J, V321, P536, DOI 10.1136/bmj.321.7260.536; 2002, MED LETT DRUGS THER, V44, P29; 1994, PHARM ZTG, V139, P986	130	390	424	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2002	347	25					2046	2056		10.1056/NEJMra020398	http://dx.doi.org/10.1056/NEJMra020398			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626LT	12490687				2022-12-28	WOS:000179874500009
J	Lynfield, J; Nelson, PK				Lynfield, J; Nelson, PK			Mycotic aneurysms.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									NYU, Med Ctr, New York, NY 10016 USA	New York University	Lynfield, J (corresponding author), NYU, Med Ctr, New York, NY 10016 USA.								0	5	5	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2002	347	25					2030	2030		10.1056/NEJMicm000081	http://dx.doi.org/10.1056/NEJMicm000081			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626LT	12490684				2022-12-28	WOS:000179874500006
J	Detmar, SB; Muller, MJ; Schornagel, JH; Wever, LDV; Aaronson, NK				Detmar, SB; Muller, MJ; Schornagel, JH; Wever, LDV; Aaronson, NK			Health-related quality-of-life assessments and patient-physician communication - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENERAL-PRACTITIONERS; CLINICAL-PRACTICE; CHRONIC DISEASE; ASKING PATIENTS; WRITE LISTS; CARE; IMPACT; CANCER; SATISFACTION; ONCOLOGISTS	Context There has been increasing interest in the use of health-related quality-of-life (HRQL) assessments in daily clinical practice, yet few empirical studies have been conducted to evaluate the usefulness of such assessments. Objective To evaluate the efficacy of standardized HRQL assessments in facilitating patient-physician communication and increasing physicians' awareness of their patients' HRQL-related problems. Design Prospective, randomized crossover trial. Setting Outpatient clinic of a cancer hospital in the Netherlands. Participants Ten Physicians and 214 patients (76% women; mean age, 57 years) undergoing palliative chemotherapy who were invited to participate between June 11 996 and June 1998. Intervention At 3 successive outpatient visits, patients completed an HRQL questionnaire (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30). The responses were computer scored and transformed into a graphic summary. Physicians and patients received a copy of the summary before the consultation. Main Outcome Measures Audiotapes of the consultations were content analyzed to evaluate patient-physician communication. Physicians' awareness of their patients' health problems was assessed by comparing physicians' and patients' ratings on the Dartmouth Primary Care Cooperative Information Functional Health Assessment (COOP) and the World Organisation Project of National Colleges and Academics (WONCA) charts. Results The H RQL-related issues were discussed significantly more frequently in the intervention than in the control group (mean [SDI communication composite scores: 4.5 [2.3] vs 3.7 [1.9], respectively (P=.01). Physicians in the intervention group identified a greater percentage of patients with moderate-to-severe health problems in several HRQL domains than did those in the control group. All physicians and 87% of the patients believed that the intervention facilitated communication and expressed interest in its continued use. Conclusion Incorporating standardized HRQL assessments in daily clinical oncology practice facilitates the discussion of HRQL issues and can heighten physicians' awareness of their patients' HRQL.	Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands; Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Aaronson, NK (corresponding author), Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.		Aaronson, Neil K/AAV-8194-2021					Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Albrecht G, 1996, HEALTH CARE ANAL, V4, P284, DOI 10.1007/BF02249315; BLANCHARD CG, 1983, ANN INTERN MED, V99, P694, DOI 10.7326/0003-4819-99-5-694; BLANCHARD CG, 1986, CANCER, V58, P387, DOI 10.1002/1097-0142(19860715)58:2<387::AID-CNCR2820580233>3.0.CO;2-3; CALKINS DR, 1994, J GEN INTERN MED, V9, P590, DOI 10.1007/BF02599291; CONILL C, 1990, CANCER, V65, P1864, DOI 10.1002/1097-0142(19900415)65:8<1864::AID-CNCR2820650832>3.0.CO;2-U; Curt G A, 2000, Oncologist, V5, P353, DOI 10.1634/theoncologist.5-5-353; Detmar SB, 1998, EUR J CANCER, V34, P1181, DOI 10.1016/S0959-8049(98)00018-5; Dowrick C, 1995, FAM PRACT, V12, P461, DOI 10.1093/fampra/12.4.461; Espallargues M, 2000, MED CARE, V38, P175, DOI 10.1097/00005650-200002000-00007; Fayers P., 1999, EORTC QLQ C30 SCORIN, V2nd; FUNCH DP, 1988, MED CARE, V26, P1000, DOI 10.1097/00005650-198810000-00008; Greenhalgh J, 1999, J EVAL CLIN PRACT, V5, P401, DOI 10.1046/j.1365-2753.1999.00209.x; JADAD AR, 1995, BRIT MED J, V311, P746, DOI 10.1136/bmj.311.7007.746a; KAZIS LE, 1990, J CLIN EPIDEMIOL, V43, P1243, DOI 10.1016/0895-4356(90)90025-K; LEVINSON W, 1995, J GEN INTERN MED, V10, P375, DOI 10.1007/BF02599834; LLOYD BW, 1993, BRIT MED J, V306, P247, DOI 10.1136/bmj.306.6872.247; LOHR KN, 1992, MED CARE, V30, pMS1, DOI 10.1097/00005650-199205001-00001; MAGRUDERHABIB K, 1990, MED CARE, V28, P239, DOI 10.1097/00005650-199003000-00004; Mazonson P D, 1996, J Am Board Fam Pract, V9, P336; McHorney CA, 1999, ANNU REV PUBL HEALTH, V20, P309, DOI 10.1146/annurev.publhealth.20.1.309; McLachlan SA, 2001, J CLIN ONCOL, V19, P4117, DOI 10.1200/JCO.2001.19.21.4117; MIDDLETON JF, 1995, BRIT MED J, V311, P34, DOI 10.1136/bmj.311.6996.34; Moore AA, 1997, AM J MED, V102, P371, DOI 10.1016/S0002-9343(97)00089-2; Nelson EC, 1987, J CHRON DIS, V40, P55; Rosenthal GE, 1997, MED CARE, V35, pNS58, DOI 10.1097/00005650-199711001-00007; Roter D.L., 1992, DOCTORS TALKING PATI; RUBENSTEIN LV, 1995, J GEN INTERN MED, V10, P607, DOI 10.1007/BF02602744; SPRANGERS MAG, 1992, J CLIN EPIDEMIOL, V45, P743, DOI 10.1016/0895-4356(92)90052-O; STREET RL, 1994, MED CARE, V32, P732, DOI 10.1097/00005650-199407000-00006; Taenzer P, 2000, PSYCHO-ONCOLOGY, V9, P203, DOI 10.1002/1099-1611(200005/06)9:3<203::AID-PON453>3.3.CO;2-P; Taenzer PA, 1997, CANCER PRACT, V5, P168; TILL JE, 1994, QUAL LIFE RES, V3, P279, DOI 10.1007/BF00434902; Wagner AK, 1997, QUAL LIFE RES, V6, P329, DOI 10.1023/A:1018479209369; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasson J, 1992, Qual Life Res, V1, P99, DOI 10.1007/BF00439717; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694	37	710	713	0	44	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2002	288	23					3027	3034		10.1001/jama.288.23.3027	http://dx.doi.org/10.1001/jama.288.23.3027			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CG	12479768	Bronze			2022-12-28	WOS:000179854200038
J	Barrett, BP; Brown, RL; Locken, K; Maberry, R; Bobula, JA; D'Alessio, D				Barrett, BP; Brown, RL; Locken, K; Maberry, R; Bobula, JA; D'Alessio, D			Treatment of the common cold with unrefined echinacea - A randomized, double-blind, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							EXPERIMENTAL RHINOVIRUS COLDS; VIRAL RESPIRATORY-INFECTIONS; IMPORTANT DIFFERENCE; CLINICAL-TRIALS; EFFICACY; ANTIBIOTICS; PREVENTION; SEVERITY; PURPUREA; SYMPTOMS	Background: Echinacea preparations are widely used to treat the common cold. Objective: To assess the efficacy of dried, encapsulated, whole-plant echinacea as early treatment for the common cold. Design: Randomized, double-blind, placebo-controlled community-based trial. Setting: University of Wisconsin-Madison, Madison, Wisconsin. Participants: 148 registered students with common colds of recent onset. Intervention: An encapsulated mixture of unrefined Echinacea purpurea herb (25%) and root (25%) and E angustifolia root (50%) taken in 1-g doses six times on the first day of illness and three times on each subsequent day of illness for a maximum of 10 days. Measurements: severity and duration of self-reported symptoms of upper respiratory tract infection. Results: No statistically significant differences were detected between the echinacea and placebo groups for any of the measured outcomes. Trajectories of severity over time were nearly identical in the two groups. Mean cold duration was 6.01 days in both groups as a whole, 5.75 days in the placebo group, and 6.27 days in the echinacea group (between-group difference, -0.52 day [95% Cl, -1.09 to 0.22 days]). After controlling for severity and duration of symptoms before study entry, sex, date of enrollment, and use of nonprotocol medications, researchers found no statistically significant treatment effect (adjusted hazard ratio, 1.24 [Cl, 0.86 to 1.78]). Multivariable regression models assessing severity scores over time failed to detect statistically significant differences between the echinacea and placebo groups. Conclusion: Compared with placebo, unrefined echinacea provided no detectable benefit or harm in these college students who had the common cold.	Univ Wisconsin, Dept Family Med, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison	Barrett, BP (corresponding author), Univ Wisconsin, Dept Family Med, 777 S Mills St, Madison, WI 53715 USA.				NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K23AT000051] Funding Source: NIH RePORTER; NCCIH NIH HHS [K23 AT00051-01] Funding Source: Medline; PHS HHS [T-32 HP 10010-09] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLISON PD, 1995, SURVIVAL ANAL USING, P175; Arruda E, 1997, J CLIN MICROBIOL, V35, P2864, DOI 10.1128/JCM.35.11.2864-2868.1997; Barrett B, 1999, J FAM PRACTICE, V48, P628; BARRETT B, 2000, HLTH NOTES REV COMPL, V7, P211; BARRETT B, 2003, IN PRESS PHYTOMEDICI, P10; Barrett Bruce, 2002, J Fam Pract, V51, P265; Bauer R., 1999, Journal of Herbs, Spices & Medicinal Plants, V6, P51, DOI 10.1300/J044v06n03_05; BAUER R, 1998, PHYTOMEDICINES EUROP, P140; Bauer R, 1999, IMMUNOMODULATORY AGE, P41, DOI DOI 10.1007/978-3-0348-8763-22; Bone K., 1997, Alternative Medicine Review, V2, P87; BRAUNIG B, 1992, Z PHYTOTHER, V13, P7; Brinkeborn RM, 1999, PHYTOMEDICINE, V6, P1; BROWN RL, 1989, EDUC PSYCHOL MEAS, V49, P26; COX DR, 1972, J R STAT SOC B, V34, P187; DAVIS CS, 1991, STAT MED, V10, P1959, DOI 10.1002/sim.4780101210; Dillon WilliamR., 1984, MULTIVARIATE ANAL ME; Dorn M., 1997, COMPLEMENT THER MED, V5, P40, DOI [DOI 10.1016/S0965-2299(97)80089-1, 10.1016/S0965-2299(97)80089-1]; DORN M, 1989, NATUR GANZHEITSMEDIZ, V2, P314; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fahey T, 1998, BRIT MED J, V316, P906, DOI 10.1136/bmj.316.7135.906; Fischer D, 1999, JAMA-J AM MED ASSOC, V282, P1157, DOI 10.1001/jama.282.12.1157; Flannery M A, 1999, Pharm Hist, V41, P52; Forth H, 1981, ZFA (Stuttgart), V57, P2272; FOSTER S, 1996, ECHINACEA PURPLE CON; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; Giles JT, 2000, PHARMACOTHERAPY, V20, P690, DOI 10.1592/phco.20.7.690.35173; Grimm W, 1999, AM J MED, V106, P138, DOI 10.1016/S0002-9343(98)00406-9; GUYATT G, 1987, J CHRON DIS, V40, P171, DOI 10.1016/0021-9681(87)90069-5; GWALTNEY J M JR, 1985, Rhinology (Utrecht), V23, P265; Gwaltney JM, 1996, ANTIVIR RES, V29, P287, DOI 10.1016/0166-3542(95)00935-3; Henneicke-Von Zepelin HH, 1999, CURR MED RES OPIN, V15, P214, DOI 10.1185/03007999909114094; Hoheisel O., 1997, EUR J CLIN RES, V9, P261; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Juniper EF, QUALITY LIFE PHARMAC, V2nd; Jû┬reskog KG., 1993, LISREL 8 USERS REFER; Lindenmuth GF, 2000, J ALTERN COMPLEM MED, V6, P327, DOI 10.1089/10755530050120691; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; LITTLE PS, 1994, BRIT MED J, V309, P1010, DOI 10.1136/bmj.309.6960.1010; Mainous AG, 1996, J FAM PRACTICE, V42, P357; McDowell I., 1996, MEASURING HLTH GUIDE; Melchart D, 1998, ARCH FAM MED, V7, P541, DOI 10.1001/archfami.7.6.541; MELCHART D, 2000, COCHRANE DATABASE SY; MELCHART D, 1999, IMMUNOMODULATORY AGE, P105; Monto AS, 1995, AM J MED, V99, pS24, DOI 10.1016/S0002-9343(99)80307-6; Parnham MJ, 1999, IMMUNOMODULATORY AGE, P119; RAO SS, 1995, AM J RHINOL, V9, P49, DOI 10.2500/105065895781874114; Redelmeier DA, 1996, J CLIN EPIDEMIOL, V49, P1215, DOI 10.1016/S0895-4356(96)00206-5; REITZ HD, 1990, NOTABENE MED, V20, P362; SCHMID M, 1990, J HYPERTENS, V8, P277; Schulten B, 2001, ARZNEIMITTELFORSCH, V51, P563; SMITH MBH, 1993, JAMA-J AM MED ASSOC, V269, P2258, DOI 10.1001/jama.269.17.2258; STOKES M, 1995, CATEGORICAL DATA ANA; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; Turner RB, 2000, ANTIMICROB AGENTS CH, V44, P1708, DOI 10.1128/AAC.44.6.1708-1709.2000; Turner RB, 2001, ANTIVIR RES, V49, P1, DOI 10.1016/S0166-3542(00)00135-2; VORBERG G, 1984, ARZTLICHE PRAXIS, V36, P97; VORBERG G, 1989, ARZTL FORSCH, V36, P3; WALKER TA, 1994, PEDIATR CLIN N AM, V41, P1365; WITTENBORN JR, 1972, J NERV MENT DIS, V154, P79, DOI 10.1097/00005053-197202000-00001; 2002, DIAGNOSIS TREATMENT	60	90	96	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2002	137	12					939	946		10.7326/0003-4819-137-12-200212170-00006	http://dx.doi.org/10.7326/0003-4819-137-12-200212170-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626DR	12484708				2022-12-28	WOS:000179857500001
J	De Jonghe, B; Sharshar, T; Lefaucheur, JP; Authier, FJ; Durand-Zaleski, I; Boussarsar, M; Cerf, C; Renaud, E; Mesrati, F; Carlet, J; Raphael, JC; Outin, H; Bastuji-Garin, S				De Jonghe, B; Sharshar, T; Lefaucheur, JP; Authier, FJ; Durand-Zaleski, I; Boussarsar, M; Cerf, C; Renaud, E; Mesrati, F; Carlet, J; Raphael, JC; Outin, H; Bastuji-Garin, S		Grp Reflexion d'Etude Neuromyopath	Paresis acquired in the intensive care unit - A prospective multicenter study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL PATIENTS; CRITICAL ILLNESS POLYNEUROPATHY; STATUS-ASTHMATICUS; MUSCLE WEAKNESS; ORGAN FAILURE; SEPTIC SHOCK; MYOPATHY; STRENGTH; ATROPHY; HYDROCORTISONE	Context Although electrophysiologic and histologic neuromuscular abnormalities are common in intensive care unit (ICU) patients, the clinical incidence of ICU-acquired neuromuscular disorders in patients recovering from severe illness remains unknown. Objectives To assess the clinical incidence, risk factors, and outcomes of ICU-acquired paresis (ICUAP) during recovery from critical illness in the ICU and to determine the electrophysiologic and histologic patterns in patients with ICUAP. Design Prospective cohort study conducted from March 1999 to June 2000. Setting Three medical and 2 surgical ICUs in 4 hospitals in France. Participants All consecutive ICU patients without preexisting neuromuscular disease who underwent mechanical ventilation for 7 or more days were screened daily for awakening. The first day a patient was considered awake was day 1. Patients with severe muscle weakness on day 7 were considered to have ICUAP. Main Outcome Measures Incidence and duration of ICUAP, risk factors for ICUAP, and comparative duration of mechanical ventilation between ICUAP and control patients. Results Among the 95 patients who achieved satisfactory awakening, the incidence of ICUAP was 25.3% (95% confidence interval [CI], 16.9%-35.2%). All ICUAP patients had a sensorimotor axonopathy, and all patients who underwent a muscle biopsy had specific muscle involvement not related to nerve involvement. The median duration of ICUAP after day 1 was 21 days. Mean (SD) duration of mechanical ventilation after day 1 was significantly longer in patients with ICUAP compared with those without (18.2 [36.3] vs 7.6 [19.2] days; P=.03). Independent predictors of ICUAP were female sex (odds ratio [OR], 4.66; 95% CI, 1.19-18.30), the number of days with dysfunction of 2 or more organs (OR, 1.28; 95% CI, 1.11-1.49), duration of mechanical ventilation (OR, 1.10; 95% CI 1.00-1.22), and administration of corticosteroids (OR, 14.90; 95% CI, 3.20-69.80) before day 1. Conclusions identified using simple bedside clinical criteria, ICUAP was frequent during, recovery from critical illness and was associated with a prolonged duration of mechanical ventilation. Our findings,suggest an important role of corticosteroids in the development of ICUAP.	Ctr Hosp Poissy St Germain en Laye, Serv Reanimat Med, F-78300 Poissy, France; Hop Ray Poincare, Garches, France; Hop Henri Mondor, Serv Physiol Explorat Fonct, F-94010 Creteil, France; Hop Henri Mondor, Dept Pathol, F-94010 Creteil, France; Hop Lariboisiere, F-75475 Paris, France; Fdn Hop St Joseph, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite	De Jonghe, B (corresponding author), Ctr Hosp Poissy St Germain en Laye, Serv Reanimat Med, 10 Rue Champ Gaillard, F-78300 Poissy, France.		Sharshar, Tarek/ABF-4117-2021; Bastuji-Garin, Sylvie/R-3479-2018; Boussarsar, Mohamed/L-9772-2019	Bastuji-Garin, Sylvie/0000-0001-9855-5183; Boussarsar, Mohamed/0000-0002-7557-2156; AUTHIER, Francois Jerome/0000-0002-0182-2052				Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Berek K, 1996, INTENS CARE MED, V22, P849; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BOLTON CF, 1984, J NEUROL NEUROSUR PS, V47, P1223, DOI 10.1136/jnnp.47.11.1223; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Campellone JV, 1998, NEUROLOGY, V50, P46, DOI 10.1212/WNL.50.1.46; COAKLEY JH, 1993, INTENS CARE MED, V19, P323, DOI 10.1007/BF01694705; De Jonghe B, 1998, INTENS CARE MED, V24, P1242, DOI 10.1007/s001340050757; de Letter MACJ, 2001, CRIT CARE MED, V29, P2281, DOI 10.1097/00003246-200112000-00008; DEJONGHE B, 1999, YB INTENSIVE CARE EM, P322; DOUGLASS JA, 1992, AM REV RESPIR DIS, V146, P517, DOI 10.1164/ajrccm/146.2.517; DUBOIS DC, 1980, ENDOCRINOLOGY, V107, P1649, DOI 10.1210/endo-107-5-1649; DUBOIS DC, 1981, MUSCLE NERVE, V4, P370, DOI 10.1002/mus.880040504; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI, P82; FAGON JY, 1993, INTENS CARE MED, V19, P137, DOI 10.1007/BF01720528; HELLIWELL TR, 1991, J PATHOL, V164, P307, DOI 10.1002/path.1711640406; KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111; KONAGAYA M, 1986, ENDOCRINOLOGY, V119, P375, DOI 10.1210/endo-119-1-375; Latronico N, 1996, LANCET, V347, P1579, DOI 10.1016/S0140-6736(96)91074-0; Leatherman JW, 1996, AM J RESP CRIT CARE, V153, P1686, DOI 10.1164/ajrccm.153.5.8630621; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Leijten FSS, 1996, INTENS CARE MED, V22, P856, DOI 10.1007/BF02044107; LEIJTEN FSS, 1995, JAMA-J AM MED ASSOC, V274, P1221, DOI 10.1001/jama.274.15.1221; Levy BD, 1998, INTENS CARE MED, V24, P105, DOI 10.1007/s001340050530; Liveson JA, 1992, LAB REFERENCE CLIN N; MACFARLANE IA, 1977, LANCET, V2, P615; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Murray MJ, 2002, CRIT CARE MED, V30, P142, DOI 10.1097/00003246-200201000-00021; PHILLIPS SK, 1993, CLIN SCI, V84, P95, DOI 10.1042/cs0840095; Van der Schaaf M, 2000, DISABIL REHABIL, V22, P808; WITT NJ, 1991, CHEST, V99, P176, DOI 10.1378/chest.99.1.176; Xue FS, 1998, ANESTH ANALG, V86, P1322, DOI 10.1097/00000539-199806000-00036	34	916	943	1	46	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2859	2867		10.1001/jama.288.22.2859	http://dx.doi.org/10.1001/jama.288.22.2859			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623YM	12472328				2022-12-28	WOS:000179732600031
J	Lim, V; Pande, I				Lim, V; Pande, I			Drug points - Leflunomide can potentiate the anticoagulant effect of warfarin	BRITISH MEDICAL JOURNAL			English	Letter									City Hosp Nottingham, Dept Rheumatol, Nottingham NG5 1PB, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital	Lim, V (corresponding author), City Hosp Nottingham, Dept Rheumatol, Hucknall Rd, Nottingham NG5 1PB, England.							*BLAZ ROZM LEFL IN, 1998, J RHEUMATOL S53, V25, pS27; *BRIT MED ASS, 2001, 41 BMA RPS; *HOECHST MAR ROUSS, 1999, SUMM PROD CHAR AR; *HOECHST MAR ROUSS, 1999, LEFL INF BOOKL HEALT; MLADENOVIC V, 1995, ARTHRITIS RHEUM-US, V38, P1595, DOI 10.1002/art.1780381111	5	22	22	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2002	325	7376					1333	1333		10.1136/bmj.325.7376.1333	http://dx.doi.org/10.1136/bmj.325.7376.1333			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468482	Bronze, Green Published			2022-12-28	WOS:000179817100020
J	Wyse, DG; Waldo, AL; DiMarco, JP; Domanski, MJ; Rosenberg, Y; Schron, EB; Kellen, JC; Greene, HL; Mickel, MC; Dalquist, JE; Corley, SD				Wyse, DG; Waldo, AL; DiMarco, JP; Domanski, MJ; Rosenberg, Y; Schron, EB; Kellen, JC; Greene, HL; Mickel, MC; Dalquist, JE; Corley, SD		Atrial Fibrillation Follow Investi	A comparison of rate control and rhythm control in patients with atrial fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SINUS RHYTHM; ANTITHROMBOTIC THERAPY; RISK-FACTORS; STROKE; MANAGEMENT; ANTICOAGULATION; CARDIOVERSION; MAINTENANCE; PREVALENCE; CONVERSION	Background: There are two approaches to the treatment of atrial fibrillation: one is cardioversion and treatment with antiarrhythmic drugs to maintain sinus rhythm, and the other is the use of rate-controlling drugs, allowing atrial fibrillation to persist. In both approaches, the use of anticoagulant drugs is recommended. Methods: We conducted a randomized, multicenter comparison of these two treatment strategies in patients with atrial fibrillation and a high risk of stroke or death. The primary end point was overall mortality. Results: A total of 4060 patients (mean [+/-SD] age, 69.7+/-9.0 years) were enrolled in the study; 70.8 percent had a history of hypertension, and 38.2 percent had coronary artery disease. Of the 3311 patients with echocardiograms, the left atrium was enlarged in 64.7 percent and left ventricular function was depressed in 26.0 percent. There were 356 deaths among the patients assigned to rhythm-control therapy and 310 deaths among those assigned to rate-control therapy (mortality at five years, 23.8 percent and 21.3 percent, respectively; hazard ratio, 1.15 [95 percent confidence interval, 0.99 to 1.34]; P=0.08). More patients in the rhythm-control group than in the rate-control group were hospitalized, and there were more adverse drug effects in the rhythm-control group as well. In both groups, the majority of strokes occurred after warfarin had been stopped or when the international normalized ratio was subtherapeutic. Conclusions: Management of atrial fibrillation with the rhythm-control strategy offers no survival advantage over the rate-control strategy, and there are potential advantages, such as a lower risk of adverse drug effects, with the rate-control strategy. Anticoagulation should be continued in this group of high-risk patients.	AFFIRM Clin Trial Ctr, Axio Res, Seattle, WA 98121 USA		Wyse, DG (corresponding author), AFFIRM Clin Trial Ctr, Axio Res, 2601 4th Ave,Ste 200, Seattle, WA 98121 USA.	leong@axioresearch.com		Corley, Scott/0000-0001-5288-9188	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055139] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-55139] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AFFIRM INV, 2002, N AM SOC PAC EL LAT; Albers GW, 2001, CHEST, V119, p194S, DOI 10.1378/chest.119.1_suppl.194S; ANTMAN E, 1993, J AM COLL CARDIOL, V22, P1830; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BRODSKY MA, 1987, AM J CARDIOL, V60, P572, DOI 10.1016/0002-9149(87)90307-9; COX DR, 1972, J R STAT SOC B, V34, P187; Cox J L, 2000, Semin Thorac Cardiovasc Surg, V12, P15; CRIJNS HJ, 1991, AM J CARDIOL, V68, P335, DOI 10.1016/0002-9149(91)90828-9; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Epstein AE, 2002, J CARDIOVASC ELECTR, V13, P667, DOI 10.1046/j.1540-8167.2002.00667.x; Epstein AE, 2002, AM HEART J, V143, P991, DOI 10.1067/mhj.2002.122875; Falk RH, 2001, NEW ENGL J MED, V344, P1067, DOI 10.1056/NEJM200104053441407; FLEGEL KM, 1987, LANCET, V1, P878; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Gage BF, 2000, STROKE, V31, P822, DOI 10.1161/01.STR.31.4.822; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hart RG, 1999, ANN INTERN MED, V131, P688, DOI 10.7326/0003-4819-131-9-199911020-00010; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LIPKIN DP, 1986, BRIT MED J, V292, P653, DOI 10.1136/bmj.292.6521.653; MANOLIO TA, 1994, J AM COLL CARDIOL, V23, P916, DOI 10.1016/0735-1097(94)90638-6; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Miller MR, 2000, J FAM PRACTICE, V49, P1033; Narasimhan C, 1998, J CARDIOVASC ELECTR, V9, pS146; Nichol G, 2002, HEART, V87, P535, DOI 10.1136/heart.87.6.535; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Oral H, 2002, CIRCULATION, V105, P1077, DOI 10.1161/hc0902.104712; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Scheinman MM, 2001, CIRCULATION, V103, P2120; Stewart S, 2002, INT J CARDIOL, V82, P229, DOI 10.1016/S0167-5273(01)00626-X; Taylor FC, 2001, BMJ-BRIT MED J, V322, P321, DOI 10.1136/bmj.322.7282.321; VanGelder IC, 1996, ARCH INTERN MED, V156, P2585, DOI 10.1001/archinte.156.22.2585; Waldo AL, 1999, AM J CARDIOL, V84, P698; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; Wood MA, 2000, CIRCULATION, V101, P1138, DOI 10.1161/01.CIR.101.10.1138; Wyse DG, 1997, AM J CARDIOL, V79, P1198; Wyse DG, 2001, J INTERV CARD ELECTR, V5, P267, DOI 10.1023/A:1011460631369	43	2894	3043	0	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2002	347	23					1825	1833		10.1056/nejmoa021328	http://dx.doi.org/10.1056/nejmoa021328			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NW	12466506	Bronze			2022-12-28	WOS:000179596900002
J	Schraeder, TL; Campion, EW				Schraeder, TL; Campion, EW			Smallpox vaccination - The call to arms	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mt Auburn Hosp, Dept Med, Cambridge, MA 02238 USA	Harvard University; Mount Auburn Hospital	Schraeder, TL (corresponding author), Mt Auburn Hosp, Dept Med, Cambridge, MA 02238 USA.								0	11	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					381	382		10.1056/NEJMp020177	http://dx.doi.org/10.1056/NEJMp020177			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12496350				2022-12-28	WOS:000180643800002
J	Seashore, MR				Seashore, MR			Tetrahydrobiopterin and dietary restriction in mild phenylketonuria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Seashore, MR (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2094	2095		10.1056/NEJMp020147	http://dx.doi.org/10.1056/NEJMp020147			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501220				2022-12-28	WOS:000180040900001
J	Howden-Chapman, P; Mackenbach, J				Howden-Chapman, P; Mackenbach, J			Poverty and painting: representations in 19th century Europe	BRITISH MEDICAL JOURNAL			English	Article									Univ Otago, Wellington Sch Med & Hlth Sci, Dept Publ Hlth, Wellington, New Zealand; Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	University of Otago; Erasmus University Rotterdam; Erasmus MC	Howden-Chapman, P (corresponding author), Univ Otago, Wellington Sch Med & Hlth Sci, Dept Publ Hlth, POB 7343, Wellington, New Zealand.							Durkheim E., 1947, DIVISION LABOUR SOC; Halbwachs Maurice, 1951, COLLECTIVE MEMORY; Hauser Arnold, 1951, SOCIAL HIST ART, V2; Schama Simon, 1987, EMBARRASSMENT RICHES; Schapiro Meyer, 1999, WORLDVIEW PAINTING; Stevens Maryanne, 2000, 1900 ART CROSSROADS; TOMORY PA, 1969, FDN EUROPEAN ART; Varnedoe Kirk, 1988, NO LIGHT NORDIC ART	8	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1502	1505		10.1136/bmj.325.7378.1502	http://dx.doi.org/10.1136/bmj.325.7378.1502			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	631VX	12493683	Green Published			2022-12-28	WOS:000180188600035
J	Kazmierczak, J; Altermann, W				Kazmierczak, J; Altermann, W			Neoarchean biomineralization by benthic cyanobacteria	SCIENCE			English	Article							TRANSVAAL SUPERGROUP; MICROFOSSILS		Univ Pretoria, Dept Geol, ZA-0002 Pretoria, South Africa; Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland	University of Pretoria; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences	Altermann, W (corresponding author), Univ Pretoria, Dept Geol, ZA-0002 Pretoria, South Africa.	wlady.altermann@iaag.geo.uni-muenchen.de	Altermann, Wladyslaw/AAV-7520-2021; Altermann, Wladyslaw/B-4336-2008	Altermann, Wladyslaw/0000-0002-9499-424X; Altermann, Wladyslaw/0000-0002-9499-424X				Altermann W, 1998, SEDIMENT GEOL, V120, P225, DOI 10.1016/S0037-0738(98)00034-7; ALTERMANN W, 1995, PRECAMBRIAN RES, V75, P65, DOI 10.1016/0301-9268(95)00018-Z; Barker WW, 1998, GEOMICROBIOL J, V15, P223, DOI 10.1080/01490459809378078; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; GROTZINGER JP, 1989, SOC ECON PA, V44, P79, DOI 10.2110/pec.89.44.0079; HORODYSKI RJ, 1975, J SEDIMENT PETROL, V45, P894; KEMPE S, 1991, NATURE, V349, P605, DOI 10.1038/349605a0; Kempe Stephan, 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P61; KLEIN C, 1987, PRECAMBRIAN RES, V36, P81, DOI 10.1016/0301-9268(87)90018-0; Schopf JW, 2002, NATURE, V416, P73, DOI 10.1038/416073a	10	60	65	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2351	2351		10.1126/science.1075933	http://dx.doi.org/10.1126/science.1075933			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493906				2022-12-28	WOS:000179915900045
J	King, MC; Motulsky, AG				King, MC; Motulsky, AG			Mapping human history	SCIENCE			English	Editorial Material							POPULATION		Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	King, MC (corresponding author), Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA.	mcking@u.washington.edu		King, Mary-Claire/0000-0001-9426-1743				Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Pritchard JK, 2000, GENETICS, V155, P945; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WILSON AC, 1992, SCI AM, V266, P68; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815	11	37	37	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2342	2343		10.1126/science.1080373	http://dx.doi.org/10.1126/science.1080373			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493903				2022-12-28	WOS:000179915900042
J	Eknoyan, G; Beck, GJ; Cheung, AK; Daugirdas, JT; Greene, T; Kusek, JW; Allon, M; Bailey, J; Delmez, JA; Depner, TA; Dwyer, JT; Levey, AS; Levin, NW; Milford, E; Ornt, DB; Rocco, MV; Schulman, G; Schwab, SJ; Teehan, BP; Toto, R				Eknoyan, G; Beck, GJ; Cheung, AK; Daugirdas, JT; Greene, T; Kusek, JW; Allon, M; Bailey, J; Delmez, JA; Depner, TA; Dwyer, JT; Levey, AS; Levin, NW; Milford, E; Ornt, DB; Rocco, MV; Schulman, G; Schwab, SJ; Teehan, BP; Toto, R		HEMO Study Grp	Effect of dialysis dose and membrane flux in maintenance hemodialysis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UREA REDUCTION RATIO; STAGE RENAL-DISEASE; MORTALITY; CLEARANCE; MORBIDITY; SURVIVAL; PRODUCT; MODELS; INDEX; REUSE	Background: The effects of the dose of dialysis and the level of flux of the dialyzer membrane on mortality and morbidity among patients undergoing maintenance hemodialysis are uncertain. Methods: We undertook a randomized clinical trial in 1846 patients undergoing thrice-weekly dialysis, using a two-by-two factorial design to assign patients randomly to a standard or high dose of dialysis and to a low-flux or high-flux dialyzer. Results: In the standard-dose group, the mean (+/-SD) urea-reduction ratio was 66.3+/-2.5 percent, the single-pool Kt/V was 1.32+/-0.09, and the equilibrated Kt/V was 1.16+/-0.08; in the high-dose group, the values were 75.2+/-2.5 percent, 1.71+/-0.11, and 1.53+/-0.09, respectively. Flux, estimated on the basis of beta(sub 2)-microglobulin clearance, was 3+/-7 ml per minute in the low-flux group and 34+/-11 ml per minute in the high-flux group. The primary outcome, death from any cause, was not significantly influenced by the dose or flux assignment: the relative risk of death in the high-dose group as compared with the standard-dose group was 0.96 (95 percent confidence interval, 0.84 to 1.10; P=0.53), and the relative risk of death in the high-flux group as compared with the low-flux group was 0.92 (95 percent confidence interval, 0.81 to 1.05; P=0.23). The main secondary outcomes (first hospitalization for cardiac causes or death from any cause, first hospitalization for infection or death from any cause, first 15 percent decrease in the serum albumin level or death from any cause, and all hospitalizations not related to vascular access) also did not differ significantly between either the dose groups or the flux groups. Possible benefits of the dose or flux interventions were suggested in two of seven prespecified subgroups of patients. Conclusions: Patients undergoing hemodialysis thrice weekly appear to have no major benefit from a higher dialysis dose than that recommended by current U.S. guidelines or from the use of a high-flux membrane.	Cleveland Clin Fdn, Dept Biostat & Epidemiol, HEMO Data Coordinating Ctr, Cleveland, OH 44195 USA; Baylor Coll Med, Houston, TX 77030 USA; Univ Utah, Salt Lake City, UT USA; Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; Univ Illinois, Chicago, IL USA; Vet Affairs Chicago Hlth Care Syst, Chicago, IL USA; NIDDKD, Bethesda, MD 20892 USA; Univ Alabama Birmingham, Birmingham, AL USA; Emory Univ Hosp, Atlanta, GA 30322 USA; Washington Univ, St Louis, MO USA; Univ Calif Davis, Sacramento, CA 95817 USA; Tufts Univ New England Med Ctr, Boston, MA 02111 USA; Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Univ Rochester, Rochester, NY USA; Wake Forest Univ, Winston Salem, NC 27109 USA; Vanderbilt Univ, Nashville, TN USA; Duke Univ, Durham, NC USA; Lankenau Hosp & Med Res Ctr, Wynnewood, PA USA; Univ Texas, SW Med Ctr, Dallas, TX USA	Cleveland Clinic Foundation; Baylor College of Medicine; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Alabama System; University of Alabama Birmingham; Emory University; Washington University (WUSTL); University of California System; University of California Davis; Tufts Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; University of Rochester; Wake Forest University; Vanderbilt University; Duke University; Lankenau Medical Center; Lankenau Institute for Medical Research; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Beck, GJ (corresponding author), Cleveland Clin Fdn, Dept Biostat & Epidemiol, HEMO Data Coordinating Ctr, Wb4,9500 Euclid Ave, Cleveland, OH 44195 USA.	beckg@ccf.org	Dwyer, Johanna/AAI-5027-2020; Toto, Robert/AAQ-3336-2021	Dwyer, Johanna/0000-0002-0783-1769				Cheung AK, 1999, J AM SOC NEPHROL, V10, P117; COLLINS A, 1994, AM J KIDNEY DIS, V24, P157; COX DR, 1972, J R STAT SOC B, V34, P187; DAUGIRDAS JT, 1995, ASAIO J, V41, pM719, DOI 10.1097/00002480-199507000-00107; Depner TA., 1991, PRESCRIBING HEMODIAL, V2nd Ed.; Dunn D, 2002, CONTROL CLIN TRIALS, V23, P106, DOI 10.1016/S0197-2456(01)00200-8; Eknoyan G, 1997, KIDNEY INT, V52, P1395; Eknoyan G, 1996, SEMIN DIALYSIS, V9, P24, DOI 10.1111/j.1525-139X.1996.tb00897.x; Eknoyan G, 2001, AM J KIDNEY DIS, V37, P179, DOI 10.1016/S0272-6386(01)80074-3; Eknoyan G, 2001, AM J KIDNEY DIS, V37, pS5, DOI 10.1016/S0272-6386(01)70004-2; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Greene T, 2000, CONTROL CLIN TRIALS, V21, P502, DOI 10.1016/S0197-2456(00)00062-3; Held PJ, 1996, KIDNEY INT, V50, P550, DOI 10.1038/ki.1996.348; HORNBERGER JC, 1992, J AM SOC NEPHROL, V3, P1227; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Leypoldt JK, 1997, ASAIO J, V43, P904, DOI 10.1097/00002480-199711000-00011; Li ZS, 2000, AM J KIDNEY DIS, V35, P598, DOI 10.1016/S0272-6386(00)70004-7; Locatelli F, 1999, KIDNEY INT, V55, P286, DOI 10.1046/j.1523-1755.1999.00236.x; LOWRIE EG, 1981, NEW ENGL J MED, V305, P1176, DOI 10.1056/NEJM198111123052003; Lowrie EG, 1999, KIDNEY INT, V56, P729, DOI 10.1046/j.1523-1755.1999.00584.x; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Miskulin DC, 2001, KIDNEY INT, V60, P1498, DOI 10.1046/j.1523-1755.2001.00954.x; Mohr PE, 2001, AM J KIDNEY DIS, V37, P777, DOI 10.1016/S0272-6386(01)80127-X; *NAT I DIAB DIG KI, 1999, HEMO STUD PROT; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Owen WF, 1998, JAMA-J AM MED ASSOC, V280, P1764, DOI 10.1001/jama.280.20.1764; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Pocock SJ, 1983, CLIN TRIALS PRACTICA, P50; Port FK, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341061; Port FK, 2001, AM J KIDNEY DIS, V37, P276, DOI 10.1053/ajkd.2001.21290; *REN DAT SYST, 2000, USRDS 2000 ANN DAT R; *REN DAT SYST, 2001, USRDS 2001 ANN DAT R; Rocco MV, 2002, AM J KIDNEY DIS, V39, P146, DOI 10.1053/ajkd.2002.29905; Shinzato T, 1997, NEPHROL DIAL TRANSPL, V12, P884, DOI 10.1093/ndt/12.5.884; Vos PF, 2001, AM J KIDNEY DIS, V37, pS99, DOI 10.1053/ajkd.2001.20761; Ward RA, 2000, J AM SOC NEPHROL, V11, P2344, DOI 10.1681/ASN.V11122344; Winchester JF, 2002, ADV RENAL REPLACE TH, V9, P19, DOI 10.1053/jarr.2002.30472; Wolfe RA, 2000, AM J KIDNEY DIS, V35, P80, DOI 10.1016/S0272-6386(00)70305-2	38	1363	1415	5	83	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2002	347	25					2010	2019		10.1056/NEJMoa021583	http://dx.doi.org/10.1056/NEJMoa021583			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626LT	12490682				2022-12-28	WOS:000179874500004
J	Burns, A; Zaudig, M				Burns, A; Zaudig, M			Mild cognitive impairment in older people	LANCET			English	Review							MEMORY IMPAIRMENT; DEMENTIA; DIAGNOSIS; CRITERIA; DISEASE	Context As public awareness, of Alzheimer's disease increases, more people are asking for help and advice about memory: problems. Memory complaints may be secondary to psychiatric, psychological, and physical conditions and is an almost universal early symptom of dementia. The concept of amnestic mild, cognitive impairment attempts to describe those people in whom memory loss is not of such severity to merit a diagnosis of dementia. The importance of this group of people is not just the need to develop interventions which ameliorate individual suffering but that they represent a population at high risk of developing dementia, especially Alzheimer's disease, and are an appropriate target for dementia prevention strategies. Starting point K Karitarci and colleagues (Dement Geriatr Cogn Disord 2002 14:198-207) looked at the diagnostic accuracy of magnetic-resonance hippocampal volumetry and spectroscopy in patients with mild cognitive impairment in normal older people, and in patients with Alzheimer's disease. Hippocampal volumes and N-acetyl aspartate/creatine spectroscopy were the most sensitive assessments discriminating; people with mild cognitive impairment from Alzheimer's disease. Combination assessments were better at discriminating these two groups from normal controls. The histological underpinning of cognitive symptoms in older people has been demonstrated by the Cognitive Function and Ageing study (Lancet 2001; 357:169-75); which showed that a third of people with no clinical evidence of dementia had histopathological hallmarks of Alzheimer's disease. Where next? 25 million people across the world have dementia. Mild cognitive impairment, if a validated concept, represents an opportunity for preventing dementia. As more information becomes available about the cause of Alzheimer's disease and prospects emerge for prevention, identification of predementia states offers considerable scope to reduce the individual and societal cost of the illness. Continued validation of the criteria for mild cognitive impairment and studies of intervention should be a priority. As more evidence becomes available highlighting the relatively arbitrary nature of-dementia diagnosis (based largely on interference with activities) and interventions become available for the prevention of dementia, mild cognitive impairment and related conditions will become more important.	Univ Manchester, Wythenshawe Hosp, Sch Psychiat & Behav Sci, Educ & Res Ctr, Manchester M23 9LT, Lancs, England; Windach Hosp, Windach, Germany; Inst Neurobehav Res & Therapy, Windach, Germany	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Burns, A (corresponding author), Univ Manchester, Wythenshawe Hosp, Sch Psychiat & Behav Sci, Educ & Res Ctr, PBS18,2nd Floor, Manchester M23 9LT, Lancs, England.	a_burns@man.ac.uk		Burns, Alistair/0000-0002-9837-0645				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; BLACKFORD RC, 1989, DEV NEUROPSYCHOL, V5, P295, DOI 10.1080/87565648909540440; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Bozoki A, 2001, ARCH NEUROL-CHICAGO, V58, P411, DOI 10.1001/archneur.58.3.411; Chen PJ, 2001, ARCH GEN PSYCHIAT, V58, P853, DOI 10.1001/archpsyc.58.9.853; Crook T, 1986, DEV NEUROPSYCHOL, V2, P261, DOI 10.1080/87565648609540348; de Groot JC, 2001, NEUROLOGY, V56, P1539, DOI 10.1212/WNL.56.11.1539; De Santi S, 2001, NEUROBIOL AGING, V22, P529, DOI 10.1016/S0197-4580(01)00230-5; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Grundman M, 2000, AM J CLIN NUTR, V71, p630S; Jorm AF, 2001, PSYCHOL MED, V31, P441, DOI 10.1017/S0033291701003245; Kantarci K, 2002, DEMENT GERIATR COGN, V14, P198, DOI 10.1159/000066021; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; KRAL VA, 1962, CAN MED ASSOC J, V86, P257; Levy R, 1994, Int Psychogeriatr, V6, P63, DOI 10.1017/S1041610294001626; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; OBRIEN J, IN PRESS LANCET NEUR; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Reisberg B, 2001, INT PSYCHOGERIATR, V13, P163, DOI 10.1017/S1041610201007566; Ritchie K, 2000, LANCET, V355, P225, DOI 10.1016/S0140-6736(99)06155-3; Ritchie K, 2001, NEUROLOGY, V56, P37, DOI 10.1212/WNL.56.1.37; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; TARBERT M, 2002, NEUROLOGY, V58, P758; UNKENSTEIN A, 2000, DEMENTIA, P615; Waite LM, 2001, J NEUROL NEUROSUR PS, V71, P296, DOI 10.1136/jnnp.71.3.296; WHO, 2012, ICD 10 CLASS MENT BE; Zaudig M, 2002, CURR OPIN PSYCHIATR, V15, P387, DOI 10.1097/00001504-200207000-00008; ZAUDIG M, 1991, PSYCHOL MED, V21, P225, DOI 10.1017/S0033291700014811	32	155	166	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2002	360	9349					1963	1965		10.1016/S0140-6736(02)11920-9	http://dx.doi.org/10.1016/S0140-6736(02)11920-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	626KC	12493278				2022-12-28	WOS:000179870200030
J	Boutanaev, AM; Kalmykova, AI; Shevelyov, YY; Nurminsky, DI				Boutanaev, AM; Kalmykova, AI; Shevelyov, YY; Nurminsky, DI			Large clusters of co-expressed genes in the Drosophila genome	NATURE			English	Article							DOSAGE COMPENSATION; HISTONE ACETYLATION; TRANSCRIPTION; LOCUS; POTENTIATION; ACTIVATION	Clustering of co-expressed, non-homologous genes on chromosomes implies their co-regulation. In lower eukaryotes, coexpressed genes are often found in pairs(1,2). Clustering of genes that share aspects of transcriptional regulation has also been reported in higher eukaryotes(3,4). To advance our understanding of the mode of coordinated gene regulation in multicellular organisms, we performed a genome-wide analysis of the chromosomal distribution of co-expressed genes in Drosophila. We identified a total of 1,661 testes-specific genes, one-third of which are clustered on chromosomes. The number of clusters of three or more genes is much higher than expected by chance. We observed a similar trend for genes upregulated in the embryo and in the adult head, although the expression pattern of individual genes cannot be predicted on the basis of chromosomal position alone. Our data suggest that the prevalent mechanism of transcriptional co-regulation in higher eukaryotes operates with extensive chromatin domains that comprise multiple genes.	Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA; Russian Acad Sci, Inst Mol Genet, Dept Mol Genet Anim, Moscow 123182, Russia	Tufts University; Russian Academy of Sciences	Nurminsky, DI (corresponding author), Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA.	dmitry.nurminsky@tufts.edu	Kalmykova, Alla/AAG-2381-2021; Boutanaev, Alexander/AAO-7132-2021	Shevelyov, Yuri/0000-0002-0568-9236	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061549] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061549-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Bhadra U, 1999, GENETICS, V152, P249; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Elefant F, 2000, J BIOL CHEM, V275, P13827, DOI 10.1074/jbc.275.18.13827; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kramer JA, 1998, DEVELOPMENT, V125, P4749; Kramer JA, 2000, MOL REPROD DEV, V56, P254, DOI 10.1002/(SICI)1098-2795(200006)56:2+<254::AID-MRD9>3.0.CO;2-#; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; MEIKLEJOHN CD, 2002, 43 ANN DROS RES C GE; Meller VH, 2000, TRENDS CELL BIOL, V10, P54, DOI 10.1016/S0962-8924(99)01693-1; PARISI MJ, 2002, 43 ANN DROS RES C GE; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Schubeler D, 2000, GENE DEV, V14, P940; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Soury E, 2001, IMMUNOGENETICS, V53, P634, DOI 10.1007/s00251-001-0374-z; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Wynn SL, 2000, GENOMICS, V68, P57, DOI 10.1006/geno.2000.6254	22	256	263	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					666	669		10.1038/nature01216	http://dx.doi.org/10.1038/nature01216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478293				2022-12-28	WOS:000179751800045
J	Check, E				Check, E			Safety panel backs principle of gene-therapy trials	NATURE			English	News Item																			0	13	14	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					595	595		10.1038/420595b	http://dx.doi.org/10.1038/420595b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478252	Bronze			2022-12-28	WOS:000179751800008
J	Groppe, J; Greenwald, J; Wiater, E; Rodriguez-Leon, J; Economides, AN; Kwiatkowski, W; Affolter, M; Vale, WW; Belmonte, JCI; Choe, S				Groppe, J; Greenwald, J; Wiater, E; Rodriguez-Leon, J; Economides, AN; Kwiatkowski, W; Affolter, M; Vale, WW; Belmonte, JCI; Choe, S			Structural basis of BMP signalling inhibition by the cystine knot protein Noggin	NATURE			English	Article							BONE-MORPHOGENETIC PROTEIN; PROGRAMMED CELL-DEATH; TGF-BETA-S; SEQUENCE ALIGNMENT; SPEMANN ORGANIZER; DIRECT BINDING; LIMB; MUTATIONS; EXPRESSION; RECEPTOR	The interplay between bone morphogenetic proteins (BMPs) and their antagonists governs developmental and cellular processes as diverse as establishment of the embryonic dorsal-ventral axis, induction of neural tissue, formation of joints in the skeletal system and neurogenesis in the adult brain. So far, the three-dimensional structures of BMP antagonists and the structural basis for inactivation have remained unknown. Here we report the crystal structure of the antagonist Noggin bound to BMP-7, which shows that Noggin inhibits BMP signalling by blocking the molecular interfaces of the binding epitopes for both type I and type II receptors. The BMP-7-binding affinity of site-specific variants of Noggin is correlated with alterations in bone formation and apoptosis in chick limb development, showing that Noggin functions by sequestering its ligand in an inactive complex. The scaffold of Noggin contains a cystine (the oxidized form of cysteine) knot topology similar to that of BMPs; thus, ligand and antagonist seem to have evolved from a common ancestral gene.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Inst Gulbenkian Ciencias, P-2780901 Oeiras, Portugal; Biozentrum, CH-4056 Basel, Switzerland; Regeneron Pharmaceut Inc, New York, NY 10591 USA	Salk Institute; Salk Institute; Salk Institute; Instituto Gulbenkian de Ciencia; Regeneron	Choe, S (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	choe@salk.edu	Leon, Joaquin Maria Rodriguez/S-9814-2019; Leon, Joaquin Maria Rodriguez/C-6957-2013	Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Affolter, Markus/0000-0002-5171-0016; Economides, Aris/0000-0002-6508-8942				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Dixon ME, 2001, GENET MED, V3, P349, DOI 10.1097/00125817-200109000-00004; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; ECONOMIDES AN, 2000, Patent No. 6075007; Enomoto-Iwamoto M, 1998, J CELL BIOL, V140, P409, DOI 10.1083/jcb.140.2.409; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; Hatta T, 2000, BIOPOLYMERS, V55, P399, DOI 10.1002/1097-0282(2000)55:5<399::AID-BIP1014>3.0.CO;2-9; Healy C, 1999, DEV DYNAM, V215, P69, DOI 10.1002/(SICI)1097-0177(199905)215:1<69::AID-DVDY8>3.3.CO;2-E; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Macias D, 1997, DEVELOPMENT, V124, P1109; Mangino M, 2002, Hum Mutat, V19, P308, DOI 10.1002/humu.9016.abs; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; Merino R, 1999, DEVELOPMENT, V126, P5515; Ogawa K, 2002, DEV BIOL, V250, P59, DOI 10.1006/dbio.2002.0790; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Stanley E, 1998, MECH DEVELOP, V77, P173, DOI 10.1016/S0925-4773(98)00139-7; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; Takahashi T, 2001, CLIN GENET, V60, P447, DOI 10.1034/j.1399-0004.2001.600607.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Yokouchi Y, 1996, DEVELOPMENT, V122, P3725; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	49	411	476	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					636	642		10.1038/nature01245	http://dx.doi.org/10.1038/nature01245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478285				2022-12-28	WOS:000179751800037
J	Smaglik, P				Smaglik, P			Building Nordic networks	NATURE			English	Article																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916		S			A3	+		10.1038/420a03a	http://dx.doi.org/10.1038/420a03a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625LG	12501120	Bronze			2022-12-28	WOS:000179817500002
J	Bae, M; Watanabe, C; Inaoka, T; Sekiyama, M; Sudo, N; Bokul, MH; Ohtsuka, R				Bae, M; Watanabe, C; Inaoka, T; Sekiyama, M; Sudo, N; Bokul, MH; Ohtsuka, R			Arsenic in cooked rice in Bangladesh	LANCET			English	Article								In Bangladesh, rice Is boiled with an excessive amount of water, and the water remaining after cooking will be discarded. We did an on-site experiment to assess the effect of this cooking method on the amount of arsenic retained in cooked rice. The concentration of arsenic in cooked rice was higher than that in raw rice and absorbed water combined, suggesting a chelating effect by rice grains, or concentration of arsenic because of water evaporation during cooking, or both. The method of cooking and water used can affect the amount of arsenic in cooked rice, which will have implications for the assessment of the health risks of arsenic.	Univ Tokyo, Grad Sch Med Sci, Sch Int Hlth, Dept Human Ecol,Bunkyo Ku, Tokyo 1130033, Japan; Saga Univ, Fac Agr, Dept Environm Sociol, Saga 840, Japan; Natl Inst Publ Hlth, Dept Hlth Promot & Res, Wako, Saitama, Japan; Directorate Gen Hlth Serv, Dhaka, Bangladesh	University of Tokyo; Saga University; National Institute of Public Health - Japan	Watanabe, C (corresponding author), Univ Tokyo, Grad Sch Med Sci, Sch Int Hlth, Dept Human Ecol,Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.			Sekiyama, Makiko/0000-0002-2104-9140				JAHAN K, 1998, NATURE EXTENT MALNUT, P10; Schoof RA, 1998, HUM ECOL RISK ASSESS, V4, P117, DOI 10.1080/10807039891284235; Watanabe C, 2001, ENVIRON HEALTH PERSP, V109, P1265, DOI 10.2307/3454749; YAMAZAKI K, 1983, COOKERY ITS THEORY	4	143	148	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1839	1840		10.1016/S0140-6736(02)11738-7	http://dx.doi.org/10.1016/S0140-6736(02)11738-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480363				2022-12-28	WOS:000179706100013
J	The, AM; Pasman, R; Onwuteaka-Philipsen, B; Ribbe, M; van der Wal, G				The, AM; Pasman, R; Onwuteaka-Philipsen, B; Ribbe, M; van der Wal, G			Withholding the artificial administration of fluids and food from elderly patients with dementia: ethnographic study	BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE	Objective To clarify the practice of withholding the artificial administration of fluids and food from elderly patients with dementia in nursing homes. Design Qualitative, ethnographic study in two phases. Setting 10 wards in two nursing homes in the Netherlands. Participants 35 patients with dementia, eight doctors, 43 nurses, and 32 families. Results The clinical course of dementia was considered normal and was rarely reason to begin the artificial administration of fluids and food in advanced disease. Fluids and food seemed to be given mainly when there was an acute illness or a condition that needed medical treatment and which required hydration to be effective. The medical condition of the patient, the wishes of the family, and the interpretations of the patients' quality of life by their care providers were considered more important than living wills and policy agreements. Conclusions Doctors' decisions about withholding the artificial administration of fluids and food from elderly patients with dementia are influenced more by the clinical course of the illness, the presumed quality of life of the patient, and the patient's medical condition than they are by advanced planning of care. In an attempt to understand the wishes of the patient doctors try to create the broadest possible basis for the decision making process and its outcome, mainly by involving the family.	Free Univ Amsterdam, Med Ctr, Inst Res Extramural Med, Dept Social Med, NL-1081 BT Amsterdam, Netherlands; Inst Res Extramural Med, Dept Nursing Home Med, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	The, AM (corresponding author), Free Univ Amsterdam, Med Ctr, Inst Res Extramural Med, Dept Social Med, NL-1081 BT Amsterdam, Netherlands.		The, Anne-Mei/AAE-3468-2020					Ackerman TF, 1996, J AM GERIATR SOC, V44, P1265, DOI 10.1111/j.1532-5415.1996.tb01383.x; Dyer C, 1999, BRIT MED J, V318, P895; Dyer C, 1999, BRIT MED J, V318, P143, DOI 10.1136/bmj.318.7177.143; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; Huang ZB, 2000, CLIN GERIATR MED, V16, P313, DOI 10.1016/S0749-0690(05)70058-6; KMIETOWICZ Z, 1997, BRIT MED J, V314, P1501; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; ONWUTEAKA BD, 1998, WITHHOLDING ARTIFICI; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Savage J, 2000, BMJ-BRIT MED J, V321, P1400, DOI 10.1136/bmj.321.7273.1400; Sheiman SL, 1996, J AM GERIATR SOC, V44, P1268, DOI 10.1111/j.1532-5415.1996.tb01384.x; Sheldon T, 1997, BRIT MED J, V315, P327; Strauss A., 1990, BASICS QUALITATIVE R; VOLICER I, 1993, CARING MAGAZINE  NOV, P50	15	66	68	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2002	325	7376					1326	1329		10.1136/bmj.325.7376.1326	http://dx.doi.org/10.1136/bmj.325.7376.1326			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468479	Green Published, Bronze			2022-12-28	WOS:000179817100016
J	Zambon, M; Barclay, W				Zambon, M; Barclay, W			Unravelling the mysteries of influenza	LANCET			English	Editorial Material							A VIRUS; HONG-KONG; INTERFERON; INFECTION		Cent Publ Hlth Lab, Virus Reference Lab, London NW9 5HT, England; Univ Reading, Sch Anim & Microbial Sci, Reading RG6 2AJ, Berks, England	Public Health England; University of Reading	Zambon, M (corresponding author), Cent Publ Hlth Lab, Virus Reference Lab, 61 Colindale Ave, London NW9 5HT, England.			Barclay, Wendy/0000-0002-3948-0895				Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; KILBOURNE ED, 1980, PHILOS T R SOC LON B, V228, P291; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N	12	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1801	1802		10.1016/S0140-6736(02)11845-9	http://dx.doi.org/10.1016/S0140-6736(02)11845-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480355				2022-12-28	WOS:000179706100005
J	Polster, B				Polster, B			Mathematics - What is the best way to lace your shoes?	NATURE			English	Article									Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia	Monash University	Polster, B (corresponding author), Monash Univ, Sch Math Sci, POB 28M, Clayton, Vic 3800, Australia.							HALTON JH, 1995, MATH INTELL, V17, P37; Misiurewicz M, 1996, MATH INTELL, V18, P32; STEWART I, 1996, SCI AM           DEC, P86; STEWART I, 1996, SCI AM           JUL, P78	4	10	10	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					476	476		10.1038/420476a	http://dx.doi.org/10.1038/420476a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466832	Bronze			2022-12-28	WOS:000179611600034
J	Lakka, HM; Laaksonen, DE; Lakka, TA; Niskanen, LK; Kumpusalo, E; Tuomilehto, J; Salonen, JT				Lakka, HM; Laaksonen, DE; Lakka, TA; Niskanen, LK; Kumpusalo, E; Tuomilehto, J; Salonen, JT			The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSULIN-RESISTANCE SYNDROME; CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE PROFESSIONALS; TIME PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; DIABETES-MELLITUS; PROVISIONAL REPORT; SYNDROME PREDICTS; LIFE-STYLE	Context The metabolic syndrome, a concurrence of disturbed glucose and insulin metabolism, overweight and abdominal fat distribution, mild dyslipidemia, and hypertension, is associated with subsequent development of type 2 diabetes mellitus and cardiovascular disease (CVD). Despite its high prevalence, little is known of the prospective association of the metabolic syndrome with cardiovascular and overall mortality. Objective To assess the association of the metabolic syndrome with cardiovascular and overall mortality using recently proposed definitions and factor analysis. Design, Setting, and Participants The Kuopio Ischaemic Heart Disease Risk Factor Study, a population-based, prospective cohort study of 1209 Finnish men aged 42 to 60 years at baseline (1984-1989) who were initially without CVD, cancer, or diabetes. Follow-up continued through December 1998. Main Outcome Measures Death due to coronary heart disease (CHID), CVD, and any cause among men with vs without the metabolic syndrome, using 4 definitions based on the National Cholesterol Education Program (NCEP) and the World Health Organization (WHO). Results The prevalence of the metabolic syndrome ranged from 8.8% to 14.3%, depending on the definition. There were 109 deaths during the approximately 11.4-year follow-up, of which 46 and 27 were due.,to CVD and CHD, respectively. Men with the metabolic syndrome as defined by the. NCEP were 2.9 (95% confidence interval [Cl], 1.2-7.2) to 4.2 (95% Cl, 1.6-10.8) times more likely and , as defined by the WHO, 2.9 (95% Cl, 1.2-6.8) to 3.3 (95% Cl, 1.4-7.7) times more likely to die of CHD after adjustment for conventional cardiovascular risk factors. The metabolic syndrome as defined by the WHO was associated with 2.6 (95 % Cl, 1.4-5.1) to 3.0 (95% Cl, 1.5-5.7) times higher CVD mortality and 1.9 (95% Cl, 1.2-3.0) to 2.1 (95% Cl, 1.3-3.3) times higher all-cause mortality. The NCEP definition less consistently predicted CVD and all-cause mortality. Factor analysis using 13 variables associated with metabolic or cardiovascular risk yielded a metabolic syndrome factor that explained 18% of total variance. Men with loadings on the metabolic factor in the highest quarter were 3.6 (95% Cl, 1.7-7.9),3.2 (95% Cl, 1.7-5.8), and 2.3 (95% Cl, 1.5-3.4) times more likely to die of CHD, CVD, and any cause, respectively. Conclusions Cardiovascular disease and all-cause mortality are increased in men with the metabolic syndrome, even in the absence of baseline CVD and diabetes. Early identification, treatment, and prevention of the metabolic syndrome present a major challenge for health care professionals facing an epidemic of overweight and sedentary lifestyle.	Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; Univ Kuopio, Publ Hlth Res Inst, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Physiol, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Med, Kuopio, Finland; Kuopio Res Inst Exercise Med, Kuopio, Finland; Inner Savo Hlth Ctr, Suonenjoki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Helsinki; Finland National Institute for Health & Welfare	Lakka, HM (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	lakkah@pbrc.edu		Lakka, Timo/0000-0002-9199-2871	NHLBI NIH HHS [HL44199] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Balkau B, 1999, DIABETIC MED, V16, P442; BOUCHARD C, 1995, INT J OBESITY, V19, pS52; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; Chalmers J, 1999, J HYPERTENS, V17, P151; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cureton E.E., 1983, FACTOR ANAL APPL APP; EDWARDS KL, 1994, ARTERIOSCLER THROMB, V14, P1940, DOI 10.1161/01.ATV.14.12.1940; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jenkins DJA, 2000, BRIT J NUTR, V83, pS157; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; LAAKSONEN DE, IN PRESS AM J EPIDEM; Lahti-Koski M, 2000, AM J CLIN NUTR, V72, P1436; Lahti-Koski M, 2001, INT J OBESITY, V25, P727, DOI 10.1038/sj.ijo.0801588; Lakka HM, 2002, EUR HEART J, V23, P706, DOI 10.1053/euhj.2001.2889; Lakka HM, 2000, ARCH INTERN MED, V160, P1160, DOI 10.1001/archinte.160.8.1160; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; Lempiainen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123; Liese AD, 1998, EPIDEMIOL REV, V20, P157, DOI 10.1093/oxfordjournals.epirev.a017978; Lynch J, 1996, ARCH INTERN MED, V156, P1307, DOI 10.1001/archinte.156.12.1307; Meigs JB, 1997, DIABETES, V46, P1594, DOI 10.2337/diabetes.46.10.1594; Meigs JB, 2000, AM J EPIDEMIOL, V152, P908, DOI 10.1093/aje/152.10.908; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pyorala M, 2000, ARTERIOSCL THROM VAS, V20, P538, DOI 10.1161/01.ATV.20.2.538; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SALONEN JT, 1988, ANN CLIN RES, V20, P46; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; SELBY JV, 1991, JAMA-J AM MED ASSOC, V265, P2079, DOI 10.1001/jama.265.16.2079; Smith SC, 2001, J AM COLL CARDIOL, V38, P1581, DOI 10.1016/S0735-1097(01)01682-5; STEVENS J, 1986, APPL MULTIVARIATE ST; Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3; TUOMILEHTO J, 1992, EUR HEART J, V13, P577, DOI 10.1093/oxfordjournals.eurheartj.a060219; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; TUOMILEHTO J, 1992, AM J EPIDEMIOL, V135, P1259, DOI 10.1093/oxfordjournals.aje.a116232; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; *WHO MONICA PROJ, 2002, MONICA MAN 4	42	3473	3730	2	272	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2002	288	21					2709	2716		10.1001/jama.288.21.2709	http://dx.doi.org/10.1001/jama.288.21.2709			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620UA	12460094				2022-12-28	WOS:000179549800030
J	Weber, T; Herbig, J; Mark, M; Nagerl, HC; Grimm, R				Weber, T; Herbig, J; Mark, M; Nagerl, HC; Grimm, R			Bose-Einstein condensation of cesium	SCIENCE			English	Article							ATOMS; GAS	Bose-Einstein condensation of cesium atoms is achieved by evaporative cooling using optical trapping techniques. The ability to tune the interactions between the ultracold atoms by an external magnetic field is crucial to obtain the condensate and offers intriguing features for potential applications. We explore various regimes of condensate self-interaction (attractive, repulsive, and null interaction strength) and demonstrate properties of imploding, exploding, and non-interacting quantum matter.	Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria	University of Innsbruck	Weber, T (corresponding author), Univ Innsbruck, Inst Expt Phys, Tech Str 25, A-6020 Innsbruck, Austria.		Grimm, Rudolf/D-2864-2009; Naegerl, Hanns-Christoph/E-7329-2010	Grimm, Rudolf/0000-0003-1085-5558; Naegerl, Hanns-Christoph/0000-0002-7789-4431; Herbig, Jens/0000-0003-1251-8029				ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Arlt J, 1998, J PHYS B-AT MOL OPT, V31, pL321, DOI 10.1088/0953-4075/31/7/006; Barrett MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.010404; BRADLEY CC, 1995, PHYS REV LETT, V75, P1687, DOI 10.1103/PhysRevLett.75.1687; Chin C, 2000, PHYS REV LETT, V85, P2717, DOI 10.1103/PhysRevLett.85.2717; Chin C, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.033401; Cornish SL, 2000, PHYS REV LETT, V85, P1795, DOI 10.1103/PhysRevLett.85.1795; CORNISH SL, 2002, 7 WORKSH AT OPT INT; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Donley EA, 2002, NATURE, V417, P529, DOI 10.1038/417529a; Fried DG, 1998, PHYS REV LETT, V81, P3811, DOI 10.1103/PhysRevLett.81.3811; Grimm R, 2000, ADV ATOM MOL OPT PHY, V42, P95, DOI 10.1016/S1049-250X(08)60186-X; Guery-Odelin D, 1998, EUROPHYS LETT, V44, P25, DOI 10.1209/epl/i1998-00425-9; Gupta S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.140401; Hammes M, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.051401; Han DJ, 2000, PHYS REV LETT, V85, P724, DOI 10.1103/PhysRevLett.85.724; Han DJ, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.023405; HENSLEY JM, 2001, P 17 INT C AT PHYS I, P43; Julienne P S, COMMUNICATION; Kerman AJ, 2001, CR ACAD SCI IV-PHYS, V2, P633, DOI 10.1016/S1296-2147(01)01196-9; Kerman AJ, 2000, PHYS REV LETT, V84, P439, DOI 10.1103/PhysRevLett.84.439; Khaykovich L, 2002, SCIENCE, V296, P1290, DOI 10.1126/science.1071021; Leo PJ, 2000, PHYS REV LETT, V85, P2721, DOI 10.1103/PhysRevLett.85.2721; Masnou-Seeuws F, 2001, ADV ATOM MOL OPT PHY, V47, P53; Modugno G, 2001, SCIENCE, V294, P1320, DOI 10.1126/science.1066687; Perrin H, 1998, EUROPHYS LETT, V42, P395, DOI 10.1209/epl/i1998-00261-y; Robert A, 2001, SCIENCE, V292, P461, DOI 10.1126/science.1060622; SALOMON, 2001, P 17 INT C AT PHYS I, P23; Snadden MJ, 1998, PHYS REV LETT, V81, P971, DOI 10.1103/PhysRevLett.81.971; Soding J, 1998, PHYS REV LETT, V80, P1869, DOI 10.1103/PhysRevLett.80.1869; Stamper-Kurn DM, 1998, PHYS REV LETT, V81, P2194, DOI 10.1103/PhysRevLett.81.2194; Strecker KE, 2002, NATURE, V417, P150, DOI 10.1038/nature747; Treutlein P, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.051401; WEISS DS, COMMUNICATION; WIERNAN CE, 1999, P 16 INT C AT PHYS I, P1	37	388	398	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					232	235		10.1126/science.1079699	http://dx.doi.org/10.1126/science.1079699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12471267				2022-12-28	WOS:000180284000033
J	Trowbridge, RL; Rutkowski, NK; Shojania, KG				Trowbridge, RL; Rutkowski, NK; Shojania, KG			Does this patient have acute cholecystitis?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DELAYED LAPAROSCOPIC CHOLECYSTECTOMY; ACUTE ACALCULOUS CHOLECYSTITIS; SUSPECTED ACUTE CHOLECYSTITIS; PULMONARY-EMBOLISM; ABDOMINAL-PAIN; CLINICAL-DIAGNOSIS; EMERGENCY; DISEASE; TESTS; BIAS	Context Although few patients with acute abdominal pain will prove to have cholecystitis, ruling in or ruling out acute cholecystitis consumes substantial diagnostic resources. Objective To determine if aspects of the history and physical examination or basic laboratory testing clearly identify patients who require diagnostic imaging tests to rule in or rule out the diagnosis of acute cholecystitis. Data Sources Electronic search of the Science Citation Index, Cochrane Library, and English-language articles from January 1966 through November 2000 indexed in MEDLINE. We also hand-searched Index Medicus for 1950-1965, and scanned references in identified articles and bibliographies of prominent textbooks of physical examination, surgery, and gastroenterology. To identify relevant articles appearing since the comprehensive search, we repeated the MEDLINE search in July 2002. Study Selection Included studies evaluated the role of the history, physical examination, and/or laboratory tests in adults with abdominal pain or suspected acute cholecystitis. Studies had to report data from a control group found not to have acute cholecystitis. Acceptable definitions of cholecystitis included surgery, pathologic examination, hepatic iminodiacetic acid scan or right upper quadrant ultrasound, or clinical course consistent with acute cholecystitis and no evidence for an alternate diagnosis. Studies of acalculous cholecystitis were included. Seventeen of 195 identified studies met the inclusion criteria. Data Extraction Two authors independently abstracted data from the 17-included studies. Disagreements were resolved by discussion and consensus with a third author. Data Synthesis No clinical or laboratory finding had a sufficiently high positive likelihood ratio (LR) or low negative LR to rule in or rule out the diagnosis of acute cholecystitis. Possible exceptions were the Murphy sign (positive LR, 2.8; 95% CI, 0.8-8.6) and right upper quadrant tenderness (negative LR, 0.4; 95% CI, 0.2-1.1), though the 95% CIs for both included 1.0. Available data on diagnostic confirmation rates at laparotomy and test characteristics of relevant radiological investigations suggest that the diagnostic impression of acute cholecystitis has a positive LR of 25 to 30. Unfortunately, the available literature does not identify the specific combinations of clinical and laboratory findings that presumably account for this diagnostic success. Conclusions No single clinical finding or laboratory test carries sufficient weight to establish or exclude cholecystitis without further testing (eg, right upper quadrant ultrasound). Combinations of certain symptoms, signs, and laboratory results likely have more useful LRs, and presumably inform the diagnostic impressions of experienced clinicians. Pending further research characterizing the pretest probabilities associated with different clinical presentations, the evaluation of patients with abdominal pain suggestive of cholecystitis will continue to rely heavily on the clinical gestalt and diagnostic imaging.	Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco	Shojania, KG (corresponding author), 533 Parnassus Ave,Room U137,UCSF Box 0120, San Francisco, CA 94143 USA.	shojania@medicine.ucsf.edu	Trowbridge, Robert/U-8278-2019	Trowbridge, Robert/0000-0002-0460-2733				Adedeji OA, 1996, J ROY COLL SURG EDIN, V41, P88; AHRENDT SA, 2001, SABISTON TXB SURG; ALDEA P A, 1986, Journal of Emergency Medicine, V4, P57, DOI 10.1016/0736-4679(86)90113-7; BEDNARZ GM, 1986, MED J AUSTRALIA, V145, P316, DOI 10.5694/j.1326-5377.1986.tb113836.x; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; BEGG CB, 1988, RADIOLOGY, V167, P565, DOI 10.1148/radiology.167.2.3357976; Berger MY, 2000, SCAND J GASTROENTERO, V35, P70; BORENSTEIIN M, 1999, COMPREHENSIVE METAAN; BREWER RJ, 1976, AM J SURG, V131, P219, DOI 10.1016/0002-9610(76)90101-X; Chandler CF, 2000, AM SURGEON, V66, P896; CHERRY DK, 2001, SUMMARY ADV DATA VIT, V322; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Dunlop M G, 1989, J R Coll Surg Edinb, V34, P124; EDDY D, 1992, FAST PROV V1 8 SOFTW; Eddy DM, 1992, METAANALYSIS CONFIDE; EIKMAN EA, 1975, ANN INTERN MED, V82, P318, DOI 10.7326/0003-4819-82-3-318; Eldar S, 1999, AM J SURG, V178, P303, DOI 10.1016/S0002-9610(99)00172-5; Ernst E, 2000, ARCH OPHTHALMOL-CHIC, V118, P120; Fidler J, 1996, AM J ROENTGENOL, V166, P1085, DOI 10.2214/ajr.166.5.8615248; Fitzgibbons RJ, 1996, SURG ENDOSC-ULTRAS, V10, P1180, DOI 10.1007/s004649900274; FOURNIER AM, 1992, SOUTHERN MED J, V85, P548, DOI 10.1097/00007611-199205000-00018; Gruber PJ, 1996, ANN EMERG MED, V28, P273, DOI 10.1016/S0196-0644(96)70025-2; GUNN A, 1972, LANCET, V2, P239; Guyatt G., 2015, USERS GUIDES MED LIT; HALASZ NA, 1975, AM J SURG, V130, P189, DOI 10.1016/0002-9610(75)90369-4; Harvey RT, 1999, RADIOLOGY, V213, P831, DOI 10.1148/radiology.213.3.r99dc17831; Hashizume M, 1998, Semin Laparosc Surg, V5, P69; IRVIN TT, 1989, BRIT J SURG, V76, P1121, DOI 10.1002/bjs.1800761105; JOACHIM H, 1940, PRACTICAL BEDSIDE DI; JOHNSON H, 1995, J NATL MED ASSOC, V87, P27; JUVONEN T, 1992, EUR J SURG, V158, P365; Kalliafas S, 1998, AM SURGEON, V64, P471; Kizer KW, 1998, AM J EMERG MED, V16, P357, DOI 10.1016/S0735-6757(98)90127-9; KNIPSCHILD P, 1988, BRIT MED J, V297, P1578, DOI 10.1136/bmj.297.6663.1578; Lai PBS, 1998, BRIT J SURG, V85, P764; LIDDINGTON MI, 1991, BRIT J SURG, V78, P795, DOI 10.1002/bjs.1800780710; Lillemoe KD, 2000, AM SURGEON, V66, P138; LINDENAU.SM, 1966, SURG GYNECOL OBSTETR, V123, P1205; Lo CM, 1998, ANN SURG, V227, P461, DOI 10.1097/00000658-199804000-00001; MCCAIG L, 2001, ADV DAT VITAL HLTH S, V320; MCGEE S, 2001, EVIDENCE BASED PHYSI; Miettinen P, 1996, ANN CHIR GYNAECOL FE, V85, P5; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; Panju AA, 1998, JAMA-J AM MED ASSOC, V280, P1256, DOI 10.1001/jama.280.14.1256; Parker LJ, 1997, ACAD EMERG MED, V4, P51, DOI 10.1111/j.1553-2712.1997.tb03643.x; POPOVIC JR, 2001, VITAL HLTH STAT, V13, P1; Potts FE, 1999, J GERONTOL A-BIOL, V54, pM55, DOI 10.1093/gerona/54.2.M55; POWERS RD, 1995, AM J EMERG MED, V13, P301, DOI 10.1016/0735-6757(95)90204-X; Prevot N, 1999, EUR J NUCL MED, V26, P1317, DOI 10.1007/s002590050589; PULLEN RLR, 1944, MED DIAGNOSIS APPL P; RAINE PAM, 1975, BRIT J SURG, V62, P697, DOI 10.1002/bjs.1800620907; RALLS PW, 1985, RADIOLOGY, V155, P767, DOI 10.1148/radiology.155.3.3890007; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Rodger MA, 2000, AM J RESP CRIT CARE, V162, P2105, DOI 10.1164/ajrccm.162.6.2004204; Sapira JD, 1990, ART SCI BEDSIDE DIAG; SCHOFIELD PF, 1986, ANN ROY COLL SURG, V68, P14; SHEA JA, 1994, ARCH INTERN MED, V154, P2573, DOI 10.1001/archinte.154.22.2573; SIMON A, 1979, JAMA-J AM MED ASSOC, V242, P1385, DOI 10.1001/jama.242.13.1385; Singer AJ, 1996, ANN EMERG MED, V28, P267, DOI 10.1016/S0196-0644(96)70024-0; STANILAND JR, 1972, BMJ-BRIT MED J, V3, P393, DOI 10.1136/bmj.3.5823.393; VERGHESE A, 1987, AM J GASTROENTEROL, V82, P248; Wagner JM, 1996, JAMA-J AM MED ASSOC, V276, P1589, DOI 10.1001/jama.276.19.1589; Warren BL, 1999, S AFR J SURG, V37, P99; Wasson J H, 1981, Med Decis Making, V1, P215, DOI 10.1177/0272989X8100100302; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; ZATUCHNI J, 1964, NOTES PHYSICAL DIAGN; Zhou XH, 2000, STAT MED, V19, P1697, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1697::AID-SIM455>3.0.CO;2-Q; [No title captured]	69	189	201	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					80	86		10.1001/jama.289.1.80	http://dx.doi.org/10.1001/jama.289.1.80			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630XL	12503981				2022-12-28	WOS:000180136600030
J	Dalton, R				Dalton, R			Palaeoanthropology - Face to face with our past	NATURE			English	Editorial Material																		Brunet M, 2002, NATURE, V419, P582, DOI 10.1038/419582a; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wolpoff MH, 2002, NATURE, V419, P581, DOI 10.1038/419581a	5	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					735	736		10.1038/420735a	http://dx.doi.org/10.1038/420735a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490911				2022-12-28	WOS:000179897300019
J	Dennis, C				Dennis, C			Small RNAs - The genome's guiding hand?	NATURE			English	Editorial Material							ELEGANS											Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	14	19	35	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					732	732		10.1038/420732a	http://dx.doi.org/10.1038/420732a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490907				2022-12-28	WOS:000179897300016
J	Kasahara, M; Kagawa, T; Oikawa, K; Suetsugu, N; Miyao, M; Wada, M				Kasahara, M; Kagawa, T; Oikawa, K; Suetsugu, N; Miyao, M; Wada, M			Chloroplast avoidance movement reduces photodamage in plants	NATURE			English	Article							BLUE-LIGHT; CHLOROPHYLL FLUORESCENCE; ARABIDOPSIS-THALIANA; PHOTOSYSTEM-II; STRESS; NPL1; PHOTOPROTECTION; PHOTOSYNTHESIS; RELOCATION; MEDIATE	When plants are exposed to light levels higher than those required for photosynthesis, reactive oxygen species are generated in the chloroplasts and cause photodamage. This can occur even under natural growth conditions. To mitigate photodamage, plants have developed several protective mechanisms(1-3). One is chloroplast avoidance movement(4-6), in which chloroplasts move from the cell surface to the side walls of cells under high light conditions, although experimental support is still awaited(7,8). Here, using different classes of mutant defective in chloroplast avoidance movement, we show that these mutants are more susceptible to damage in high light than wild-type plants. Damage of the photosynthetic apparatus and subsequent bleaching of leaf colour and necrosis occur faster under high light conditions in the mutants than in wild-type plants. We conclude that chloroplast avoidance movement actually decreases the amount of light absorption by chloroplasts, and might therefore be important to the survival of plants under natural growth conditions.	Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, PRESTO, Unit Proc & combined Circuit, Kawaguchi, Saitama 3320012, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); Tokyo Metropolitan University; National Institute of Agrobiological Sciences - Japan	Wada, M (corresponding author), Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Okazaki, Aichi 4448585, Japan.		Suetsugu, Noriyuki/AAB-5274-2019	Suetsugu, Noriyuki/0000-0002-3328-3313; Oikawa, Kazusato/0000-0002-1033-9089				Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; BRUGNOLI E, 1992, PHOTOSYNTH RES, V32, P23, DOI 10.1007/BF00028795; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; ESCOUBAS JM, 1995, P NATL ACAD SCI USA, V92, P10237, DOI 10.1073/pnas.92.22.10237; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; HAUPT W, 1990, PLANT CELL ENVIRON, V13, P595, DOI 10.1111/j.1365-3040.1990.tb01078.x; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; KADOTA A, 1992, BOT MAG TOKYO, V105, P265, DOI 10.1007/BF02489420; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Miyagawa Y, 2000, PLANT CELL PHYSIOL, V41, P311, DOI 10.1093/pcp/41.3.311; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Park YI, 1996, PLANT PHYSIOL, V111, P867, DOI 10.1104/pp.111.3.867; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; SUKENIK A, 1987, NATURE, V327, P704, DOI 10.1038/327704a0; TLALKA M, 1993, PLANTA, V189, P491, DOI 10.1007/BF00198211; Trojan A, 1996, PLANT PHYSIOL, V111, P419, DOI 10.1104/pp.111.2.419; WADA M, 2001, PHOTOMOVEMENT, P897; Zurzycki J., 1980, The blue light syndrome [Senger, H. (Editor)]., P50	22	411	444	6	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					829	832		10.1038/nature01213	http://dx.doi.org/10.1038/nature01213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490952				2022-12-28	WOS:000179897300060
J	Moayyedi, P; Ford, A				Moayyedi, P; Ford, A			Recent developments in gastroenterology	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HELICOBACTER-PYLORI ERADICATION; COLORECTAL-CANCER; RANDOMIZED TRIAL; RISK; HEMOCHROMATOSIS; MANAGEMENT; MUTATIONS; NEOPLASMS; THERAPY; DISEASE		City Hosp NHS Trust, Gastroenterol Unit, Birmingham B18 7QH, W Midlands, England; Leeds Gen Infirm, Gastroenterol Unit, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary; University of Leeds	Moayyedi, P (corresponding author), City Hosp NHS Trust, Gastroenterol Unit, Birmingham B18 7QH, W Midlands, England.	p.moayyedi@bham.ac.uk	Moayyedi, Paul/M-6178-2014; Ford, Alexander/K-5491-2012	Moayyedi, Paul/0000-0002-3616-9292; Ford, Alexander/0000-0001-6371-4359				*AM GASTR ASS, 1998, GASTROENTEROLOGY, V114, P579; Appleyard M, 2000, GASTROENTEROLOGY, V119, P1431, DOI 10.1053/gast.2000.20844; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; BANIHANI K, 2000, JNCI-J NATL CANCER I, V92, P1282; Bhavnani M, 2000, GUT, V46, P707, DOI 10.1136/gut.46.5.707; Camilleri M, 2001, GASTROENTEROLOGY, V120, P652, DOI 10.1053/gast.2001.21908; Camilleri M, 2000, LANCET, V355, P1035, DOI 10.1016/S0140-6736(00)02033-X; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; D'Haens G, 2001, GASTROENTEROLOGY, V120, P1323, DOI 10.1053/gast.2001.23983; DELANEY BC, 2001, COCHRANE DB SYST REV; Ehrenpreis ED, 1999, GASTROENTEROLOGY, V117, P1271, DOI 10.1016/S0016-5085(99)70276-3; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fenlon HM, 1999, NEW ENGL J MED, V341, P1496, DOI 10.1056/NEJM199911113412003; Feretis C, 2001, GASTROINTEST ENDOSC, V53, P423, DOI 10.1067/mge.2001.113912; Filipi CJ, 2001, GASTROINTEST ENDOSC, V53, P416, DOI 10.1067/mge.2001.113502; Friedel D, 2001, GASTROENTEROLOGY, V120, P557, DOI 10.1053/gast.2001.21177; Halligan S, 1999, BRIT MED J, V319, P1249, DOI 10.1136/bmj.319.7219.1249; Horton R, 2001, LANCET, V357, P1544, DOI 10.1016/S0140-6736(00)04776-0; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P167, DOI 10.1046/j.1365-2036.2002.01169.x; Mason J, 2002, ALIMENT PHARM THER, V16, P559, DOI 10.1046/j.1365-2036.2002.01204.x; McColl K. E. L., 2002, BMJ, V324, P999, DOI 10.1136/bmj.324.7344.999; Moayyedi P, 2001, GASTROENTEROLOGY, V121, P1120, DOI 10.1053/gast.2001.29332; Moayyedi P, 2000, BRIT MED J, V321, P659, DOI 10.1136/bmj.321.7262.659; *NAT I CLIN EXC, 2002, 40 NICE; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Rembacken BJ, 2000, LANCET, V355, P1211, DOI 10.1016/S0140-6736(00)02086-9; Robson KJH, 1997, GUT, V41, P841; Schoenfeld P, 1999, GASTROENTEROLOGY, V117, P312, DOI 10.1053/gast.1999.0029900312; Towler B, 1998, BRIT MED J, V317, P559, DOI 10.1136/bmj.317.7158.559; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; Triadafilopoulos G, 2002, GASTROINTEST ENDOSC, V55, P149, DOI 10.1067/mge.2002.121227; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347	36	12	13	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2002	325	7377					1399	1402		10.1136/bmj.325.7377.1399	http://dx.doi.org/10.1136/bmj.325.7377.1399			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480858	Green Published			2022-12-28	WOS:000179975000027
J	Dehal, P; Satou, Y; Campbell, RK; Chapman, J; Degnan, B; De Tomaso, A; Davidson, B; Di Gregorio, A; Gelpke, M; Goodstein, DM; Harafuji, N; Hastings, KEM; Ho, I; Hotta, K; Huang, W; Kawashima, T; Lemaire, P; Martinez, D; Meinertzhagen, IA; Necula, S; Nonaka, M; Putnam, N; Rash, S; Saiga, H; Satake, M; Terry, A; Yamada, L; Wang, HG; Awazu, S; Azumi, K; Boore, J; Branno, M; Chin-bow, S; DeSantis, R; Doyle, S; Francino, P; Keys, DN; Haga, S; Hayashi, H; Hino, K; Imai, KS; Inaba, K; Kano, S; Kobayashi, K; Kobayashi, M; Lee, BI; Makabe, KW; Manohar, C; Matassi, G; Medina, M; Mochizuki, Y; Mount, S; Morishita, T; Miura, S; Nakayama, A; Nishizaka, S; Nomoto, H; Ohta, F; Oishi, K; Rigoutsos, I; Sano, M; Sasaki, A; Sasakura, Y; Shoguchi, E; Shin-i, T; Spagnuolo, A; Stainier, D; Suzuki, MM; Tassy, O; Takatori, N; Tokuoka, M; Yagi, K; Yoshizaki, F; Wada, S; Zhang, C; Hyatt, PD; Larimer, F; Detter, C; Doggett, N; Glavina, T; Hawkins, T; Richardson, P; Lucas, S; Kohara, Y; Levine, M; Satoh, N; Rokhsar, DS				Dehal, P; Satou, Y; Campbell, RK; Chapman, J; Degnan, B; De Tomaso, A; Davidson, B; Di Gregorio, A; Gelpke, M; Goodstein, DM; Harafuji, N; Hastings, KEM; Ho, I; Hotta, K; Huang, W; Kawashima, T; Lemaire, P; Martinez, D; Meinertzhagen, IA; Necula, S; Nonaka, M; Putnam, N; Rash, S; Saiga, H; Satake, M; Terry, A; Yamada, L; Wang, HG; Awazu, S; Azumi, K; Boore, J; Branno, M; Chin-bow, S; DeSantis, R; Doyle, S; Francino, P; Keys, DN; Haga, S; Hayashi, H; Hino, K; Imai, KS; Inaba, K; Kano, S; Kobayashi, K; Kobayashi, M; Lee, BI; Makabe, KW; Manohar, C; Matassi, G; Medina, M; Mochizuki, Y; Mount, S; Morishita, T; Miura, S; Nakayama, A; Nishizaka, S; Nomoto, H; Ohta, F; Oishi, K; Rigoutsos, I; Sano, M; Sasaki, A; Sasakura, Y; Shoguchi, E; Shin-i, T; Spagnuolo, A; Stainier, D; Suzuki, MM; Tassy, O; Takatori, N; Tokuoka, M; Yagi, K; Yoshizaki, F; Wada, S; Zhang, C; Hyatt, PD; Larimer, F; Detter, C; Doggett, N; Glavina, T; Hawkins, T; Richardson, P; Lucas, S; Kohara, Y; Levine, M; Satoh, N; Rokhsar, DS			The draft genome of Ciona intestinalis: Insights into chordate and vertebrate origins	SCIENCE			English	Article							GENE-EXPRESSION PROFILES; ASCIDIAN EMBRYOS; HOMEOBOX GENES; EVOLUTION; CLUSTER; SYSTEM; DROSOPHILA; SEQUENCE; BIOLOGY; PLANT	The first chordates appear in the fossil record at the time of the Cambrian explosion, nearly 550 million years ago. The modern ascidian tadpole represents a plausible approximation to these ancestral chordates. To illuminate the origins of chordate and vertebrates, we generated a draft of the protein-coding portion of the genome of the most studied ascidian, Ciona intestinalis. The Ciona genome contains similar to16,000 protein-coding genes, similar to the number in other invertebrates, but only half that found in vertebrates. Vertebrate gene families are typically found in simplified form in Ciona, suggesting that ascidians contain the basic ancestral complement of genes involved in cell signaling and development. The ascidian genome has also acquired a number of lineage-specific innovations, including a group of genes engaged in cellulose metabolism that are related to those in bacteria and fungi.	US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto 6068502, Japan; Marine Biol Labs, Woods Hole, MA 02543 USA; Serono Reprod Biol Inst, Rockland, MA 02370 USA; Univ Queensland, Dept Zool & Entomol, Brisbane, Qld 4072, Australia; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 93950 USA; Univ Calif Berkeley, Dept Mol & Cellular Biol, Div Genet, Berkeley, CA 94720 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2T5, Canada; Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 6110011, Japan; IBDM, LGPD, F-13288 Marseille 09, France; Dalhousie Univ, Life Sci Ctr, Halifax, NS B3H 4J1, Canada; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan; H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, Tampa, FL 33612 USA; Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Sapporo, Hokkaido 0600812, Japan; Stn Zool Anton Dohrn, I-80121 Naples, Italy; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; Tohoku Univ, Grad Sch Sci, Asamushi Marine Biol Stn, Asamushi, Aomori 0393501, Japan; Univ Maryland, College Pk, MD 20742 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Programs Dev Biol Genet & Human Genet, San Francisco, CA 94143 USA; Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Kyoto University; Marine Biological Laboratory - Woods Hole; University of Queensland; Stanford University; University of California System; University of California Berkeley; McGill University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyoto University; UDICE-French Research Universities; Aix-Marseille Universite; Dalhousie University; University of Tokyo; Tokyo Metropolitan University; Tohoku University; H Lee Moffitt Cancer Center & Research Institute; Hokkaido University; Stazione Zoologica Anton Dohrn di Napoli; International Business Machines (IBM); Tohoku University; University System of Maryland; University of Maryland College Park; University of California System; University of California San Francisco; University of Edinburgh; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Berkeley	Kohara, Y (corresponding author), Natl Inst Genet, Mishima, Shizuoka 4118540, Japan.	ykohara@lab.nig.ac.jp; mlevine@uclink4.berkeley.edu; satoh@ascidian.zool.kyoto-u.ac.jp; dsrokhsar@lbl.gov	Di Gregorio, Anna/C-4766-2008; Satoh, Nori/C-4123-2009; Hotta, Kohji/D-1162-2014; Putnam, Nicholas/B-9968-2008; Rigoutsos, Isidore/C-5381-2012; Satou, Yutaka/AAJ-2194-2021; Satou, Yutaka/K-7131-2012; NONAKA, MASARU/G-4929-2014; Lemaire, Patrick/B-5560-2012; Matassi, Giorgio/G-6301-2014; Campbell, Robert/G-4112-2012; Lemaire, Patrick/D-4237-2009; Necula, Sabina/P-7113-2019; Lemaire, Patrick/P-8228-2019; Terry, Astrid Y/A-2538-2011; Francino, M.Pilar/H-9090-2015; Kawashima, Takeshi/M-4510-2015; Wang, Hong-Gang/A-3018-2015	Satoh, Nori/0000-0002-4480-3572; Hotta, Kohji/0000-0003-4614-7473; Putnam, Nicholas/0000-0002-1315-782X; Satou, Yutaka/0000-0001-5193-0708; Satou, Yutaka/0000-0001-5193-0708; Lemaire, Patrick/0000-0003-4925-2009; Matassi, Giorgio/0000-0003-4923-226X; Necula, Sabina/0000-0001-6912-2450; Lemaire, Patrick/0000-0003-4925-2009; Terry, Astrid Y/0000-0002-5234-1224; Francino, M.Pilar/0000-0002-4510-5653; Wang, Hong-Gang/0000-0003-0551-0571; Kobayashi, Kenji/0000-0002-9312-7857; Degnan, Bernard/0000-0001-7573-8518; Meinertzhagen, Ian/0000-0002-6578-4526; Goodstein, David/0000-0001-6287-2697; Levine, Michael/0000-0001-7629-0081; Mount, Steve/0000-0003-2748-8205; Spagnuolo, Antonietta/0000-0001-6660-071X; Davidson, Brad/0000-0001-5082-7872; Imai, Kaoru/0000-0001-9113-6074; Rokhsar, Daniel/0000-0002-8704-2224; Stainier, Didier/0000-0002-0382-0026; Rigoutsos, Isidore/0000-0003-1529-8631	NICHD NIH HHS [HD-37105] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Brennan K, 2002, BIOESSAYS, V24, P405, DOI 10.1002/bies.10089; Burglin T.R, 1994, EVOLUTION HOMEOBOX G, P27; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cameron RA, 2000, P NATL ACAD SCI USA, V97, P9514, DOI 10.1073/pnas.160261897; Capponi AM, 2002, TRENDS ENDOCRIN MET, V13, P118, DOI 10.1016/S1043-2760(01)00538-0; CHOURROUT D, COMMUNICATION; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Corbo JC, 1997, DEVELOPMENT, V124, P589; Corbo JC, 2001, CELL, V106, P535, DOI 10.1016/S0092-8674(01)00481-0; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Darwin Charles, 1871, DESCENT MAN; Di Gregorio A, 2002, DIFFERENTIATION, V70, P132; DIGREGORIO A, 1995, GENE, V156, P253, DOI 10.1016/0378-1119(95)00035-5; DOLLE P, 1994, DEVELOPMENT, P143; Dunn JT, 2001, THYROID, V11, P407, DOI 10.1089/105072501300176363; Ferrier DEK, 2000, EVOL DEV, V2, P284, DOI 10.1046/j.1525-142x.2000.00070.x; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Gee H., 1996, BACKBONE VIEWS ORIGI; Gionti M, 1998, DEV GENES EVOL, V207, P515, DOI 10.1007/s004270050142; HAFAFUJI N, 2002, P NATL ACAD SCI USA, V99, P6802; Hall B.K., 1998, EVOLUTIONARY DEV BIO; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hill CS, 1999, INT J BIOCHEM CELL B, V31, P1249, DOI 10.1016/S1357-2725(99)00093-X; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HOLLAND PWH, 1994, DEVELOPMENT, P125; Imai KS, 2002, DEVELOPMENT, V129, P3441; Jeffery WR, 2001, INT REV CYTOL, V203, P3; JOOST P, IN PRESS GENOME BIOL; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KEYS DN, UNPUB; Kirsten D, 2000, Neonatal Netw, V19, P11; KOVILUR S, 1993, J MOL EVOL, V36, P361; Kowalevsky A., 1866, Mem. Acad. Imp. des Sciences de St. Petersbourg, tome, Vx, P1; KRISHNAN G, 1975, INDIAN J EXP BIOL, V13, P172; Kusakabe T, 2002, DEV BIOL, V242, P188, DOI 10.1006/dbio.2002.0538; Lacroix L, 2001, THYROID, V11, P1017, DOI 10.1089/105072501753271699; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; Lo N, 2000, CURR BIOL, V10, P801, DOI 10.1016/S0960-9822(00)00561-3; Martinez P, 1999, P NATL ACAD SCI USA, V96, P1469, DOI 10.1073/pnas.96.4.1469; MEEDEL TH, 1984, DEV BIOL, V105, P479, DOI 10.1016/0012-1606(84)90305-1; Meinertzhagen LA, 2001, TRENDS NEUROSCI, V24, P401, DOI 10.1016/S0166-2236(00)01851-8; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Nakatani Y, 1999, DEVELOPMENT, V126, P3293; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; NISHIDA H, 1997, INT REV CYTOL, V176, P24; Nishino A, 2001, GENESIS, V29, P36, DOI 10.1002/1526-968X(200101)29:1<36::AID-GENE1003>3.0.CO;2-J; Nobles DR, 2001, PLANT PHYSIOL, V127, P529, DOI 10.1104/pp.010557; Oota S, 1999, MOL BIOL EVOL, V16, P856, DOI 10.1093/oxfordjournals.molbev.a026170; Ornitz DM, 2001, GENOME BIOL, V2; Papaioannou VE, 2001, INT REV CYTOL, V207, P1; Pennisi E, 2000, SCIENCE, V287, P2182, DOI 10.1126/science.287.5461.2182; PUTNAM N, UNPUB; Read SM, 2002, SCIENCE, V295, P59, DOI 10.1126/science.1068155; Romer AS., 1970, VERTEBRATE BODY; Ruvinsky I, 2000, DEVELOPMENT, V127, P5233; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Satoh N, 2001, DIFFERENTIATION, V68, P1, DOI 10.1046/j.1432-0436.2001.068001001.x; Satoh N., 1994, DEV BIOL ASCIDIANS; Satou Y, 2002, DEV GENES EVOL, V212, P432, DOI 10.1007/s00427-002-0266-8; Satou Y, 2002, GENESIS, V33, P153, DOI 10.1002/gene.10119; Satou Y, 2001, DEVELOPMENT, V128, P2893; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Seo HC, 2001, SCIENCE, V294, P2506, DOI 10.1126/science.294.5551.2506; Simmen MW, 1998, P NATL ACAD SCI USA, V95, P4437, DOI 10.1073/pnas.95.8.4437; Sordino P, 2000, SARSIA, V85, P173, DOI 10.1080/00364827.2000.10414567; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; Takahashi H, 1999, GENE DEV, V13, P1519, DOI 10.1101/gad.13.12.1519; Tomarev SI, 1997, INT J DEV BIOL, V41, P835; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ulrich HD, 2002, CURR TOP MICROBIOL, V268, P137; van Holde KE, 2001, J BIOL CHEM, V276, P15563, DOI 10.1074/jbc.R100010200; VANDEKERCKHOVE J, 1984, J MOL BIOL, V179, P391, DOI 10.1016/0022-2836(84)90072-X; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weichert C.K., 1953, ELEMENTS CHORDATE AN; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	90	1304	1349	3	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2157	2167		10.1126/science.1080049	http://dx.doi.org/10.1126/science.1080049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481130				2022-12-28	WOS:000179773700039
J	Sandy, LG				Sandy, LG			Homeostasis without reserve - The risk of health system collapse	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							POLICY; VIEWS; CARE		Robert Wood Johnson Fdn, Princeton, NJ 08543 USA	Robert Wood Johnson Foundation (RWJF)	Sandy, LG (corresponding author), Robert Wood Johnson Fdn, Princeton, NJ 08543 USA.							Bazzoli GJ, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.6.188; BERENSON RA, 2001, MEDICARE CHOICE DOUB; Blendon RJ, 2001, HEALTH AFFAIR, V20, P233, DOI 10.1377/hlthaff.20.3.233; Blendon RJ, 2001, HEALTH AFFAIR, V20, P33, DOI 10.1377/hlthaff.20.2.33; Burns LR, 2002, HEALTH AFFAIR, V21, P128, DOI 10.1377/hlthaff.21.4.128; BURTON TM, 2001, WALL STREET J   1123, pB5; BURTON TM, 2001, WALL STREET J   0911, pB1; Callahan Daniel., 1998, FALSE HOPES WHY AM Q; Cannon W.B., 1932, WISDOM BODY; CHEN K, 2002, WALL STREET J   0205, pA1; CRANE M, 2001, MED EC          0917; CUNNINGHAM PJ, 2001, TARGETING COMMUNITIE; Cunningham R, 2001, HEALTH AFFAIR, V20, P233, DOI 10.1377/hlthaff.20.2.233; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; Draper DA, 2002, HEALTH AFFAIR, V21, P11, DOI 10.1377/hlthaff.21.1.11; *GEN ACC OFF, 2001, GAO01944; GREENE J, 2002, AM MED NEWS     0128; Harrison MG, 2002, HEALTH AFFAIR, V21, P118, DOI 10.1377/hlthaff.21.1.118; Herzlinger RE, 2002, HARVARD BUS REV, V80, P44; HOLAHAN J, 2002, CHANGES INSURANCE CO; Institute of Medicine, 2001, CROSSING QUALITY CHA; Johnson H., 1997, SYSTEM AM WAY POLITI; *KAIS FAM FDN HLTH, 2001, EMPL HLTH BEN 2001 A; KOWALCZYK L, 2002, BOSTON GLOBE    0305, pC1; Levit K, 2002, HEALTH AFFAIR, V21, P172, DOI 10.1377/hlthaff.21.1.172; Manton KG, 2001, P NATL ACAD SCI USA, V98, P6354, DOI 10.1073/pnas.111152298; MCCAIG LF, 2002, ADV DATA VITAL HLTH, V326; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; *NAT CTR HLTH STAT, 2001, HLTH US 2001 URB RUR; *OFF PERS MAN, 2001, OPM PROJ 2002 FED EM; OSHEA H, 2001, STATE DISCIPLINE NUR; REINHARDT UE, 2002, BOSTON GLOBE    0819, pA11; SCHWARTZ WB, 1998, LIFE DIS PURSUIT MED; Skocpol T., 1997, BOOMERANG HLTH CARE; STRUNK BC, 2001, TRACKING HLTH CARE C; Williams ES, 2002, HEALTH SERV RES, V37, P121; 2002, KAISER DAILY HL 0211; 2002, CALPERS ADOPTS NEW 2; 2001, NUMBER US MED SCH AP; 2000, WORTH NOTING NURSING	40	12	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1971	1975		10.1056/NEJMsb021260	http://dx.doi.org/10.1056/NEJMsb021260			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	623ZX	12477951				2022-12-28	WOS:000179735800013
J	Pasteris, JD; Wopenka, B				Pasteris, JD; Wopenka, B			Laser-Raman spectroscopy (Communication arising): Images of the Earth's earliest fossils?	NATURE			English	Article							STRUCTURAL CHARACTERIZATION; GRAPHITE; CARBONS; SPECTRA		Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	Washington University (WUSTL)	Pasteris, JD (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.			Pasteris, Jill/0000-0001-7041-6966				BENYBASSEZ C, 1985, SCAN ELECTRON MICROS, P119; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; DRESSELHAUS MS, 1982, LIGHT SCATTERING SOL, V3, P2; ELMAN BS, 1982, PHYS REV B, V25, P4142, DOI 10.1103/PhysRevB.25.4142; LESPADE P, 1982, CARBON, V20, P427, DOI 10.1016/0008-6223(82)90043-4; PASTERIS JD, 1998, APPL MICROANALYTICAL, P233; SATO Y, 1978, CARBON, V16, P279, DOI 10.1016/0008-6223(78)90042-8; Schopf JW, 2002, NATURE, V416, P73, DOI 10.1038/416073a; VIDANO R, 1978, J AM CERAM SOC, V61, P13, DOI 10.1111/j.1151-2916.1978.tb09219.x; WOPENKA B, 1993, AM MINERAL, V78, P533	10	50	51	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					476	477		10.1038/420476b	http://dx.doi.org/10.1038/420476b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466833				2022-12-28	WOS:000179611600035
J	Wabnitz, H; Bittner, L; de Castro, ARB; Dohrmann, R; Gurtler, P; Laarmann, T; Laasch, W; Schulz, J; Swiderski, A; von Haeften, K; Moller, T; Faatz, B; Fateev, A; Feldhaus, J; Gerth, C; Hahn, U; Saldin, E; Schneidmiller, E; Sytchev, K; Tiedtke, K; Treusch, R; Yurkov, M				Wabnitz, H; Bittner, L; de Castro, ARB; Dohrmann, R; Gurtler, P; Laarmann, T; Laasch, W; Schulz, J; Swiderski, A; von Haeften, K; Moller, T; Faatz, B; Fateev, A; Feldhaus, J; Gerth, C; Hahn, U; Saldin, E; Schneidmiller, E; Sytchev, K; Tiedtke, K; Treusch, R; Yurkov, M			Multiple ionization of atom clusters by intense soft X-rays from a free-electron laser	NATURE			English	Article							EXPLOSION; EMISSION; DYNAMICS; PULSES; FIELD	Intense radiation from lasers has opened up many new areas of research in physics and chemistry, and has revolutionized optical technology. So far, most work in the field of nonlinear processes has been restricted to infrared, visible and ultraviolet light(1), although progress in the development of X-ray lasers has been made recently(2). With the advent of a free-electron laser in the soft-X-ray regime below 100 nm wavelength(3), a new light source is now available for experiments with intense, short-wavelength radiation that could be used to obtain deeper insights into the structure of matter. Other free-electron sources with even shorter wavelengths are planned for the future. Here we present initial results from a study of the interaction of soft X-ray radiation, generated by a free-electron laser, with Xe atoms and clusters. We find that, whereas Xe atoms become only singly ionized by the absorption of single photons, absorption in clusters is strongly enhanced. On average, each atom in large clusters absorbs up to 400 eV, corresponding to 30 photons. We suggest that the clusters are heated up and electrons are emitted after acquiring sufficient energy. The clusters finally disintegrate completely by Coulomb explosion.	DESY, HASYLAB, D-22603 Hamburg, Germany; LNLS, BR-13084971 Campinas, SP, Brazil; Univ Estadual Campinas, IFGW, BR-13083970 Campinas, SP, Brazil; Joint Inst Nucl Res, Dubna 141980, Moscow Region, Russia	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Laboratorio Nacional de Luz Sincrotron (LNLS); Universidade Estadual de Campinas; Joint Institute for Nuclear Research - Russia	Moller, T (corresponding author), DESY, HASYLAB, Notkestr 85, D-22603 Hamburg, Germany.	thomas.moeller@desy.de	Laarmann, Tim/ABD-6460-2021; Feldhaus, Josef/C-1130-2014; von Haeften, Klaus/A-6225-2008; Treusch, Rolf/C-3935-2015; Laarmann, Tim/M-1411-2017; Treusch, Rolf/P-4876-2019	von Haeften, Klaus/0000-0002-2758-8030; Laarmann, Tim/0000-0003-4289-8536; Treusch, Rolf/0000-0001-8479-8862; Schulz, Joachim/0000-0002-9310-8832				ABERG T, 1995, 9503 DESY TESLA FEL; Andruszkow J, 2000, PHYS REV LETT, V85, P3825, DOI 10.1103/PhysRevLett.85.3825; AUGST S, 1989, PHYS REV LETT, V63, P2212, DOI 10.1103/PhysRevLett.63.2212; Ayvazyan V, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.104802; BATANI DCJ, 2001, ATOMS SOLIDS PLASMAS; Brewczyk M, 1998, PHYS REV LETT, V80, P1857, DOI 10.1103/PhysRevLett.80.1857; Brewczyk M, 1999, J PHYS B-AT MOL OPT, V32, pL1, DOI 10.1088/0953-4075/32/1/001; BRUNEL F, 1987, PHYS REV LETT, V59, P52, DOI 10.1103/PhysRevLett.59.52; Delone N B, 2000, SPR S ATOMS, V13; Ditmire T, 1997, NATURE, V386, P54, DOI 10.1038/386054a0; Ditmire T, 1996, PHYS REV A, V53, P3379, DOI 10.1103/PhysRevA.53.3379; HAGENA OF, 1987, Z PHYS D ATOM MOL CL, V4, P291, DOI 10.1007/BF01436638; KARNBACH R, 1993, REV SCI INSTRUM, V64, P2838, DOI 10.1063/1.1144371; Koller L, 1999, PHYS REV LETT, V82, P3783, DOI 10.1103/PhysRevLett.82.3783; Kostyukov IY, 2001, JETP LETT+, V73, P393, DOI 10.1134/1.1381634; Krainov VP, 2001, J PHYS B-AT MOL OPT, V34, pL297, DOI 10.1088/0953-4075/34/9/103; Last I, 1999, PHYS REV A, V60, P2215, DOI 10.1103/PhysRevA.60.2215; Last I, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.013201; Lezius M, 1998, PHYS REV LETT, V80, P261, DOI 10.1103/PhysRevLett.80.261; MATERLIK G, 2001, 200105 DESY TESLA FE; MCPHERSON A, 1994, NATURE, V370, P631, DOI 10.1038/370631a0; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; RosePetruck C, 1997, PHYS REV A, V55, P1182, DOI 10.1103/PhysRevA.55.1182; Rusek M, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.013203; SAMSON JAR, 1964, PHYS LETT, V8, P107, DOI 10.1016/0031-9163(64)90729-2; Shao YL, 1996, PHYS REV LETT, V77, P3343, DOI 10.1103/PhysRevLett.77.3343; SHENOY G, 2000, LCLS 1 EXPT; SMITH R, 2000, XRAY LASERS 2000, P383; Snyder EM, 1996, PHYS REV LETT, V77, P3347, DOI 10.1103/PhysRevLett.77.3347	29	389	395	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					482	485		10.1038/nature01197	http://dx.doi.org/10.1038/nature01197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466837				2022-12-28	WOS:000179611600039
J	Mironov, AS; Gusarov, I; Rafikov, R; Lopez, LE; Shatalin, K; Kreneva, RA; Perumov, DA; Nudler, E				Mironov, AS; Gusarov, I; Rafikov, R; Lopez, LE; Shatalin, K; Kreneva, RA; Perumov, DA; Nudler, E			Sensing small molecules by nascent RNA: A mechanism to control transcription in bacteria	CELL			English	Article							SUBTILIS RIBOFLAVIN OPERON; BACILLUS-SUBTILIS; SALMONELLA-TYPHIMURIUM; TERMINATION CONTROL; BIOSYNTHESIS GENES; MESSENGER-RNA; EXPRESSION; BOX; ANTITERMINATION; SYNTHETASE	Thiamin and riboflavin are precursors of essential coenzymes-thiamin pyrophosphate (TPP) and flavin mononucleotide (FMN)/flavin adenine dinucleotide (FAD), respectively. In Bacillus spp, genes responsible for thiamin and riboflavin biosynthesis are organized in tightly controllable operons. Here, we demonstrate that the feedback regulation of riboflavin and thiamin genes relies on a novel transcription attenuation mechanism. A unique feature of this mechanism is the formation of specific complexes between a conserved leader region of the cognate RNA and FMN or TPP. In each case, the complex allows the termination hairpin to form and interrupt transcription prematurely. Thus, sensing small molecules by nascent RNA controls transcription elongation of riboflavin and thiamin operons and possibly other bacterial operons as well.	NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA; State Res Inst Genet & Select Ind Microorganisms, Moscow 113545, Russia; Integrated Genom Inc, Chicago, IL 60612 USA; BP Konstantinov Nucl Phys Inst, Dept Mol & Radiat Biophys, St Petersburg 188350, Russia	New York University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute	Nudler, E (corresponding author), NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA.		Rafikov, Ruslan/AAG-9352-2019; Gusarov, Ivan/AAJ-6282-2020; Mironov, Alexander/G-8531-2013	Nudler, Evgeny/0000-0002-8811-3071; Mironov, Alexander/0000-0003-3914-1380; Rafikov, Ruslan/0000-0001-5950-4076	NIGMS NIH HHS [GM58750] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anthony LC, 2000, PROTEIN EXPRES PURIF, V19, P350, DOI 10.1006/prep.2000.1272; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; BRESLER SE, 1973, GENETIKA+, V9, P84; FULLER TE, 1995, J BACTERIOL, V177, P7265, DOI 10.1128/jb.177.24.7265-7270.1995; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Grundy FJ, 1998, MOL MICROBIOL, V30, P737, DOI 10.1046/j.1365-2958.1998.01105.x; Grundy FJ, 1997, J BACTERIOL, V179, P2587, DOI 10.1128/jb.179.8.2587-2594.1997; Grundy FJ, 1997, J BACTERIOL, V179, P3767, DOI 10.1128/jb.179.11.3767-3772.1997; Grundy FJ, 2002, P NATL ACAD SCI USA, V99, P11121, DOI 10.1073/pnas.162366799; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Gusarov I. I., 1997, Molekulyarnaya Biologiya (Moscow), V31, P820; Gusarov I. I., 1997, Molekulyarnaya Biologiya (Moscow), V31, P446; Henkin TM, 2000, CURR OPIN MICROBIOL, V3, P149, DOI 10.1016/S1369-5274(00)00067-9; KIL YV, 1992, MOL GEN GENET, V233, P483, DOI 10.1007/BF00265448; KRENEVA RA, 1990, MOL GEN GENET, V222, P467, DOI 10.1007/BF00633858; LANDICK R, 1996, ESCHERICHIA COLI SAL; Mack M, 1998, J BACTERIOL, V180, P950, DOI 10.1128/JB.180.4.950-955.1998; Miranda-Rios J, 2001, P NATL ACAD SCI USA, V98, P9736, DOI 10.1073/pnas.161168098; MIRONOV VN, 1990, MOL BIOL MOSK, P256; Nou XW, 2000, P NATL ACAD SCI USA, V97, P7190, DOI 10.1073/pnas.130013897; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Perkins JB, 2002, BACILLUS SUBTILIS IT, P271, DOI DOI 10.1128/9781555817992.CH20; Ravnum S, 2001, MOL MICROBIOL, V39, P1585, DOI 10.1046/j.1365-2958.2001.02346.x; Solovieva IM, 1999, MICROBIOL-SGM, V145, P67, DOI 10.1099/13500872-145-1-67; Stormo GD, 2001, P NATL ACAD SCI USA, V98, P9465, DOI 10.1073/pnas.181334498; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; van de Guchte M, 1998, MOL MICROBIOL, V29, P61, DOI 10.1046/j.1365-2958.1998.00903.x; Webb E, 1996, J BACTERIOL, V178, P2533, DOI 10.1128/jb.178.9.2533-2538.1996; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Yanofsky C, 1996, BIOCHIMIE, V78, P1017, DOI 10.1016/S0300-9084(97)86725-9; Zuker M., 1999, V70, P11	32	496	531	1	66	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 27	2002	111	5					747	756		10.1016/S0092-8674(02)01134-0	http://dx.doi.org/10.1016/S0092-8674(02)01134-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464185	Bronze			2022-12-28	WOS:000179594500015
J	Pearson, H				Pearson, H			Stem cells - Articles of faith adulterated	NATURE			English	Editorial Material							BONE-MARROW; BRAIN											Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	14	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					734	735		10.1038/420734a	http://dx.doi.org/10.1038/420734a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490909				2022-12-28	WOS:000179897300018
J	Prandoni, P; Lensing, AWA; Prins, MH; Bernardi, E; Marchiori, A; Bagatella, P; Frulla, M; Mosena, L; Tormene, D; Piccioli, A; Simioni, P; Girolami, A				Prandoni, P; Lensing, AWA; Prins, MH; Bernardi, E; Marchiori, A; Bagatella, P; Frulla, M; Mosena, L; Tormene, D; Piccioli, A; Simioni, P; Girolami, A			Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; ORAL ANTICOAGULANT-THERAPY; 1ST EPISODE; COMPRESSION ULTRASONOGRAPHY; IMPEDANCE PLETHYSMOGRAPHY; RISK; COMPLICATIONS; PROTHROMBIN; MANAGEMENT; DURATION	Background: The optimum duration of anticoagulant therapy after an episode of deep venous thrombosis (DVT) is controversial. Contributing to the controversy is uncertainty about whether residual venous thrombosis, as assessed by repeated ultrasonography over time, increases the risk for recurrent thromboembolism. Objective: To determine the risk for recurrent thromboembolism in patients who have persistent residual thrombosis compared with patients who have early vein recanalization. Design: Prospective cohort study. Setting: A university hospital in Padua, Italy. Patients: 313 consecutive symptomatic outpatients with proximal DVT who received conventional short-term anticoagulation. Measurements: Ultrasonographic assessment of the common femoral and popliteal veins was performed 3 months after acute DVT in all patients and at 6, 12, 24, and 36 months in patients found to have residual venous thrombosis. Veins were considered recanalized if they were 2.0 mm or less in diameter on a single test or 3.0 mm or less in diameter on two consecutive tests. Recurrent thromboembolism was assessed during a 6-year period. Results: The cumulative incidence of normal results on ultrasonography was 38.8% at 6 months, 58.1% at 12 months, 69.3% at 24 months, and 73.8% at 36 months. Of 58 recurrent episodes, 41 occurred while the patient had residual thrombosis. The hazard ratio for recurrent thromboembolism was 2.4 (95% Cl, 1.3 to 4.4; P = 0.004) for patients with persistent residual thrombosis versus those with early vein recanalization. Conclusions: Residual venous thrombosis is an important risk factor for recurrent thromboembolism. Ultrasonographic assessment of residual venous thrombosis may help clinicians modify the duration of anticoagulation in patients with DVT.	Univ Hosp Padua, Padua, Italy; Univ Amsterdam, NL-1012 WX Amsterdam, Netherlands; Maastricht Univ, Maastricht, Netherlands	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Amsterdam; Maastricht University	Prandoni, P (corresponding author), Univ Padua, Dept Med & Surg Sci, Via Osped Civile 105, I-35128 Padua, Italy.	paoprand@tin.it	Simioni, Paolo/AAC-5416-2022; SIMIONI, PAOLO/AAC-5438-2022	SIMIONI, PAOLO/0000-0002-6744-383X				Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Bolard P, 2001, J CLIN EPIDEMIOL, V54, P986, DOI 10.1016/S0895-4356(01)00363-8; Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566; Ginsberg JS, 1996, NEW ENGL J MED, V335, P1816, DOI 10.1056/NEJM199612123352407; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; HEIJBOER H, 1992, ACTA RADIOL, V33, P297; HUISMAN MV, 1988, ARCH INTERN MED, V148, P681, DOI 10.1001/archinte.148.3.681; HULL RD, 1984, JAMA-J AM MED ASSOC, V252, P235, DOI 10.1001/jama.252.2.235; Hyers TM, 2001, CHEST, V119, p176S, DOI 10.1378/chest.119.1_suppl.176S; JAY R, 1984, THROMB RES, V36, P259, DOI 10.1016/0049-3848(84)90225-1; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; LENSING AWA, 2000, HEMOSTASIS THROMBOSI, P1277; LEVINE MN, 1995, THROMB HAEMOSTASIS, V74, P606; Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S; Miles JS, 2001, J AM COLL CARDIOL, V37, P215, DOI 10.1016/S0735-1097(00)01080-9; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Pinede L, 2001, CIRCULATION, V103, P2453; Piovella F, 2002, HAEMATOLOGICA, V87, P515; PRANDONI P, 1993, CIRCULATION, V88, P1730, DOI 10.1161/01.CIR.88.4.1730; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Prins MH, 2002, THROMB HAEMOSTASIS, V87, P1; RIDKER PM, 1995, CIRCULATION, V92, P2800, DOI 10.1161/01.CIR.92.10.2800; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Simioni P, 2000, BLOOD, V96, P3329; VANBEEK EJ, 2000, HEMOSTASIS THROMBOSI, P1303; vandenBelt AGM, 1997, ARCH INTERN MED, V157, P2227, DOI 10.1001/archinte.157.19.2227; VANRAMSHORST B, 1992, CIRCULATION, V86, P414, DOI 10.1161/01.CIR.86.2.414; Vollmer RT, 1996, AM J CLIN PATHOL, V106, P522; White RH, 1999, AM J MED, V107, P414, DOI 10.1016/S0002-9343(99)00267-3	33	390	403	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2002	137	12					955	960		10.7326/0003-4819-137-12-200212170-00008	http://dx.doi.org/10.7326/0003-4819-137-12-200212170-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626DR	12484710				2022-12-28	WOS:000179857500003
J	Sharp, D				Sharp, D			Cholera and climate - the evidence grows	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Patz JA, 2002, P NATL ACAD SCI USA, V99, P12506, DOI 10.1073/pnas.212467899; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999	4	0	0	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1902	1902		10.1016/S0140-6736(02)11937-4	http://dx.doi.org/10.1016/S0140-6736(02)11937-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493254				2022-12-28	WOS:000179870200006
J	Panda, S; Sato, TK; Castrucci, AM; Rollag, MD; DeGrip, WJ; Hogenesch, JB; Provencio, I; Kay, SA				Panda, S; Sato, TK; Castrucci, AM; Rollag, MD; DeGrip, WJ; Hogenesch, JB; Provencio, I; Kay, SA			Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting	SCIENCE			English	Article							RETINOHYPOTHALAMIC TRACT; OCULAR PHOTORECEPTION; CRYPTOCHROMES; ENTRAINMENT; RHYTHMS; BLIND; MOUSE; CELLS; NIGHT; OPSIN	The master circadian oscillator in the hypothalamic suprachiasmatic nucleus is entrained to the day/night cycle by retinal photoreceptors. Melanopsin (Opn4), an opsin-based photopigment, is a primary candidate for photoreceptor-mediated entrainment. To investigate the functional role of melanopsin in light resetting of the oscillator, we generated melanopsin-null mice (Opn4(-/-)). These mice entrain to a light/dark cycle and do not exhibit any overt defect in circadian activity rhythms under constant darkness. However, they display severely attenuated phase resetting in response to brief pulses of monochromatic light, highlighting the critical role of melanopsin in circadian photoentrainment in mammals.	Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Sao Paulo, Dept Physiol, BR-05422 Sao Paulo, Brazil; Univ Nijmegen, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	Uniformed Services University of the Health Sciences - USA; Novartis; Scripps Research Institute; Universidade de Sao Paulo; Radboud University Nijmegen	Provencio, I (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.		de Grip, W.J./L-4335-2015; Kay, Steve A/F-6025-2011; Panda, Satchidananda/J-6891-2012; Jansen, Heiko T./A-5770-2008; Castrucci, Ana Maria L/C-3296-2014	Kay, Steve A/0000-0002-0402-2878; Jansen, Heiko T./0000-0003-0178-396X; Castrucci, Ana Maria/0000-0002-2065-8198	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062405, R01MH051573] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51573, MH 62405] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hannibal J, 2001, J BIOL RHYTHM, V16, P457, DOI 10.1177/074873001129002132; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; Nielsen HS, 2001, NEUROSCIENCE, V103, P433, DOI 10.1016/S0306-4522(00)00563-7; PICKARD GE, 1994, NEUROREPORT, V5, P2186, DOI 10.1097/00001756-199410270-00049; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Yanovsky MJ, 2000, CURR BIOL, V10, P1013, DOI 10.1016/S0960-9822(00)00651-5	24	607	627	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2213	2216		10.1126/science.1076848	http://dx.doi.org/10.1126/science.1076848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481141				2022-12-28	WOS:000179773700055
J	Ruby, NF; Brennan, TJ; Xie, XM; Cao, V; Franken, P; Heller, HC; O'Hara, BF				Ruby, NF; Brennan, TJ; Xie, XM; Cao, V; Franken, P; Heller, HC; O'Hara, BF			Role of melanopsin in circadian responses to light	SCIENCE			English	Article							RETINAL GANGLION-CELLS; OCULAR PHOTORECEPTION; MICE; CRYPTOCHROMES; PROJECTIONS; EXPRESSION; MELATONIN; SYSTEM; BLIND	Melanopsin has been proposed as an important photoreceptive molecule for the mammalian circadian system. Its importance in this role was tested in melanopsin knockout mice. These mice entrained to a light/dark cycle, phase-shifted after a light pulse, and increased circadian period when light intensity increased. Induction of the immediate-early gene c-fos was observed after a nighttime light pulse in both wild-type and knockout mice. However, the magnitude of these behavioral responses in knockout mice was 40% lower than in wild-type mice. Although melanopsin is not essential for the circadian clock to receive photic input, it contributes significantly to the magnitude of photic responses.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Deltagen Inc, Redwood City, CA 94063 USA	Stanford University	Ruby, NF (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	ruby@stanford.edu; bfo@stanford.edu	Franken, Paul/A-9633-2018; Heller, H. Craig/C-9785-2011	Franken, Paul/0000-0002-2500-2921; Xie, Xinmin Simon/0000-0002-4049-6499; Heller, H Craig/0000-0003-4479-5880	NHLBI NIH HHS [HL64148] Funding Source: Medline; NIDA NIH HHS [DA13349] Funding Source: Medline; NIMH NIH HHS [MH60385] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013349] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Lucas RJ, 1999, J BIOL RHYTHM, V14, P4, DOI 10.1177/074873099129000380; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Ruby NF, 1998, J BIOL RHYTHM, V13, P506, DOI 10.1177/074873098129000336; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; SUTIN EL, 1992, MOL BRAIN RES, V15, P281, DOI 10.1016/0169-328X(92)90119-V; Thompson CL, 2001, P NATL ACAD SCI USA, V98, P11708, DOI 10.1073/pnas.201301498; UNDERWOOD H, 1990, EXPERIENTIA, V46, P120, DOI 10.1007/BF01955437; Van den Pol AN, 1998, AM J PHYSIOL-REG I, V275, pR654, DOI 10.1152/ajpregu.1998.275.2.R654; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; YOSHIMURA T, 1994, J BIOL RHYTHM, V9, P51, DOI 10.1177/074873049400900105	26	477	493	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2211	2213		10.1126/science.1076701	http://dx.doi.org/10.1126/science.1076701			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481140				2022-12-28	WOS:000179773700054
J	Richardson, CR; Resnick, PJ; Hansen, DL; Derry, HA; Rideout, VJ				Richardson, CR; Resnick, PJ; Hansen, DL; Derry, HA; Rideout, VJ			Does pornography-blocking software block access to health information on the Internet?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context The Internet has become an important tool for finding health information, especially among adolescents. Many computers have software designed to block access to Internet pornography. Because pornography-blocking software cannot perfectly discriminate between pornographic and nonpornographic Web sites, such products may block access to health information sites, particularly those related to sexuality. Objective To quantify the extent to which pornography-blocking software used in schools and libraries limits access to health information Web sites. Design and Setting In a simulation of adolescent Internet searching, we compiled search results from 24 health information searches (n=3206) and 6 pornography searches (n=781). We then classified the content of each site as either health information (n=2467), pornography (n=516); or other (n=1004). We also compiled a list of top teen health information sites (n=586). We then tested 6 blocking products commonly used in schools and libraries and 1 blocking product used on home computers, each at 2 or 3 levels of blocking restrictiveness. Main Outcome Measure Rates of health information and pornography blocking. Results At the least restrictive blocking setting, configured to block only pornography, the products blocked a mean of only 1.4% of health information sites. The differences between blocking products was small (range, 0.6%-2.3%). However, about 10% of health sites found using some search terms related to sexuality (eg, safe sex, condoms) and homosexuality (eg, gay) were blocked. The mean pornography blocking rate was 87% (range, 84%-90%): At moderate settings, the mean blocking rate was 5% for health information and 90% for pornography. At the most restrictive settings, health information blocking increased substantially (24%), but pornography blocking was,only slightly higher (91%). Conclusions Blocking settings have a greater impact than choice of blocking product on frequency of health information blocking. At their least restrictive settings, over-blocking of general health information poses a relatively minor impediment. However, searches on some terms related to sexuality led to substantially more health information blocking. More restrictive blocking configurations blocked pornography only slightly more, but substantially increased blocking of health information sites.	Univ Michigan, Sch Med, Dept Family Med, Vet Affairs Hlth Serv Res & Dev Serv, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA; Univ Michigan, Hlth Media Res Lab, Ann Arbor, MI 48109 USA; Henry J Kaiser Family Fdn, Menlo Pk, CA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Richardson, CR (corresponding author), Univ Michigan, Sch Med, Dept Family Med, Vet Affairs Hlth Serv Res & Dev Serv, 1018 Fuller St, Ann Arbor, MI 48109 USA.		Hansen, Derek/X-4483-2019; Richardson, Caroline R/A-9237-2009	Hansen, Derek/0000-0002-9645-3279; Richardson, Caroline/0000-0002-1945-6046; Resnick, Paul J./0000-0001-8368-0600				Brunessaux S., 2001, REPORT CURRENTLY AVA; CATTAGNI A, 2001, INTERNET ACCESS US P, P20; CURRY A, 2001, SCH LIB J, V1, P42; FOX S, 2000, ONLINE HLTH CARE REV, P23; GREENFIELD P, 2001, EFFECTIVENESS INTERN, P90; *J KAIS FAM FDN, 2001, GEN RX COM SURV; Jansen BJ, 2000, INFORM PROCESS MANAG, V36, P207, DOI 10.1016/S0306-4573(99)00056-4; Oder N, 2002, LIBR J, V127, P55; RESNICK P, 1997, SCI AM, V273, P106; RIDEOUT V, 2001, RX COM YOUNG PEOPLE, P37; *STAT CORP, 2001, STAT STAT SOFTW REL; THORNBURGH D, 2002, YOUTH PORNOGRAPHY IN; *US DEP JUST, 2001, WEB CONT FILT SOFTW, P18	13	35	36	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2887	2894		10.1001/jama.288.22.2887	http://dx.doi.org/10.1001/jama.288.22.2887			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	623YM	12472332	Bronze			2022-12-28	WOS:000179732600035
J	Aristegui, J; Duarte, CM; Agusti, S; Doval, M; Alvarez-Salgado, XA; Hansell, DA				Aristegui, J; Duarte, CM; Agusti, S; Doval, M; Alvarez-Salgado, XA; Hansell, DA			Dissolved organic carbon support of respiration in the dark ocean	SCIENCE			English	Article							FLUX		Univ Las Palmas Gran Canaria, Fac Ciencias Mar, Las Palmas Gran Canaria 35017, Spain; UIB, CSIC, IMEDEA, Inst Mediterraneo Estudios Avanzados, Esporles 07190, Oslas Baleares, Spain; CCCMM XUGA, Vilagarcia De Arousa, Spain; CSIC, IIM, Vigo 36208, Spain; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	Universidad de Las Palmas de Gran Canaria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Miami	Aristegui, J (corresponding author), Univ Las Palmas Gran Canaria, Fac Ciencias Mar, Campus Univ Tafira, Las Palmas Gran Canaria 35017, Spain.		Duarte Quesada, Carlos Manuel/ABD-6208-2021; Duarte, Carlos M/A-7670-2013; Alvarez-Salgado, Xose Anton/A-8365-2012; Agusti, Susana/G-2864-2017; Arístegui, Javier/D-5833-2013; Hansell, Dennis A./AAC-1271-2019; Agusti, Susana/H-8421-2012	Duarte, Carlos M/0000-0002-1213-1361; Alvarez-Salgado, Xose Anton/0000-0002-2387-9201; Agusti, Susana/0000-0003-0536-7293; Arístegui, Javier/0000-0002-7526-7741; Hansell, Dennis A./0000-0001-9275-3445; Doval, Marylo/0000-0002-8565-8703				Alvarez-Salgado XA, 2001, SCI MAR, V65, P1; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; Doval MD, 2000, MAR CHEM, V68, P249, DOI 10.1016/S0304-4203(99)00081-X; Hansell D.A., 2002, BIOGEOCHEMISTRY MARI, P685716, DOI [10.1016/B978-012323841-2/50017-8, DOI 10.1016/B978-012323841-2/50017-8]; Hansell DA, 1998, GLOBAL BIOGEOCHEM CY, V12, P443, DOI 10.1029/98GB01928; Hansell DA, 1998, NATURE, V395, P263, DOI 10.1038/26200; Jahnke RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P71, DOI 10.1029/95GB03525; PELTZER ET, 1996, DEEP SEA RES 2, V43, P155; SCHOLTEN JC, 2001, DEEP SEA RES 2, V48, P243	10	100	102	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1967	1967		10.1126/science.1076746	http://dx.doi.org/10.1126/science.1076746			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471250	Green Submitted			2022-12-28	WOS:000179629200037
J	Shapiro, L; McAdams, HH; Losick, R				Shapiro, L; McAdams, HH; Losick, R			Generating and exploiting polarity in bacteria	SCIENCE			English	Review							CELL-SPECIFIC TRANSCRIPTION; BACILLUS-SUBTILIS SPORULATION; ACTIN-BASED MOTILITY; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; PSEUDOMONAS-AERUGINOSA; UNIPOLAR LOCALIZATION; DYNAMIC LOCALIZATION; ASYMMETRIC DIVISION; RESPONSE REGULATOR	Bacteria are often highly polarized, exhibiting specialized structures at or near the ends of the cell. Among such structures are actin-organizing centers, which mediate the movement of certain pathogenic bacteria within the cytoplasm of an animal host cell; organized arrays of membrane receptors, which govern chemosensory behavior in swimming bacteria; and asymmetrically positioned septa, which generate specialized progeny in differentiating bacteria. This polarization is orchestrated by complex and dynamic changes in the subcellular localization of signal transduction and cytoskeleton proteins as well as of specific regions of the chromosome. Recent work has provided information on how dynamic subcellular localization occurs and how it is exploited by the bacterial cell.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Stanford University; Harvard University	Shapiro, L (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, B300 Beckman Ctr, Stanford, CA 94305 USA.				NIGMS NIH HHS [GM32506, GM18568, GM51426] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018568, R37GM032506, R01GM018568, R01GM032506] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x; ALLEY MC, COMMUNICATION; ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; ARIGONI F, 1995, SCIENCE, V270, P637, DOI 10.1126/science.270.5236.637; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Boyd JM, 2000, MOL MICROBIOL, V36, P153, DOI 10.1046/j.1365-2958.2000.01836.x; Charles M, 2001, P NATL ACAD SCI USA, V98, P9871, DOI 10.1073/pnas.171310498; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; DORMIAN IJ, 1997, CELL, V90, P415; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; Dworkin J, 2001, CELL, V107, P339, DOI 10.1016/S0092-8674(01)00528-1; Egile C, 1997, MOL MICROBIOL, V23, P1063, DOI 10.1046/j.1365-2958.1997.2871652.x; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; Feucht A, 1996, GENE DEV, V10, P794, DOI 10.1101/gad.10.7.794; Feucht A, 1999, MOL MICROBIOL, V33, P1015, DOI 10.1046/j.1365-2958.1999.01543.x; Frandsen N, 1999, GENE DEV, V13, P394, DOI 10.1101/gad.13.4.394; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; GOLDBERG MB, 1993, J BACTERIOL, V175, P2189, DOI 10.1128/JB.175.8.2189-2196.1993; Gordon GS, 2000, ANNU REV MICROBIOL, V54, P681, DOI 10.1146/annurev.micro.54.1.681; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Howard M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278102; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998; Jenal U, 2000, FEMS MICROBIOL REV, V24, P177, DOI 10.1111/j.1574-6976.2000.tb00538.x; Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Khvorova A, 2000, J BACTERIOL, V182, P4425, DOI 10.1128/JB.182.16.4425-4429.2000; King N, 1999, GENE DEV, V13, P1156, DOI 10.1101/gad.13.9.1156; KOCKS C, 1993, J CELL SCI, V105, P699; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; LOH JT, 1993, P NATL ACAD SCI USA, V90, P3033, DOI 10.1073/pnas.90.7.3033; MADDOCK JR, 1993, SCIENCE, V259, P1717; Maki N, 2000, J BACTERIOL, V182, P4337, DOI 10.1128/JB.182.15.4337-4342.2000; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; Shere KD, 1997, MOL MICROBIOL, V25, P451, DOI 10.1046/j.1365-2958.1997.4681827.x; Shimizu TS, 2000, NAT CELL BIOL, V2, P792, DOI 10.1038/35041030; SMITH GA, 1995, MOL MICROBIOL, V17, P945, DOI 10.1111/j.1365-2958.1995.mmi_17050945.x; TRUEBA FJ, 1982, ARCH MICROBIOL, V131, P55, DOI 10.1007/BF00451499; VANOOIJ C, IN PRESS J BACTERIOL; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; WOLDRINGH CL, 1991, RES MICROBIOL, V142, P309, DOI 10.1016/0923-2508(91)90046-D; Wolgemuth C, 2002, CURR BIOL, V12, P369, DOI 10.1016/S0960-9822(02)00716-9; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; ZOUTMAN DE, 1991, SCANNING MICROSCOPY, V5, P109; Zupancic ML, 2001, MOL MICROBIOL, V39, P1471, DOI 10.1046/j.1365-2958.2001.02331.x	56	195	198	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1942	1946		10.1126/science.1072163	http://dx.doi.org/10.1126/science.1072163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471245				2022-12-28	WOS:000179629200032
J	Alben, S; Shelley, M; Zhang, J				Alben, S; Shelley, M; Zhang, J			Drag reduction through self-similar bending of a flexible body	NATURE			English	Article							SOAP FILMS; TURBULENCE; ORGANISMS; DYNAMICS; LAMINAR; WATER; FLOWS; WIND	The classical theory of high-speed flow(1) predicts that a moving rigid object experiences a drag proportional to the square of its speed. However, this reasoning does not apply if the object in the flow is flexible, because its shape then becomes a function of its speed-for example, the rolling up of broad tree leaves in a stiff wind(2). The reconfiguration of bodies by fluid forces is common in nature, and can result in a substantial drag reduction that is beneficial for many organisms(3,4). Experimental studies of such flow-structure interactions(5) generally lack a theoretical interpretation that unifies the body and flow mechanics. Here we use a flexible fibre immersed in a flowing soap film to measure the drag reduction that arises from bending of the fibre by the flow. Using a model that couples hydrodynamics to bending, we predict a reduced drag growth compared to the classical theory. The fibre undergoes a bending transition, producing shapes that are self-similar; for such configurations, the drag scales with the length of self-similarity, rather than the fibre profile width. These predictions are supported by our experimental data.	NYU, Courant Inst Math Sci, Appl Math Lab, New York, NY 10012 USA; NYU, Dept Phys, New York, NY 10003 USA	New York University; New York University	Shelley, M (corresponding author), NYU, Courant Inst Math Sci, Appl Math Lab, 251 Mercer St, New York, NY 10012 USA.			Alben, Silas/0000-0002-8020-4999; Shelley, Michael/0000-0002-4835-0339				Batchelor G.K., 2000, INTRO FLUID DYNAMICS; Birkhoff G., 1957, JETS WAKES CAVITIES; COUDER Y, 1989, PHYSICA D, V37, P384, DOI 10.1016/0167-2789(89)90144-9; DENNY MW, 1994, J EXP BIOL, V194, P97; DUGAN JP, 1970, J FLUID MECH, V42, P433, DOI 10.1017/S0022112070001398; GHARIB M, 1989, PHYSICA D, V37, P406, DOI 10.1016/0167-2789(89)90145-0; Goldburg WI, 1997, PHYSICA A, V239, P340, DOI 10.1016/S0378-4371(97)00029-0; GOLDSTEIN RE, 1995, PHYS REV LETT, V75, P1094, DOI 10.1103/PhysRevLett.75.1094; Helmholtz H. L., 1868, PHILOS MAG, V36, P337, DOI [10.1080/14786446808640073, DOI 10.1080/14786446808640073]; Hureau J, 1996, J COMPUT APPL MATH, V72, P193, DOI 10.1016/0377-0427(95)00272-3; KOEHL MAR, 1984, AM ZOOL, V24, P57; Rivera M, 2000, PHYS REV LETT, V85, P976, DOI 10.1103/PhysRevLett.85.976; Rivera M, 1998, PHYS REV LETT, V81, P1417, DOI 10.1103/PhysRevLett.81.1417; Rutgers MA, 2001, REV SCI INSTRUM, V72, P3025, DOI 10.1063/1.1379956; Segel LA, 1977, MATH APPL CONTINUUM; SMITH FT, 1979, J FLUID MECH, V92, P171, DOI 10.1017/S0022112079000574; VOGEL S, 1989, J EXP BOT, V40, P941, DOI 10.1093/jxb/40.8.941; Vogel S, 1994, LIFE MOVING FLUIDS; WU TY, 1972, ANNU REV FLUID MECH, V4, P243, DOI 10.1146/annurev.fl.04.010172.001331; Zhang J, 2000, NATURE, V408, P835, DOI 10.1038/35048530	20	184	188	12	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					479	481		10.1038/nature01232	http://dx.doi.org/10.1038/nature01232			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466836				2022-12-28	WOS:000179611600038
J	Reymond, A; Marigo, V; Yaylaoglu, MB; Leoni, A; Ucla, C; Scamuffa, N; Cacciopoli, C; Dermitzakis, ET; Lyle, R; Banfi, S; Eichele, G; Antonarakis, SE; Ballabio, A				Reymond, A; Marigo, V; Yaylaoglu, MB; Leoni, A; Ucla, C; Scamuffa, N; Cacciopoli, C; Dermitzakis, ET; Lyle, R; Banfi, S; Eichele, G; Antonarakis, SE; Ballabio, A			Human chromosome 21 gene expression atlas in the mouse	NATURE			English	Article							HUMAN-CHROMOSOME-21; MAP; VI; MUTATIONS; SEQUENCE; DISEASE; REGION; DNA	Genome-wide expression analyses have a crucial role in functional genomics. High resolution methods, such as RNA in situ hybridization provide an accurate description of the spatiotemporal distribution of transcripts as well as a three-dimensional 'in vivo' gene expression overview(1-5). We set out to analyse systematically the expression patterns of genes from an entire chromosome. We chose human chromosome 21 because of the medical relevance of trisomy 21 (Down's syndrome)(6). Here we show the expression analysis of all identifiable murine orthologues of human chromosome 21 genes (161 out of 178 confirmed human genes) by RNA in situ hybridization on whole mounts and tissue sections, and by polymerase chain reaction with reverse transcription on adult tissues. We observed patterned expression in several tissues including those affected in trisomy 21 phenotypes (that is, central nervous system, heart, gastrointestinal tract, and limbs). Furthermore, statistical analysis suggests the presence of some regions of the chromosome with genes showing either lack of expression or, to a lesser extent, co-expression in either lack of expression or, to a lesser extent, co-expression in specific tissues. This high resolution expression 'atlas' of an entire human chromosome is an important step towards the understanding of gene function and of the pathogenetic mechanisms in Down's syndrome.	Telethon Inst Genet & Med, I-80131 Naples, Italy; Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, CMU, CH-1211 Geneva, Switzerland; Max Planck Inst Expt Endocrinol, D-30625 Hannover, Germany; Univ Naples 2, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Geneva; University of Geneva; Max Planck Society; Universita della Campania Vanvitelli	Eichele, G (corresponding author), Telethon Inst Genet & Med, Via Pietro Castellino 111, I-80131 Naples, Italy.		Kutalik, Zoltan/HHZ-5697-2022; BALLABIO, Andrea/AAL-2672-2020; Banfi, Sandro/K-3963-2018; Marigo, Valeria/B-7947-2015; Dermitzakis, Emmanouil/B-7687-2013; Antonarakis, Stylianos E/N-8866-2014	Kutalik, Zoltan/0000-0001-8285-7523; BALLABIO, Andrea/0000-0003-1381-4604; Banfi, Sandro/0000-0002-6541-8833; Marigo, Valeria/0000-0002-4428-2084; Antonarakis, Stylianos E/0000-0001-8907-5823; Reymond, Alexandre/0000-0003-1030-8327	Telethon [TGM06S01, TGM00S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; BALLABIO A, 1993, NAT GENET, V3, P277, DOI 10.1038/ng0493-277; Barlow GM, 2001, GENET MED, V3, P91, DOI 10.1097/00125817-200103000-00002; Bortoluzzi S, 1998, GENOME RES, V8, P817, DOI 10.1101/gr.8.8.817; Bulfone A, 1998, HUM MOL GENET, V7, P1997, DOI 10.1093/hmg/7.13.1997; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Davisson MT, 2001, GENOMICS, V78, P99, DOI 10.1006/geno.2001.6639; Egeo A, 2000, MECH DEVELOP, V90, P313, DOI 10.1016/S0925-4773(99)00253-1; Epstein C.J., 1995, METABOLIC MOL BASES, P749; Gawantka V, 1998, MECH DEVELOP, V77, P95, DOI 10.1016/S0925-4773(98)00115-4; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Herzig U, 2001, NOVART FDN SYMP, V239, P129; Higuchi I, 2001, ANN NEUROL, V50, P261, DOI 10.1002/ana.1120; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; LERCHER MJ, 2002, NAT GENET, V6, P6; Neidhardt L, 2000, MECH DEVELOP, V98, P77, DOI 10.1016/S0925-4773(00)00453-6; Pletcher MT, 2001, GENOMICS, V74, P45, DOI 10.1006/geno.2001.6533; Reymond A, 2002, GENOMICS, V79, P824, DOI 10.1006/geno.2002.6781; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Reymond A, 2001, GENOMICS, V78, P46, DOI 10.1006/geno.2001.6640; Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Strachan T, 1997, NAT GENET, V16, P126, DOI 10.1038/ng0697-126; Sumarsono SH, 1996, NATURE, V379, P534, DOI 10.1038/379534a0; Tang H, 1999, GENETICS, V153, P485; Vanegas OC, 2001, P NATL ACAD SCI USA, V98, P7516	27	177	182	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					582	586		10.1038/nature01178	http://dx.doi.org/10.1038/nature01178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466854	Green Published, Bronze			2022-12-28	WOS:000179611600057
J	Prendergast, TJ; Puntillo, KA				Prendergast, TJ; Puntillo, KA			Withdrawal of life support - Intensive caring at the end of life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE-UNIT PATIENTS; SUSTAINING TREATMENT; ADVANCE DIRECTIVES; MECHANICAL VENTILATION; MEDICAL FUTILITY; DECISION-MAKING; FAMILY-MEMBERS; DYING PATIENTS; ILL PATIENTS; IMPACT	The technology and expertise of critical care practice support patients through life-threatehing illnesses. Most recover; some die quickly; others, however, linger-neither improving nor acutely dying, alive but with a dwindling capacity to recover from their injury or illness. Management of these patients is often dominated by the question: Is it appropriate to continue life-sustaining therapy? Patients rarely participate in these pivotal discussions because they are either too sick or too heavily sedated. As a result, the decision often falls to the family or the surrogate decision maker, in consultation with the medical team. Decisions of such import are emotionally stressful and are often a source of disagreement. Failure to resolve such disagreements may create conflict that compromises patient care, engenders guilt among family members, and creates dissatisfaction for health care professionals. However, the potential for strained communications is mitigated if clinicians provide timely clinical and prognostic information and support the patient and family with aggressive symptom control, a comfortable setting,and continuous psychosocial support. Effective communication includes sharing the burden of decision making with family members. This shift from individual responsibility to patient-focused consensus often permits the family to understand, perhaps reluctantly and with great sadness, that intensive caring may involve letting go of life-sustaining interventions.	Dartmouth Hitchcock Med Ctr, Dept Med, Sect Pulm & Crit Care Med 3D, Lebanon, NH 03756 USA; Dartmouth Hitchcock Med Ctr, Dept Anesthesiol, Lebanon, NH 03766 USA; Univ Calif San Francisco, Sch Nursing, Dept Physiol Nursing, San Francisco, CA 94143 USA	Dartmouth College; Dartmouth College; University of California System; University of California San Francisco	Prendergast, TJ (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Med, Sect Pulm & Crit Care Med 3D, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	thomas.j.prendergast@hitchcock.org						Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; *AM ASS COLL NURS, PEAC DEATH REC COMP; *AM NURS ASS, PROM COMF REL PAIN D; [Anonymous], 1990, CRIT CARE MED, V18, P1435; Asch DA, 1999, AM J MED, V107, P153, DOI 10.1016/S0002-9343(99)00198-9; Asch DA, 1996, MED CARE, V34, P103, DOI 10.1097/00005650-199602000-00002; ASCH DA, 1995, AM J RESP CRIT CARE, V151, P288, DOI 10.1164/ajrccm.151.2.7842181; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Azoulay E, 2002, AM J RESP CRIT CARE, V165, P438, DOI 10.1164/ajrccm.165.4.200108-006oc; BAGGS JG, 1993, NURS OUTLOOK, V41, P108; BONE RC, 1990, CHEST, V97, P949, DOI 10.1378/chest.97.4.949; Brody H, 1997, NEW ENGL J MED, V336, P652, DOI 10.1056/NEJM199702273360910; Campbell ML, 1999, CRIT CARE MED, V27, P73, DOI 10.1097/00003246-199901000-00029; CHRISTAKIS NA, 1995, J GEN INTERN MED, V10, P491, DOI 10.1007/BF02602399; Claessens MT, 2000, J AM GERIATR SOC, V48, pS146, DOI 10.1111/j.1532-5415.2000.tb03124.x; CLARKE DE, 1993, CHEST, V104, P1322, DOI 10.1378/chest.104.5.1322; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; Cook DJ, 1999, CAN MED ASSOC J, V161, P1109; Cook DJ, 2001, MANAGING DEATH ICU, P59; Covinsky KE, 2000, J AM GERIATR SOC, V48, pS187, DOI 10.1111/j.1532-5415.2000.tb03131.x; Danis M, 1996, CRIT CARE MED, V24, P1811, DOI 10.1097/00003246-199611000-00009; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; Desbiens NA, 1996, CRIT CARE MED, V24, P1953, DOI 10.1097/00003246-199612000-00005; Desbiens NA, 1999, J PAIN SYMPTOM MANAG, V17, P248, DOI 10.1016/S0885-3924(98)00149-3; Drought TS, 1996, CHEST, V110, P589, DOI 10.1378/chest.110.3.589; Ellershaw J, 2001, J PAIN SYMPTOM MANAG, V21, P12, DOI 10.1016/S0885-3924(00)00240-2; Faber-Langendoen K, 2000, ANN INTERN MED, V133, P886, DOI 10.7326/0003-4819-133-11-200012050-00013; FaberLangendoen K, 1996, ARCH INTERN MED, V156, P2130, DOI 10.1001/archinte.156.18.2130; FABERLANGENDOEN K, 1994, CHEST, V106, P880, DOI 10.1378/chest.106.3.880; Fisher R, 1991, GETTING YES; Foley KM, 2001, MANAGING DEATH INTEN, p[103, 127]; GIANAKOS D, 1995, CHEST, V108, P1405, DOI 10.1378/chest.108.5.1405; GILLIGAN T, 1995, CHEST, V108, P1407, DOI 10.1378/chest.108.5.1407; Goodman MD, 1998, CRIT CARE MED, V26, P701, DOI 10.1097/00003246-199804000-00018; Goold, 2000, JAMA, V283, P3199; Halevy A, 1996, JAMA-J AM MED ASSOC, V276, P571, DOI 10.1001/jama.276.7.571; Hall RI, 2000, CHEST, V118, P1424, DOI 10.1378/chest.118.5.1424; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; Hansot E, 1996, ANN INTERN MED, V125, P149, DOI 10.7326/0003-4819-125-2-199607150-00016; HARPER R, 1991, PRESENCE VARIATIONS, P132; Harvey M A, 1996, Am J Crit Care, V5, P7; *HAST CTR, 1987, GUID TERM LIF SUST T; Huang ZB, 2000, CLIN GERIATR MED, V16, P313, DOI 10.1016/S0749-0690(05)70058-6; Kaplow R, 2000, Am J Crit Care, V9, P87; KAPP MB, 2001, MANAGING DEATH INTEN, P231; Keenan SP, 2000, J PALLIAT CARE, V16, pS40, DOI 10.1177/082585970001601S08; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KOLLEF MH, 2001, MANAGING DEATH ICU, P39; Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009; LANKEN PN, 1991, AM REV RESPIR DIS, V144, P726, DOI 10.1164/ajrccm/144.3_Pt_1.726; Lilly CM, 2000, AM J MED, V109, P469, DOI 10.1016/S0002-9343(00)00524-6; Luce JM, 2000, AM J RESP CRIT CARE, V162, P2029, DOI 10.1164/ajrccm.162.6.1-00; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; Lynn J, 1997, New Horiz, V5, P56; McLean RF, 2000, CRIT CARE MED, V28, P100, DOI 10.1097/00003246-200001000-00016; Miles S., 2001, MANAGING DEATH INTEN, P207; MILLER DK, 1992, J GEN INTERN MED, V7, P475, DOI 10.1007/BF02599446; MURPHY DJ, 1990, JAMA-J AM MED ASSOC, V264, P2103, DOI 10.1001/jama.264.16.2103; Nelson HK, 2001, WILDLIFE SOC B, V29, P2; Nelson JE, 2001, CRIT CARE MED, V29, P277, DOI 10.1097/00003246-200102000-00010; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2229; Plows CW, 1999, JAMA-J AM MED ASSOC, V281, P937; POHLMAN AS, 1994, CRIT CARE MED, V22, P1241, DOI 10.1097/00003246-199408000-00007; Prendergast T J, 1997, New Horiz, V5, P62; Prendergast T. J, 2002, PRINCIPLES PRACTICE; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Prendergast TJ, 2001, CRIT CARE MED, V29, pN34, DOI 10.1097/00003246-200102001-00007; PRENDERGAST TJ, 1995, CHEST, V107, P836, DOI 10.1378/chest.107.3.836; Prendergast TJ, 2000, HOSP PRACT, V35, P91; *PRES COMM STUD ET, 1983, DEC FOR LIF SUST TRE; Puchalski CM, 2000, J AM GERIATR SOC, V48, pS84, DOI 10.1111/j.1532-5415.2000.tb03146.x; PUNTILLO K, 1994, NURS RES, V43, P31; PUNTILLO K, 2000, P 9 WORLD C PAIN AUG, V16; Puntillo K A, 2001, Am J Crit Care, V10, P216; Puntillo KA, 1997, CRIT CARE MED, V25, P1159, DOI 10.1097/00003246-199707000-00017; Puntillo KA, 2001, MANAGING DEATH INTEN, P149; Quill TE, 2001, ANN INTERN MED, V135, P551, DOI 10.7326/0003-4819-135-7-200110020-00022; Rubenfeld G., 2001, MANAGING DEATH INTEN, P127; Schneiderman LJ, 1996, ANN INTERN MED, V125, P669, DOI 10.7326/0003-4819-125-8-199610150-00007; SCHNEIDERMAN LJ, 1990, ANN INTERN MED, V112, P949, DOI 10.7326/0003-4819-112-12-949; Schneiderman LJ, 2000, CRIT CARE MED, V28, P3920, DOI 10.1097/00003246-200012000-00033; SCHNEIDERMAN LJ, 1992, ANN INTERN MED, V117, P599, DOI 10.7326/0003-4819-117-7-599; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; SHAPIRO BA, 1995, CRIT CARE MED, V23, P1596, DOI 10.1097/00003246-199509000-00021; SOLOMON MZ, 1993, AM J PUBLIC HEALTH, V83, P14, DOI 10.2105/AJPH.83.1.14; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sulmasy DP, 1999, ARCH INTERN MED, V159, P545, DOI 10.1001/archinte.159.6.545; Sulmasy DP, 1998, ANN INTERN MED, V128, P621, DOI 10.7326/0003-4819-128-8-199804150-00002; Sulmasy DP, 1997, JAMA-J AM MED ASSOC, V277, P1854; Swigart V, 1996, HEART LUNG, V25, P483, DOI 10.1016/S0147-9563(96)80051-3; TENO JM, 1994, J AM GERIATR SOC, V42, P1202, DOI 10.1111/j.1532-5415.1994.tb06990.x; TILDEN VP, 1995, ARCH INTERN MED, V155, P633, DOI 10.1001/archinte.155.6.633; Tonelli MR, 1996, CHEST, V110, P816, DOI 10.1378/chest.110.3.816; WILSON WC, 1992, JAMA-J AM MED ASSOC, V267, P949	97	84	87	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2002	288	21					2732	2740		10.1001/jama.288.21.2732	http://dx.doi.org/10.1001/jama.288.21.2732			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620UA	12460097				2022-12-28	WOS:000179549800033
J	Doitsidou, M; Reichman-Fried, M; Stebler, J; Koprunner, M; Dorries, J; Meyer, D; Esguerra, CV; Leung, T; Raz, E				Doitsidou, M; Reichman-Fried, M; Stebler, J; Koprunner, M; Dorries, J; Meyer, D; Esguerra, CV; Leung, T; Raz, E			Guidance of primordial germ cell migration by the chemokine SDF-1	CELL			English	Article							RECEPTOR CXCR4; LYMPHOCYTE CHEMOATTRACTANT; EXPRESSION PATTERN; PERIPHERAL-BLOOD; GENETIC-ANALYSIS; VASA RNA; NO TAIL; ZEBRAFISH; MOUSE; EMBRYOS	The signals directing primordial germ cell (PGC) migration in vertebrates are largely unknown. We demonstrate that sdf-1 mRNA is expressed in locations where PGCs are found and toward which they migrate in wild-type as well as in mutant embryos in which PGC migration is abnormal. Knocking down SDF-1 or its receptor CXCR4 results in severe defects in PGC migration. Specifically, PGCs that do not receive the SDF-1 signal exhibit lack of directional movement toward their target and arrive at ectopic positions within the embryo. Finally, we show that the PGCs can be attracted toward an ectopic source of the chemokine, strongly suggesting that this molecule provides a key directional cue for the PGCs.	Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Univ Freiburg, Inst Biol 1, Dept Dev Biol, D-79104 Freiburg, Germany; Mermaid Pharmaceut GmbH, D-20251 Hamburg, Germany	Max Planck Society; University of Freiburg	Raz, E (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	eraz@gwdg.de	Esguerra, Camila/N-6159-2015; Esguerra, Camila/D-7657-2014	Esguerra, Camila/0000-0002-2271-8094; Esguerra, Camila/0000-0001-7891-1427; Meyer, Dirk/0000-0002-4020-4484				Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Anderson R, 1999, DEVELOPMENT, V126, P1655; Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bendel-Stenzel MR, 2000, MECH DEVELOP, V91, P143, DOI 10.1016/S0925-4773(99)00287-7; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; CIRUNA B, 2002, IN PRESS P NATL ACAD; Deshpande G, 2001, CELL, V106, P759, DOI 10.1016/S0092-8674(01)00488-3; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; GODIN I, 1990, DEVELOPMENT, V108, P357; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Gu J, 2002, RHEUMATOLOGY, V41, P759, DOI 10.1093/rheumatology/41.7.759; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; HAY B, 1988, DEVELOPMENT, V103, P625; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; JAGLARZ MK, 1995, DEVELOPMENT, V121, P3495; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Koprunner M, 2001, GENE DEV, V15, P2877; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; Kuwana T, 1999, CELL MOL BIOL, V45, P725; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Muller K, 2002, MECH DEVELOP, V117, P253, DOI 10.1016/S0925-4773(02)00174-0; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Niewkoop P, 1979, PRIMORDIAL GERM CELL; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pfeffer PL, 1998, DEVELOPMENT, V125, P3063; Schisa JA, 2001, DEVELOPMENT, V128, P1287; Schober A, 1997, MICROSYST TECHNOL, V4, P35, DOI 10.1007/s005420050089; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; Starz-Gaiano M, 2001, MECH DEVELOP, V105, P5, DOI 10.1016/S0925-4773(01)00392-6; STROME S, 1982, P NATL ACAD SCI-BIOL, V79, P1558, DOI 10.1073/pnas.79.5.1558; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Weidinger G, 2002, DEVELOPMENT, V129, P25; Weidinger G, 1999, DEVELOPMENT, V126, P5295; Weinberg ES, 1996, DEVELOPMENT, V122, P271; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Wylie C, 2000, CURR OPIN GENET DEV, V10, P410, DOI 10.1016/S0959-437X(00)00105-2; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yelon D, 1999, SEMIN CELL DEV BIOL, V10, P93, DOI 10.1006/scdb.1998.0278; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0; Zhang N, 1996, GENETICS, V143, P1231; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	74	519	535	5	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	2002	111	5					647	659		10.1016/S0092-8674(02)01135-2	http://dx.doi.org/10.1016/S0092-8674(02)01135-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464177	Green Published, Bronze			2022-12-28	WOS:000179594500007
J	Rottbauer, W; Saurin, AJ; Lickert, H; Shen, XT; Burns, CG; Wo, ZG; Kemler, R; Kingston, R; Wu, C; Fishman, M				Rottbauer, W; Saurin, AJ; Lickert, H; Shen, XT; Burns, CG; Wo, ZG; Kemler, R; Kingston, R; Wu, C; Fishman, M			Reptin and pontin antagonistically regulate heart growth in zebrafish embryos	CELL			English	Article							CHROMATIN REMODELING COMPLEX; BETA-CATENIN; BRANCH MIGRATION; BINDING-PROTEIN; COLON-CARCINOMA; RUVB PROTEINS; DNA HELICASE; CYCLIN D1; C-MYC; EXPRESSION	Organ size is precisely regulated during development, but the control mechanisms remain obscure. We have isolated a mutation in zebrafish, liebeskummer (lik), which causes development of hyperplastic embryonic hearts. lik encodes Reptin, a component of a DNA-stimulated ATPase complex. The mutation activates ATPase activity of Reptin complexes and causes a cell-autonomous proliferation of cardiomyocytes to begin well after progenitors have fashioned the primitive heart tube. With regard to heart growth, beta-catenin and Pontin, a DNA-stimulated ATPase that is often part of complexes with Reptin, are in the same genetic pathways. Pontin reduction phenocopies the cardiac hyperplasia of the lik mutation. Thus, the Reptin/Pontin ratio serves to regulate heart growth during development, at least in part via the beta-catenin pathway.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Max Planck Inst Immunobiol, Dept Mol Embryol, D-79108 Freiburg, Germany; NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Max Planck Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fishman, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA 02114 USA.	mark.fishman@pharma.novatis.com	Lickert, Heiko/K-9045-2013	Saurin, Andrew/0000-0001-5162-003X; Shen, Xuetong/0000-0002-4267-5298	NHLBI NIH HHS [5R01HL49579, 1R01HL63206, T32 HL007208] Funding Source: Medline; NIDDK NIH HHS [5R01DK55383] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063206, R01HL049579, T32HL007208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055383] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Brannon M, 1996, DEV BIOL, V180, P344, DOI 10.1006/dbio.1996.0306; Cho SG, 2001, MOL CELL BIOL, V21, P8398, DOI 10.1128/MCB.21.24.8398-8413.2001; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Etard C, 2000, MECH DEVELOP, V94, P219, DOI 10.1016/S0925-4773(00)00305-1; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Gunster MJ, 2001, J CELL BIOCHEM, P129, DOI 10.1002/jcb.1093; GUNTHER B, 1975, PHYSIOL REV, V55, P659, DOI 10.1152/physrev.1975.55.4.659; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Jonsson ZO, 2001, J BIOL CHEM, V276, P16279, DOI 10.1074/jbc.M011523200; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lacerra G, 2000, P NATL ACAD SCI USA, V97, P9591, DOI 10.1073/pnas.97.17.9591; Lough JW, 2002, DEV DYNAM, V223, P419, DOI 10.1002/dvdy.10058; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Monzen K, 2001, J CELL BIOL, V153, P687, DOI 10.1083/jcb.153.4.687; MULLER B, 1993, J BIOL CHEM, V268, P17185; Parfait B, 2000, ANN GENET-PARIS, V43, P69, DOI 10.1016/S0003-3995(00)01016-9; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Rottbauer W, 2001, DEV CELL, V1, P265, DOI 10.1016/S1534-5807(01)00023-5; Salzer U, 1999, BBA-GENE STRUCT EXPR, V1446, P365, DOI 10.1016/S0167-4781(99)00104-9; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Soonpaa MH, 1997, J CLIN INVEST, V99, P2644, DOI 10.1172/JCI119453; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X	40	153	157	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	2002	111	5					661	672		10.1016/S0092-8674(02)01112-1	http://dx.doi.org/10.1016/S0092-8674(02)01112-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464178	Bronze			2022-12-28	WOS:000179594500008
J	Chan, FKL; Hung, LCT; Suen, BY; Wu, JCY; Lee, KC; Leung, VKS; Hui, AJ; To, KF; Leung, WK; Wong, VWS; Chung, SCS; Sung, JJY				Chan, FKL; Hung, LCT; Suen, BY; Wu, JCY; Lee, KC; Leung, VKS; Hui, AJ; To, KF; Leung, WK; Wong, VWS; Chung, SCS; Sung, JJY			Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SERIOUS GASTROINTESTINAL COMPLICATIONS; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID-ARTHRITIS; CYCLOOXYGENASE-2 INHIBITION; DOUBLE-BLIND; OSTEOARTHRITIS; MISOPROSTOL; PREVENTION; ROFECOXIB	Background: Current guidelines recommend that patients at risk for ulcer disease who require treatment for arthritis receive nonsteroidal antiinflammatory drugs (NSAIDs) that are selective for cyclooxygenase-2 or the combination of a nonselective NSAID with a proton-pump inhibitor. We assessed whether celecoxib would be similar to diclofenac plus omeprazole in reducing the risk of recurrent ulcer bleeding in patients at high risk for bleeding. Methods: We studied patients who used NSAIDs for arthritis and who presented with ulcer bleeding. After their ulcers had healed, we randomly assigned patients who were negative for Helicobacter pylori to receive either 200 mg of celecoxib twice daily plus daily placebo or 75 mg of diclofenac twice daily plus 20 mg of omeprazole daily for six months. The end point was recurrent ulcer bleeding. Results: In the intention-to-treat analysis, which included 287 patients (144 receiving celecoxib and 143 receiving diclofenac plus omeprazole), recurrent ulcer bleeding occurred in 7 patients receiving celecoxib and 9 receiving diclofenac plus omeprazole. The probability of recurrent bleeding during the six-month period was 4.9 percent (95 percent confidence interval, 3.1 to 6.7) for patients who received celecoxib and 6.4 percent (95 percent confidence interval, 4.3 to 8.4) for patients who received diclofenac plus omeprazole (difference, -1.5 percentage points; 95 percent confidence interval for the difference, -6.8 to 3.8). Renal adverse events, including hypertension, peripheral edema, and renal failure, occurred in 24.3 percent of the patients receiving celecoxib and 30.8 percent of those receiving diclofenac plus omeprazole. Conclusions: Among patients with a recent history of ulcer bleeding, treatment with celecoxib was as effective as treatment with diclofenac plus omeprazole, with respect to the prevention of recurrent bleeding. Renal toxic effects are common in high-risk patients receiving celecoxib or diclofenac plus omeprazole.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Pharm, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; United Christian Hosp, Med Unit, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; United Christian Hospital	Chan, FKL (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, 30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.		Wong, Vincent WS/K-3864-2014; Wu, Justin/N-6916-2015; Lee, Yeong Yeh/G-2470-2010; Sung, Joseph J. Y./R-3203-2018; Chan, Francis K. L./F-4851-2010; Leung, Wai Keung/B-8140-2011	Wong, Vincent WS/0000-0003-2215-9410; Lee, Yeong Yeh/0000-0002-6486-7717; Sung, Joseph J. Y./0000-0003-3125-5199; Chan, Francis K. L./0000-0001-7388-2436; Leung, Wai Keung/0000-0002-5993-1059				Altman D.G., 1991, PRACTICAL STAT MED R; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Chan FKL, 2001, GASTROENTEROLOGY, V120, pA143, DOI 10.1016/S0016-5085(08)80705-6; Chan FKL, 2001, NEW ENGL J MED, V344, P967, DOI 10.1056/NEJM200103293441304; Emery P, 1999, LANCET, V354, P2106, DOI 10.1016/S0140-6736(99)02332-6; *FOOD DRUG ADM, 2000, STAT REV BRIEF DOC A; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; Graham DY, 2002, ARCH INTERN MED, V162, P169, DOI 10.1001/archinte.162.2.169; GRAHAM DY, 1993, ANN INTERN MED, V119, P257, DOI 10.7326/0003-4819-119-4-199308150-00001; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Laine L, 1999, GASTROENTEROLOGY, V117, P776, DOI 10.1016/S0016-5085(99)70334-3; Laine L, 2001, GASTROENTEROLOGY, V120, P594, DOI 10.1053/gast.2001.21907; Mizuno H, 1997, GASTROENTEROLOGY, V112, P387, DOI 10.1053/gast.1997.v112.pm9024292; Peterson WL, 1999, JAMA-J AM MED ASSOC, V282, P1961, DOI 10.1001/jama.282.20.1961; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; RODRIGUEZ LAG, 1994, LANCET, V343, P769, DOI 10.1016/S0140-6736(94)91843-0; RODRIGUEZ LAG, 1994, LANCET, V343, P1048; Rodriguez LAG, 1999, EPIDEMIOLOGY, V10, P228, DOI 10.1097/00001648-199905000-00006; ROEBRUCK P, 1995, STAT MED, V14, P1583, DOI 10.1002/sim.4780141409; Rossat J, 1999, CLIN PHARMACOL THER, V66, P76, DOI 10.1016/S0009-9236(99)70056-1; Shigeta JI, 1998, J PHARMACOL EXP THER, V286, P1383; Silverstein F, 2001, JAMA-J AM MED ASSOC, V286, P2399; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Simon LS, 1999, JAMA-J AM MED ASSOC, V282, P1921, DOI 10.1001/jama.282.20.1921; Singh G, 1999, J RHEUMATOL, V26, P18; Swan SK, 2000, ANN INTERN MED, V133, P1, DOI 10.7326/0003-4819-133-1-200007040-00002; Wolfe MM, 1999, NEW ENGL J MED, V341, P548	29	351	359	0	17	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2104	2110		10.1056/NEJMoa021907	http://dx.doi.org/10.1056/NEJMoa021907			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501222	Bronze			2022-12-28	WOS:000180040900003
J	Whitsett, JA; Weaver, TE				Whitsett, JA; Weaver, TE			Mechanisms of disease: Hydrophobic surfactant proteins in lung function and disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							COLONY-STIMULATING FACTOR; PULMONARY SURFACTANT; SP-C; SP-B; DEFICIENCY; MUTATION; CDNA; INFANT; MICE		Cincinnati Childrens Hosp, Med Ctr, Div Neonatol & Pulm Biol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Whitsett, JA (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Neonatol & Pulm Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jeff.whitsett@chmcc.org			NHLBI NIH HHS [HL38859, HL61646, HL56285] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL061646, R37HL038859, R01HL056285, R01HL038859, R37HL056285] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Amin RS, 2001, J PEDIATR-US, V139, P85, DOI 10.1067/mpd.2001.114545; BAATZ JE, 1992, CHEM PHYS LIPIDS, V63, P91, DOI 10.1016/0009-3084(92)90026-L; BALLARD PL, 1995, PEDIATRICS, V96, P1046; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Conkright JJ, 2002, AM J RESP CELL MOL, V26, P85, DOI 10.1165/ajrcmb.26.1.4686; Conkright JJ, 2001, J BIOL CHEM, V276, P14658, DOI 10.1074/jbc.M011770200; CURSTEDT T, 1990, P NATL ACAD SCI USA, V87, P2985, DOI 10.1073/pnas.87.8.2985; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Dunbar AE, 2000, PEDIATR RES, V48, P275, DOI 10.1203/00006450-200009000-00003; GLASSER SW, 1987, P NATL ACAD SCI USA, V84, P4007, DOI 10.1073/pnas.84.12.4007; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; GLASSER SW, 1988, J BIOL CHEM, V263, P9; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; GREGORY TJ, 1991, J CLIN INVEST, V88, P1976, DOI 10.1172/JCI115523; Gustafsson M, 1999, FEBS LETT, V464, P138, DOI 10.1016/S0014-5793(99)01692-0; Hamvas A, 1997, J PEDIATR-US, V130, P231, DOI 10.1016/S0022-3476(97)70348-2; Hawgood S, 1998, BBA-MOL BASIS DIS, V1408, P150, DOI 10.1016/S0925-4439(98)00064-7; Horowitz AD, 1996, AM J PHYSIOL-LUNG C, V270, pL69, DOI 10.1152/ajplung.1996.270.1.L69; HOROWITZ AD, 1993, BIOCHEMISTRY-US, V32, P9513, DOI 10.1021/bi00088a001; HOROWITZ AD, 1992, BIOCHIM BIOPHYS ACTA, V1107, P44, DOI 10.1016/0005-2736(92)90327-I; Johansson J, 1997, EUR J BIOCHEM, V244, P675, DOI 10.1111/j.1432-1033.1997.00675.x; Johansson J, 1998, BBA-MOL BASIS DIS, V1408, P161, DOI 10.1016/S0925-4439(98)00065-9; Kitamura T, 1999, J EXP MED, V190, P875, DOI 10.1084/jem.190.6.875; Klein JM, 1998, J PEDIATR-US, V132, P244, DOI 10.1016/S0022-3476(98)70439-1; Nogee LM, 2000, AM J RESP CRIT CARE, V161, P973, DOI 10.1164/ajrccm.161.3.9903153; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; NOGEE LM, 1993, NEW ENGL J MED, V328, P406, DOI 10.1056/NEJM199302113280606; PRYHUBER GS, 1991, PEDIATR RES, V30, P597, DOI 10.1203/00006450-199112000-00023; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Stahlman MT, 2000, LAB INVEST, V80, P395, DOI 10.1038/labinvest.3780044; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Tokieda K, 1999, AM J RESP CELL MOL, V21, P463, DOI 10.1165/ajrcmb.21.4.3436; Tokieda K, 1997, AM J PHYSIOL-LUNG C, V273, pL875, DOI 10.1152/ajplung.1997.273.4.L875; VORBROKER DK, 1995, AM J PHYSIOL-LUNG C, V268, pL647, DOI 10.1152/ajplung.1995.268.4.L647; WARR RG, 1987, P NATL ACAD SCI USA, V84, P7915, DOI 10.1073/pnas.84.22.7915; WEAVER TE, 1989, AM J PHYSIOL, V257, pL100, DOI 10.1152/ajplung.1989.257.2.L100; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Whitsett JA, 2002, AM J RESP CRIT CARE, V165, P1201, DOI 10.1164/rccm.2203017; Yusen RD, 1999, AM J RESP CRIT CARE, V159, P411, DOI 10.1164/ajrccm.159.2.9806033	41	342	356	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2141	2148		10.1056/NEJMra022387	http://dx.doi.org/10.1056/NEJMra022387			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501227				2022-12-28	WOS:000180040900008
J	Maldonado, YA				Maldonado, YA			Current controversies in vaccination - Vaccine safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NO EVIDENCE; MEASLES; AUTISM; MUMPS; IMMUNIZATION; ASSOCIATION; CHILDREN; RISK		Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Lucile Salter Packard Childrens Hosp Stanford, Palo Alto, CA USA	Stanford University; Lucile Packard Children's Hospital (LPCH)	Maldonado, YA (corresponding author), Stanford Univ, Sch Med, Dept Pediat, MC 5208,300 Pasteur Dr, Stanford, CA 94305 USA.	niem@stanford.ed						Bonanni P, 1999, VACCINE, V17, pS120, DOI 10.1016/S0264-410X(99)00306-0; CDC, 1999, MMWR MORB MORTAL WKL, V48, P243; *CDCP, 2002, MMWR-MORBID MORTAL W, V50, P1161; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P986; *CDCP, 2002, EP PREV VACC PREV DI; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P241; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P622; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P1007; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P855; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P904; Centers for Disease Control and Prevention (CDC), 2001, MMWR-MORBID MORTAL W, V50, P707; Classen DC, 1997, INFECT DIS CLIN PRAC, V6, P449, DOI 10.1097/00019048-199706070-00007; Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; DeStefano F, 2001, PHARMACOEPIDEM DR S, V10, P403, DOI 10.1002/pds.613; Fombonne E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e58; Graves PM, 1999, DIABETES CARE, V22, P1694, DOI 10.2337/diacare.22.10.1694; *I MED, 2001, IMM SAF REV MULT IMM; *I MED, 2001, IMM SAF REV THIM CON; *I MED, 2001, IMM SAF REV MEASL MU; Institutes of Medicine, 2002, IMM SAF REV HEP B VA; Karvonen M, 1999, BRIT MED J, V318, P1169, DOI 10.1136/bmj.318.7192.1169; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; *NAT CTR HLTH STAT, 2000, NAT VIT STAT SYST NU; Peltola H, 1998, LANCET, V351, P1327, DOI 10.1016/S0140-6736(98)24018-9; Singleton J A, 2000, MMWR CDC Surveill Summ, V49, P39; Taylor B, 2002, BRIT MED J, V324, P393, DOI 10.1136/bmj.324.7334.393; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wolfe RM, 2002, JAMA-J AM MED ASSOC, V287, P3245, DOI 10.1001/jama.287.24.3245	28	25	25	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2002	288	24					3155	3158		10.1001/jama.288.24.3155	http://dx.doi.org/10.1001/jama.288.24.3155			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628QQ	12495396				2022-12-28	WOS:000180008200026
J	Gruber, N; Keeling, CD; Bates, NR				Gruber, N; Keeling, CD; Bates, NR			Interannual variability in the North Atlantic Ocean carbon sink	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; SARGASSO SEA; EL-NINO; INORGANIC CARBON; C-13; CO2; OSCILLATION; SEAWATER; BERMUDA; DIOXIDE	The North Atlantic is believed to represent the largest ocean sink for atmospheric carbon dioxide in the Northern Hemisphere, yet little is known about its temporal variability. We report an 18-year time series of upper-ocean inorganic carbon observations from the northwestern subtropical North Atlantic near Bermuda that indicates substantial variability in this sink. We deduce that the carbon variability at this site is largely driven by variations in winter mixed-layer depths and by sea surface temperature anomalies. Because these variations tend to occur in a basinwide coordinated pattern associated with the North Atlantic Oscillation, it is plausible that the entire North Atlantic Ocean may vary in concert, resulting in a variability of the strength of the North Atlantic carbon sink of about +/-0.3 petagrams of carbon per year (1 petagram=10(15) grams) or nearly +/-50%. This extrapolation is supported by basin-wide estimates from atmospheric carbon dioxide inversions.	Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Atmospher Sci, Los Angeles, CA 90095 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Bermuda Biol Stn Res Inc, Ferry Reach GE01, Bermuda	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; Scripps Institution of Oceanography	Gruber, N (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.	ngruber@igpp.ucla.edu	Gruber, Nicolas/B-7013-2009	Gruber, Nicolas/0000-0002-2085-2310				Bacastow RB, 1996, GLOBAL BIOGEOCHEM CY, V10, P335, DOI 10.1029/96GB00192; Bates NR, 1998, J GEOPHYS RES-OCEANS, V103, P15567, DOI 10.1029/98JC00247; Bates NR, 2002, NATURE, V420, P489, DOI 10.1038/nature01253; Bates NR, 2001, DEEP-SEA RES PT II, V48, P1507, DOI 10.1016/S0967-0645(00)00151-X; Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; Bjerknes J., 1964, ADV GEOPHYS, V10, P1, DOI [10.1016/S0065-2687(08)60005-9, DOI 10.1016/S0065-2687(08)60005-9]; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; CAYAN DR, 1992, J PHYS OCEANOGR, V22, P859, DOI 10.1175/1520-0485(1992)022<0859:LASHFA>2.0.CO;2; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; CONWAY TJ, 1994, J GEOPHYS RES-ATMOS, V99, P22831, DOI 10.1029/94JD01951; Cullen HM, 2001, PALEOCEANOGRAPHY, V16, P27, DOI 10.1029/1999PA000434; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dickson R, 1996, PROG OCEANOGR, V38, P241, DOI 10.1016/S0079-6611(97)00002-5; Feely RA, 1999, NATURE, V398, P597, DOI 10.1038/19273; FRANCEY RJ, 1995, NATURE, V373, P326, DOI 10.1038/373326a0; GLOOR M, IN PRESS GEOPHYS RES; Gruber N, 1999, GLOBAL BIOGEOCHEM CY, V13, P307, DOI 10.1029/1999GB900019; Gruber N, 1998, DEEP-SEA RES PT I, V45, P673, DOI 10.1016/S0967-0637(97)00098-8; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Joyce TM, 1996, J CLIMATE, V9, P3121, DOI 10.1175/1520-0442(1996)009<3121:TLTHRA>2.0.CO;2; KAWAMURA R, 1994, J PHYS OCEANOGR, V24, P707, DOI 10.1175/1520-0485(1994)024<0707:AREAOG>2.0.CO;2; Keeling C. D., 1993, GLOBAL CARBON CYCLE, P413; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; Le Quere C, 2000, GLOBAL BIOGEOCHEM CY, V14, P1247, DOI 10.1029/1999GB900049; Lee K, 1998, NATURE, V396, P155, DOI 10.1038/24139; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Michaels AF, 1996, DEEP-SEA RES PT II, V43, P157, DOI 10.1016/0967-0645(96)00004-5; Molinari RL, 1997, J GEOPHYS RES-OCEANS, V102, P3267, DOI 10.1029/96JC03544; Rubinstein R. Y., 1981, SIMULATION MONTE CAR; Siegel DA, 1997, DEEP-SEA RES PT I, V44, P1519, DOI 10.1016/S0967-0637(97)00028-9; Sonnerup RE, 1999, GLOBAL BIOGEOCHEM CY, V13, P857, DOI 10.1029/1999GB900027; Stammer D, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000888; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; *US DOE, 1994, ORNLCDIAC74 US DEP E; WINGUTH AME, 1994, GLOBAL BIOGEOCHEM CY, V8, P39, DOI 10.1029/93GB03134	36	184	188	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2374	2378		10.1126/science.1077077	http://dx.doi.org/10.1126/science.1077077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493911				2022-12-28	WOS:000179915900052
J	Alberti, A; Noventa, F; Benvegnu, L; Boccato, S; Gatta, A				Alberti, A; Noventa, F; Benvegnu, L; Boccato, S; Gatta, A			Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection	ANNALS OF INTERNAL MEDICINE			English	Article							NATURAL-HISTORY; BLOOD-DONORS; AMINOTRANSFERASE LEVELS; PROGRESSION; FIBROSIS	Background: The prevalence of significant liver disease in persons with asymptomatic hepatitis C virus (HCV) infection is unclear. Objective: To determine the prevalence and severity of HCV infection in asymptomatic persons. Design: Population-based cross-sectional study. Setting: Northeastern Italy. Patients: 4820 apparently healthy Telecom Italy employees or their relatives who underwent screening for cardiovascular risk factors. Measurements: Initial screening for anti-HCV by enzyme-linked immunosorbent assay followed by HCV RNA testing by polymerase chain reaction and monitoring of alanine aminotransferase levels in viremic persons (92% of viremic persons also had liver biopsies to assess their METAVIR scores). Results: 116 persons (2.4% [95% Cl, 1.97% to 2.84%]) were positive for anti-HCV and 85 (1.76% [Cl, 1.39% to 2.14%]) were also viremic. The ALT level was persistently normal in 39 (46%) of viremic patients and elevated in 46 (54%). Significant hepatic histologic abnormalities were detected in 19% (Cl, 7.21% to 36.4%) of persons with persistently normal ALT levels and in 61% (Cl, 45.4% to 74.9%) of viremic persons who had elevated ALT levels (P < 0.001). The prevalence of HCV infection and number of persons with chronic liver fibrosis increased with age (P = 0.003). Conclusions: Hepatitis C is histologically active and progressive in up to 40% of asymptomatic persons with HCV infection. The severity of liver disease correlates with abnormal ALT levels and increases with age.	Univ Padua, Clin Med 5, Dept Clin & Expt Med, I-35100 Padua, Italy	University of Padua	Alberti, A (corresponding author), Univ Padua, Clin Med 5, Dept Clin & Expt Med, Via Giustiniani 2, I-35100 Padua, Italy.	alfredo.alberti@unipd.it	Noventa, Franco/C-1202-2008	Noventa, Franco/0000-0003-4622-5523; ALBERTI, ALFREDO/0000-0001-9926-2382				Alberti A, 1999, J HEPATOL, V31, P17, DOI 10.1016/S0168-8278(99)80369-9; ALBERTI A, 1991, ANN INTERN MED, V114, P1010, DOI 10.7326/0003-4819-114-12-1010; ALBERTI A, 1992, LANCET, V340, P697, DOI 10.1016/0140-6736(92)92234-7; Alter HJ, 1997, HEPATOLOGY, V26, pS29, DOI 10.1002/hep.510260705; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Deuffic S, 1999, HEPATOLOGY, V29, P1596, DOI 10.1002/hep.510290528; ESTEBAN JI, 1991, ANN INTERN MED, V115, P443, DOI 10.7326/0003-4819-115-6-443; Hirsch KR, 2000, AM J MED, V109, P66, DOI 10.1016/S0002-9343(00)00456-3; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mathurin P, 1998, HEPATOLOGY, V27, P868, DOI 10.1002/hep.510270333; Ostapowicz G, 1998, HEPATOLOGY, V27, P1730, DOI 10.1002/hep.510270637; Pagliaro L, 1999, ITAL J GASTROENTEROL, V31, P28; Persico M, 2000, GASTROENTEROLOGY, V118, P760, DOI 10.1016/S0016-5085(00)70145-4; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2000, SEMIN LIVER DIS, V20, P47, DOI 10.1055/s-2000-9258; RoudotThoraval F, 1997, HEPATOLOGY, V26, P485, DOI 10.1002/hep.510260233; Saadeh S, 2001, HEPATOLOGY, V33, P196, DOI 10.1053/jhep.2001.20534; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; 1999, EASL INT CONS C HEP, V31, P3	20	117	122	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2002	137	12					961	964		10.7326/0003-4819-137-12-200212170-00009	http://dx.doi.org/10.7326/0003-4819-137-12-200212170-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626DR	12484711				2022-12-28	WOS:000179857500004
J	Niederhofer, H; Staffen, W; Mair, A				Niederhofer, H; Staffen, W; Mair, A			Galantamine may be effective in treating autistic disorder	BRITISH MEDICAL JOURNAL			English	Letter									Reg Hosp Bolzano, Dept Paediat, I-39100 Bolzano, Italy; Christian Doppler Klin, Dept Neurol, A-5020 Salzburg, Austria	Krankenhaus Bozen	Niederhofer, H (corresponding author), Reg Hosp Bolzano, Dept Paediat, Via L Boehler 5, I-39100 Bolzano, Italy.							AMMAN MG, 1985, AM J MENT DEFIC, V99, P492; BIRMAHER B, 1988, J AM ACAD CHILD PSY, V27, P248, DOI 10.1097/00004583-198803000-00020; CAMPBELL M, 1988, PSYCHOPHARMACOL BULL, V24, P251; CAMPBELL M, 1972, J AUTISM CHILD SCHIZ, V2, P943; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445	5	35	36	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1422	1422						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480867				2022-12-28	WOS:000179975000047
J	Marhas, KK; Goswami, JN; Davis, AM				Marhas, KK; Goswami, JN; Davis, AM			Short-lived nuclides in hibonite grains from Murchison: Evidence for solar system evolution	SCIENCE			English	Article							EXTINCT RADIOACTIVITIES; COSMIC-RAYS; INCLUSIONS; METEORITES; ORIGIN; AL-26; CA-41	Records of now-extinct short-lived nuclides in meteorites provide information about the formation and evolution of the solar system. We have found excess B-10 that we attribute to the decay of short-lived Be-10 (half-life 1.5 million years) in hibonite grains from the Murchison meteorite. The grains show no evidence of decay of two other short-lived nuclides - Al-26 (half-life 700,000 years) and Ca-41 (half-life 100,000 years)-that may be present in early solar system solids. One plausible source of the observed Be-10 is energetic particle irradiation of material in the solar nebula. An effective irradiation dose of similar to2 x 10(18) protons per square centimeter with a kinetic energy of greater than or equal to10 megaelectronvolts per atomic mass unit can explain our measurements. The presence of Be-10, coupled with the absence of Ca-41 and Al-26, may rule out energetic particle irradiation as the primary source of Ca-41 and Al-26 present in some early solar system solids and strengthens the case of a stellar source for Ca-41 and Al-26.	Phys Res Lab, Ahmadabad 380009, Gujarat, India; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	Department of Space (DoS), Government of India; Physical Research Laboratory - India; University of Chicago	Goswami, JN (corresponding author), Phys Res Lab, Ahmadabad 380009, Gujarat, India.	goswami@prl.ernet.in		Davis, Andrew/0000-0001-7955-6236; Marhas, Kuljeet/0000-0002-3375-3047				Bloemen H, 1999, ASTROPHYS J, V521, pL137, DOI 10.1086/312185; CAFFEE MW, 1987, ASTROPHYS J, V313, pL31, DOI 10.1086/184826; Cameron AGW, 2001, ASTROPHYS J, V562, P456, DOI 10.1086/323869; Goswami JN, 2001, ASTROPHYS J, V549, P1151, DOI 10.1086/319434; Goswami JN, 2000, PROTOSTARS PLANETS, VIV, P965; GOSWAMI JN, 2001, LUNAR PLANET SCI, V32, P1576; Gounelle M, 2001, ASTROPHYS J, V548, P1051, DOI 10.1086/319019; HASHIMOTO A, 1986, LUNAR PLANET SCI, V17, P317; HEYMANN D, 1976, SCIENCE, V191, P79, DOI 10.1126/science.191.4222.79; IRELAND TR, 1990, GEOCHIM COSMOCHIM AC, V54, P3219, DOI 10.1016/0016-7037(90)90136-9; Lee T, 1998, ASTROPHYS J, V506, P898, DOI 10.1086/306284; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; MACPHERSON GJ, IN PRESS GEOCHIM COS; MARHAS KK, 2001, THESIS D AHILYA U; McKeegan K. D., 2001, LUNAR PLANET SCI, V32, P2175; McKeegan KD, 2000, SCIENCE, V289, P1334, DOI 10.1126/science.289.5483.1334; PROVOST A, 1990, CHEM GEOL, V80, P85, DOI 10.1016/0168-9622(90)90017-7; Ramaty R, 1996, ASTROPHYS J, V456, P525, DOI 10.1086/176677; Reedy RC, 1998, P INDIAN AS-EARTH, V107, P433; REEVES H, 1994, REV MOD PHYS, V66, P193, DOI 10.1103/RevModPhys.66.193; Sahijpal S, 1998, ASTROPHYS J, V509, pL137, DOI 10.1086/311778; Sahijpal S, 1998, NATURE, V391, P559, DOI 10.1038/35325; SAHLJPAL S, 2000, GEOCHIM COSMOCHIM AC, V64, P1989; Shu FH, 1997, SCIENCE, V277, P1475, DOI 10.1126/science.277.5331.1475; SISTERSON JM, 1997, LUNAR PLANET SCI, V28, P1329; Srinivasan G, 1996, GEOCHIM COSMOCHIM AC, V60, P1823, DOI 10.1016/0016-7037(96)00054-3; Srinivasan G., 2001, METEORIT PLANT SCI, V36, pA195; Sugiura N, 2001, METEORIT PLANET SCI, V36, P1397, DOI 10.1111/j.1945-5100.2001.tb01832.x; YONEDA S, 1995, GEOCHIM COSMOCHIM AC, V59, P3413, DOI 10.1016/0016-7037(95)00214-K	29	88	89	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2182	2185		10.1126/science.1078322	http://dx.doi.org/10.1126/science.1078322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481135				2022-12-28	WOS:000179773700045
J	Poss, KD; Wilson, LG; Keating, MT				Poss, KD; Wilson, LG; Keating, MT			Heart regeneration in zebrafish	SCIENCE			English	Article							MITOTIC CHECKPOINT; MPS1	Cardiac injury in mammals and amphibians typically leads to scarring, with minimal regeneration of heart muscle. Here, we demonstrate histologically that zebrafish fully regenerate hearts within 2 months of 20% ventricular resection. Regeneration occurs through robust proliferation of cardiomyocytes localized at the leading epicardial edge of the new myocardium. The hearts of zebrafish with mutations in the Mps1 mitotic checkpoint kinase, a critical cell cycle regulator, failed to regenerate and formed scars. Thus, injury-induced cardiomyocyte proliferation in zebrafish can overcome scar formation, allowing cardiac muscle regeneration. These findings indicate that zebrafish will be useful for genetically dissecting the molecular mechanisms of cardiac regeneration.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Dept Cell Biol,Dept Cardio, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Poss, KD (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Dept Cell Biol,Dept Cardio, 320 Longwood Ave, Boston, MA 02115 USA.			Poss, Kenneth/0000-0002-6743-5709				Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; BADER D, 1978, J MORPHOL, V155, P349, DOI 10.1002/jmor.1051550307; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Flink IL, 2002, ANAT EMBRYOL, V205, P235, DOI 10.1007/s00429-002-0249-6; HOGG D, 1994, ONCOGENE, V9, P89; JOHNSON SL, 1995, GENETICS, V141, P1583; Kurth T, 1996, CELL TISSUE RES, V286, P1, DOI 10.1007/s004410050669; Linask KK, 1997, DEV BIOL, V185, P148, DOI 10.1006/dbio.1997.8570; Neff AW, 1996, INT J DEV BIOL, V40, P719; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Poss KD, 2002, DEVELOPMENT, V129, P5141; POSS KD, UNPUB; RUMYANTSEV PP, 1973, Z ZELLFORSCH MIK ANA, V139, P431, DOI 10.1007/BF00306596; SCHNITT SJ, 1993, CIRC RES, V72, P914, DOI 10.1161/01.RES.72.4.914; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111	17	1268	1309	3	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2188	2190		10.1126/science.1077857	http://dx.doi.org/10.1126/science.1077857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481136				2022-12-28	WOS:000179773700047
J	Yamada, Y; Izawa, H; Ichihara, S; Takatsu, F; Ishihara, H; Hirayama, H; Sone, T; Tanaka, M; Yokota, M				Yamada, Y; Izawa, H; Ichihara, S; Takatsu, F; Ishihara, H; Hirayama, H; Sone, T; Tanaka, M; Yokota, M			Prediction of the risk of myocardial infarction from polymorphisms in candidate genes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY ATHEROSCLEROSIS; HEART-DISEASE; PROMOTER; PROGRESSION; STROMELYSIN-1; THROMBOSIS; VARIANT; WOMEN	Background: Although epidemiologic studies have suggested that several genetic variants increase the risk of myocardial infarction, large-scale association studies that examine many polymorphisms simultaneously are required to allow reliable prediction of the genetic risk of myocardial infarction. Methods: We used a fluorescence- or colorimetry-based allele-specific DNA-primer-probe assay system to determine the genotypes of 112 polymorphisms of 71 candidate genes in 2819 unrelated Japanese patients with myocardial infarction (2003 men and 816 women) and 2242 unrelated Japanese controls (1306 men and 936 women). Results: In an initial screening of the 112 polymorphisms for an association with myocardial infarction in 909 subjects, 19 polymorphisms were selected in men and 18 in women by means of logistic-regression analysis, after adjustment for age, body-mass index, and the prevalence of smoking, hypertension, diabetes mellitus, hypercholesterolemia, and hyperuricemia. In a large-scale study involving the selected polymorphisms and the remaining 4152 subjects, similar logistic-regression analysis revealed that the risk of myocardial infarction was significantly associated with the C1019T polymorphism in the connexin 37 gene (P<0.001) in men and the 4G-668/5G polymorphism in the plasminogen-activator inhibitor type 1 gene (P<0.001) and the 5A-1171/6A polymorphism in the stromelysin-1 gene (P<0.001) in women. Conclusions: Determination of the genotypes of the connexin 37, plasminogen-activator inhibitor type 1, and stromelysin-1 genes may prove reliable in predicting the genetic risk of myocardial infarction and might thus contribute to the primary prevention of this condition.	Gifu Int Inst Biotechnol, Dept Gene Therapy, Mitake, Tokyo, Japan; Nagoya Univ, Grad Sch Med, Dept Pathophysiol, Div Cardiovasc, Nagoya, Aichi, Japan; Kosei Hosp, Div Cardiol, Anjo, Japan; Okazaki City Hosp, Div Cardiol, Okazaki, Aichi, Japan; Nagoya Daini Red Cross Hosp, Ctr Cardiovasc, Nagoya, Aichi, Japan; Ogaki Municipal Hosp, Dept Cardiol, Ogaki, Japan	Nagoya University; Japanese Red Cross Nagoya Daini Hospital; Ogaki Municipal Hospital	Yokota, M (corresponding author), Nagoya Univ Hosp, Dept Clin Lab & Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.							Boerma M, 1999, J INTERN MED, V246, P211, DOI 10.1046/j.1365-2796.1999.00564.x; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Cahilly C, 2000, CIRC RES, V86, P391, DOI 10.1161/01.RES.86.4.391; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Guetta V, 1996, CIRCULATION, V93, P1928, DOI 10.1161/01.CIR.93.10.1928; Guzik TJ, 2000, CIRCULATION, V102, P1744; Iacoviello L, 1998, NEW ENGL J MED, V338, P79, DOI 10.1056/NEJM199801083380202; Inoue N, 1998, CIRCULATION, V97, P135, DOI 10.1161/01.CIR.97.2.135; KNIVENHOVEN JA, 1998, NEW ENGL J MED, V338, P86; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Rauramaa R, 2000, ARTERIOSCL THROM VAS, V20, P2657, DOI 10.1161/01.ATV.20.12.2657; Richard G, 1997, J INVEST DERMATOL, V109, P666, DOI 10.1111/1523-1747.ep12337713; Ridker PM, 1997, CIRCULATION, V95, P59, DOI 10.1161/01.CIR.95.1.59; Roest M, 2000, CIRCULATION, V101, P67, DOI 10.1161/01.CIR.101.1.67; Rundek T, 2002, STROKE, V33, P1420, DOI 10.1161/01.STR.0000015558.63492.B6; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; YE S, 1995, BRIT HEART J, V73, P209; Yeh HI, 2001, INT J CARDIOL, V81, P251, DOI 10.1016/S0167-5273(01)00574-5	22	546	593	1	21	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1916	1923		10.1056/NEJMoa021445	http://dx.doi.org/10.1056/NEJMoa021445			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623ZX	12477941				2022-12-28	WOS:000179735800003
J	Horton, R; Pablos-Mendez, A				Horton, R; Pablos-Mendez, A			Who's next Director-General: the person and the programme	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England; Rockefeller Fdn, New York, NY USA		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1799	1800		10.1016/S0140-6736(02)11843-5	http://dx.doi.org/10.1016/S0140-6736(02)11843-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480353				2022-12-28	WOS:000179706100003
J	Echeverri, K; Tanaka, EM				Echeverri, K; Tanaka, EM			Ectoderm to mesoderm lineage switching during axolotl tail regeneration	SCIENCE			English	Article							NEURAL STEM-CELLS; SPINAL-CORD REGENERATION; NERVOUS-SYSTEM; IN-VIVO; BRAIN; NEUROGENESIS; BLASTEMA; DERMIS	Foreign environments may induce adult stem cells to switch lineages and populate multiple tissue types, but whether this mechanism is used for tissue repair remains uncertain. Urodele amphibians can regenerate fully functional, multitissue structures including the limb and tail. To determine whether lineage switching is an integral feature of this regeneration, we followed individual spinal cord cells live during tail regeneration in the axolotl. Spinal cord cells frequently migrate into surrounding tissue to form regenerating muscle and cartilage. Thus, in axolotls, cells switch lineage during a real example of regeneration.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Tanaka, EM (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.		Echeverri, Karen/F-5422-2010; Tanaka, Elly M/F-8572-2010	Tanaka, Elly/0000-0003-4240-2158				Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; ARSANTO JP, 1992, J EXP ZOOL, V264, P273, DOI 10.1002/jez.1402640307; Benraiss A, 1999, DEV GENES EVOL, V209, P363, DOI 10.1007/s004270050265; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Chernoff EAG, 1996, INT J DEV BIOL, V40, P823; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; CLARKE JDW, 1988, NEUROSCI LETT, V89, P1, DOI 10.1016/0304-3940(88)90471-5; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; ECHEVERRI K, UNPUB; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; GERAUDIE J, 1988, AM J ANAT, V183, P359, DOI 10.1002/aja.1001830409; HAY ED, 1961, DEV BIOL, V3, P26, DOI 10.1016/0012-1606(61)90009-4; HOLDER N, 1988, TRENDS NEUROSCI, V11, P94, DOI 10.1016/0166-2236(88)90151-8; HOLTZER HOWARD, 1955, J MORPH, V96, P145, DOI 10.1002/jmor.1050960107; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Nolte C, 2001, GLIA, V33, P72; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Shih CC, 2001, BLOOD, V98, P2412, DOI 10.1182/blood.V98.8.2412; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	25	170	177	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1993	1996		10.1126/science.1077804	http://dx.doi.org/10.1126/science.1077804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471259				2022-12-28	WOS:000179629200046
J	Kashiwabara, S; Noguchi, J; Zhuang, T; Ohmura, K; Honda, A; Sugiura, S; Miyamoto, K; Takahashi, S; Inoue, K; Ogura, A; Baba, T				Kashiwabara, S; Noguchi, J; Zhuang, T; Ohmura, K; Honda, A; Sugiura, S; Miyamoto, K; Takahashi, S; Inoue, K; Ogura, A; Baba, T			Regulation of spermatogenesis by testis-specific, cytoplasmic poly(A) polymerase TPAP	SCIENCE			English	Article							GERM-CELL APOPTOSIS; MICE LACKING; SPERMIOGENESIS DEFICIENCY; GENE; TRANSCRIPTION; MOUSE; CREM; DIFFERENTIATION; TRANSLATION; EXPRESSION	Spermatogenesis is a highly specialized process of cellular differentiation to produce spermatozoa. This differentiation process accompanies morphological changes that are controlled by a number of genes expressed in a stage-specific manner during spermatogenesis. Here we show that in mice, the absence of a testis-specific, cytoplasmic polyadenylate [poly(A)] polymerase, TPAP, results in the arrest of spermiogenesis. TPAP-deficient mice display impaired expression of haploid-specific genes that are required for the morphogenesis of germ cells. The TPAP deficiency also causes incomplete elongation of poly(A) tails of particular transcription factor messenger RNAs. Although the overall cellular level of the transcription factor TAF10 is unaffected, TAF10 is insufficiently transported into the nucleus of germ cells. We propose that TPAP governs germ cell morphogenesis by modulating specific transcription factors at posttranscriptional and posttranslational levels.	Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058572, Japan; Natl Inst Agrobiol Resources, Germ Cell Conservat Lab, Tsukuba, Ibaraki 3058602, Japan; Inst Phys & Chem Res RIKEN, Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan	University of Tsukuba; University of Tsukuba; National Institute of Agrobiological Sciences - Japan; RIKEN	Baba, T (corresponding author), Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan.	acroman@sakura.cc.tsukuba.ac.jp	Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988				Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Chen Z, 2000, MOL CELL BIOL, V20, P5064, DOI 10.1128/MCB.20.14.5064-5076.2000; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Fimia GM, 2001, MOL CELL ENDOCRINOL, V179, P17, DOI 10.1016/S0303-7207(01)00463-4; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Han SY, 2001, BIOL REPROD, V64, P507, DOI 10.1095/biolreprod64.2.507; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; KASHIWABARA S, 1990, BIOCHEM BIOPH RES CO, V173, P240, DOI 10.1016/S0006-291X(05)81047-2; Kashiwabara S, 2000, DEV BIOL, V228, P106, DOI 10.1006/dbio.2000.9894; KIERSZENBAUM AL, 1975, J CELL BIOL, V65, P258, DOI 10.1083/jcb.65.2.258; KLEENE KC, 1989, DEVELOPMENT, V106, P367; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Metzger D, 1999, EMBO J, V18, P4823, DOI 10.1093/emboj/18.17.4823; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Steger K, 1999, ANAT EMBRYOL, V199, P471, DOI 10.1007/s004290050245; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	22	99	104	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					1999	2002		10.1126/science.1074632	http://dx.doi.org/10.1126/science.1074632			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471261				2022-12-28	WOS:000179629200048
J	Buckling, A; Rainey, PB				Buckling, A; Rainey, PB			The role of parasites in sympatric and allopatric host diversification	NATURE			English	Article							ESCHERICHIA-COLI; DIVERSITY; COEVOLUTION; COMPETITION; ADAPTATION; DIVERGENCE; PREDATION; EVOLUTION; MODEL	Exploiters (parasites and predators) are thought to play a significant role in diversification, and ultimately speciation, of their hosts or prey(1-3). Exploiters may drive sympatric (within-population) diversification if there are a variety of exploiter-resistance strategies or fitness costs associated with exploiter resistance(4-8). Exploiters may also drive allopatric (between-population) diversification by creating different selection pressures and increasing the rate of random divergence(9,10). We examined the effect of a virulent viral parasite (phage) on the diversification of the bacterium Pseudomonas fluorescens in spatially structured microcosms(11). Here we show that in the absence of phages, bacteria rapidly diversified into spatial niche specialists with similar patterns of diversity across replicate populations. In the presence of phages, sympatric diversity was greatly reduced, as a result of phage-imposed reductions in host density decreasing competition for resources. In contrast, allopatric diversity was greatly increased as a result of phage-imposed selection for resistance, which caused populations to follow divergent evolutionary trajectories. These results show that exploiters can drive diversification between populations, but may inhibit diversification within populations by opposing diversifying selection that arises from resource competition.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Bath; University of Oxford; University of Auckland	Buckling, A (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssagjb@bath.ac.uk	Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795; Buckling, Angus/0000-0003-1170-4604				Abram PA, 2000, AM NAT, V156, pS45, DOI 10.1086/303415; Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; BROWN JS, 1992, EVOLUTION, V46, P1269, DOI 10.1111/j.1558-5646.1992.tb01123.x; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Darwin C, 1872, ORIGIN SPECIES; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; HELLING RB, 1987, GENETICS, V116, P349; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Lack D., 1947, DARWINS FINCHES; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; SCHLUTER D, 2000, ECOLOGY ADAPTIVE RAD, V157, pS4; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stone HMI, 1998, PALAEONTOLOGY, V41, P1051; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Travis J, 1996, AM NAT, V148, pS1, DOI 10.1086/285899; Vamosi SM, 2002, P ROY SOC B-BIOL SCI, V269, P923, DOI 10.1098/rspb.2001.1946; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1111/j.1095-8312.1997.tb01777.x	29	203	209	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					496	499		10.1038/nature01164	http://dx.doi.org/10.1038/nature01164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466840				2022-12-28	WOS:000179611600043
J	Burke, W				Burke, W			Genomic medicine: Genetic testing	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FACTOR-V-LEIDEN; MEDULLARY-THYROID CARCINOMA; DEEP-VEIN THROMBOSIS; BREAST-CANCER; VENOUS THROMBOEMBOLISM; HEREDITARY HEMOCHROMATOSIS; PROPHYLACTIC THYROIDECTOMY; 22Q11.2 DELETION; IRON OVERLOAD; DOWN-SYNDROME		Univ Washington, Dept Med Hist & Eth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Burke, W (corresponding author), Univ Washington, Dept Med Hist & Eth, Box 357120,1959 NE Pacific,Rm A204, Seattle, WA 98195 USA.	wburke@u.washington.edu			NHGRI NIH HHS [R01-HG02263] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002263] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ABBS S, 1993, NEUROMUSCULAR DISORD, V3, P241, DOI 10.1016/0960-8966(93)90066-S; Adams P, 2000, J HEPATOL, V33, P487, DOI 10.1016/S0168-8278(01)80874-6; Andrews NC, 2000, NEW ENGL J MED, V342, P364; [Anonymous], 1975, Am J Hum Genet, V27, P240; Armstrong K, 2001, JAMA-J AM MED ASSOC, V285, P2907, DOI 10.1001/jama.285.22.2907; Asberg A, 2001, SCAND J GASTROENTERO, V36, P1108; Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Bacon BR, 1997, AM J GASTROENTEROL, V92, P784; Bauer KA, 2001, ANN INTERN MED, V135, P367, DOI 10.7326/0003-4819-135-5-200109040-00013; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; Brody LC, 1998, MEDICINE, V77, P208, DOI 10.1097/00005792-199805000-00006; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Burke W, 2000, GENET MED, V2, P271, DOI 10.1097/00125817-200009000-00001; Cao A, 1998, BAILLIERE CLIN HAEM, V11, P215, DOI 10.1016/S0950-3536(98)80076-0; Capone GT, 2001, J DEV BEHAV PEDIATR, V22, P40, DOI 10.1097/00004703-200102000-00007; *CDCP, 2002, HUM GEN EP NETW HUGE; Cogswell ME, 1998, ANN INTERN MED, V129, P971, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00008; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Crow JF, 2000, ANNU REV GENOM HUM G, V1, P21, DOI 10.1146/annurev.genom.1.1.21; Cummings S, 2000, J CLIN ONCOL, V18, p60S; De Decker HP, 2001, GENET MED, V3, P2, DOI 10.1097/00125817-200101000-00002; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Grody WW, 1999, ARCH PATHOL LAB MED, V123, P1041; Grody WW, 2001, GENET MED, V3, P87, DOI 10.1097/00125817-200103000-00001; Hanson EH, 2001, AM J EPIDEMIOL, V154, P193, DOI 10.1093/aje/154.3.193; Harper PS, 2000, J MED GENET, V37, P567, DOI 10.1136/jmg.37.8.567; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Hoff AO, 2000, ANNU REV PHYSIOL, V62, P377, DOI 10.1146/annurev.physiol.62.1.377; Holtzman N.A., 1999, PROMOTING SAFE EFFEC; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Hubbard R, 1996, NEW ENGL J MED, V334, P1192, DOI 10.1056/NEJM199605023341812; Kaprio J, 2000, BRIT MED J, V320, P1257, DOI 10.1136/bmj.320.7244.1257; Kebebew E, 2000, CANCER-AM CANCER SOC, V88, P1139, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z; KORF BR, 2000, DYSTROPHINOPATHIES I; Marteau TM, 2001, BMJ-BRIT MED J, V322, P1056, DOI 10.1136/bmj.322.7293.1056; Martinelli I, 2000, BRIT J HAEMATOL, V111, P1223, DOI 10.1046/j.1365-2141.2000.02502.x; McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006; MCDONALDMCGINN D, 2002, CHILDRENS HOSP PHILA; Meyer G, 2001, AM J MED, V110, P12, DOI 10.1016/S0002-9343(00)00653-7; Michie S, 1999, J Genet Couns, V8, P275, DOI 10.1023/A:1022930215375; Middeldorp S, 2001, ANN INTERN MED, V135, P322, DOI 10.7326/0003-4819-135-5-200109040-00008; *NAT CANC I, 2001, CANCERNET CANCERNET; *NAT CANC I, 2002, CANCERNET PDQ; *NAT CTR BIOT INF, 2002, OMIM ONL MEND INH MA; Niccoli-Sire P, 1999, EUR J ENDOCRINOL, V141, P468, DOI 10.1530/eje.0.1410468; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Pagon RA, 2001, BRIT MED J, V322, P1035, DOI 10.1136/bmj.322.7293.1035; PERGAMENT E, 2002, BAILLIERES BEST PRAC, V14, P677; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Raue F, 1998, LANGENBECK ARCH SURG, V383, P334, DOI 10.1007/s004230050143; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; Stewart A, 2001, BRIT MED J, V322, P1037, DOI 10.1136/bmj.322.7293.1037; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; TAIT JF, 2002, CYSTIC FIBROSIS; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; U.S. Preventive Services Task Force, 1996, GUID CLIN PREV SERV; *U WASH, 2002, GENETESTS GENECLINIC; Wald NJ, 2000, BEST PRACT RES CL OB, V14, P563, DOI 10.1053/beog.2000.0097; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241; WEISNER GL, 1999, MULTIPLE ENDOCRINE N; Welch HG, 1998, JAMA-J AM MED ASSOC, V280, P1525, DOI 10.1001/jama.280.17.1525; Wells SA, 1998, EXP CLIN ENDOCR DIAB, V106, P29, DOI 10.1055/s-0029-1211946; Ziv E, 2001, JAMA-J AM MED ASSOC, V285, P2859, DOI 10.1001/jama.285.22.2859	69	110	117	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2002	347	23					1867	1875		10.1056/NEJMoa012113	http://dx.doi.org/10.1056/NEJMoa012113			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NW	12466512				2022-12-28	WOS:000179596900009
J	Butler, D				Butler, D			Prion data suggest BSE link to sporadic CJD	NATURE			English	News Item																		Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; 2002, NATURE, V418, P266	3	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					450	450		10.1038/420450a	http://dx.doi.org/10.1038/420450a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466801	Bronze			2022-12-28	WOS:000179611600004
J	Lee, Y; Vogt, T; Hriljac, JA; Parise, JB; Hanson, JC; Kim, SJ				Lee, Y; Vogt, T; Hriljac, JA; Parise, JB; Hanson, JC; Kim, SJ			Non-framework cation migration and irreversible pressure-induced hydration in a zeolite	NATURE			English	Article							X-RAY; MOLECULAR-SIEVE; DIFFRACTION; NATROLITE; TEMPERATURE; PORES; RHO	Zeolites crystallize in a variety of three-dimensional structures in which oxygen atoms are shared between tetrahedra containing silicon and/or aluminium, thus yielding negatively charged tetrahedral frameworks that enclose cavities and pores of molecular dimensions occupied by charge-balancing metal cations and water molecules(1). Cation migration in the pores and changes in water content associated with concomitant relaxation of the framework have been observed in numerous variable-temperature studies(2-5), whereas the effects of hydrostatic pressure on the structure and properties of zeolites are less well explored(6-8). The zeolite sodium aluminosilicate natrolite was recently shown to undergo a volume expansion at pressures above 1.2 GPa as a result of reversible pressure-induced hydration(9); in contrast, a synthetic analogue, potassium gallosilicate natrolite, exhibited irreversible pressure-induced hydration with retention of the high-pressure phase at ambient conditions(10). Here we report the structure of the high-pressure recovered phase and contrast it with the high-pressure phase of the sodium aluminosilicate natrolite. Our findings show that the irreversible hydration behaviour is associated with a pronounced rearrangement of the non-framework metal ions, thus emphasizing that they can clearly have an important role in mediating the overall properties of zeolites.	Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA; Univ Birmingham, Sch Chem Sci, Birmingham B15 2TT, W Midlands, England; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; Korea Inst Sci & Technol, Nanomat Res Ctr, Seoul 130650, South Korea	United States Department of Energy (DOE); Brookhaven National Laboratory; University of Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory; Korea Institute of Science & Technology (KIST)	Vogt, T (corresponding author), Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA.	tvogt@bnl.gov	Hanson, jonathan C/E-3517-2010; Lee, Yongjae/K-6566-2016; Vogt, Thomas/A-1562-2011	Lee, Yongjae/0000-0002-2043-0804; Vogt, Thomas/0000-0002-4731-2787; Hriljac, Joseph/0000-0001-9978-6530; Hanson, Jonathan/0000-0003-0686-3985				Baur WH, 1996, NEUES JB MINER MONAT, P171; BELITSKY IA, 1992, PHYS CHEM MINER, V18, P497, DOI 10.1007/BF00205264; Breck D. W., 1984, ZEOLITE MOL SIEVES; Hazen R., 1982, COMP CRYSTAL CHEM, P231; HAZEN RM, 1983, SCIENCE, V219, P1065, DOI 10.1126/science.219.4588.1065; Kuznicki SM, 2001, NATURE, V412, P720, DOI 10.1038/35089052; Lee Y, 2002, J AM CHEM SOC, V124, P5466, DOI 10.1021/ja0255960; Lee Y, 2001, J AM CHEM SOC, V123, P12732, DOI 10.1021/ja017098h; Lee Y, 2001, J PHYS CHEM B, V105, P7188, DOI 10.1021/jp0100349; Lee Y, 2001, J AM CHEM SOC, V123, P8418, DOI 10.1021/ja0161554; Lee Y, 2000, MICROPOR MESOPOR MAT, V34, P255, DOI 10.1016/S1387-1811(99)00176-6; Miyamoto T, 1998, J PHYS CHEM B, V102, P6738, DOI 10.1021/jp980007r; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; SMITH GWR, 1991, NEW STATESMAN SOC, V4, P24	15	129	130	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					485	489		10.1038/nature01265	http://dx.doi.org/10.1038/nature01265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466838				2022-12-28	WOS:000179611600040
J	Kioussi, C; Briata, P; Baek, SH; Rose, DW; Hamblet, NS; Herman, T; Ohgi, KA; Lin, CJ; Gleiberman, A; Wang, JB; Brault, V; Ruiz-Lozano, P; Nguyen, HD; Kemler, R; Glass, CK; Wynshaw-Boris, A; Rosenfeld, MG				Kioussi, C; Briata, P; Baek, SH; Rose, DW; Hamblet, NS; Herman, T; Ohgi, KA; Lin, CJ; Gleiberman, A; Wang, JB; Brault, V; Ruiz-Lozano, P; Nguyen, HD; Kemler, R; Glass, CK; Wynshaw-Boris, A; Rosenfeld, MG			Identification of a Wnt/DVI/beta-catenin -> Pitx2 pathway mediating cell-type-specific proliferation during development	CELL			English	Article							BETA-CATENIN; GENE-EXPRESSION; RIEGER-SYNDROME; NEURAL CREST; DNA-REPAIR; CYCLIN D1; TRANSCRIPTION; PITX2; LIM; REQUIREMENTS	Understanding the cell type-specific molecular mechanisms by which distinct signaling pathways combinatorially control proliferation during organogenesis is a central issue in development and disease. Here, we report that the bicoid-related transcription factor Pitx2 is rapidly induced by the Wnt/Dvl/beta-catenin pathway and is required for effective cell-type-specific proliferation by directly activating specific growth-regulating genes. Regulated exchange of HDACi/beta-catenin converts Pitx2 from repressor to activator, analogous to control of TCF/LEFT. Pitx2 then serves as a competence factor required for the temporally ordered and growth factor-dependent recruitment of a series of specific coactivator complexes that prove necessary for Cyclin D2 gene induction. The molecular strategy underlying interactions between the Wnt and growth factor-dependent signaling pathways in cardiac outflow tract and pituitary proliferation is likely to be prototypic of cell-specific proliferation strategies in other tissues.	Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, UCSD Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Univ Calif Salk Program Mol Med, La Jolla, CA 92093 USA; Ist Nazl Ric Canc, I-16132 Genoa, Italy; Max Planck Inst Immunobiol, Dept Mol Embryol, D-79108 Freiburg, Germany	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Genoa; IRCCS AOU San Martino IST; Max Planck Society	Wynshaw-Boris, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, CMM-W,Room 345,9500 Gilman Dr, La Jolla, CA 92093 USA.	awynshawboris@popmail.ucsd.edu; mrosenfeld@ucsd.edu	Glass, Christopher/AAI-3933-2021; Briata, Paola/AAC-6039-2020	Glass, Christopher/0000-0003-4344-3592; Briata, Paola/0000-0003-3470-0454; gleiberman, anatoli/0000-0001-8491-0826; Brault, Veronique/0000-0002-1418-5849; Kioussi, Chrissa/0000-0001-8226-9908	NINDS NIH HHS [R01 NS073159] Funding Source: Medline; Telethon [GP0030Y01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073159] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Asahara H, 1999, MOL CELL BIOL, V19, P8219; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Brault V, 2001, DEVELOPMENT, V128, P1253; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Ericson J, 1998, DEVELOPMENT, V125, P1005; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gross MK, 2000, DEVELOPMENT, V127, P413; HAMBLET NS, 2002, IN PRESS DEVELOPMENT; Hampsey M, 1999, CURR OPIN GENET DEV, V9, P132, DOI 10.1016/S0959-437X(99)80020-3; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; HERMANSON O, 2002, IN PRESS NATURE; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; Megason SG, 2002, DEVELOPMENT, V129, P2087; Pinsonneault J, 1997, EMBO J, V16, P2032, DOI 10.1093/emboj/16.8.2032; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Serbedzija GN, 1996, J NEUROBIOL, V31, P275, DOI 10.1002/(SICI)1097-4695(199611)31:3<275::AID-NEU1>3.0.CO;2-7; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Waldo KL, 1999, DEV BIOL, V208, P307, DOI 10.1006/dbio.1999.9219; Wei Q, 2002, MOL BIOL CELL, V13, P683, DOI 10.1091/mbc.01-07-0358; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270	51	446	459	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	2002	111	5					673	685		10.1016/S0092-8674(02)01084-X	http://dx.doi.org/10.1016/S0092-8674(02)01084-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464179	Bronze			2022-12-28	WOS:000179594500009
J	Morgenstern, L				Morgenstern, L			Will the real doctor please stand up?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					18	18		10.1001/jama.289.1.18	http://dx.doi.org/10.1001/jama.289.1.18			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630XL	12503955				2022-12-28	WOS:000180136600001
J	Andrulis, ED; Werner, J; Nazarian, A; Erdjument-Bromage, H; Tempst, P; Lis, JT				Andrulis, ED; Werner, J; Nazarian, A; Erdjument-Bromage, H; Tempst, P; Lis, JT			The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila	NATURE			English	Article							HEAT-SHOCK LOCI; TRANSCRIPTION ELONGATION; PROMOTER; SPT5; IDENTIFICATION; INFORMATION; RECRUITMENT; COMPLEX; HSF	The RNA polymerase II elongation complex contains several factors that facilitate transcription elongation and catalyse the processing of precursor messenger RNAs (pre-mRNAs)(1-3). The conserved elongation factor Spt6 is recruited rapidly and robustly to sites of active transcription(4,5). Here we show that Drosophila Spt6 (dSpt6) co-purifies with the exosome, a complex of 3' to 5' exoribonucleases that is implicated in the processing of structural RNA and in the degradation of improperly processed pre-mRNA(6-10). Immunoprecipitation assays of Drosophila nuclear extracts show that the exosome also associates with the elongation factor dSpt5 and RNA polymerase II. In vivo, exosome subunits colocalize with dSpt6 at transcriptionally active loci on polytene chromosomes during normal development and are strongly recruited to heat-shock loci on gene induction. At higher resolution, chromatin immunoprecipitation analysis shows that the exosome is recruited to transcriptionally active units of heat-shock genes. These data provide a physical basis for the hypothesis that exosome-mediated pre-mRNA surveillance accompanies transcription elongation.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.			Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Fenyo D, 1998, ELECTROPHORESIS, V19, P998, DOI 10.1002/elps.1150190615; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geromanos S, 2000, ANAL CHEM, V72, P777, DOI 10.1021/ac991071n; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Hirose Y, 2000, GENE DEV, V14, P1415; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Lis JT, 2000, GENE DEV, V14, P792; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; Mitchell P, 2000, NAT STRUCT BIOL, V7, P843, DOI 10.1038/82817; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Shopland LS, 1996, CHROMOSOMA, V105, P158, DOI 10.1007/BF02509497; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272	23	206	210	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					837	841		10.1038/nature01181	http://dx.doi.org/10.1038/nature01181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490954				2022-12-28	WOS:000179897300062
J	Shinkai, K; Mohrs, M; Locksley, RM				Shinkai, K; Mohrs, M; Locksley, RM			Helper T cells regulate type-2 innate immunity in vivo	NATURE			English	Article							NIPPOSTRONGYLUS-BRASILIENSIS; AIRWAY HYPERRESPONSIVENESS; EOSINOPHILS; DEGRANULATION; IL-5; INTERLEUKIN-5; EXPRESSION; RESPONSES; INDUCTION; PROTEINS	Type-2 immunity requires orchestration of innate and adaptive immune responses to protect mucosal sites from pathogens. Dysregulated type-2 responses result in allergy or asthma(1). T helper 2 (T(H)2) cells elaborate cytokines, such as interleukin (IL)-4, IL-5, IL-9 and IL-13, which work with toxic mediators of innate immune cells to establish environments that are inhospitable to helminth or arthropod invaders(2). The importance of T(H)2 cells in coordinating innate immune cells at sites of inflammation is not known. Here we show that polarized type-2 immune responses are initiated independently of adaptive immunity. In the absence of B and T cells, IL-4-expressing eosinophils were recruited to tissues of mice infected with the helminth Nippostrongylus brasiliensis, but eosinophils failed to degranulate. Reconstitution with CD4 T cells promoted accumulation of degranulated IL-4-expressing cells, but only if T cells were stimulated with cognate antigen. Degranulation correlated with tissue destruction, which was attenuated if eosinophils were depleted. Helper T cells confer antigen specificity on eosinophil cytotoxicity, but not cytokine responses, so defining a novel mechanism that focuses tissue injury at sites of immune challenge.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Immunol Microbiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.							Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; CONRAD DH, 1990, J EXP MED, V171, P1497, DOI 10.1084/jem.171.5.1497; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Dvorak AM, 1998, INT REV CYTOL, V180, P87; Dvorak AM, 2000, CHEM IMMUNOL, V76, P1; Erjefalt JS, 2000, AM J RESP CRIT CARE, V161, P2074, DOI 10.1164/ajrccm.161.6.9906085; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Foster PS, 2002, TRENDS MOL MED, V8, P162, DOI 10.1016/S1471-4914(02)02302-X; Foster PS, 2001, IMMUNOL REV, V179, P173, DOI 10.1034/j.1600-065X.2001.790117.x; Fowell DJ, 1997, IMMUNITY, V6, P559, DOI 10.1016/S1074-7613(00)80344-1; Justice JP, 2002, AM J PHYSIOL-LUNG C, V282, pL302, DOI 10.1152/ajplung.00158.2001; Karawajczyk M, 2000, AM J RESP CELL MOL, V23, P521, DOI 10.1165/ajrcmb.23.4.4025; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee NA, 1997, J IMMUNOL, V158, P1332; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Milgrom H, 1999, NEW ENGL J MED, V341, P1966, DOI 10.1056/NEJM199912233412603; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mould AW, 2000, J IMMUNOL, V164, P2142, DOI 10.4049/jimmunol.164.4.2142; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Rumbley CA, 1999, J IMMUNOL, V162, P1003; Sabin EA, 1996, J EXP MED, V184, P1871, DOI 10.1084/jem.184.5.1871; SCHNARE M, 2001, NAT IMMUNOL, V29, P47; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Walsh GM, 2001, CURR OPIN HEMATOL, V8, P28, DOI 10.1097/00062752-200101000-00006; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255	30	158	165	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					825	829		10.1038/nature01202	http://dx.doi.org/10.1038/nature01202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490951				2022-12-28	WOS:000179897300059
J	Williams, KA; Veenhuizen, PTM; de la Torre, BG; Eritja, R; Dekker, C				Williams, KA; Veenhuizen, PTM; de la Torre, BG; Eritja, R; Dekker, C			Nanotechnology - Carbon nanotubes with DNA recognition	NATURE			English	Article							ROOM-TEMPERATURE; TRANSISTORS		Delft Univ Technol, Dept Nanosci, NL-2628 CJ Delft, Netherlands; CSIC, Inst Biol Mol Barcelona, Barcelona 08034, Spain	Delft University of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Williams, KA (corresponding author), Delft Univ Technol, Dept Nanosci, NL-2628 CJ Delft, Netherlands.		de la Torre, Beatriz G./N-6995-2019; de la Torre, Beatriz G/AAF-1419-2020; Eritja, Ramon/B-5613-2008	de la Torre, Beatriz G./0000-0001-8521-9172; Eritja, Ramon/0000-0001-5383-9334; Dekker, Cees/0000-0001-6273-071X				Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95; Derycke V, 2001, NANO LETT, V1, P453, DOI 10.1021/nl015606f; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Huang WJ, 2002, NANO LETT, V2, P311, DOI [10.1021/nl010095i, 10.1021/n1010095i]; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Wang J, 1998, BIOSENS BIOELECTRON, V13, P757, DOI 10.1016/S0956-5663(98)00039-6; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873	12	459	482	2	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					761	761		10.1038/420761a	http://dx.doi.org/10.1038/420761a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490938	Green Submitted			2022-12-28	WOS:000179897300045
J	Als, C; Stussi, Y; Boschung, U; Trohler, U; Waber, JH				Als, C; Stussi, Y; Boschung, U; Trohler, U; Waber, JH			Visible signs of illness from the 14th to the 20th century: systematic review of portraits	BRITISH MEDICAL JOURNAL			English	Article								Objectives To see whether a collection of portraits depicting inhabitants of a defined geographical region and covering several centuries is a useful source for studying the sociocultural significance and epidemiology of particular visible diseases, such as goitre, which is known to have been common in this region. Design Systematic review of portraits and description of visible signs of illness. Setting The Burgerbibliothek (archives of the burghers' community) in Berne, Switzerland. Data sources 3615 portraits; 2989 of individuals whose identity is known and 626 of individuals whose identity is unknown. Main outcome measures Visible signs of illness evaluated by means of a standardised visual assessment. Results Visible signs of disease in portraits were common and appeared in up to 82% (451/553) of paintings from the 17th and 18th centuries. The most common findings were signs of goitre in women and overweight in men. In only the portraits where the neck region could be evaluated, 41% of women with known identifies (139/343) had goitre compared with 24% of men with known identities (21/86). ne prevalence of goitre was even higher in sitters whose identities were unknown: 63% in men (5/8) and 68% in women (82/121). Overweight in sitters with known identities was more common in men than in women (30%, 346/1145 v 44%, 811/1844). It was more common in sitters aged >40 than in those aged 40 or younger. Other conditions, such as missing teeth, amputated limbs, or osteoarthritic deformations were surprisingly rare in the portraits under evaluation. Conclusions Goitre and other diseases are under-represented in the people depicted in these portraits. Artistic idealisation is a likely explanation for this observation: what was reproduced depended on what was considered pathological or shameful at the time, and thus depended on age and sex. Stigmatising details may have been omitted. Further, artistic skills and contemporary fashion may have influenced the way in which people were reproduced. People depicted are possibly not representative of the general Bernese population as they constituted a socioeconomically advantaged group.	Univ Bern, Inselspital, Chem Lab, CH-3010 Bern, Switzerland; Univ Bern, Inst Hist Med, CH-3010 Bern, Switzerland; Univ Freiburg, Inst Hist Med, D-79104 Freiburg, Germany; Burgerbibliothek, CH-3011 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Freiburg	Als, C (corresponding author), Univ Bern, Inselspital, Chem Lab, CH-3010 Bern, Switzerland.							Als C, 2000, EUR J ENDOCRINOL, V143, P629, DOI 10.1530/eje.0.1430629; ALS C, 2002, IN PRESS HIST LEXIKO, V2; ALS G, 2002, IN PRESS HIST LEXIKO, V2; Appelboom T, 1988, AFFECTIONS RHUMATISM, P41; Berger HM, 2000, LANCET, V356, P847, DOI 10.1016/S0140-6736(00)02665-9; BORRONI G, 1992, AM J DERMATOPATH, V14, P170, DOI 10.1097/00000372-199204000-00017; DIEKMEYER L, 1960, ORVOSI HETILAB, V36, P1289; EBSTEIN W, 1887, FETTLEIBIGKEIT CORPU, P9; FREIVOGEL T, 2002, E HANDMANN 1718 1781, P77; HACKMANN WD, 1986, APPLES ATOMS PORTRAI; HADORN W, 1960, LEHRBUCH MED SYMPTOM, P1; HAEBERLI H, 1983, ANGESICHT ANGESICHT; Jordanova Ludmilla, 2000, DEFINING FEATURES SC; KOCHER T, 1889, MITTEILUNGEN NATURFO, V6, P141; MERKE F, 1987, HIST ICONOGRAPHY END; Merke F., 1984, HIST ICONOGRAPHY END; MULLER C, 1959, BERNER BEITRAGE GESC, P1; MULLER C, 1959, BERNER BEITRAGE GESC, V17, P1; PFISTER C, 1998, HIST STAT ATLAS KANI; PFISTER C, 1998, HIST STAT ATLAS KANT; PIRSIG W, 1995, AM J OTOLARYNG, V2, P141; SALOMONE G, 1994, ITAL J NEUROL SCI, V15, P203, DOI 10.1007/BF02339324; Sharma P, 1997, LANCET, V349, P1470, DOI 10.1016/S0140-6736(96)12216-9; WABER JH, 2002, BURGERBIBLIOTHEK BER, P131	24	10	11	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1499	+		10.1136/bmj.325.7378.1499	http://dx.doi.org/10.1136/bmj.325.7378.1499			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493682	Green Published			2022-12-28	WOS:000180188600034
J	Lomborg, B				Lomborg, B			How healthy is the world?	BRITISH MEDICAL JOURNAL			English	Article								We are often told that we are destroying our environment and that living conditions are deteriorating. The author of The Skeptical Environmentalist looks at global data and comes up with a more optimistic view.	Danish Environm Assessment Inst, DK-1361 Copenhagen K, Denmark		Lomborg, B (corresponding author), Danish Environm Assessment Inst, Linnesgade 18, DK-1361 Copenhagen K, Denmark.							Bongaarts J, 2002, SCI AM, V286, P67; SHAFIK N, 1994, OXFORD ECON PAP, V46, P757, DOI 10.1093/oep/46.Supplement_1.757; Wigley TML, 1998, GEOPHYS RES LETT, V25, P2285, DOI 10.1029/98GL01855	3	1	1	2	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1461	1464		10.1136/bmj.325.7378.1461	http://dx.doi.org/10.1136/bmj.325.7378.1461			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493669				2022-12-28	WOS:000180188600021
J	Boehning, D; Snyder, SH				Boehning, D; Snyder, SH			Carbon monoxide and clocks	SCIENCE			English	Editorial Material							HEME OXYGENASE-2; NERVOUS-SYSTEM; NITRIC-OXIDE; GENE; DELETION; NEURONS; NPAS2; MICE		Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Boehning, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Boehning, Darren/I-8539-2015	Boehning, Darren/0000-0001-7920-6922				Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; BOEHNING D, 2002, 32 ANN M SOC NEUR OR; Burnett AL, 1998, NAT MED, V4, P84, DOI 10.1038/nm0198-084; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Ingi T, 1996, J NEUROSCI, V16, P5621; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; VINCENT SR, 1994, NEUROSCIENCE, V63, P223, DOI 10.1016/0306-4522(94)90018-3; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Xue L, 2000, P NATL ACAD SCI USA, V97, P1851, DOI 10.1073/pnas.97.4.1851; Zakhary R, 1997, P NATL ACAD SCI USA, V94, P14848, DOI 10.1073/pnas.94.26.14848; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	15	41	42	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2339	2340		10.1126/science.1080339	http://dx.doi.org/10.1126/science.1080339			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493901				2022-12-28	WOS:000179915900040
J	Innerarity, TL				Innerarity, TL			LDL receptor's beta-propeller displaces LDL	SCIENCE			English	Editorial Material							APOLIPOPROTEIN-E; TRANSPORT PROTEIN; BINDING SITE; IDENTIFICATION; APO-B100		Gladstone Inst Cardiovasc Dis, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes	Innerarity, TL (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94110 USA.	tinnerarity@gladstone.ucsf.edu						Boren J, 1998, J CLIN INVEST, V101, P1084, DOI 10.1172/JCI1847; Boren J, 1998, J CLIN INVEST, V101, P2658, DOI 10.1172/JCI2265; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194	10	23	23	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2337	2339		10.1126/science.1080669	http://dx.doi.org/10.1126/science.1080669			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493900				2022-12-28	WOS:000179915900039
J	Raymond, CF				Raymond, CF			Ice sheets on the move	SCIENCE			English	Editorial Material							ANTARCTICA		Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Raymond, CF (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.							Alley R.B., 2001, W ANTARCTIC ICE SHEE, V77, P1, DOI [10.1029/AR077p0001, DOI 10.1029/AR077P0001]; ALLEY RB, 1994, ANN GLACIOL, V20, P187, DOI 10.3189/172756494794587032; Bamber JL, 2000, SCIENCE, V287, P1248, DOI 10.1126/science.287.5456.1248; Gregory JM, 1998, NATURE, V391, P474, DOI 10.1038/35119; HUGHES T, 1992, J GLACIOL, V38, P125, DOI 10.3189/S0022143000009667; HUGHES TJ, 1981, J GLACIOL, V27, P518, DOI 10.3189/S002214300001159X; Jacobson HP, 1998, J GEOPHYS RES-SOL EA, V103, P12111, DOI 10.1029/98JB00574; Jezek KC, 1999, ANN GLACIOL-SER, V29, P286, DOI 10.3189/172756499781820969; Joughin I, 2002, SCIENCE, V295, P476, DOI 10.1126/science.1066875; Kamb B., 2001, ANTARCT RES SER, V77, DOI DOI 10.1029/AR077P0157; Parizek BR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014326; PARIZEK BR, 2002, GEOPHYS RES LETT, V29, P1682, DOI DOI 10.1029/2002GL015704; Rignot E, 2002, SCIENCE, V297, P1502, DOI 10.1126/science.1073888; Shepherd A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014183; Tulaczyk S, 2000, J GEOPHYS RES-SOL EA, V105, P483, DOI 10.1029/1999JB900328	15	6	7	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2147	2148		10.1126/science.1079169	http://dx.doi.org/10.1126/science.1079169			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481127				2022-12-28	WOS:000179773700036
J	Smaglik, P				Smaglik, P			Blurred vision	NATURE			English	Article																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916		S			A19	+		10.1038/420a19a	http://dx.doi.org/10.1038/420a19a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625LG	12501122	Bronze			2022-12-28	WOS:000179817500004
J	Bliss, S; Weinberger, S; Meier, M; Saint, S				Bliss, S; Weinberger, S; Meier, M; Saint, S			The unusual suspect	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PAGET-SCHROETTER-SYNDROME; PULMONARY-EMBOLISM; CATHETERIZATION; PATIENT		Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Vet Affairs Hlth Serv Res & Dev Field Program, Ann Arbor, MI USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Michigan Hlth Syst, Patient Safety Enhancement Program, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan	Bliss, S (corresponding author), Univ Michigan Hlth Syst, Canton Hlth Ctr, 1051 N Canton Ctr Rd, Canton, MI 48187 USA.		Saint, Sanjay/AAF-5126-2019		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011540] Funding Source: NIH RePORTER; AHRQ HHS [P20-HS11540] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Adelman MA, 1997, ANN VASC SURG, V11, P149, DOI 10.1007/s100169900025; BERNSTEIN D, 1986, AM J DIS CHILD, V140, P667, DOI 10.1001/archpedi.1986.02140210065028; CONNORS AF, 1983, NEW ENGL J MED, V308, P263, DOI 10.1056/NEJM198302033080508; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P630, DOI 10.1001/jama.275.8.630; DAVID M, 1993, J PEDIATR-US, V123, P337, DOI 10.1016/S0022-3476(05)81730-5; EISENBERG PR, 1984, CRIT CARE MED, V12, P549, DOI 10.1097/00003246-198407000-00001; Goldhaber SZ, 1998, NEW ENGL J MED, V339, P93, DOI 10.1056/NEJM199807093390207; GREEN RM, 1992, CHEST, V101, P1507, DOI 10.1378/chest.101.6.1507; Kommareddy A, 2002, SEMIN THROMB HEMOST, V28, P89, DOI 10.1055/s-2002-20567; Kreienberg PB, 2001, J VASC SURG, V33, pS100, DOI 10.1067/mva.2001.111664; MACHLEDER HI, 1993, J VASC SURG, V17, P305, DOI 10.1016/0741-5214(93)90416-J; MAKHOUL RG, 1992, J VASC SURG, V16, P534, DOI 10.1016/0741-5214(92)90161-Z; Nichols A W, 1996, J Am Board Fam Pract, V9, P346; Urschel HC, 2000, ANN THORAC SURG, V69, P1663, DOI 10.1016/S0003-4975(00)01151-6	14	14	14	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2002	347	23					1876	1881		10.1056/NEJMcps021566	http://dx.doi.org/10.1056/NEJMcps021566			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NW	12466513				2022-12-28	WOS:000179596900010
J	Clarke, CE; Guttman, M				Clarke, CE; Guttman, M			Dopamine agonist monotherapy in Parkinson's disease	LANCET			English	Review							6-HYDROXYDOPAMINE; PRAMIPEXOLE; LEVODOPA; TOXICITY; NEURONS; DEATH	Context Levodopa is the gold-standard therapy for Parkinson's disease. However, long-term treatment leads to involuntary movements and response fluctuations which add to the complexities of later disease-management. In addition, preclinical evidence suggests that levodopa is toxic to dopaminergic neurons. These problems have led to a move away from levodopa towards initial monotherapy with a dopamine agonist. Starting point Positron-emission tomography (PET) and single-photon emission computed tomography (SPECT) tracers have been developed which may be considered surrogate markers for remaining dopaminergic neurons. In a randomised controlled trail in patients with early Parkinson's disease, the Parkinson Study Group used I-123-beta-CIT SPECT (JAMA 2002; 287: 1653-61). Those patients give pramipexole had significantly reduced loss of straital uptake at 46 months compared with those given levodopa (16.0% vs 25.5% ). In a similar trial, Alan Whone and colleagues used F-18-DOPA PET (Neurology 2002; 58 [suppl 3]: A82-83). Patients given ropinirole had significantly reduced loss of striatal uptake at 24 months compared with those given levodopa (13% vs 20%). These studies suggest that agonist monotherapy may be neuroprotective and/or that levodopa is toxic. This work has been criticised as the SPECT results may have resulted from a differential effect of the agonist and levodopa on the regulation of the dopamine transporter, thereby influencing the imaging outcome measure. Other criticisms include insufficient data on the use of the potential neuroprotectant selegiline and patients on pramipexole in the SPECT study appear to have been clinically slow progressors. Single clinical trials with each of the four modern agonists compared with levodopa show that as monotherpy the agonist delay the onset of involuntary movements, although at the expense of poorer treatment of motor impairments and disability and more dopaminergic adverse events. The only health-related quality of life data show no difference between pramipexole and levodopa after 4-years. No information on health-economics measures is available but agonists cost two to three times as much as levodopa. Where next? Young patients should be treated with agonist monotherapy since the trials included predominantly younger patients who have a higher incidence of motor complications. Those with significant co-morgidity, dementia, or a short life-expectancy should be treated with the lowest dose of levodopa required to maintain motor function. For the vast majority though, no clear guidance can be given. Further large-scale pragmatic trails in large numbers of patients over prolonged periods are urgently required.	Univ Birmingham, Dept Neurol, Birmingham, W Midlands, England; Univ Toronto, Div Neurol, Toronto, ON, Canada	University of Birmingham; University of Toronto	Clarke, CE (corresponding author), City Hosp, Dept Neurol, Birmingham B18 7QH, W Midlands, England.			Clarke, Carl/0000-0003-2478-3436				ASANUMA M, 1995, ARCH INT PHARMACOD T, V329, P221; BROOKS DJ, 2000, MOVEMENT DISORD S3, V15, P308; Carvey PM, 1997, J NEURAL TRANSM, V104, P209, DOI 10.1007/BF01273182; Clarke CE, 2002, NEUROLOGY, V58, pA469; Gassen M, 1998, MOVEMENT DISORD, V13, P661, DOI 10.1002/mds.870130409; Guttman M, 2001, NEUROLOGY, V56, P1559, DOI 10.1212/WNL.56.11.1559; Holloway R, 2000, JAMA-J AM MED ASSOC, V284, P1931, DOI 10.1001/jama.284.15.1931; Marek K, 2002, JAMA-J AM MED ASSOC, V287, P1653; MICHEL PP, 1990, J NEUROSCI RES, V26, P428, DOI 10.1002/jnr.490260405; Morrish P, 2002, MOVEMENT DISORD, V17, P229, DOI 10.1002/mds.10112; OERTEL WH, 2000, MOV DISORD S3, V15, P4; *PARK DIS SOC, 1994, M NEED; *PARK STUD GROUP, 2002, NEUROLOGY S3, V58, pA81; QUINN N, 1986, LANCET, V2, P985; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Rinne UK, 1999, PARKINSONISM RELAT D, V5, pS84; TANAKA M, 1991, J NEUROL SCI, V101, P198, DOI 10.1016/0022-510X(91)90046-A; Wheatley K, 2002, BMJ-BRIT MED J, V324, P1508, DOI 10.1136/bmj.324.7352.1508; Whone AL, 2002, NEUROLOGY, V58, pA82; ZIV I, 1994, NEUROSCI LETT, V170, P136, DOI 10.1016/0304-3940(94)90258-5	20	93	103	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1767	1769		10.1016/S0140-6736(02)11668-0	http://dx.doi.org/10.1016/S0140-6736(02)11668-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480442				2022-12-28	WOS:000179636800026
J	Georgiou, G				Georgiou, G			How to flip the (redox) switch	CELL			English	Review							OXYR TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; ACTIVATION; OXIDATION; STRESS	Redox-sensitive transcription factors such as the E. coli OxyR and S. cerevisiae Yap1, are activated by conformational changes that stem from the posttranslational modification of reactive protein thiols. Recent studies provide new insights on how different agents that cause redox stress mediate the activation of transcription through distinct and specific pathways.	Univ Texas, Dept Chem Engn, Austin, TX 78712 USA; Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA; Univ Texas, Inst Cell & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Georgiou, G (corresponding author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.							Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Avery AM, 2001, J BIOL CHEM, V276, P33730, DOI 10.1074/jbc.M105672200; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; HELMANN JD, 2002, SCI STKE; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; KISHIGAMI S, 1995, FEBS LETT, V364, P55, DOI 10.1016/0014-5793(95)00354-C; SEEBORG DE, 1989, PROCESS DYNAMICS CON; Tao K, 1999, FEBS LETT, V457, P90, DOI 10.1016/S0014-5793(99)01013-3; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	16	123	130	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 27	2002	111	5					607	610		10.1016/S0092-8674(02)01165-0	http://dx.doi.org/10.1016/S0092-8674(02)01165-0			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464172	Bronze			2022-12-28	WOS:000179594500002
J	Tronvik, E; Stovner, LJ; Helde, G; Sand, T; Bovim, G				Tronvik, E; Stovner, LJ; Helde, G; Sand, T; Bovim, G			Prophylactic treatment of migraine with an angiotensin II receptor blocker - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANDESARTAN; PLACEBO; COUGH; RATS	Context There is a paucity of effective, well-tolerated drugs available for migraine prophylaxis. Objective To determine whether treatment with the angiotensin II receptor blocker candesartan is effective as a migraine-prophylactic drug. Design and Setting Randomized, double-blind, placebo-controlled crossover study performed in a Norwegian neurological outpatient clinic from January 2001 to February 2002. Patients Sixty patients aged 18 to 65 years with 2 to 6 migraine attacks per month were recruited mainly from newspaper advertisements. Interventions A placebo run-in period of 4 weeks was followed by two 12-week treatment periods separated by 4 weeks of placebo washout. Thirty patients were randomly assigned to receive one 16-mg candesartan cilexetil tablet daily in the first treatment period followed by 1 placebo tablet daily in the second period. The remaining 30 received placebo followed by candesartan. Main Outcome Measures The primary end point was number of days with headache; secondary end points included hours with headache, days with migraine, hours with migraine, headache severity index, level of disability, doses of triptans, doses of analgesics, acceptability of treatment,days of sick leave, and quality-of-life variables on the Short Form 36 questionnaire. Results In a period of 12 weeks, the mean number of days with headache was 18.5 with placebo vs 13.6 with candesartan (P=.001) in the intention-to-treat analysis (n=57). Some secondary end points also favored candesartan, including hours with headache (139 vs 95; P<.001), days with migraine (12.6 vs 9.0; P<.001), hours with migraine (92.2 vs 59.4; P<.001), headache severity index (293 vs 191; P<.001), level of disability (20.6 vs 14.1; P<.001) and days of sick leave (3.9 vs 1.4; P=.01), although there were no significant differences in health-related quality of life. The number of candesartan responders (reduction of &GE;50% compared with placebo) was 18 (31.6%) of 57 for days with headache and 23 (40.4%) of 57 for days with migraine. Adverse events Were similar in the 2 periods. Conclusion In this study, the angiotensin II receptor blocker candesartan provided effective migraine prophylaxis, with a tolerability profile comparable with that of placebo.	Norwegian Univ Sci & Technol, Dept Neurol & Clin Neurophysiol, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Tronvik, E (corresponding author), St Olavs Hosp, Dept Neurol & Clin Neurophysiol, Olav Kyrres Gate 17, N-7030 Trondheim, Norway.							Allen AM, 1998, BRAIN RES BULL, V47, P17, DOI 10.1016/S0361-9230(98)00039-2; Baltatu O, 2002, J NEUROCHEM, V80, P328, DOI 10.1046/j.0022-3042.2001.00701.x; CHEL, 1998, ACC SCN S REP, P82; Diener HC, 2002, CEPHALALGIA, V22, P209, DOI 10.1046/j.1468-2982.2002.t01-1-00309.x; Etminan M, 2002, AM J MED, V112, P642, DOI 10.1016/S0002-9343(02)01100-2; Ferrari MD, 2001, LANCET, V358, P1668, DOI 10.1016/S0140-6736(01)06711-3; HERING R, 1992, CEPHALALGIA, V12, P81, DOI 10.1046/j.1468-2982.1992.1202081.x; HOLROYD KA, 1991, HEADACHE, V31, P333, DOI 10.1111/j.1526-4610.1991.hed3105333.x; Kirk JK, 1999, AM FAM PHYSICIAN, V59, P3140; Lalloo UG, 1996, J ALLERGY CLIN IMMUN, V98, pS91, DOI 10.1016/S0091-6749(96)80134-5; Limmroth V, 2001, BRIT J CLIN PHARMACO, V52, P237, DOI 10.1046/j.0306-5251.2001.01459.x; Lorenzo O, 2002, J AM SOC NEPHROL, V13, P1162, DOI 10.1681/ASN.V1351162; Mathew NT, 2001, HEADACHE, V41, pS18; MENDELSOHN FAO, 1993, BRAIN RES, V613, P221; Nishimura Y, 2000, STROKE, V31, P2478, DOI 10.1161/01.STR.31.10.2478; Phillips P, 1998, JAMA-J AM MED ASSOC, V280, P1975, DOI 10.1001/jama.280.23.1975; Pillans PI, 1996, EUR J CLIN PHARMACOL, V51, P123, DOI 10.1007/s002280050171; RAMADAN NM, 2002, EVIDENCE BASED GUIDE; Reuter U, 2002, ANN NEUROL, V51, P507, DOI 10.1002/ana.10159; Schrader H, 2001, BMJ-BRIT MED J, V322, P19, DOI 10.1136/bmj.322.7277.19; Stoukides CA, 1999, ANN PHARMACOTHER, V33, P1287, DOI 10.1345/aph.19005; Tanaka H, 2001, CIRCULATION, V104, P281, DOI 10.1161/01.CIR.104.3.281; Tfelt-Hansen P, 2000, CEPHALALGIA, V20, P765; van der Kuy PH, 2002, CEPHALALGIA, V22, P265, DOI 10.1046/j.1468-2982.2002.00363.x; WARE JE, 1994, INT J MENT HEALTH, V23, P49, DOI 10.1080/00207411.1994.11449283	25	212	223	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					65	69		10.1001/jama.289.1.65	http://dx.doi.org/10.1001/jama.289.1.65			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630XL	12503978	Bronze			2022-12-28	WOS:000180136600027
J	Nathan, C				Nathan, C			Points of control in inflammation	NATURE			English	Review							LEUKOCYTE PROTEASE INHIBITOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ENCODING MEVALONATE KINASE; COLONY-STIMULATING FACTOR; ALDRICH-SYNDROME PROTEIN; MICE LACKING; TARGETED DISRUPTION; HYDROGEN-PEROXIDE; DEFICIENT MICE; NEUTROPHIL ACTIVATION	Inflammation is a complex set of interactions among soluble factors and cells that can arise in any tissue in response to traumatic, infectious, post-ischaemic, toxic or autoimmune injury. The process normally leads to recovery from infection and to healing, However, if targeted destruction and assisted repair are not properly phased, inflammation can lead to persistent tissue damage by leukocytes, lymphocytes or collagen. Inflammation may be considered in terms of its checkpoints, where binary or higher-order signals drive each commitment to escalate, go signals trigger stop signals, and molecules responsible for mediating the inflammatory response also suppress it, depending on timing and context. The non-inflammatory state does not arise passively from an absence of inflammatory stimuli; rather, maintenance of health requires the positive actions of specific gene products to suppress reactions to potentially inflammatory stimuli that do not warrant a full response.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Grad Program Immunol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Grad Program Mol Biol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Nathan, C (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, Box 62,1300 York Ave, New York, NY 10021 USA.	cnathan@med.cornell.edu	Matsue, Tomokazu/CAF-0782-2022; Matsue, Tomokazu/F-9688-2010; Torimitsu, Keiichi/A-3078-2011					Aksentijevich I, 1997, CELL, V90, P797; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Barton D, 2000, EUR J IMMUNOL, V30, P2323, DOI 10.1002/1521-4141(2000)30:8<2323::AID-IMMU2323>3.0.CO;2-H; Basu S, 2000, CELL STRESS CHAPERON, V5, P443, DOI 10.1379/1466-1268(2000)005<0443:HSPTFO>2.0.CO;2; Bernot A, 1997, NAT GENET, V17, P25; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Biesma DH, 2001, J CLIN INVEST, V108, P233, DOI 10.1172/JCI12023; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Bunting M, 2002, CURR OPIN HEMATOL, V9, P30, DOI 10.1097/00062752-200201000-00006; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Chen ZB, 2000, J EXP MED, V192, P1339, DOI 10.1084/jem.192.9.1339; CLARK RA, 1979, J CLIN INVEST, V64, P913, DOI 10.1172/JCI109557; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Daheshia M, 2001, J EXP MED, V194, P227, DOI 10.1084/jem.194.2.227; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Fink M P, 1994, Semin Respir Infect, V9, P256; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Grobmyer SR, 2000, CRIT CARE MED, V28, P1276, DOI 10.1097/00003246-200005000-00003; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hodge-Dufour J, 1998, P NATL ACAD SCI USA, V95, P13806, DOI 10.1073/pnas.95.23.13806; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ishikawa H, 1998, J EXP MED, V187, P985, DOI 10.1084/jem.187.7.985; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Kaplan AP, 2002, J ALLERGY CLIN IMMUN, V109, P195, DOI 10.1067/mai.2002.121316; Kastner DL, 2001, NAT GENET, V29, P241, DOI 10.1038/ng1101-241; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Klement JF, 1996, MOL CELL BIOL, V16, P2341; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Leverrier Y, 2001, J IMMUNOL, V166, P4831, DOI 10.4049/jimmunol.166.8.4831; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Lipsker DM, 2000, ARCH DERMATOL, V136, P1508, DOI 10.1001/archderm.136.12.1508; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Morales A, 1996, Int J Urol, V3, P329, DOI 10.1111/j.1442-2042.1996.tb00548.x; MORGANJG, 1991, ADV EXP MED BIOL, V305, P89; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; NATHAN C, 1993, J CELL BIOL, V122, P243, DOI 10.1083/jcb.122.1.243; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Okkenhaug K, 2002, SCIENCE, V297, P1031; Panwala CM, 1998, J IMMUNOL, V161, P5733; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schur P H, 1978, Arthritis Rheum, V21, pS153, DOI 10.1002/art.1780210924; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Smahi A, 2000, NATURE, V405, P466; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; SNELLER MC, 1992, J CLIN INVEST, V90, P334, DOI 10.1172/JCI115867; Soiffer R, 1998, P NATL ACAD SCI USA, V95, P13141, DOI 10.1073/pnas.95.22.13141; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Sullivan Kathleen E., 1998, Current Opinion in Pediatrics, V10, P600; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Vaishnaw AK, 1999, ARTHRITIS RHEUM, V42, P1833, DOI 10.1002/1529-0131(199909)42:9<1833::AID-ANR7>3.0.CO;2-Q; van der Poll T, 2001, J ENDOTOXIN RES, V7, P301, DOI 10.1177/09680519010070040301; Walport MJ, 1997, ANN NY ACAD SCI, V815, P267, DOI 10.1111/j.1749-6632.1997.tb52069.x; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; ZHU J, IN PRESS CELL; Zweifach BW, 2014, INFLAMMATORY PROCESS; [No title captured]	113	1841	1957	6	222	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					846	852		10.1038/nature01320	http://dx.doi.org/10.1038/nature01320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490957				2022-12-28	WOS:000179897300065
J	Tamblyn, R; Abrahamowicz, M; Dauphinee, WD; Hanley, JA; Norcini, J; Girard, N; Grand'Maison, P; Brailovsky, C				Tamblyn, R; Abrahamowicz, M; Dauphinee, WD; Hanley, JA; Norcini, J; Girard, N; Grand'Maison, P; Brailovsky, C			Association between licensure examination scores and practice in primary care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL-PRACTICE; MYOCARDIAL-INFARCTION; PHYSICIANS; PERFORMANCE; MANAGEMENT; DOCTORS; GUIDELINES; KNOWLEDGE; DATABASES; SPECIALTY	Context Standards for licensure are designed to provide assurance to the public of a physician's competence to practice. However, there has been little assessment of the relationship between examination scores and subsequent practice performance. Objective To determine if there is a sustained relationship between certification examination scores and practice performance and if licensing examinations taken at the end of medical school are predictive of future practice in primary care. Design, Setting, and Participants A total of 912 family physicians, who passed the Quebec family medicine certification examination (QLEX) between 1990 and 1993 and entered practice. Linked databases were used to assess physicians' practice performance for 3.4 million patients in the universal health care system in Quebec, Canada. Patients were seen during the follow-up period for the first 4 years (1993 cohort of physicians) to 7 years (1990 cohort of physicians) of practice from July 1 of the certification examination to December 31, 1996. Main Outcome Measures Mammography screening rate, continuity of care index, disease-specific and symptom-relief prescribing rate, contraindicated prescribing rate, and consultation rate. Results Physicians achieving higher scores on both examinations had higher rates (rate increase per SD increase in score per 1000 persons per year) of mammography screening (P for QLEX, 16.8 [95% confidence interval {CI], 8.7-24.9]; beta for Medical Council of Canada Qualifying Examination [MCCQE], 17.4 [95% Cl, 10.6-24.1]) and consultation (p for, QLEX, 4.9 [95% Cl, 2.1-7.8]; beta for MCCQE, 2.9 [95% Cl, 0.4-5.4]). Higher subscores in diagnosis were predictive of higher rates in the difference between disease-specific and symptom-relief prescribing (beta for QLEX, 3.9 [95% Cl, 0.9-7.0]; beta for MCCQE, 3.8 [95% Cl, 0.3-7.3]). Higher scores of drug knowledge were predictive of a lower rate (relative risk per SD increase in score) of contraindicated prescribing for MCCQE (relative risk, 0.88; 95% Cl, 0.17-1.00). Relationships between examination scores and practice performance were sustained through the first 4 to 7 years in practice. Conclusion Scores achieved on certification examinations and licensure examinations taken at the end of medical school show a sustained relationship, over 4 to 7 years, with indices of preventive care and acute and chronic disease management in primary care practice.	McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Med Council Canada, Ottawa, ON, Canada; Fdn Advancement Int Med Educ & Res, Philadelphia, PA USA; Univ Sherbrooke, Dept Family Med, Sherbrooke, PQ J1K 2R1, Canada; Univ Laval, Ctr Evaluat Sci Sante, Ste Foy, PQ G1K 7P4, Canada	McGill University; McGill University; University of Sherbrooke; Laval University	Tamblyn, R (corresponding author), McGill Univ, Dept Med, Morrice House,1140 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	robyn.tamblyn@mcgill.ca	Tamblyn, Robyn/L-6010-2016	Abrahamowicz, Michal/0000-0002-3172-3952; Norcini, John/0000-0002-8464-4115				AYANIAN JZ, 1994, NEW ENGL J MED, V331, P1136, DOI 10.1056/NEJM199410273311707; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; CALMAN NS, 1992, J FAM PRACTICE, V35, P31; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Edep ME, 1997, J AM COLL CARDIOL, V30, P518, DOI 10.1016/S0735-1097(97)00176-9; FRANKS P, 1992, NEW ENGL J MED, V327, P424, DOI 10.1056/NEJM199208063270613; GRANDMAISON P, 1992, CAN MED ASSOC J, V146, P1735; Hulscher MEJL, 1997, BRIT J GEN PRACT, V47, P711; Irvine D, 1997, BRIT MED J, V314, P1540, DOI 10.1136/bmj.314.7093.1540; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; Lambrew JM, 1996, MED CARE, V34, P138, DOI 10.1097/00005650-199602000-00006; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Legorreta AP, 1998, ARCH INTERN MED, V158, P457, DOI 10.1001/archinte.158.5.457; Levy AR, 1999, CAN J CARDIOL, V15, P1277; LIVINGSTON SA, 1989, PASSING SCORES; MCAULEY RG, 1990, CAN MED ASSOC J, V143, P1193; McLeod PJ, 1997, CAN MED ASSOC J, V156, P385; *MED COUNC CAN, 1991, INF PAMPHL QUAL EX; MURATA PJ, 1992, J FAM PRACTICE, V35, P644; Nicolucci A, 1996, DIABETES CARE, V19, P927, DOI 10.2337/diacare.19.9.927; Norcini JJ, 1999, ACAD MED, V74, P1088, DOI 10.1097/00001888-199910000-00010; NORCINI JJ, 1985, ANN INTERN MED, V102, P385, DOI 10.7326/0003-4819-102-3-385; RAMSEY PG, 1989, ANN INTERN MED, V110, P719, DOI 10.7326/0003-4819-110-9-719; *REG ASS MAL QUEB, 1995, STAT ANN; REYNOLDS GA, 1991, BMJ-BRIT MED J, V302, P1250, DOI 10.1136/bmj.302.6787.1250; Safran DG, 2001, J FAM PRACTICE, V50, P130; Salive ME, 1996, PREV MED, V25, P561, DOI 10.1006/pmed.1996.0090; SCHAFFNER W, 1983, JAMA-J AM MED ASSOC, V250, P1728, DOI 10.1001/jama.250.13.1728; SHEA S, 1992, NEW ENGL J MED, V327, P776, DOI 10.1056/NEJM199209103271107; Southgate L, 2001, MED EDUC, V35, P474, DOI 10.1046/j.1365-2923.2001.00897.x; STARFIELD B, 1991, HEALTH SERV RES, V26, P53; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; Tamblyn R, 1998, JAMA-J AM MED ASSOC, V280, P989, DOI 10.1001/jama.280.11.989; TAMBLYN R, 1994, EVAL HEALTH PROF, V17, P198, DOI 10.1177/016327879401700205; VELOSKI JJ, 1987, P ANN C RES MED ED, V26, P54; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; WEINER JP, 1995, JAMA-J AM MED ASSOC, V273, P1503, DOI 10.1001/jama.273.19.1503; WILCHESKY M, 2001, J CLIN PHARM S, V220; Wilkins R, 1993, Health Rep, V5, P157; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; 1999, J EVAL CLIN PRACT, V5, P335; [No title captured]	45	167	169	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2002	288	23					3019	3026		10.1001/jama.288.23.3019	http://dx.doi.org/10.1001/jama.288.23.3019			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CG	12479767	Green Published, Bronze			2022-12-28	WOS:000179854200037
J	Vavricka, SR; Himmelmann, A; Schaffner, A				Vavricka, SR; Himmelmann, A; Schaffner, A			Uses of error - Brugada syndrome	LANCET			English	Editorial Material									Univ Zurich Hosp, Dept Internal Med, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Vavricka, SR (corresponding author), Univ Zurich Hosp, Dept Internal Med, CH-8091 Zurich, Switzerland.								0	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1913	1913		10.1016/S0140-6736(02)11912-X	http://dx.doi.org/10.1016/S0140-6736(02)11912-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493256				2022-12-28	WOS:000179870200008
J	Smaglik, P				Smaglik, P			Bridging sectors Medicon Valley	NATURE			English	Article																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916		S			A24	+		10.1038/420a24a	http://dx.doi.org/10.1038/420a24a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625LG	12501123	Bronze			2022-12-28	WOS:000179817500005
J	Bassand, JP; Martin, J; Ryden, L; Sirnoons, M				Bassand, JP; Martin, J; Ryden, L; Sirnoons, M			The need for resources for clinical research: the European Society of Cardiology calls for European, international collaboration	LANCET			English	Editorial Material							PHARMACEUTICAL-INDUSTRY; ACADEMIC MEDICINE; EUROASPIRE-II; HEART SURVEY; GUIDELINES; COUNTRIES		Univ Hosp Jean Minjoz, Dept Cardiol, F-25030 Besancon, France; UCL, London, England; Karolinska Hosp, S-10401 Stockholm, Sweden; Erasmus Univ, Thoraxctr, NL-3000 DR Rotterdam, Netherlands	Universite de Franche-Comte; CHU Besancon; University of London; University College London; Karolinska Institutet; Karolinska University Hospital; Erasmus University Rotterdam; Erasmus MC	Bassand, JP (corresponding author), Univ Hosp Jean Minjoz, Dept Cardiol, F-25030 Besancon, France.	jean-pierre.bassand@ufc-chu.univ-fcomte.fr						Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; Bell JI, 1999, NAT MED, V5, P477, DOI 10.1038/8353; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; KAITIN KI, 1993, J CLIN PHARMACOL, V33, P412, DOI 10.1002/j.1552-4604.1993.tb04680.x; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Kotseva K, 2001, LANCET, V357, P995, DOI 10.1016/S0140-6736(00)04235-5; Lindahl S, 2000, LANCET, V356, pS54, DOI 10.1016/S0140-6736(00)92040-3; Montaner JSG, 2001, LANCET, V358, P1893, DOI 10.1016/S0140-6736(01)06891-X; Sans S, 1997, EUR HEART J, V18, P1231; Simoons ML, 2002, EUR HEART J, V23, P1148, DOI 10.1053/euhj.2002.3269; Williams N, 2002, CURR BIOL, V12, pR267, DOI 10.1016/S0960-9822(02)00795-9	13	22	22	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1866	1869		10.1016/S0140-6736(02)11776-4	http://dx.doi.org/10.1016/S0140-6736(02)11776-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480378				2022-12-28	WOS:000179706100028
J	Iratni, R; Yan, YT; Chen, CH; Ding, JX; Zhang, Y; Price, SM; Reinberg, D; Shen, MM				Iratni, R; Yan, YT; Chen, CH; Ding, JX; Zhang, Y; Price, SM; Reinberg, D; Shen, MM			Inhibition of excess nodal signaling during mouse gastrulation by the transcriptional corepressor DRAP1	SCIENCE			English	Article							IN-VIVO; EXPRESSION; REPRESSION; PROTEINS; ACTIVIN; PATTERNS; PROMOTER; BINDING; HOMOLOG; LEFTY2	The formation and patterning of mesoderm during mammalian gastrulation require the activity of Nodal, a secreted mesoderm-inducing factor of the transforming growth factor-beta (TGF-beta) family. Here we show that the transcriptional corepressor DRAP1 has a very specific role in regulation of Nodal activity during mouse embryogenesis. We find that loss of Drap1 leads to severe gastrulation defects that are consistent with increased expression of Nodal and can be partially suppressed by Nodal heterozygosity. Biochemical studies indicate that DRAP1 interacts with and inhibits DNA binding by the winged-helix transcription factor FoxH1 (FAST), a critical component of a positive feedback loop for Nodal activity. We propose that DRAP1 limits the spread of a morphogenetic signal by down-modulating the response to the Nodal autoregulatory loop.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Reinberg, D (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, 679 Hoes Lane, Piscataway, NJ 08854 USA.		Shen, Michael M/C-7546-2009; Yan, Yu-Ting/Q-3065-2018	Shen, Michael M/0000-0002-4042-1657; Yan, Yu-Ting/0000-0002-9559-706X; Reinberg, Danny/0000-0003-4288-2016; Zhang, Yi/0000-0002-2789-0811				Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Kim S, 2000, MOL CELL BIOL, V20, P2455, DOI 10.1128/MCB.20.7.2455-2465.2000; Kim S, 1997, P NATL ACAD SCI USA, V94, P820, DOI 10.1073/pnas.94.3.820; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Latinkic BV, 1997, GENE DEV, V11, P3265, DOI 10.1101/gad.11.23.3265; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; Norris DP, 1999, GENE DEV, V13, P1575, DOI 10.1101/gad.13.12.1575; Norris DP, 2002, DEVELOPMENT, V129, P3455; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002	26	65	68	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1996	1999		10.1126/science.1073405	http://dx.doi.org/10.1126/science.1073405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471260				2022-12-28	WOS:000179629200047
J	Manning, G; Whyte, DB; Martinez, R; Hunter, T; Sudarsanam, S				Manning, G; Whyte, DB; Martinez, R; Hunter, T; Sudarsanam, S			The protein kinase complement of the human genome	SCIENCE			English	Article							BINDING-PROTEIN; DOMAIN; EVOLUTION; RECEPTOR; CELLS; DUPLICATIONS; YEAST; SITE	We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences. This provides a starting point for comprehensive analysis of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome analysis through a focus on one large gene family. We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases. New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms. Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages. We also identified 106 protein kinase pseudogenes. Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.	SUGEN Inc, San Francisco, CA 94080 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Pharmacia Corp, Genom & Biotechnol, San Francisco, CA 94080 USA	Pfizer; Salk Institute; Pfizer	Manning, G (corresponding author), SUGEN Inc, 230 E Grand Ave, San Francisco, CA 94080 USA.	gerard-manning@sugen.com	Manning, Gerard/C-8308-2009	Manning, Gerard/0000-0002-5087-9151				Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Abi-Rached L, 2002, NAT GENET, V31, P100, DOI 10.1038/ng855; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bork P, 1996, SCIENCE, V271, P1431, DOI 10.1126/science.271.5254.1431; Chen M, 2000, MOL CELL BIOL, V20, P947, DOI 10.1128/MCB.20.3.947-956.2000; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cormand B, 2000, BLOOD CELL MOL DIS, V26, P409, DOI 10.1006/bcmd.2000.0317; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gaozza E, 1997, ONCOGENE, V15, P3127, DOI 10.1038/sj.onc.1201575; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; How GF, 1996, GENOME RES, V6, P1185, DOI 10.1101/gr.6.12.1185; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Knuutila S, 1998, AM J PATHOL, V152, P1107; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li YH, 2002, J BIOL CHEM, V277, P4159, DOI 10.1074/jbc.M110792200; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Morrison DK, 2001, J CELL SCI, V114, P1609; Rickert P, 1996, ONCOGENE, V12, P2631; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sasakura Y, 1998, MECH DEVELOP, V76, P161, DOI 10.1016/S0925-4773(98)00100-2; Seeley TW, 1999, BIOCHEM BIOPH RES CO, V257, P589, DOI 10.1006/bbrc.1999.0514; Tabuchi K, 2002, J NEUROSCI, V22, P4264, DOI 10.1523/JNEUROSCI.22-11-04264.2002; Tanaka H, 1999, J BIOL CHEM, V274, P17049, DOI 10.1074/jbc.274.24.17049; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Zervas CG, 2002, CURR BIOL, V12, pR350, DOI 10.1016/S0960-9822(02)00856-4	36	5821	6218	15	644	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1912	+		10.1126/science.1075762	http://dx.doi.org/10.1126/science.1075762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471243				2022-12-28	WOS:000179629200030
J	Khan, K; Muennig, P; Behta, M; Zivin, JG				Khan, K; Muennig, P; Behta, M; Zivin, JG			Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOREIGN-BORN PERSONS; ISONIAZID PREVENTIVE THERAPY; HEPATOTOXICITY; PREVALENCE; POPULATION; TRENDS	Background: In the United States, an increasingly disproportionate burden of tuberculosis among the foreign-born population has led to calls for improvements in the detection and treatment of latent infection in new immigrants. Current treatment guidelines do not take into account global differences in drug-resistance patterns or their implications for the treatment of immigrants. The use of multinational surveillance systems to guide the management of latent infection according to region-specific drug-resistance profiles could improve the efficiency of efforts to reduce the burden of tuberculosis in immigrants to the United States. Methods: We constructed a decision-analysis model by using a hypothetical cohort of all documented immigrants entering the United States from developing nations. Region-specific drug-resistance profiles were derived from data on 30,388 cases of infection. The model examined the effectiveness and cost effectiveness of four strategies: no intervention or tuberculin skin testing followed by treatment with isoniazid, treatment with rifampin, or treatment with rifampin plus pyrazinamide for those with a positive test result. Results: A strategy of detecting and treating latent tuberculosis infection was cost-saving among immigrants from Mexico, Haiti, sub-Saharan Africa, South Asia, and developing nations in East Asia and the Pacific. This strategy was highly cost effective among immigrants from other developing nations. Rifampin plus pyrazinamide was the preferred strategy for treating latent infection in immigrants from Vietnam, Haiti, and the Philippines. Conclusions: For new immigrants to the United States from developing nations, a strategy of detecting and treating latent tuberculosis infection would lead to substantial health and economic benefits. Because of the high prevalence of resistance to isoniazid, treatment with a rifampin-containing regimen should be strongly considered for immigrants from Vietnam, Haiti, and the Philippines.	New York Presbyterian Hosp, Dept Publ Hlth, New York, NY USA; New York Presbyterian Hosp, Dept Med, Div Int Med & Infect Dis, New York, NY USA; New York Presbyterian Hosp, Dept Pharm, New York, NY USA; Cornell Univ, Weill Med Coll, New York, NY USA; Columbia Univ, Program Gen Publ Hlth, New York, NY USA; Columbia Univ, Joseph L Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA; Columbia Univ, Int Ctr Hlth Outcomes & Innovat Res, New York, NY USA; CUNY, Sophie Davis Sch Biomed Educ, New York, NY 10021 USA	NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; Cornell University; Columbia University; Columbia University; Columbia University; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education	Khan, K (corresponding author), Univ Toronto, St Michaels Hosp, Inner City Hlth Res Unit, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Zivin, Joshua Graff/ABF-1697-2020	Graff Zivin, Joshua/0000-0002-0820-4900; Muennig, Peter/0000-0002-4234-0498				*AG HEALTHC RES QU, 2002, HEALTC COST UT PROJ; *AM PUBL TRANSP AS, 2002, PASS FAR SUMM; [Anonymous], 2001, MMWR MORB MORTAL WKL, V50, P733; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; BROWN RE, 1995, ARCH INTERN MED, V155, P1595, DOI 10.1001/archinte.155.15.1595; *BUR LAB STAT DEP, 2002, CONS PRIC IND; *BUR LAB STAT DEP, 2002, NAT EMPL WAG DAT OCC; *CDCP, 1996, NAT TUB SURV SYST; *CDCP, 2002, TUB CAS FOR BORN PER; *CDCP, 2002, TUB CAS CAS RAT 1000; *CENS BUR, JOURN WORK PLAC WORK; *CENS BUR, 2002, 2000 DEC CENS; Chaisson RE, 2002, JAMA-J AM MED ASSOC, V288, P165, DOI 10.1001/jama.288.2.165; Coker R, 2001, Lancet Infect Dis, V1, P270, DOI 10.1016/S1473-3099(01)00122-0; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P827; COOK PP, 2001, INF DIS SOC AM 39 AN, P1147; *CTR MED MED SERV, 2002, MED PAYM SYST CLIN L; *CTR MED MED SERV, 2000, NAT PHYS FEE SCHED P; *CTR MED MED SERV, 2002, MED PROV AN REV MEDP; *DEP EN, 2002, MOT GAS RET PRIC; *DEP EN, 2002, MOT VEH MIL FUEL CON; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; *EUROTB, 2002, SURV DRUG RES EUR; FAIRSHTER RD, 1975, AM REV RESPIR DIS, V112, P37; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; GEITER L, 2000, ENDING NEGLECT ELIMI; GEITER LJ, 1997, THESIS JOHNS HOPKINS, P180; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36; GIRLING DJ, 1991, AM REV RESPIR DIS, V143, P262; Gold MR, 1996, COST EFFECTIVENESS H; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Granich RM, 2001, INT J TUBERC LUNG D, V5, P53; Gushulak BD, 2000, CLIN INFECT DIS, V31, P776, DOI 10.1086/313998; *IMM NAT SERV, 2002, STATISTICS; Jasmer RM, 2002, ANN INTERN MED, V137, P640, DOI 10.7326/0003-4819-137-8-200210150-00007; KING MD, 2001, INF DIS SOC AM 39 AN, P1146; Kochanek K.D., 2001, NATL VITAL STAT REPO, V49; LOLLOCK L, 1908, P20534 CENS BUR; MCGLYNN KA, 1986, AM REV RESPIR DIS, V134, P666; *MED EC, 2000, DRUG TOP RED BOOK PH; Moore M, 1998, JAMA-J AM MED ASSOC, V279, P656; Moore M, 1997, JAMA-J AM MED ASSOC, V278, P833, DOI 10.1001/jama.278.10.833; *NAT CTR HLTH STAT, 1997, MULT CAUSE DEATH PUB; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; Sadaphal P, 2001, CLIN INFECT DIS, V33, P1687, DOI 10.1086/323896; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Talbot EA, 2000, JAMA-J AM MED ASSOC, V284, P2894, DOI 10.1001/jama.284.22.2894; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Weis SE, 2001, AM J RESP CRIT CARE, V164, P953, DOI 10.1164/ajrccm.164.6.2102132; *WORLD BANK GROUP, 2002, COUNTR REG; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304; 2000, MMWR MORB MORTAL WKL, V49, P1	55	126	129	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2002	347	23					1850	1859		10.1056/NEJMsa021099	http://dx.doi.org/10.1056/NEJMsa021099			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NW	12466510	Green Published			2022-12-28	WOS:000179596900007
J	Waterston, RH; Lindblad-Toh, K; Birney, E; Rogers, J; Abril, JF; Agarwal, P; Agarwala, R; Ainscough, R; Alexandersson, M; An, P; Antonarakis, SE; Attwood, J; Baertsch, R; Bailey, J; Barlow, K; Beck, S; Berry, E; Birren, B; Bloom, T; Bork, P; Botcherby, M; Bray, N; Brent, MR; Brown, DG; Brown, SD; Bult, C; Burton, J; Butler, J; Campbell, RD; Carninci, P; Cawley, S; Chiaromonte, F; Chinwalla, AT; Church, DM; Clamp, M; Clee, C; Collins, FS; Cook, LL; Copley, RR; Coulson, A; Couronne, O; Cuff, J; Curwen, V; Cutts, T; Daly, M; David, R; Davies, J; Delehaunty, KD; Deri, J; Dermitzakis, ET; Dewey, C; Dickens, NJ; Diekhans, M; Dodge, S; Dubchak, I; Dunn, DM; Eddy, SR; Elnitski, L; Emes, RD; Eswara, P; Eyras, E; Felsenfeld, A; Fewell, GA; Flicek, P; Foley, K; Frankel, WN; Fulton, LA; Fulton, RS; Furey, TS; Gage, D; Gibbs, RA; Glusman, G; Gnerre, S; Goldman, N; Goodstadt, L; Grafham, D; Graves, TA; Green, ED; Gregory, S; Guigo, R; Guyer, M; Hardison, RC; Haussler, D; Hayashizaki, Y; Hillier, LW; Hinrichs, A; Hlavina, W; Holzer, T; Hsu, F; Hua, A; Hubbard, T; Hunt, A; Jackson, I; Jaffe, DB; Johnson, LS; Jones, M; Jones, TA; Joy, A; Kamal, M; Karlsson, EK; Karolchik, D; Kasprzyk, A; Kawai, J; Keibler, E; Kells, C; Kent, WJ; Kirby, A; Kolbe, DL; Korf, I; Kucherlapati, RS; Kulbokas, EJ; Kulp, D; Landers, T; Leger, JP; Leonard, S; Letunic, I; Levine, R; Li, J; Li, M; Lloyd, C; Lucas, S; Ma, B; Maglott, DR; Mardis, ER; Matthews, L; Mauceli, E; Mayer, JH; McCarthy, M; McCombie, WR; McLaren, S; McLay, K; McPherson, JD; Meldrim, J; Meredith, B; Mesirov, JP; Miller, W; Miner, TL; Mongin, E; Montgomery, KT; Morgan, M; Mott, R; Mullikin, JC; Muzny, DM; Nash, WE; Nelson, JO; Nhan, MN; Nicol, R; Ning, Z; Nusbaum, C; O'Connor, MJ; Okazaki, Y; Oliver, K; Larty, EO; Pachter, L; Parra, G; Pepin, KH; Peterson, J; Pevzner, P; Plumb, R; Pohl, CS; Poliakov, A; Ponce, TC; Ponting, CP; Potter, S; Quail, M; Reymond, A; Roe, BA; Roskin, KM; Rubin, EM; Rust, AG; Santos, R; Sapojnikov, V; Schultz, B; Schultz, J; Schwartz, MS; Schwartz, S; Scott, C; Seaman, S; Searle, S; Sharpe, T; Sheridan, A; Shownkeen, R; Sims, S; Singer, JB; Slater, G; Smit, A; Smith, DR; Spencer, B; Stabenau, A; Strange-Thomann, NS; Sugnet, C; Suyama, M; Tesler, G; Thompson, J; Torrents, D; Trevaskis, E; Tromp, J; Ucla, C; Vidal, AU; Vinson, JP; von Niederhausern, AC; Wade, CM; Wall, M; Weber, RJ; Weiss, RB; Wendl, MC; West, AP; Wetterstrand, K; Wheeler, R; Whelan, S; Wierzbowski, J; Willey, D; Williams, S; Wilson, RK; Winter, E; Worley, KC; Wyman, D; Yang, S; Yang, SP; Zdobnov, EM; Zody, MC; Lander, ES				Waterston, RH; Lindblad-Toh, K; Birney, E; Rogers, J; Abril, JF; Agarwal, P; Agarwala, R; Ainscough, R; Alexandersson, M; An, P; Antonarakis, SE; Attwood, J; Baertsch, R; Bailey, J; Barlow, K; Beck, S; Berry, E; Birren, B; Bloom, T; Bork, P; Botcherby, M; Bray, N; Brent, MR; Brown, DG; Brown, SD; Bult, C; Burton, J; Butler, J; Campbell, RD; Carninci, P; Cawley, S; Chiaromonte, F; Chinwalla, AT; Church, DM; Clamp, M; Clee, C; Collins, FS; Cook, LL; Copley, RR; Coulson, A; Couronne, O; Cuff, J; Curwen, V; Cutts, T; Daly, M; David, R; Davies, J; Delehaunty, KD; Deri, J; Dermitzakis, ET; Dewey, C; Dickens, NJ; Diekhans, M; Dodge, S; Dubchak, I; Dunn, DM; Eddy, SR; Elnitski, L; Emes, RD; Eswara, P; Eyras, E; Felsenfeld, A; Fewell, GA; Flicek, P; Foley, K; Frankel, WN; Fulton, LA; Fulton, RS; Furey, TS; Gage, D; Gibbs, RA; Glusman, G; Gnerre, S; Goldman, N; Goodstadt, L; Grafham, D; Graves, TA; Green, ED; Gregory, S; Guigo, R; Guyer, M; Hardison, RC; Haussler, D; Hayashizaki, Y; Hillier, LW; Hinrichs, A; Hlavina, W; Holzer, T; Hsu, F; Hua, A; Hubbard, T; Hunt, A; Jackson, I; Jaffe, DB; Johnson, LS; Jones, M; Jones, TA; Joy, A; Kamal, M; Karlsson, EK; Karolchik, D; Kasprzyk, A; Kawai, J; Keibler, E; Kells, C; Kent, WJ; Kirby, A; Kolbe, DL; Korf, I; Kucherlapati, RS; Kulbokas, EJ; Kulp, D; Landers, T; Leger, JP; Leonard, S; Letunic, I; Levine, R; Li, J; Li, M; Lloyd, C; Lucas, S; Ma, B; Maglott, DR; Mardis, ER; Matthews, L; Mauceli, E; Mayer, JH; McCarthy, M; McCombie, WR; McLaren, S; McLay, K; McPherson, JD; Meldrim, J; Meredith, B; Mesirov, JP; Miller, W; Miner, TL; Mongin, E; Montgomery, KT; Morgan, M; Mott, R; Mullikin, JC; Muzny, DM; Nash, WE; Nelson, JO; Nhan, MN; Nicol, R; Ning, Z; Nusbaum, C; O'Connor, MJ; Okazaki, Y; Oliver, K; Larty, EO; Pachter, L; Parra, G; Pepin, KH; Peterson, J; Pevzner, P; Plumb, R; Pohl, CS; Poliakov, A; Ponce, TC; Ponting, CP; Potter, S; Quail, M; Reymond, A; Roe, BA; Roskin, KM; Rubin, EM; Rust, AG; Santos, R; Sapojnikov, V; Schultz, B; Schultz, J; Schwartz, MS; Schwartz, S; Scott, C; Seaman, S; Searle, S; Sharpe, T; Sheridan, A; Shownkeen, R; Sims, S; Singer, JB; Slater, G; Smit, A; Smith, DR; Spencer, B; Stabenau, A; Strange-Thomann, NS; Sugnet, C; Suyama, M; Tesler, G; Thompson, J; Torrents, D; Trevaskis, E; Tromp, J; Ucla, C; Vidal, AU; Vinson, JP; von Niederhausern, AC; Wade, CM; Wall, M; Weber, RJ; Weiss, RB; Wendl, MC; West, AP; Wetterstrand, K; Wheeler, R; Whelan, S; Wierzbowski, J; Willey, D; Williams, S; Wilson, RK; Winter, E; Worley, KC; Wyman, D; Yang, S; Yang, SP; Zdobnov, EM; Zody, MC; Lander, ES		Mouse Genome Sequencing Consor	Initial sequencing and comparative analysis of the mouse genome	NATURE			English	Review							SEMINAL-VESICLE AUTOANTIGEN; SINGLE-NUCLEOTIDE POLYMORPHISMS; X-CHROMOSOME INACTIVATION; RADIATION HYBRID MAP; GENE FAMILY; HOMEOBOX GENE; INTERSPERSED REPEATS; GROWTH-HORMONE; MESSENGER-RNA; MUTATION-RATE	The sequence of the mouse genome is a key informational tool for understanding the contents of the human genome and a key experimental tool for biomedical research. Here, we report the results of an international collaboration to produce a high-quality draft sequence of the mouse genome. We also present an initial comparative analysis of the mouse and human genomes, describing some of the insights that can be gleaned from the two sequences. We discuss topics including the analysis of the evolutionary forces shaping the size, structure and sequence of the genomes; the conservation of large-scale synteny across most of the genomes; the much lower extent of sequence orthology covering less than half of the genomes; the proportions of the genomes under selection; the number of protein-coding genes; the expansion of gene families related to reproduction and immunity; the evolution of proteins; and the identification of intraspecies polymorphism.	Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02141 USA; European Bioinformat Inst, Cambridge CB10 1SD, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Pompeu Fabra, Inst Municipal Invest Med, Res Grp Biomed Informat, Barcelona, Catalonia, Spain; GlaxoSmithKline, King Of Prussia, PA 19406 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva 10, Switzerland; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; MRC, Mammalian Genet Unit, UK MRC Mouse Sequencing Consortium, Harwell OX11 0RD, Berks, England; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Washington Univ, Dept Comp Sci, St Louis, MO 63130 USA; Univ Waterloo, Sch Comp Sci, Waterloo, ON N2L 3G1, Canada; Jackson Lab, Bar Harbor, ME 04609 USA; Yokohama Inst, RIKEN Genom Sci Ctr, Lab Genome Explorat, Kanagawa 2300045, Japan; Affymetrix Inc, Oakland, CA 94608 USA; Penn State Univ, Dept Stat, University Pk, PA 16802 USA; Penn State Univ, Dept Hlth Evaluat Sci, University Pk, PA 16802 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Calif Berkeley, Dept Elect Engn, Berkeley, CA 94720 USA; Univ Oxford, Dept Human Anat & Genet, MRC, Funct Genet Unit, Oxford OX1 3QX, England; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Inst Syst Biol, Seattle, WA 98103 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Univ Oklahoma, Dept Chem & Biochem, Adv Ctr Genome Technol, Norman, OK 73019 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; Penn State Univ, Dept Stat, University Pk, PA 16802 USA; Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Western Ontario, Dept Comp Sci, London, ON N6A 5B7, Canada; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Wellcome Trust Res Labs, London NW1 2BE, England; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Genome Therapeut Corp, Waltham, MA 02453 USA; Bioinformat Solut Inc, Waterloo, ON N2L 3L2, Canada; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; MIT, Dept Biol, Cambridge, MA 02138 USA	Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Whitehead Institute; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); GlaxoSmithKline; National Institutes of Health (NIH) - USA; University of California System; University of California Berkeley; University of Geneva; University of California System; University of California Santa Cruz; European Molecular Biology Laboratory (EMBL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL); University of Waterloo; Jackson Laboratory; RIKEN; Affymetrix; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California Berkeley; University of Oxford; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Baylor College of Medicine; Institute for Systems Biology (ISB); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of Oklahoma System; University of Oklahoma - Norman; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Western University (University of Western Ontario); Cold Spring Harbor Laboratory; University of California System; University of California San Diego; Max Planck Society; Baylor College of Medicine; Massachusetts Institute of Technology (MIT)	Waterston, RH (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,4444 Forest Pk Ave, St Louis, MO 63108 USA.	waterston@gs.washington.edu; kersli@genome.wi.mit.edu	Ning, Zemin/D-2411-2013; Whelan, Simon/A-6638-2011; Kucherlapati, Raju/ABC-8807-2021; Dermitzakis, Emmanouil/B-7687-2013; Eduardo, Eyras/L-1053-2014; Couronne, Olivier Couronne/G-1244-2012; Letunic, Ivica/K-1102-2019; Brent, Michael/AAK-3702-2020; Seaman, Steven/A-2755-2013; Mardis, Elaine/W-2202-2019; Ma, Bin/C-7550-2013; McPherson, John D/D-2633-2017; Guigo, Roderic/D-1303-2010; Hardison, Ross C/G-1142-2010; Bork, Peer/F-1813-2013; Gasull, Martina/J-4076-2019; Hinrichs, Angie S./H-9159-2019; Ferrando, Josep F Abril/B-3877-2014; Zdobnov, Evgeny M/K-1133-2012; Kawai, Jun/A-6451-2016; Antonarakis, Stylianos E/N-8866-2014; Emes, Richard D/C-5341-2008; Elnitski, Laura/AAD-3595-2021; Quail, michael/ABE-6131-2020; Letunic, Ivica/A-6032-2009; Zdobnov, Evgeny/AAB-2745-2022; Hubbard, Tim J.P./AAT-4571-2020; Eyras, Eduardo/A-1560-2010; Hubbard, Tim J/C-2567-2008; Kutalik, Zoltan/HHZ-5697-2022; Mesirov, Jill/AGF-7626-2022; Schultz, Joerg/B-9346-2008; Carninci, Piero/K-1568-2014; Ponting, Chris/AAV-2621-2021; Wendl, Michael C/A-2741-2008; Eyras, Eduardo/ABG-7144-2020; Wilson, Richard K./AAF-4139-2019; Tromp, Jasper/GSD-4895-2022; Agarwal, Pankaj/N-2147-2019; Dickens, Nicholas/G-1445-2013; Torrents, David/G-5785-2015	Eduardo, Eyras/0000-0003-0793-6218; Letunic, Ivica/0000-0003-3560-4288; Brent, Michael/0000-0002-8689-0299; Seaman, Steven/0000-0003-3349-3334; McPherson, John D/0000-0001-8049-9347; Guigo, Roderic/0000-0002-5738-4477; Hardison, Ross C/0000-0003-4084-7516; Bork, Peer/0000-0002-2627-833X; Hinrichs, Angie S./0000-0002-1697-1130; Ferrando, Josep F Abril/0000-0001-7793-589X; Antonarakis, Stylianos E/0000-0001-8907-5823; Emes, Richard D/0000-0001-6855-5481; Zdobnov, Evgeny/0000-0002-5178-1498; Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Kutalik, Zoltan/0000-0001-8285-7523; Carninci, Piero/0000-0001-7202-7243; Eyras, Eduardo/0000-0003-0793-6218; Wilson, Richard K./0000-0002-1992-1358; Rust, Alistair/0000-0001-7287-192X; Worley, Kim/0000-0002-0282-1000; McCombie, W. Richard/0000-0003-1899-0682; Ning, Zemin/0000-0003-4359-776X; Gregory, Simon/0000-0002-7805-1743; Flicek, Paul/0000-0002-3897-7955; Hunt, Adrienne/0000-0002-1227-0310; Glusman, Gustavo/0000-0001-8060-5955; Slater, Guy/0000-0002-4202-8285; Birney, Ewan/0000-0001-8314-8497; Goldman, Nick/0000-0001-8486-2211; Reymond, Alexandre/0000-0003-1030-8327; Suyama, Mikita/0000-0001-9526-3193; Wade, Claire/0000-0003-3413-4771; Chinwalla, Asif/0000-0001-7831-3996; Ponting, Chris/0000-0003-0202-7816; Eddy, Sean/0000-0001-6676-4706; Mott, Richard/0000-0002-1022-9330; Okazaki, Yasushi/0000-0003-3241-5502; Parra, Genis/0000-0002-0575-2936; Brown, Dan/0000-0002-5205-5762; Cuff, James/0000-0003-0570-4106; Kulp, David/0000-0001-6540-0222; Dickens, Nicholas/0000-0003-0492-5855; Axelson-Fisk, Marina/0000-0003-3068-9593; Jackson, Ian/0000-0001-6526-0688; Furey, Terry/0000-0001-5546-9672; Agarwal, Pankaj/0000-0002-4165-9990; Karlsson, Elinor/0000-0002-4343-3776; Schultz, Brian/0000-0003-4964-976X; Torrents, David/0000-0002-6086-9037; Pachter, Lior/0000-0002-9164-6231; Nicol, Robert/0000-0003-1932-1392; Elnitski, Laura/0000-0003-1065-019X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abou-Haila A, 1998, BBA-MOL CELL RES, V1401, P177, DOI 10.1016/S0167-4889(97)00117-1; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ADAMS RLP, 1984, NUCLEIC ACIDS RES, V12, P5869, DOI 10.1093/nar/12.14.5869; ADEY NB, 1994, MOL BIOL EVOL, V11, P778; Afonso S, 2002, MOL REPROD DEV, V61, P155, DOI 10.1002/mrd.1142; ALEXANDERSSON M, IN PRESS GENOME RES; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANN DK, 1988, J BIOL CHEM, V263, P10887; Ansari-Lari MA, 1998, GENOME RES, V8, P29; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Ashburner M, 2001, GENOME RES, V11, P1425; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; BAIN PA, 1991, P NATL ACAD SCI USA, V88, P8870, DOI 10.1073/pnas.88.20.8870; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Baron Christian, 1995, P529; Batten D, 1997, NUCLEIC ACIDS RES, V25, P4235, DOI 10.1093/nar/25.21.4235; Battey J, 1999, NAT GENET, V21, P73, DOI 10.1038/5012; Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; BERNARDI G, 1986, J MOL EVOL, V24, P1, DOI 10.1007/BF02099946; Bernardi G, 2001, GENE, V276, P3, DOI 10.1016/S0378-1119(01)00644-8; BERNARDI G, 1988, J MOL EVOL, V28, P7, DOI 10.1007/BF02143493; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BIRKY CW, 1988, P NATL ACAD SCI USA, V85, P6414, DOI 10.1073/pnas.85.17.6414; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Blume N, 2000, ARCH BIOCHEM BIOPHYS, V381, P191, DOI 10.1006/abbi.2000.1978; Boissinot SP, 2001, MOL BIOL EVOL, V18, P2186, DOI 10.1093/oxfordjournals.molbev.a003765; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bourque G, 2002, GENOME RES, V12, P26; BOYLE AL, 1990, P NATL ACAD SCI USA, V87, P7757, DOI 10.1073/pnas.87.19.7757; Briand L, 2000, FEBS LETT, V476, P179, DOI 10.1016/S0014-5793(00)01719-1; Bromham L, 1999, TRENDS ECOL EVOL, V14, P113, DOI 10.1016/S0169-5347(98)01507-9; Bromham L, 2002, MOL BIOL EVOL, V19, P302, DOI 10.1093/oxfordjournals.molbev.a004083; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; CAMPBELL SM, 1984, NUCLEIC ACIDS RES, V12, P8685, DOI 10.1093/nar/12.22.8685; CASTLE WE, 1919, CARNEGIE I WASHINGTO, V288, P29; Castresana J, 2002, NUCLEIC ACIDS RES, V30, P1751, DOI 10.1093/nar/30.8.1751; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; Chen FC, 2001, J HERED, V92, P481, DOI 10.1093/jhered/92.6.481; Chiaromonte F, 2001, P NATL ACAD SCI USA, V98, P14503, DOI 10.1073/pnas.251423898; Chun JY, 1999, DEV DYNAM, V216, P257, DOI 10.1002/(SICI)1097-0177(199911)216:3<257::AID-DVDY4>3.0.CO;2-0; CLARK FRANK H., 1938, CONTR LAB VERT GENETICS UNIV MICHIGAN, V7, P1; Clausen BE, 1998, IMMUNITY, V8, P143, DOI 10.1016/S1074-7613(00)80467-7; Coffin J, 1997, RETROVIRUSES; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cormier RT, 2000, ONCOGENE, V19, P3182, DOI 10.1038/sj.onc.1203646; Cormier SA, 2001, MAMM GENOME, V12, P352, DOI 10.1007/s003350020007; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Daly MJ, 2002, CELL, V109, P283, DOI 10.1016/S0092-8674(02)00742-0; DANIELS GR, 1985, NATURE, V317, P819, DOI 10.1038/317819a0; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DAVISSON MT, 1989, GENETIC VARIANTS STR, P416; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; Dehal P, 2001, SCIENCE, V293, P104, DOI 10.1126/science.1060310; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802; Deussing J, 2002, GENOMICS, V79, P225, DOI 10.1006/geno.2002.6696; DIETRICH W, 1992, GENETIC MAPS; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; DLOUHY SR, 1987, GENETICS, V115, P535; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Easteal S., 1995, MAMMALIAN MOL CLOCK; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; Ellsworth RE, 2000, P NATL ACAD SCI USA, V97, P1172, DOI 10.1073/pnas.97.3.1172; ELNITSKI L, IN PRESS GENOME RES; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Ferretti V., 1996, Combinatorial Pattern Matching. 7th Annual Symposium, CPM 96. Proceedings, P159; FLICEK P, IN PRESS GENOME RES; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Fredman D, 2002, NUCLEIC ACIDS RES, V30, P387, DOI 10.1093/nar/30.1.387; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GARCIAMEUNIER P, 1993, MAMM GENOME, V4, P695, DOI 10.1007/BF00357792; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; GOODMAN M, 1971, NATURE, V233, P604, DOI 10.1038/233604a0; Goodstadt L, 2001, HUM MOL GENET, V10, P2209, DOI 10.1093/hmg/10.20.2209; Gottgens B, 2001, GENOME RES, V11, P87, DOI 10.1101/gr.153001; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Green ED, 2001, NAT REV GENET, V2, P573, DOI 10.1038/35084503; Gregory SG, 2002, NATURE, V418, P743, DOI 10.1038/nature00957; GU X, 1994, J MOL EVOL, V38, P468, DOI 10.1007/BF00178846; GUIGO R, IN PRESS P NATL ACAD; Guthrie C., 1982, MOL BIOL YEAST SACCH, P487; Haldane JBS, 1915, J GENET, V5, P133, DOI 10.1007/BF02985370; Hamilton BA, 2001, CELL, V107, P13, DOI 10.1016/S0092-8674(01)00514-1; Han YJ, 1998, GENE, V207, P159, DOI 10.1016/S0378-1119(97)00620-3; Hardies SC, 2000, MOL BIOL EVOL, V17, P616, DOI 10.1093/oxfordjournals.molbev.a026340; HARDISON R, IN PRESS GENOME RES; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Heiskanen M, 2001, ANAL CELL PATHOL, V22, P229, DOI 10.1155/2001/981218; HENDERSON CJ, 1994, BBA-GEN SUBJECTS, V1200, P182, DOI 10.1016/0304-4165(94)90134-1; Hogan B, 1994, MANIPULATING MOUSE E; Hogenesch JB, 2001, CELL, V106, P413, DOI 10.1016/S0092-8674(01)00467-6; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Huang YH, 1999, BIOCHEM J, V343, P241, DOI 10.1042/0264-6021:3430241; Huang YH, 2000, BIOL REPROD, V63, P1562, DOI 10.1095/biolreprod63.5.1562; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; HUDSON RR, 1995, GENETICS, V141, P1605; Hudson TJ, 2001, NAT GENET, V29, P201, DOI 10.1038/ng1001-201; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Hurst LD, 2000, GENE, V261, P107, DOI 10.1016/S0378-1119(00)00489-3; Huson D H, 2001, Bioinformatics, V17 Suppl 1, pS132; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; ICHIKAWA T, 1989, BIOCHEMISTRY-US, V28, P4779, DOI 10.1021/bi00437a039; JAFFE DB, IN PRESS GENOME RES; Janne PA, 1998, J CLIN INVEST, V101, P2042, DOI 10.1172/JCI2414; Jareborg N, 1999, GENOME RES, V9, P815, DOI 10.1101/gr.9.9.815; Jia HP, 2000, J BIOL CHEM, V275, P33314, DOI 10.1074/jbc.M006603200; JOSEPH A, 1989, EXP CELL RES, V183, P494, DOI 10.1016/0014-4827(89)90408-4; Joyner A. L., 1999, GENE TARGETING PRACT; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; KAM RC, 2002, MOL BIOL EVOL, V19, P462; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Karn RC, 1999, MOL BIOL EVOL, V16, P1192, DOI 10.1093/oxfordjournals.molbev.a026209; Kasper S, 2000, BBA-PROTEIN STRUCT M, V1482, P249, DOI 10.1016/S0167-4838(00)00170-9; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; KEELER CE, 1931, LAB MOUSE ITS ORIGIN; Kidwell MG, 1992, CURR OPIN GENET DEV, V2, P868, DOI 10.1016/S0959-437X(05)80109-1; Kim J, 1996, J MOL BIOL, V261, P322, DOI 10.1006/jmbi.1996.0464; KOHNE D E, 1970, Quarterly Reviews of Biophysics, V3, P327; Kollmar R, 2001, P NATL ACAD SCI USA, V98, P10196, DOI 10.1073/pnas.171325898; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KOOP BF, 1995, TRENDS GENET, V11, P367, DOI 10.1016/S0168-9525(00)89108-8; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Kozak M, 2000, GENOMICS, V70, P396, DOI 10.1006/geno.2000.6412; Krivan W, 2001, GENOME RES, V11, P1559, DOI 10.1101/gr.180601; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; Kulp D, 1996, PACIFIC SYMPOSIUM ON BIOCOMPUTING '97, P232; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LAIRD CD, 1969, NATURE, V224, P149, DOI 10.1038/224149a0; LAKSO M, 1991, EUR J BIOCHEM, V195, P477, DOI 10.1111/j.1432-1033.1991.tb15728.x; LALLEY PA, 1978, NATURE, V274, P160, DOI 10.1038/274160a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LAWRENCE CB, 1985, NUCLEIC ACIDS RES, V13, P4239, DOI 10.1093/nar/13.12.4239; Lee IY, 1998, GENOME RES, V8, P1022, DOI 10.1101/gr.8.10.1022; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Lercher MJ, 2001, MOL BIOL EVOL, V18, P2032, DOI 10.1093/oxfordjournals.molbev.a003744; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Lin J, 2000, RECENT PROG HORM RES, V55, P37; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Linzer DIH, 1999, MOL ENDOCRINOL, V13, P837, DOI 10.1210/me.13.6.837; Loftus SK, 2002, P NATL ACAD SCI USA, V99, P4471, DOI 10.1073/pnas.072087599; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; LUNDWALL A, 1995, FEBS LETT, V374, P53, DOI 10.1016/0014-5793(95)01076-Q; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Makalowski W, 1998, J MOL EVOL, V47, P119, DOI 10.1007/PL00006367; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Mallon AM, 2000, GENOME RES, V10, P758, DOI 10.1101/gr.10.6.758; Marra M, 1999, NAT GENET, V21, P191, DOI 10.1038/5976; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Matassi G, 1999, CURR BIOL, V9, P786, DOI 10.1016/S0960-9822(99)80361-3; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Mears ML, 2001, J MOL EVOL, V52, P51, DOI 10.1007/s002390010133; Mei R, 2000, GENOME RES, V10, P1126, DOI 10.1101/gr.10.8.1126; MIAO YJ, 1995, EUR J BIOCHEM, V228, P343, DOI 10.1111/j.1432-1033.1995.00343.x; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; MIYAWAKI A, 1994, EMBO J, V13, P5835, DOI 10.1002/j.1460-2075.1994.tb06927.x; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morel L, 2001, J ANDROL, V22, P549; MORSE HC, 1978, ORIGINS INBRED MICE, P1; Morse HC, 1981, MOUSE BIOMEDICAL RES, P1; Mott R, 2002, GENOME RES, V12, P1168, DOI 10.1101/gr.96802; MOUCHIROUD D, 1988, J MOL EVOL, V27, P311, DOI 10.1007/BF02101193; MOUCHIROUD D, 1990, J MOL EVOL, V31, P81, DOI 10.1007/BF02109477; MOUCHIROUD D, 1991, GENE, V100, P181, DOI 10.1016/0378-1119(91)90364-H; MOUCHIROUD D, 1987, J MOL EVOL, V26, P198, DOI 10.1007/BF02099852; *MOUS GEN SEQ CONS, 2001, GENESIS, V31, P137; MULLIKIN J, IN PRESS GENOME RES; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; MYAL Y, 1994, ENDOCRINOLOGY, V135, P1605, DOI 10.1210/en.135.4.1605; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Nadeau JH, 1998, MAMM GENOME, V9, P491, DOI 10.1007/s003359900806; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Natarajan K, 2002, MOL IMMUNOL, V38, P1023, DOI 10.1016/S0161-5890(02)00031-7; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Nei M, 2001, P NATL ACAD SCI USA, V98, P2497, DOI 10.1073/pnas.051611498; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nusbaum C, 1999, NAT GENET, V22, P388, DOI 10.1038/11967; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Oeltjen JC, 1997, GENOME RES, V7, P315, DOI 10.1101/gr.7.4.315; Ogata H, 1996, FEBS LETT, V390, P99, DOI 10.1016/0014-5793(96)00636-9; OHNO S, 1996, SEX CHROMOSOMES SEX; Ohshima K, 1996, MOL CELL BIOL, V16, P3756; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ooi GT, 1998, MOL ENDOCRINOL, V12, P675, DOI 10.1210/me.12.5.675; Osoegawa K, 2000, GENOME RES, V10, P116; Paigen K, 2000, MAMM GENOME, V11, P715, DOI 10.1007/s003350010152; PAIGEN K, 1995, NAT MED, V1, P215, DOI 10.1038/nm0395-215; Parham P, 1999, IMMUNOL REV, V167, P5, DOI 10.1111/j.1600-065X.1999.tb01378.x; PARRA G, IN PRESS GENOME RES; Payne AH, 1997, STEROIDS, V62, P169, DOI 10.1016/S0039-128X(96)00177-8; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Perry J, 1999, CURR BIOL, V9, P987, DOI 10.1016/S0960-9822(99)80430-8; PETERS J, 1982, BIOCHEM GENET, V20, P585, DOI 10.1007/BF00484706; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; PURMANN L, 1992, GENOMICS, V12, P80, DOI 10.1016/0888-7543(92)90410-T; QUENTIN Y, 1994, NUCLEIC ACIDS RES, V22, P2222, DOI 10.1093/nar/22.12.2222; Rajkovic A, 2002, GENOMICS, V79, P711, DOI 10.1006/geno.2002.6759; Ranz JM, 2001, GENOME RES, V11, P230, DOI 10.1101/gr.162901; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Robinson M, 1997, MOL BIOL EVOL, V14, P823, DOI 10.1093/oxfordjournals.molbev.a025823; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; ROSINSKICHUPIN I, 1990, J BIOL CHEM, V265, P10709; ROSKIN KM, 2002, UCSCCRL0230 SCH ENG; Rossant J, 2001, TRENDS MOL MED, V7, P502, DOI 10.1016/S1471-4914(01)02164-5; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Rouquier S, 1998, NAT GENET, V18, P243, DOI 10.1038/ng0398-243; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SABEUR G, 1993, J MOL EVOL, V37, P93, DOI 10.1007/BF02407344; Saccone S, 2001, CHROMOSOME RES, V9, P533, DOI 10.1023/A:1012443217627; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALINAS J, 1986, EUR J BIOCHEM, V160, P469, DOI 10.1111/j.1432-1033.1986.tb10063.x; Santibanez-Koref MF, 2001, MOL BIOL EVOL, V18, P2119, DOI 10.1093/oxfordjournals.molbev.a003753; SCHWARTZ S, IN PRESS GENOME RES; Serdobova IM, 1998, J MOL EVOL, V46, P202, DOI 10.1007/PL00006295; Sharp PM, 1997, NATURE, V385, P111, DOI 10.1038/385111a0; Shiraishi T, 2001, P NATL ACAD SCI USA, V98, P5722, DOI 10.1073/pnas.091095898; Silver Lee M., 1995; SIMON AM, 1995, J MOL ENDOCRINOL, V15, P305, DOI 10.1677/jme.0.0150305; Simpson AECM, 1997, GEN PHARMACOL-VASC S, V28, P351, DOI 10.1016/S0306-3623(96)00246-7; SINGER AG, 1986, J BIOL CHEM, V261, P3323; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Smith NGC, 2002, GENOME RES, V12, P1350, DOI 10.1101/gr.220502; *SNP CONS, 2000, NATURE, V407, P513; Sokal R. H., 1995, BIOMETRY PRINCIPLES; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; Storz G, 2002, SCIENCE, V296, P1260, DOI 10.1126/science.1072249; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Sturtevant AH, 1936, GENETICS, V21, P554; SUEOKA N, 1962, P NATL ACAD SCI USA, V48, P582, DOI 10.1073/pnas.48.4.582; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; SUNDSETH SS, 1992, J BIOL CHEM, V267, P3915; Sutton KA, 1997, GENOMICS, V45, P447, DOI 10.1006/geno.1997.4946; Sutton KA, 1997, J MOL EVOL, V45, P579, DOI 10.1007/PL00006262; Suwanichkul A, 2000, ENDOCRINOLOGY, V141, P833, DOI 10.1210/en.141.2.833; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Takasaki N, 2000, DEV BIOL, V223, P181, DOI 10.1006/dbio.2000.9741; Talley HM, 2001, EVOLUTION, V55, P631, DOI 10.1554/0014-3820(2001)055[0631:FPFMSI]2.0.CO;2; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tegoni M, 2000, BBA-PROTEIN STRUCT M, V1482, P229, DOI 10.1016/S0167-4838(00)00167-9; THIERY JP, 1976, J MOL BIOL, V108, P219, DOI 10.1016/S0022-2836(76)80104-0; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Toyoda A, 2002, GENOME RES, V12, P1323, DOI 10.1101/gr.153702; TRAUT W, 1984, CYTOGENET CELL GENET, V38, P290, DOI 10.1159/000132077; TSUI FWL, 1993, GENOMICS, V15, P507, DOI 10.1006/geno.1993.1101; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; Van Etten WJ, 1999, NAT GENET, V22, P384, DOI 10.1038/11962; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wasserman WW, 1998, J MOL BIOL, V278, P167, DOI 10.1006/jmbi.1998.1700; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; WEBER JL, 1989, AM J HUM GENET, V44, P388; Weichenhan D, 2001, MAMM GENOME, V12, P590, DOI 10.1007/s00335-001-3015-9; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Wiehe T, 2001, GENOME RES, V11, P1574, DOI 10.1101/gr.177401; WILKINSON MF, 1990, DEV BIOL, V141, P451, DOI 10.1016/0012-1606(90)90400-D; Williams EJB, 2000, NATURE, V407, P900, DOI 10.1038/35038066; Wilson MD, 2001, NUCLEIC ACIDS RES, V29, P1352, DOI 10.1093/nar/29.6.1352; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; WOLFE KH, 1991, J THEOR BIOL, V149, P441, DOI 10.1016/S0022-5193(05)80092-X; WONG AKC, 1988, NUCLEIC ACIDS RES, V16, P11645, DOI 10.1093/nar/16.24.11645; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Yang CQ, 2000, TEXT CHEM COLOR AM D, V32, P43; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Yeager M, 1999, IMMUNOL REV, V167, P45, DOI 10.1111/j.1600-065X.1999.tb01381.x; Yoshida M, 2001, BIOCHEM BIOPH RES CO, V281, P94, DOI 10.1006/bbrc.2001.4311; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; ZERIAL M, 1986, EUR J BIOCHEM, V160, P479, DOI 10.1111/j.1432-1033.1986.tb10064.x; Zhang JZ, 2000, P NATL ACAD SCI USA, V97, P4701, DOI 10.1073/pnas.080071397; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao SY, 2001, GENOME RES, V11, P1736, DOI 10.1101/gr.179201; Zoubak S, 1996, GENE, V174, P95, DOI 10.1016/0378-1119(96)00393-9	329	4999	5208	8	437	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					520	562		10.1038/nature01262	http://dx.doi.org/10.1038/nature01262			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466850	Bronze			2022-12-28	WOS:000179611600053
J	Libby, P				Libby, P			Inflammation in atherosclerosis	NATURE			English	Review							COLONY-STIMULATING FACTOR; ACUTE CORONARY SYNDROMES; RECEPTOR-DEFICIENT MICE; LEUKOCYTE ADHESION MOLECULE; TISSUE FACTOR EXPRESSION; FATTY STREAK FORMATION; NF-KAPPA-B; HUMAN ATHEROMA; MATRIX METALLOPROTEINASES; REDUCES ATHEROSCLEROSIS	Abundant data link hypercholesterolaemia to atherogenesis. However, only recently have we appreciated that inflammatory mechanisms couple dyslipidaemia to atheroma formation. Leukocyte recruitment and expression of pro-inflammatory cytokines characterize early atherogenesis, and malfunction of inflammatory mediators mutes atheroma formation in mice. Moreover, inflammatory pathways promote thrombosis, a late and dreaded complication of atherosclerosis responsible for myocardial infarctions and most strokes. The new appreciation of the role of inflammation in atherosclerosis provides a mechanistic framework for understanding the clinical benefits of lipid-lowering therapies. Identifying the triggers for inflammation and unravelling the details of inflammatory pathways may eventually furnish new therapeutic targets.	Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Libby, P (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.		Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X	NHLBI NIH HHS [R01 HL034636] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aikawa M, 2001, CIRCULATION, V103, P276; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; BRUSCHKE AVG, 1989, AM HEART J, V117, P296, DOI 10.1016/0002-8703(89)90772-2; CLINTON SK, 1992, AM J PATHOL, V140, P301; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; de Boer OJ, 1999, CARDIOVASC RES, V41, P443, DOI 10.1016/S0008-6363(98)00255-7; DE CR, 1995, J CLIN INVEST, V96, P60; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Haley KJ, 2000, CIRCULATION, V102, P2185; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Johnson RC, 1997, J CLIN INVEST, V99, P1037, DOI 10.1172/JCI119231; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Lee RT, 1997, ARTERIOSCL THROM VAS, V17, P1859, DOI 10.1161/01.ATV.17.10.1859; LI H, 1993, ARTERIOSCLER THROMB, V13, P197, DOI 10.1161/01.ATV.13.2.197; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Marx N, 2001, CIRCULATION, V103, P213; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Navab M, 1998, CURR OPIN LIPIDOL, V9, P449, DOI 10.1097/00041433-199810000-00009; Neve BP, 2001, CIRCULATION, V103, P207; POOLE JCF, 1958, J PATHOL BACTERIOL, V75, P245, DOI 10.1002/path.1700750202; Qiao JH, 1997, AM J PATHOL, V150, P1687; Rajavashisth T, 1998, J CLIN INVEST, V101, P2702, DOI 10.1172/JCI119891; Rajavashisth TB, 1999, J BIOL CHEM, V274, P11924, DOI 10.1074/jbc.274.17.11924; Ramos MA, 1998, ARTERIOSCL THROM VAS, V18, P1188, DOI 10.1161/01.ATV.18.7.1188; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; ROSENFELD ME, 1992, AM J PATHOL, V140, P291; ROSS R, 1976, SCIENCE, V193, P1094, DOI 10.1126/science.822515; Saren P, 1996, J IMMUNOL, V157, P4159; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0; Virmani R, 2002, PROG CARDIOVASC DIS, V44, P349, DOI 10.1053/pcad.2002.122475; Yokoya K, 1999, CIRCULATION, V100, P903, DOI 10.1161/01.CIR.100.9.903; Yusuf S, 2000, NEW ENGL J MED, V342, P145	51	6699	7157	30	1122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					868	874		10.1038/nature01323	http://dx.doi.org/10.1038/nature01323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490960				2022-12-28	WOS:000179897300068
J	Schiermeier, Q				Schiermeier, Q			Postdoc positions axed as economic crisis takes its toll	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					452	452						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466805				2022-12-28	WOS:000179611600009
J	Schiermeier, Q				Schiermeier, Q			Funding freeze leaves eastern Germany out in the cold	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					452	452						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466805				2022-12-28	WOS:000179611600008
